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PRESIDENT'S
REPORT
There has long been much controversy as to the relative contributions of nature
versus nurture to our potentialities as human beings. To what extent are our suc-
cesses or failures in dealing with given tasks due to the exact set of genes that
we inherit from our parents as opposed to the nurture provided, say, by our
families, our teachers, and the work ethic into which we are first introduced in
early life? As an adolescent growing up in Chicago, I used to have friendly dis-
agreements with my mother, who came down strongly on the nature side. She
wanted to believe that it was the genes she inherited from her Scottish-born fa-
ther that made possible her later success in rising above the boarding-house at-
mosphere in which she was raised after his premature death.
I knew then enough of the basic facts of genetics to know that human
genetics was still a very soft science. Human geneticists were obviously unable
to make genetic crosses in the way that their peers working with flies or corn so
efficiently did. Although some human attributes such as mental stability seemed
to have real genetic components, many different genes had to be involved since
no obvious Mendelian rules of inheritance could be ascertained by analysis of
extended families in which mental illness appeared. Whether there was any
strong genetic component to intelligence was even more unclear. Since as a boy
I never did super well on the tests said to measure intelligence, I wanted my later
nurture within universities to be the major factor determining my success in later
life.
In the absence of real facts, past strong views about which human traits have
a genetic basis usually reflected culturally derived prejudices. Not surprisingly,
many families with long histories of financial and intellectual triumphs wanted to
owe their successes to their genes. Correspondingly, they ascribed the failure of
other families to prosper to their genetic inadequacies. Francis Galton, the upper-
class Englishman and cousin of Charles Darwin, was a very serious proponent of
this viewpoint. He originated the term eugenics, the supposed science of improv-
ing the qualities of a species or breed by the careful selection of parents. From
his viewpoint, human beings were the products of a long evolutionary selection
for the intelligence and emotional stability needed for the social societies of mod-
ern man. This late nineteenth century way of thinking, frequently referred to as
Social Darwinism, became even more popular with the 1900 rediscovery of
Mendel's laws which gave the world the gene as the fundamental unit of heredity.
Until evolutionists could think in terms of genes, they had no explanation for the
multitude of new biological features that emerged during the evolution of an
original primitive form of life into the extraordinary variety of life forms existing on
the earth today.
Charles Davenport, who directed the Biological Laboratory (now Cold Spring
Harbor Laboratory) from soon after its inception until his retirement in 1934 at the
age of 68, became a strong proponent of Social Darwinism and used his position
as director to enthusiastically promote eugenics. Using money he obtained from
Mrs. E.H. Harriman, he founded in 1910 a satellite endowed operation, the
Eugenics Record Office, which had its own buildings on land above the
Laboratory on Stewart Lane. Its attempts to show genetic origins for widespread
human traits initially met with wide approval among the then small band of Amer-
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ican geneticists. But it soon became clear that the eugenicists' main experimen-
tal approach, the identification of multi-generational human families in which
specific traits passed from one generation to another, was inadequate to prove
genetic causations for most human conditions. Davenport correctly hypothesized
that Huntington's disease was caused by a dominant gene that gave each mem-
ber of the subsequent generation a 50% risk, but he went far beyond his data, for
example, in his wartime postulating of the existence of a dominant thalassophilia
gene that predisposed its bearers to lives as naval officers. Equally suspect, and
of much more consequence in its social implication, was his belief that those
families marked by alcoholism, criminality, and poverty were likely to be geneti-
cally destined to produce more children with these same afflictions. Already by
1930, the hope that eugenics could be a science as opposed to a social philoso-
phy had largely vanished in the United States, particularly since the great Stock
Market Crash and subsequent Great Depression had made Wall Street, not bad
genes, the more compelling villain behind our nation's social problems.
Tragically, the situation in Germany proved to be just the opposite, with the
eugenics movement gaining ever greater prominence when the Nazis assumed
power in 1933. Most leading German geneticists continued to view eugenics in a
positive way and welcomed the rise to power of Adolph Hitler, whose radical
ideas had been reinforced by his reading in 1923 of The Principles of Human
Heredity and Rare Hygiene by the then well-respected German geneticists
Bauer, Fisher, and Lenz. Although Lenz initially deplored the anti-Semitism of the
Nazis, he saw the central question before society to be the quality of our genetic
endowment, which was to him one hundred times more important than disputes
over the relative merit of capitalism and socialism. Key to much Nazi thinking was
superiority of the Aryan race, thereby giving to
such people the right to dominate the world. Anthropology quickly became a
major Nazi science, with its role being to identify inferior non-Germans such as
the Gypsies, Slays, and, in particular, the "anti-Christ" Jews, whom they saw as
the principal enemy of German culture. To make their supposed German superi-
ority even more perfect, the Nazis turned also to their psychiatric community for
assistance with sterilization policies aimed at preventing the Aryan inhabitants of
their mental institutions from having further children.
Within 6 months of the Nazi takeover, the law for the prevention of progeny
with hereditary defects was put into force, allowing the compulsory sterilization of
individuals with congenital mental defects, schizophrenia, manic depression
psychoses, hereditary epilepsy, and severe alcoholism. By 1937, sterilization was
extended to all German "colored" children. Only two more years passed before
the decision was made at the start of World War II to replace such sterilization ef-
forts with a psychiatrist-assisted euthanasia program that dispatched more than
70,000 mental patients to the gas chambers. After the so-designated intractable
mental patients had been killed, their gas chambers then became the fate for ap-
proximately 30,000 Gypsies, as well as for the much larger, Jewish population of
several million.
Not surprisingly, when the war ended and the true extent of the Nazi
genocide horrors was revealed, the term eugenics fell into deep disrepute. Past
preoccupations with supposedly genetically based racial differences were re-
placed by social policies aimed at more equalizing the potential for economic
and social advancement of the world's different populations by educational, nutri-
tional, and medical policies.
Human genetics as a science, not as a social movement, of course continued
to exist after World War II, but it lagged behind other aspects of genetics due to
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the obvious inability to do human genetic crosses. Except for recessive diseases
due to mutations on the X chromosome (e.g., Duchenne muscular dystrophy), the
chromosomal location of virtually all genetic diseases remained unknown until the
middle 1980s, when the extraordinary powers of recombinant DNA technology
became directed toward human genetics. Here, the key insight was the realiza-
tion in the late 1970s by David Botstein and Walter Bodmer independently that
naturally occurring DNA polymorphic markers could be followed through ex-
tended multigenerational families to see which markers segregate together, thus
revealing their location on the same human chromosome. Genetic analysis could
thus be done without new genetic crosses by collecting blood samples from mul-
tigenerational families and using the DNA isolated from such cells to follow the
segregational patterns of large numbers of different cloned polymorphic markers.
Using this trick, teams led by Helen Donis-Keller outside Boston and Ray
White in Salt Lake City assembled the first human genetic maps; both teams
used DNA obtained from the Center for Human Polymorphisms (CEPH) estab-
lished in Paris by Jean Dausset. With such maps in hand, a number of important
genetic diseases could quickly be assigned to specific chromosomal locations.
Huntington's disease was located on chromosome 4 and cystic fibrosis was as-
signed to chromosome 7. The way then became open for the actual cloning (iso-
lation) of the disease genes themselves, with the cystic fibrosis gene being
cloned in 1989. The cloning of the Huntington's disease gene was more difficult,
and was not achieved until early in 1993.
As soon as a gene becomes cloned, the amino acid sequence of its protein
product also becomes known, information that often provides important clues to
its function and that frequently eventually leads to more effective treatment of the
respective disease. In the late 1980s, we nonetheless worried that the very large
size of the human genome (3 x 109 base pairs distributed over the 24 different
human DNA molecules [chromosomes]) meant even then that the future mapping
and actual cloning of most human genetic disease genes would move very slow-
ly; that is, unless an essentially worldwide, international project on the human
genome was initiated, with the eventual aim of sequencing the entire human
genome. Initially, there was fear that such a Human Genome Project would be
prohibitively expensive, but these fears were unfounded, and by 1990 the United
States component Human Genome Project officially started with the goal of iden-
tifying through DNA sequencing all the anticipated 100,000 human genes by
2005 at a total cost of three billion dollars.
By now we have good reason to believe that the Human Genome Project will
achieve its intellectual objective within the desired time frame and so start provid-
ing the genetic information that will totally revolutionize our capacity for studying
biology and medicine. The human genome is our ultimate blueprint, providing the
instructions for the normal development and functioning of the human body. That
we are human beings and not chimpanzees, for example, is not due in any sense
to our nurturing but to our nature, that is, our genes. Yet in both species, sets of
some 100,000 genes carry out roughly the same biochemical tasks. But the five
million years of evolution that have separated us from the chimps have led to sig-
nificant divergencies as to the exact times at which some genes function and the
rates at which they produce their respective protein products. Successive, still to
be worked out, changes in certain key genes, for example, have led to the reten-
tion of many juvenile chimp features into adult human life. The shape of our adult
brain is that of the baby chimp brain, and our general lack of body hair resem-
bles the situation in baby apes.
As the Human Genome Project thus moves toward completion and the func-
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tions of more and more of our human genes are revealed, we will increasingly
have the power to understand the essential genetic features that make us human.
Moreover, we will be able to understand at the molecular level the ever-
increasing number of human diseases such as diabetes, cancer, and
Alzheimer's which arise in part because of imperfections in our genetic instruc-
tions.
At the same time, the new human genetics at last gives us the power to begin
to assess the relative importance of nature (genes) versus nurture (both social
and physical) in controlling human behavior. For example, to what extent do
genes cause individuals to become alcoholic as opposed to either poverty or the
lack of light during the long nights of winter? Are the schizophrenic inhabitants of
mental hospitals more the victims of genes inherited from their parents or have
they become psychotic in reaction to the brutality and unloving nurture of all too
much of modern society? Equally at question is to what extent is the capacity to
perform well on the so-called intelligence tests determined by genes as opposed
to the nurture of the home and schooling environment of the respective students.
How we answer these questions has immediate impact on how we as human
societies respond to the personal tragedies of alcoholism, mental illness, and the
inability to learn. These issues have always generated more controversy than
questions of how to deal with diseases that appear indifferent to the boundaries
of class and economic well being.
Recently, for example, much controversy erupted about the use of govern-
ment monies to fund a conference in Maryland concerned with the possible ge-
netic factors in violent behavior. Those who opposed the meeting argued that its
real purpose was to reinforce the harmful idea that genes might be the primary
factor leading to criminal behavior as opposed to inequalities in the distribution of
wealth and that any such meetings would lead to more discrimination against
members of low economic classes. That the meeting had been structured to con-
tain participants who would strongly argue against genetic determination for most
criminal behavior unfortunately did not prevent the director of the National In-
stitutes of Health from effectively blocking it by stopping governmental funding.
In canceling the conference, however, the impression was given that political
correctness, not scientific judgment, was behind the decision, leading many to
give much more credence to genetic causality of criminal behavior than the facts
themselves warrant.
In an attempt to negate this unfortunate impression, our Laboratory was soon
after urged, in particular by sympathizers to the economically disadvantaged, to
hold a more general meeting on the Genetics of Human Behavior. Thus, after
much planning by both sides of the apparent nature and nurture chasm, we held
this meeting in early March of this year (1995) using funds given to us by the Wil-
liam Stamps Farish Fund. Initially, we expected much vigorous debate between
the human behavioral geneticists and their nurture-oriented critics, but virtually all
the real arguments were among the behavioral geneticists themselves. Effectively
unassailable were the conclusions coming from observations on identical versus
fraternal twins that genes play a significant role in predisposing individuals to
most behavioral traits, including alcoholism, manic depressive diseases, and
schizophrenia, as well as seriously influencing an individual's performance on in-
telligence tests. At the same time, strong influences of nurture were seen in every
behavioral trait studied. Thus, for example, performance on I.Q. tests is in-
fluenced by the quality of schools we attend and by the home environment in
which we are raised. That the scientific facts now seem so firm in most nature
versus nurture arguments does not mean, however, that they will soon be
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generally accepted by the worlds of the disadvantaged and those who want to
protect them. Those individuals who push environmental causations exclusively
for human behavior still can see only harm coming from the increasing role
genetics might play in understanding the origins of human inequality.
I suspect, however, that if we avoid using science to find the molecular evi-
dence underlying our abilities to learn and think rationally, we effectively will be
condemning those who cannot easily learn or behave to remain forever dis-
advantaged within modern society. If we could use genetic analysis to help work
out the biochemical pathways underlying memory and clear thinking, for exam-
ple, we might be able to find pharmaceutical compounds to improve these most
needed human attributes. Thus, those who want to protect the mentally ill or the
slow learner may not get what they strive for if they portray them exclusively as
victims of their environment. We might like to think otherwise, but only by reduc-
ing the differences in abilities among human beings will we ever have a society in
which we can effectively view all individuals as truly equal. Obviously, we shall
never be truly able to reach this ideal, for it would be naive to believe that we
shall find the pharmaceutical means to fight effectively against all those genes
that do not function as we would like. On the other hand, if we were to totally un-
ravel how failures in gene functioning lead, for example, to manic depressive dis-
ease, it would be most surprising if we cannot use this knowledge positively to
help control this pernicious human affliction.
The high ground for us as scientists is to use all the means at our disposal to
understand the human body and the human nature that comes out of it in order to
ultimately find the patterns for those who need and want assistance in improving
life's lot wherever possible.
June 13, 1995 James D. Watson
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DIRECTOR'S
REPORT
In the annual reports written after the first year of tenure of all the previous Direc-
tors of Cold Spring Harbor Laboratory and its two parent organizations, particu-
larly the Biological Laboratory that existed here from 1890 to 1963, the central
concern and topic of discussion was the precarious financial status of the
Laboratory. Although I do not wish to appear overconfident in the current climate
of tremendous national debt and cuts in science budgets, I am happy that I was
appointed Director when finances were more secure than in previous eras.
Through the efforts of John Cairns, who nurtured the newly reorganized Cold
Spring Harbor Laboratory through its first precarious years in the 1960s, and par-
ticularly through the extraordinary efforts of Jim Watson during the last 25 years
in redirecting the science, securing an endowment, and expanding the facilities,
the status of the Laboratory's finances and infrastructure now parallels its out-
standing history. We must owe a great debt of gratitude to Jim Watson for the
marvelous renaissance the Laboratory has gone through during his years as
Director, and we must be equally pleased that he continues his love affair with
Cold Spring Harbor as the Laboratory's first President. As President, Jim con-
tinues to make his mark in the scientific arena by working for the continued suc-
cess of the many facets of Cold Spring Harbor Laboratory and for the scientific
enterprise in general. It is certainly my privilege and pleasure to work with him.
have asked me why I have taken on what appears to be a huge admin-
istrative task while still trying to run a laboratory to study the replication of DNA. I
believe that this field of research is in the middle of its own renaissance and there
is much to do that should be exciting and worthwhile. Moreover, as an active
scientist, I can remain close to new developments that are constantly being pre-
sented. Thus, my science will remain a high priority. At the same time, however,
having the opportunity to contribute to the Laboratory as Director is an equally
exciting challenge and a privilege. There are many reasons one takes on what
appears from the outside to be a considerable task, but the tremendous support
from many people makes the challenge a pleasure.
The laboratory has long enjoyed vigorous and generous support from the lo-
cal community. This support has in many instances throughout our history
ensured the very existence and survival of the institution. It is quite common for
members of the local community to take a keen interest in our scientific achieve-
ments; to get to know the students, postdoctoral fellows, and the staff; and to fa-
vor us with encouragement. Unfailing support also comes from the Laboratory
Board of Trustees, perhaps one of the most "hands on" Boards of any like institu-
tion. They enthusiastically work to ensure future success at the Laboratory, and
their marvelous efforts have certainly given me the confidence to pursue what
others may deem to be risky science. This confidence also comes from seeing
Jim Watson in action, since he has initiated new areas of research at Cold Spring
Harbor against the advice of more conservative scientists. This is what Cold
Spring Harbor Laboratory should be about. I also am fortunate to receive help
from the newly appointed Assistant Director, Winship Herr, and from a lean ad-
ministration under Morgan Browne that thankfully minimizes bureaucracy and is
remarkably efficient. With all this support, it will be much easier to think about
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those critical issues that will be important for our continued strength.
Like so many scientists, I first came to Cold Spring Harbor while a graduate
student to present my thesis research at a meeting. The meeting was the 1978
Symposium on DNA replication and recombination, and there I had the op-
portunity to absorb an entire week of outstanding science, meet the leading
scientists in the field, and see firsthand the impact Cold Spring Harbor meetings
have on science throughout the world. It was a memorable experience and it
made me realize the importance of a strong meetings program.
Science at Cold Spring Harbor began following the establishment of a re-
search station that hosted scientists who then had the luxury of a summer without
distraction. These researchers came to this lovely setting to pursue research and
interact with others of their ilk. This naturally led to the summer courses and later
to the scientific meetings which today are one of the most important and unique
features of the Laboratory. Both the larger scientific meetings on the main
Laboratory campus and the smaller meetings at the beautiful "biological think
tank" at Banbury on the other side of the harbor serve the scientific community as
a whole and keep us in touch with the latest developments. This aspect of our en-
terprise is certainly key to our future as a leading research institution, for it is the
meetings program that allows us to see firsthand the best young people and pro-
vides the scientists here enormous exposure to the scientific community as a
whole. Similarly, our laboratory courses, now expanded successfully beyond the
summer months, are key to our future success as an educational institution. Not
only do the courses serve the needs of the scientific community as a whole, but
they also broaden our intellectual makeup in a unique way. So often good
science, both here and elsewhere, has emanated from discussions among
participants at our meetings and courses. Important for the continued success of
our academic program is the ability to provide sufficient temporary "on -site" hous-
ing for our visitors so that they can optimally benefit from the Cold Spring Harbor
meeting experience. We have certainly progressed from the days of tents on
Blackford lawn, a feature of the meetings not so long ago.
Equally important for our educational program is the DNA Learning Center in
the village of Cold Spring Harbor. This advanced teaching laboratory aims to
educate the next generation in matters relating to DNA and modern biology. As
the use of DNA and genetics has an increasing impact in society, the general
public has to be more aware of the huge advantages, and the potential pitfalls, of
the technology. This can only come from education at an early age, and therefore
the programs at the DNA Learning Center must continue to grow to meet these
challenges. A steady source of funding for these programs is essential, but un-
fortunately, such funding is perhaps harder to obtain than research support.
Nine months after attending the 1978 Symposium, I returned to the
Laboratory as a Postdoctoral Fellow to experience another aspect of Cold Spring
Harbor. I initially intended to stay for just two years, the duration of my Damon
Runyon-Walter Winchell Fellowship, but this is such a marvelous place to do
science that I simply could not say no when the opportunity arose to join the staff
and stay a little longer. The laboratory then was a powerhouse for innovative re-
search, and I learned a style of science that has served me well over the years.
It is remarkable that throughout the laboratory's entire history, the quality of
science accomplished here has been outstanding, and this was particularly so
over the last quarter of a century. It is striking that much of this success has
come from scientists who were (or are) in the formative stages of their careers.
Such young scientists come here and enjoy the luxury of focusing on research
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without the burden of distractions so often found at other institutions. Cold Spring
Harbor Laboratory should be a place where first-rate science is the priority and
where the individual feels emboldened to achieve the best. This is an atmo-
sphere that we must strive to maintain by continuing to offer young scientists the
necessary encouragement, resources, and help needed for excellence. Of
course a large part of this is to secure sufficient funds so that newly appointed in-
vestigators can jump head first into their research projects while they attempt to
attract grant support that will sustain them in the long run. In today's climate of in-
tense competition for ever-diminishing federal research funds, it is becoming
more difficult to sustain our successful and established investigators, let alone to
support new endeavors. But it is these new endeavors and the young investi-
gators that will keep the institution vibrant. Thus, to remain at the forefront of re-
search, we must maintain a healthy balance of outstanding, established investi-
gators and newer bright young people, both of whom continue to break new
ground.
This principle should also apply to the entire scientific community as we de-
cide where to allocate funds for peer-reviewed research. The peer-review system
that has served this country so well in the past is in danger of hindering scientific
progress if review panels fund only the obvious and incremental science and shy
away from the bold new approaches that may have a lower probability of suc-
cess. It is often difficult to convince colleagues on review panels to take a chance
on an untested idea or new approach when only one quarter to one tenth of the
research grant applications to the National Institutes of Health receive funding.
Moreover, it is all too easy to criticize innovative ideas compared to the ordinary
and obvious. Although the task of deciding where to allocate limited funds is in-
creasingly difficult, peer reviewers should recognize that new ideas and research
directions must be given a chance if our science is to remain vigorous. Senior in-
vestigators who have benefited from such support in the past should work to
keep these valuable goals alive.
As I look to the future of research at Cold Spring Harbor and to science in
general, I am sure that we will not be immune to the financial pressures that have
so concerned previous Directors. But at the same time, we can be proud of our
past and look to an exciting future with the hope that great science will be self-
sustaining.
May 15, 1995 Bruce Stillman
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HIGHLIGHTS OF THE YEAR
Research Highlights
Our research programs in cancer biology, plant genetics, neurobiology, com-
putational biology, and structural biology all saw significant progress this year. In
cancer research, some of the most exciting work came from David Beach's
laboratory. In 1993, David's group discovered the first members of a new family
of cancer-related genes. Called cyclin-dependent kinase inhibitors, the proteins
made by these genes inhibit a major class of proteins, the cyclin-dependent
kinases, which are the key regulators of the cell division cycle. The first two of
these proteins called p16INK and p21 were the founders of two different families
of growth regulators that have grown during the last year. The p16INK gene is
altered in a wide variety of human tumors, suggesting that it acts as a tumor sup-
pressor, and a new member of this family has been demonstrated to be induced
by an extracellular growth inhibitor called tumor growth factor 0. In other work,
the Beach laboratory has linked signal transduction through the RAS pathway to
control of the cell cycle by cyclin-dependent kinases, via a known regulatory
protein called cdc25. In collaboration with the Beach laboratory, Bruce Stillman's
group has shown that the p21 cell proliferation inhibitor has a dual role in cell
cycle regulation. The p21 protein inhibits DNA replication via its interaction with
proliferating cell nuclear antigen (PCNA), an essential protein required for DNA
replication and DNA repair, but interestingly, it still allows DNA repair. The gene
encoding the p21 protein is activated by the well-known tumor suppressor
protein p53. Damage to a cell's DNA, by radiation or other mutagen, will induce
p53, which in turn induces p21 and begins a molecular cascade that inhibits
progression through the cell cycle. This allows the cell to respond to genetic
damage by pausing its progression through the cell cycle while it repairs its
DNA, thus helping to prevent the propagation of potentially dangerous mutations.
The ras gene was among the first human oncogenes to be discovered, back
in 1981 by Mike Wigler's group, and last year Mike reported that the RAS protein
signals to another oncogene product, the RAF protein kinase, thereby controlling
cell growth and proliferation. This year, Wigler's group obtained evidence that
RAS and RAF are near the beginning of a signal transduction cascade of protein
kinases that passes extracellular signals to the nucleus. Staff Investigator Linda
Van Aelst and Wig ler also isolated several additional RAS-binding proteins.
Among these was AF6, a protein that has been implicated in acute lymphoblastic
leukemias. In collaboration with Senior Staff Investigator Nikolai Lisitsyn, Mike
Wig ler has been developing a powerful technique called representational dif-
ference analysis (RDA). This technique, which allows researchers to identify sub-
tle differences between two DNA sequences, can detect both additions to a
chromosome, such as the insertion of viral DNA, and deletions caused by muta-
tion. Recently, the technique was used by researchers at Columbia University
who found that Kaposi's sarcoma, a common complication of AIDS, may be
caused by a virus that is related to the herpes simplex viruses.
In other work, Nouria Hernandez has dissected a complex of transcription
factors that regulates transcription of small nuclear RNAs (snRNAs), short RNA
molecules that do not code for proteins. Surprisingly, one of the components of
the transcription factor for snRNAs turned out to be the same as a major mes-
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senger RNA transcription factor, the TATA-box-binding protein (TBP). TBP has
now been shown to have an essential role in the transcription of all genes in the
nucleus of cells. Transcription is activated by other gene-specific DNA-binding
proteins, and in the last year, Winship Herr's group collaborated with scientists
at MIT to elucidate the crystal structure of the POU domain, an unusual bipartite
DNA-binding domain common to a number of transcriptional regulatory proteins.
A major breakthrough in studies on the replication of DNA came from Carol
Greider and her group's work on telomerase, a ribonucleoprotein that adds
telomeric DNA sequences onto the ends of chromosomes. Telomerase has been
attracting a great deal of interest because of its potential target for anti-cancer
therapy. Most normal human cells have little or no telomerase because they do
not need to extend the length of their chromosomes' ends, but in many kinds of
cancer cells, telomerase is activated. Several years ago, Carol and her col-
leagues suggested that telomerase may be required for the growth of immortal
cancer cells. This year, Carol's group, in collaboration with scientists at Geron
Corp. in Palo Alto, California, succeeded in cloning the RNA component of the
human telomerase. Using this information, they also cloned the mouse
telomerase RNA and found that it is regulated during mouse development. The
cloned RNAs will enable her group to pursue experiments to determine the role
of telomerase in normal and cancerous cell growth. Finally, Kathy Collins and
Greider, in collaboration with Senior Staff Investigator Ryuji Kobayashi, suc-
ceeded this year in cloning genes encoding two protein components of
telomerase. These proteins do not have striking similarity to other polymerases,
except for a distant relatedness to RNA-dependent RNA polymerases, indicating
that telomerase represents an entirely new class of polymerase enzyme.
Since 1990, the Plant Group has been developing potentially powerful genet-
ic methods for the detection and mapping of new plant genes. Called the gene
trap/enhancer trap system, the technique was first developed in bacteria and has
been used with impressive results in Drosophila. The group has succeeded in
adapting this approach to the small mustard-family plant Arabidopsis. Their ap-
proach employs the Ac/Ds transposable elements discovered at Cold Spring
Harbor more than 50 years ago by Barbara McClintock. These transposable ele-
ments come in two versions that have been transferred into the Arabidopsis
genome. In one plant, the Ds transposable element has a genetic marker associ-
ated with it and is stable in the absence of an enzyme called transposase. In the
other plant, the modified Ac element encodes the enzyme transposase. When
these two plants are crossed, the transposase in the hybrid plants of the first
generation cause the Ds transposon to "jump" around the genome, randomly in-
serting into the plant's genes. Self-fertilization produces a new generation of
thousands of plants that all differ by the insertion of a single Ds element. If the Ds
element is inserted into a gene, the genetic marker it carries is often expressed,
telling where in the plant the gene is functional. Phenotypic alterations in the plant
give clues to the function of the disrupted gene. This work is a collaboration
among Venkatesan Sundaresan, Rob Martienssen, Hong Ma, and our new Cold
Spring Harbor Fellow, Ueli Grossniklaus, who comes to us following graduate
studies in Walter Gehring's laboratory in Switzerland. This exciting work promises
to yield much new information about plant development.
Our neurobiology program has had success in teasing out the genetic basis
of learning and memory. For many years, a central question in learning and
memory research has been to define a difference between long-term and short-
term memory. Is long-term memory simply short-term memory that lasts a long
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time or is it a physiologically distinct process? An important breakthrough came
when Senior Staff Investigator Tim Tully and his group were able to establish
long-term memory in Drosophila and show that formation of memory can be
divided into genetically separable components. These different forms of memory,
called short-term, anesthesia-resistant, and long-term, combine to produce
specific memory patterns in the brain of flies. A collaborative effort among Tim
Tully, Jerry Yin, and Alcino Silva has shown that a DNA sequence-specific tran-
scription factor in the nucleus of cells, the CREB protein, has a key role in long-
term memory in both fruit flies and mice. The complementary approaches of
"knockout" mice and transgenic mutant flies with inducible genes have yielded in-
sight into what appears to be a highly conserved mechanism for producing last-
ing memories. In subsequent research, Yin and Tully have demonstrated that it is
possible to enhance long-term memory formation in transgenic flies by inducing
the expression of an activating form of CREB. Flies normally require ten (spaced)
training sessions to form a permanent long-term memory. Remarkably, trans-
genic flies carrying the CREB activator do it after only one training session, which
is functionally equivalent to a "photographic" memory.
In structural biology, Xiaodong Cheng, who has collaborated with Rich
Roberts to produce a high-resolution crystal structure of the DNA methyl trans-
ferase Hha-1, has produced a structure for the important cellular enzyme casein
kinase 1. Our computational biology group, headed by Senior Scientist Tom
Marr, has been undertaking one of the most difficult tasks of molecular
biology-identifying the genetic components of complex, multigene diseases.
This effort is centered on the Laboratory's effort within the Dana Consortium for
Manic Depressive Illness (MDI), a cooperative alliance with research groups at
both the Johns Hopkins University and Stanford University Schools of Medicine.
Tom's group has been working with Staff Investigator Harriet Feilotter to identify
the genes involved in MDI by screening families with a history of MDI, document-
ing their genotypes, and analyzing the pedigrees statistically. An ultimate goal is
to use powerful modern genetic analyses to identify the genes involved and
eventually bring some relief to this all too common disease.
Finally, the Laboratory has expanded its cancer research effort into an area
known as programmed cell death, or apoptosis. Two new scientists, Michael
Hengartner and Yuri Lazebnik, have moved into the first-floor labs of Demerec
Laboratory to pursue investigations of genetically programmed cell death, which
is an essential feature of normal development but is often abnormal in human
cancer. They were joined early in 1995 by Scott Lowe, our new Cold Spring Har-
bor Fellow, who as a graduate student at MIT studies apoptosis in cancer pro-
gression and remission.
Symposium LIX: Molecular Genetics of Cancer
More than 450 scientists gathered this year at the annual Symposium to share
their insights and data on the genetic origins of cancer and how it can best be
controlled. Research has progressed rapidly, and it is now possible with some
cancers to define the genetic changes that occur as the disease progresses from
a barely detectable growth to a vigorous metastatic tumor. This was emphasized
by Harold Varmus, Director of the National Institutes of Health, in this year's an-
nual Dorcas Cummings Lecture entitled, Why Is It Important to Understand the
Genetic Basis of Cancer? Varmus, along with Michael Bishop, was awarded the
1989 Nobel prize in Physiology or Medicine for his role in demonstrating that cel- Harold Varmus
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lular genes can cause cancer. His lecture drove the point home: Cancer is funda-
mentally a genetic disease. "This does not mean that all cancers are inherited,"
he pointed out, "rather it means cancer results from defects, inherited or ac-
quired, in genes." Other discussions covered basic research into how cancer
cells develop, function, and proliferate. Former Cold Spring Harbor scientist Ed
Harlow delivered a thoughtful summary that harbored cautious optimism that un-
derstanding the genes and their products will lead to new therapies.
An Exciting Roster of Meetings at the Banbury Center
Of all the meeting places where molecular biologists congregate, none enjoys a
greater reputation than the Laboratory's Banbury Center. We strive to select
topics that have reached that stage of development when critical review is
necessary to prepare for further advances. There were some outstanding exam-
ples of such meetings this year. "Secretory Pathways: The Molecular Basis for
Their Specificity" was a remarkable synthesis of studies across organisms and
cell systems, focusing on the newly emerging molecular understanding of the
transport of proteins. It was especially fitting that Nobel laureate George Palade,
one of the founders of the field, attended the meeting and made the closing
remarks. Another meeting that achieved the same degree of synthesis was that
on 'Telomeres." These structures found at the ends of chromosomes and
telomerase, the enzyme complex that keeps them the correct length, are fas-
cinating in their own right, but it now seems that they have a role in aging and
cancer. Banbury Center is also noted as a neutral ground for meetings in which
matters of science policy loom as large as matters of science. A meeting in the
spring of 1994 on "The Genome of Arabidopsis" was devoted to research on the
genome of this small plant whose enthusiasts see as the laboratory mouse of the
plant world. The meeting reviewed progress in mapping and sequencing the
Arabidopsis genome and, through the participation of representatives of the Na-
tional Science Foundation and the United States Department of Agriculture, was
able to make significant progress in setting new research priorities.
Sabin Meeting
In October, the Laboratory hosted the 1994 Albert B. Sabin Vaccine Foundation
Colloquium. The Sabin Foundation, named for the inventor of the oral polio vac-
cine, promotes the control and eradication of infectious diseases by sponsoring
research and scientific meetings and by increasing public awareness of the need
for vaccination. Participants at the Colloquium represented all disciplines of vac-
cine development, manufacture, and distribution. Among them were scientists,
pharmaceutical and biotech representatives, congressional staffers, and
physicians. The goal of the Colloquium was to improve the development and dis-
tribution of vaccines to American children. A highlight of the Colloquium was the
presentation in Bush Auditorium of the 1994 Albert B. Sabin Gold Medal Award,
to D.A. Henderson, Deputy Assistant Secretary for Health at the Health and Hu-
man Services Agency in Washington. Henderson then gave a moving lecture on
arguably the world's most successful public health effort-the eradication of
smallpox. The Sabin Foundation also sponsored this year's October meeting on
"Molecular Approaches to the Control of Infectious Diseases.'
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E.O. Wilson and J.D. Watson
J.P. Morgan Executive Meeting
The Laboratory has a long and fruitful relationship with the J.P. Morgan Bank,
stretching back to J.P. Morgan himself who, in 1924, was a founding patron of
the Long Island Biological Association, continuing with the enormous contribu-
tions of our long-time Trustee and Morgan CEO, Walter Page, through to the
present day with Sandy Warner, the current CEO of J.P. Morgan, also one of our
Trustees. So it was with great pleasure, and not a little trepidation, that we
learned that J.P. Morgan Bank was going to take over sponsorship of our annual
Executives' Conference. The trepidation came from fear that we would not be
able to reproduce the quality of the remarkable series of meetings of the past
eight years. Our fears proved groundless, for the meeting's topic-The Biology of
Human Behavior-could hardly have been better timed with the extraordinary
current interest in human behavior and genetics. The speakers were outstanding,
and it was particularly pleasing that E.O. Wilson, the celebrated Harvard
zoologist, gave the keynote talk. Dean Hamer later discussed his controversial
findings on a genetic basis for male homosexuality. Helen Fisher, author of Ana-
tomy of Love, also gave a stimulating discussion of the evolution of human behav-
ior and later followed with a public lecture with the provocative title of "The Evolu-
tion of Marriage" to members of the Cold Spring Harbor Laboratory Association.
A Vital Board of Trustees
At our annual Board meeting in November, we bid farewell to two Trustees, who
have been members of our Board since 1988-Laurie J. Landeau, distinguished
veterinarian and Assistant Director of the Program in Aquatic Veterinary Medicine
at Woods Hole, Massachusetts, and W. Maxwell Cowan, Vice President and
Chief Scientific Officer of the Howard Hughes Medical Institute. Mr. Cowan has
been a major force in the development of the Laboratory's Neuroscience Pro-
gram since the early 1970s. Happily, they are replaced by new members also of
high caliber-Bruce Stillman and Henry Wendt. Bruce joins the Board as he
steps into the role of Laboratory Director. Henry Wendt has just stepped down as
Laurie J. Landeau
M. Maxwell Cowan
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J.D. Watson, Henry Wendt, and David Luke III at the Wendt Cabin Dedication
chairman of SmithKline Beecham. By becoming a Trustee, he strengthens his al-
ready solid relationship with the Laboratory, which involved a major role in the
Laboratory's Infrastructure Program. We also welcome to the Board our neighbor
John P. Cleary, Esq., who is a distinguished local attorney associated with the
firm Farrell, Fritz, Caemmerer, Cleary, Barnosky & Armentano. Mr. Cleary is a
long-time member and is now Chairman of the CSHL Association.
Wendt Cabin Dedicated
On November 4, we dedicated the last of our current cabins for visiting scientists
to new trustee Henry Wendt, who now divides his time between Philadelphia and
his Northern California winery, Quivira Vineyards. In 1986, as the Chairman of the
Board of SmithKline, Inc., Mr. Wendt participated in our first "hands-on" Banbury
Conference designed to expose leading executives in the pharmaceutical and
biotechnology industries to the latest ideas, results, and techniques of molecular
biology. The cabin dedication was in recognition of Mr. Wendt's establishment of
the Wendt Fellows program, which provides postdoctoral fellowships in neuro-
science. The first two Wendt Fellows are Jim DeZazzo, in Tim Tully's group, and
Zhong Wang, who works with Alcino Silva. Following the dedication, Tim Tully
and Alcino Silva gave a special lecture on their exciting recent findings on the
genetics of learning and memory in fruit flies and mice.
Robertson Research Fund
The Robertson Research Fund is an essential financial resource that gives the
Laboratory a measure of independence essential to a small private research in-
stitution. It allows us to support scientists who are early in their careers or who
are beginning untried research projects for which it is difficult to obtain federal
grants-the kind of cutting-edge research that is a bit risky but has a high payoff.
The Fund was established in 1973 by the generosity of Lloyd Harbor neighbor
Charles Robertson and his family. After Charles Robertson died in 1981, his son
Bill Robertson and daughter Anne Meier continued the family tradition of associa-
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tion with the Laboratory. Through conservative management, the original endow-
ment of $8 million has grown to nearly $48 million. This year, the Fund distributed
$1.6 million in research support to Cold Spring Harbor scientists. The Robertson
Research Fund supported 12 staff scientists this year, as well as our Cold Spring
Harbor Laboratory Fellow, Ueli Grossniklaus. In addition, the Fund supported
postdoctoral fellows, graduate students, and scientific communications via the
meetings and courses programs. The Robertson family, through the Banbury
Foundation, supports the Marie Robertson Memorial Fund for neuroscience re-
search at Cold Spring Harbor, long a special interest of Charles Robertson. This
year, Marie Robertson funds supported an April meeting on the Genetics of
Learning and Memory at the Banbury Center as well as memory and learning re-
search in Beckman Laboratory by Alcino Silva and Tim Tully.
Major Gifts
We gratefully acknowledge the support we received last year from individuals,
foundations, and corporations. The Cancer Research Fund was brought to near
completion, thanks to gifts of $300,000 from the Ira De Camp Foundation; $75,000
from the William and Maude Pritchard Charitable Trust; $25,000 each from the
Louis Berkowitz Family Foundation, the David Koch Foundation, and the Edward
S. Moore Foundation; $10,000 each from Arrow Electronic, Inc., and the Daphne
Seyboldt Culpepper Foundation; and $5,000 from the Dextra Baldwin McGonagle
Foundation, and a bequest of $5,000 from H. Turner Slocum. Dr. David Pall
donated $21,750, and the Marks Family Foundation made a gift of $10,000 in
honor of Dr. Pall's 80th birthday. These contributions came to us as unrestricted
funds, which allows the Laboratory to apply the funds where they are most
needed. A grant of $45,000 made to the Carnegie Library by the Gladys Brooks
Foundation will help address the cramped situation in our library by providing
funds for microfilm.
Fellowships were funded in 1994 by the Goldring Family Foundation
($30,000) and the Seligson Foundation ($75,000). The Robert Leet and Clara
Guthrie Patterson Trust awarded $50,000 to support of the research of CSHL
scientist Hollis Cline. The Laboratory found a new and wonderful friend in 1-in-9:
The Long Island Breast Cancer Action Coalition. 1-in-9 donated $20,000 to sup-
port cancer research in the lab of Michael Wig ler and pledged their ongoing sup-
port.
In June, we launched a new planned giving program, the "Next 100 Years.'
Planned giving utilizes creative financial planning, enabling donors to see real
lifetime benefits as a result of their charitable donations. The program is
designed to help build our endowment, a step that is vital to the maintenance of
the Laboratory. We currently have 30 donors in the planned giving program, with
gifts in the neighborhood of $6.5 million.
In addition to their generous personal support of the capital projects of the
DNA Learning Center, our long-time friends Henry and Mary Jeanne Harris have
gifted $20,000 through the Edwin S. Webster Foundation for unrestricted support
of Learning Center programs.
DNA Learning Center
In July, the DNALC received a five-year grant of $400,000 from the Howard
Hughes Medical Institute's Pre-college Science Education Initiative for Biomedi-
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cal Research Institutions. The DNALC grant was the second largest of the 42
awards given. The Hughes program will support ongoing work with local school
districts to vertically integrate genetics instruction at the elementary, middle, and
high school levels. Significant resources will also be used to provide intensive en-
richment for minority students at several New York City schools and to link these
resource-poor schools to North Shore schools that have well-developed genetics
education programs. The grant provides large-scale support for the Learning
Center's BioMedia Computer Laboratory to model uses of high-level computing
in biology education, including the Student Allele Database, which allows stu-
dents to submit electronically their own DNA fingerprints and compare them with
those of other students from around the world. This grant, plus annual support
from the Corporate Advisory Board, allowed the Learning Center to recruit com-
putational scientist Robert Muratore. Robert has training in engineering and
biophysics, with work experience in the aerospace industry, medical research,
and academia. Robert is responsible for operating the BioMedia Laboratory and
administering the Learning Center's local area network of 25 UNIX, Macintosh,
and Pentium computers. He is also developing an Internet node, through which
students and teachers will access the Student Allele Database. His thesis work
on three-dimensional imaging of brain activity will be important in an upcoming
project to develop a computer-generated tour of a human cell to play in the Multi-
torium theater.
Scientific Awards
Several of our scientists were honored with prestigious awards this year. On No-
vember 11, David Beach was elected a Fellow in the American Academy of Mi-
crobiology, the highest honor awarded in this national organization. Earlier in the
year, Nouria Hernandez was appointed Associate Investigator by the Howard
Hughes Medical Institute. At year-end, James Watson was honored by the
Charles A. Dana Foundation with a Distinguished Achievement Award in Health.
The award was in recognition of Watson's work with the Human Genome Project
and his participation in the founding of the Dana Alliance for Brain Initiatives.
CSHL Press
In 1994, CSHL Press published 12 new books and 3 new videotapes, launched a
new journal, doubled the frequency of both existing journals, and prepared a new
publication, The Lab Manual Source Book. Among the notable new books was
the second edition of Manipulating The Mouse Embryo by Brigid Hogan, Rosa
Beddington, Frank Costantini, and Elizabeth Lacy. The first edition published in
1986 illustrated the techniques needed for the new molecular approaches to the
study of development. The new and entirely revised edition brings those tech-
niques completely up to date and has already joined those perennial best-sellers
Molecular Cloning and Antibodies as the most sought-after lab manuals from
Cold Spring Harbor.
The popularity of these manuals prompted the development of a com-
plementary publication-an annually updated source book for the users of the
techniques the manuals describe. The Lab Manual Source Book organizes and
indexes the materials needed for work with genes, cells, and proteins and con-
nects users with commercial suppliers of these materials. The 1995 edition has
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data on 15,000 products and 1400 companies and will be distributed free to
manual purchasers early in 1995.
The development of publications with a popular, educational purpose con-
tinued with the release of a videotape and teachers guide, Stories from the
Scientists, and a beautifully illustrated book/audiotape package, The Double
Talking Helix Blues. The scientific "talking blues," sung by twins Ira and Joel
Herskowitz, was featured on both network and cable television programs. Joel is
a physician and Ira is a noted molecular biologist whose association with the
Laboratory goes back to the late 1960s.
In journals, both Genes & Development and PCR Methods and Applications
made strong progress editorially and in subscription levels. Both fared well in the
annual release of citation analysis data, a measure of the extent to which papers
published in journals are subsequently referenced in the scientific literature, and
confirmed their respective importance in the areas of science they serve. We in-
creased publication of G&D to twice monthly and of PCR to bi-monthly. In both
cases, the transition was managed smoothly and has resulted in more rapid pub-
lication for the papers submitted. In June, we launched a new journal entitled
Learning & Memory. Its appearance as a forum for the new molecular and cel-
lular analysis of higher brain functions is an indicator of the optimism within this
young, growing, and immensely exciting field. The journal has started well, and
its distinguished editors are dedicated to publishing only papers of a high stan-
dard. Making this publication a financial as well as an editorial success will be a
challenge in this underfunded field, but everyone concerned is agreed that the
task is important and also optimistic that the goals will be reached as the ex-
traordinary science in this area continues to advance.
A Strong Year for the CSHL Association
Since the Long Island Biological Association was formed in 1924 to assume con-
trol of the Biological Laboratory at Cold Spring Harbor from the Brooklyn Institute
of Arts and Sciences, loyal supporters from the local community have been an
important source of strength. The Cold Spring Harbor Laboratory Association,
descendant of LIBA, continues to support science with its Annual Fund, which
provides unrestricted money for research. This year, the Association raised near-
ly $600,000 to support Cold Spring Harbor science. Special mention should be
made of a $100,000 gift from Edna Davenport, widow of John Davenport, our first
"angel" in the late 1960s. Mrs. Davenport continues to be an angel to the
Laboratory. Under the able direction of Association President Mary Lindsay,
membership in the Association reached 741. Mary's strong leadership of the As-
sociation this last year has been a boon. Although we are sad to report that she
has stepped down from the presidency, we are pleased that she retains a vital
presence as Vice Chairman of the Laboratory's Board of Trustees. Long-time
Laboratory friend and supporter John Cleary is now the new president of the As-
sociation. We look forward to a productive term under John's able hand.
CSHL Cruises onto the World Wide Web
This year, the Laboratory merged onto the Infobahn. A joint effort among the
Press, Meetings, and Public Affairs Departments and with programming by Corp
Reed from Tom Marr's group has resulted in CLIO-CSHL Information Online.
CLIO is a server on the World Wide Web, the multimedia branch of the Internet.
Mary Lindsay
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Via CLIO, anyone with Internet access can obtain information about CSHL Press
books, upcoming meetings, or general information about the Laboratory. Users
can even order books or register for meetings right from their desktop. Having a
"Web server" provides us with an opportunity to increase our on-line offerings and
continue to serve the academic community. The URL, or Internet address, for
CLIO is http://www.cshl.org/.
A Broad Spectrum of Fund-raising Events
In our perpetual search for novel ways to combine the arts or recreation with
fund-raising for science, we hosted a variety of events this year. On May 1,
piano virtuoso Peter Orth returned to the Laboratory for a fund-raising concert.
Mr. Orth's concert raised $7400 for the Undergraduate Research Program. On
June 7, we held the first CSHL Golf Tournament at the nearby Piping Rock
Club. This event attracted 125 participants who helped to raise more than
$48,000 for science education at the DNA Learning Center. Special thanks are
due to the tournament's organizers, led by Rick Clark (who replaced Douglas Fox
this year as chairman of the Corporate Advisory Board): Morgan Browne,
Douglas Fox, Arthur Herman, Michael Vittorio, and William Keen. We also thank
the Badge Agency and ITT Hartford for co-sponsoring a $30,000 hole-in-one op-
portunity on the 17th hole. In July, the CSHL Association put on "Hot Jazz at Cold
Spring Harbor," a dinner and concert featuring the Big Band sounds of Jerry
Jerome and his All-Stars. This concert netted over $7500 to support Laboratory
scientists.
Undergraduate Research Program
Each summer the Laboratory welcomes a new group of promising college stu-
dents to take part in the Laboratory's Undergraduate Research Program. In 1994,
21 students were selected from a field of 180 applicants to spend 10 weeks living
and working here at the Laboratory. The program not only taught the students
about molecular biology, but also acquainted them with scientific life and modern
research tools and methods. As ever, the 1994 participants worked on a wide
range of projects, including crystallization of biologically important proteins, the
biochemistry of nerve cells, biochemical pathways involved in cancer, and plant
genetics. This year, the URP projects represented a particularly good cross-
section of the science at the Laboratory, with nearly every major research group
represented. Funding for the Undergraduate Research Program came from Bio-
Rad Laboratories, Burroughs-Wellcome Fund, C. Bliss Memorial Fund, The Gar-
field Internship, Hanson Industries, Libby Internship, National Science Founda-
tion, Phillips Petroleum Foundation, Inc., Powers Foundation, William
Shakespeare Internship, and Frederica von Stade Internship.
Partners for the Future
Autumn of 1994 ushered in a new group of Partners for the Future-five high
school seniors who worked 10 or more hours per week in our labs after school
from October through March. This was the fifth such group to have the op-
portunity to work in high-level molecular biology labs of noted scientists and to be
paid a stipend for doing so. The students, their respective high schools, and their
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Front row. Maureen Berejka, J.D. Watson, Herb Parsons
Middle row: Susan Schultz, Judy Cuddihy, Carlos Mendez
Back row: Jim Hope, Mike Ockler, Bruce Stillman, John Meyer
mentors were as follows: Michael Burstein (Syosset High School) carried out can-
cer research in the Lab of Dr. Michael Wig ler; Jay Bikoff (Huntington High
School) studied plant genetics with Dr. Venkatesan Sundaresan; Vinay Gupta
(Half Hollow Hills High School) studied neuroscience with Dr. Jerry Yin; Sharon
Hoffmann (Oyster Bay High School) worked with Dr. James DeZazzo on
Drosophila learning and memory; and Brian Fox (Cold Spring Harbor High
School) worked with Dr. Michael Regulski and also studied learning and memory
in Drosophila.
Long-term Service
Three of our employees celebrated 20-year anniversaries with us in 1994. An-
nette Kirk, Print Buyer and Production Manager; Michael Mathews, Senior Staff
Scientist; and Lane Smith, Lead Plumber, were each congratulated on two
decades of service. Celebrating their 15-year anniversaries this year were
Maureen Berejka, Administrative Assistant to the President; Judith Cuddihy,
Editor of PCR Methods and Applications; James Hope, Director of Food Service;
Carlos Mendez, Cash Management Bookkeeper; John Meyer, Painter; Michael
Ockler, Art/Photo Supervisor; James Herb Parsons, Audiovisual Manager; James
Sabin, Materials Supervisor; Susan Schultz, Grants Manager; and Bruce Stillman,
Director.
Changes in Scientific Staff
Cold Spring Harbor is traditionally a place with a high turnover of scientists. Most
of our scientists are young and spend several highly productive years here be-
fore moving on to tenured positions at universities. Adding to this situation is the
change in scientific funding, which in recent years has made jobs in industry in-
creasingly appealing. This year, an unprecedented number of staff scientists
took positions in industry. Michael Gilman, Senior Staff Scientist and a member of
the Lab since 1986, accepted a position as Vice President and Science Director
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of Ariad Pharmaceuticals in Cambridge, Massachusetts. Robert Franza, who had
been with us since 1982, moved to Delmar, California, to start a new company.
Dan Marshak moved to Baltimore to become Senior Vice President of Research
and Development for Osiris Therapeutics, Inc. Several members of our structural
biology group moved on as well. Senior Staff Investigator James Pflugrath, with
us since 1986, has taken a position with Molecular Structure Corp., in The Wood-
lands, Texas. Senior Staff Investigator Jeff Kuret went to Molecular Geriatrics in
Lake Bluff, Illinois, and Senior Staff Investigator and crystallographer John Ander-
son moved on to Jacksonville, Florida. We also said goodbye to the excellent
crystallographer and CSHL Fellow David Barford, who is now a University Lec-
turer at Oxford University in the U.K. David has maintained a collaboration with
Senior Staff Scientist Nick Tonks. Senior Staff Investigator Dafna Bar-Sagi has
taken a tenured faculty position at SUNY Stony Brook.
Several visiting scientists have wrapped up their stays here. Saulius
Klimasauskas from Rich Roberts' and Xiaodong Cheng's laboratory has gone to
the Institute of Biotech Fermentas in Lithuania as a Senior Staff Scientist;
Alexandre Melnikov is now a visiting scientist at the University of Georgia; Brian
Cox from Bruce Futcher's lab has returned to the U.K.; and Gavin Screaton, who
spent a sabbatical in Adrian Krainer's lab, returned to Oxford University. John
Scott, a visiting scientist in the Stillman lab, has returned to Hawaii. Tokio Tani,
visiting David Spector's lab, returned to Kyushu University in Japan. Visiting com-
puter scientist Stephen Lincoln spent the year in Tom Marr's group and left for
Molecular Tool, Inc., and Roussoundan Bourtchouladze from Alcino Silva's lab
accepted a staff position at the Psychiatric Institute at Columbia University.
New Staff Members
With the arrival of Michael Hengartner and Yuri Lazebnik in the fall, the
Laboratory begins a new research program in apoptosis. Hengartner comes to
us straight from graduate school at MIT for a Staff Investigator position, and
Lazebnik comes from postdoctoral work at Johns Hopkins as a Senior Staff In-
vestigator. The Laboratory welcomed two new neuroscientists this year: Robert
Malinow and Hollis Cline, a husband-and-wife team who come to us from the Uni-
versity of Iowa in Iowa City to become Senior Staff Investigators. Visiting
scientists coming this year include Young-Seuk Bae from Kyungpook University
in Korea, working with Dan Marshak; Boris Kuzin from the Russian Academy of
Science, working with Grigori Enikolopov; and Ron Pruzan from Geron Corpora-
tion in Menlo Park, California, working in Carol Greider's lab.
Promotions
With the creation of the position of President of the Laboratory for James Watson,
on January 1 Bruce Stillman assumed the directorship, while still running a large,
vigorous research lab-a feat no CSHL director has managed since Milislav
Demerec retired in 1960, when the Laboratory had about one-fifth the staff it does
today. To aid in some of the administrative duties of running a research lab,
Stillman has appointed Senior Staff Scientist Winship Herr as Assistant Director.
Winship received his Ph.D. from Harvard in 1982, after which he worked with
DNA sequencing pioneer Fred Sanger at the MRC in Cambridge. He came to
Cold Spring Harbor as a postdoc in 1983 to work with tumor virologist Joe Sam-
brook. Winship was promoted to the scientific staff in 1984 and became a Senior
Staff Investigator in 1985 and Senior Staff Scientist in 1988.
Senior Staff Investigators Adrian Krainer, Carol Greider, Nick Tonks, and Tom
Marr were promoted to Senior Staff Scientist. Although Cold Spring Harbor does
not have a formal tenured position, Senior Staff Scientists have an appointment
called "rolling five," which is renewed each day for five years. Adrian received his
Ph.D. from Harvard in 1986. He came to Cold Spring Harbor that year as our first
Cold Spring Harbor Laboratory Fellow and worked with Rich Roberts on RNA
splicing. The Cold Spring Harbor Fellows program was modeled after Harvard's
Junior Fellows program, which allows young investigators to pursue independent
research. Adrian was awarded the fellowship in 1987, was promoted to the
scientific staff in 1989, and then to Senior Staff Investigator in 1990. Carol Greider
has followed a similar trajectory. After finishing up her Ph.D. at the University of
California at Berkeley, where under Liz Blackburn she discovered the enzyme
telomerase, Carol came to Cold Spring Harbor as a CSHL Fellow in 1988. She
was appointed to the scientific staff the next year and to Senior Staff Investigator
in 1992. Nick Tonks came to Cold Spring Harbor from the University of Washing-
ton in Seattle as a Senior Staff Investigator in 1990. Carol, Adrian, and Nick have
in common the fact that they are all Pew Scholars. This prestigious program of
support for young lab heads selects candidates from a small, elite group of
nominating institutions. The Laboratory joined the ranks of Pew nominating institu-
tions in 1990, and in the first three years, first Carol, then Adrian, and then Nick
were elected to the Pew Scholars program. Tom Marr received his Ph.D. in 1981
from New Mexico State University. He then went on to research positions at the
University of Arizona, E.G. & G., and Los Alamos National Laboratory, before
coming to Cold Spring Harbor as Senior Staff Investigator in 1989. He is a lead-
ing expert on computational informatics, the science of using computers to un-
cover and analyze information in biological sequences. He has also become an
integral part of the Dana Foundation Consortium on the genetics of manic
depressive disease.
Crystallographer Xiaodong Cheng and protein chemist Ryuji Kobayashi were
promoted to Senior Staff Investigator. Linda Van Aelst from Mike Wigler's lab was
promoted to Staff Investigator. Rui-Ming Xu was promoted to Staff Associate II,
and William Chang from Tom Marr's group was promoted to Staff Associate I.
Postdoctoral Fellows
From Bruce Stillman's lab, Stephen Bell has accepted an Assistant Professorship
at MIT and Thomas Melendy is now an Assistant Professor of Microbiology at
SUNY Buffalo School of Medicine. Jeffrey Kazzaz finished up in David Helfman's
lab and took a position at Winthrop University Hospital Cardiopulmonary Re-
search Institute as a Research Scientist and Assistant Professor, while Mark Pit-
tenger has gone on to work with Dan Marshak as a Senior Research Scientist at
Osiris Therapeutics, Inc., in Baltimore. Timothy Connolly from David Beach's lab
has also gone to Osiris as a Senior Scientist, and Tomohiro Matsumoto, also from
Beach's group, has moved to Albert Einstein College of Medicine as an Assistant
Professor. From Michael Mathews' group, Ben-Hao Dong returned to China as a
postdoc and Claude Labrie has gone on to Lavel University Medical Center in
Quebec. From Dafna Bar-Sagi's lab, Judy Cupp-Burris moved to West Palm
Beach, Florida, and Michael Boyer has taken a position at Children's Hospital in
Pittsburgh, Pennsylvania. Scott Henderson, from David Spector's lab, accepted a
position with Mount Sinai School of Medicine as Director of Microscopy/Research
Tom Marr
Adrian Krainer
Carol Greider
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Assistant Professor. Gokul Das left Winship Herr's lab for a position at the Texas
Medical Center-Baylor College of Medicine, Cancer Therapy Research Center in
San Antonio as an Assistant Professor. Three of Robert Franza's staff departed:
Manfred Neumann and Annette Wilisch went to Tubingen, Germany, and Judith
Scheppler went to SUNY Stony Brook. From Tom Marr's lab, Wentian Li left for
Columbia University Department of Psychiatry. From Mike Wigler's lab, Anthony
Polverino and Stevan Marcus have moved on, Polverino as a visiting scientist to
Amgen, Inc. in Thousand Oaks, California, and Marcus to the University of Texas
M.D. Anderson Cancer Center as an Assistant Professor. Lin Mantell, from Carol
Greider's lab, is now a research associate at Winthrop University Hospital.
Graduate Students
From Bruce Stillman's lab, Karen Fein and York Marahrens went on to postdoc
positions, Karen at Columbia University and York at the Whitehead Institute at
MIT. From Dafna Bar-Sagi's group, Kurt Degenhardt, Tom Joneson, and Shao-
Song Yang have moved with her to Stony Brook; Nicholas Gale went to
Regeneron Pharmaceuticals in Tarrytown, New York; and Linda Graziadei went to
MIT in Cambridge, Massachusetts. From David Helfman's lab, George Mulligan
has gone on to a postdoc position at the MIT Center for Cancer Research, while
Stefan Stamm has gone on to the Max-Planck Institute for Psychiatrie in Munich,
Germany. Raymond O'Keefe, from David Spector's lab, went on to postdoc work
at the Medical Resource Council Laboratory of Molecular Biology in Cambridge,
England. From Robert Malinow's group, Neal Hessler took a postdoc position at
cogene Science in Uniondale, New York, and Diana Pettit has gone to Duke Uni-
versity in North Carolina. Zhong Wang, from Alcino Silva's lab, departed for
Cornell Medical College in New York City as a research assistant and Celeste
Casciato went from the lab of Xiadong Cheng to a position in Philadelphia.
Sridaran Natesan went with Mike Gilman to Ariad Pharmaceuticals in Cambridge,
Massachusetts, and Gary Lee left Gilman's lab to become a Research Assistant
at Tularik, Inc., in San Francisco. Gilles Carmel went from the lab of Jeff Kuret to
Molecular Geriatrics in Lake Bluff, Illinois. Dusan Kostic left Hong Ma's lab to ac-
cept a position with the Roswell Park Cancer Institute/Grace Cancer Drug Center
in Buffalo. Roberto Mariani left Jacek Skowronski's group for a position at the
Aaron Diamond AIDS Research Center. From Bruce Futcher's group, Wolfgang
Seufert went to University of Munich in Germany as a Heisenberg Fellow. William
Thomann has left Winship Herr's group to attend NYU Law School.
Residential Transitions for the President and Director
Late this spring of 1995, both of our families completed moves to our new homes,
Ballybung and Airs lie. The new position of President, with its major fund-raising
activities, necessitated an on-campus President's House, and construction of
Ballybung commenced in June 1992. It is located on virtually the same site where
the Henry de Forest house Nethermuir had stood for almost 100 years before it
mysteriously burned to the ground at the end of World War II. By then, it had
been vacated by the elderly Mrs. de Forest following her husband's death and
the breakup of its adjoining estate lands into two-acre parcels. In its place was
built an unimaginative split-level ranch-style house, inappropriate for its mag-
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nificent site looking down Cold Spring Harbor and across to the Connecticut
shore. No sighs were heard when it disappeared in less than two May days,
since it was soon to be replaced by a much more appropriate dwelling of classi-
cal, somewhat Regency style. Preparing its plans were the talented architects,
William Grover and Mandad Saniee of Centerbrook, the widely respected Essex,
Connecticut, architectural firm. During the past 20 years, Centerbrook has
designed many important buildings for the Laboratory, including the Grace
Auditorium and the Neuroscience Center.
The shape of the land parcel on which Ballybung was to be built dictated its
almost square shape, with its key design feature being a skylight-topped two and
one-half storied central hall which uses mirrors to magnify the light sent below,
particularly into the eight internal windows that open into second-floor rooms and
corridors. This architectural trick was employed near the end of the eighteenth
century by the English architect John Soane, who was celebrated for the plans of
many fine country homes as well as his London town home in Lincoln's Inn Fields
and the monumental Bank of England located in the City.
Its unusual design made the construction not simple, and we were served
well by the builder, William Baldwin, who previously played key roles in our
Blackford Hall and McClintock Laboratory renovation-expansion projects. Equally
important was the supervision by our own talented builder and Director of Build-
ings and Grounds, Jack Richards, who saw that the final costs closely approxi-
mated the budgeted target forecasts. Until its completion, we (Jim and Liz)
remained uncertain as to what we should call it, but finally its name reverted to
our first choice, Ballybung, the Gaelic name for Bungtown. From the start, we
were tempted to give its exterior stucco-like "drivit" finish a strong color, finally
settling on a creamy pumpkin orange hue frequently used in Italy. Helping us
make the decision was our friend the English landscape architect, Elizabeth
Banks, who while touring Lloyd Harbor noted the effective use of this color on a
house on Middle Hollow Road. Later, Liz stood firmly behind the color choice
when most of us were more faint-hearted.
The basement level of Ballybung contains windows with marvelous views of
the Harbor, and adjacent to them there exists living space for visiting scientists.
Currently, it is occupied by two English students, Jonathan Montagu and Greg
Jefferis, who are here for a year doing research in their "gap year" between Eton
College and their later university years in Oxford and Cambridge, respectively.
Also within the basement is a specially designed archival space for the storage
and study of the scientific and personal papers of what we anticipate will be a
long line of accomplished Laboratory presidents.
Airs lie was constructed in 1806 on the grounds of Nethermuir for cavalry of-
ficer and agricultural enthusiast Major William Jones, a member of the dis-
tinguished Long Island Jones family. The house and surrounding land changed
hands several times over the following century-its name was found on a map
dated 1855 detailing the estate of G.L. Willard, Esq. -and by the early 1900s
was a part of the Henry de Forest estate. In 1942, four years after Henry de
Forest's death, his widow donated the de Forest stables, built in 1914, and a par-
cel of land to the Laboratory, and the following year the Laboratory purchased
Airs lie and the surrounding seven acres.
Built in traditional Federal style, with a wide front porch and stately columns,
the two and one-half story house has served as director's residence since that
time. When then-director Milislav Demerec took up residence in Airs lie, the
century-old building underwent little change. Renovations on the house did not
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take place until 1974 after former Laboratory director John Cairns departed for
England. Prior to the Watsons moving into Airs lie, the house was updated
through structural renovations, the upgrading of mechanical services, and recon-
figuration of the interior space to accommodate a young twentieth-century family.
The renovations included the creation of a central staircase in the front of the
house to the third floor. As they extended the twisting stairs upward, the ar-
chitects opened the area in an inverted V-shape, to reveal the upper-most
window of the house, a round, arched window in a sunburst design, created
some 100 years before. Masterminded by architect Charles Moore and associa-
tes, this renovation was the beginning of an ongoing professional relationship be-
tween the Laboratory and Moore and his collaborators in the creative re-use of
old buildings.
Despite 20 years of family living since the 1974 renovation, the stately house
needed little renovation prior to the arrival of the Stillman family earlier this year.
The exterior was repainted, the body of the house in its original cream color, and
the trim changed from a greenish-gray to a rich, dark red. Set in the natural beau-
ty of the harbor region, Airs lie is shaded on the north side by an Amun Cork and
a Kobus Magnolia, rare trees imported from the Orient, and an American Horse
Chestnut, all planted for Miss Julia De Forest circa 1909 by Olmstead Brothers
Landscape Artists (noted for their landscaping of Central Park and other major
sites). Now mature trees, they are all among the largest of their kind on Long Is-
land. Symposium picnics, Easter egg hunts, and other outdoor functions have
been held on Airs lie lawn since its acquisition in 1943, making it an integral part
of our Laboratory home.
Inside Airs lie, Grace has restored a cozy nineteenth century decor. With dark
wood and traditional country furniture, the house is welcoming and warm.
Flooded with sunlight-Airslie has large bay windows at both ends of the house
and large windows all around-the house is spacious and airy. Soft mauves and
greens are comfortable and soothing, making Airs lie a wonderful home in which
to raise a boy and a girl as well as a suitable place for the social affairs that are
so vital to the Lab's function.
As we settle into our new dwellings, our residential relocations complete, we
both look forward to many more productive and satisfying years at Cold Spring
Harbor Laboratory.
July 19, 1995 James D. Watson, President
Bruce Stillman, Director
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ADMINISTRATION
The Laboratory's science program in 1994 was once again at the leading edge of biology with re-
markable new discoveries in all three of our primary fields of research-cancer, neuroscience, and
plants. The latter two areas have been funded in large part by Laboratory resources, and it is par-
ticularly encouraging that these laboratory groups have become so productive. Much concern con-
tinues about the level of federal support for science as the congress in Washington focuses on
deficit reduction. Clearly, there is going to be a serious need for new sources of money if our nation
is to retain the leadership in basic research that has so benefited the well-being of our citizens and
provided important impetus for the national economy. In any event, it will be the quality of science
here at the Laboratory that will determine our ability to compete for available funding, and in this
regard there is reason for confidence at Cold Spring Harbor.
Financial results for the year were good with revenues exceeding $41 million for the first time. A
surplus from operations after provision for depreciation which now amounts to more than $2.6 mil-
lion per year was achieved despite a 5% reduction, about $500,000 per year, in the Laboratory's
recovery of indirect costs on federal grants. This stems from a 1993 agreement with the govern-
ment, which approved our prior overhead procedures and established a new predetermined in-
direct cost rate through 1996. Results for the year were about $400,000 better than budget, once
again reflecting successful competition for Federal and other grants, strong meetings attendance,
better than anticipated interest and royalty receipts, and good control of costs. These results were
also aided by the release of a small portion ($200,000) of the reserves set aside in prior years to
provide for reduced overhead recovery and for start-up costs of the neuroscience program. 1994
was the sixth consecutive year of a balanced budget, and the cash flow from operations during this
period has amounted to more than $14 million, which has been invested in facilities, equipment,
and new programs.
Banbury Center and the DNA Learning Center again had very good years conducting unique
meetings and education programs dealing with a broad range of nationally important matters of
science and ethics. Banbury meetings bring together leading authorities, often from a variety of
disciplines, with the aim of focusing a range of viewpoints to shed new light on subjects of current
importance. The DNA Learning Center has led the way in exciting a new generation of young
people, fifth grade through freshman college, with the power of molecular biology and genetics
and how the new science will change their lives. The Cold Spring Harbor Laboratory Press con-
tinued to publish first-rate science in its remarkably successful new books and journals. Much effort
was directed to exploring the future potential of electronic publishing and, just after year-end, to the
publication of "The Lab Manual Source Book," a new and comprehensive product directory for
scientists in the academic, biotechnology, and pharmaceutical worlds. The Source Book is proving
extremely popular and should make an important contribution to the operations of the Press.
The Meetings Office has made good progress in adding new meetings in the normally less ac-
tive months of fall, winter, and early spring. By making greater use of our now greatly upgraded
facilities, it should be possible to generate additional revenues that can hold down the cost of our
more traditional scientific symposia. Doing so is increasingly important as affordability becomes
paramount for graduate students and even for many scientists with strained research budgets.
David Stewart, in his first full year as Director of Meetings, has done a first-rate job of finding meet-
ings that are appropriate and scientifically interesting while also maintaining the quality and am-
bience of the regular meetings schedule.
At year-end, the Laboratory's Endowment, consisting of the Robertson Funds and the Cold
Spring Harbor Fund, was little changed from the prior year at approximately $91,000,000. In a year
of difficult investment climate in both the equity and fixed-income markets, the Funds benefited im-
portantly from the Laboratory's conservative policy for drawdown of income, which has averaged
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less than 3.5% per year since inception. This has tended to stabilize the Endowment during difficult
times and enabled it to grow over the years at a rate that provides both for inflation and for the sup-
port of new programs. Investments include a balanced mix of domestic and foreign equity, fixed-
income securities, and short-term liquid instruments. Endowment is the primary internal source of
funding for science at the Laboratory and serves as important support for $30,000,000 of outstand-
ing tax-exempt bonds issued in recent years to help fund the construction here of new science and
infrastructure facilities. During 1994, the Cold Spring Harbor Fund benefited again from a generous
gift to the Charles S. Robertson Chair by the Banbury Fund and also from an addition of $500,000
from Laboratory operations.
The Cold Spring Harbor Fund now includes the year-old Science Fund, where are placed all
royalties or equity shares received from a growing number of Laboratory technology transfer agree-
ments. John Maroney, Director of Commercial Relations, manages these agreements and has had
much success in working closely with Laboratory scientists to explore the commercial potential of
their discoveries. The Science Fund was established by the Board of Trustees for the direct and in-
direct support of science here at the Laboratory, with the aim that one day royalties, and perhaps
also the equity shares from our fledgling biotech participations, will make this Fund an important
source of research funding.
Trends that were evident in 1994 serve to emphasize some of the financial challenges we will
need to resolve during the next few years. Federal funding will continue to be extremely competi-
tive and may actually decline on an inflation-adjusted basis. Overhead rates will trend downward.
Last year, federal funding of about $11 million represented two thirds of the direct support for our
science program, whereas nonfederal and Laboratory in-house resources provided the other third
or about $5 million. We must further increase the percentage of nonfederal funds and we must con-
vince the sources of such funds of the importance of carrying a larger share of indirect costs. In
coming years, we should expect that our facilities-related overhead will continue to grow, as the
physical plant is larger and must be properly maintained. There is an increasing need for scientific
equipment, and present instruments will be replaced with more expensive new models. The rising
cost of the data processing infrastructure, housing support for our scientists, and payments to local
school districts and municipalities are additional concerns.
Contributing to the strong financial results of recent years has been the restraint in hiring ex-
ercised by administrative departments despite continued rapid growth of the Laboratory's pro-
grams. The result is a lean organization with individuals who should feel great satisfaction in the
large amount of work they accomplish with limited resources.
As grant competition has intensified, the number of applications to multiple funding sources has
soared. The Grants Department, headed by Susan Schultz, has handled the mushrooming
paperwork with remarkable efficiency. In recent years, there has been a large expansion of time-
consuming new federal audit requirements and reporting regulations. Much effort must also be
devoted to monitoring the very complex individual laboratory budgets and to maintaining a rea-
sonable balance of available resources with what sometimes seem the insatiable needs of world
class science.
Each year, the Buildings & Grounds Department, led so capably by Jack Richards, astonishes
us with their accomplishments. Although a village-wide moratorium stopped all nonresidential con-
struction at the Laboratory for the latter half of the year, many necessary renovations were com-
pleted. In Demerec, three small laboratories for Mike Wig ler were modernized and converted to a
single larger one with adjoining post-doc offices. Barbara McClintock's historic space was modern-
ized for Michael Hengartner who joined us in the fall to study apoptosis (programmed cell death),
one of the newest and most intriguing areas of cancer research. A new tissue-culture facility was
created in Jones by the conversion of an older cold room. The exterior of Olney was completely
refurbished, and at Banbury Center, the basement of Sammis Hall was renovated to resolve the
Lab-wide need for long-term record storage. Also at Banbury, the severely storm-damaged seawall
and jetty were rebuilt with funding provided by the Robertson Maintenance Fund, exhibiting again
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Jack Richards with montage of his
25 years at the Laboratory
the foresight of Charles Robertson in endowing the maintenance of the beautiful estate he donated
to the Laboratory in 1972.
Jack Richards supervised construction of the Laboratory's wonderful new President's House
("Ballybung") where Jim and Liz Watson are now happily in residence. Together with Peter Stahl,
Jack watched over the completion and start-up of our new sewage disposal system that now con-
nects the entire Laboratory campus to the Nassau County sewage lines. Our new system has func-
tioned virtually trouble-free for more than a year and has permanently ended the disposal of treated
effluent into the inner harbor. With Cablevision Systems as prime contractor, the installation of our
new high-speed ATM data transmission network was completed smoothly and on time with only a
minimum disruption of the campus. This installation, consisting of a perimeter bank of 9 un-
derground conduits and 8 manholes connecting 19 major Laboratory buildings with fiber optic
cable will provide state-of-the-art data transmission, telephone, and other utility services well into
the next century. The new network began operation in late fall.
As of April 1, 1995, Jack Richards completed his 25th year as Director of Buildings & Grounds
and has now assumed the new position of Assistant Director for Special Projects. Hopefully, he will
also be able to spend a little more time with his wife Corey and his family at their new house in Flor-
ida. Jack's contributions to the Laboratory have been too numerous to enumerate, and we feel
most fortunate to have his continued availability in years to come. At a dinner on March 30th, held
appropriately at the waterfront clubhouse of the Centerport Yacht Club, Jack's years at the
Laboratory were celebrated by some 65 members of his department, outside contractors, family
members, and friends. Jim Watson ended the memorable evening with the announcement that the
new Buildings & Grounds facility will be named the Richards Building. Art Brings, who has been
our very effective Director of Environmental Health & Safety, has been appointed to head the De-
partment, succeeding Jack Richards.
The newly integrated Public Affairs and Development Department represents the Laboratory to
the local community and outside world via written communications, events, and other activities. It
conducts the multitude of fund-raising efforts that have become so important to the entire range of
Laboratory programs from science to the DNA Learning Center. Its accomplishments would not be
possible without the leadership and management skills of its Director, Susan Cooper, and her dedi-
cated staff.
During 1994, the effort to raise $1 million for scientific equipment for the newly renovated
McClintock Laboratory comfortably exceeded its goal, allowing the focus of equipment funding
to now turn to the major needs of the neuroscience program. Annual Giving, conducted primarily
through the CSHL Association, raised a record of almost $600,000 for science, particularly in
support of our younger staff members. Nearly $100,000 was raised for the DNA Learning Center
through the Corporate Advisory Board, chaired by Rick Clark, from contributions by Long Island
businesses and from the hugely successful first Laboratory golf tournament held in June at
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the Piping Rock Club. There was a summer jazz benefit, a return by Peter Orth for his third piano
concert here, and numerous "friend-raising" events such as lectures on science and health, the lat-
ter co-sponsored by the Huntington Hospital, joint programs with area garden clubs, and tours for
the community and other groups. Perhaps most importantly, a new planned giving program called
the 'Next 100 Years' was launched. Planned giving will be the primary focus of the Laboratory's
goal to at least double the current Endowment by the year 2000. Sadly, year-end marked the
departure of Joan Pesek after 8 years in the Development Department. Joan was the primary sup-
port for the CSHL Association and also made important contributions to the hugely successful Sec-
ond Century capital campaign. Support for the CSHL Association will now be provided by Jean
Schwind formerly in our Grants Office. Deb Rizzieri, Administrative Assistant for 7 years, also
departed at year-end as did Claire Fairman. For the past 6 years, Claire was responsible for many
of the friend-raising events that have so brightened the Laboratory, and she also played a key role
in the capital campaign.
The Library continued to provide a vital resource for the scientific staff and so many others at
the Laboratory who marvel at the quiet efficiency of Margaret Henderson, Head of Library Services,
and her staff. In the face of the increasing costs of journal subscriptions and book purchases, she
continues with limited resources to provide improved services. A particularly gratifying event was
the receipt of a grant of $45,000 from the Gladys Brooks Foundation for the purchase of a micro-
fiche, and we are most grateful for a gift of the 1994 edition of the Encyclopedia Britannica from Dr.
and Mrs. Gervin Marahens.
Greatly important to the functioning of the Laboratory is our Controller, Bill Keen, and his As-
sistant Controller, Barbara Wang, who take responsibility for much of the annual budget prepara-
tion and monitoring. Cheryl Sinclair manages the Human Resources Department with much caring
and efficiency, and we welcomed in the fall Phil Lembo who joined us as Manager of Purchasing.
His predecessor, Sande Chmelev, departed in November, 1994 to join her husband in Moscow.
Roberta Sa lant provides John Maroney and myself with the assistance that is essential to our
functioning and also provides for the needs of our very active Board of Trustees.
With 1995 now well under way, we are pleased with an improvement in relations between the
Laboratory and the Village of Laurel Hollow. We have tried to listen carefully to concerns raised by
local residents and address them fairly. Early in 1994, an agreement was reached with the Cold
Spring Harbor School District regarding financial and other forms of support and interaction. New
landscaping has been installed to screen a number of our buildings, improving the views from
across the harbor and from Route 25A. Motion sensors have been installed to reduce nighttime
lighting in many laboratories that must be visited throughout the night by scientists tending experi-
ments or working late. A series of letters from our Chairman, David L. Luke III, and Vice Chairman,
Mary D. Lindsay, were sent to local residents discussing the issues of concern, and communicat-
ing a sense of the spectacular science under way here at the Laboratory. The draft environmental
impact study requested by the Village regarding the Laboratory's proposed child care center and
other future buildings plans was prepared by our environmental and land use consultants, Buck-
hurst Fish & Jacquemart, Inc., and has been submitted for consideration and comments. We be-
lieve that village residents will find the study to be professional and very thorough. The Village
moratorium on nonresidential construction was enacted in May of 1994 to remain in place pending
revision of the local zoning ordinance. We understand that the Village is now progressing with the
planned revision to the ordinance and we look forward to being included in discussion of the provi-
sions directly affecting our property. Through dialogue, the Laboratory and the Village can go for-
ward together with cooperation and mutual respect.
G. Morgan Browne
June 15, 1995 Administrative Director
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(Top) Kim Arndt; Dafna Bar-Sagi; Tao Zhong. (Center) Rob Martienssen (left) showing ears of corn to Jack Pryor and his stu-
dents after Rob's talk on Maize Genetics. Winship and Isabella Herr at 'Easter Hunt.' (Bottom) John, Ian, and Mary Horton
(left), and Rachael Frenguelli, Robert, Elinor, and Bethan Hulse (right) at "Easter Hunt' at Airs lie.
TUMOR VIRUSES
The Tumor Virus section originated from the idea that DNA tumor viruses are excellent probes to
uncover the mechanisms of cell function and to identify the changes a cell undergoes when it be-
comes transformed. Although much of the research has diversified as new methods to isolate cel-
lular genes and to dissect their structure and function have developed, the guiding principles and
questions remain remarkably similar. For example, Bruce Stillman and Eileen White of the DNA
Synthesis section initiated studies over a decade ago that have led to the realization that the prod-
uct of the adenovirus E1B 19K gene protects virally transformed cells from committing suicide by
programmed cell death or apoptosis. Although we no longer study the function of the E1B 19K
protein, the cellular proteins involved in the mechanics and regulation of apoptosis are now being
studied by Yuri Lazebnik, a new member of this section. The research has also diversified into the
study of non-DNA tumor viruses, such as herpes simplex virus (HSV) and human immunode-
ficiency virus (HIV). Indeed, Jacek Skowronski, a long-standing colleague of ours who this year
joined this section, studies how HIV influences the regulation of cellular functions. As is evident
from the following descriptions, the addition of these two new members and the continuing strength
of the research by long-standing members have produced a vital research program.
DNA SYNTHESIS
B. Stillman C. Prives M. Hidaka A. Verreault J. Mitchell
J. Scott P. Kaufman S. Waga H. Rao
M. Akiyama R. Li M. Weinreich L. Borzillo
S. Bell C. Liang K. Fien V. Filadora
G. Cullmann T. Melendy K. Gavin R. Yates
V. Ellison C. Mirzayan Y. Marahrens C. Dreissens
Research over the last year continued to focus on the
replication of DNA in eukaryotic cells. As in the
past, we have studied in parallel two different experi-
mental systems. The first of these is to understand the
replication of DNA that has been initiated at the
simian virus 40 origin of DNA replication so that we
may gain insight into the mechanism of replication
fork movement and the control of this process. In ad-
dition to these studies, progress on the understanding
of the initiation of chromosomal DNA replication in
eukaryotic cells has been facilitated by the study of
this process in the yeast Saccharomyces cerevisiae.
During the past year, we have observed links be-
tween DNA replication and other events in the cell
division cycle, such as control of cell cycle progres-
sion and DNA repair. Moreover, studies on the initia-
tion of chromosomal DNA replication are beginning
to recognize links between this process and controls
of cell cycle progression. Finally, we have continued
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to study the mechanism of assembly of chromatin
during DNA replication, and work over the past year
has led to considerable advances in our understand-
ing of this replication-coupled process.
SV40 DNA Replication
L. Borzillo, G. Cullman, V. Ellison, K. Fien,
T. Melendy, C. Prives, S. Waga,
R. Yates, B. Stillman
In last year's Annual Report, we described experi-
ments that led to the complete reconstitution with
purified proteins of DNA replication from the simian
virus 40 (SV40) origin. In addition to the virus-
encoded SV40 T antigen, many replication proteins
that have been purified from human cells are required
for this process. These proteins include DNA poly-
merase a and 8 and their accessory proteins, the
proliferating cell nuclear antigen (PCNA), replication
factor C (RFC), and the single-stranded DNA-
binding protein called replication protein A (RPA).
Also required for complete replication are three en-
zymes that cooperate with the DNA polymerases to
synthesize efficiently Okazaki fragments on the lag-
ging strand. These enzymes are maturation factor 1
(MF1, henceforth called FEN1), DNA ligase 1, and
ribonuclease Hl. These studies have led to consider-
able insight into the mechanism of eukaryotic DNA
replication and the realization that the essentials of
this replicative process are conserved from bacteria to
humans. One enigma that remains is the role of DNA
polymerase E in the replication of DNA. Experiments
from other investigators in the yeast S. cerevisiae
have demonstrated a role for this essential DNA
polymerase in S-phase progression in vivo, but the
polymerase appears not to be required for replication
in vitro. It is possible that DNA polymerase 8 can
substitute for polymerase E in the purified system or
that upon fractionation of the crude cell extract, we
have lost proteins that cause polymerase E to be es-
sential.
For many years, we have focused on the role of
PCNA in the replication of SV40 DNA in vitro. In
the last year, David Beach's laboratory discovered
that PCNA was present in a quaternary complex with
cyclin-dependent protein kinases (CDKs) and their
cyclin subunits together with a novel protein called
p21. It is apparent that all cyclin/CDK complexes can
associate with PCNA and p21, although cyclin
E/CDK2 and cyclin A/CDK2 appear to have high af-
finity for the p21/PCNA complex. The Beach
laboratory cloned a cDNA from human cells that en-
codes the p21 protein and found the expressed
recombinant protein to be a potent inhibitor of CDK
activity. Since CDK cyclin complexes are required
for progression through multiple stages of the cell
cycle, expression of the p21 protein in mammalian
cells inhibited cell cycle progression. cDNA encod-
ing p21 was also isolated at about the same time in
other laboratories and the protein has been alterna-
tively called WAF1, SDI1, or CIP1. Transcription of
the gene encoding the p21 protein was found to be in-
duced following DNA damage in a process depen-
dent on the p53 tumor suppressor protein. Moreover,
P21 was found to be present at high levels in senes-
cent and terminally differentiated cells. In collabora-
tion with members of the Beach laboratory, we have
characterized the interaction between this interesting
CDK inhibitor and PCNA.
Addition of increasing amounts of p21 to DNA
replication reactions containing a crude extract from
human cells or purified human proteins demonstrated
that the p21 CDK inhibitor was a potent repressor of
SV40 origin-dependent DNA replication in vitro. The
observation that p21 inhibited SV40 origin-dependent
DNA replication in a highly purified reconstituted
system which did not require CDK cyclin complexes
suggested that p21 was having an effect on DNA
replication independent of its CDK inhibitory func-
tion. Using purified human cell proteins, it was
demonstrated that p21 blocked the ability of PCNA
to stimulate DNA polymerase 8, thereby explaining
the inhibition of SV40 DNA replication. Thus, the
p21 protein appeared to be bifunctional because it
could inhibit CDK activity and also inhibit PCNA's
function in DNA replication. This observation creat-
ed a paradox, however, because PCNA apparently is
required for nucleotide excision repair in cells that
express high levels of p21 protein due to transcrip-
tional induction of the p21 gene by p53.
We therefore investigated in vitro the effect of
p21 on nucleotide excision repair of UV-induced
damage in DNA. Using a partially reconstituted cell-
free system for repair of UV-damaged DNA that had
been described previously by R. Wood and T.
Lindahl at the Imperial Cancer Research Fund in
England, we confirmed that these repair reactions
were dependent on PCNA. Surprisingly, however,
addition of increasing amounts of the p21 CDK in-
hibitor did not affect the repair of DNA damage in
vitro. Yet in the same extract, SV40 T antigen and
oh-dependent DNA replication was completely in-
hibited. Thus, the p21 protein was able to dis-
criminate between PCNA-dependent replication and
repair, allowing DNA repair while inhibiting DNA
replication. Using purified proteins, we demonstrated
that DNA polymerase E, another eukaryotic cell DNA
polymerase implicated in both DNA replication and
DNA repair, appeared to be more refractory than
polymerase 8 to the inhibition of p21.
These results obtained in vitro suggest that- the
p21 CDK inhibitor is a key coordinator of control of
cell cycle progression and DNA replication. If DNA
damage occurred at any stage of the cell cycle, then a
p53-dependent increase in transcription of the gene
encoding p21 could lead to higher levels of the p21
protein, simultaneously blocking cell cycle progres-
sion and elongation of DNA replication, but allowing
DNA repair in these cells. We have recently begun to
test this model by examining the localization of p21
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during the cell cycle in mammalian cells and in the
nucleus following DNA damage.
A key protein that also associates with PCNA is
RFC. RFC is essential for SV40 DNA replication in
vitro and recognizes primer template junctions to
load PCNA onto the DNA. PCNA then functions as a
DNA polymerase accessory protein to stimulate the
processivity of DNA polymerase 8 during SV40
DNA replication. RFC is a complex protein consist-
ing of five polypeptide subunits in both human and
mammalian cells. In past years, we have reported the
purification of RFC from both yeast and human cells.
To examine further the biochemical functions of RFC
and its role in DNA replication, we have cloned each
of the cDNAs encoding the five human subunits into
baculovirus vectors so that the RFC proteins may be
expressed individually or in combination. Prelim-
inary data suggest that we can reconstitute the RFC
complex from these recombinant proteins. In parallel,
each of the genes encoding RFC from the yeast S.
cerevisiae has been cloned and shown to be essential
for cell viability. The genes from yeast and human
cells are highly related to each other, and in both
species, each of the five proteins shares extensive se-
quence similarity. We are currently performing bio-
chemical and genetic experiments to further examine
the function of RFC and its interaction with other
cellular proteins, including PCNA.
DNA Replication-dependent
Chromatin Assembly
V. Filadora, P. Kaufman, A. Verreault, B. Stillman
A number of years ago, we described the establish-
ment of a cell-free system that is capable of assem-
bling chromatin during SV40 DNA replication in
vitro. In this cell-free system, a three-subunit protein
called chromatin assembly factor 1 (CAFI) is re-
quired for the assembly of nucleosomes concomitant
with passage of the replication fork during DNA
replication. cDNAs encoding each of the subunits
from CAFI have been isolated and expressed in in-
sect cells by infection with a recombinant baculovirus
vector. Using these recombinant proteins, we have
further characterized the mechanism of DNA-
replication-dependent chromatin assembly.
Both the CAF1 p150 and p60 proteins are essen-
tial for chromatin assembly. These proteins interact
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with each other and cooperate to assemble nucleo-
somes onto replicating DNA. In addition to CAF1
and the essential DNA replication proteins described
above, other proteins are required for chromatin as-
sembly in vitro. We have previously identified
histones H2A and H2B as essential for nucleosome
assembly, but interestingly, histones H3 and H4
purified from chromatin inhibit the DNA-replication-
dependent chromatin assembly reaction. We there-
fore hypothesized that modified forms of histones H3
and H4 would be required for this reaction, and in the
past year, we have demonstrated that CAF1 binds to
acytelated forms of histone H3 and H4. These acyte-
lated forms of histone H4 correspond to those that are
newly synthesized following translation of the
protein. Newly synthesized histone H4 is modified by
acytelation of specific lysine residues near the amino
terminus of the protein. These studies suggest that
CAF1 may be a molecular link between the synthesis
of newly synthesized histones H3 and H4 and
chromatin assembly at the DNA replication fork. In
addition to proteins associated with these modified
forms of histones H3 and H4, we have identified
other proteins that associate specifically with CAFI
and are currently characterizing them.
Cell Chromosome Replication
M. Akiyama, S. Bet, K. Gavin, M. Hidaka, C. Liang,
Y. Marahrens, C. Mirzayan, J. Mitchell, H. Rao,
J. Scott, M. Weinreich, B. Stillman
Our studies on viral DNA replication have led to an
understanding of the mechanism of replication fork
progression. Because the SV40 T antigen plays mul-
tiple roles in the initiation of DNA replication, an un-
derstanding of SV40 DNA replication has not led to
insight into the mechanism and control of initiation
of cell chromosomal DNA replication. We have
therefore studied in parallel with SV40, DNA replica-
tion in the yeast S. cerevisiae because of the op-
portunity to combine biochemical and genetic ap-
proaches to understanding this complex process. In
previous years, we have reported the identification of
an origin recognition complex (ORC), a six-subunit
protein that binds to origins of DNA replication in the
yeast genome. Previous work has demonstrated that
ORC binds to replicator sequences in an ATP-
dependent manner and requires the degenerate 11-
base -pair consensus sequence found within the A ele-
ment of all autonomously replicating sequences
(ARSs) in the yeast genome.
Work over the last year has demonstrated clearly
that for efficient sequence-specific DNA binding,
ORC also requires the previously identified B1 DNA
element that contributes to replicator function. In the
absence of the B1 element, ORC binds to DNA, but
binding is not sufficiently tight to allow complete
protection from digestion of the DNA with a nonspe-
cific nuclease. In contrast, in the presence of both the
A and the B1 elements, ORC binds tightly to the
DNA and forms a stable complex. Concomitant with
this binding is the induction of several nuclease hy-
persensitive sites in the DNA. Work from John Dif-
fley's laboratory at the Imperial Cancer Research
Fund in the U.K. has demonstrated that these hyper-
sensitive sites vary in intensity throughout the cell
cycle, suggesting that regulation of DNA replication
may be in part due to binding of proteins to ORC on
the DNA only at certain stages within the cell divi-
sion cycle. We conclude from these studies that ORC
binds to a bipartite DNA-binding site within yeast
replicators and that these sequences are conserved
among the various replicators in the yeast genome.
Moreover, ORC binding to these sequences probably
marks the DNA as a target for establishing active
origins of DNA replication.
Through collaborative studies with Jasper Rine's
laboratory at the University of California, Berkeley,
we have identified a number of temperature-sensitive
mutants in the genes encoding ORC2 and ORC5. In
the last year, we have further characterized the
phenotype of these temperature-sensitive mutants
with respect to the role of ORC in DNA replication.
In parallel, Jasper Rine's laboratory has continued to
study the role of the ORC proteins in silencing of
transcription at the silent mating-type loci that control
yeast sexual development. Using two different physi-
cal mapping techniques that determine the location of
origins of DNA replication in the yeast genome, and
in particular, two-dimensional agarose gel elec-
trophoresis techniques originally published by Bonita
Brewer and Walter Fangman at the University of
Washington, Seattle, we have examined the effect of
mutations in the ORC2 and ORC5 genes on initiation
of chromosomal DNA replication. At both the ARS1
and ARS501 loci on chromosomes IV and V, respec-
tively, initiation of DNA replication in wild-type
cells occurs with near 100% efficiency every cell
cycle. In contrast, in both the orc2-1 and orc5-1
mutants, initiation of DNA replication is much less
efficient, even at the permissive temperature for these
temperature-sensitive mutants. Upon a shift to the
nonpermissive temperature, initiation of replication at
these two loci is reduced dramatically and the cells
are no longer able to grow. We interpret these results
as demonstrating that ORC determines the frequency
of initiation of DNA replication in the genome by
binding to specific DNA sequences and thereby
locating an origin of DNA replication at that site. In
the orc mutants where the amount of ORC is greatly
reduced, the frequency of initiation in the genome is
lower than in wild-type cells. Because of the
redundancy of replicator sequences in the genome, at
the permissive temperature, the cells can still grow
and divide. In contrast, at the nonpermissive tempera-
ture where there is even less active ORC protein, the
frequency of initiation in the genome is so low that
cells cannot complete S phase in the time normally
taken to proceed through the cell division cycle. As a
consequence, these cells die.
To identify proteins that may interact with the
ORC proteins, we have initiated a number of genetic
screens to search for interacting proteins. One such
gene identified by high-copy-number suppression of
the orc5-1 mutant was CDC6. Overexpression of the
CDC6 protein in the orc5-1 mutant allowed cells to
grow at 37°C, the nominal nonpermissive tempera-
ture for the temperature-sensitive mutant; however,
these cells grew slower than when they were comple-
mented by the wild-type ORC5 gene. Using two-
dimensional gel electrophoresis, we have demon-
strated that the frequency of initiation at replicators in
the genome is increased by overexpression of CDC6
protein in the orc5-1 cells, thereby enabling the cells
to grow at 37°C. Overexpression of CDC6, however,
does not restore initiation to 100%, and the cells
grow more slowly than wild-type cells. These experi-
ments led us to investigate whether a temperature-
sensitive mutant in the CDC6 gene might also be
defective for initiation of DNA replication; indeed,
two-dimensional gel origin-mapping techniques have
demonstrated that the levels of CDC6 protein also
determine the frequency of initiation of DNA replica-
tion in the genome. A link between CDC6 and the
ORC6 gene has previously been reported by Joachim
Li and Ira Herskovitz because overexpression of
ORC6 in a cdc6 mutant strain causes inviability. Fur-
thermore, in collaboration with Jasper Rine's
laboratory, we have demonstrated that cdc6 is
synthetically lethal with both orc2-1 and orc5-1
mutants.
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These genetic results encouraged us to search for
a physical interaction between the ORC proteins and
CDC6. The CDC6 gene was cloned into a recom-
binant baculovirus vector, and the CDC6 protein was
produced upon infection into sf9 insect cells. When
an extract from these cells was made and mixed with
purified ORC protein, the recombinant CDC6 protein
could be immunoprecipitated with anti-ORC mono-
clonal antibodies. CDC6 was not immunoprecipi-
tated with anti-ORC monoclonal antibodies or when
ORC was omitted from the sf9 cell extract. These
data suggest that ORC and CDC6 physically interact
with each other and cooperate to determine the fre-
quency of initiation of DNA replication in the yeast
genome.
The CDC6 protein is of considerable interest be-
cause it is highly related to a protein from Schizosac-
caromyces pombe called cdc18+. cdc18+ was identi-
fied previously by Tom Kelly, Stephen Martin, and
Paul Nurse at the Imperial Cancer Research Fund in
the U.K. as a protein that is required for entry into S
phase in S. pombe. Interestingly, cdc18+ is also re-
quired for prevention of entry into mitosis until DNA
replication is completed. Other studies have sug-
gested that CDC6 from S. cerevisiae may also be in-
volved in controlling the G2-to-M phase transition.
Thus, our studies link an important cell cycle
regulatory protein to the initiation of DNA replication
by binding to the ORC proteins.
We have also pursued a number of other genetic
studies that point to additional proteins that may in-
teract with ORC and control DNA replication in the
cell cycle. Furthermore, we have cloned cDNAs en-
coding the ORC proteins from a number of other
species, including humans, and this will ultimately
facilitate the identification of origins of DNA replica-
tion in metazoan species.
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MOLECULAR BIOLOGY OF PAPILLOMAVIRUSES
A. Stenlund M. Berg J. Sedman
T. Sedman M. Da Costa
The papillomaviruses infect and transform the basal
epithelium in their hosts, inducing proliferation of the
cells at the site of infection. The resulting tumors are
in most cases benign and will usually regress after
some time, but certain types of human papil-
lomaviruses (HPVs 16, 18, 31, 33, and 39) give rise
to tumors that are prone to progress toward malig-
nancy, especially frequently cervical carcinoma. In
total, HPV DNA can now be found in biopsies from
approximately 80% of all cervical carcinomas.
A key impediment to the study of human papil-
lomaviruses has been the inability to define a simple
in vitro cell culture system for these viruses. This is
largely due to the fact that these papillomaviruses
normally require specialized differentiating cells that
only with great difficulty can be generated in cell cul-
ture. Therefore, a bovine papillomavirus (BPV-1) has
become the prototype virus for the papillomavirus
group largely because a convenient cell culture sys-
tem exists for this virus where viral gene expression,
oncogenic transformation, and viral DNA replication
can be studied.
The DNA replication properties of papilloma-
viruses show some unique and interesting character-
istics. As part of their normal life cycle, these viruses
can exist in a state of latency that is characterized by
maintenance of the viral DNA as a multicopy plas-
mid in the infected cells. The copy number of the
viral DNA appears to be tightly controlled, and the
viral DNA is stably inherited under these conditions.
This system therefore provides a unique opportunity
to study plasmid replication in mammalian cells.
In previous years, we have reported the develop-
ment of a short-term replication assay that has
enabled us to define the viral components required
for viral DNA replication. More recently, we have
directed our attention toward detailed biochemical
analysis of the replication process. We have con-
tinued to refine the expression and purification of the
two viral proteins (El and E2) that are required for
viral DNA replication as well as continued the analy-
sis of the initiation complexes that are formed on the
Ori. We have also adapted and modified a cell-free
replication system that was originally developed in
M. Botchan's laboratory. From these studies, we now
have a detailed picture of the relative roles of the El
and E2 proteins in replication. El has all the charac-
teristics of an initiator protein, including on recogni-
tion, DNA dependent ATPase activity, and DNA
helicase activity. El can also function to unwind a
supercoiled plasmid that contains the Oni sequence.
The E2 polypeptide, whose function has remained
more elusive, appears to serve simply as a specificity
factor for El. Through an interaction with both El
and the ori, E2 provides sequence specificity in the
formation of the initiation complex (Fig. 1). This
year, we have also completed some work (in col-
laboration with T. Melendy in Bruce Stillman's
laboratory) to identify the cellular factors that are re-
quired for viral DNA replication. The results from
this study indicate that a number of the replication
factors that have been identified as being required for
replication of SV40 are also required for BPV
replication; however, one or more additional factors
appear to be required for BPV replication.
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FIGURE 1 Schematic representation of the interactions be-
tween El and E2 proteins and the BPV origin of replication.
The sum of the three interactions, El with DNA, E2 with
DNA, and El with E2, determines the stability of the com-
plex and the replication activity of the ori.
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Formation of Initiation
Complexes
T Sedman, A. Stenlund
The smallest sequence element from BPV that can
direct initiation of replication in vivo (ori) is approxi-
mately 60 nucleotides long. This sequence contains
three different, separable, elements. Two of these ele-
ments have known functions and constitute the bind-
ing sites for the viral El and E2 proteins, respective-
ly. The third element has been termed the A+T-rich
region and its function is unknown. Our earlier genet-
ic experiments have demonstrated that the presence
of these elements is necessary for replication activity.
We have developed a series of assays to study the
binding of El and E2 to the ori sequence to
determine the requirements for binding and for
formation of productive replication complexes. By a
combination of DNase protection, gel retardation,
and interference assays, we have established that El
is capable of binding to the Ori in at least two dif-
ferent forms, either together with E2 to form an
El/E2/ori complex or by itself to form a multimeric
El/ori complex. The ori /El/E2 complex is formed by
cooperative binding of El and E2 to Ori and requires
low concentrations of El. The El/ori complex re-
quires higher concentrations of El and forms on the
same ori sequence, but it does not require E2- or E2-
binding sites for its formation. To determine which of
these complexes are important for replication in vivo,
we have generated a large number of point mutations
in the ori. These mutants have been tested for their
ability to form the two different complexes and for
replication. Mutations in the El-binding site reduce
the ability to form both complexes and reduce
replication.
Mutations in the E2-binding site do not affect the
formation of the El complex, reduce the ability to
form the El/E2/ori complex, and also reduce replica-
tion. The sum of these results indicated that the
ability to form the El/E2/ori complex is important for
replication activity in vivo. The role of the El/ori
complex, however, was unclear, since all the muta-
tions that affected the formation of the El/ori com-
plex also affected the El/E2/ori complex. To circum-
vent this problem, we combined mutations that
reduce the affinity of the El-binding site with muta-
tions that increase the affinity of the E2-binding site.
These mutants, which have a reduced ability to form
the El/ori complex but retain the wild-type ability to
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form the El/E2/ori complex, replicate at wild-type
levels, indicating that the ability to form the El/ori
complex is not limiting for replication.
DNA Replication
In Vitro
J. Sedman, A. Stenlund
As indicated above, we have demonstrated that
replication in vivo requires the formation of an
El/E2/ori complex. The formation of this complex
requires binding sites at the ori for both El and E2
proteins. For replication in vitro under standard con-
ditions, El alone is sufficient to initiate replication in
an ori-specific manner, and addition of E2 has only
minor effects on replication. Furthermore, replication
in vitro does not require an E2-binding site at the ori.
These results present an apparent paradox; in the ab-
sence of E2 and an E2-binding site, the El/E2/ori
complex obviously cannot form. Consequently,
replication can clearly be initiated in vitro without the
formation of the El/E2/ori complex. A possible
resolution to this paradox could be that assembly of a
replication complex is a multistep process where
formation of the El/E2/ori complex is a required ear-
ly intermediate which can be bypassed under the con-
ditions used for in vitro replication. One clear dif-
ference between the in vitro and in vivo conditions is
the presence of vast quantities of competing DNA se-
quences under in vivo conditions. Since El appears
to have a relatively modest sequence specificity, E2
might function to increase the selectivity of binding.
By challenging binding of El with nonspecific com-
petitor DNA, in the absence or presence of E2, we
could demonstrate that the sequence specificity of El
is greatly increased in the presence of E2. On the
basis of these binding studies, we have modified the
conditions used for replication in vitro by generating
conditions where DNA binding of El is limiting for
replication. This modification results in a complete
dependence on E2 protein and the presence of an E2-
binding site for replication, resulting in an in vitro
system that in all important aspects reflects the re-
quirements observed for replication in vivo. These
results also establish that E2 is likely to function as a
specificity factor for El and probably does not take
part directly in the replication process.
Cellular Factors Required
for Replication of
BPV In Vitro
J. Sedman, A. Stenlund [in collaboration with T. Melendy
and B. Stillman, Cold Spring Harbor Laboratory]
The SV40 system has for a number of years served as
the paradigm for DNA replication in mammalian
cells. This system relies on the viral initiator large T
antigen for on recognition, on unwinding, and
helicase activity. With the use of this system, a num-
ber of cellular factors involved in DNA synthesis
have been purified and characterized. A minimal
purified system, which contains all the cellular fac-
tors that are required for SV40 replication, has been
developed by B. Stillman and co-workers. For a num-
ber of homologs of these factors, an involvement in
chromosomal DNA replication has been demonstrat-
ed through genetic experiments in Saccharomyces
cerevisiae.
To determine if BPV utilizes the same set of cel-
lular replication factors that are required for SV40
replication, we have tested the requirement for a
number of these factors in a BPV in vitro replication
system. All the factors required for SV40 replication
also appear to be involved in BPV replication; how-
ever, the purified minimal system that can replicate
SV40 is not capable of replicating BPV, indicating
that one or more additional factors are required for
BPV replication. In addition, the degree of depen-
dence on some of the known factors appears to be
different. For example, substantial amounts of
replication can be achieved in the SV40 system in the
absence of RFC or PCNA: The BPV system is essen-
tially devoid of activity in the absence of these fac-
tors. These results indicate that mechanistic dif-
ferences exist between the replication systems for
SV40 and BPV.
Physical Interactions
between the El and
E2 Proteins
M. Berg, A. Stenlund
In a majority of the eukaryotic replicons that have
been studied so far, it has been observed that a tran-
scriptional component is associated with the origin of
replication. In most of these systems, including
SV40, polyomavirus, and ARS elements from S.
cerevisiae, the required activity can be supplied by
various transcriptional trans-activators with little ap-
parent specificity.
A similar requirement also exists for papil-
lomavirus replicons; however, the requirement is
much more specific and only the virus-encoded tran-
scription factor E2 can serve as an auxiliary factor for
replication. The requirement for E2 in replication of
BPV extends beyond a mere requirement for E2
bound to the ori; a physical interaction with El is
also required. This interaction can be detected as
cooperative binding of the two proteins to the Ori,
when the respective binding sites are located in the
correct position relative to each other. The E2
proteins are well conserved between different papil-
lomaviruses, and they appear to have a conserved
overall structure. For example, the sequence
specificity for DNA binding is identical for E2
proteins from all papillomaviruses tested so far.
When tested for their ability to bind cooperatively
with BPV El, some E2 proteins from other papil-
lomaviruses fail to show detectable interaction with
BPV El.
This observation presented us with an opportunity
to map the regions of E2 that were required for this
interaction by construction of chimeric proteins be-
tween BPV E2, on the one hand, and HPV11 E2, on
the other hand. These chimeras could then be tested
for their ability to interact physically with BPV El in
a biochemical assay and for the ability to support
replication in a functional assay. This approach has a
distinctive advantage over conventional mutagenesis
in that the overall structure of the protein can be
maintained. Following this procedure we have gener-
ated and tested a large number of chimeric E2
proteins. The results from these experiments have
revealed a more complex situation than we had
anticipated. Multiple regions from both the amino-
terminal trans-activation domain of E2 as well as
from the carboxy-terminal "hinge" and DNA-
binding/dimerization domain, cooperate to generate a
strong interaction with El. Two regions of the BPV
E2 protein are specific for interaction with El, the
corresponding domains in HPV E2 do not interact. At
least one other region of BPV E2 located in the
amino-terminal half of the protein and coinciding
with the trans-activation domain interacts with El;
however, this interaction is not specific to BPV E2
but is also shared with HPV E2.
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TRANSCRIPTIONAL REGULATION
W. Herr
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L. Pella
We study the mechanisms of transcriptional regula-
tion in eukaryotes. To probe these mechanisms, we
use both cellular and viral regulatory factors, includ-
ing two cellular POU-domain proteins, Oct-1 and
Oct-2, and a herpes simplex virus (HSV) protein,
VP16. Although the cellular proteins Oct-1 and Oct-2
possess the same intrinsic DNA-binding specificity,
their transcriptional regulatory properties are dif-
ferent. For example, both proteins recognize the oc-
tamer sequence ATGCAAAT found in a variety of
promoters, but the efficiencies with which they ac-
tivate such promoters differ. These differences result
from the activities of promoter-selective transcrip-
tional activation domains that can discriminate
among promoters. The viral protein VP16 is a com-
ponent of the HSV virion that, after infection, associ-
ates with Oct-1 and a second cellular factor called
HCF to form a multiprotein-DNA regulatory com-
plex. By its association with Oct-1, VP16 alters the
transcriptional regulatory properties of Oct-1 in two
ways: It recruits Oct-1 to new DNA sites that are not
recognized effectively by Oct-1 alone, and it pro-
vides a potent transcriptional activation domain to ac-
tivate the HSV immediate-early promoters, a type of
promoter that is normally resistant to activation by
Oct-1.
Our studies continue to focus on four issues:
1. How does a eukaryotic transcription factor recog-
nize a diverse and yet specific set of DNA se-
quences?
2. How is a multiprotein-DNA regulatory complex,
such as the VP16-induced complex, assembled?
3. What are the rules for how transcriptional activa-
tion domains and the basal transcriptional appara-
tus communicate with one another?
4. What are the effects of variation in promoter struc-
ture in naturally occurring human immunodefi-
ciency virus (HIV) promoters isolated from in-
fected individuals? Below are descriptions of ac-
complishments we made during the past year.
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POU Domain Interaction
with DNA and VP16
M. Cleary, C. Huang
DNA binding by the Oct-1 protein is directed by its
POU domain, a bipartite DNA-binding domain made
up of two helix-turn-helix-containing DNA-binding
modules that cooperate in DNA recognition: the
POU-specific (POUs) and POU-homeo (POUH)
domains. Although the highest-affinity Oct-1 DNA-
binding site contains the octamer sequence
ATGCAAAT, Oct-1 displays significant flexibility in
the range of sequences to which it binds. For exam-
ple, Oct-1 recognizes a form of the HSV VP16-
responsive TAATGARAT element, called the
(OCTA-)TAATGARAT site, that lacks octamer site
similarity.
We have been studying mechanisms by which the
Oct-1 POU domain achieves sequence recognition
flexibility by examining the contribution of the POUs
domain to the overall binding ability of the entire
POU domain. Analysis of the effects of amino acid
substitutions in the POUs domain and base substitu-
tions in the Oct-1 binding sites has shown that the
two subdomains of the POU domain can adopt dif-
ferent orientations on different binding sites. We
have shown that on the (OCTA-)TAATGARAT site,
the POUs domain is positioned over the GARAT se-
quence, on the side of the POUH domain opposite
from where it is located on an octamer site.
This flexibility of the Oct-1 POU domain has an
impact on its participation in the VP16-induced com-
plex. Oct-1 POU domain residues that contact DNA
have different effects on VP16-induced complex
formation, depending on whether or not the VP16-
responsive element involved has an overlapping oc-
tamer sequence (called [OCTAlTAATGARAT). On
an (OCTA+)TAATGARAT site, the POUs domain is
probably positioned over the octamer sequence, away
from the GARAT sequence which is necessary for
VP16-induced complex formation. Here, mutations
in the POUs domain that affect DNA binding affect
VP16-induced complex formation in a manner that
parallels their effect on affinity for the site. In con-
trast, on the (OCTA-)TAATGARAT site, where the
POUs domain and VP16 may have superimposed in-
teractions, the effects of these same mutations do not
correlate directly with affinity for the site. Instead,
some mutations have a much greater effect on VP16-
induced complex formation than on DNA binding
alone, suggesting a specific influence of these
residues on VP16-induced complex formation. Thus,
through its ability to bind DNA flexibly, Oct-1 can
differentially influence VPi6- induced complex
formation on different VP16-responsive elements.
To study VP16 in more detail, we are determining
its structure by X-ray crystallography in collaboration
with Dr. Xiaodong Cheng and colleagues at Cold
Spring Harbor Laboratory. Additionally, we continue
to study VP16 structure and function by mutagenesis.
A comparison of VPi6 sequences from four herpes-
viruses has revealed five conserved regions in the
core of VP16 responsible for association with Oct-1
and HCF on DNA. These regions are important for
VP16-induced complex formation, because amino
acid substitutions in any one of these conserved seg-
ments can disrupt formation of the VPi6- induced
complex.
As shown in Figure 1, we are also analyzing the
activity of the HSV VPi6 homolog in bovine herpes-
virus (BHV). The BHV VPi6 protein forms a VP16-
induced complex with human Oct-1 and HCF on a
binding site from the BHV ICP4 promoter but, inter-
estingly, not on an HSV (OCTA+) or (OCTA-)
TAATGARAT site. Furthermore, the HSV VP16
protein does not form a VP16-induced complex on
the BHV site. This result shows that Oct-1 can func-
tion in combination with different transcriptional co-
factors to generate different regulatory specificities.
Structure and Function of HCF:
A Cellular VP16 Cofactor
A. Wilson, R. Freiman, L. Pena [in collaboration with
M.G. Peterson, Tularik, Inc.]
HCF is involved in initiating HSV gene expression
after infection by promoting complex assembly be-
tween VPi6 and Oct-1, but the normal cellular func-
tion of HCF is unknown. Its ubiquitous presence in
proliferating cells and its high conservation among
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FIGURE 1 Bovine herpesvirus (BHV) VP16 displays different
DNA-binding specificities for VP16-induced complex forma-
tion than herpes simplex virus (HSV) VP16 in an elec-
trophoretic mobility retardation assay. Three different DNA
probes were used. (Lanes 1, 4, 7, 10) H-ICP0 (OCTAT)
TAATGARAT probe from the HSV !CPO promoter; (lanes 2,
5, 8, 11) H-ICP4 (OCTA-)TAATGARAT probe from the HSV
ICP4 promoter; (lanes 3, 6, 9, 12) B-ICP4 TAATGARAT
probe from the BHV ICP4 promoter. Partially purified human
HeLa cell Oct-1 and HCF (lanes 4-12) were used either
alone (lanes 4-6) or with added HSV (H-VP16; lanes 7-9) or
BHV (B-VP16; lanes 10-12) VP16 protein. The position of
the free probe, contaminating single-stranded DNA (S.S.),
Oct-1, and VP16-induced complex (VIC) is shown to the
right. Note that the HSV and BHV VP16-induced complexes
display the opposite binding site preference (compare VIC
in lanes 7-12).
mammals, insects, and nematodes suggest an impor-
tant role in cell function. Human HCF consists of a
series of polypeptides between 110 and 300 kD in
size. All of these polypeptides are encoded by a
single large 2035-codon open reading frame (ORF)
that initially gives rise to the largest (300 kD)
polypeptide. This precursor is then processed in vivo
through proteolytic cleavage to generate smaller
amino- and carboxy-terminal polypeptides that
remain tightly but noncovalently associated.
HCF contains two novel repeated sequence
motifs: One directs HCF processing and the other is
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involved in VP16-induced complex formation. The
first repeat motif-the HCF repeat-is present as six
nearly perfect copies located toward the center of the
primary translation product. In collaboration with
M.G. Peterson, we have now demonstrated that
proteolytic cleavage occurs near the center of this
repeat between a glutamic acid and threonine residue,
in the sequence CETH, and that transfer of a single
HCF repeat into an unrelated protein (Oct-1) is suffi-
cient to signal specific cleavage of that hybrid
protein. Subcellular fractionation experiments sug-
gest that HCF processing occurs within the nucleus.
The relatively slow kinetics of HCF processing com-
bined with our inability to recapitulate processing in
vitro are consistent with this being a regulated event
associated with HCF function.
The second repeat motif is present as six copies
clustered at the amino terminus of HCF. Unlike the
HCF repeats, this second repeat motif occurs in a va-
riety of proteins from organisms as diverse as fungi
and plants. In flu virus neuraminidase and a fungal
galactose oxidase, similar repeats are known to form
a "super-barrel" structure of six or seven 13-sheets,
respectively, each made up from four 13-strands. Our
mapping studies show that this 380-amino-acid puta-
tive HCF super-barrel structure interacts with VP16
and is sufficient for VP16-induced complex forma-
tion. Identification of this discrete domain within
HCF is an important advance in our understanding of
VP16-induced complex assembly.
To explore the natural cellular function of HCF,
we have taken two approaches: In one case, we are
identifying and characterizing human proteins that
associate with HCF, and, in the second case, we are
studying the structure and function of HCF in a more
genetically tractable organism, the nematode Caenor-
habditis elegans. To identify HCF-interacting pro-
teins, we have used the yeast two-hybrid assay. We
fused the amino-terminal VP16-interaction domain of
human HCF to the yeast GAL4 DNA-binding domain
and used this fusion protein to screen a He La cDNA
transcriptional activation domain fusion library for
cDNAs encoding HCF-interacting proteins. In this
manner, a human cDNA encoding a bZIP protein was
isolated, suggesting a role for HCF in regulation of
cellular transcription. To investigate the function of
HCF in C. elegans, we have monitored its expression
through C. elegans development by use of an elec-
trophoretic mobility retardation assay. In extracts
from developmentally staged worms, HCF activity
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peaked in the Li larval stage. These results suggest
that HCF is developmentally regulated.
Transcriptional Activation
by Promoter-selective
Activation Domains
G. Das, C. Hinkley
In eukaryotes, activation of transcription involves an
interplay between activators bound to cis-regulatory
elements and factors bound to basal elements near the
Start site of transcription. The basal elements, such as
the TATA box, nucleate the assembly of basal tran-
scription complexes, components of which interact
with the activation domains of activators. Although
in vitro studies have addressed the general interaction
of activators with the basal transcription machinery,
the importance of basal elements in directing dif-
ferent responses to activators has not been described.
We have now shown in vivo that changes in the ar-
rangement of basal elements within a promoter can
switch its response to activation domains.
We used the human U6 small nuclear RNA
(snRNA) promoter as a model to study the effects of
changes in basal element organization on activator
function, because this promoter naturally contains
both a TATA box and an snRNA-specific proximal
sequence element called the PSE. Both of these ele-
ments bind multiprotein complexes containing the
TATA box-binding protein TBP (see N. Hernandez,
this Annual Report). By mutational analysis, we
found that the presence of just the TATA box or the
PSE element within the U6 snRNA promoter results
in diametrically opposed responses to the acidic ac-
tivation domain from VP16 and a glutamine-rich ac-
tivation domain from the human transcription factor
Spl. These findings provide a mechanism for differ-
ential regulation of transcription by activators that is
based on the identity of basal promoter elements rath-
er than of upstream elements.
We have previously shown that the octamer
motif-binding proteins Oct-1 and Oct-2 also display
promoter-selective properties: Oct-1 activates a PSE-
containing snRNA promoter better than Oct-2, and
Oct-2 activates a typical TATA box-containing
mRNA promoter better than Oct-1. We have now
shown that the promoter-selective properties of Oct-1
and Oct-2 can be reproduced by tandem reiteration of
short 19- and 18-amino-acid segments derived from
the glutamine-rich activation domains of these two
proteins (called Q19 and Q18, respectively). Because
the're is only a five-amino-acid difference between
the Q19 and Q18 segments, we individually sub-
stituted the Oct-2 Q18 residues with their Oct-1 Q19
counterparts and examined the effect of these sub-
stitutions on activation of mRNA and snRNA pro-
moters. Four of these substitutions had little or
modest effects on selective activation of an mRNA
and an snRNA promoter compared to wild-type Q18.
In contrast, substitution of an important phenylal-
anine residue in Q18 with the two corresponding Oct-
1 residues almost completely eliminated mRNA
promoter activation by Q18 and instead activated
snRNA transcription-like Oct-1.
These results demonstrate that small differences
in activation domains can have a profound influence
on their ability to activate transcription in different
promoter contexts.
Response of TBP to
Transcriptional Activators In Vivo
W. Tansey [in collaboration with S. Ruppert and R. Tjian,
University of California, Berkeley)
To elucidate mechanisms of transcriptional activa-
tion, we have studied the response of the basal tran-
scriptional machinery to different transcriptional ac-
tivator proteins in vivo. We have focused our atten-
tion on the TATA box-binding protein TBP and have
analyzed the effects of mutations on the surface of
TBP on its ability to respond to various types of tran-
scriptional activators in human cells. By use of a TBP
protein with an altered DNA-binding specificity, we
have shown that the ability of TBP to respond to tran-
scriptional activators in vivo is curiously resistant to
clustered sets of alanine-substitution mutations in in-
dividual regions of the protein; combined sets of
these mutations, however, can attenuate the activity
of TBP in vivo. Remarkably, the combined sets of
mutations can selectively affect the response to indi-
vidual activation domains, indicating the existence of
more than one way in which TBP is used by ac-
tivators to stimulate transcription.
To address the mechanistic basis for this behavior,
we have assayed the activity of the TBP mutants in
several in vitro assays, including DNA binding, basal
transcription, direct interaction with activation
domains (e.g., the VP16 activation domain), and, in
collaboration with S. Ruppert and R. Tjian, interac-
tion with the largest subunit of the TBP-containing
complex TFIID, the TBP-associated factor
hTAF250. We have found that DNA binding, basal
transcription, and the direct interaction between TBP
and VP16 in vitro can be disrupted by single sets of
mutations that have little if any effect on TBP's ac-
tivity in vivo. In contrast, the interaction between
TBP and hTAF250 in vitro is resistant to single sets
of mutations in TBP but is sensitive to combined sets
of mutations in TBP in a way that mirrors the in vivo
activity. Taken together, these data suggest that TBP
utilizes multiple interactions across its surface to
respond to RNA polymerase II transcriptional ac-
tivators in vivo; some of these interactions appear to
involve recruitment of TBP into TFIID, whereas
others are involved in the response to specific types
of transcriptional activators.
Enhancement of In Vivo Promoter
Occupancy of Transcriptional
Activator Proteins through Their
Activation Domains
M. Tanaka
Eukaryotic transcriptional activator proteins are often
composed of two separate modular domains, a DNA-
binding domain and an activation domain. The DNA-
binding domain is generally sufficient for sequence-
specific DNA binding of activator proteins in vitro.
The activation domain is thought to be simply
tethered to the promoter by the DNA-binding domain
and to provide a surface that interacts directly or in-
directly with the general transcription factors to ac-
tivate transcription.
I have found, however, through an in vivo DNA-
binding analysis in yeast cells, that activation
domains can augment by up to two orders of mag-
nitude the binding of activator proteins to their
promoter target sites, essentially tethering the DNA-
binding domain to the promoter. This function of ac-
tivation domains on DNA binding contributes to the
ability of potent activator proteins to activate tran-
scription at low concentrations, concentrations at
which less potent activators did not activate transcrip-
tion or bind to the promoter. This observation implies
that enhancement of DNA binding by activation
domains may be generally important in depositing ac-
tivator proteins to their target sites in vivo and can
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profoundly affect how promoters respond to activator pie regions of TBP participate in the response to tran-
proteins. scriptional activators in vivo. Genes Dev. 8: 2756-2769.
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MECHANISMS OF MAMMALIAN PRE -mRNA SPLICING
AND SPLICE SITE SELECTION
RNA splicing is a required step in the expression of
most eukaryotic protein-coding genes. The selection
and pairing of authentic splice sites within the
spliceosome occur with a very high degree of fidel-
ity, which requires that limited and dispersed se-
quence information present throughout introns and
exons be precisely interpreted. The expression of
many cellular and viral genes occurs via alternative
splicing, which involves substantial flexibility in the
choice of splice sites, allowing the expression of mul-
tiple protein isoforms from individual genes. The
choice of alternative splice sites is commonly regu-
lated, either tissue-specifically or in response to a de-
velopmental program or to extracellular stimuli, and
thus alternative splicing is a common point in the
control of gene expression. Both constitutive and
alternative splicing mechanisms involve multiple
protein components, as well as RNA components that
are part of small nuclear ribonucleoprotein (snRNP)
particles. Our lab has focused on the identification,
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purification, and molecular characterization of
protein factors that are necessary for the catalysis of
splicing and/or for the regulation of alternative splice
site selection.
REGULATION OF ALTERNATIVE SPLICING IN VIVO BY
CHANGES IN THE EXPRESSION OF SF2/ASF AND
hnRNP Al
SR proteins have a characteristic carboxy-terminal
Ser/Arg-rich repeat (RS domain) of variable length
and constitute a family of highly conserved nuclear
phosphoproteins. As was first demonstrated for hu-
man SF2/ASF, individual SR proteins have an ac-
tivity required for general splicing in vitro, at the
level of early spliceosome assembly. In addition,
SF2/ASF and the remaining SR proteins promote
utilization of proximal alternative 5' splice sites in a
concentration-dependent manner, with a variety of
pre-mRNAs. The latter activity results from antag-
onistic interactions with the protein hnRNP Al,
which stimulates use of distal 5' splice sites in vitro.
We have proposed that the intracellular ratios of
SF2/ASF (or other SR proteins) and hnRNP Al may
control the specificity of splice site selection and that
in vivo regulation of one or both of these activities
may have an important role in the tissue-specific or
developmental regulation of alternative splicing. A.
Hanamura used quantitative immunoblotting to
demonstrate that the molar ratio of hnRNP Al to
SF2/ASF varies over a very wide range in different
rat tissues, well above the range required to elicit
splice site switching in vitro.
To investigate whether alternative splicing can be
regulated by the relative amounts of these antag-
A
onistic factors in vivo, J. Caceres transiently over-
expressed human SF2/ASF or hnRNP Al cDNAs in
HeLa cells and measured the effect on the expression
of several cotransfected reporter genes whose pri-
mary transcripts are processed via alternative splic-
ing. Increased expression of SF2/ASF resulted in the
selection of the most proximal of three cryptic 5'
splice sites in a thalassemia allele of human 3- globin
and selectively increased splicing via the proximal
13S 5' splice site of adenovirus ElA (Fig. 1).
SF2/ASF overexpression also promoted inclusion of
the clathrin light-chain B neuron-specific exon and
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FIGURE 1 Effect of hnRNP Al or SF2/ASF transient overexpression on alternative
splicing of adenovirus E1A pre-mRNA. (A) Diagram of the major E1A mRNAs gener-
ated by alternative 5' splice site selection and primers used for RT-PCR analysis.
The 10S and 11S mRNAs, which arise from double-splicing events that do not in-
volve simple competition between alternative 5' splice sites, are not shown in the
diagram. (B) Patterns of E1A alternative splicing upon transfection of an E1A gene
(lane 1) or cotransfection with pCG-Al (lane 2), pCG (lane 3), or pCG-SF2 (lane 4).
The asterisk indicates a PCR artifact band that is also detected in mock-transfected
cells (lane 5). (C) The 13S, 12S, and 9S mRNA isoforms were quantitated with a
phosphorimager, and the percentage of each isoform is shown.
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prevented abnormal skipping of two mutually exclu-
sive 8-tropomyosin exons (in collaboration with S.
Stamm and D. Helfman, CSHL). Increased expres-
sion of hnRNP Al activated the distal 9S 5' splice
site of adenovirus E1A (Fig. 1). These results suggest
that variations in the intracellular levels of
antagonistic splicing factors influence different
modes of alternative splicing in vivo and may be a
natural mechanism for tissue-specific or developmen-
tal regulation of gene expression.
STRUCTURE, FUNCTION, AND RNA-BINDING
PROPERTIES OF hnRNP A/B PROTEINS
To examine the structural requirements for hnRNP
Al function, mutagenesis of recombinant human
hnRNP Al was carried out by A. Mayeda in col-
laboration with Steve Munroe (Marquette Univer-
sity). The activity of hnRNP Al in an alternative
splicing assay was abolished by mutation of pairs of
conserved phenylalanine residues in the RNP-1 sub-
motifs of each of the two RNA recognition motifs
(RRMs). The structure of the RRMs is unlikely to
have been altered by these mutations, since the result-
ing proteins were unaffected in binding to 3- globin
pre-mRNA in a filter-binding assay. Analogous
RRMs have been shown to
stack with single-stranded bases. The above results
suggest that the RRM mutations in either RRM of
hnRNP Al affect sequence-specific interactions with
one or more RNA target sites and that these interac-
tions are essential for alternative splicing function.
The glycine-rich carboxyl terminus of hnRNP Al
was also found to be essential for alternative splicing
activity. This portion of the protein contributes to the
stability of RNA binding, since a truncated protein
lacking the carboxyl terminus but containing both in-
tact RRMs bound RNA very weakly.
To determine if other proteins, besides hnRNP
Al, antagonize one or more SR proteins to select
alternative 5' splice sites, A. Mayeda measured the
activities of other members of the human hnRNP A/B
family, which bind most, if not all, nascent pre-
mRNA transcripts. The hnRNP A2 and BI proteins,
which are alternatively spliced isoforms derived from
the same gene and are related in sequence to hnRNP
Al (68% amino acid identity), were expressed in bac-
teria, purified, and assayed for alternative splicing in
vitro. Both proteins were highly active in switching
alternative 5' splice site selection toward the distal
site and were in fact more active than hnRNP Al. In
contrast, hnRNP Al B, an alternatively spliced
46
isoform of hnRNP Al that differs only in having a
longer carboxy-terminal glycine-rich domain, had
very limited activity. Surprisingly, there was an in-
verse correlation between the activities of these four
proteins in alternative splicing and their binding af-
finity for pre-mRNA.
Although each of these abundant hnRNP A/B
proteins can bind RNA, it is unclear if their effects on
alternative splicing are mediated by binding to the
same pre-mRNA sequences. Whether each hnRNP
A/B protein regulates alternative splicing of different
pre-mRNAs in vivo is also unknown at present.
Recently, C. Burd and G. Dreyfuss (HHMI, Univer-
sity of Pennsylvania School of Medicine) demon-
strated that hnRNP Al is a sequence-specific RNA-
binding protein. S. Perera, A. Hanamura, and I.
Watakabe used SELEX to sample an RNA library
with 425-fold degeneracy, in order to identify
preferred binding sites for hnRNP A2 and Bl. After
six rounds of SELEX, both proteins selected RNAs
that are purine-rich and, in almost all cases, contain
one or more copies of the tetranucleotide UAGG.
This selected sequence is part of the high-affinity
binding site selected by hnRNP Al, UAGGGA/U,
and also matches a portion of the vertebrate 3' splice
site consensus, UUAGG. I. Watakabe used a filter-
binding assay to measure the affinity of hnRNP A/B
proteins for representative RNAs. Each of the
selected RNAs bound to hnRNP A2, Bl, and Al with
comparable affinities, and in most cases the affinity
was much greater than for control RNAs from round
0. hnRNP A113, which has an extended carboxy-
terminal domain, bound all RNAs nonspecifically.
We are currently testing the above-mentioned RRM1
and RRM2 mutants of hnRNP Al to determine if the
loss of alternative splicing activity correlates with the
loss of sequence-specific RNA binding. In parallel
SELEX experiments, A. Hanamura and I. Watakabe
showed that recombinant SF2/ASF and SC35
selected different short purine-rich motifs positioned
variably within a purine-rich context. This finding is
consistent with the previously determined role of
SF2/ASF and other SR proteins in binding to purine-
rich exonic splicing enhancers and activating splicing
of the preceding intron.
ISOLATION AND CHARACTERIZATION OF NOVEL
SR PROTEINS
G. Screaton (a visiting scientist from J. Bell's labora-
tory, Oxford University) cloned a cDNA encoding a
novel human SR protein designated SRp30c, which
has an unusually short RS domain. cDNA clones en-
coding the human homologs of Drosophila
SRp55/B52 and rat SRp40/HRS were also isolated.
Recombinant proteins expressed from these cDNA
clones were shown to be active in constitutive splic-
ing, i.e., they functionally complemented a He La cell
5100 extract deficient in SR proteins (in collabora-
tion with A. Mayeda). Additional cDNA clones
reflect extensive alternative splicing of SRp40 and
SRp55 pre-mRNAs. The predicted protein isoforms
lack the carboxy-terminal RS domain and might be
involved in feedback regulatory loops. The ability of
human SRp30c, SRp40, and SRp55 to modulate
alternative splicing was measured in a transient
cotransfection assay (in collaboration with J.
Caceres). SR proteins affected the choice of alterna-
tive 5' splice sites in the transcripts of adenovirus
E1A or human I3-thalassemia reporters upon over-
expression in HeLa cells, and this choice was charac-
teristic for each SR protein. Consistent with the
postulated importance of SR proteins in alternative
splicing in vivo, complex changes in the expression
of mRNA isoforms encoding the above SR proteins
were observed by RNase protection upon T-cell ac-
tivation.
PURIFICATION AND CHARACTERIZATION OF
FACTORS THAT CONTROL ALTERNATIVE
3' SPLICE SITE SELECTION
In addition to their effects on spliceosome assembly
and alternative 5' splice site selection, several SR
proteins have been shown to affect alternative 3'
splice site selection, favoring the use of the proximal
sites. More recently, A. Mayeda showed that none of
the known hnRNP A/B proteins antagonizes the
alternative 3' splice site selection activities of these
SR proteins. Instead, a novel activity, designated
SF7, promotes the selection of distal alternative 3'
splice sites. Following four steps of purification from
HeLa cell nuclear extracts, SF7 activity has been
separated into two independently active fractions,
SF7A and SF7B, which are distinct from hnRNP A/B
and SR proteins. Partial amino acid sequences for the
four major polypeptides detected in the purest SF7A
fractions were determined (in collaboration with R.
Kobayashi, CSHL). The sequences of several pep-
tides from the best candidate polypeptide match the
conceptual translation of a cDNA in GenBank, which
has characteristic features of an RNA-binding
protein. It has a single RNA recognition motif (RRM)
with well-conserved RNP-1 and RNP-2 submotifs,
preceded by an extensive serine-rich domain. The
candidate polypeptide appears to be highly
phosphorylated, since a pronounced increase in elec-
trophoretic mobility was seen upon phosphatase
treatment. Significant SF7 activity was recovered
after preparative SDS-PAGE and renaturation of the
SF7A candidate polypeptide, suggesting that this
polypeptide is sufficient for activity. To study the
structure, function, and in vivo expression of SF7A in
detail, we are currently trying to overexpress the can-
didate polypeptide in Escherichia coli. Further
purification and characterization of the SF7B fraction
are also in progress.
The potential combinatorial effects of variations
in the concentrations of different SR proteins (eight
human ones are currently known, not including
alternatively spliced isoforms), each with some
measure of substrate specificity, and of several
antagonistic factors that act at either 5' or 3' splice
sites (i.e., four hnRNP A/B proteins and SF7A) are
very large. In addition to the 32 pairwise combina-
tions of SR and hnRNP A/B proteins, additional
specificity may arise from two or more members of
each family cooperating to affect the splicing of
certain substrates, or through interactions between
these proteins and gene-specific positive or negative
regulators. When yet more variables, such as regula-
tion of protein accessibility or localization, and
potential regulation of protein activity by changes in
phosphorylation are added into the equation, the sys-
tem gains a complexity perhaps sophisticated enough
to control the numerous alternative splicing choices
made in living cells.
YEAST AND HUMAN SPLICING FACTOR HOMOLOGS
AND NEW HUMAN SPLICING FACTORS
To characterize further the relationship between pre-
mRNA splicing in yeast and metazoans, we are using
different approaches to identify related splicing
proteins in humans and in yeast. The Prp18 protein is
involved in the second step of pre-mRNA splicing in
Saccharomyces cerevisiae and is a component of the
U5 snRNP. From similarities among Prp18 and the
translations of ESTs from rice and nematode, D.
Horowitz designed polymerase chain reaction (PCR)
primers which he used to identify a human homolog
of Prp18 (termed hPrp18). A full-length cDNA en-
coding hPrp18 was cloned and sequenced. The
47
deduced amino acid sequence of hPrp18 is 30%
identical to that of yeast Prp18; hPrp18 is not related
to other proteins in the databases. hPrp18 has been
overexpressed in E. coli and antibodies against it are
currently being produced. These antibodies will be
used to assess the role of hPrp18 in pre-mRNA splic-
ing. We initially want to determine whether hPrp18 is
required for the second step of splicing and whether it
is a component of the human U5 snRNP.
T.-L. Tseng is searching for proteins with RS
domains in budding and fission yeast, with the
ultimate goal of studying the structure and function
of RS domain-containing splicing factors by genetic
methods. The rationale is based on the observation
that very few known proteins in the databases contain
significant repeats of alternating arginine and serine
residues, and virtually all of these proteins have been
directly or indirectly implicated in constitutive or
regulated splicing. Using two monoclonal antibodies
that recognize either phosphorylated or unphosphory-
lated RS domains, several yeast proteins were found
to react with both antibodies and showed the ap-
propriate sensitivity or resistance to phosphatase
treatment. These observations suggest that several
proteins containing phosphorylated RS domains exist
in both budding and fission yeast. Several candidate
clones were isolated by screening expression libraries
with the antibody that recognizes unphosphorylated
RS domains, and these are currently being character-
ized.
We are continuing to purify and characterize addi-
tional protein factors that are essential for one or both
RNA cleavage-ligation reactions. M. Murray frac-
tionated a He La cell nuclear extract and obtained a
fraction in which a single, or a limited number of, re-
PROTEIN SYNTHESIS
M.B. Mathews
quired component(s) has been separated from known
protein splicing factors and snRNPs. This fraction is
required to complement cruder fractions containing
the remaining essential components, thus defining a
novel activity required for cleavage at the 5' splice
site and lariat formation. Further purification of this
activity is in progress.
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S. Brand C. Labrie L. Manche D. Taylor
M. Greenberg B. Lee P. Nahreini P. Wendel
S. Gunnery H.-J. Liao T. Pe'ery C. Yordan
B. Hofmann Y. Ma
Gene expression is controlled in many different
ways. Our laboratory is studying several systems that
illustrate the diversity of regulatory processes in hu-
man cells. All of the systems involve viral genes that
interact with cellular pathways, resulting in modula-
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tion of the level of cellular or viral gene product(s)
synthesized and impinging on processes such as cel-
lular growth control and viral multiplication. The fol-
lowing paragraphs summarize the progress made in
1994 on each topic. During the year, Huey-Jane Liao
and Tsafrira Pe'ery joined the laboratory, and Claude
Labrie left to take up a faculty position at the Univer-
sity of Laval in Quebec.
Regulation of PCNA
B. Lee, C. Labrie, P. Wendel, M.B. Mathews
The proliferating cell nuclear antigen (PCNA) is an
adenovirus E1A-inducible cellular protein that is in-
timately linked to the processes of DNA replication
and cell cycle regulation. Initially discovered as an
antigen in autoimmune disease, PCNA is also known
as the DNA polymerase 8 auxiliary factor, in which
context it functions as a "sliding clamp" during DNA
replication. PCNA synthesis is triggered by a variety
of growth stimuli. Its induction by the adenovirus
E1A gene was first described during the oncogenic
transformation of quiescent rodent cells and has since
been studied in much greater detail using transient
expression experiments in He La cells and other cell
types. Activation of the human PCNA promoter is a
property of the 243-residue adenovirus El A on-
coprotein (E1A 243R).
We showed previously that trans-activation of the
PCNA promoter by the E1A 243R protein is media-
ted through a novel cis-acting element termed the
PERE (an acronym for the PCNA E1A-responsive
element) which contains a sequence resembling an
activating transcription factor (ATF)-binding site.
This site lies about 50 nucleotides upstream of the
PCNA transcriptional start site. To elucidate the
mechanism whereby PCNA expression is regulated
by E1A 243R, we have begun to identify cellular
transcription factors that associate with the PERE. In
electrophoretic mobility shift assays, an oligo-
nucleotide probe containing the PERE site forms
three major complexes (P1, P2, and P3) with proteins
in nuclear extracts from HeLa or 293 cells. Muta-
tional analysis showed that the formation of com-
plexes P2 and P3 correlates with PCNA promoter ac-
tivity in vivo and requires the ATF-binding site found
within the PERE. Antibody interference experiments
and mobility shift assays performed with protein
synthesized in vitro indicate that the transcription fac-
tor ATF-1 is a major component of these complexes.
Similar assays demonstrated that the hepatitis B virus
enhancer-associated protein RFX1 constitutes a
major component of the P1 complex, but at present,
we have no evidence that this protein participates in
the induction of the PCNA promoter.
Last year we reported that the PCNA promoter
contains a p53-binding site approximately 220
nucleotides upstream of the transcription initiation
site. The binding of p53 to this site is important for
both the basal activity of the promoter and its
response to E1A 243R. We have extended the analy-
sis to examine the binding of proteins to the minimal
E1A-responsive promoter in order to identify other
factors that might be important for transcription from
the PCNA promoter. Mobility shift assays revealed
that a fragment encompassing this region, extending
from -87 to +62 relative to the transcription initiation
site, forms at least five major complexes (EH1 -E115)
with HeLa cell nuclear extracts. Examination of these
complexes indicated that the transcription factor YY1
associates with the initiator element of the PCNA
promoter. In addition to identifying other cellular
transcription factors contained within these promoter-
proximal complexes, current studies are investigating
the roles of cellular E1A-binding proteins in the ac-
tivation of PCNA expression.
Regulation of HIV-1
Gene Expression
M. Greenberg, P. Nahreini, T. Pe'ery,
C. Yordan, M.B. Mathews
The HIV-1 protein Tat stimulates transcription from
the HIV promoter, located in the viral long terminal
repeat (LTR), at least in part by controlling transcrip-
tional elongation and overcoming premature tran-
scriptional termination. These actions of Tat can be
reproduced in a cell-free system using purified, bac-
terially expressed Tat to stimulate HIV transcription.
Tat appears to achieve trans-activation in vitro by
improving the processivity of RNA polymerase com-
plexes, presumably by recruiting or modifying cel-
lular elongation factors, but a detailed picture of Tat's
interactions with cellular factors has yet to emerge.
Recently, A. Rice and co-workers (Baylor College of
Medicine) demonstrated specific binding of the ac-
tivation domain of Tat to a cellular kinase, TAK,
which can phosphorylate the carboxy-terminal
domain (CTD) of RNA polymerase II (pol II). Since
phosphorylation of the CTD is believed to trigger the
transition from polymerase complex assembly to the
elongation phase of transcription, this observation
suggests a mechanism whereby Tat could increase
elongation via TAK-catalyzed phosphorylation of the
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CTD. However, it is also possible that TAK activates
other transcription factors because it appears to
phosphorylate other nuclear (and cytoplasmic) pro-
teins whose nature is as yet unknown.
We have set out to explore the role of the Tat-
associated kinase activity in trans-activation of the
HIV promoter. Various GST-Tat fusion constructs,
and their mutant derivatives, were used to detect
TAK activity in He La cell nuclear extracts. We found
a similar activity in the S-100 cytoplasmic fraction of
human 293 and He La cells. TAK isolated by adsorp-
tion to GST-Tat phosphorylates a GST-yeast CTD fu-
sion protein as well as a synthetic peptide containing
three copies of the CTD repeat. We are currently
working to assess the role of TAK activity in the Tat
response. In related studies, conducted with D.
Ostapenko (Weizmann Institute, Israel), we have
demonstrated that the ability of Tat to trans-activate
in vitro depends on preincubation with nuclear ex-
tract. This suggests that factors in the nuclear extract
are required to "potentiate" Tat trans-activation.
Potentiation could be due to the formation of a com-
plex between Tat and nuclear protein(s) or to
covalent modification of Tat. Heat inactivation of the
extract or its depletion by column chromatography
abrogated the potentiation effect. We are attempting
to purify the factor(s) that potentiates Tat function in
vitro and to determine their relationship to TAK.
In previous Annual Reports, we described experi-
ments indicating that replication and chromosomal
integration can influence transcription from the HIV-
1 LTR. To explore these effects in more detail, we
have exploited the ability of recombinant adeno-
associated virus (AAV-1) to transfer and stably in-
tegrate a reporter gene cassette into the human
genome. AAV-1 DNA inserts into the genome in a
site-specific fashion on chromosome 19 as well as at
apparently random sites elsewhere. We have con-
structed several recombinant AA Vs containing the
LTR-CAT reporter cassette. In some of these
chimeric vectors, a selectable marker gene (the Neor
gene, encoding neomycin resistance) was inserted to
facilitate the isolation of clones containing the in-
tegrated HIV gene cassette. Such recombinant viruses
were used to infect He La cells; in some instances, the
recombinant was coinfected with wild-type AAV
containing the rep gene, which is believed to impart
site-specific integration into chromosome 19. Thus
far, we have isolated 25 independent neomycin-
resistant clones of He La cells containing the in-
tegrated recombinant virus. The basal HIV promoter
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activity, measured in CAT enzyme assays, varies sig-
nificantly among these clones, and a few clones show
no CAT activity at all, even though the linked Neor
gene within the integrated proviral genome is biologi-
cally active. In most ways, these clones behave as ex-
pected. For instance, transfection of the Tat gene
dramatically increases CAT expression in those
clones that have some measurable basal CAT expres-
sion. In contrast to a report in the literature, the cell
lines displayed no differences in their responses to
full-length Tat (86 amino acids) and exon 1 Tat (72
amino acids). Finally, at least in some clones, coex-
pression of the adenovirus E1A and Tat genes
synergistically stimulates CAT expression from the
HIV promoter. On the basis of Southern blot analysis
of genomic DNA from some clones, a single copy of
the LTR-CAT cassette is integrated into the chromo-
somal DNA, and in at least two clones, the integra-
tion appears to be at the previously characterized
chromosome 19 site. We now plan to characterize the
integration sites of the proviral DNA in these clones.
Translation of an RNA
Polymerase III Transcript
S. Gunnery, P. Wendel, M.B. Mathews
Last year, we showed that a transcript generated by
RNA polymerase III (pol III) can be translated in
vivo to produce a functional protein. The adenovirus
VA RNA promoter, a pol III promoter, was placed
upstream of the HIV-1 Tat-coding sequence to con-
struct pVA-Tat. When transfected into cells, this con-
struct produced VA-Tat RNA that was recruited by
the polysomes for translation, giving rise to a Tat
protein that was able to trans-activate the HIV-1
promoter. As would be expected of a pol III tran-
script, VA-Tat RNA lacks a poly(A) tract at its 3'
end and a cap structure at its 5' end. These findings
imply that functional mRNA synthesis is not
restricted to pol II, that pol III transcripts can be
transported within the cell and assembled with the
translational components, and that neither the 5' cap
structure nor the 3' poly(A) tail is obligatory for
translation. Examination of polysome profiles sug-
gested that the rate of initiation of translation on the
pol III RNA is reduced compared to mRNA made by
pol II, however. Therefore, it seems that the terminal
structures characteristic of normal mRNAs enhance
translational efficiency.
To study the mechanism of translation of this pol
III transcript, we took advantage of a short upstream
open reading frame (ORF) which is out-of-frame
with that of Tat and lies in the 5' -untranslated region
of VA-Tat RNA. In other RNAs, such upstream
ORFs can reduce the translation of a downstream
ORF, especially if the ORF begins with an AUG in a
favorable context. This observation is commonly in-
terpreted to imply that initiating ribosomal subunits
bind first to the 5' cap, then scan along the mRNA
until they encounter a suitable AUG codon. To dis-
cover whether the upstream ORF has any role in the
translation of VA-Tat RNA, we eliminated it by
mutating the start codon from AUG to GCG (mutant
I) or extended it by ten nucleotides into the Tat ORF
by mutating the upstream stop codon from UAG to
CAG (mutant S). The initiation codon mutant gave
twofold more Tat activity than wild-type pVA-Tat
and the stop codon mutant gave twofold less activity
than wild-type pVA-Tat, suggesting that the upstream
ORF can be translated and that its utilization
decreases Tat synthesis. Consistent with this conclu-
sion, trans-activation by the double mutant (I+S) was
similar to that by the I mutant, indicating that the stop
codon is influential only if the upstream ORF is util-
ized. These results indicate that scanning of the 5'
UTR may be involved in translation of the uncapped
VA-Tat RNA. To test this conclusion further, we ex-
amined the effect of stem-loop structures inserted up-
stream of the Tat ORF. Stem-loop structures of high.
stability are thought to decrease the translation of a
downstream ORF in capped mRNAs because scan-
ning ribosomes are stalled by the secondary structure.
Translation of the Tat ORF was inhibited by the in-
sertion of such stem-loop structures, reaffirming the
conclusion that the VA-Tat, despite being uncapped,
is subject to scanning.
When the two ORFs overlap, as in mutant S,
trans-activation of the downstream Tat ORF is
reduced but not eliminated. To determine whether
this is due to reinitiation after termination of transla-
tion of the upstream ORF by ribosomes that "back-
scan" along the RNA, we made mutations that in-
crease the overlap of the two ORFs to 22 and 219
nucleotides. Both of these mutations further reduced
the translation of the Tat ORF, consistent with back-
scanning. Similar results were obtained with con-
structs driven by a pol II promoter. Taken together,
these results demonstrate that pol III transcripts can
be recruited by ribosomes and translated by mechan-
isms similar to those used for normal (i.e., pol II-
directed) mRNAs, albeit less efficiently. We are now
examining the processing of the pol III transcripts to
determine whether they are handled in the nucleus in
the same way as conventional mRNAs.
Translational Control
S. Brand, D. Taylor, L. Manche, M.B. Mathews
The protein kinase DAI, the double-stranded (ds)
RNA activated inhibitor of translation (also known as
PKR, Pl, p68, etc.), regulates the first step of protein
synthesis by phosphorylating an initiation factor
known as eIF-2 (eukaryotic initiation factor 2).
Phosphorylation of eIF-2 leads to the slowing or ces-
sation of translation, and the enzyme has been impli-
cated in a wide range of processes from oncogenic
transformation and growth control to viral infection.
As its name implies, the enzyme is controlled by
RNA regulators. In previous years, we described
studies of the RNA-binding properties of DAI: This
work continues at the biochemical level, with the aid
of mutagenesis, and (together with Dr. Alan Hin-
nebusch's lab at the National Institutes of Health) in
yeast. DAI contains two copies of a dsRNA-binding
motif that exhibit different properties. It seems that
RNA binding requires the cooperative action of both
motifs. In collaboration with the laboratories of Dr.
Tom Steitz at Yale and Dr. Peter Wright at the
Scripps Institute, we are presently attempting to ob-
tain detailed structures of the RNA-binding domain
of DAI, both with and without its RNA ligands, by
biophysical methods.
Recent studies lend support to the view that DAI
activation requires dimerization of the enzyme, al-
lowing intermolecular phosphorylation to occur. This
autophosphorylation is correlated with the activation
of DAI as an eIF-2 kinase. To understand the process
and its role in activation, we are studying the auto-
phosphorylation sites. In collaboration with Dr. Dan
Marshak and Georgia Binns (Protein Chemistry Core
section), the locations of several autophosphorylated
sites have been identified through peptide mapping
and sequencing. Some of these sites may define an
autoregulatory region, separating the enzyme's RNA-
binding and kinase domains. Other phosphorylated
residues are located within the RNA-binding domain.
To determine which, if any, of these sites are impor-
tant for the activation of the enzyme, alanine substitu-
tion mutants have been made and are being tested in
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vivo in the yeast Saccharomyces cerevisiae. Prelimi-
nary results show that some of the mutants have
reduced activity, but none of the mutants tested as yet
abolishes kinase activity.
Although it is usually assumed that elF -2 is the
physiologically relevant substrate for DAI, the en-
zyme has also been shown to phosphorylate histone
H2A, a 90-kD protein found in rabbit reticulocytes,
and the inhibitory subunit of the NF-x13 transcription
factor. In addition, it is likely that the activated kinase
is responsible for the modification of as yet uniden-
tified substrates. One of our aims is to elucidate the
nature of the 90-kD phosphoprotein and to search for
additional substrates of DAI. Using monoclonal
antibodies to immunopurify the 90-kD protein, a par-
tial peptide sequence has been obtained. Degenerate
oligonucleotides have been synthesized based on the
predicted amino acid sequence and are being used to
screen a cDNA library in an attempt to clone the
cDNA for this protein. Preliminary data suggest that
activated DAI is also able to phosphorylate the HIV-
1 trans-activation protein Tat. Experiments using a
purified preparation of Tat-72 (exon 1 only) and a
series of GST-Tat fusion proteins indicate that serine
residues within the carboxy-terminal domain of the
Tat protein are phosphorylated by DAI in a dsRNA-
dependent manner. We will attempt to further identi-
fy the specific residues phosphorylated by DAI and
to elucide the functional significance of the Tat/DAI
interaction.
Virus-Host Interplay
F. Ma, H.-J. Liao, M.B. Mathews
The synthesis of DAI is induced by interferon, and
this enzyme forms part of the antiviral defenses of the
host organism. In response to the threat, viruses have
evolved mechanisms to protect themselves against
activation of the kinase. Some of these defense me-
chanisms involve the production of small RNA
molecules that prevent DAI activation. The best
known of these RNAs are the virus-associated (VA)
RNAs of adenovirus. In previous years, we described
how adenovirus 2 (Ad2) VA RNA/ blocks DAI ac-
tivation in vivo and in vitro by binding to DAI. The
function of VA RNA/ is critically dependent on its
structure, which has been explored by several means
including mutagenesis and probing with nucleases
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and chemical reagents. Most recently, we have turned
to phylogenetic comparisons and site-specific muta-
genesis to refine the structural model of VA RNA/.
Sequence analysis of the VA RNA genes of all 47
human adenoviruses separates the VA RNAs into
three superfamilies: Cluster 1 contains the single VA
RNAs of adenoviruses in groups A and F and the VA
RNA/ species of group C; cluster 2 contains the VA
RNA/ species of groups B, D, and E, and six un-
classified viruses, as well as the single VA RNAs of
group B; and cluster 3 contains all of the VA RNAH
species. We have combined the sequence data with
nuclease sensitivity analysis and computer-assisted
RNA folding in order to derive secondary structural
models for the VA RNAs. The RNAs in each cluster
were compared to each other, and the impact of se-
quence variations on secondary structure models was
evaluated. Within clusters 1 and 2, the major features
of the previous VA RNA secondary structure
model-the terminal stem, apical stem-loop, and cen-
tral domain-are conserved despite considerable se-
quence variation. The central domain structure is crit-
ical for the inhibition of DAI activation. It contains a
side stem-loop linked to the base of the apical stem
and to a stem formed by the highly conserved
tetranucleotides GGGU and ACCC
viously. These three stems contain all the regions re-
quired for VA RNA function and interaction with
DAI. Flanking this central domain are two internal
loops further connecting the upper part of the apical
stem-loop and the terminal stem. In contrast, the VA
RNA!' species comprising cluster 3 apparently do not
conform to the structural model developed for the
other VA RNAs. Instead, they can be accommodated
by a Y-shaped structure in which the conserved
tetranucleotides are paired but not to each other. We
suspect that these structural differences correlate with
functional differences: VA RNAll substitutes poorly
for VA RNA/ in functional assays, and we speculate
that it subserves a different role in virus infection.
Current work is directed toward elucidating this role.
Although there is little sequence conservation in
the VA RNAs apart from that related to the transcrip-
tion signals (A box and B box), the mutually com-
plementary tetranucleotides GGGU and ACCC are
invariable except in two viruses where there is a con-
servative change (ACCC to ACCU) which still
permits pairing. To verify the functional significance
of the conserved tetranucleotides experimentally, we
have made three sets of potentially compensating
mutations in Ad2 VA RNA/. Each set consists of
three mutants, one in the GGGU sequence, a cor-
responding mutation in the ACCC sequence, and a
double mutant containing both changes. The muta-
tions are designed such that the single mutations
should disrupt pairing if it exists in the wild-type
molecule, but the combination should allow pairing
to reform. We compared the ability of these mutants
to substitute for Ad2 VA RNA/ in two functional as-
says, a viral protein synthesis rescue assay and a
CAT expression enhancement assay. In each case, the
two single mutants displayed low activity, but the
double mutants were partially active, indicating that
the GGGU and ACCC sequences do indeed base-
pair. The double mutants did not achieve wild-type
activity levels, however, presumably because they do
not restore the wild-type structure completely.
Alternatively, the precise sequence of the tetranucleo-
tide stem might be important for the interaction of
VA RNA with DAI. We are presently attempting to
distinguish between these two interpretations through
RNA structure analysis.
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MOLECULAR MECHANISMS OF APOPTOSIS
Y. Lazebnik Yifan Xu
Our laboratory is interested in dissecting molecular
mechanisms of apoptosis. Apoptosis is a type of cell
death that results from the activation of a specialized
intrinsic cell machinery that is aimed at the cell self-
disassembling. The role of apoptosis in the develop-
ment and functioning of an organism is as important
as that of cell proliferation and differentiation. As a
corollary, the derangement of the apoptotic machin-
ery is a significant etiological factor and a potential
pharmacological target in a variety of illnesses, in-
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eluding neurodegenerative diseases, viral infections,
cancer, and autoimmune disorders. However, at pres-
ent, our knowledge of the biochemical mechanisms
of apoptosis is too limited to make possible the de-
sign of drugs that would affect the apoptotic machin-
ery.
The biochemical study of apoptosis has proven to
be difficult. Due to the highly variable time of com-
mitment to apoptosis (hours to days) and the relative-
ly constant time of execution of apoptosis (1-2
hours), a cell population treated with an apoptosis-
inducing factor becomes a complex mixture of viable
cells, cells committed to death, cells undergoing the
active phase of apoptosis, and necrotic cells. As a
result, it is difficult to assign an activity that is
purified from this complex mixture to a particular
cell subpopulation and consequently to a process par-
ticular to apoptosis.
To overcome this problem, we have developed
and characterized a cell-free system that accurately
mimics the execution stage of apoptosis. This system
uses an extract prepared from chicken tumor cells
that have been committed to apoptosis by a transient
synchronization in the S phase of the cell cycle and
collected in mitosis (S/M extracts). Control extracts
are prepared from cells collected in mitosis without
S-phase presynchronization (RME, real mitotic ex-
tract). When isolated nuclei are added to S/M ex-
tracts, the nuclei synchronously undergo biochemical
and morphological changes characteristic of apop-
tosis. In contrast, RME extracts are not able to induce
any of these changes. Using this cell-free system as a
tool, we began to dissect the biochemical mechanism
of apoptotic cell execution.
Extensive genetic studies of programmed cell
death in the nematode Caenorhabditis elegans have
revealed that the mechanism of apoptosis is tightly
controlled and the expression of genes responsible for
commitment of cells to apoptosis is cell-type-
specific. In contrast, the execution of cells committed
to apoptosis is controlled by the same set of three
genes in all cell types. Two of the genes, ced-3 and
ced-9, are conserved between worms and vertebrates.
ced-9, an inhibitor of apoptosis, is a functional and
structural homolog of the vertebrate oncogene bcl -2.
ced-3, an inductor of apoptosis, has significant se-
quence similarity to the gene encoding the mam-
malian cysteine proteinase interleukin 1 a-converting
enzyme, or ICE. This similarity, along with the
ability of some ICE inhibitors to inhibit apoptosis,
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suggests that the CED-3 protein may induce apo-
ptosis by working as a proteinase and that a CED-3
homolog also induces apoptosis in vertebrates.
To date, several genes with sequences similar to
those of genes encoding ICE and CED-3 have been
cloned and together are referred to as the ICE /ced -3
family. However, only ICE has been biochemically
and functionally characterized. A study published
recently clearly showed that ICE is not essential for
apoptosis in mice. Therefore, the CED-3 equivalent
in vertebrates is yet to be identified. Our laboratory
has been set up to identify and purify this equi-
valent(s), to dissect pathways of their regulation, and
to find out their substrates.
Identification of Proteinase(s)
from the ICE/CED-3 Family
That Are Essential for
the Onset of Apoptosis
Y. Lazebnik, Y. Xu [in collaboration with Merck Research
Laboratories, Rahway, NJ, and with Merck Frosst Center
for Therapeutic Research, Montreal, Canada]
Using our cell-free system, we have identified a
proteinase resembling ICE (prICE) that is involved in
the execution of apoptosis and fulfills criteria for a
vertebrate homolog of the CED-3 protein. First,
biochemically, prICE belongs to the ICE family of
proteinases.
Second, active prICE was detected only in ex-
tracts made from cells committed to apoptosis. Third,
prICE is activated at the beginning of the execution
stage of apoptosis. Finally, prICE activity appears to
be pivotal in driving apoptosis in vitro. Inactivation
of prICE blocks apoptotic changes in the cell-free
system, including both morphological transformation
and DNA cleavage.
We began a project aimed at the isolation, clon-
ing, and molecular identification of prICE activity.
We have made use of reagents that allow specific in-
hibition, labeling, and affinity purification of ICE-
like enzymes and have found that S/M extracts ac-
tually have at least two different ICE-like protein-
ases, prICE-1 and prICE-2. Our preliminary data sug-
gest that prICE-1 and prICE-2 have different sub-
strate specificities. Further purification of the prICEs
is under way.
Activation of ICE/CED-3
Proteinases at the Onset
of the Execution Stage
of Apoptosis
Y. Xu [in collaboration with H. Robert Horvitz,
Massachusetts Institute of Technology]
ICE is expressed in cells as an inactive pro-enzyme
which is then activated by a specific cleavage,
presumably by another ICE-like proteinase. The me-
chanism of this activation is unknown. The high de-
gree of structural similarity between members of the
ICE /ced -3 family suggests that CED-3 and the verte-
brate CED-3 equivalent are also expressed as pro-
enzymes and then are also activated by proteolysis.
Therefore, an important step to the understanding of
the apoptotic machinery is to dissect mechanisms of
activation of the ICE/CED-3-like enzymes.
In an attempt to understand ICE/CED-3 activa-
tion, we are now screening for proteins that interact
with subdomains of CED-3 by using the yeast two-
hybrid system. This approach will be useful in identi-
fying proteins required for ICE/CED-3 activation as
well as for identifying substrates of these enzymes.
Biochemical Identification
of the Substrates of the
Vertebrate CED-3 Homo logs
Y. Lazebnik, Y. Xu
The identification of substrates that are cleaved at the
onset of apoptosis by either CED-3 or its vertebrate
equivalents is important for at least two reasons.
First, it will increase our knowledge about the cell
execution, which in turn may result in the identifica-
tion of novel markers of cell death. Second, it will
provide new insight as to how the cell is organized,
because it appears that the structures that are specifi-
cally affected during apoptosis are essential for cell
life.
We have shown previously that nuclear enzyme
poly(ADP-ribose) polymerase, or PARP, is cleaved
into two fragments at the onset of apoptosis. Using
the cell-free system, we found that PARP is cleaved
by prICE. To date, PARP is the first and only known
substrate cleaved during apoptosis by an ICE/CED-3-
like enzyme. Another group of proteins that appear to
be cleaved during apoptosis are nuclear lamins. We
are investigating the role of prICE in this cleavage.
ACCESSORY GENES OF HUMAN IMMUNODEFICIENCY VIRUS
J. Skowronski S. Bronson A. lafrate
M. Lock R. Mariani
S. Salghetti
AIDS immunodeficiency is invariably associated
with depletion of the regulatory subset of T cells that
express CD4 antigen on the cell surface. These CD4+
T cells are preferentially infected by human im-
munodeficiency virus (HIV), but neither the mechan-
ism(s) that subverts the normal function of the in-
fected cells nor the identity of viral genes involved is
well understood. Besides the gag, pol, and env genes
found in all retroviruses, immunodeficiency viruses
encode several additional "accessory" proteins. Some
of these accessory genes are not required for the viral
life cycle in established cell lines, and their function
has been difficult to assess. Several lines of evidence
indicate that these "nonessential" genes have an es-
sential function in vivo for efficient virus replication
and pathogenesis. Research in this laboratory is
focused on the function and mechanism of action of
these accessory proteins.
Our recent work has focused on understanding the
function and mechanism of action of the HIV-1 nef
gene. nef is dispensable for the viral life cycle in vitro
but is strictly required for high viral load and CD4+
T-cell depletion in animal models for AIDS. Our
laboratory has been using approaches in vivo, using
transgenic mice, and in vitro to address the con-
sequences of Nef expression on normal cellular func-
tions and its interaction with cellular regulatory me-
chanisms. We have shown previously that (1) HIV-1
Nef alleles isolated directly from peripheral blood of
HIV-1-infected individuals decrease expression of
CD4 antigen on the surface of human T cells and (2)
HIV-1 Nef alters activation and blocks development
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of CD4+ T-cell subset when expressed in T cells in
transgenic mice. These effects of Nef expression in
transgenic T cells correlated with abnormally low
CD4 antigen expression on the cell surface.
These results have broad implications, because
CD4 antigen is a cell-surface receptor for HIV that is
involved in many aspects of CD4+ T-cell biology.
CD4 is an integral membrane glycoprotein expressed
primarily on the immature thymic T cells and the ma-
ture helper T lymphocytes. The extracellular domain
of CD4 binds to a nonpolymorphic region of major
histocompatibility complex (MHC) class II molecules
expressed on the antigen-presenting cells. These
events are associated with activation of a nonreceptor
src-like protein tyrosine kinase p56ick, associated
with CD4 via its cytoplasmic tail, which couples CD4
to cellular signaling. In mature T cells, CD4 is in-
volved in T-cell activation. In addition, under some
experimental conditions, CD4 is involved in specify-
ing programmed cell death and/or Gt block in the cell
cycle progression of CD4+ T cells.
We have shown previously that CD4 down-
modulation by Nef requires a membrane proximal
region in the CD4 cytoplasmic tail and involves dis-
ruption of CD4 association with p56" During the
last year, we continued a detailed analysis of Nef in-
teraction with the CD4-p56" complex. Moreover,
we have shown that interaction of Nef with the CD4
cytoplasmic domain is required for defects in devel-
opment of CD4+ T cells in CD3 Nefl transgenic
animals.
IN T CELLS, NEF-INDUCED CD4 ENDOCYTOSIS
INVOLVES A CLUSTER OF HYDROPHOBIC AMINO
ACID RESIDUES IN THE CD4 CYTOPLASMIC TAIL
To examine the CD4 sequences required for down-
modulation by Nef, CD4 proteins bearing various
deletion or point mutations in the cytoplasmic tail
were expressed in the CD4(-) 171.22 T-cell hybrido-
ma. The derived cell lines were subsequently trans-
duced with a retroviral vector containing either an ac-
tive allele of HIV-1 nef or an empty control vector.
Expression of CD4 on the cell surface of the resultant
populations was then analyzed by flow cytometry
(Fig. 1). This analysis initially defined a short region
between M407 and 1(418 as required for the effect of
Nef. Interestingly, deletion of C420 and C422, which
Mutant
cytoplasmic
CD4 modulation Association
Mutation
439
QCPHRFQKTCSPI
Nef
+++
CD4-Ick
400
RCHMRSRQAEAMSQIKHLLSERF
.
419 420
1.0 CD4
+++ 0.2-0.5 d423
C-term +++ <0.05 6418
A +/- ND 6415
+/- ND
ND
8409
6402
<0.05 6403-418
I nt +++ 1.0 6403-406
+/- 0.2-0.4 6407-412
+/- <0.05 8412-417
C -term ND 6407-412/6423& intAL ND 6412-417/6423
A GA +++ ND Q403A,E405G,R406A
A A 0.2-0.5 m407A,1410A
A A <0.05 m407A,1410A/6423
.A.AA +++ ND Q409A,E411,,,R412Apm 0.15-0.2 L413A,L414A
A.A +++ ND T419A,Q421A
A A +++ <0.05 C420A,C422A
+++ 0.5 6411N,R412Q
..DE +++ 0.5 K411D,R412E
FIGURE 1 Effect of mutations in CD4 cytoplasmic domain on down-modulation by Nef and on asso-
ciation with p56Ick. (A) Amino acid sequences of the cytoplasmic tails of mutant CD4 proteins are
aligned on the left with that of the wild-type human CD4. Dots indicate amino acid identities with the
wild-type protein, dashes indicate the extent of internal deletions, and capital letters identify amino
acid substitutions in the single-letter code. The 12-amino-acid membrane-proximal region in the CD4
cytoplasmic tail required for down-modulation by Nef is boxed. The extent of change in CD4 expres-
sion on the cell surface following transduction with HIV-1 NA13 nef expression vector (Nef) is indi-
cated by (+++), (++), (+), (+/-) and (-). Quantitation of CD4-p56Ic5 association was performed by
Western blot analysis. The degree of p56Ick association with mutant CD4 proteins was normalized to
that observed with wild-type CD4 (1.0). ND indicates not determined.
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are required for CD4 association with p56" kinase,
is not essential for the effect of Nef.
To assess which amino acids in this region are re-
quired for down-modulation by Nef, mutants bearing
double or triple amino acid substitutions were ana-
lyzed. As shown in Figure 1, substitutions at posi-
tions proximal to M407 and distal to K418 had no
detectable effect on Nef-induced CD4 down-
modulation. In contrast, replacement of leucines 413
and 414 by alanines abrogated down-modulation by
Nef (L413A, L414A), whereas the double alanine
substitution for methionine 407 and isoleucine 410
(M407A, I410A) still responded to Nef, but at much
reduced levels. Deleting ten amino acids from the
carboxy-terminal end of the latter mutant CD4
resulted in unresponsiveness to Nef (M407A,
1410A/d423). Together, these data demonstrated that
CD4 down-modulation by Nef requires a cluster of
hydrophobic amino acids in the membrane-proximal
region of CD4 cytoplasmic tail and provided evi-
dence that the carboxy-terminal region of the tail
contributes to the interaction of CD4 with Nef.
EFFICIENT CD4-p56LCK ASSOCIATION
REQUIRES THE NEF-RESPONSIVE ELEMENT
In T cells, the cytoplasmic tail of CD4 is associated
with p56" protein tyrosine kinase, and Nef disrupts
this association by an unknown mechanism. As the
hydrophobic element required for Nef-induced CD4
endocytosis and the double cysteine motif (C420,
C422) involved in CD4 association with p56" are
located in close proximity, we tested whether the
region that is involved with CD4 endocytosis also in-
teracts with p56".
Association of mutant CD4 proteins with endog-
enous p56" was analyzed by immunoblot analysis of
anti-CD4 immune complexes prepared from deter-
gent lysates of 171.22 cells expressing selected
mutant CD4 proteins. Initially, analysis of mutant
CD4 proteins bearing various deletions of the cyto-
plasmic domain revealed that mutations affecting
residues M407 through K418, the region required for
CD4 down-modulation, also resulted in a decrease in
CD4-associated p56", suggesting that CD4 se-
quences required for down-modulation by Nef also
contribute to interaction with p56". This was seen
even more clearly with analysis of alanine substitu-
tion mutants. For example, substitution of alanines
for M407 and 1410, which dramatically reduces CD4
down-modulation by Nef, resulted in approximately a
two- to fourfold reduction in CD4-associated p56".
When the same mutations were combined with dele-
tion d423 (which lacks ten carboxy-terminal amino
acids, but retains residues C420 and C422 and is
completely unresponsive to Net), no detectable
p56" was coimmunoprecipitated. Moreover, when
alanines were substituted for L413 and L414, which
abolishes CD4 internalization induced by Nef, the
amount of coimmunoprecipitated p56" was only
one-eighth to one-fourth of that observed with wild-
type CD4. In contrast, substitutions at K411 and
R412, which had no effect on Nef-induced CD4
endocytosis, resulted in only a modest decrease in as-
sociation with p56". Therefore, the hydrophobic
amino acid residues in the membrane proximal region
in the CD4 cytoplasmic tail required for down-
modulation by Nef are also involved with efficient
recruitment of p56" into a complex with CD4 and/or
with stabilization of the complex. The overlap in
CD4 sequences required for interaction with Nef and
p56" suggests that Nef, or cellular factors recruited
by Nef, act via this region of CD4 to release p56"
from the complex and induce CD4 endocytosis.
The CD4-p56" complex is thought to involve
direct interaction between the two proteins, mediated
by cysteine motifs in the amino-terminal unique
domain in p56" and the CD4 cytoplasmic tail. Thus,
the membrane-proximal segment in the CD4 cyto-
plasmic tail may form additional contacts with the
p56" unique domain. Alternatively, our data are also
consistent with a possibility that a third component
may be required for formation or stabilization of
CD4-p56" complexes. Indeed, the relatively tight
correlation between the Nef-induced CD4 down-
modulation and formation of CD4-p56" observed
with mutant CD4 proteins suggests a model where an
additional factor(s) could interact with the mem-
brane-proximal region in CD4 cytoplasmic tail,
masking the endocytotic motif and stabilizing CD4-
p56" association. This possibility will be further ex-
plored in the future.
In Press
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PROTEIN CHEMISTRY
D.R. Marshak E. Araya
Y.-S. Bae
G. Binns
N. Carpino
G.-Y. Cha
N. Chester
S. Goren
J. Kehler
J.-P. Liu
C. van den Bos
The members of the Protein Chemistry laboratory
conduct research on cell growth using advanced
methods of analytical and preparative biochemistry.
The major focus of our efforts is the biochemistry of
protein kinases involved in controlling the responses
of cells to external signals for growth and the interac-
tions with the internal cell division cycle. Our interest
is in the role of protein phosphorylation in normal,
physiological cell division and in abnormal, patho-
physiological responses, including cancer.
Some of the methods we utilize include automated
protein sequence analysis, high-performance liquid
chromatography, quantitative amino acid analysis,
preparative electrophoresis, mass spectrometry, and
peptide synthesis. Use of such procedures allows us
to deduce chemical structures of proteins and to
synthesize their structural and functional domains. In
addition, physical analysis of proteins by mass spec-
trometry, in conjunction with chemical studies,
permits the determination of posttranslational modifi-
cations of proteins, such as phosphorylation and
acylation. This chemical approach to cell biology is
highly complementary to genetic approaches in many
of the other laboratories at Cold Spring Harbor.
Synthetic Peptides from
Protein Kinases
D. Marshak, G. Binns, N. Carpino
Protein kinases are enzymes that catalyze the transfer
of phosphates from the y-phosphate position of ATP
to a hydroxyl moiety (serine, threonine, or tyrosine)
on proteins. Protein kinases are themselves often
regulated by phosphorylation. We continue to use the
new chemistry introduced last year that allows the
synthesis of phosphorylated peptides as models of
these regulatory phosphorylation sites. Such peptides,
usually 10-20 residues in length, can be synthesized
by solid-phase methods using automated instrumen-
tation. They are constructed as protected molecules
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on polystyrene supports and then deprotected and
cleaved from the support by treatment with acid. In
our lab, rigorous purification and characterization are
carried out to assure purity and identity of the
material. We use mass spectrometric measurements
to assess the molecular weight of the product to
eliminate unwanted, modified side products that arise
from incomplete removal of protecting groups or
other modifications. The availability of this chemistry
has permitted the production of several phosphopep-
tides that have been used to prepare antibodies
specific to phosphorylation sites on proteins. We are
preparing antibodies to the various phosphorylation
sites on the cdc2 kinase, as well as the protein kinase
CKII. In addition, for kinases that require target sites
that are already phosphorylated at a site nearby the
substrate hydroxyl, these synthetic phosphopeptides
can be used as quantitative probes of activity. We
have synthesized peptides representing the phos-
phorylation site for the enzyme glycogen synthase
kinase 3, which requires a phosphorylated residue
within the recognition site of the substrate.
Molecular Cloning and
Expression of Casein
Kinase II Subunits
N. Chester, D. Marshak [in collaboration with J. Horton,
Cold Spring Harbor Laboratory, and J. Brooks,
New England Bio labs]
The enzyme casein kinase II (CKII) is a protein
serine/threonine kinase found in all eukaryotic cells.
Its ubiquitous distribution among species and tissues
implies a function central to all nucleated cells. The
enzyme consists of two subunits, catalytic and regu-
latory, with molecular masses of 37-44 kD and
24-28 kD, respectively. To answer questions about
the mechanism of enzyme regulation, we have cloned
and expressed DNA molecules coding for the full-
length forms of the subunits, using an innovative var-
iation of the polymerase chain reaction. This cloning
has allowed us to insert the coding sequences for the
CKII subunits into various expression vectors, in-
cluding a new bicistronic vector supplied by New
England Biolabs. Using these constructs, we have ex-
pressed the proteins in large amounts in bacteria. The
purified, recombinant catalytic subunits are enzymat-
ically active, and the activity is increased by the
regulatory subunit. We have purified large amounts
of the regulatory subunit for structural analysis. In
collaboration with J. Horton, we have crystallized the
regulatory subunit of CKII in forms that appear to
diffract X-rays. We continue to produce larger crys-
tals to solve the three-dimensional structure of this
protein. The regulatory subunit is a unique structure
that will be a novel contribution to the field.
Regulation of cdc2/CDC28 by
Serine Phosphorylation
C. van den Bos, D.R. Marshak [in collaboration with
A. Sutton, Cold Spring Harbor Laboratory, and
G.L. Russo, Naples]
A major player in cell cycle progression and its
regulation in mammalian cells is the protein kinase
p34cdc2. The has been found in all eukaryotes
tested; in baker's yeast (Saccharomyces cerevisiae),
for example, it has been termed cdc28. An important
aspect of this protein kinase and its functions is its
regulation by phosphorylation on multiple sites. The
enzyme is highly conserved both structurally and
functionally between evolutionary distant organisms
such as humans and yeast, and we have exploited this
by using cdc28 from S. cerevisiae as a model system
for investigating possible functions of a phosphoryla-
tion site (Ser-39) described for the human analog ear-
lier by our group. Previous work indicated that
abolishing this particular phosphorylation by mutat-
ing Ser-46 to alanine might alter the growth behavior
of S. cerevisiae, yet the phenotype observed was sub-
tle as compared to, for example, wee mutants; in ad-
dition, Ser-46/Asp mutants seemed to behave similar
to the Ser-46/Ala mutants, indicating that aspartic
acid may not be able to mimic a permanent
phosphorylation. We have now extended this work
(1) by producing a Ser-46/Glu mutant that may have
a better chance of mimicking a permanent phos-
phorylation, (2) by evaluating large numbers of size
measurements (by linking a computer to a Coulter
counter) to obtain more reliable data, (3) by challeng-
ing the yeast by means of different growth conditions
(media), and (4) by testing the influence of the Ser-46
phosphorylation upon binding of ligands to cdc28
employing our mutated strains.
Regarding the size measurements, our work
showed that indeed the Ser-46/Ala mutants exhibited
a reduced cell size; in particular, cells from Gi phase
were affected. Exposure to different growth condi-
tions (media) resulted in much more pronounced
phenotypes: Both G1 and G2 cells seemed to be af-
fected, and, furthermore, differences were observed
between the Ser-46/Ala mutant and the Ser-46/Glu
mutant (see Fig. 1). This might indicate a role of Ser-
46 phosphorylation in S. cerevisiae in both G1 and G2
as well as a functional difference between the Ser-
46/Ala mutant and the Ser-46/Glu mutant. Hence, the
Ser-46/Glu mutant might indeed mimic a permanent
phosphorylation.
As to possible influences of Ser-46 phosphoryla-
tion upon ligand binding to cdc28, we found that dif-
ferent amounts of H1 kinase activities could be
precipitated from lysates of our mutant strains. This
may indicate that the phosphorylation of cdc28 at
Ser-46 modulates the affinity toward ligand(s) or
that, depending on the phosphorylation state of cdc28
at Ser-46, different ligand(s) binds to it.
cdc28 see* mutations
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FIGURE 1 Growth curve of S. cerevisiae (cdc28 [Ser-46-
Ala/Glu]) in rich medium; curves represent averages from
15 measurements each.
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Cellular Isoforms of
Protein Kinase CKII
N. Chester, D. Marshak
The CKII enzyme activity is found both in cytosol
and in nuclei, and there are substrates identified in
both locations. Cytosolic substrates include proteins
involved in translational control (eIF-2, -3, -4B, -5),
metabolic regulation (glycogen synthase), and the
cytoskeleton (nonmuscle myosin heavy chain, (3-
tubulin). Substrates found in the nucleus include
DNA topoisomerase II, RNA polymerases I and II,
oncoproteins such as Myc, Myb, and SV40 large T
antigen, and transcription factors such as serum
response factor. The extraordinary range of substrates
for this enzyme supports the contention that CKII has
a significant role in cell physiology. We have devel-
oped a large set of specific antibodies to synthetic
peptide antigens that react with the individual sub-
units of CKII.
Protein kinase CKII can be isolated as a hetero-
tetramer, containing two catalytic (a or a') and two
regulatory (() subunits. We have characterized the
forms of CKII in He La cells using antibodies specific
for the a or a' labeling
with [35Slmethionine, whole-cell soluble extracts
were analyzed by immunoprecipitation and gel elec-
trophoresis. Both a and a' coprecipitate with (3 and
with each other. However, when extracts are depleted
of a, a pool of CKII containing only a' and 13 is iden-
tified. Similarly, depletion of a' revealed a pool ex-
clusively of a and 13. Therefore, we propose that there
exist three distinct isoforms of CKII within He La
cells with different catalytic subunit stoichiometries
(a2P2, aa'132 and a'2(2). With our immunodepletion
procedure, we have characterized the isoforms by ac-
tivity analysis, turnover of pulse-labeled subunits,
and localization in subcellular fractions obtained
from labeled cells. We have also analyzed complex
formation between the catalytic and regulatory sub-
units by examining differences in the rate of signal
incorporation into subunits in immunoprecipitates ob-
tained from continuously labeled and pulse-labeled
cells. We have found that the a2132 and ace132
isoforms assemble relatively slowly (12-16 hr),
whereas complex formation of the a'2132 isoform oc-
curs more rapidly (2-4 hr). Analysis of isoform com-
plex formation in subcellular fractions from pulse-
labeled cells revealed that the majority of nuclear
CKII is assembled in the nucleus from free catalytic
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and regulatory subunit polypeptides, rather than
being transported into the nucleus as a preassembled
complex.
CKII-binding Proteins
G.-Y. Cha, Y.-S. Bae, N. Chester, D. Marshak
The regulation of protein kinase CKII may be
through interactions with other proteins. N. Chester
has optimized immunoprecipitation methods to allow
the isolation of protein complexes involving CKII
subunits. Using these methods, he has identified can-
didate proteins as CKII-binding proteins. In a parallel
set of experiments, G.-Y. Cha and Y.-S. Bae have
used the yeast two-hybrid screening system to identi-
fy CKII-binding proteins. Initially, they demonstrated
that this system will reproducibly show subunit inter-
actions within CKII, between the catalytic and
regulatory subunits. They continued by screening the
CKII subunits individually against a cDNA library
from human cells. The goal is to isolate clones that
code for proteins that interact with CKII physiologi-
cally. Bae and Cha will continue this work in col-
laboration from their home institution, Kyungpook
University, Taegu, Korea, during 1995.
Protein Phosphorylation
in Chronic Myelogenous
Leukemia
N. Carpino, S. Goren, J. Kahler, D.R. Marshak
[in collaboration with B. Clarkson, Memorial
Sloan-Kettering Cancer Center]
Chronic myelogenous leukemia (CML) is a disease
characterized by the presence of the unregulated
p210bcrabl fusion protein tyrosine kinase, which is
associated with an uncontrolled proliferation of
myeloid cells. This project has two parts, both of
which are designed to address the role of phos-
phorylation in CML. This project is part of a Program
grant from the National Cancer Institute.
In the first project, N. Carpino and J. Kahler are
purifying proteins that are potential substrates for the
abnormally active bcr:abl tyrosine kinase. These
proteins were first identified in leukemic cells by B.
Clarkson at Memorial Sloan-Kettering Cancer Center
in New York. In collaboration with that laboratory,
we are purifying two proteins, p62 and p56, that are
both hyperphosphorylated in leukemic cells. Initial
characterization has been done by a combination of
standard chromatographic methods and affinity meth-
ods, particularly using anti-phosphotyrosine immuno-
blobulin.
The second study aims at mapping and character-
izing p34cdc2 phosphorylation sites on the p210bcnabl
protein as compared to their counterparts on the
normal c-abl protein. This work is being carried out
by S. Goren. Putative phosphorylation sites will be
mutated, and the proteins produced will be assayed
for their tyrosine kinase activity and their transforma-
tion potential using Rat-1 cells. These sites will be
confirmed in in vivo phosphorylation studies of the
p2i0bccabl protein, compared with the mutant
proteins, in COS cells. In addition, transformation ac-
tivity of the mutant proteins will be assayed in the
human myeloid cell line MO7 in comparison with the
transformed cell line M07/p210, which stably ex-
presses the p210b":abl protein. The phenotypes of the
mutant proteins will be further characterized by
determining their subcellular localization, identifying
substrate specificity, cell division cycle dependence
of c-abl, and bcr:abl phosphorylation by the p34cdc2
kinase.
Protein Chemistry Core
Facility: Peptide Synthesis
G. Binns, D. Marshak
The Protein Chemistry Core facility provides high-
technology methods, equipment, and expertise for
use by all of the scientists here at the Laboratory.
Among the services available is the preparation of
synthetic peptides for use as antigens, as enzyme sub-
strates, as hormones and growth factors, and as
entities for structural analysis. Peptides are assembled
in the solid phase, usually of polystyrene supports. In
this classic approach, first developed by Bruce Mer-
rifield at The Rockefeller University, the solid sup-
port allows reagents and unwanted side products to
be washed away continuously at every step without
the requirement for purification of the peptide at each
stage. At the end, the peptide is cleaved from the
resin in a very active acid, hydrogen fluoride, under
closed conditions. We then purify the peptide to
homogeneity by reversed-phase HPLC. Using this
approach, more than 400 peptides have been
synthesized during the last few years. The structures
are confirmed by amino acid analysis, mass spec-
trometry, and analytical HPLC. In addition, we pro-
vide assistance for investigators who are attempting
to use synthetic peptides as antigens to prepare
antibodies that will react with a cellular protein.
There is a particular strategy that one takes to obtain
good anti-peptide immunoglobulin. This strategy
takes into consideration both the synthesis itself and
the position in the target protein, as well as coupling
methods for the antigen.
The Protein Chemistry Core facility is active in the
Association of Biomolecular Resource Facilities
(ABRF). This is worldwide organization of resource
facilities whose purposes are (1) to promote and fa-
cilitate discussion and cooperation among facilities;
(2) to provide research mechanisms for evaluation
and improvement of the capabilities of facilities; and
(3) to promote the education of facility staff, users,
administrators, and interested members of the
scientific community regarding facility functions.
The ABRF exists because facilities have demanded
an organization that will provide them with a mech-
anism for sharing information, maintaining state-of-
the-art procedures, evaluating performance, and ex-
panding to new areas. D. Marshak is a member of the
Executive Board of the ABRF, and he hosted the
winter board meeting. Involvement with the ABRF
helps to maintain communication with other facilities
around the world and improves our ability to
maintain high standards of work. The ABRF provides
standards that allow facilities to self-evaluate their
performance and obtain expert advice on improve-
ment, as necessary.
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MOLECULAR GENETICS OF EUKARYOTIC CELLS
The Section on "Molecular Genetics of Eukaryotic Cells"can boast several major accomplishments
during 1994. Dr. Spector's laboratory has demonstrated the recruitment of splicing factors within
the nucleus to sites of nascent RNA transcripts containing introns, but not at sites of intronless
transcripts. Dr. Helfman's group has identified factors that promote muscle-specific alternative
splicing and demonstrated that the dimerization pattern of tropomyosins is determined by alterna-
tive splicing. Dr. Tonk's laboratory has completed the structure of the first phosphotyrosine
phosphatase complexed with a peptide substrate and utilized the MAP kinase phosphatase, MKP-
1, to demonstrate the physiological roles of the MAP kinase (together with Dr. Bar-Sagi). Dr.
Wigler's laboratory has demonstrated multiple pathways activated by Ras in the sexual differentia-
tion of fission yeast and in mammalian cell transformation. Dr. Lisitsyn, in collaboration with Dr.
Wigler's group, has discovered new loci in human cancers that are the frequent site of genetic
deletion. Dr. Hengartner joined our section and studies the pathways of programmed cell death, or
apoptosis, based on his ground-breaking observations that these pathways are conserved in
metazoans.
MAMMALIAN CELL GENETICS
M. Wig ler G. Asouline D. Esposito C. Nicolette
P. Barker K. Farina K. O'Neill
M. Barr M. Hamaguchi T. Polverino
J. Brodsky V. Jung M. Riggs
E. Chang R. Lucito L. Rodgers
J. Douglas S. Marcus J. Stolarov
During 1994, work in our group fell into two areas:
signal transduction, the pathways that process the
biochemical information that directs cellular ac-
tivities, and the detection and characterization of ge-
netic lesions in cancer cells. The first area stems from
our long-term interest in the RAS genes, the genes
that we first demonstrated were commonly activated
in human cancers and that we subsequently dis-
covered to be conserved in evolution. The second
area stems from the use of representational difference
analysis, or RDA, a method for comparative genomic
analysis. These latter studies were conducted in col-
laboration with Dr. Nikolai Lisitsyn.
Signal Transduction
H.-P. Xu, L. Van Aelst, E. Chang, S. Marcus, T. Polverino,
M. White, V. Jung, C. Nicolette, K. O'Neill, M. Barr,
J. Stolarov, H. Tu
We have been studying RAS pathways in yeasts and
vertebrates. In the budding yeast, Saccharomyces
J. Troge
H. Tu
L. Van Aelst
M. White
H.-P. Xu
cerevisiae, RAS regulates adenylyl cyclase and is re-
quired for the progression of the cell through the Gi
phase of the cell cycle (Wig ler et al., Cold Spring
Harbor Symp. Quant. Biol. 53: 649 [1988]). Our
studies in this organism are nearly complete. Vincent
Jung (Jung et al. 1995) has cloned the gene for a new
component required for normal RAS function in S.
cerevisiae. Called SHR5 (the fifth suppressor of hy-
peractive RAS), it appears to be required for the effi-
cient localization of RAS to the membrane. Studies
of SHR5 also confirm earlier studies demonstrating
multiple functions of RAS in S. cerevisiae. Kathy
O'Neill, a graduate student from Columbia Univer-
sity, continues to study the cellular role of CAP (the
second suppressor of hyperactive RAS), a protein
that we demonstrated to be associated with adenylyl
cyclase and to be required in vivo for the efficient in-
teraction of the latter with RAS. She has identified
cytoskeletal elements that interact with CAP and that
may direct its localization and consequently that of
adenylyl cyclase to regions of the cell where it can
encounter RAS.
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The majority of our recent studies of RAS have
been in the fission yeast Schizosaccharomyces
pombe. In this organism, RAS is required for sexual
differentiation. It regulates gene expression, as shown
by Hao-Peng Xu and others (Xu et al. 1994), by way
of a protein kinase cascade (Wang et al., Mol. Cell.
Biol. 11: 3554 [1991]), and it also regulates cellular
morphology by way of a completely distinct path-
way, as shown by Eric Chang (Chang et al. 1994).
These two distinct pathways are the clearest
demonstration of multiple RAS functions in the same
organism, a conclusion that was drawn first from
studies in budding yeast (Wig ler et al., Cold Spring
Harbor Symp. Quant. Biol. 53: 649 [1988]). The
morphogenic pathway has a homolog in budding
yeast and may involve proteins that regulate another
GTP-binding protein, a member of the RHO family
(Chang et al., Cell 79: 131 [1994]). This in turn may
regulate another protein kinase, SHK1, which is
likewise conserved in evolution, as shown by Stevan
Marcus and others (S. Marcus et al., in press). Further
studies in the fission yeast by V. Jung have led to the
discovery of a new mutation in RAS that dominantly
interferes with wild-type RAS function (Jung et al.
1994). These studies suggest the existence of multi-
ple independent regulators of RAS in S. pombe.
The kinase cascade regulated by RAS in S. pombe
is conserved in evolution, and it is now called a MAP
kinase module. We have extended our studies to this
module. Working with the budding yeast pathway re-
quired for sexual differentiation, S. Marcus dis-
covered that STE5 is a scaffolding protein that can
interact with the STE11, STET, and FUS3 protein
kinases (Marcus et al. 1994). This led us to postulate
that STE5 promotes the interaction of these protein
kinases and also serves as an insulator, limiting cross
talk between this MAP kinase module and others
with distinct functions and regulators. In S. pombe,
byr2 is the protein kinase required for sexual differ-
entiation that interacts directly with RAS. Maureen
Barr, a graduate student from Columbia University,
has identified another upstream regulator of byr2.
The existence of this upstream regulator may help ex-
plain the concerted action of RAS and G proteins in
the sexual differentiation of S. pombe (Xu et al., Mol.
Cell. Biol. 14: 1333 [1994]). Maureen Barr and Hua
Tu, a graduate student from SUNY, Stony Brook, are
identifying the domains of byr2 that interact with its
upstream regulators.
The observation that a MAP kinase module was
conserved in evolution and that this module was
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regulated by RAS in both fission yeast and verte-
brates led to the demonstration that RAF was an im-
mediate downstream target of RAS in vertebrates
(Van Aelst et al., Proc. Natl. Acad. Sci. 90: 6213
[1993]). RAF is itself encoded by a proto-oncogene
and is a protein kinase capable of activating the MAP
kinase module. Current work by Javor Stolarov, a
graduate student from Columbia University, is
directed at defining the domains of RAF that are in-
volved in its regulation. To ask further if RAF
mediates RAS effects in vertebrates, Michael White
created mutant RAS proteins that fail to interact with
RAF and complementary RAF mutants that restored
interaction (White et al., Cell 80: 533 [1995]). Exper-
iments with these mutants led to the unambiguous
conclusion that RAF can mediate transformation of
mammalian cells and induction of gene expression by
RAS. However, these same types of experiments also
led to the clear conclusion that other RAF-
independent pathways can also contribute to trans-
formation by RAS (White et al., Cell 80: 533
[1995]).
As in fission yeast, RAS thus has multiple targets
in vertebrate cells. To begin to define these, Linda
Van Aelst has used the yeast two-hybrid system of
Fields and Song to identify new genes encoding
proteins that bind to RAS (Van Aelst et al. 1994).
Comparative Genomic Analysis
M. Hamaguchi, P. Barker, H.-P. Xu, R. Lucito,
D. Esposito, with Dr. N. Lisitsyn
The method of representational difference analysis,
which was developed here at the Laboratory by Dr.
Nikolai Lisitsyn and Michael Wigler, has been de-
scribed in our previous reports (Lisitsyn et al.,
Science 259: 946 [1993]). It enables the cloning of
differences between two similar genomes. Recently,
it has been used by other investigators to discover
viruses associated with human disease, including
Kaposi's sarcoma and hepatitis. We have been apply-
ing it to the analysis of the differences between the
genomes of tumor cells and the normal cells from
which they derived. When we seek sequences lost in
tumor cells, we generally find probes for loci that
have either undergone homozygous deletion or loss
of heterozygosity. Two of the loci we have identified,
one on chromosome 3 and one on chromosome 20,
undergo frequent deletions in gastrointestional
tumors (Lisitsyn et al. 1994, 1995). We have ob-
served lesions at these loci in breast cancer and rarely
in other types of cancers. So far, RNA transcripts
from these loci have not been detected.
When we seek sequences gained in tumor cells rel-
ative to normal cells, we generally have found probes
that detect gene amplification. We have isolated such
probes from melanomas, lung cancers, and breast
cancers, mapping, respectively, to chromosomes 3, 2,
and 17. The second and third may represent the N-
myc and ERB-B2 locus, respectively. The first may
represent a novel locus.
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CANCER GENETICS
N. Lisitsyn N:Lisitsina
We are interested in the discovery of critical genes,
disrupted in cancer cells by various types of genetic
alterations, and understanding the biological function
of these genes. Our approach to detection of DNA
changes in tumors is based on application of a new
powerful technology for finding the differences be-
tween genomes, developed in Mike Wigler's labo-
ratory (Lisitsyn et al., Science 259: 946 [1993]). This
year, our efforts have been focused on the finding
and mapping of homozygous deletions in DNA of
certain types of tumors. Such genetic alterations have
been regarded as evidence that the affected genomic
regions are harboring tumor suppressor genes, which
we have sought to identify by positional cloning.
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Identification and Mapping
of Homozygous Deletions
in Tumors
N. Lisitsina, N. Lisitsyn [in collaboration with R. Lucito and
M. Wigler, Cold Spring Harbor Laboratory]
Extensive search for DNA losses has been performed
in 30 kidney cancer and colon cancer cell lines, using
a new powerful technology for finding the dif-
ferences between the genomes, called representa-
tional difference analysis (RDA). In 12 cases, we
have searched for losses in tumor DNAs isolated
from aneuploid nuclei, which have been fractionated
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from tumor biopsies by the fluorescence-activated
cell sorter. We have found probes, detecting homo-
zygous losses in kidney cancer cell lines (six probes),
colon cancer cell lines (three probes), and esophageal
and breast cancer biopsies (one of each), and have lo-
cated these probes in nine separate genomic regions
(Lisitsyn et al. 1995). Two of the regions, harboring
previously known tumor suppressor genes MTS 1
and DCC, have been excluded from further analysis,
and the other seven regions have been cloned by
screening of yeast artificial chromosome (YAC)
and/or cosmid libraries.
We have searched for the most frequently deleted
loci by isolating sequence-tagged sites (STSs) from
YACs, using a new subtraction technology, which we
have developed for this purpose, and determining the
frequency of their loss in a large collection of DNAs
isolated from cancer cell lines. Two STSs from two
separate genomic regions, located on chromosomes 3
and 20, have been found to be deleted with remark-
able frequency (-10%) in DNAs isolated from cancer
cell lines established from tumors of the gastrointesti-
nal tract. Simultaneous homozygous loss of both
STSs has been detected in two tumor DNAs, indicat-
ing that potential tumor suppressor genes, encoded in
these regions, are involved in different pathways.
Positional Cloning of a
Potential Tumor Suppressor
Gene from Region 3p21
N. Lisitsina, N. Lisitsyn [in collaboration with F. Leach
and B. Vogelstein, The Johns Hopkins Oncology Center,
and M. Hamaguchi, R. McCombie, and M. Wig ler, Cold
Spring Harbor Laboratory]
We have identified the genomic region, frequently
deleted in tumors of the gastrointestinal tract, and
mapped it to band p21 on human chromosome 3 by
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polymerase chain reaction (PCR) of radiation
hybrids. On the basis of the absence of the micro-
satellite instability phenotype in most colon cancer
cell lines with homozygous losses in this region, a
potential tumor suppressor gene has proved to be dif-
ferent from the mutL gene homolog (a gene altered in
patients with hereditary nonpolyposis colon cancer,
which is located in the same place). Four overlapping
cosmids, spanning a minimal region of homozygous
loss (100 kb long), have been used for the cloning of
transcribed sequences by direct cDNA selection and
exon-trapping methodologies, providing five exons
of candidate genes expressed in colon and stomach
cells. The sequences of full-length cDNA copies of
these genes will be determined and used for muta-
tional analysis.
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TRANSMEMBRANE SIGNALING
D. Bar-Sagi M. Boyer
K. Degenhardt
J. Hong
T. Joneson
S. Kaplan
S-.S.Yang
Our interest is in the regulation of cell growth by ex-
tracellular signals. Our research has continued to
focus on the mechanisms of signal transduction by
Ras proteins. ras genes comprise a highly conserved
eukaryotic gene family. They encode membrane-
associated guanine nucleotide-binding proteins that
function as molecular switches passing signals that
control cell growth and differentiation to intracellular
effector molecules. The chemical basis for this
switch function involves the cycling of Ras proteins
between active GTP-bound and inactive GDP-bound
states. In normal quiescent cells, the Ras proteins ex-
ist primarily in the inactive GDP-bound form. Upon
stimulation by a variety of mitogenic and differentia-
tion signals, rapid and transient elevation of Ras-GTP
levels are observed. Thus, the GTP/GDP cycle pro-
vides a rapid and regulatable mechanism for Ras
modulation of signal transduction pathways. Muta-
tions found in oncogenic forms of Ras proteins im-
pair their GTPase activity, thus perturbing this cycle,
and render these mutated proteins in a chronically ac-
tive state. During the past year, we have continued
and extended our studies on the characterization of
the mechanisms by which Ras proteins mediate the
transduction of signals from cell surface receptors to
intracellular effector molecules. In addition, we have
devoted much effort during this past year toward the
identification of the cellular components that mediate
the mitogenic activity of Ras proteins with the aim of
furthering our understanding of the molecular events
underlying the aberrant growth properties of Ras-
transformed cells.
Regulation of the Mammalian
Ras Exchange Factor Sos
K. Degenhardt
The Son of sevenless (Sos) proteins are guanine
nucleotide exchange factors involved in the activa-
tion of Ras by cytoplasmic and receptor tyrosine
kinases. In virtually all cells examined thus far, Sos is
found in complex with the adaptor protein GRB2.
We have previously shown that the interaction be-
tween Sos and GRB2 is mediated by the proline-rich
carboxy-terminal domain of Sos and the SH3 domain
of GRB2. Upon growth factor stimulation, the
GRB2-Sos complex binds to the activated receptor
through the SH2 domain of GRB2. However, the
guanine nucleotide exchange activity of Sos is not
measurably affected by growth factor stimulation.
Thus, it has been postulated that receptor stimulation
serves to translocate the GRB2-Sos complex to the
activated receptor. This translocation could lead to an
increase in the guanine nucleotide exchange on Ras
by increasing the local concentration of the exchange
factor in the plasma membrane where Ras is located.
Growth factor stimulation rapidly induces the
phosphorylation of Sos on serine and threonine
residues. Under conditions where Ras activity is in-
hibited, no phosphorylation of Sos occurs, suggesting
that the phosphorylation of Sos may be mediated by
downstream components of the Ras signaling path-
way. We have characterized the phosphorylation of
Sos by two-dimensional phosphopeptide mapping.
Growth factor stimulation results in the phosphoryla-
tion of Sos on multiple sites. A significant proportion
of these sites are also phosphorylated by MAP kinase
in vitro, indicating a role for MAP kinase in mediat-
ing the growth-factor-induced Sos phosphorylation.
Other cellular serine/threonine kinases of as yet un-
known identity also contribute to Sos phosphoryla-
tion. Sos phosphorylation in vivo and by MAP kinase
in vitro occurs at the carboxy-terminal region of the
molecule. GRB2 binding to Sos does not affect the
ability of MAP kinase to phosphorylate Sos. How-
ever, growth factor stimulation is accompanied by an
apparent decrease in the affinity of GRB2 for Sos
both in vivo and in vitro. The growth-factor-induced
dissociation of the GRB2-Sos complex coincides
with Sos phosphorylation. Moreover, phosphorylated
Sos molecules are preferentially localized to the
cytosol. These findings point to a potential negative
feedback mechanism to control growth-factor-in-
duced activation of Ras.
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Differential Interaction of
hSOS1 and hSOS2 with GRB2
S. -S. Yang
Mammalian cells contain two related but distinct
SOS proteins designated SOS1 and SOS2. Although
SOS1 and SOS2 share a high degree of overall
similarity (69% identity), it is not known to what ex-
tent their biological and biochemical properties over-
lap. The most divergent region between these two
proteins lies in their carboxyl terminus (38%
identity). A number of studies have shown that the
carboxy-terminal proline-rich domain of SOS1
directly interacts with the SH3 domain(s) of the adap-
tor protein GRB2 /SemS/Drk. The biochemical fea-
tures and physiological significance of this interac-
tion have also been well documented. In contrast,
little is known about the interaction of SOS2 with
GRB2. In the present study, we have compared the
interaction of hSOS1 and hSOS2 with GRB2. Using
the yeast two-hybrid system, we showed that the
carboxy-terminal proline-rich domain of hSOS2 is
necessary and sufficient for association with GRB2.
As in the case of its counterpart hSOS1, the interac-
tion of hSOS2 with GRB2 relies on the intact SH3
RTK
domains of GRB2. However, the apparent binding af-
finity of hSOS2 for GRB2 is significantly higher rel-
ative to that of hSOS1 both in vitro and in vivo. The
region conferring this higher binding affinity has
been mapped to residues 1126-1242 of the hSOS2
carboxyl terminus using chimeric proteins. This
region of hSOS2 is enriched in putative high-affinity
SH3-binding motifs relative to hSOS. Therefore, we
propose that the higher-affinity of hSOS2 could be
due to the increased abundance of high-affinity SH3 -
binding sites for GRB2 and/or their relative position
within the carboxyl terminus of hSOS2. Our data
show, for the first time, that SOS1 and SOS2 display
a difference in their biochemical properties. It will be
interesting to test whether this can provide a mechan-
ism for signal diversity.
Ras Signaling and the Regulation
of Cell Growth and Motility
T. Joneson [in collaboration with M. White and M. Wigler,
Cold Spring Harbor Laboratory]
Genetic and biochemical studies have identified the
mitogen-activated protein (MAP) kinase cascade as a
critical downstream mediator of Ras signaling. Ras
FIGURE 1 Increasing complexity of the Ras signal transduction pathway. Our
studies have established that the mitogenic activity of Ras is mediated by at least
two distinct signaling cascades: the MAP kinase cascade, which regulates tran-
scriptional events in the nucleus, and the Rac cascade, which mediates changes in
cytoskeletal organization. The functional relationship between these two Ras-
dependent pathways will be the subject of our future studies.
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proteins are also known to induce the reorganization
of the actin cytoskeleton (Fig. 1). We have used a mi-
croinjection assay to analyze the functional rela-
tionship between these two Ras-dependent signals
and to establish their relative contribution to the
mitogenic effects of Ras. In this assay, the expression
of the microinjected reporter construct containing the
serum response element (SRE) is used to monitor the
activation of the MAP kinase cascade, membrane ruf-
fling is used to detect the reorganization of actin
cytoskeleton, and DNA synthesis is used to score
mitogenic effects. In quiescent rat embryo
fibroblasts, activated Ras (RasV12) induces MAP
kinase activation, membrane ruffling, and DNA
synthesis. Coinjection of RasV12 and the MAP
kinase phosphatase MKP -1 blocks MAP kinase ac-
tivation and DNA synthesis but not membrane ruf-
fling. Injection of activated forms of Raf (v-Raf or
Raf-CAAX) induces MAP kinase activation but has
no effect on membrane ruffling, suggesting that ac-
tivation of the MAP kinase cascade is neither neces-
sary nor sufficient for the induction of membrane ruf-
fling. We have identified an effector- binding-loop
mutant of Ras that is defective in Raf interaction and
MAP kinase activation but retains the ability to in-
duce membrane ruffling. An activated form of this
mutant containing the V12 substitution is unable to
stimulate DNA synthesis when injected into quies-
cent fibroblasts. Another effector-binding-loop
mutant of Ras, RasV12S35, does not induce mem-
brane ruffling but has previously been shown to inter-
act with Raf and activate MAP kinase. This mutant is
also unable to induce DNA synthesis in quiescent
fibroblasts, indicating that activation of MAP kinase
is not sufficient for Ras-induced mitogenesis. Coin-
jection of both Ras mutants results in a significant
stimulation of DNA synthesis. These results indicate
that stimulation of membrane ruffling and activation
of the MAP kinase cascade represent two indepen-
dent Ras effector systems that bifurcate at the level of
the Ras protein itself. An input from both pathways is
required for the mitogenic activity of Ras.
Inhibition of Ras-induced
Proliferation by p16INK4
D. Bar-Sagi [in collaboration with M. Serrano and
D. Beach, Cold Spring Harbor Laboratory]
In mammalian cells, Ras proteins have a critical role
in stimulating the transition from the quiescent to the
DNA replication phase of the cell cycle. A key
regulatory component in the progression of cells
through the Gi phase of the cell cycle is the cyclin-
dependent kinase 4 (CDK4). The activity of CDK4 is
controlled by the opposing effects of the D-type
cyclin, an activating subunit, and pl6INK4, an in-
hibitory subunit. It has been postulated that pl6INK4
acts as a tumor suppressor protein because the
1 6INK4 gene is frequently deleted in tumor cell lines
and shows a high frequency of point mutations and
small deletions in some tumor cell lines and primary
tumors. We have utilized the mitogenic activity of
Ras proteins to investigate whether pl6INK4 can exert
growth-suppressing activity. Ectopic expression of
pl6INK4 blocked entry into S phase of the cell cycle
induced by oncogenic Ras. This block was relieved
by coexpression of a catalytically inactive CDK4
mutant, indicating that the inhibition of Ras-induced
mitogenesis by pl6tNK4 is specifically mediated via
its inhibitory effect on CDK4. Expression of p16INK4
also suppressed cellular transformation of primary rat
embryo fibroblasts by oncogenic Ras and Myc. To-
gether, these observations provide evidence that the
growth-promoting activity of the Ras oncogene can
be effectively antagonized by pl6INK4. These find-
ings further support the notion that pl6INK4 functions
as a tumor suppressor gene.
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PROTEIN TYROSINE PHOSPHATASES AND THE CONTROL OF
CELLULAR SIGNALING RESPONSES
N.K. Tonks S.M. Brady-Kalnay A.J. Garton S.N. Mamajiwalla
M.A. Daddario M.J. Gutch A.A. Samatar
R.L. Del Vecchio Y.F. Hu H. Sun
A.J. Flint K.R. La Montagne S.H. Zhang
The phosphorylation of tyrosyl residues in proteins is
a key component of the control of many fundamental
physiological processes. Our lab is particularly inter-
ested in the role of tyrosine phosphorylation in trans-
ducing an extracellular signal into an intracellular
response, such as proliferation or differentiation.
Protein phosphorylation is a reversible, dynamic pro-
cess in which the net level of phosphate observed in a
target substrate reflects not only the activity of the
kinases that phosphorylate it, but also the competing
action of protein phosphatases that catalyze the
dephosphorylation reaction. We study the expanding
family of protein tyrosine phosphatases (PTPs) that,
like the kinases, comprise both transmembrane,
receptor-linked forms and nontransmembrane, cyto-
solic species. The structures of the PTPs indicate im-
portant roles in the control of key cellular functions.
During the last year, Bill Eckberg completed his
sabbatical and returned to Howard University, Wash-
ington, D.C. and Peter Guida, Jr., left to begin Ph.D.
studies at Albert Einstein. We were joined by Mike
Gulch as a postdoctoral fellow and Martha Daddario
as a technician.
Receptor PTPs: Roles in
Cell-Cell Contact Phenomena
S.M. Brady-Kalnay, S.N. Mamajiwalla,
A.A. Samatar, N.K. Tonks
A characteristic feature of the extracellular segment
of many receptor-like PTPs is the presence of im-
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munoglobulin (Ig)-like and fibronectin type III
(FNIII) domains. These are motifs that are commonly
found in cell adhesion molecules. PTPR comprises
(1) an extracellular segment containing a MAM
domain, one Ig-like domain, and four FNIII domains,
(2) a single transmembrane domain, and (3) an in-
tracellular segment containing two PTP domains
separated from the transmembrane domain by a jux-
tamembrane sequence that displays homology with
the intracellular segment of the cadherin superfamily
of cell adhesion molecules. We have previously
shown that when expressed in Sf9 cells, PTPR in-
duces the formation of cell:cell aggregates through a
homophilic binding mechanism, i.e., PTPR on one
cell binds to PTPIA, on an adjacent cell. Such
homophilic binding required only the presence of the
extracellular segment and was also observed for
PTP[t as normally expressed on the surface of mink
lung MvLu cells. Thus, the ligand for PTPtt is anoth-
er PTPR molecule on the surface of an adjacent cell.
We have now generated, expressed, and purified var-
ious fragments of the extracellular segment of PTPIA
and have used fluorescent beads (covaspheres)
coated with these fragments in a number of binding
assays to establish that the Ig domain is both neces-
sary and sufficient for homophilic binding. Schles-
singer's group at New York University have found
that when Sf9 cells expressing PTP1,t and PTPx (a
close homolog of PTPR displaying -75% overall
identity) were mixed, they sorted independently. In
other words, PTPR binds to itself but not to PTPx,
suggesting that the homophilic binding interaction is
highly specific. Therefore, the reagents we have de-
veloped toward the Ig domain of PTPit may prove
very useful in defining the physiological significance
of these homophilic binding interactions.
As far as we can tell, aggregation, i.e., ligand bind-
ing to the extracellular segment of PTPR, had no
detectable direct effect on the activity of the in-
tracellular PTP domains. However, it is possible that
the activity of PTPI..t may be controlled indirectly by
restricting its distribution in the membrane and thus
restricting the spectrum of substrates with which it
interacts. Our most recent data suggest that under
physiological conditions of expression in mink lung
cells, PTPµ is localized to adherens junctions, which
are defined points of cell-cell contact at which the ac-
tin cytoskeleton is anchored. Within these junctions,
we have found that PTPR associates directly with
members of the cadherin superfamily and is
recovered as part of a complex with cadherin, a
catenin and f3 catenin. Preliminary data suggest that
the cadherins may be endogenous substrates for
PTPR. These data are provocative because tyrosine
phosphorylation of the cadherin/catenin complex has
been observed under a variety of physiological condi-
tions and interferes with its normal adhesive function,
potentially contributing to transformation and metas-
tasis. It appears that PTPR may provide the re-
gulatory balance to this phorylation event, thus
maintaining the complex in its normal dephosphory-
lated state.
We are also studying a broadly expressed receptor
PTP termed DEP-1 (density-enhanced PTP). The
cDNA predicts an enzyme with eight FNIII repeats in
its extracellular segment and a single intracellular
PTP domain. The most striking property of this en-
zyme is that its expression is increased dramatically
in dense relative to sparse cell cultures. In a series of
experiments currently under way, we have detected
striking morphological changes in cells in which this
enzyme is overexpressed that are not seen in cells
overexpressing other members of the PTP family. We
are currently trying to identify the important sub-
strates for this effect, and preliminary data suggest a
number of cytoskeletal targets.
These observations suggest that receptor PTPs
may be important contributors to the mechanism of
contact inhibition of cell growth. As normal cells in
culture approach confluence, and adjacent cells touch
each other, growth is inhibited. In cancer cells, this
process is disrupted. Since tyrosine phosphorylation
has been implicated in promoting cell growth and
proliferation, PTPs as the natural antagonists of PTK
function may exert a negative effect on such growth-
promoting signals by triggering net dephosphoryla-
tion of proteins in the membrane. The advantage of
the involvement of receptor PTPs in such a pheno-
menon is that their extracellular segments may
"sense" directly cell-cell contact. Engagement of the
extracellular segment of a receptor PTP in this way in
confluent cells may either modulate its activity
directly or target it to a particular junctional complex
so as to trigger dephosphorylation of a defined subset
of phosphotyrosyl proteins and initiate the growth in-
hibitory response.
MKP-1, a TyrfThr Dual Specificity
Phosphatase That Dephosphorylates,
and Blocks Signaling Downstream
from, MAP Kinase
H. Sun and N.K. Tonks [in collaboration with
D. Bar-Sagi, Cold Spring Harbor Laboratory]
Recently, progress has been made by many labs in
defining signaling pathways initiated by mitogenic
stimuli. Growth-factor-induced autophosphorylation
of tyrosyl residues in receptor-PTKs induces the
formation of multiprotein complexes in the mem-
brane that trigger conversion of Ras from an inactive
GDP-bound form to an active GTP-bound state. Ac-
tivated Ras then initiates a cascade of sequential
phosphorylation events in which the Ser/Thr kinase
Raf phosphorylates and activates MAP kinase kinase
(also known as MEK), which is a dual specificity
kinase that in turn phosphorylates both Thr-183 and
Tyr-185 in MAP kinase. Phosphorylation of both
tyrosine and threonine regulatory sites is essential for
activation. The MAP kinase family of enzymes has
been implicated as common and essential com-
ponents of signaling pathways induced by diverse
mitogenic stimuli. Once activated, MAP kinase can
phosphorylate a number of substrates, including tran-
scription factors, that are essential for triggering the
expression of genes required for the mitogenic
response. Therefore, growth factor binding initiates a
complex network of protein phosphorylation events
that lead a quiescent cell to enter the cell cycle, un-
dergo DNA replication, and ultimately divide. One of
these immediate early genes that is activated rapidly
and transiently in quiescent fibroblasts treated with
serum growth factors is 3CH134, which encodes a
dual specificity (Tyr/Thr) phosphatase termed MKP-
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1. MKP-1 possesses intrinsic phosphatase activity
that is highly specific for both the tyrosine and
threonine regulatory sites in MAP kinases. It thus has
the potential to feed back on the growth factor signal-
ing pathway to prevent uncontrolled growth and
proliferation.
In light of the high degree of substrate specificity
displayed by MKP-1, we set out to use it as a
molecular probe to investigate physiological roles for
MAP kinase. Using a microinjection strategy in
REF52 rat fibroblasts, we showed that expression of
MKP-1 inhibits the ability of growth factors, TPA,
and oncogenic Ras, which signal through the MAP
kinase pathway, to trans-activate a promoter contain-
ing five copies of a serum response element (SRE)
linked to a CAT reporter. Furthermore, MKP-1
blocked the induction of DNA synthesis in quiescent
REF52 fibroblasts by the Val-12 oncogenic mutant
form of Ras (Fig. 1). These results suggest an essen-
tial role for the activation of MAP kinases in the
transition from quiescence to the DNA replication
phase of the eukaryotic cell cycle. In similar experi-
ments in Xenopus egg extracts, in collaboration with
Jeremy Minshull and Andrew Murray (University of
California, San Francisco), we have shown that the
activation of MAP kinase is required for the estab-
lishment and maintenance of the mitotic arrest in-
duced by depolymerization of spindle microtubles.
We are currently using MKP-1 as a probe to investi-
gate other physiological roles for MAP kinase as well
as trying to characterize mechansims for posttransla-
tional control of the activity of the phosphatase in
vivo.
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Cytoplasmic PTPs: Analysis of
the Structure, Regulation, and
Function of PTP1B
A.J. Flint, Y.F. Hu, K.R. La Montagne, N.K. Tonks
PTP1B was the first member of the family to be iso-
lated in homogeneous form. The amino-terminal seg-
ment of the protein comprises the catalytic domain to
which is fused a regulatory carboxy-terminal tail. We
have previously characterized a cell-cycle-dependent
phosphorylation of seryl residues in this regulatory
segment. Furthermore, others have shown that the ex-
treme carboxy-terminal 35 amino acids are highly
hydrophobic and both necessary and sufficient for
targeting the enzyme to the cytoplasmic face of mem-
branes of the endoplasmic reticulum.
In collaboration with David Barford (now at the
University of Oxford), we determined the crystal
structure of the catalytic domain of PTP1B. It is com-
posed of a single domain with the polypeptide chain
organized into 8 a helices and 12 strands with a 10-
stranded mixed r3 sheet, which adopts a highly
twisted conformation, spanning the entire length of
the molecule. The structure illustrates that the se-
quence motif [I/V]FICXAGXXR[S/T]G, which con-
tains the catalytically essential nucleophilic cysteinyl
residue and uniquely defines the PTP family of en-
zymes, forms the phosphate recognition site and is lo-
cated at the base of a cleft on the surface of the
protein. We proposed that specificity for phos-
photyrosine-containing substrates probably resulted
from the depth of the cleft, since the structure sug-
FIGURE 1 Inhibition of V12 Ras-induced DNA synthesis by MKP-1. Quiescent REF52
cells were microinjected with bacterially expressed V12 Ras protein together with
control plasmid (e) or plasmid expressing MKP-1 (f). BrdU incorporation was
detected by immunohistochemical staining. The fields were visualized and photo-
graphed with phase-contrast microscopy. (Reprinted, with permission, from Sun et
al. Science 265: 285-288 [1994].)
gested that the smaller phosphoserine and phos-
phothreonine residues would not reach down to the
phosphate-binding site.
We have now examined this issue of substrate
binding by determining the structure of PTP1B corn-
plexed with a high-affinity peptide substrate repre-
senting an autophosphorylation site of the epidermal
growth factor receptor. We made use of the fact that a
catalytically inactive mutant of PTP1B, in which the
essential cysteine from the signature motif, C215,
was replaced by serine, retained the ability to bind
substrate even though it could not dephosphorylate it.
We observed that peptide binding to the protein was
accompanied by a large conformational change in a
surface loop at one end of the substrate-binding cleft,
which created a recognition pocket that surrounded
the phosphotyrosine in the substrate. In fact, PTP1B
represents an example of Koshland's concept of "in-
duced fit", whereby substrate binding induces a con-
formational change that creates the catalytically com-
petent form of the enzyme. As we initially postulated,
the depth of the pTyr binding pocket, which at -9 A
exactly matches the length of a pTyr residue, is a
major determinant of specificity for phosphotyrosine.
A similar mechanism has been proposed to explain
the specificity of SH2 domains for pTyr residues. An-
other determinant of specificity for PTP1B is the
presence of nonpolar side chains lining the cleft that
form hydrophobic interactions with the phenyl ring of
the pTyr residue. Engagement of pTyr by the binding
pocket anchors the peptide to the peptide-binding
site. Hydrogen bonds between peptide main-chain
atoms and the protein contribute to binding affinity,
and specific interactions of acidic residues of the pep-
tide with basic residues on the surface of the enzyme
confer sequence specificity. However, the relatively
open structure of the peptide-binding site is con-
sistent with the ability of PTP1B to dephosphorylate
a variety of pTyr substrates.
We are currently using this structural information
as a guide for preparing various mutant forms of
PTP1B in which we have altered key residues that are
important for substrate recognition. Preliminary
studies suggest that some of these mutants, for exam-
ple, D181A, retain a high affinity for substrate but
display an exceedingly poor ability to catalyze
dephosphorylation. We are currently expressing such
mutants to see if we can trap and thus identify
physiological substrates for PTP1B. We are particu-
larly intrigued by the possibility that PTP1B may be
involved in chronic myelogenous leukemia (CML).
CML is a clonal disorder of the hematopoietic stem
cell characterized by the Philadelphia chromosome,
in which the c-Abl proto-oncogene on chromosome
9, encoding a PTK, becomes linked to the bcr gene
on chromosome 22. This results in the production of
a fusion protein termed p210 bcr:abl, the PTK ac-
tivity of which is enhanced relative to c-Abl generat-
ing abnormal patterns of tyrosine phosphorylation in
CML cells. We have observed that the level of ex-
pression of PTP1B, but not TCPTP, which displays
74% identity to PTP1B, is increased severalfold in a
variety of cells that express p210 bcr:abl, including
lines derived from a CML patient. This effect, which
is due to enhanced stability of the PTP1B protein, re-
quires the PTK activity of p210 bcr:abl and is not
seen in cells expressing v-abl or the v-src PTK or in
cells transformed by myc, a non-PTK oncogene.
Therefore, it appears that specifically following ex-
pression of bcr:abl PTK oncoproteins, there is selec-
tively enhanced expression of PTP1B, implying an
important function for this phosphatase in signaling
pathways triggered by bcr:abl. We are in the process
of expressing PTP1B mutants, such as D181A, in
cells expressing p210 bcr:abl, to determine whether
we can trap either the oncoprotein PTK or some of its
signaling components as complexes with the mutant
phosphatase.
Regulation of PTP Activity
R.L. Del Vecchio, A.J. Garton, M.J. Gutch,
S.H. Zhang, N.K. Tonks
The activity of members of the PTP family may be
regulated at several levels. In the case of the receptor-
like enzymes, there is obviously the potential for
modulation of activity by ligand binding to the ex-
tracellular segment. In addition, it appears that many
of the members of this family will be responsive to
regulation by reversible phosphorylation, intracellular
targeting and association with other proteins. We are
currently investigating each of these potential modes
of regulation in various members of the family.
PTP-PEST is a soluble enzyme that is expressed
ubiquitously in mammalian tissues. We have shown,
both in vitro and in vivo, that PICA and PKC are
capable of phosphorylating two sites, Ser-39 and Ser-
435, in PTP-PEST. Phosphorylation of Ser-39 is in-
hibitory, reducing the affinity of PTP-PEST for sub-
strate, offering a mechanism whereby signal trans-
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duction pathways acting through Ser/Thr kinases
(PICA or PKC) may indirectly influence the phos-
phorylation of tyrosyl residues in cellular proteins.
We have now observed that phosphorylation of Ser-
435 appears to affect the subcellular distribution of
PTP-PEST, promoting association with an endosomal
membrane fraction. We are currently trying to identi-
fy the components of the membranes with which
PTP-PEST associates and to define which other sig-
nal transduction pathways promote the phosphoryla-
tion of Ser-435 in the phosphatase.
The importance of subcellular targeting is also
seen in the case of PTPX1 and X10 from Xenopus.
These enzymes possess amino-terminal segments that
have homology with lipid-binding proteins and can
associate with endosomal membranes, which corre-
lates with an increase in activity. In addition, PTPH1
displays homology, in its amino-terminal segment,
with the band-4.1 superfamily of proteins which are
targeted to interfaces between the plasma membrane
and the cytoskeleton. We have shown that this seg-
ment exerts a negative influence on catalytic activity
and are currently trying to identify potential
regulatory proteins that interact with this segment.
Finally, in collaboration with Michael Hengart-
ner's group here at the Laboratory, we have recently
initiated a study of PTPs in Caenorhabditis elegans.
We hope to use the power of this genetic system to
provide insights into the regulation and function of
members of the PTP family.
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NUCLEAR SIGNAL TRANSDUCTION
M. Gilman D. Grueneberg
G. Lee
T. Nahreini
S. Natesan
A. Ryan
H. Sadowski
K. Simon
M.-L. Vignais
We continue our focus on how extracellular signals interpreted there into specific patterns of gene ex-
are communicated to the nucleus and how they are pression for the biological response requested by
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each signal. Our work revolves primarily around our
understanding of how the mammalian proto-
oncogene c-fos is activated by extracellular stimuli.
In past years, we have worked out aspects of the or-
ganization of the c-fos promoter and the identification
of DNA-binding proteins and signal transduction
pathways that relay signals to the gene. Most of our
recent attention has focused on the serum response
element (SRE), a DNA sequence required for the
transcriptional response of the c-fos gene to multiple
independent signal transduction pathways. Activity
of the SRE requires binding of a protein termed
serum response factor (SRF), a ubiquitously ex-
pressed MADS-box transcription factor. SRF is the
nucleus for the formation of multiprotein complexes
at the SRE that contain proteins whose activities are
directly modulated by signals. Thus, one of the clear
roles of SRF in this process is to recruit these signal-
responsive proteins to the DNA.
Our work this year has focused in three general
areas. First, we have studied how SRF itself is
recruited to the DNA, because we believe that SRF
recruitment is a critical step in determining which
genes in a cell have the potential to respond to ex-
tracellular signals. We have identified two types of
partners that can help SRF bind DNA-homeo-
domains of the Paired class and the ubiquitous zinc-
finger protein YY1. Second, we have studied one of
the signal transduction pathways that links growth
factor receptors with the c-fos gene, which involves
transcription factors of the STAT family. Third, we
have extended our studies of nuclear signal transduc-
tion to Drosophila, in which we can more readily as-
sess the role of these pathways in an intact animal.
We have isolated and studied a gene encoding a fly
homolog of SRF and a fly member of the JAK kinase
family, thought to be involved in STAT activation by
cytokines.
SRF-Homeodomain Complexes
and the Specificity of Signal
Transduction to the Nucleus
D. Grueneberg
A key unresolved issue in development is how
similar signal transduction pathways can elicit dis-
tinct patterns of gene expression in different cells.
Our working hypothesis is that such signals are inter-
preted at the transcriptional level by factors that regu-
late cell-type-specific gene expression. We believe
that interactions between SRF and homeodomain
proteins may serve as a model for understanding this
mechanism. We have found that a novel human
homeodomain protein, Phoxl, and related homeo-
domains of the Paired class, can interact with SRF in
vitro and enhance its binding to certain sequences.
We have now devised an assay to study the inter-
action between SRF and Phox 1 in vivo. In He La
cells, Phox 1 can enable an SRE-containing reporter
gene to respond to serum growth factors. By a variety
of criteria, we believe that the activity of Phoxl in
this assay reflects its ability to recruit functional SRF
to the reporter. Although we do not know the organi-
zation of the SRF-Phox 1 complex, testing of various
Phox 1 homeodomain mutants in this assay shows that
activation of the reporter requires amino acids in all
three helices of the Phoxl homeodomain. Most inter-
estingly, the Phoxl homeodomain activates transcrip-
tion from only a subset of SRE-binding sites in He La
cells. It appears that Phoxl targets SRF to specific
moderate-affinity binding sites for transcriptional ac-
tivation in response to extracellular signals.
Our working model implies that ubiquitously in-
ducible genes contain an SRE that strongly binds
SRF without requirement for a homeodomain partner
and that SRF in turn recruits its signal-responsive ac-
cessory proteins to confer a transcriptional response
to signals. Genes induced in a cell-type-specific pat-
tern may contain an imperfect SRE that binds SRF
only in the presence of an appropriate homeodomain
protein. The resulting SRF-homeodomain complexes
retain the ability to recruit signal-responsive SRF ac-
cessory proteins to confer a transcriptional response
to incoming signals, but only in cells expressing the
correct homeodomain protein.
Structure of SRF-Homeodomain
Complexes
K. Simon
We have previously cloned a novel human homeo-
domain protein, Phox 1, that interacts with SRF to en-
hance its binding to DNA. Our working hypothesis is
that Phoxl can recruit SRF to DNA-binding sites that
SRF does not recognize alone and thereby bring the
entire SRF transcriptional activation apparatus to
sites that would be enhancers of cell-type-specific
genes. To test this hypothesis, we have generated a
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series of Phoxl mutants and tested their activities in
vitro and in vivo to determine which amino acids in
Phox 1 are important for interaction with SRF.
The homeodomain consists of three a helices
separated by short loops and an amino-terminal arm
of disordered structure in solution. In cocrystals of
homeodomains and DNA, both the amino-terminal
arm and helix 3 make contact with the DNA
molecule. Helices 1 and 2 are situated away from the
DNA, toward the solvent. In scanning the Phox 1
homeodomain by mutagenesis, we find that mutants
fall into three classes. One class fails to bind DNA in
vitro and to activate an SRE reporter gene in vivo.
These mutations suggest a role for major-groove
DNA contacts for activation by Phoxl in vivo. A sec-
ond class of mutations, localized on the solvent-
exposed surfaces of helices 1 and 2, does not affect
DNA binding but still abolishes activation in vivo.
These mutations suggest a requirement for contact of
the Phoxl homeodomain with another protein,
presumably, but not necessarily, SRF. The third class
of mutations, mainly in the amino-terminal arm,
abolishes DNA binding but leaves transcriptional ac-
tivation intact. We believe that these mutations iden-
tify portions of the homeodomain that have a dif-
ferent function in vivo than is indicated in the simple
binary protein-DNA structures revealed by crystal-
lography and nuclear magnetic resonance (NMR).
We have also made mutations in the Drosophila
homeoprotein Deformed, which is in a different
homeodomain class. Deformed has no detectable ac-
tivity on the SRE in vivo, but when amino acid
residues on the surface of Deformed helix 2 are re-
placed with the corresponding residues on Phoxl, the
resulting chimeric proteins acquire the ability to ac-
tivate the SRE in vivo. This observation suggests that
the specificity of action of a homeodomain can be
changed by alterations to the solvent-exposed surface
of the protein. It adds to the presumed importance of
protein-protein interactions in the function of the
homeodomain.
Regulation of SRF-SRE Complex
Formation by YY1
S. Natesan
The c-fos proto-oncogene is rapidly induced by a va-
riety of growth factors, cytokines, and other ex-
tracellular stimuli. Several DNA elements in the
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promoter region of the gene mediate the transcrip-
tional response to these signals. These elements are in
close proximity to each other and to the transcrip-
tional start site, and each binds one or more transcrip-
tion factors responsive to multiple signals. Thus, the
structural and functional organization of the c-fos
promoter region may be crucial to its prompt and
coordinated transcriptional response to extracellular
signals.
We have previously shown that the zinc-finger
transcription factor YY1 has a role in the structural
organization of the c-fos promoter by bending DNA
upstream of the TATA box. YY1 binds to at least
three sites in the mouse c-fos promoter and induces
DNA bends of approximately 80° in each of these
sites. YY1-induced DNA bending at a site between
the cAMP response element (CRE) and the TATA
box in the c-fos promoter affects the interaction be-
tween proteins bound at these sites.
YY1 also regulates the activity of the c-fos SRE
by promoting the assembly of a multiprotein complex
at this element. YY1 binds to and induces a phased
bend in the SRE. Binding of YY1 to the SRE ac-
celerates the association of SRF with the SRE. This
effect requires binding of YY1 to the SRE, and we
observe a ternary complex in which YY1 and SRF
co-occupy the SRE. In this complex, SRF makes pre-
dominantly minor groove contacts with the DNA,
whereas YY1 contacts the major groove. We propose
that YY1 binding induces a conformation in SRE
DNA that is kinetically favorable for subsequent
binding by SRF. Together with its role at the TATA-
proximal site, this observation suggests a general role
for YY1 in the building of highly organized promoter
complexes. The diverse functions of YY1 in impart-
ing structural organization to protein DNA com-
plexes may account for its role in complex elements
such as developmentally regulated silencers and
highly regulated genes like c-fos.
Regulation of c-fos Transcription by
Tyrosine Phosphorylation of Latent
Cytoplasmic Transcription Factors
H. Sadowski
Receptor tyrosine kinases (RTKs) activate c-fos tran-
scription through multiple pathways. One signal pro-
ceeds through the ras/MAP kinase pathway, resulting
in the phosphorylation and activation of Elk-1 and
other ternary complex factors that bind to the SRE.
But RTKs activate a second pathway that targets a
distinct element in the c-fos promoter, termed the SIE
(v/c-sis-inducible element). Treatment of cells with
PDGF rapidly induces novel DNA-binding activities,
termed SIF, that recognize the c-fos SIE. During the
past 3 years, we have extensively characterized these
proteins, showing that SIF DNA-binding activity is
regulated by tyrosine phosphorylation and that SIF
proteins are members of the STAT family of tran-
scription factors, specifically, STAT1 and STAT3.
The STAT pathway defines a novel and highly direct
signal transduction pathway from the cell surface to
the nucleus shared by receptors of distinct structural
organization.
Our recent work has focused on the mechanism of
activation of STATs by RTKs, with a particular focus
on the receptor for PDGF. We have tested a set of
PDGFR mutants carrying substitutions in critical
tyrosine residues required for the recruitment and ac-
tivation of various downstream signaling proteins.
We find that SIF activation requires the protein-
tyrosine kinase activity of the PDGFR. Furthermore,
mutations that eliminate the recruitment, and pre-
sumably the activation, of PI3 kinase, GAP, phos-
pholipase C-y, and the protein tyrosine phosphatase
Syp (which in turn recruits proteins required for ac-
tivation of the ras pathway) have no effect on SIF ac-
tivation. In contrast, a single substitution of
phenylalanine for tyrosine at position 579 in the
PDGFR nearly totally abolishes SIF activation by
PDGF. This residue was previously identified as a
site of recruitment for Src family protein tyrosine
kinases, thus raising the possibility that Src kinases
are intermediates in the activation of SIF by RTKs.
Consistent with this hypothesis, we have observed
that activation of a temperature-sensitive v-Src
protein results in the rapid activation of STAT3 inde-
pendently of new protein synthesis, suggesting that
STAT3 activation is a direct consequence of the in-
duction of Src activity.
Regulation of SIF/Stat Activity
by Polypeptide Growth Factors
M.-L. Vignais
STAT1 and STAT3 proteins are also activated by a
number of cytokines, whose receptors, unlike those
of EGF and PDGF, do not harbor intrinsic protein
tyrosine kinase activity. Signaling by these receptors
relies on noncovalently associated protein tyrosine
kinases of the JAK family. The role of specific pairs
of JAK kinases in the activation of STAT1 by inter-
ferons a or y has been demonstrated using a powerful
genetic approach. We have adapted this approach to
evaluate the contribution of JAK kinases to the ac-
tivation of STAT proteins by the PDGFR. Using
amphotrophic retroviral vectors encoding functional
PDGF-(3 receptors, we have derived cell lines carry-
ing comparable numbers of cell-surface receptors but
lacking individual JAK kinases. We have tested these
cell lines for their ability to support SIF activation by
PDGF. In wild-type cells, all three ubiquitously ex-
pressed JAK kinases-JAK1, JAK2, and Tyk2-are
tyrosine phosphorylated when cells are treated with
PDGF. However, none of these kinases are individu-
ally required for the activation of STAT1 or STAT3
by PDGF. These results contrast with data obtained
for interferon receptors, where kinases of the JAK
family have been shown to be individually required
for full activation of the STAT proteins.
To address the mechanism of STAT activation by
the PDGFR directly, we are exploiting our previously
developed cell-free assay for STAT activation. We
now find that recombinant STAT1 protein produced
in Escherichia coli can be activated in vitro by EGF
in the presence of A431 membranes. Activation is not
augmented by the addition of cytosol, indicating that
no cellular components beyond those supplied by the
membrane fraction are required. We will use conven-
tional biochemical approaches, such as fractionation
and depletion, to identify the membrane components
required for STAT activation in vitro.
The Structure and Function of a
Drosophila Homolog of SRF
A. Ryan
To study further the role of SRF in cell signaling and
activation of transcription during animal develop-
ment, we have isolated a full-length cDNA encoding
a closely related protein from Drosophila. Amino
acid identity in the region encompassing DNA-
binding and dimerization activity is greater than 95%.
The DSRF gene was mapped by in situ hybridization
to the right arm of chromosome 2 at site 60C. DSRF
mRNA is ubiquitously distributed in the early precel-
lular embryo. RNA levels decline during cellulariza-
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tion and increase upon gastrulation and organ-
ogenesis, during which RNA appears in localized
patterns that coincide with the developing trachea.
Immunocytochemistry using a monoclonal antibody
against DSRF indicates that DSRF protein is found in
most imaginal discs of the Drosophila larva.
DSRF shares many biochemical properties with
the human protein, including DNA-binding speci-
ficity and the ability to form cooperative ternary
complexes with the Ets-domain protein Elk-1. DSRF
interacts productively with Elk-1 in transfected
Drosophila tissue culture cells and can mediate Rasl-
induced transcription of a reporter gene.
To evaluate the function of SRF during develop-
ment, we are constructing transgenic flies carrying
reporter genes with SRF-binding sites. We have con-
structed a set of reporter genes that direct lacZ ex-
pression under the control of an 85-base-pair element
from the mouse c-fos promoter that is sufficient for
the response to multiple signal transduction pathways
emanating from receptor tyrosine kinases. This ele-
ment includes binding sites for SRF, Elkl, and the
STAT proteins. A set of analogous reporters carrying
mutations in each of these factor binding sites has
also been constructed. These plasmids are being in-
jected into Drosophila embryos with the goal of es-
tablishing stable lines of flies in which lacZ expres-
sion is activated in response to various characterized
signaling systems in the fly embryo.
Biochemical Analysis of a
Drosophila JAK Kinase
Involved in Hematopoietic
Neoplasia
T. Nahreini [in collaboration with D. Harrison, R. Binari,
and N. Perrimon, Harvard Medical School]
The hopscotch (hop) gene of Drosophila melano-
gaster encodes a nonreceptor tyrosine kinase of the
JAK family identified in mammals. Drosophila hop
has been implicated in the regulation of cellular
proliferation. The first characterized allele of hop,
Tumorous-lethal (hopTum-l), is a dominant temper-
ature-sensitive mutation associated with the forma-
tion of melanotic tumors and hypertrophy of the lar-
val lymph glands, which are the hematopoietic
organs of Drosophila. At restrictive temperatures,
hopTum-I is lethal, with dominant induction of
melanotic tumors. At lower temperatures, hopTum-1
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mutants are viable, but they also develop tumors.
hopTum-1 is the only known dominantly acting on-
cogene in Drosophila.
Sequence analysis of a wild-type hop cDNA and a
cDNA derived from the hopTum-1 allele, performed
by Douglas Harrison, Richard Binari, and Norbert
Perrimon in the Department of Genetics at Harvard
Medical School, showed that hopTum-1 encodes a
protein with a single-amino-acid substitution of
glutamic acid for glycine in a region of the protein
that encodes neither the kinase nor the kinase-like
domain. Overexpression of either wild-type hop or
hopTum-1 in the larval lymph glands of flies caused
melanotic tumors and lymph gland hypertrophy. This
observation suggests that the hopTum-1 lesion gener-
ates a hyperactive enzyme.
To test this hypothesis biochemically, we exam-
ined the level of phosphotyrosine in Hop and
HopTum -1 proteins overexpressed in Drosophila tis-
sue culture cells by transient transfection. cDNAs
from hop and hopTum-I were placed under the tran-
scriptional control of the cytoplasmic actin promoter
and transiently transfected into SL2 cells. Both plas-
mids directed the expression of similar amounts of an
immunoreactive protein with a molecular weight of
130 kD, similar to that predicted for Hop. In addition,
both overexpressed proteins were phosphorylated on
tyrosine. The HopTum-I protein, however, exhibited
a three- to fivefold elevation in tyrosine phosphoryla-
tion compared to Hop. Therefore, our results are con-
sistent with the hypothesis that hop encodes a
protein-tyrosine kinase and that the hopTum-I lesion
causes hyperactivity of the enzyme. The combined
genetic and biochemical data support the idea that
elevated Hop activity is sufficient for formation of
melanotic tumors in Drosophila.
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MOLECULAR CELL BIOLOGY
D.M. Helfman M. Gimona M. Selvakumar J. Wang
J. Grossman C. Temm-Grove A. Watakabe
W. Guo
The work in our group is focused on two fundamen-
tal areas in molecular and cell biology: (1) the me-
chanisms responsible for cell-type-specific gene ex-
pression and (2) the reason cells express specific
gene products. The genes that we have been studying
are among the major components of the cytoskeleton
in eukaryotic cells. The cytoskeleton is involved in a
multitude of cellular functions such as cell shape and
motility, organelle movement, chromosome move-
ment, and cytokinesis. In particular, our laboratory
has been interested in understanding the regulation
and function of tropomyosin gene expression in mus-
cle and nonmuscle cells. Tropomyosins are a diverse
group of actin filament-binding proteins with distinct
isoforms present in striated muscle (skeletal and car-
diac), smooth muscle, and nonmuscle cells. We now
know that at least 16 different tropomyosin isoforms
are expressed from four separate genes in vertebrates
through a complex pattern of alternative RNA splic-
ing. We have been studying the expression of these
genes with particular attention to understanding the
mechanisms of tissue-specific alternative RNA splic-
ing. In addition, the function of these different
isoforms is not known and is under study.
This year, a number of people from our lab have
moved on to new positions. George Mulligan com-
pleted his Ph.D. and has taken a postdoctoral position
with Tyler Jacks at the Massachusetts Institute of
Technology. Three postdoctoral fellows left our
group, including Stefan Stamm who moved to the
Max Plank Institute for Psychiatry in Munich,
Germany; Jeff Kazzaz took a position at Winthrop
University Hospital on Long Island; and Mark Pit-
tenger has moved to a biotechnology company. Be-
low is a summary of our studies during the past year.
Exon Sequences Have a
Role in Cooperation Across
a 3' and 5' Splice Site
M. Selvakumar
gene which contains exon 5-intron 5-exon 6 could
not be spliced in an in vitro splicing assay. This can
be overcome by three different cis-acting elements
using He La cell nuclear extract: (1) a previous splic-
ing event joining exon 6 to exon 8, (2) a poly(U) sub-
stitution in the 3' splice site of exon 6, and (3) a 5'
consensus mutation in the 5' splice site of exon 6
(Tsukahara et al. 1994). Examination of the se-
quences in exons 6 and 8 revealed the presence of
purine-rich motifs that have been implicated as ex-
onic enhancers in other systems. To determine if
these motifs have a critical role in this splicing event,
we made substitutions (purine to pyrimidine) in indi-
vidual motifs as well as combinations of motifs. Our
results show that mutating all the motifs completely
abolishes splicing. Interestingly, longer pre-mRNA
substrates containing multiple exons and introns (ex-
ons 5 through 8) skip the nonmuscle exon 6 in an in
vitro assay using nonmuscle nuclear extract. Exon 6
was included when a poly(U) substitution was made
in its 3' splice site. However, mutating the two
purine-rich motifs in exon 6, in the poly(U) context,
causes exon 6 to be skipped. This is in accordance
with the exon definition model which predicts that
exons are recognized via their splice sites instead of
across an intron. It has been shown that factors that
interact with the 3' and 5' splice sites of an exon are
involved in protein:protein interactions via bridging
factors across an exon. Presumably, purine-rich
motifs act by stabilizing these bridging factors. To
look at effects of these mutations in an in vivo con-
text, these mutations were made in an SV40 vector
and will be transfected into HeLa cells and REF52
cells. RNA-binding assays are planned to look for
proteins interacting with these purine-rich motifs.
Use of Antibodies against
PTB to Detect Specific
RNA-Protein Interactions
J. Grossman
Previously, it has been shown in our lab that a simple We recently found that at least one protein, the
pre-mRNA substrate derived from the 13-tropomyosin polypyrimidine tract-binding protein (PTB), specifi-
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cally interacts with sequences upstream of exon 7
which are involved in alternative splicing of 13-TM
pre-mRNA (Mulligan et al., J. Biol. Chem. 267:
25480 [1992]). To identify other proteins that interact
with these sequences, [35S]methionine-labeled nu-
clear extracts from He La cells were mixed with non-
biotinylated RNAs. The RNA-protein complexes
were recovered by immunoprecipitation using
monoclonal antibodies to PTB, and the proteins were
resolved using one- and two-dimensional gel elec-
trophoresis. When RNAs containing intron 6 were
coprecipitated with antibodies to PTB, a novel set of
proteins were found to coprecipitate. In contrast, ad-
dition of RNAs containing introns 5 or 7 gave the
same results as no RNA, indicating that these RNAs
are unable to form a stable complex with PTB. These
results are in agreement with our previous studies
demonstrating that PTB interacts with sequences with
intron 6 but not with sequences in introns 5 or 7.
When [35S]methionine-labeled nuclear extracts were
mixed with biotin-RNA containing intron 6, and the
RNA protein complexes recovered using avidin-
agarose beads, the identical patterns of proteins were
observed compared to the immunoprecipitation as-
say.
Finally, analysis of the proteins that assembled on
introns 5, 6, or 7 using biotin-RNA revealed a unique
set of proteins that interact with each of these se-
quences, indicating that different hnRNP proteins are
bound to different regions of the pre-mRNA. Experi-
ments are in progress to study the interaction of
proteins obtained from myogenic cells in order to
identify cell-type-specific factors that interact with
distinct regions in the (1-TM pre-mRNA.
Analysis of Factors from Myogenic
Cells That Promote the
Recognition of a Muscle-specific
Exon in p-Tropomyosin Pre-mRNA
Y.-C. Wang
The 13-tropomyosin ((3 -TM) gene in rat and mouse
contains two pairs of alternative exons that are
spliced in a tissue-specific manner. The regulation of
the internal exon pair (exons 6 and 7) has been ex-
tensively studied. Exon 6 is incorporated in non-
muscle and smooth muscle cells, whereas exon 7 is
exclusively used in skeletal muscle cells. To date, in
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vitro studies have been limited to extracts derived
from He La cells. Previous studies suggest that the
splicing of exons 5 to 7 (skeletal muscle-type splice)
is suppressed in He La cells by a negative factor (Guo
et al., Genes Dev. 5: 2096 [1991]). Muscle cells may
simply lack this negative factor or express a muscle-
specific factor that promotes the inclusion of exon 7.
To understand the regulation of the splicing of 13-TM
pre-mRNA in skeletal muscle cells, we have been de-
veloping an in vitro splicing system from the mouse
BC3H1 myogenic cell line.
We are also utilizing a complementation assay of
the BC3H1 nuclear extract or its fractions added to
the human 293 nonmuscle cell nuclear extract to
identify factors involved in the regulation. The addi-
tion of BC3H1 nuclear extracts to 293 nuclear ex-
tracts stimulated the splicing of exons 5 to 7 in a 13-
TM minigene transcript. This stimulatory activity
was also detected in nuclear extracts from the mouse
C2C12 skeletal muscle cell line but not in 3T3
fibroblasts or HeLa cells. This activity was resistant
to treatment with micrococcal nuclease and was
precipitated in 20 mu of MgC12, which is a character-
istic feature of the SR protein family. When the SR
proteins purified from HeLa cells were added to the
293 nuclear extract, the splicing of
not stimulated. But when the SR proteins were added
to the BC3H1 nuclear extract, stimulation was
detected. Thus, a stimulatory factor(s) present in
skeletal muscle cells may cooperate with the SR
proteins in promoting the splicing of exons 5 to 7 in
pre-mRNA. Work is in progress to further
characterize this activity.
Study of PTB-binding
Proteins using the Yeast
Two-hybrid System
W. Guo
The functional role of PTB in the regulation of
alternative splicing of exons 6 and 7 remains to be
elucidated. We are using the yeast two-hybrid system
to identify proteins interacting with PTB. Fusion
proteins in which PTB1 and PTB3 fused to GAL4-
binding domain (pGBT9PTB) have been constructed
and used as baits to screen a HeLa cDNA library that
has been fused to GALA transcriptional activation
domain (GAD). We have detected protein S20, a
mammalian ribosome small subunit protein, interact-
ing with PTB1 and PTB3 bait proteins and turning
blue in the filter color assay. The interaction between
PTB and S20 detected by the two-hybrid system
seems to be specific, as we did not detect any interac-
tions between PTB and Ras, PTB and SNF4, S20
with Raf, and S20 with SNF1 in similar pairwise
two-hybrid assays.
We are currently studying the binding of PTB with
S20 in an in vitro system to see if the interaction
detected in vivo occurs in vitro. In picornavirus, PTB
has been shown to bind to IRES (internal ribosomal
entry site) and is essential for IRES function in the
translation of viral RNA. It has been proposed that
PTB will specifically attach to the IRES and bring the
40S ribosomal subunit into the vicinity of a potential
initiation codon. The interaction between PTB and
S20 detected by the two-hybrid system suggests that
S20 could be a potential candidate that brings the 40S
ribosomal subunit to IRES via PTB and initiates the
viral RNA translation.
TM-5-Rhodamine
Isolation and Characterization of
cDNA Clones Encoding a
Low-molecular-weight Fibroblast
Tropomyosin TM-5
W. Guo, C. Temm -Grove
Last year we reported the isolation and characteriza-
tion of a cDNA clone encoding a seventh rat
fibroblast TM, herein referred to as TM-5, that is the
product of a fourth gene which is homologous to the
human hTMnm gene. Expression of TM-5 in a vari-
ety of rat tissues and transformed cell lines was ex-
amined using Northern blot and RNase protection as-
says. The gene encoding TM-5 is expressed in all tis-
sues examined including skeletal muscle, stomach,
heart, liver, kidney, uterus, spleen, brain, and
diaphragm. However, RNase protection analysis
revealed the presence of different mRNAs in fibro-
blasts, striated muscle (skeletal and diaphragm), and
brain, which are expressed via alternative RNA splic-
Phalloidin-FTTC
A
FIGURE 1 Labeling of microfilaments in rat fibroblasts by microinjection of fluores-
cently tagged TM-5. Bacterially expressed TM-5 was conjugated with rhodamine
and microinjected into REF52 cells to study in vivo actin filament binding and
localization. Rhodamine-labeled TM-5 can be seen along the stress fibers and at the
leading lamella (arrow) of the cells (A, 8). The cells were double-stained with
phalloidin-FITC to demonstrate the localization of F-actin (1A' , B').
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ing and the use of alternative promoters. The TM-5
protein was expressed in a bacterial system and tested
for its ability to bind actin in vitro and in vivo. It was
found that TM-5 bound to actin with a similarly high
affinity as TM-5b and it localized to the stress fibers
and ruffles of the leading lamella (Fig. 1).
Characterization of Brain-type
Isoforms of Tropomyosin
A. Watakabe
Among numerous isoforms of tropomyosin, TmBrl
and TmBr3 are distinguished in that they are highly
tissue-specific. These isoforms are expressed only in
brain or cells derived from the nervous system. Both
of these isoforms contain unique carboxy-terminal
coding sequences due to the use of exon 9c. To begin
to study the role of these isoforms, we examined if
these tropomyosins bind to F-actin. In vitro experi-
ments using purified muscle F-actin and recombinant
TmBrl and TmBr3 showed that TmBrl and 3 bind to
F-actin at reduced efficiency compared with other
tropomyosin isoforms. To determine if this weaker
binding would also occur in vivo, we transfected
fibroblast with either TmBrl or 3 and examined if
these isoforms are incorporated into actin-based
structures such as stress fibers. Consistent with the in
vitro results, both of these isoforms were poorly in-
corporated into stress fibers, whereas other.
tropomyosin isoforms such as Tm2 and TmSa were
efficiently incorporated. Collectively, these studies
show that TmBrl and 3 have intrinsically weak af-
finity for F-actin. We are also examining if there is
any protein that binds to the brain-type tropomyosin
isoforms using antibody-based blot overlay (AnBO)
assay. In this AnBO assay, brain proteins are run on
SDS gels and transferred to a nitrocellulose mem-
brane, which is probed with epitope-tagged recom-
binant tropomyosin. Subsequently, the binding of
tropomyosin to the blotted protein was detected by
Western blotting with anti-epitope antibody. Using
this assay, we found that TmBr3 as well as TmSa
bind to tropomodulin, a protein originally identified
as the tropomyosin-binding protein in platelets. In ad-
dition, we detected another protein that binds prefer-
entially to TmBr3 and does not bind to TmBrl or
Tm2. AnBO assay showed that this protein is specific
to brain. We have partially purified this protein for
microsequencing. Future characterization of this
protein will provide greater insights into understand-
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ing the function of brain-type tropomyosins. These
studies will increase our understanding of the role of
the cytoskeleton in nervous system functions.
Tropomyosin Isoform Diversity
in Epithelial Cells
C.J. Temm-Grove [in collaboration with B.M. Jockusch,
Braunschweig Technical University, Germany]
Tropomyosin isoform expression is highly cell- and
tissue-specific. One interest of our work has been to
characterize and understand the significance of the
tropomyosin (TM) diversity in renal brush border
epithelial cells (BB). Previously, it was reported that
the porcine kidney epithelial cell line, LLC-PK1, has
retained much of the character of renal brush border
cells. We have characterized the TM isoform expres-
sion of these cells and found that primary BB cells
and LLC-PK1 cells express the same isoforms of TM
(TM-1, TM-2, TM-3, TM-5, TM-5a, TM-5b, TM-6),
whereas the other cell lines exhibited some dif-
ferences in the patterns of TMs expressed. Further-
more, it was found that the high-molecular-weight
(HMW) isoforms TM-1 and TM-3 are present in
larger amounts relative to the other isoforms in BB-
type cells, in contrast to those of rat fibroblasts,
where TM-1 and TM-2 are predominant. In addition,
whereas fibroblasts express primarily TM-5a, the BB
cells express only TM-5b among the low-molecular-
weight (LMW) products of the a gene. Im-
munofluorescence analysis using antibodies directed
against HMW TMs (TM-1, TM-2, TM-3, and TM-6)
and LMW TMs (TM-5, TM-5a, TM-5b) revealed that
HMW isoforms were localized to stress fibers but not
in adhesion belts, whereas the LMW isoforms were
found in the adhesion belts. These results were con-
firmed using the epitope-tagged TM constructs. The
dynamic distribution of these isoforms was verified
by the microinjection of representative fluorescently
labeled recombinant TM isoforms expressed in the
pET bacterial expression system.
Tropomyosin Characterization
and Expression during
Differentiation of LLC-Pki Cells
C.J. Temm-Grove
The relationship of TM expression and localization to
cell growth and differentiation during morphological-
ly differentiating stages has been tested in the renal
epithelial cell line, LLC-PK1, using available iso-
form-specific antibodies. It was found that at least the
low-molecular-weight isoform, TM-5b, switches on
at a certain stage of development. These biochemical
assays were correlated with fluorescence microscopy
and F-actin structure (as seen with phalloidin stain-
ing). It was found that the expression of TM-5b be-
gins with the stable development of adhesion belts.
This suggests that these isoforms may fulfill a
specific function at that site, which is not required at
stress fibers. Signal transduction pathways that are
stimulated by cell-cell contact or default pathways in-
duced by removal of serum probably cause the devel-
opment of the adhesion belt. These may also be
responsible for TM-5b expression simultaneous with
adhesion belt/terminal web formation.
The Specificity of Dimer
Formation of Tropomyosin
M. Gimona, A. Watakabe
Tropomyosins consist of nearly 100% a-helix and as-
semble into parallel and in-register coiled-coil
dimers. In vitro, it has been established that non-
muscle as well as native muscle TMs can form homo-
dimers but that the mixture of both a and muscle
TMs rapidly adopts the more stable a/13 heterodimer
conformation. Although the assembly preference of
the muscle TM heterodimer can be understood
thermodynamically, the significance of its predomi-
nance in several muscles is not known. Studies of
TMs from fibroblasts demonstrate that these isoforms
exist as homodimers. TM functions as a dimer and
isoform diversity allows a variety of different dimers
to be formed. Because specificity is determined addi-
tionally by the relative thermodynamic stability of all
possible protein-protein interactions, understanding
this process requires identifying forces that stabilize
preferentially the favored complex as well as forces
that destabilize the incorrect one. Several groups
have previously addressed the question of homo-
versus heterodimer formation using purified muscle
or nonmuscle TMs. However, all of these approaches
had to either denature or chemically stabilize the TM
chains. We have investigated the dimerization of
tropomyosins in vivo at low temperature where chain
exchange is minimized using epitope tagging with a
16-amino-acid sequence of influenza hemagglutinin
(HA-tag). We used immunoprecipitation from ex-
tracts of transfected cells to analyze the composition
of the dimers, taking advantage of the slight changes
in electrophoretic mobility and differential antibody
specificity conferred to the TMs due to the epitope
tag. Single transfections demonstrate the preference
of the 284-amino-acid HMW nonmuscle isoforms
TM-1, TM-2, and TM-3 to form homodimers. Co-
transfections of tagged TM constructs in parallel with
untagged TMs did not alter the homodimer prefer-
ence of both HMW and LMW 248-amino-acid non-
muscle isoforms. When tagged smooth muscle a-TM
or skeletal muscle a-TM isoforms were cotrans-
fected with untagged HMW nonmuscle TM isoforms,
the formation of heterodimer was predominant.
Similarly, the I3-skeletal muscle TM was found to
form heterodimers with TM-1, TM-2, and TM-3. Co-
transfection of tagged muscle (a-smooth and (3-
skeletal) or tagged nonmuscle TM-2 together with the
LMW nonmuscle variants TM-4, TM-5a, or TM-5b
failed to form stable heterodimers in the cells.
Our results indicate that the selectivity for homo-
versus heterodimerization is a property intrinsic to
the TM molecule itself and that this information is
conveyed by combinatorial alternative splicing of ex-
ons. These results have important implications for
models of the regulation of cytoskeletal dynamics.
Expressing Functional Domains
of Mouse Calponin
M. Gimona
Calponin (CaP) is a 34-kD actin, calmodulin (CaM)-,
and tropomyosin (TM)-binding protein that inhibits
the actomyosin ATPase activity, as well as the move-
ment of actin filaments over coated myosin in in vitro
enzyme and motility assays, respectively. Previous
work (Mezgueldi et al., J. Biol. Chem. 267: 15943
[1992]) reported indirect evidence for the binding of
F-actin to the 38-residue stretch of gizzard CaP en-
compassing the sequence A145-Y182 and postulated
the hexapeptide motif VKYAEK, representing
residues 142-147, as the putative actin-binding site.
In collaboration with Drs. Mezgueldi and Fattoum at
the University of Montpellier (France), we have in-
vestigated size and location of the actomyosin AT-
Pase inhibitory domain of smooth muscle h1CaP by
expressing fragments of mouse h1CaP with or
without substitution or deletion at the latter motif
using cosedimentation with F-actin, actomyosin S1-
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ATPase assays, cross-linking reactions, and affinity
chromatography over immobilized CaM or TM.
Collectively, the data show that the polypeptide
stretch Ala-131-Ile-228 contains the entire actin-
binding site and inhibitory sequence. This segment
also interacts with TM and Ca++-CaM, the binding of
the latter protein resulting in the reversal of ATPase
inhibition. Furthermore, structural alterations of the
VKYAEK motif by site-directed mutagenesis strong-
ly affect the inhibitory activity of CaP with only a
slight decrease of actin binding.
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CELL BIOLOGY OF THE NUCLEUS
D.L. Spector S. Huang A. Chi
R.T. O'Keefe R. Derby
P. Mintz S. Kaurin
Studies in our laboratory are focused on the struc-
tural-functional organization of the mammalian cell
nucleus. Our research program evolves around under-
standing the nuclear organization of factors associa-
ted with pre-mRNA splicing and the RNA substrates
with which these factors interact. The microscopy
core facility has been used extensively over the past
year and numerous collaborations are under way with
the excellent technical expertise of Robert Derby.
The Spatial Association of
Nascent Pre-mRNA with
Splicing Factors Is Intron-dependent
S. Huang, D.L. Spector
We have been interested in the organization of RNA
polymerase II transcripts within the mammalian cell
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nucleus. Several models have been proposed for the
functional organization of RNA within the eukaryotic
nucleus and for the relationship of this organization
to the distribution of pre-mRNA splicing factors. One
model suggests that RNAs which must be spliced are
capable of recruiting splicing factors to the sites of
transcription from storage and/or reassembly sites
(Jimenez-Garcia and Spector, Cell 73: 47 [1993]). To
further evaluate this model, we have transiently
transfected HeLa cells with constructs that express
RNA transcripts containing introns, lacking introns,
or containing an intron with a deletion at the 3'
splice site. The expression of RNAs was detected by
in situ hybridization, and their association with splic-
ing factors was evaluated by immunostaining using
specific antibodies (Y12, SC35) in the same cells.
We have found that the majority of the RNA tran-
scripts produced from constructs that express intron-
containing genes such as 3-globin, tropomyosin, and
HIV tat are associated with splicing factors. In con-
trast, RNAs lacking introns, such as 0-galactosidase
and adenovirus VA', are not associated with splicing
factors in the nucleus. Furthermore, the majority of
HIV tat RNA, which contains a deletion in its intron
at the 3' splice site, showed little association with
splicing factors. These observations suggest that the
spatial association of RNA transcripts with splicing
factors is intron-dependent. Such an association is
functionally significant as transcripts containing
mutated introns, which are incapable of being
spliced, are not associated with splicing factors.
Therefore, we propose that the organization of RNA
and splicing factors in the cell nucleus reflects the
transcriptional activity of the cell and the localization
patterns of splicing factors will change to reflect
changes in transcriptional activity.
Organization of Polyadenylation in
the Mammalian Cell Nucleus
P. Mintz, D.L. Spector
Most RNAs transcribed by RNA polymerase II are
spliced and polyadenylated prior to their export from
the nucleus. During the past few years, we have been
concentrating our studies on the organization of pre-
mRNA splicing in the cell nucleus. We have found
FIGURE 1 A close association is observed between the localization of transiently ex-
pressed RNA transcripts with introns and the localization of splicing factors, sug-
gesting that the sites of association represent the sites of splicing. HeLa cells were
transfected with expression vectors that encode RNA transcripts with introns such
as CG-Tat (A and B) or 11-globin (C and D). The localization of these RNAs was ex-
amined 7-8 hr posttransfection by in situ hybridization with biotinylated probes (A
and C). The localization of splicing factors in the same cells was detected by im-
munostaining with monoclonal antibody specifically recognizing SC35 (B and D).
RNAs and splicing factors are colocalized to the same nuclear regions (ar-
rowheads). Bar, 10 gm.
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FIGURE 2 The majority of transiently expressed intron-less RNAs or RNAs with a
truncated intron do not associate with splicing factors in the cell nucleus. HeLa cells
were transfected with expression vectors that encode RNA transcripts without in-
trons, p-galactosidase (A and B) or RNA transcripts containing an intron with a
deleted 3' splice site, CMV Tat (C and D). The localization of these RNAs in the cell
nucleus was observed 7-8 hr posttransfection by in situ hybridization with biotiny-
lated probes (A and C). The localization of splicing factors in the same cells was
detected by the monoclonal antibody specifically recognizing SC35 (B and D). Little
to no colocalization was observed (arrowheads). Bar, 10 Rm.
that factors involved in pre-mRNA splicing are con-
centrated in a speckled pattern in interphase nuclei.
When this pattern was examined by immunoelectron
microscopy, it was found to correspond to inter-
chromatin granule clusters and perichromatin fibrils.
Interchromatin granule clusters are thought to
represent sites of splicing factor storage and/or reas-
sembly, whereas perichromatin fibrils are thought to
represent transcription sites.
During the past year, we have been interested in
determining where in the nucleus polyadenylation oc-
curs. Work from our laboratory has previously shown
that poly(A)+ RNA is localized to the entire speckled
pattern. However, we know that a portion of this
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poly(A)+ RNA is stable nuclear RNA and therefore it
is not localized at the site of transcription. We were
interested in determining where in the nucleus
polyadenylation occurred and the relationship of the
sites of polyadenylation to those of transcription, pre-
mRNA splicing, and total poly(A)+ RNA localiza-
tion. Using an antibody obtained from Jim Manley
(Columbia University), we have found poly(A)
polymerase to be localized in a discrete pattern of
dots which extend throughout the nucleoplasm but
which are excluded from the nucleoli. Studies are
currently under way to determine the relationship of
these sites of poly(A) polymerase to sites of RNA
polymerase II transcription.
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FIGURE 3 Histogram showing a statistical evaluation of the association of RNA
transcripts with the splicing factor SC35 in HeLa cell nuclei.
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PROGRAMMED CELL DEATH IN CAENORHABDITIS ELEGANS
M. Hengartner T. Gumienny J. Keller
D. Hoeppner Q. Liu
G. Jefferis M. Spector
We are interested in understanding the molecular
basis of programmed cell death (apoptosis). This pro-
cess, which allows multicellular organisms to
eliminate cells that are not needed or are potentially
dangerous, is evolutionarily highly conserved. Proper
control of programmed cell death is crucial, and
breakdown in the regulation of this process has been
associated with several types of cancer, auto-
immunity, and possibly neurodegenerative diseases.
We have taken a genetic approach to identify
genes that function in programmed cell death in the
small nematode Caenorhabditis elegans. The worm
provides an attractive system for the study of this
problem, as its development has been extensively
characterized, and the animal is readily amenable to
genetic and molecular manipulations. So far, we and
other investigators have identified 14 genes that af-
fect programmed cell death during C. elegans devel-
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FIGURE 1 The genetic pathway for programmed cell death in C. elegans. Mutations in 14 genes af-
fect programmed cell deaths. These mutations divide the process of programmed cell death into
four steps; genes that act in the last three steps are common to all programmed cell deaths,
whereas genes that act in the first step affect only a few cells. Regulatory interactions deduced from
genetic studies are shown. (--) Positive regulation; (-I) negative regulation.
opment (Fig. 1), and we have begun the molecular
characterization of these genes. For example, we
found that the gene ced-9, which is required to pre-
vent cells that normally survive from undergoing pro-
grammed cell death, is a homolog of the mammalian
proto-oncogene bcl -2. Interestingly, bcl -2 is thought
to have a function in mammals similar to that of
ced-9 in C. elegans. Similarly, the cell death gene
ced-3 is homologous to the mammalian cysteine
protease interleukin-1P-converting enzyme (ICE),
and overexpression of either CED-3 or ICE induces
apoptotic death in rat fibroblasts. The conservation in
sequence and function of these two C. elegans cell
death genes strongly suggests that nematodes and
mammals share a common molecular pathway for
programmed cell death.
We are now searching for and characterizing addi-
tional genes that function in this pathway and are de-
veloping tools to continue these studies at the
biochemical level. The conservation of the molecular
pathway between nematodes and mammals suggests
that the genes we will identify in our screens for C.
elegans cell death mutants will have homologs that
have similar roles in mammalian apoptosis. Thus, the
knowledge gained about programmed cell death in C.
elegans promises to be relevant to our understanding
of apoptosis in human development and disease.
Identification of Proteins
That Interact with CED-9
G. Jefferis, D. Hoeppner, J. Keller
The CED-9/Bc1-2 family members possess no known
enzymatic activity, suggesting that these proteins
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might regulate programmed cell death by binding to
other proteins and altering their activities. To identify
proteins that interact with CED-9, we are using the
yeast two-hybrid system to screen a C. elegans
cDNA library using CED-9 fused to the GAL4 DNA-
binding domain as a bait. To complement and assist
the two-hybrid studies, we are developing antibodies
against CED-9 that will be used to identify proteins
that coimmunoprecipitate with CED-9.
Molecular Genetic Analysis
of the Gain-of-Function
Mutation ced-9(n1950)
M. Hengartner [in collaboration with Bob Horvitz,
Massachusetts Institute of Technology]
Dominant gain-of-function mutations have been de-
scribed in both ced-9 and bcl -2. In bcl -2, such muta-
tions-which are commonly found in follicular
lymphoma-are invariably translocations that result
in overexpression of normal Bcl -2 protein. In con-
trast, we found that the ced-9(n1950) gain-of-
function mutation affects the open reading frame of
ced-9 and results in a glycine-to-glutamate substitu-
tion in a region highly conserved among all ced -9/
bcl -2 family members. This region has been shown to
be required for heterodimerization of BcI-2 with
other members of the CED-9/Bc1-2 family, suggest-
ing that the n1950 mutation might affect the ability of
CED-9 to interact with other proteins. We are plan-
ning to test this hypothesis by identifying proteins
that show preferential binding to either the wild-type
or mutated form of CED-9. Such interactions will be
tested by coimmunoprecipitation with CED-9 and by
use of the yeast two-hybrid system.
Isolation and Characterization
of ced-9 Suppressors
M. Spector, M. Hengartner, T. Gumienny, G. Jefferis
We have previously shown that ced-9 is required to
protect C. elegans cells from programmed cell death:
In the absence of ced-9, many cells that normally live
undergo programmed cell death, eventually resulting
in the death of the animal. Mutations in ced-3 or
ced-4 block the ectopic deaths and the lethality asso-
ciated with ced-9 loss-of-function (If) mutants. To
identify additional genes that function in pro-
grammed cell death, we have screened for suppres-
sors of the ced-9(1f) maternal-effect lethality
phenotype. So far, we have isolated over three dozen
suppressors. As expected, some of these are muta-
tions in ced-3 and ced-4. We have also identified one
mutation, n2431, that identifies a new cell death
gene, which we are currently characterizing (see be-
low). To increase the proportion of suppressors that
are in novel cell death genes, we are now setting up
screens for dominant suppressors of ced-9(1f), as well
as screens in strains carrying additional copies of
ced-3.
Characterization of ced(n2431),
a New ced-9 Suppressor
D. Hoeppner, M. Hengartner
The mutation n2341 suppresses the maternal-effect
lethality of the weak loss-of-function allele ced-9
(n1950 n2161). We have mapped n2431 to the gene
cluster on chromosome III. No known cell death gene
resides in this region, indicating that n2431 identifies
a new C. elegans ced gene. Although unable to sup-
press ced-9 null alleles, n2431 can also suppress
n1653, another weak ced-9 allele. Furthermore,
n2431 has no obvious phenotype on its own. These
observations suggest that ced(n2431) is only a weak
suppressor of cell death and that the wild-type gene
might have a partially redundant role in C. elegans
cell death. We are currently determining the precise
position of ced(n2431) on the genetic map as a
prelude to its cloning.
Programmed Cell Death
in the C. elegans Germ Line
T. Gumienny, D. Hoeppner, M. Hengartner [in collaboration
with Erika Hartwieg, Massachusetts Institute of Technology]
We have recently undertaken an in-depth study of
programmed cell death in the germ line of C. elegans.
The germ line tissue offers a number of advantages
over the C. elegans soma, including a more
vertebrate-like regulation of proliferation and the
possibility of isolating significant amounts of dying
cells for biochemical analysis. Even though little at-
tention had been given to germ cell death in the past,
we found that programmed cell death has a major
role in the germ line. In fact, our results suggest that
programmed cell death is the most common fate in
the germ line. Germ cells are by far the most com-
mon cell type to undergo programmed cell death:
During development, 131 somatic cells die. In con-
trast, more than 300 germ cells die during adulthood.
Thus, during an animal's lifetime, more programmed
cell deaths occur in the germ line than in all the
somatic tissues combined.
We have found that most, but not all, mutations
that affect programmed cell death in the soma also af-
fect germ cell death. ced-3 and ced-4 are both re-
quired for germ cells to undergo programmed cell
death, whereas ced-9 is required to protect oocytes
from death: In the absence of ced-9, too many germ
cells die, resulting in sterility. In contrast, genes that
affect programmed cell death only in specific cells
(such as the ces genes and egl-1) do not affect germ
cell death.
To understand how germ cells make the decision
between life and death, we are screening for muta-
tions that affect germ cell death. Characterization of
the genes identified by these mutations promises to
further our understanding of how cells control the ac-
tivation of the death machinery.
Reverse Genetic Studies
of Programmed Cell Death
Q. Liu, M. Spector, T. Gumienny
A number of cell death genes have been identified in
other organisms, such as mammals and Drosophila.
The observation that the pathway for programmed
cell death is conserved between nematodes and mam-
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mals suggests that these cell death genes might also
function in C. elegans. We have been using a variety
of techniques and approaches to test this hypothesis.
The simplest involves the generation of transgenic
worms that express the "foreign" cell death gene. We
have shown that this approach is feasible by
demonstrating that overexpression of human Bcl -2
from a C. elegans heat-shock promoter is able to pre-
vent programmed cell death in C. elegans. We are
now pursuing a number of other genes that have been
implicated in programmed cell death, including mam-
malian Bcl-x, Bax, and sphingomyelinase, as well as
the Drosophila gene reaper. Studies of this type not
only promise to confirm that the gene in question in-
teracts with, or is part of, a conserved part of the cell
death machinery, but they can also be used to order
the point of action of these genes in the pathway by
testing the effect of the transgene in the various cell
death mutant backgrounds available in C. elegans.
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QUEST PROTEIN DATABASE CENTER
J.I. Garrels B. Futcher N. Sareen
G.I. Latter R. Kobayashi B. Schwender
P.J. Monardo T. Volpe
N. Bizios L. Jokhan
Our research focuses on the construction and analysis
of two-dimensional gel (2D gel) protein databases.
The 2D gel (see Fig. 1) serves as an assay system
which allows us to visualize and measure the in vivo
abundance of a large proportion of the proteins in an
organism at one time. Utilizing the Quest II computer
software that we have designed and constructed, we
are able to measure the volume of each protein as
well. A 2D gel database is a collection of 2D gels
along with the measured volumes of the proteins un-
der various cellular conditions. We are able to use
these databases to study the functional changes of
gene expression across changed states of the cell.
As the genomes of organisms are sequenced, the
value of these protein databases begins to increase.
90
We have been focusing our efforts on the study of
yeast (Saccharomyces cerevisiae) for more than 1
year now. More than one half of the genomic se-
quence of S. cerevisiae is now available, and the
entire genome of this organism is expected to be se-
quenced by 1996. The availability of this sequence
data has had major consequences in our work. The
techniques that we employ for identification, such as
amino acid analysis and microsequencing, and the
use of overexpression plasmids all benefit from the
availability of sequence data. We have in a short time
been able to identify more than 100 spots on the
yeast 2D gels. These identifications in turn aid our
study of function.
We have developed databases and tools to help us
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F GURE 1 A region of a 2D gel of the yeast Saccharomyces cerevisiae viewed from
the Quest II software showing the identified spots. Of particular interest are BMH1,
BMH2, and GSP1.
in our identification of proteins on 2D gels and for
the distribution of these data to scientists over the In-
ternet. Additionally, we have developed a YPD data-
base which is a nonredundant database of S.
cerevisiae proteins that lists information about their
properties, which will also assist us in identifications.
Our identification data as well as YPD are being
made available to the scientific community via the
Internet in a number of ways including the World
Wide Web.
Protein Identifications
J.I. Garrels, B. Futcher, R. Kobayashi, G.I. Latter,
T. Volpe, B. Schwender
We have now identified more than 120 of the most
highly expressed yeast proteins on our 2D gel maps.
Using combined approaches of protein sequencing,
gene overexpression from high-copy-number plas-
mids, and amino acid composition analysis, we have
been able to identify many of the prominent proteins.
These efforts are also guided by the YPD database,
which can be used to predict which known proteins
should appear in each region of the gel based on pre-
dicted molecular weight, isoelectric point, and codon
bias.
Identification by amino acid analysis has used a
combination of single-label and double-label anal-
yses. Both methods (see 1993 Annual Report) use
radioactive labeling with 14C- and 35S-labeled amino
acids and image quantitation to determine partial
amino acid compositions. A scoring system was de-
veloped to determine which proteins of known se-
quence best match to the amino acid composition
data for each protein. When the scoring system was
first tested on proteins already known by other
means, 25 of 43 known proteins were correctly and
uniquely predicted. In five cases, two or more
proteins, including the correct one, were predicted. In
only one case did the scoring system make a unique
but incorrect prediction. Analysis of 163 unknown
proteins by the same scoring system has resulted in
34 new unique predictions. Subsequent studies using
new sequences that have appeared from genomic se-
quencing have led to even more proteins identified
through amino acid composition.
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Many of the identified proteins fall into categories
that are expected to contain abundant proteins. These
include glycolytic enzymes, ribosomal proteins,
protein synthesis factors, enzymes of amino acid me-
tabolism, and heat-shock proteins. Other identified
proteins of interest are BMH1 and BMH2 (homologs
of mammalian 14-3-3 protein), GSP1 (the Ras-like
protein involved in regulating nuclear import), SRP1
(also called "importin" for its role in nuclear import),
CYPD (a cyclophilin of the endoplasmic reticulum),
TCP20 (a cytoplasmic chaperonin), and CIM5 (a 26S
protease subunit).
Not all of the highly expressed proteins are
known in yeast. One of the major proteins (YEPD
6260) is an unknown acidic ribosomal protein. It is
present in purified ribosomes and, like most riboso-
mal proteins, its gene has an intron. Partial sequence
data has been obtained but does not match to any
known protein. Another major protein (YEPD 7260)
is a close match to two sequences (YIL053W and
YER062C) that have recently appeared from geno-
mic sequencing, but this protein probably represents
a third member of this newly discovered protein fam-
ily of unknown function.
The various observations for the major proteins of
yeast are being assembled into the Yeast Elec-
trophoretic Protein Database (YEPD). So far, YEPD
contains information on amino-terminal modification,
splicing, heat shock, glucose stimulation, phosphor-
ylation, and subcellular fractionation (ribosomes,
mitochondria, soluble vs. pellet fractions).
Quest II Software
P. Monardo, G.I. Latter
Quest II software is a software system that we have
designed and built for creating and analyzing 2D gel
protein databases. Figure 1 shows a view of Quest II
which depicts a region of the gel showing some of
the identified proteins discussed above. Using the
Quest II system and the growing number of identi-
fications on the gel, we have been able not only to
begin to perform detailed quantitative studies on the
variation of protein expression across an experiment,
but also to begin to attach identity to the proteins that
show interesting patterns of variation. Using the
cluster analysis feature that has now been built into
our system, we can automatically find these coregu-
lated patterns and create sets of spots for use in fur-
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ther studies. The Quest II software is now in use at a
growing number of institutions in the United States
and Europe.
Network Protein
Information Resource
P. Monardo, T. Boutell, G.I. Latter
We continue to make our 2D gel identifications avail-
able via the Internet using the World Wide Web sys-
tem. We are now also making the YPD database
available (discussed below). Documentation on our
Quest II software and miscellaneous software tools
developed for the QUEST project are also being pro-
vided by this server. The total accesses to our World
Wide Web server have grown to more than 30,000
per week.
The YPD Database for
Yeast Proteins
J.I. Garrets, G.I. Latter
The yeast protein database (YPD) is a compilation of
protein information for all yeast proteins of known
sequence, including many sequences known only
through genomic sequencing projects. The original
aim was to collect information from the protein se-
quence databases and from the literature that would
be useful in 2D gel interpretation. Such information
includes calculated molecular weight, calculated
isoelectric point, calculated codon bias, amino acid
composition, known subcellular localization, known
modifications, and key regulatory information. The
scope of YPD has since been expanded to be a gener-
al purpose database for yeast protein information.
Some new features in YPD are the addition of ge-
netic information (chromosome number, presence of
introns, effect of knockout mutation); accession num-
bers to the 2D gel database YEPD; more localization
and functional categories; precursor peptide lengths;
motif information (CDC28 sites, N-glycosylation
sites, and transmembrane domains), longer protein
descriptions, and a reference list. YPD continues to
be distributed as a spreadsheet, in which each protein
is presented as a single nonredundant entry. In the
spreadsheet format, users can easily search or sort the
proteins by localization, modification, size, amino-
terminal sequence, etc. The files are available by ftp
from isis.cshl.org.
YPD is available on-line through the World Wide
Web (WWW) server of the QUEST Protein Database
Center (http://siva.cshl.org). The on-line version al-
Table 1 Yeast Proteins by Subcellular Localization
A. Of the 1871 proteins known from genetic or
biochemical studiesa
401
377
240
82
56
51
45
34
28
23
22
15
497
(21.4%)
(20.1%)
(12.8%)
(4.4%)
(3.0%)
(2.7%)
(2.4%)
(1.8%)
(1.5%)
(1.2%)
(1.2%)
(0.8%)
(26.6%)
Nuclear
Cytoplasmic
Mitochondrial
Plasma membrane
Endoplasmic reticulum
Unspecified membrane
Cytoskeletal
Extracellular or cell wall
Vacuolar
Vesicles of secretory pathway
Golgi
Peroxisomal
Unknown
B. Of the 2395 proteins known by genetics,
biochemistry, or homology
By molecular environment
318 (13.3%) Integral membrane
299 (12.5%) DNA-associated (not neces-
sarily direct DNA-binding)
130 (5.4%) Ribosomal
83 (3.5%) Peripheral membrane
80 (3.3%) RNA-associated
39 (1.6%) Protein synthesis factors
16 (0.7%) Actin cytoskeleton-associated
13 (0.5%) Tubulin cytoskeleton-
associated
By functional category
106 (4.4%)
81 (3.4%)
61 (2.5%)
43 (1.8%)
31 (1.3%)
30 (1.3%)
27 (1.1%)
24 (1.0%)
20 (0.8%)
16 (0.7%)
16 (0.7%)
15 (0.6%)
14 (0.6%)
10 (0.4%)
9 (0.4%)
8 (0.3%)
Transcription factors
Protein kinases
Enzymes of amino acid
metabolism
GTPases
Heat shock
tRNA synthetases
Protein phosphatases
Proteases other than
proteasome subunits
Conserved ATPase domain
family (Secl8p/Paslp/Suglp)
Enzymes of glucose
metabolism
Serine-alanine-rich proteins
(Srp1/Tiplp family)
Cyclins
Proteasome components
Ubiquitin-conjugating
enzymes
GTPase-activating proteins
Guanine nucleotide exchange
factors
°The unknown category contains many metabolic and house-
keeping proteins are likely to be cytoplasmic, but definitive studies
on their localization are difficult to find.
lows proteins to be selected by various functional,
localization, or modification categories. In addition,
proteins can be selected by the region of the gel
within which they are predicted to run. YPD data
have also been incorporated into the Stanford
Saccharomyces Genome Database (http://genome-
www.stan ford.edu).
The latest release (3.0) of YPD contains entries
for 3512 proteins. Of these, 1871 are proteins that
have been characterized genetically or biochemically,
524 are proteins known only by homology with
known proteins, and 1117 are proteins of unknown
function (known only from DNA sequence). Table 1
shows the breakdown of the proteins by localization
and by functional category.
Spot Identification by
Gene Overexpression
T. Volpe, B. Futcher
We have been identifying spots on the 2D gel map of
yeast proteins by overexpressing particular genes on
high-copy-number plasmids and looking to see which
spots get darker. Preliminary experiments have been
done to test the abilities of this method. In a screen of
about 30 genes cloned on 2-mm circle-based, high-
copy-number LEU2 plasmids, we found that success
is correlated with the codon bias of the cloned gene.
For genes with a codon bias of 0.3 or greater, the
method was almost always successful; for genes with
a codon bias between 0.1 and 0.3, the method was
sometimes successful, and for genes with a codon
bias less than 0.1, the method has not worked. In a
recent test of 18 genes with a codon bias greater than
0.3, we unambiguously identified 15 of the gene
products (often as a set of multiple spots). Gene prod-
ucts identified by this method in the last year include
EFT1, PRT1, TEF1, TIF1, TPM1, HOM2, PGI1,
PFK1, TPI1, ADE1, LEU2, SAM1, SAM2, PYK1,
and HIS3.
Global Experiments:
Phosphorylation and
Subcellular Fractionation
B. Futcher, T . Volpe
We have labeled yeast with 32P and run the extracts
on 2D gels. Mixing experiments with 35S-labeled ex-
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tracts allowed us to align the 32P map with the 35S
map. A large number of phosphorylated spots were
noted, and some of these are known proteins.
We have also started doing subcellular fractiona-
tion experiments to see which spots go into which
fractions. Simple centrifugation experiments have
been particularly successful. The pellet and super-
natant fractions of a 100,000g centrifugation have
been compared. The experiment is easy to do, and
results have been highly reproducible. A large num-
ber of spots fractionate into the supernatant only.
Some are split between supernatant and pellet, and
other spots are found primarily in the pellet (although
very few are solely in the pellet). In many cases, the
identity of the protein is known. The behavior of
certain translation factors has been particularly inter-
esting. We have found that many of these factors
have a soluble pool and an insoluble pool, suggesting
that they may be cycling on and off the endoplasmic
reticulum. Our methods will allow quantification of
these two pools under different conditions.
Microsequencing
R. Kobayashi, B. Schwender
We continue to apply in-gel digestion techniques to
obtain internal amino acid sequence analysis of
protein after SDS-PAGE for use in the construction
of the yeast database. We have up to now been utiliz-
ing 1-2 Rg of protein to obtain sequence. This re-
quires from one to six gels. We are working on tech-
niques that will allow us to microsequence with a
smaller amount of protein (see Kobayashi, Structure
and Computation Section).
We have now identified 38 proteins from S.
cerevisiae 2D gels using microsequencing and have
obtained sequence data on five proteins that are not
yet in the sequence databases and thus are unknown
proteins. Three of these unknown proteins for which
we have obtained clear sequences are major yeast
proteins as seen on the 2D gel pattern.
Quantitative Analysis of Apoptosis
in Jurkat T Lymphoblasts
G.I. Latter, S.D. Patterson
In a previous annual report, we described the induc-
tion of apoptosis in Jurkat T lymphoblasts using two
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reagents, lovastatin and EGTA. Following separation
of the apoptotic cells using Percoll density gradient
centrifugation, the control and apoptotic cells were
each labeled with [35S]methionine, lysed, and sepa-
rated by 2D PAGE. Surprisingly, the 2D PAGE pat-
terns generated from the apoptotic cells did not differ
dramatically from those of control cells. Thus, apo-
ptotic Jurkat cells are able to synthesize new proteins
and do not exhibit extensive proteolysis. Qualitative
analysis revealed that one protein clearly displayed
decreased labeling in the apoptotic cells following
both treatments, and this was subsequently identified
as the abundant nucleolar phosphoprotein numatrin/
B23/nucleophosmin (NPM) by amino acid sequence
analysis, immunoblotting using monospecific anti-
serum, and laser desorption/ionization time-of-flight
mass spectrometry.
We are interested in proteins that may be com-
ponents of a putative final common pathway in apo-
ptosis. Therefore, we undertook a quantitative com-
puter analysis of the 2D PAGE patterns using the
Quest II software to look for proteins that exhibit
repeatable coordinate regulation (either increase or
decrease) in both apoptotic inductions. Stringent
criteria for both fold-change and level were used for
the analysis. This resulted in only five proteins dis-
playing decreases in turnover that were common to
the two treatments (and replicates). One of these is
NPM. No increases in protein turnover were able to
be confirmed across the replicate experiments, but
this is most likely due to the stringent analysis criteria
imposed. NPM is implicated in a range of diverse
cellular functions, but its role in apoptosis is unclear.
The other proteins await identification.
2D Gel Core Facility
J.I. Garrels, N. Bizios, N. Sareen, G.I. Latter
The 2D gel laboratory facility produced 1625 gels in
1994. These gels were produced for 17 groups within
Cold Spring Harbor Laboratory and 8 external
groups.
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GENETICS
The three immutables of present human existence have been posed as Birth, Death, and Taxes. It
seems to be true, and given the debate about the allocation of resources toward military activities
versus others, it is not clear whether we have learned much about raising or spending taxes since
the Romans. I can even hear our forebears debating the value of investing in new technologies, un-
less perhaps for military uses.
We have, however, learned a great deal in the last 2000 years about birth and death. We know
more than ever what it means to be human, how we are physically and biologically constructed,
and how we pass our genetic nature to our children. We have discovered an extraordinary biologi-
cal relatedness not only to our closest animal relatives, which Darwin's contemporaries so enjoyed
lampooning, but also to all other biological beings. Perhaps this in some way contributes to our
deepening sense that we should let species other than ourselves also survive.
All of this is due to biological science, the slow, painstaking process of understanding how cells
and organisms are made, how they function, and how they propagate. The work done by scientists
rarely leads them to be as rich or famous as film stars or baseball players, but an accurate contri-
bution to our understanding of biological mechanisms is an achievement that lasts forever, and
upon which the edifice of science will continue to build. The recent contribution of the local
geneticists to this process is described below.
EUKARYOTIC CELL CYCLE CONTROL
D. Beach S. Allan D. Demetrick J. Hudson
M. Caligiuri K. Galaktionov T.K. Kim
D. Casso C. Gawel D. Lombardi
T. Connolly G. Hannon B. Nefsky
K. Dai G. Hannon T. Matsumoto
S. Davey J. Hofmann
During the course of the year, Greg Hannon was
promoted to Staff Scientist II at Cold Spring Harbor,
Tim Connolly left to take a Senior Staff Scientist
position at Osiris Therapeutics, Inc., and Tomo Mat-
sumoto became a Staff Scientist at Albert Einstein
College of Medicine. We were joined by two new
postdocs, Tae Kook Kim and Kang Dai, a new lab
technician, Simone Salghetti, and a computer pro-
grammer, Diane Lombardi.
Cell Cycle Kinases in Nontransformed
and Transformed Cells
H. Zhang, D. Beach
In normal proliferating cells, the various functionally
distinct cell cycle kinases exist primarily in the form
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S. Matsumoto
K. Okamoto
S. Salghetti
M. Serrano
H. Zhang
of a quaternary complex of cyclin/CDK/p21/PCNA.
Our study indicated that p21 is a universal inhibitor
for all these cell cycle kinases. p21 is transcriptional-
ly regulated by the p53 tumor suppressor protein,
which leads to the proposal that p21 may serve as the
effector of cell cycle arrest during the activation of
p53-mediated checkpoint control during DNA-
damage response. However, our in vivo analysis of
the quaternary complex suggested that in normal
cells, the majority of the cell cycle kinases are in
complex with p21 and PCNA. This raises a paradox
as to how these cells divide at a normal rate if the
majority of their cell cycle kinases are in complex
with an inhibitor.
Our subsequent study suggested that p21-con-
taining kinases can exist in both active and inactive
states. The binding of single p21 molecules to the
cyclin/CDK kinase does not inhibit the kinase ac-
tivity. The binding of more than one p21 molecule to
the kinase leads to kinase inhibition. We therefore es-
tablished that in normal cells, the quaternary complex
is the primary active kinase form that regulates cell
cycle progression. Furthermore, our in vitro study
also indicated that p21 can promote active cyclin/
CDK kinase formation, raising the possibility that in
vivo, p21 may have both positive and negative
regulatory effects on the cell cycle kinases.
In certain transformed cells, especially the viral
oncogene-transformed cells, p21 and PCNA dis-
appear from the cell cycle kinase complex. In these
cells, the cell cycle kinases associate with new
proteins. For example, in transformed cells, cyclin
A/CDK2 kinase primarily associates with a new set
of proteins of 9 kD (p9), 19 kD (p19), and 45 kD
(p45). The association of these proteins to the cyclin
A/CDK2 kinase is S-phase-dependent. We have
purified this protein complex and obtained peptide
sequences. p9 is a human homolog of yeast sucl
protein that binds to cdc2 kinase; both p19 and p45
are novel proteins. Based on the peptide sequences,
we have isolated the cDNA clones that encode the
full-length p19 and p45 proteins. We have success-
fully reconstituted the five protein complexes in
vitro. Both p9 and p45 can bind to the cyclin
A/CDK2 kinase independently. However, the binding
of p19 to the kinase depends on the prior binding of
p45 to the kinase. In He La cells, the expression of p9,
p19, and p45, similar to cyclin A, are S-phase-
specific. The expressions of p9 and p45 are highly
enhanced in transformed cells. Further study sug-
gested that p9 is an inhibitor of the cyclin A/CDK2
kinase that behaves differently from p21. There are
no detectable effects of p45 and p19 on the kinase ac-
tivity in vitro: However, microinjection of anti-p45
antibody into Gt cells blocks S-phase entry, whereas
no DNA synthesis inhibition was observed if the
antibody was injected during S phase, suggesting that
p45 is essential for the establishment of S phase.
Detailed analysis of this five-protein complex is still
under way.
Using a genetic approach that aims at isolating
new cyclins, we have successfully isolated one more
human cyclin. This cyclin, which shares 40% identity
with human cyclin A, can cooperate with human
CDK5 to complement the cell cycle defect of a cdc28
temperature-sensitive mutant at a nonpermissive
temperature, although neither the cyclin itself nor
CDK5 alone can rescue the mutant. The characteriza-
tion of this new human cyclin is also under way.
The Tumor Suppressor and
Cell Cycle Inhibitor pl6lNK4
M. Serrano, D. Beach
The cyclin-D-dependent kinase 4, CDK4, is required
for progression through the cell cycle. The activity of
CDK4 is positively regulated by association with a
D-type cyclin and is negatively regulated by binding
to the p16INK4 tumor suppressor protein. We have
studied the effect of p16INK4 overexpression on the
proliferation of normal rat fibroblasts. Microinjection
of p16INK4-encoding DNA inhibited entry into S
phase of the cell cycle induced by oncogenic Ha-Ras,
and this inhibition was relieved by coexpression of a
catalytically inactive CDK4 mutant (studies done in
collaboration with Dr. Dafna Bar-Sagi, CSHL). This
observation provides direct evidence that p16'14K4
can inhibit cell growth.
We are also interested in the characterization of
the CDK4-p161NK4 interaction. We have studied the
phenotype of a CDK4 mutation found in a sporadic
melanoma. This mutation does not affect the catalytic
activity of CDK4 or its interaction with D-type
cyclins or with the cell cycle inhibitors p21WAF1
and p27KIP1. However, this tumor-specific mutation
renders CDK4 unable to associate with pl6INK4 and,
consequently, insensitive to its inhibitory effect. This
is the first tumor-specific dominant mutation found in
a CDC2-like kinase. Guided by the position of the
above-mentioned mutation, we have identified by
site-directed mutagenesis other residues in CDK4
that are involved in the interaction with p16INK4. A
three-dimensional model of the CDK4 structure
based on the known structure of CDK2 has allowed
us to locate the p16°""- binding surface in CDK4
(studies done in collaboration with Dr. Rui-Ming Xu,
CSHL). The p16INK4-binding site is located at the
junction between the small and large lobes of CDK4,
near the ATP-binding site but distant from the
substrate-binding site or the cyclin-binding site. We
propose that pl6INK4 induces a conformational
change in the ATP-binding site of CDK4 that is
responsible for inhibition of CDK4 kinase activity.
Cell Cycle Genes and Cancer
D.J. Demetrick, D. Beach
The gene for cyclin D1 (CCNDI) is the first cell
cycle regulatory gene identified to have a role in can-
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cer. Trans locations affecting the regulation of
CCND1 are found in lymphomas (centrocytic) and
solid tumors (parathyroid adenomas). The CCND1
gene is also amplified in numerous types of solid
tumors including breast, esophageal, and squamous
carcinomas of the head and neck, where it presumab-
ly gives the malignant cells a survival advantage.
During the last year, a diagnostic test for CCND1
amplification, utilizing fluorescence in situ hybridiza-
tion (FISH), was developed. This method was applied
to frozen tissue specimens from breast carcinomas
and clearly demonstrated cyclin D1 amplification in
individual tumor cells. This test may be applied to
fine-needle aspirates and, if shown to be prognosti-
cally useful, may provide surgeons and oncologists
with prognostic information about a breast carcinoma
before it is even excised.
In addition to CCND1, several other cell cycle
regulatory genes are considered likely to be involved
in cancer. The approach utilized to study these genes
involved first obtaining genomic clones of the candi-
date cDNA and mapping the gene by FISH to deter-
mine chromosomal location (and potential involve-
ment at sites of known karyotypic abnormalities).
Genes that are mapped to known sites of deletion or
loss of heterozygosity are partially sequenced to
determine intron-exon boundaries. Cell lines or tumor
samples, potentially having alterations of the candi-
date tumor suppressor gene, are studied by single-
stranded conformational polymorphism (SSCP) anal-
ysis and polymerase chain reaction (PCR)-based se-
quencing to detect mutations or homozygous dele-
tions. Using this methodology, the p161NK4 gene was
mapped to 9p21-22 by FISH and PCR from a
somatic cell hybrid panel. Analysis of many cell lines
found homozygous deletions in approximately 35%.
Studies done in collaboration with the C. Harris
laboratory (National Institutes of Health) demon-
strated that although many cell lines were found to
have deletions or other alterations of the pl 0'1(4
gene, alterations were not found in numerous tumor
specimens from esophagus, liver, and colon, whereas
rare deletions were present in non-small cell lung car-
cinomas.
Interestingly, the deletions of pl6INK4 in cell lines
were inversely correlated to regulatory abnormalities
of the Rb gene, implying that disruption of the Rb
regulatory pathway at more than one point was
potentially oncogenic. Recently, p15INK4b, a
homolog of pl6INK4, was isolated and mapped to the
same chromosomal area by our laboratory. This gene
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may also be involved in the cancer-associated ab-
normalities at 9p21.
Several other cell cycle regulatory genes have
been mapped to areas of cancer-associated karyotypic
abnormality, including CDK2 and CDK4 (12q13),
RBr-2 (16q12-13), CCNE (19q12-13), CCNC (6q21),
p21 (6p21.2), and HCKS2 (9q22). Studies of the
potential role for some of these genes are in progress.
p15INK4B Is an Effector of
TGF-I3-induced Cell Cycle Arrest
G.J. Hannon, D. Beach
In an animal, cell proliferation is held in check by a
number of mechanisms. These include cell-cell con-
tact, irreversible cell cycle withdrawal that accomp-
anies terminal differentiation, the presence of growth
inhibitory cytokines and tissue homeostasis factors,
and, failing all else, a genetically programmed limit
on division potential (senescence). One fundamental
characteristic of tumor cells is that they are not sub-
ject to many of these growth controls. With the
ultimate goal of understanding how tumor cells es-
cape the inhibitory signals that constrain the
proliferation of normal cells, we have explored the
mechanisms by which one growth inhibitory
cytokine, transforming growth factor-I3 (TGF -Il), pre-
vents cell proliferation.
TGF-I3 is a multifunctional polypeptide that elicits
different responses in different cell types. For most
cells, TGF-I3 is a negative growth factor that induces
cell cycle arrest in the G, phase. Previous studies in
other laboratories had indicated that one of the
ultimate effects of TGF-f3 treatment was the ac-
cumulation of the product of the retinoblastoma sus-
ceptibility gene (Rb) in its hypophosphorylated form.
In this state, Rb prevents passage of cells from G,
into S phase.
The phosphorylation state of Rb during G, (and
consequently the G, to S transition) is controlled by a
pair of related cyclin-dependent kinases, CDK4 and
CDK6, in concert with their associated D-type
cyclins. Since the sole critical responsibility of these
kinases appears to be Rb phosphorylation, we asked
whether treatment of cells with TGF -ft had any effect
on the activity of the CDK4 and CDK6 enzymes. We
found that addition of TGF-p to HaCaT cells (an im-
mortal but nontumorigenic human keratinocyte cell
line) suppressed the activity of CDK6 kinase (CDK4
cannot yet be reliably assayed in vivo). Coincident
with this loss of activity, CDK6 became associated
with a protein with a molecular mass of 15 kD (p15).
The p15 protein was weakly cross-reactive with
an antiserum raised against a known CDK4/CDK6
inhibitor, p16INK4, suggesting that these two proteins
shared some sequence homology. The cDNA encod-
ing p15 was cloned based on this homology, and se-
quence analysis confirmed that p15 and p16 were
closely related proteins. Functional studies demon-
strated that the two were essentially indistinguishable
in their ability to inhibit CDK4 and CDK6 kinases in
vitro, and p15 was therefore designated pl5INK4B
(inhibitor of CDK4-B).
Treatment of cells with TGF-P is known to alter
the expression of a number of genes, including PAI,
whose activity is related to the role of TGF-13 in
promoting wound healing. Similarly, TGF-13 treat-
ment induced the mRNA encoding p15 to greater
than 30 times its level in untreated cells. Considered
together, our results suggest that p15 may function as
the effector of TGF-P-induced cell cycle arrest.
The gene encoding p15 was mapped to human
chromosome 9 at position p21, adjacent to the gene
encoding p16. Cytogenetic abnormalities at 9p21 are
common in many types of human tumors, suggesting
the presence of a tumor suppressor gene at this locus.
p16INK4 was initially proposed as a candidate for this
gene, and p16 has been conclusively demonstrated to
be the familial melanoma susceptibility gene. The
presence of a second member of the p16 gene family
at 9p21 raises the possibility that, in some cases, loss
of tumor suppression may involve inactivation of ei-
ther or both genes. In this regard, homozygous dele-
tion of both the p15 and p16 genes is common in a
number of cancers (e.g., in gliomas and leukemias).
The response of p16 to viral oncoproteins indicates
that it may function in intracellular growth regulatory
pathways, and the response of p15 to TGF-I3 indi-
cates that p15 may act as an effector of extracellular
growth inhibitory signals. Thus, deletions that
remove both genes could simultaneously negate two
major proliferation control pathways.
Regulation of Cell Cycle
Commitment in Fission Yeast
T. Connolly, M. Caligiuri, D. Beach
In the fission yeast Schizosaccharomyces pombe, pas-
sage through Start and subsequent commitment to the
mitotic cell cycle requires the function of the Cdc2
protein kinase (p34cdc2) and the Cdc10/Sctl tran-
scription complex (p85cdc10/p72sctl,.) We have identi-
fied the presumed G5 form of the kinase as a complex
containing p34cdc2 and the p4OPue1 cyclin. p4OPucl
activates p34cdc2 as a histone H1 kinase, an activity
that is thermolabile in strains carrying one specific
temperature-sensitive allele of cdc2. We have found
that when a strain carrying this mutation is grown un-
der restrictive conditions, the cells arrest predomi-
nately in G1 due to the dissociation of the
pg5cdcio/p-,2scit/ complex. The binding of this tran-
scription complex to the cdc22 promoter oscillates
during the cell cycle and is absent when cells carry-
ing a temperature-sensitive mutation in cdc2 are
raised to the nonpermissive temperature. Therefore,
we considered the possibility that a component of this
transcription complex may be a substrate of the
p4opuctip34cdc2 kinase, and we found that p4OPue1 is
in fact associated with p85cdcl° in vivo. We have ex-
plored the biochemical consequences of amino acid
substitutions at a canonical p34cdc2 recognition site in
p85cdc1°. Our results indicate that phosphorylation at
this site is required for the stabilization of the
pgscacto/prsctiL complex, a necessary prerequisite
for the formation of a transcriptionally active DNA-
binding complex.
In addition to cdc2, sctl, and cdc10, progression
through the G5 phase of the cell cycle requires the
rant gene product. rani encodes a protein kinase that
functions as a negative regulator of the meiotic path-
way under conditions that promote vegetative
growth. Inactivating mutations in rani cause cells to
undergo meiosis from the haploid state. A genetic in-
teraction between pucl and rani prompted biochemi-
cal studies that led to our finding that p4OPuc1 is also
associated p52rant in vivo and that p4OPuc1 may in
fact be a substrate of the Ranl kinase. We have in-
vestigated the consequences of the interaction be-
tween p52ranl and p40Puc1 and have found that
p52rani functions at least in part to control the associ-
ation between p4OPuc1 and p85cdc1° On the basis of
these data, we suggest a molecular model for Start in
which the Puci cyclin is phosphorylated by Ranl
which enables it to associate with and phosphorylate
Cdc10. This either promotes or stabilizes the associa-
tion between Cdc10 and Scti, allowing the transcrip-
tional activation of genes required for DNA replica-
tion and commitment to a subsequent round of cell
division.
The sctl gene protein has a pivotal role in the cell
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cycle both as an activator of the mitotic cell cycle and
as a repressor of the cell's alternative developmental
fate leading to sexual differentiation. This gene there-
fore provides a means to dissect the elements of Start
genetically. We have initiated a suppression analysis
of the sctl null allele and have isolated two bypass
suppressors of sctl , bst1-10 and bstl -12. The charac-
terization of these mutants indicates that at least one
of them (bstl -12) is dominant to its wild-type
counterpart, providing a genetic screen for the
molecular cloning of this gene that is currently under
way. In addition, strains carrying sctl and bst1 -12 are
cold-sensitive for growth, whereas those carrying
bstl-12 in a wild-type genetic background are not.
This strain therefore provides another means to dis-
sect the regulation of Start at the genetic level and
has been used for the isolation of multicopy suppres-
sors of the cold-sensitive phenotype, which may lead
to the identification of additional elements of the
pathway leading to cell cycle commitment.
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CELL CYCLE CONTROL IN SACCHAROMYCES CEREVISIAE
B. Futcher B. Elliott B. Schneider T. Volpe
D. Germain B. Steiner H. Wijnen
K. Hidaka G. Tokiwa Q.-H. Yang
Our main interest continues to be the regulation of
Start and mitosis in Saccharomyces cerevisiae. We
are most interested in the tethering of division to cell
growth and in the generation of the basic cell cycle
oscillation. Many key cell cycle events are regulated
by protein kinase complexes formed between Cdc28
and a cyclin. More than a dozen known yeast cyclins
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now exist, and there are probably more to come.
These fall into two broad groups: the G1 cyclins, in-
cluding Clnl, Cln2, and Cln3, that regulate Start and
the mitotic, B-type cyclins Clb I, C1b2, C1b3, and
C1b4. Two other cyclins, Clb5 and Clb6, are very im-
portant for DNA replication, but they also have roles
at Start and perhaps also in early mitosis.
Interaction of Cyclin-Cdc28
Complexes with G1 and
Mitotic Inhibitors
D. Germain [in collaboration with M. Mendenhall,
University of Kentucky]
It has recently been shown that the protein p4Osicl is
an inhibitor of at least some cyclin-Cdc28 complexes.
Passage into S phase requires destruction of Sicl so
that S-, G2-, and M-phase cyclin-Cdc28 complexes
can be activated. It is thought that destruction of Sicl
is triggered by phosphorylation, allowing recognition
by Cdc34, a ubiquitin-conjugating enzyme.
We have studied the interactions of Sicl with vari-
ous cyclin-Cdc28 complexes and have found that it is
phosphorylated by all tested complexes, including the
G5 cyclin complexes (Clnl, Cln2, and Cln3), the S-
phase complexes (C1b5 and C1b6), and the mitotic
complexes (Clb, 2, 3, and 4). Although Sicl has only
five consensus Cdc28 phosphorylation sites, two-
dimensional gels showed that as many as 12 phos-
phates can be added by Cdc28. Sicl inhibited only
the Clb-Cdc28 complexes and did not inhibit Cln-
Cdc28 complexes. This supports a model where Cln-
Cdc28 complexes are responsible for phosphor-
ylating Sicl, leading to degradation and allowing ac-
tivation of S-, G2-, and M-phase kinase activities.
We also examined the effects of p21 (a gift from
D. Beach and co-workers, CSHL), a mammalian in-
hibitor of G1 cyclincdk complexes. This protein
strongly inhibited the three Cln-Cdc28 complexes
and also inhibited C1b5 and Clb6 complexes, but
failed to inhibit Clbl, 2, 3, or 4 complexes. Thus, per-
haps surprisingly, p21 recognizes some feature of Gl-
and S-phase cyclins, but not other cyclins, conserved
from yeast to humans. p21 and p40 seem to be large-
ly cyclin-specific rather than cdk-specific.
Critical Thresholds of G1
Cyclins for Start
B. Schneider
We are interested in knowing how much G1 cyclin is
required for Start. Is a critical level required? Or will
a small amount suffice if given long enough to work?
As a first step, we measured the amount of Gi cyclin
at Start in different cells. Surprisingly, the amount
varied tremendously with growth rate: Rapidly grow-
ing cells had at least 50-fold more Clnl or Cln2 than
slowly growing cells. This difference may be due to
the very short half-lives of the Cln proteins and their
mRNAs: Short half-lives make steady-state levels
very sensitive to rates of synthesis.
In normal cells, CLN expression is size-depen-
dent-larger cells make more CLN than smaller cells.
We constructed a strain with genotype clnl cln2 cln3
GAL -CLNJ gall. In this strain, very small amounts of
galactose can be used to turn on the GAL-CLN1 con-
struct, and the amount of expression is proportional
to the amount of galactose used. In this strain, CLN
expression is independent of size. We are now using
this strain to measure the level of CLN required for
Start under different conditions (growth rate, etc.).
The RAS/cAMP Pathway
Connects G1 Cyclins
to Growth
G. Tokiwa, T. Volpe [in collaboration with M. Tyers,
University of Toronto]
As described in the section above, slowly growing
cells have relatively low levels of Cln protein. This
may be a simple consequence of the short half-lives
of Cln mRNA and protein. The difference in Cln
levels between slowly growing and rapidly growing
cells might be even greater than the difference ob-
served, except that rapidly growing cells seem to
have mechanisms for partially repressing CLN ex-
pression. This mechanism works through the cAMP
pathway: The faster the growth rate, the higher the
intracellular le'vels of cAMP, and the greater the CLN
repression. This repression is only relative-rapidly
growing, "repressed" cells actually have more Cln
protein than slowly growing, nonrepressed cells. The
fact that there is repression at all is demonstrated by
the fact that (1) CLN mRNA levels drop briefly but
sharply when glucose is first added to a culture and
(2) cells lacking a RAS/cAMP signaling pathway
have more CLN at high growth rates than do wild-
type cells.
It has been known for many years that rapidly
growing cells are larger than slowly growing cells.
This now appears to be an effect of the cAMP-
mediated repression of CLNs. In addition to CLNI
and CLN2, all of the other known genes dependent on
the SBF or MBF transcription factors are also at least
partly repressed by cAMP (Fig. 1). The significance
of this is not yet clear.
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FIGURE 1 High levels of cAMP repress many SBF- and
MBF-regulated genes. Either cAMP or 3' AMP was added
to W303 pde2.TRP1 cells growing in raffinose, and samples
were analyzed for mRNA abundance by Northern blotting.
Mechanisms of Transcriptional
Activation by Cyclin-Cdc28
Complexes
H. Wijnen
One effect of the Cln3-Cdc28 complex-perhaps the
only effect-is to induce transcription of a family of
genes that includes CLNI, CLN2, CLB5, and CLB6.
We are trying to discover the mechanism of induc-
tion. The promoters of the CLN3-inducible genes all
include binding sites for the Swi4 transcription factor
or for its close relative Mbpl. Thus, we imagine that
Cln3 somehow allows activation from Swi4/Mbpl-
regulated promoters. To examine this, we constructed
a reporter consisting of an HIS3 open reading frame
downstream from a set of binding sites for Swi4 or
Mbpl. Surprisingly, it appears that this reporter is not
significantly induced by CLN3. It may be that
Swi4/Mbp1 sites are necessary but not sufficient for
CLN3 inducibility, consistent with previous results of
C. DiComo and K. Arndt (CSHL). Addition of other
elements found in the CLNI and CLN2 promoters to
the reporter may allow induction by CLN3 and in this
way point to the mechanism of activation.
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G1 Cyclins Are the Only
Limiting Factors for Start
Q.-H. Yang
When the Gt cyclin CLN3 is overexpressed in rapidly
growing cells, it accelerates all or nearly all of the
cells through Start, so that there are almost no cells in
Gt phase. However, in slowly growing cells, about
half the population is in Gt even when CLN3 is over-
expressed. This could mean that some proteins other
than CLNs are limiting for Start in slowly growing
cells. Alternatively, since the main function of CLN3
is to promote transcription of CLNI and CLN2, it is
possible that under poor conditions, insufficient
CLNI and CLN2 are synthesized to make Start con-
stitutive. Therefore, we overexpressed CLNI and
CLN2 in slowly growing cells. In this case, we found
that all of the cells were in S, G2, or M.
In a more extreme experiment, cells were starved
for carbon source so that they were unable to grow at
all. Galactose was then used to induce a GAL -CLNI
construct in a strain carrying a gall mutation so that
galactose could not be used as a carbon source. The
cells then proceeded past Start into S, even though
they were synthesizing very little protein and under
normal circumstances would have arrested quantita-
tively in Gt phase.
It appears that the only limiting factors for Start,
for budding, for DNA synthesis, and for spindle pole
body duplication are the CLNs. All other needed
components must be present even in very small, very
slowly growing G., cells. This is somewhat surpris-
ing, given the large number of genes known to be
cell-cycle-regulated at the Gt /S transition.
Cell Cycle Exit and
Stress Resistance
B. Elliott
Previously, we identified TPS2, which encodes
trehalose-6-phosphate phosphatase, as a gene needed
for stress resistance in yeast. Yeast are known to ac-
cumulate trehalose in response to stress, but it has
been controversial whether or not the trehalose is a
cause or an effect of the stress-resistant state. Our
tps2 mutant is stress-sensitive and accumulates much
less trehalose than a wild-type cell, but it also ac-
cumulates trehalose-6-phosphate (tre-6-P). Sugar
phosphates are often toxic, and tre-6-P is known to be
an inhibitor of glycolysis. We therefore considered
the possibility that the stress sensitivity of the tps2
mutant was due to accumulation of tre-6-P. We com-
pared tpsl mutants (which are defective in the first
step of trehalose synthesis and do not make tre-6-P)
with tps2 mutants and tpsl tps2 double mutants. All
three were stress-sensitive, but the tps2 single mutant
was significantly more sensitive than the other two.
Furthermore, a novel gene isolated as a partial sup-
pressor of tps2 encodes a phosphomutase and partial-
ly converts tre-6-P into trehalose. These results sug-
gest that although part of the stress sensitivity of tps2
is due to the accumulation of tre-6-P, another part is
genuinely due to the lack of trehalose. Thus, we be-
lieve that trehalose is a stress protectant.
Esti Is a Protein Component
of Yeast Telomerase
B. Steiner, K. Hidaka
The ESTI gene (Ever Shorter Telomeres) was identi-
fied many years ago in a screen for telomere
maintenance mutants. Cells lacking EST1 suffer a
gradual shortening of telomeres, then senesce and
die. This has led to speculation that the Esti protein
might be a component of yeast telomerase.
We tested this idea by tagging Estl with an
epitope and then immunoprecipitating. Northern blots
show that the immunoprecipitates contain the yeast
telomerase RNA. When immunoprecipitates are
resuspended in a reaction mix containing telomere-
like oligonucleotides, dill', and 32P-labeled dGTP,
the oligonucleotides are elongated to give a telomer-
ase-like ladder of reaction products. The activity is
sensitive to RNase digestion, it is specific for im-
munoprecipitates from tagged Estl strains, and it
fails to elongate most nontelomeric oligonucleotides.
At present, we are working to confirm that the ac-
tivity is telomerase by asking whether we can change
the nucleotides that are incorporated by changing the
sequence of the telomerase RNA.
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REGULATION OF GROWTH AND CELL CYCLE
COMMITMENT IN BUDDING YEAST
K.T. Arndt A. Sutton F. Lin
C.J. Di Como M. Luke
C. Devlin F. Della Seta
A. Doseff T. Zhong
Our research focuses on the regulation of the G1
phase of the cell cycle. For most eukaryotic
organisms, it is during G, that decisions are made as
to whether or not to divide. For these studies, we use
the model organism Saccharomyces cerevisiae,
which is commonly called budding yeast. Budding
yeast cells that have executed the late G1 event(s)
termed Start are committed to initiate DNA synthe-
sis, form a bud, and divide. Start is the point where
growth signals and mating pheromones control entry
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into the cell division cycle. The execution of Start
seems to require some threshold level of G,
cyclin/CDC28 kinase activity, which is determined in
large part by the rate and levels at which the G,
cyclin RNAs accumulate during late G1. However,
very little is known about the mechanisms that
determine if G1 cyclin RNAs accumulate and the rate
at which G, cyclin RNAs accumulate.
Many cell cycle events are controlled by the
regulation of the phosphorylation of certain key cell
cycle substrates. We have found that the SIT4 protein
phosphatase, which is a type-2A-related phosphatase
that removes phosphate groups from phospho-serine
and phospho-threonine residues, is required during
G, for the execution of Start, for bud formation, for
the initiation of DNA synthesis, and for spindle pole
body duplication. Our major goals are to determine
how growth signals control the ability of SIT4 to pro-
mote Start and bud initiation and to determine the
downstream targets of SIT4 that function for Start
and bud initiation.
SIT4 Is Required for G1
Cyclin Accumulation
K. Arndt, C.J. Di Como
SIT4 is required for the execution of Start because it
is required for the expression of the CLNI and CLN2
G, cyclin genes. CLNI and CLN2 proteins bind to
CDC28, thereby activating the kinase activity of
CDC28. When some threshold level of CLN/CDC28
kinase activity is achieved, Start is executed and the
cells are committed for DNA synthesis and the com-
pletion of the cell cycle. During early Gt, the levels
of CLNI and CLN2 RNAs are very low. During late
G1, the levels of CLN1 and CLN2 RNAs increase at a
very rapid rate. The rate at which CLN1 and CLN2
RNAs increase is determined in part by the activity of
the CLN3 gene, which encodes a cyclin-like protein.
Hyperactive alleles of CLN3 cause a more rapid rate
of increase of CLNI and CLN2 RNA levels, whereas
loss-of-function alleles of CLN3 cause a slower rate
of increase.
Much evidence shows that CLN3 and SIT4 pro-
vide additive pathways for the activation of CLNI
and CLN2 expression. In fact, mutation of both SIT4
and CLN3 causes an essentially lethal effect. More-
over, this lethal effect is due only to a defect in Gt
104
cyclin expression because it is completely cured by
expression of CLN2 from a SIT4- independent pro-
moter. Like a sit4 mutation, a mutation in any gene
required in the SIT4 pathway for Gt cyclin expres-
sion should also be lethal in combination with a cln3
mutation. We used the colony sectoring assay to iso-
late 400 mutants that could not grow in the absence
of CLN3. These mutants, termed ctr for CLN Three
Requiring, fell into 12 complementation groups. So
far, we have analyzed CTR7 in the most depth. The
CTR7 gene is the same gene as BCK2, which was
originally isolated as a gene that in high copy number
can suppress the temperature-sensitive cell lysis
defect of mutations in the protein kinase C pathway.
BCK2 and CLN3 have similar effects on Start
regulation. Cells containing a single deletion of either
BCK2 or CLN3 have a modest defect in CLNI and
CLN2 expression that causes the cells to be more
sensitive of a-factor and to execute Start at a larger
than normal cell volume. Therefore, either BCK2
alone (without CLN3) or CLN3 alone (without
BCK2) can activate CLNI and CLN2 expression.
However, in the absence of both BCK2 and CLN3,
CLNI andCLN2 expression is so low that the cells
have a severe growth rate defect. These findings sug-
gest that BCK2 and CLN3 activate G, cyclin expres-
sion by parallel pathways. Moreover, additional ge-
netic tests show that unlike CLN3, BCK2 functions
within the SIT4 pathway for CLNI andCLN2 expres-
sion. Overexpression of either BCK2 or CLN3 hyper-
activates CLNI and CLN2 expression. This effect
gave us a convenient way to determine the CLN2
promoter elements through which BCK2 functions.
The CLN2 promoter contains DNA sequence ele-
ments to which SW14/SWI6 and possibly
MBP1/SWI6 complexes bind to activate CLN2 ex-
pression. We have found that overexpression of
BCK2 activates these elements about twofold. How-
ever, overexpression of BCK2 activates the intact
CLN2 promoter about tenfold. We have determined
that a region that lies between the SWI4/SWI6- and
MBP1/SWI6-binding sites and the TATA element
has no substantial UAS activity on its own, but
modulates the ability of the SWI4 and MBP1 ele-
ments to activate CLN2 expression. How BCK2
modulates the SWI4/SWI6 and MBP1/SWI6 ele-
ments is not currently known. Our future goals will
be to determine if BCK2 function is regulated by
SIT4 and to obtain additional components of the
SIT4-BCK2 pathway for CLNI and CLN2 expres-
sion.
Function and Regulation
of the SIT4 Phosphatase
during the Cell Cycle
M. Luke, F. Della Seta
SIT4 is a protein phosphatase catalytic subunit whose
levels are constant throughout the cell cycle. There-
fore, the activity of SIT4 might be regulated in the
cell cycle by association with regulatory subunits. In
G, daughter cells, SIT4 exists mostly as monomeric
uncomplexed SIT4. During late Gt, at a time close to
Start, SIT4 is found in separate complexes with two
high-molecular-mass phosphoproteins, termed SAP-
155 and SAP190. After mitosis, SIT4 is again found
primarily as monomeric uncomplexed SIT4.
SAP155 and SAP190 were purified by large-scale
affinity purification of epitope-tagged SIT4 followed
by SDS-gel separation. R. Kobayashi (CSHL) ob-
tained partial peptide sequences for both proteins and
this information was used to clone the SAP155 and
SAP190 genes. The predicted SAP155 and SAP190
proteins show no significant homology with other
proteins in the current databases. However, SAP155
and SAP190 are homologous to each other, with
about 30% identical amino acids over the entire
lengths of the proteins. This finding raises the pos-
sibility that SAP155 and SAP190 share common
functions. Indeed, deletion of SAP190 causes no
growth-rate defects, deletion of SAP155 causes a
slight growth-rate defect, but deletion of both
SAP155 and SAP190 causes a strong growth-rate
defect.
We have prepared antibodies to both SAP155 and
SAP190. With the tools (antibodies and mutations in
the genes) to analyze SAP155 and SAP190 in hand,
we can now address the following important ques-
tions.
Do SAP155 and SAP190 regulate, positively or
negatively, the activity of SIT4 toward its in vivo
substrates? Are SAP155 and SAP190 substrates of
SIT4? How is the association of SIT4 with SAP155
and SAP190 regulated: via regulation of the associa-
tion itself (as by phosphorylation of SAP155 and
SAP190) or via regulation of the abundance of
SAP155 and SAP190? How do growth signals and
cell cycle signals regulate the association of SAP155
and SAP190 with SIT4? Our future experiments will
be directed toward answering these questions.
Identification of Genes
Functioning in the SIT4
Pathway for Bud Formation
A. Doseff
sit4 mutants arrest as large unbudded G, cells
blocked at Start. In contrast, if CLN2 is expressed
from a SIT4-independent promoter, sit4 mutants are
able to execute Start and replicate their DNA. How-
ever, they are still blocked for bud initiation. We used
a synthetic lethal screen to identify genes that func-
tion in the SIT4 budding pathway. This approach was
based on the fact that whereas in certain strain back-
grounds, SIT4 is essential, in some backgrounds,
SIT4 is not essential, but the cells grow very slowly
with a greatly expanded G, phase. The viability or in-
viability of Asit4 strains results from a polymorphism
at a single genetic locus that we termed SSDI. The al-
leles of SSDI that allow viability in the absence of
SIT4 are called SSD1-v. We isolated mutations that,
like sit4 mutations, are lethal in the absence of SSD1-
v. From this screen, we isolated 75 mutants termed
LAS (for Lethal in the Absence of SSDI) that fell into
six complementation groups. Importantly, one of the
complementation groups contained mutations in the
SIT4 gene, confirming the rationale of the screen.
The complementation group with the most members
had mutations in the LAST gene. LAS1 encodes an es-
sential protein with a predicted molecular mass of 59
kD. Loss of Lasl function causes the cells to arrest as
80% unbudded cells and 20% large budded cells. The
large budded cells have many secretory vesicles at
the mother-daughter neck. Presumably, these vesicles
accumulate because they are blocked for fusion with
the cell membrane. Overexpression of Lasl results in
the formation of extra cell surface projections in the
mother cell, alterations in the localization of com-
ponents (such as actin and Spa2) that are known to be
involved in bud formation, and the accumulation of
electron-dense structures along the periphery of the
cell. Further evidence of a role of Lasl in bud forma-
tion is that overexpression of Last promotes bud
formation in sit4 mutants. Because LAS1 localizes to
the nucleus, our current model is that LAS1 functions
in bud formation and morphogenesis via the regula-
tion of the expression of components that function
directly in these processes. Very little is known about
how components involved in bud initiation are regu-
lated during the cell cycle. LAS1 is a phosphoprotein
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and our future experiments will determine if LAS1 is
a substrate of SIT4. In addition, we will try to identi-
fy genes involved in bud initiation that are regulated
by LAS1.
Identification of Genes
That Interact with SIT4
C.J. Di Como
To identify cellular substrates and/or regulatory sub-
units of SIT4, we isolated genes that, when present
on a high-copy-number plasmid, suppress the temper-
ature-sensitive phenotype of a sit4 mutant. From this
scheme, we isolated three genes. One gene is
SAP155, which encodes the 155-kD subunit of SIT4.
High-copy-number SAP190 also suppresses the sit4
mutant, but we did not isolate SAP190 from this
screen because SAP190 is not present in the high-
copy-number library. The second gene is HCS26.
HCS26 encodes a 01 cyclin that binds not to CDC28,
but to the CDC28-related kinase PH085. Other
cyclins (CLN1, CLN2, ORFD, and CLB5) in high
copy number are not able to rescue the temperature-
sensitive phenotype of the sit4 mutant. It is not yet
clear by what mechanism HCS26 suppresses the sit4
mutant, but suppression does require PH085. The
third gene is a previously unidentified gene which we
term SAP42 (SIT4-associated protein) because it en-
codes a 42-kD protein that associates with SIT4. The
SAP42 gene is essential, and germinating Asap42
cells arrest as four to eight unbudded or large budded
cells. We are currently testing if SAP42 is a substrate
or target of SIT4 or if SAP42 regulates SIT4. In addi-
tion, we are determining the essential cellular func-
tion provided by SAP42.
Overexpression of SIS2,
Which Contains an Extremely
Acidic Region, Increases the
Expression of SWI4, CLN1
and CLN2 in sit4 mutants
C.J. Di Como
The SIS2 gene was identified by its ability, when
present on a high-copy-number plasm id, to greatly
increase the growth rate of sit4 mutants. Overexpres-
sion of SIS2, which contains an extremely acidic
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carboxy-terminal region, stimulated the rate of CLN1,
CLN2, SWI4, and CLB5 expression in sit4 mutants. In
addition, overexpression of SIS2 in a CLN1 cln2 cln3
strain stimulated the growth rate and the rate of CLN1
and CLB5 RNA accumulation during late Gi. There-
fore, SIS2 has a role in the expression of the G,
cyclins. The SIS2 protein fractionated with nuclei
and was released from the nuclear fraction by treat-
ment with either DNase I or micrococcal nuclease,
but not with RNase A. This result, combined with the
finding that overexpression of SIS2 is extremely
toxic to a strain containing lower than normal levels
of histones H2A and H2B, suggests that SIS2 might
function to stimulate transcription via an interaction
with chromatin.
PDL3 Is Required for
G2 Cyclin Expression
A. Sutton
In an effort to determine additional functions of SIT4
in the cell cycle, we carried out a genetic approach.
This approach was based on the fact that whereas in
certain strain backgrounds SIT4 is essential, in some
backgrounds, SIT4 is not essential, but the cells grow
very slowly with a greatly expanded G1 phase. The
viability or inviability of 4sit4 strains results from a
polymorphism at a single genetic locus which we
termed SSDI. The alleles of SSDI that allow viability
in the absence of SIT4 are called SSD1-v. We isolated
mutations that cause a requirement for SIT4 for
viability in an SSDI -v background. This synthetic
lethal screen should identify genes (such as SSDI -v)
whose products carry out overlapping functions with
SIT4.
One of the genes we obtained in this screen is
called PDL3 (phosphatase-deficient-lethal). PDL3
encodes a novel, essential protein kinase with several
unique structural features. The predicted PDL3
protein lacks a highly conserved GXGXXG sequence
found in protein kinases that is required for
nucleotide binding. PDL3 also lacks another invariant
G residue within the kinase catalytic domain. Despite
these features, mutational analysis and in vitro kinase
assays show that PDL3 functions as a protein kinase
in vivo and in vitro. Several lines of evidence suggest
that the essential function of the PDL3 kinase is for
cell cycle progression from G2 into M phase. First,
the phenotypes caused by the pd13-1 mutation are
identical to those of a strain deleted for CLB2. CLB2
encodes a B-type cyclin whose interaction with the
CDC28 kinase late in G2 is crucial for progression
from G2 into M. Both pd13 mutants and Aclb2
mutants have a cell cycle delay in late G2 and an
elongated cell shape. Second, pd13 mutants are defec-
tive in the accumulation of CLB2 RNA, which
normally occurs late in G2. In addition, temperature-
sensitive pd13 strains arrest with low CLB2/CDC28
kinase activity. Third, the temperature-sensitive
phenotype of a pd13 mutant is suppressed by expres-
sion of CLB2 from a heterologous promoter. These
data strongly implicate the PDL3 kinase in control of
cell cycle progression at G2/M and suggest that its
role in the cell cycle is via the activation of the
CLB/CDC28 protein kinase. We are currently inves-
tigating the mechanism by which PDL3 regulates
CLB/CDC28 activity and why mutations in PDL3
cause a requirement for SIT4 for viability.
Transcriptional Regulation
of S/S/
T. Zhong
Heat shock normally results in the rapid transcrip-
tional activation of heat shock genes and the prefer-
ential translation of heat shock messages. The essen-
tial SISI gene encodes a DnaJ homolog whose tran-
scription is activated by heat shock. Our interest in
SISI lies in the ability of overexpressed SIS1 to in-
crease the growth rate of sit4 mutants. Interestingly,
sisl mutants have greatly increased transcription of
the SISI promoter. In addition, overexpression of
SIS1 represses transcription of SISI. Therefore, SISI
autoregulates its own transcription. We have deter-
mined that the cis-acting SISI promoter sequences
responsible for SISI autoregulation are localized to a
39-base region. This 39-base promoter region con-
tains the SISI heat shock consensus element. How-
ever, the heat shock consensus element is not by it-
self sufficient for SIS1 regulation. An additional
eight bases are required on the upstream side of the
heat shock element to obtain regulation by SISI.
In addition, sisl mutants have greatly increased
transcription of the SSA4 gene, which encodes a
member of the A class of HSP70 heat shock proteins
in budding yeast. In contrast, transcription of SSB1 or
SSB2 (encode B class of HSP70) or the two genes en-
coding HSP90 homologs (HSP82 and HSC82) is not
altered in sisl mutants. The reverse is also true: Tran-
scription of SISI is activated in ssa mutants, but not
in strains defective for SSB or HSP90 function.
These findings raise the possibility that SIS1 (DnaJ)
and SSA (A class of. HSP70) may function together
for a common process.
Role of Type-2A Phosphatase
in the Actin Cytoskeleton
and in Entry into Mitosis
F. Lin
PPH22, a gene encoding a catalytic subunit of PP2A
(type-2A protein phosphatase) in budding yeast, had
been previously isolated in our lab. Later, we identi-
fied a second gene, PPH21, that encodes a PP2A
catalytic subunit. Deletion of either PPH21 or
PPH22 alone caused no detectable effect, but dele-
tion of both genes resulted in a slow growth defect
and a leaky temperature-sensitive phenotype at 37°C.
Only deletion of PPH21, PPH22, and a PP2A-related
gene, PPH3, was lethal. To investigate whether
PP2A is involved in cell cycle events, we prepared a
temperature-sensitive PP2A mutant, pph21-102. At
the restrictive temperature, the pph21-102 cells ar-
rested predominately with small or aberrant buds, and
their actin cytoskeleton and chitin deposition were
abnormal. The defects in actin organization might be
responsible for both the aberrant bud morphology and
the abnormal chitin deposition in the arrested pph21-
102 cells. Three possible functional pathways are
proposed. First, PP2A may function directly on the
actin cytoskeleton during the cell cycle and sub-
sequently might direct the mode of cell surface
growth to determine bud shape. Second, PP2A might
regulate the bud site complex, which is responsible
for bud emergence and growth, possibly through a
regulation of the actin distribution. Third, the effect
of PP2A on the actin distribution may be via the ef-
fect of PP2A on Clb/Cdc28 kinase activity. An active
Clb/Cdc28 kinase was reported to be necessary for
switching to spherical growth of the bud by a
depolarization of the cortical actin patches.
Moreover, after a shift to the nonpermissive
temperature, the pph21-102 cells were blocked in G2,
with inactive C1b2/Cdc28 complexes. Even though
CLB2 and CDC28 were present at normal levels and
interacted normally with each other, they had a
dramatically reduced kinase activity. Therefore,
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PP2A is required, directly or indirectly, for activating
the kinase activity of CLB2/CDC28 complexes, pos-
sibly via a posttranslational modification. In addition,
the Tyr-19 to phenylalanine alteration in CDC28 does
not cure the defect in CLB2/CDC28 kinase activity
seen in the absence of PP2A function. Therefore,
PP2A is required for the activation of the kinase ac-
tivity of CLB2/CDC28 complexes via a mechanism
that does not involve dephosphorylation of Tyr-19.
Mutations in the Yeast GMP
Synthase Reveal Altered HIS4
Transcription Initiation
C. Devlin
In budding yeast, the absence of the DNA-binding
transcription factors GCN4, BAS1, and BAS2/PHO2
results in a His phenotype that is due to very low
HIS4 RNA levels. Under these conditions, no detec-
table HIS4 RNA initiates at the wild-type initiation
site. Mutations in the GUA1 gene, which encodes
GMP synthetase, increased GCN4, BAS1, and
BAS2-independent initiation of HIS4 transcription at
the wild-type and additional initiation sites and
caused a His+ phenotype. This effect on HIS4 tran-
scription initiation was reversible by the addition of
guanosine to the growth medium. Adenine limitation
did not cause a His+ phenotype in the absence of
GCN4, BAS1, and BAS2. GMP synthetase RNA
levels remained constant throughout the cell cycle,
with different levels of guanosine or adenine in the
culture medium, and in bas1-2 and bas2-2 mutants.
Limitation for guanine nucleotides also increased the
amount of HIS3 mRNA that initiated at a +4 site. The
mechanism by which guanine nucleotide starvation
alters transcription initiation is under investigation.
In Press
Di Como, C.J., R. Bose, and K.T. Arndt. 1995. Overexpres-
sion of SIS2, which contains an extremely acidic region,
increases the expression of SWI4, CLN1, and CLN2 in
sit4 mutants. Genetics 139: 95-107.
Di Como, C.J., H. Chang, and K.T. Arndt. 1995. Activation of
CLNI and CLN2 Gi cyclin gene expression by BCK2.
Mol. Cell. Biol. 15: 1835-1846
INITIATION AND TERMINATION OF TRANSCRIPTION IN
HUMAN sNRNA GENES AND HIV-1
N. Hernandez T.L. Calhoun R. Mital F.C. Pessler
E. Ford V. Mital C.L. Sadowski
R.W. Henry D.J. Morrison S. Sepheri
B. Ma P.S. Pendergrast
SMALL NUCLEAR RNA GENES
In eukaryotes, transcription is carried out by three
RNA polymerases, RNA polymerases I, II, and III,
each of which recognizes a specific subset of cellular
genes. Since RNA polymerase I, II, and III promoters
are usually very different in structure, the simplest
model to account for RNA polymerase specificity is
one in which promoters from each different class are
recognized by different transcription factors, which
in turn recruit the correct RNA polymerase. It is now
clear, however, that promoters from different classes
all recruit a common transcription factor, the TATA
box-binding protein (TBP). TBP was first identified
as the DNA-binding subunit of TFIID, a multiprotein
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complex that recognizes the TATA box present in a
number of RNA polymerase II mRNA promoters.
We now know that TBP is also recruited to RNA
polymerase I promoters as part of the SL1 complex
and to TATA-less RNA polymerase III promoters as
part of the TFIIIB complex. Thus, in general, RNA
polymerase specificity appears to be determined by
the type of TBP-containing complex that is recruited
to a given promoter.
The human snRNA genes Ul, U2, and U6 are un-
usual in that they have very similar promoters, yet
the Ui and U2 genes are transcribed by RNA poly-
merase II, whereas the U6 gene is transcribed by
RNA polymerase III. To unravel how transcription of
these genes is regulated and how RNA polymerase
specificity is determined, we are identifying and
characterizing the transcription factors that recognize
the Ul, U2, and U6 promoters and comparing them
to those that recognize other RNA polymerase II and
III promoters.
Characterization of
the SNAP Complex
R.W. Henry, C.L. Sadowski, R. Kobayashi, N. Hernandez
The RNA polymerase II small nuclear RNA (snRNA)
promoters consist of a proximal sequence element
(PSE) and a distal sequence element (DSE), located
50 and 200 nucleotides upstream of the transcription
start site, respectively. The PSE is sufficient to direct
basal levels of transcription and to localize the start
site, whereas the DSE is an enhancer of transcription.
Thus, in these genes, basal transcription depends on a
single element, the PSE. In the RNA polymerase III
snRNA promoters, there is one additional promoter
element, a TATA box located 20 nucleotides up-
stream of the start site. This element is part of the
basal promoter and determines RNA polymerase III
specificity.
We have shown previously that the PSE recruits a
novel TBP-containing complex we refer to as the
SNAP complex or SNAPc. This complex is unique in
that unlike SL1, TFIID, and TFIIIB, which are dedi-
cated to transcription by a single RNA polymerase, it
is involved in transcription by two classes of RNA
polymerases, RNA polymerases II and III. Purifica-
tion of this complex to near homogeneity reveals that
it consists of TBP and at least three polypeptides with
apparent molecular masses of 43, 45, and 50 kD. We
have isolated a cDNA corresponding to the 43-kD
polypeptide. Peptide antibodies directed against p43
supershift the SNAP complex bound to a PSE probe,
confirming that this polypeptide is indeed part of
SNAPc. We therefore refer to it as SNAP43. The
SNAP43 open reading frame predicts a new protein
with a highly charged carboxy-terminal domain. The
protein contains weak homology with regions in
RAP30 (a subunit of the RNA polymerase II tran-
scription factor IIF) and a factor implicated in bind-
ing to RNA polymerase II and to Escherichia coli
core RNA polymerase, respectively. Antibody deple-
tion experiments show that, as expected, SNAP43
and/or associated proteins are required for RNA
polymerase II and III snRNA gene transcription. The
depletions have no effect on transcription from the
VAI gene, an adenovirus-2 RNA polymerase III gene
with gene internal promoter elements, nor on tran-
scription from the adenovirus-2 major late promoter,
a typical RNA polymerase II promoter, suggesting
that SNAP43 is not involved in transcription from
promoters that do not contain a PSE. We are now in
the process of obtaining cDNAs corresponding to the
other SNAPc subunits.
Characterization of TFIIIB
R. Mital, R. Kobayashi, N. Hernandez
Most RNA polymerase III promoters including the
5S, tRNA, and VAI contain gene internal elements.
On these genes, the assembly of an RNA polymerase
III transcription complex is initiated by the binding of
TFIIIA and/or TFIIIC to the gene internal promoter
elements. These transcription factors then recruit the
TFIIIB factor, which in turn recruits RNA polymer-
ase III. TFIIIB is, then, a key factor in RNA polymer-
ase III transcription because it probably contacts
RNA polymerase III directly. Despite its importance,
the mammalian TFIIIB factor is poorly characterized.
We have shown previously that TFIIIB can be sepa-
rated chromatographically into two fractions, which
we refer to as 0.38 M- TFIIIB and 0.48 M- TFIIIB ac-
cording to their salt elution profile on the column.
0.38 M- TFIIIB is a TBP-containing complex; 0.48 M-
TFIIIB is uncharacterized. We have used immuno-
precipitations with monoclonal antibodies directed
against TBP to purify an 86-kD factor tightly associa-
ted with TBP in the 0.38 M- TFIIIB fraction. We ob-
tained peptide sequences and used the information to
design degenerate oligonucleotides and obtain a
polymerase chain reaction (PCR) probe. The probe
was then used to screen a library. The open reading
frame reveals a protein that has homology with BRF,
a yeast protein associated with yeast TBP and in-
volved in RNA polymerase III transcription. We are
currently obtaining antibodies directed against this
protein. Such reagents will allow us to determine
whether this protein is indeed required for RNA
polymerase III transcription of genes with internal
promoter elements and may help us identify other
components of the complex.
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The POU Domain Potentiates
the Binding of the SNAP Complex
V. Mittal, M. Cleary, W. Herr, N. Hernandez
Both the RNA polymerase II and III snRNA pro-
moters contain a distance sequence element (DSE)
that serves as an enhancer. The DSE is characterized
by the presence of an octamer motif, the binding site
for the trans-activator Oct-1, a POU domain protein.
R. Roeder and colleagues (Rockefeller University),
have shown that on a probe containing adjacent oc-
tamer and PSE sites, the POU domain of Oct-1 binds
cooperatively with PTF, an uncharacterized factor
that recognizes the PSE and may correspond to the
SNAP complex. Indeed, we have shown that the
same is true for SNAPc. We are screening for muta-
tions in the Oct-1 POU domain that disrupt coopera-
tive binding and determining their effect on trans-
activation in vivo.
Characterization of a Novel
PSE-binding Activity
E. Ford, N. Hernandez
In addition to SNAPc, we can detect another complex
that binds specifically to the PSE. We are characteriz-
ing its composition and properties.
Characterization of Human
RNA Polymerase Ill
S. Sepheri, N. Hernandez
Although more and more of the mammalian RNA
polymerase III transcription factors are purified and
cloned, little is known about RNA polymerase III it-
self. In particular, there is no modern method to
purify the enzyme, and no good antibodies are avail-
able. We have therefore started to purify human RNA
polymerase III. We are also using PCR methods to
try to obtain cDNA clones corresponding to the
largest subunit. We could then overexpress the
protein and generate antibodies. These reagents will
be invaluable for reconstitution of RNA polymerase
III transcription in vitro and identification of all the
trans-acting factors required.
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Factors Required for
snRNA Transcription
by RNA Polymerase II
T.L. Calhoun, N. Hernandez
In the RNA polymerase II snRNA promoters, a single
element, the PSE, is capable of directing basal levels
of transcription. We know that the SNAP complex
binds to the PSE and is required for RNA polymerase
II transcription. Which other transcription factors are
involved? To answer this question, we are testing
general RNA polymerase II transcription factors in-
volved in mRNA transcription for their ability to
reconstitute RNA polymerase II snRNA gene tran-
scription in vitro and to assemble on the Ul snRNA
promoter.
HUMAN IMMUNODEFICIENCY VIRUS
Transcription from the human immunodeficiency
virus (HIV) is regulated to a large extent by a viral
protein named Tat. Tat is unusual in that instead of
binding to a DNA element, like other trans-activators
of transcription, it binds to an RNA target, the TAR
element, encoded within the first 60 nucleotides
downstream from the transcription start site. In the
absence of Tat, the HIV-1 promoter generates a large
number of short transcripts prematurely terminated
around position +60. The role of these molecules is
not understood, but they contain the TAR element
and may therefore be involved in the regulation of
Tat trans-activation.
We have identified an element, the inducer of
short transcripts (IST), which is required for forma-
tion of the short transcripts. When present, this ele-
ment activates transcription from the HIV-1 pro-
moter, but the RNA molecules resulting from this en-
hancement in transcription are all short. We are inter-
ested in elucidating the biochemical mechanisms that
govern formation of the short transcripts and in deter-
mining if similar elements exist in cellular promoters.
Identification of Trans-acting
Factors Potentially Involved
in the Formation of Short Transcripts
F.C. Pessler, N. Hernandez
We have identified a putative IST factor whose bind-
ing to wild-type and mutated versions of the IST cor-
relates well with short transcript formation. This fac-
tor has been purified to near homogeneity and con-
sists of a single polypeptide whose size is identical to
that of a polypeptide that can be specifically cross-
linked to the IST in partially purified fractions. We
are testing the role of this protein in in vitro assays.
TBP Domains Required for
Tat Trans-activation and
1ST Function
P.S. Pendergrast, D.J. Morrison, W.P. Tansey,
M. Sheldon, N. Hernandez
Tat is an unusual transcriptional activator in that (1) it
binds to RNA rather than DNA and (2) it seems to
improve the elongation properties of RNA polymer-
ase II. We are therefore interested in comparing Tat
to other trans-activators with respect to both its effect
on short and long transcripts and its sensitivity to var-
ious mutations in TBP.
In the absence of Tat, the HIV-1 promoter genera-
tes mainly short transcripts. Upon Tat trans-activa-
tion, the amounts of short transcripts are decreased,
whereas the amounts of full-length transcripts are
greatly increased. We find that when Tat is targeted
to the DNA as a GAL4 DNA-binding domain-Tat
fusion protein, trans-activation is severely dimin-
ished, suggesting that TAR does more than just re-
cruit Tat to the vicinity of the HIV-1 promoter but
may recruit, for example, a coactivator. In addition,
unlike RNA-targeted Tat trans-activation, DNA-tar-
geted Tat trans-activation results in enhancement of
the short transcripts, suggesting that short transcript
repression requires Tat bound to TAR RNA. This is
consistent with the observation that trans-activation
of the HIV-1 promoter by GAL4-VP16 and GAL4-
CTF fusion proteins also results in enhancement of
both short and long transcripts.
To compare Tat and other trans-activators with
respect to their sensitivity to mutations in TBP, we
have used the altered specificity TBP assay first de-
veloped in yeast by K. Struhl and colleagues (Har-
vard University). Our results indicate that Tat
responds to mutations in TBP similarly to CTF but
differently from VP16.
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TELOMERASE COMPONENTS AND REGULATION
C.W. Greider C. Autexier K. Buchkovich S. Le R. Pruzan
A.A. Avilion K. Collins J.-P. Liu N. Sareen
M.A. Blasco L. Falerio L. Mantell S.K. Smith
Chromosome stability is essential for cell viability.
Eukaryotes have linear chromosomes, and the telo-
meres that cap the ends protect chromosomes from
degradation and recombination. In the 1930s, Muller
and McClintock recognized that broken chromo-
somes that lacked telomeres were unstable. Sub-
sequently, experiments in protozoa, yeast, and mam-
malian cells demonstrated the essential nature of
telomeres for chromosome structure and function.
The recent finding that telomeres shorten with age in
normal human somatic cells but are stabilized in
tumor cells has suggested that regulation of telomere
length may have a role in cellular senescence and im-
mortalization.
Telomerase is the RNP polymerise that is essen-
tial for maintaining telomere length in many eukary-
otes. To understand both the telomerase enzyme me-
chanism and the role of telomerase in cell immortal-
ization, we have concentrated on cloning the protein
and RNA components of the enzyme. In the past
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year, we have collaborated with Geron Corporation
in cloning the RNA component of human telomerase.
We have cloned the mouse homolog of this gene and
showed that it is essential for telomerase function.
The identification of these genes allows the study of
both the regulation and function of mammalian telo-
merase. We have also cloned the protein component
of Tetrahymena telomerase. These proteins represent
the first telomerase protein components isolated from
any organism. The fact that the sequences are not
homologous to those of any other proteins in the
database suggests that telomerase represents a new
class of DNA polymerases.
Cloning Human
Telomerase RNA
A. Avilion [in collaboration with Calvin Harley, Bryant
Villeponteau, Jun li Feng, and Walter Funk of
Geron Corporation]
The potential role of telomerase activity in cellular
immortalization and cancer focused attention on
cloning the mammalian telomerase components.
Strategies were designed to clone the human RNA
component using approaches that would amplify the
RNAs containing potential template sequences. Spe-
cialized cDNA libraries representing small RNAs
were subjected to several rounds of selection for
RNAs containing the potential template sequence
CUAACCCUA. A number of candidate RNAs con-
taining this sequence were characterized to determine
whether the RNA copurified with telomerase activity
and whether oligonucleotides complementary to the
template region would inhibit activity. The genomic
locus for the best candidate RNA was cloned, and the
template region was altered to generate telomerases
that would synthesize either TTTGGG or TTGGGG
repeats. Using both transient transfection and stable
transformants, the mutant telomerase activity in ex-
tracts from these cells was detected.
The human RNA component (hTR) is much larger
than the ciliate telomerase RNAs. The RNA is ap-
proximately 550 nucleotides in length, and it appears
not to be a polymerase III transcript because it con-
tains internal tracts of T residues. The RNA is not
polyadenylated, and preliminary results suggest that
its transcription is inhibited by low levels of a amana-
tin, suggesting that it is transcribed by the modified
form of RNA polymerase II which transcribes many
of the U-snRNA genes in mammalian cells.
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Cloning Mouse
Telomerase RNA
M. Blasco
The mouse telomerase RNA gene was cloned from a
genomic library using the human genes as a probe.
Surprisingly, the mouse telomerase RNA (mTR) has
only 58% similarity to the human RNA gene. In con-
trast, other small RNAs are highly conserved be-
tween human and mouse. The low degree of homol-
ogy extends through the template region of the hu-
man and mouse RNAs. Interestingly, the mouse
template region is shorter than for the human RNA.
This shortened template may have a role in the
decreased processivity of the mouse telomerase rela-
tive to the human enzyme. The probability of dis-
sociation may be greater for the mouse than the hu-
man telomerase because of the lesser degree of com-
plementarity between the template and the telomere
primer. Mutational analysis of the human and mouse
RNAs will allow a greater understanding of the func-
tional consequences of the sequence divergence be-
tween these species.
Expression of Human
and Mouse RNAs
M. Blasco, A. Avilion
To study the regulation of the human and mouse
telomerase RNAs, we followed RNA levels in tissues
and cell lines where telomerase activity levels vary.
Northern analysis of 16 different human tissues
showed as expected that testis and ovary expressed
the highest level of hTR; however, surprisingly, a
number of other tissues also expressed significant
levels of RNA (Fig. 1, top). Of the tissues in which
the RNA is detected, it has been shown that normal
kidney, prostate, and adult liver lack detectable
telomerase activity. This suggests that telomerase
RNA may be present but inactive in a number of hu-
man tissues.
To examine the regulation of the telomerase RNA
in mice, we probed Northern blots containing RNA
from various tissues from both newborn and adult
mice. All of the tissues tested (intestine, brain, kid-
ney, lung, and liver) in the newborn mice had detec-
table levels of telomerase RNA. However, telomerase
Human Telomerase RNA Expression
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FIGURE 1 (Top) Expression of telomerase RNA in human
tissues. A Northern blot of human RNA (30 rag) from different
tissues was probed with hTR and with 18S RNA as a loading
control. Telomerase RNA is expressed in all tissues at vari-
ous levels, with the highest level of the RNA being in the
testes and ovary. Immortalized 293 cells have twofold more
telomerase RNA than testes on a per microgram basis.
(Bottom) Expression of telomerase RNA in mouse tissues.
Northern blots of newborn and adult tissues were probed
with the mouse telomerase RNA (mTR) and 5S RNA as a
loading control. Total RNA (25 rtg) was loaded from each
tissue: testis (adult only), intestine, brain, kidney, lung, liver.
(NB) Newborn samples; (A) adult tissues. This mouse RNA
was kindly provided by Dr. Ron DePinho (Albert Einstein
College of Medicine).
RNA was only detected in testes, intestine, lung, and
liver of the adult mice. The RNA levels were sig-
nificantly lower in the adult tissues than in newborn
tissues (Fig. 1, bottom). The detection of telomerase
RNA in adult mouse tissues correlates well with the
expression of telomerase activity in adult mice. Un-
like human somatic tissues, which do not express
detectable telomerase, activity is detected in mouse
liver, spleen, and kidney but not in mouse brain. The
increased RNA levels in newborns suggest that there
is developmental regulation of telomerase.
It is striking that the RNA levels in various tissues
are similar in mouse and humans, yet the telomerase
activity does not correlate with RNA levels in hu-
mans. This suggests that there is additional negative
regulation of telomerase in human cells that is not
present in the mouse. This difference in telomerase
regulation may help explain the long-standing ques-
tion of why mouse cells spontaneously immortalize
in culture and human cells do not. If telomerase reac-
tivation is required for immortalization and human
cells have an extra level of repression relative to
mouse, it may be easier to activate telomerase in
mouse cells. Understanding why differences in hTR
levels do not reflect a difference in telomerase ac-
tivity in these tissues may be an important lead in
targeting telomerase for anti-cancer therapies.
Cloning Telomerase Proteins
K. Collins [in collaboration with R. Kobayashi,
Cold Spring Harbor Laboratory]
To understand both the biochemistry and regulation
of telomerase, we cloned the telomerase protein com-
ponents from highly purified telomerase fractions.
Two polypeptides of 80 kD and 95 kD were identi-
fied that reproducibly copurified with telomerase ac-
tivity (Fig. 2). In collaboration with Ryuji Kobayashi
of the CSHL Protein Chemistry Facility, we obtained
7 peptides from p80 and for 25 peptides from p95.
Degenerate oligonucleotides were designed and used
to obtain polymerase chain reaction (PCR) products
from both genes. The full-length gene sequence was
then obtained using a combination of cDNA libraries,
genomic libraries, and PCR. Genomic Southern blots
probed with the PCR products for either p80 or p95
protein showed that both genes are single copy in the
Tetrahymena genome. Northern analysis showed a
band of about 2.9 kb for p95 and a band of 2.5 kb for
the p80 mRNA. All of the original peptides obtained
by direct protein sequencing were found in the se-
quence of the open reading frame of the cloned p80
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FIGURE 2 p80 and p95 copurify with telomerase. Telo-
merase was purified over five columns, and then a glycerol
gradient was loaded onto a native gel in three duplicate
lanes. The positions where telomerase migrated in the na-
tive gel were determined by Northern blotting of one lane to
detect telomerase RNA and by assaying telomerase activity
from different positions of the gel in the second lane. The
protein components were identified by SDS-PAGE analysis
of the third lane. Two proteins (p80 and p95) comigrated
with activity and with telomerase RNA in the first-dimension
gel, suggesting that these are telomerase components.
and p95 genes. Neither of the proteins has homology
with counterparts in the protein Genbank.
To determine if p80 and p95 were components of
telomerase, we generated antibodies against these
two proteins. Synthetic peptides were synthesized
utilizing sequences from each protein. Antisera were
affinity-purified and used in immunoprecipitation ex-
periments. Telomerase activity was specifically im-
munoprecipitated using an antibody directed against
p80; the activity was not precipitated if the peptide
specific for this antibody was first added to the reac-
tion to block antibody binding. An unrelated affinity-
purified antibody that did not recognize either p80 or
p95 also did not immunoprecipitate telomerase ac-
tivity. This experiment indicated that p80 is a func-
tional component of telomerase. Western analysis of
the pellet fraction showed that p95 coprecipitated
with p80 protein in fractions that had activity. In ad-
dition, the p80 and p95 proteins copurified with each
other over all columns tested and comigrated in a na-
tive gel and in a glycerol gradient even after RNase
treatment. These data suggested that p80 and p95
bind to each other directly and are required for
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telomerase activity. Based on the mass of telomerase,
the active enzyme is likely to consist of one subunit
each of the telomerase RNA, p80, and p95.
The sequences of p80 and p95 did not show sig-
nificant homology with other proteins in available
databases. The p80 protein contains a zinc finger that
may be involved in RNA or DNA binding. A region
in the p95 protein can be aligned with the active sites
from two different classes of polymerases: RNA-
dependent RNA polymerases and DNA polymerases
a and P. Sequences from the four conserved regions
in polymerases, the box A, B, C, and D regions, align
with several RNA-dependent RNA polymerases. The
lack of any other sequence homology with known
polymerases together with these motif regions sug-
gests that telomerase represents a new class of
polymerase. RNA-dependent RNA polymerases are
thought to be one of the earliest known polymerases;
if telomerase is indeed most closely related to this
class of polymerase, it suggests that telomerase may
be an ancestral form of polymerase.
Telomerase in the
Cell Cycle
K. Buchkovich, A. Avilion, L. Mantell, M. Blasco
Telomerase activity is not detected in many human
tissues. Since telomeres shorten only during replica-
tion, it was hypothesized that the telomerase may
only be active in actively dividing cells. To address
this, we assayed telomerase in actively growing cells,
quiescent arrested cells, and at various stages in the
cell cycle. Xenopus S-phase extracts and M-phase ex-
tracts had similar levels of telomerase activity. Hu-
man He La cells and mouse 3T3 cells synchronized at
S phase with hydroxyurea or at M phase with
nocodazole also have similar levels of telomerase ac-
tivity at both cell cycle phases. Consistent with this
lack of regulation, in quiescent mouse cells arrested
by either serum deprivation or growth to confluence,
telomerase activity was at levels similar to those in
log phase growing cells. Finally, we found that the
level of the mouse telomerase RNA was not altered
throughout the cell cycle, indicating that the RNA
levels paralleled the telomerase activity. Although
telomerase is clearly present at all stages of the cell
cycle, it is not yet clear when the enzyme functions to
elongate telomeres.
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Transposon Tagging and
Genetic Analysis of the
Maize Indeterminate gene
J. Colasanti, V. Sundaresan
Maize plants that are homozygous for the in-
determinate (idl) mutation have a prolonged vegeta-
tive phase of development that results in an increase
in the number of leaves and an extremely late flower-
ing phenotype or no flowering. Mutant plants that do
flower often exhibit floral reversion accompanied by
morphological aberrations; i.e., the female flower
(ear) forms as a vegetative branch and the male flow-
er (tassel) exhibits a proliferous structure of seedlings
emerging from the floral spikelets. Therefore, the Idl
gene product is required for the transition from
vegetative to reproductive growth, as well as for the
maintenance of the floral state.
We previously isolated a new indeterminate muta-
tion from a Ds2 transposon mutagenesis screen (see
1993 Annual Report) and have shown that it is allelic
to two known idl mutations, idl -R (the original idl
mutant to be identified) and idl -Compeigne (courtesy
of Ben Burr, Brookhaven National Laboratory). We
designate this new allele as idl-ml. The idl-ml allele
was crossed into several different backgrounds, and
molecular analysis was performed on these plants to
determine if a Ds2 element segregated with the idl-l -
ml allele. A Ds2-specific probe (a gift from Sarah
Hake, University of California, Berkeley) was used
to analyze several generations of idl-ml segregating
families by Southern than 120
progeny analyzed, a 4.2-kb Sad fragment was found
that was always present in plants that carried the idl-
ml allele and was absent in plants that did not carry
it.
CLONING OF idl-ml
The 4.2-kb fragment was cloned into a pUC-based
plasmid, pLITMUS29, and the position of the Ds2
insertion was determined (Fig. 1). When DNA flank-
ing the Ds2 element was used to reprobe the original
Southern blots, a single 4.2-kb Suet fragment was
found in idl-ml homozygous plants and a 2.9-kb
Sad fragment was found in plants that did not have
the idl -ml allele; heterozygous plants had both
bands. Interestingly, when flanking DNA was used to
probe SacI-cut DNA from idl-R plants, no band was
visible. This suggests that the idl -R allele might be a
deletion of part or all of the Idl gene. Furthermore,
the idl-Compeigne allele, when probed with the
flanking DNA, exhibited a pattern which suggests
that an insertion of approximately 3 kb exists in the
left flank region. Taken together, these results strong-
ly suggest that the idl-ml mutation is the result of a
Ds2 insertion.
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FIGURE 1 Position of the Ds2 insertion.
FLOWERING TIME OF idl-ml IS REGULATED BY Ac
Genetic experiments were performed to provide fur-
ther proof that the idl-ml mutation is the result of a
Ds2 transposon insertion and to get an idea of how
the Idl gene product regulates the transition from
vegetative to reproductive growth. A line was created
in which the idl-ml allele was linked to the bz2-m2
allele by the selection of crossovers between these
two loci. The genetic distance between them was
found to be approximately 1.4 cM. With the idl-ml
allele closely linked to the bz2-m2 allele, anthocyanin
sectors in the aleurone were used as a marker for Ac
activity. The Ac element used in these experiments is
located on chromosome 9 (Kelly Dawe, pers. comm.)
and therefore segregates independently of the idl-ml
bz2-m2 loci. We wanted to determine if the Ac ac-
tivity that causes a variegated phenotype in the
aleurone by somatic excision of the Ds2 element
from the bz2-m2 allele has a similar effect on the idl-
ml phenotype; i.e., does somatic excision of the Ds2
element from the idl-ml allele restore Idl function
such that the flowering time for the idl-ml mutants is
reduced in lines carrying an Ac element?
To compare flowering time of idl mutants in the
presence and absence of Ac activity, spotted and
bronze kernels from each ear of ten different families
that were the result of the self of plants with the
genotype idl- mlbz2- m2 /Idlbz2;Ac /- were planted in
the 1994 summer field. (Heterozygous idl- ml /Idl
plants were used because idl mutants normally can-
not be crossed.) As expected, 1/3 of the spotted
kernels from these ears segregated id mutant plants.
The other 2/3 had normal flowering times and should
be heterozygous plants, i.e., idl-m1bz2-m211d1bz2.
The bronze kernels of the selfed progeny of idl-
mlbz2-m211d1bz2, Ad- heterozygous plants repre-
sent 7/16 of the total kernels on each ear. Of these bz
kernels, 1/4 (or 4/16) should be homozygous for the
tester allele, Idlbz2 /Idlbz2. The other 3/16 represent
kernels that carry the idl-mlbz2-m2 allele but have
no Ac element and therefore are not spotted. Of these
kernels, 1/3 should also be homozygous for idl -
mlbz2-m2 and therefore express the indeterminate
mutant phenotype. Therefore, of the bronze kernels
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planted, 1/7 should segregate idl mutants. Overall,
the experiment involved comparing the flowering
time of idl plants grown from spotted kernels (+Ac)
with that of idl plants grown from bronze kernels
(-Ac). These were compared to the flowering time of
normal siblings found in both populations.
All kernels were planted in the third week of May,
1994; Figure 2 shows the results of the experiment.
Normal plants from both spotted and bronze kernels
usually made between 11 and 13 leaves, and all shed
pollen sometime between the third week of July and
the first week of August when they were approxi-
mately 9 to 11 weeks old. From the 10 rows of
spotted kernels planted, 47 clearly indeterminate
plants were segregating; i.e., none of these had
emerging ears or tassels by the time their normal si-
blings had shed out, and they all had more than 13
visible leaves. The 10 rows of bronze kernels yielded
17 indeterminate plants. These also showed no signs
of flowering by the time their normal sibs had shed
out, and they appeared to grow more slowly than the
spotted kernel id plants; i.e., they had fewer leaves
and they were shorter. By the first week of Septem-
ber, at about 15 weeks after planting, some of the
spotted kernel id plants had tassels emerging and
several had leafy ear shoots, whereas the bronze
kernel id plants showed no signs of flowering. In
mid-September, three of the spotted kernel id plants
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FIGURE 2 Ac effect on idl* flowering time. (Speckled
boxes) Spotted kernels (+AC); (open boxes) bronze kernels
(-Ac); (.) no flowers.
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were shedding pollen and the ears were silking; these
were either selfed or crossed to each other. These
plants had between 15 and 17 leaves. Approximately
half of the idl mutant plants from spotted kernels
were showing tassels at this time, whereas the bronze
kernel idl mutants continued to produce leaves but
no flowers.
By mid-October, when the plants were about 21
weeks old, all of the spotted kernel id plants, with the
exception of three plants in one family (see below),
had either shed out or had tassels emerging, and all
had from 17 to more than 20 visible leaves. Most of
these did not make ears, and the few ears that did
emerge had marked vegetative characteristics. All of
the id plants from bronze kernels, however, continued
to produce leaves, and they had neither tassels nor
ears. These plants continued to grow vegetatively and
make approximately 18 to 25 leaves until the first
killing frost on November 13, 1994 when they were
25 weeks old. Several of these plants were dissected
and found to have tassel primordia ranging from 0.5
to 1.0 cm in length. By comparison, several idl-R
plants that were planted at the same time in a nearby
field were dissected and found to have similar size
tassel primordia; none of these id plants produced
ears.
Since spotted kernels indicate the presence of Ac,
it appears that idl-ml plants that had an Ac element
in the background flowered significantly earlier than
plants from the same family that did not have an Ac
element. In fact, the latter plants did not flower at all,
and they made only tiny tassel primordia by the time
they were 6 months old at season's end. This is what
one would expect if the idl-ml allele had a Ds2 ele-
ment inserted into it which responded to Ac trans-
posase; i.e., Ac induces the somatic excision of the
Ds2 element, occasionally producing sectors of
normal tissue that can synthesize the functional Idl
gene product.
It is interesting to note that mosaic plants were not
seen in the idl-ml plants that flowered earlier; i.e.,
sectors of normal tissue juxtaposed to mutant tissue
were not apparent. Instead, the plants had an interme-
diate phenotype. This suggests that the Idl gene pro-
duct does not act cell autonomously and that it is a
diffusible substance or that it mediates the production
of a diffusible product. Furthermore, the progeny that
were obtained from the rare crosses of idl-ml
homozygous mutant plants all exhibited the mutant
phenotype. This shows that the tassels and ears of
these plants were not derived from sectors of normal
tissue. Rather, they are derived from mutant tissue
that flowered earlier by virtue of the presence of
normal Idl gene product that was provided by alleles
that had somatically lost the Ds2 element and
restored partial function. Clonal analysis experiments
are currently under way to confirm these observations
which suggest that Id acts non-cell autonomously.
ISOLATION OF STABLE NULL DERIVATIVES
Finally, as mentioned above, of the 47 id plants
derived from spotted kernels, all except 3 flowered
before the end of the season. These three plants
originated from the same family and, in general,
resembled idl-ml plants derived from bronze kernels
in terms of growth rate, leaf number, and inability to
flower. DNA was prepared from each of these id
plants and Southern blotting was performed using
Ds2-flanking DNA as a probe. Unlike all idl-ml
plants examined so far, which contain a single 4.2-kb
Sac! fragment, all three of these plants had a 2.9-kb
Sad band; i.e., similar in size to the Sad band found
in plants with a normal Idl allele. Primers flanking
the Ds2 insertion of idl-ml alleles were used to
amplify and clone this region from one of the three
mutants. Sequence analysis revealed that this plant
differed from normal plants in this region by having a
5-bp insertion. This sequence appears to be the rem-
nants of a target-site duplication, initially caused by
the Ds2 insertion. In effect, a stable revertant allele of
idl was created by the imprecise excision of Ds2.
This inserted DNA causes a frameshift in the putative
open reading frame of the Id protein (see below). As
observed, this new indeterminate allele (termed idl-
X) should not respond to the presence of an Ac ele-
ment. This finding provides additional evidence that
the earlier flowering phenotype of Ac-containing idl-
ml plants is the result of somatic excision of the Ds2
element during development.
THE Id CLONE INCLUDES AN ORF THAT HAS
HOMOLOGY WITH ANIMAL TRANSCRIPTION FACTORS
Sequence analysis of the regions immediately flank-
ing the Ds2 element revealed that the transposon is
inserted into a putative open reading frame (ORF) of
at least 84 amino acids. Preliminary RNA blot analy-
sis using a DNA fragment containing part of the ORF
region as a probe showed that it hybridized to a rela-
tively abundant transcript of approximately 2.0-2.2
kb in poly(A)+ RNA from shoot apex tissue and, to a
lesser extent, in mature leaf tissue. Very little
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hybridization was detected in seedling RNA, and no
transcript was detected in RNA from roots.
The 165-bp ORF fragment was used to screen two
maize cDNA libraries; one from immature ear (a gift
from Bruce Veit and Sarah Hake) and the other from
seedlings (a gift from Alice Barkan). A total of 12
cDNA clones were isolated: 3 from the immature ear
library and 9 from the other library. Restriction anal-
ysis of the clones from the immature ear library
showed that they were identical, and sequence analy-
sis of their 3' ends revealed that they had no poly(A)
tails. Sequence analysis of the 3' ends of the nine
cDNA clones from the seedling library revealed two
classes of cDNAs. However, when each of these
three cDNAs were made into probes and rehybridized
to Sad-cut genomic DNA blots, they each showed a
distinct pattern of bands, and they did not hybridize
to the 4.2-kb or 2.9-kb bands that the Ds2 flanking
probes revealed. Therefore, these clones represent
three different types of cDNAs that are distinct from
the Idl-coding sequence, yet perhaps closely related,
at least in the 165-bp ORF region. This suggests that
a family of Idl- related genes exists in maize. RT-
PCR is currently being used to isolate the Idl cDNA
clone.
Comparison of
with known sequences in the database showed that
they have similarities to "zinc-finger" DNA-binding
proteins from several species, including humans,
Drosophila, and Xenopus (Fig. 3). This is suggestive
evidence that if the ORF is a part of the /d/-coding
sequence, the Idl protein might function as an impor-
tant regulator of the vegetative to reproductive transi-
tion in maize.
Genetic Analysis of Embryogenesis
in Arabidopsis Using Gene-Trap
and Enhancer-Trap Transposon
Tagging
S. Woody, V. Sundaresan
Although there exist well-characterized animal
models such as Drosophila, mouse, and Xenopus, in
which embryo development and pattern formation are
understood in considerable molecular detail, com-
parably little is known about the mechanisms of em-
bryogenesis used by higher plants. Due to fundamen-
tal differences between plant and animal develop-
ment (e.g., immobility of plant cells and the absence
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FIGURE 3 Comparison of Idl genomic ORF sequence with
known sequences in the database.
of maternal contributions), the animal paradigms may
not be directly applicable to those of plants. Thus, an
understanding of the genetic and molecular aspects of
plant embryogenesis is crucial to our understanding
of the diversity of mechanisms that underlie em-
bryonic development in general.
We are using the gene-trap/enhancer-trap trans-
poson-tagging system described previously in the
1992-1994 Annual Reports to identify and character-
ize embryo-specific gene expression in the model
plant system Arabidopsis. Plant lines mutagenized
using an Ac /Ds transposon-tagging system are being
screened for transposon-induced mutations that pre-
vent or otherwise disrupt embryogenesis. In this sys-
tem, plants homozygous at the DsG or DsE starter
locus are crossed with lines homozygous for a deriva-
tive of Ac; the Ac element employed is incapable of
transposition, but it is able to supply transposase, the
enzyme required for Ds transposition. A selection
scheme based on the presence of selectable markers
associated with the Ac and Ds elements enables us to
identify transposant lines, in which the Ds element
has re-inserted at sites distant from the starter locus.
Insertion of Ds into coding or regulatory se-
quences important for embryogenesis may result in
an embryo-defective (emb) phenotype when homo-
zygous. Although mutations in a large number of
"housekeeping" genes (e.g., genes required for DNA
replication, protein synthesis, or metabolic functions)
are predicted to result in the emb phenotype, the
presence of the GUS reporter gene in the Ds elements
allows us to ascertain the tissue specificity of gene
expression using a simple staining procedure. Lines
that display an emb phenotype and whose staining
patterns indicate embryo-specific gene expression are
likely to carry Ds-induced mutations in loci whose
products or activities are essential for development of
the embryo as it progresses through its various differ-
entiated states. In addition, transposant lines
heterozygous for either DsG or DsE are being
screened for insertions that result in embryo-specific
GUS expression. This screen may allow identifica-
tion of duplicated or functionally redundant genes
that might have gone undetected in previous
mutagenesis schemes. We are most interested in lines
in which GUS expression is restricted to particular
embryonic cell types or is induced only at particular
developmental stages; such lines will constitute a col-
lection of marker lines that will be useful in
determining hierarchical relationships among regu-
latory genes that control embryogenesis.
Experiments are in progress to generate 4000-
5000 new transposant lines. Multiple pairwise crosses
between Ac and DsG or DsE starter lines have been
completed to produce seed representing approximate-
ly 20,000 Ft lines. In the past 9 months, seeds from
about 5000 individually grown Ft plants have been
collected; with the recent expansion of greenhouse
facilities, we have nearly 4000 F1 lines growing at
any given time. The F2 seeds are currently being
screened at a rate of 400 families per week, thereby
generating new transposant lines at a rate of about
100 per week.
In addition, working in collaboration with the
Martienssen, Ma, and Grossniklaus labs here at the
Laboratory, we have recently conducted a pilot
screen of approximately 700 previously generated
transposant lines carrying DsG or DsE elements.
Seeds corresponding to the F3 generation, in which
the Ds elements should be segregating, were allowed
to germinate on agar plates. Seedlings were examined
for mutant phenotypes indicative of insertions that
disrupt pattern formation in the embryo and stained
to determine GUS expression patterns. In a separate
phase of the screen, the same lines were sown in soil,
allowed to flower, and thus set seed. Inflorescences
containing embryos at early stages of development
(0-4 days after self-fertilization) were harvested and
stained for GUS expression. Finally, the phenotypic
screen for emb mutations, identified by the presence
of aborted seeds in nearly mature siliques, is current-
ly in progress.
In this preliminary screen, we have identified four
lines in which GUS expression segregates among de-
veloping seeds and appears to be embryo-specific.
One of these lines is shown in Figure 4 in which GUS
expression is evident throughout the embryo but ap-
pears to be stronger in the basal domain. Since this
screen was conducted in such a way as to maximize
the likelihood of detecting GUS expression, diffusion
of the products of the GUS reaction prior to forma-
FIGURE 4 GUS expression is evident throughout the em-
bryo, but appears to be stronger in the basal domain.
tion of the indigo precipitate limited the spatial
resolution of the screen. We are currently using mod-
ification of the GUS staining protocol to identify
more precisely the cell types responsible for GUS ex-
pression in these lines.
Gene-Trap and Enhancer-Trap
Reporter Gene Expression
Patterns in the Arabidopsis
Leaf and Shoot
P. Springer, Q. Gu, R. Martienssen
In vascular plants, the apical meristem represents the
ultimate source of all the postembryonic tissues of
the shoot. The meristem comprises a small dome of
cells at the tip of the seedling axis and gives rise to
axillary buds, resulting in branching, as well as
leaves and other lateral appendages. Leaves are typi-
cally initiated as small groups of founder cells on the
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flanks of the meristem, which rapidly divide and ex-
pand to form a peg-like structure. Leaf primordia are
elaborated by specification of three major axes and
sequential differentiation of leaf cell types. Leaves
are widely regarded as the "ground state" lateral
organ, as they are interchangeable with other types of
lateral organs (cotyledons, bracts, and floral organs)
by homeotic mutation or environmental signaling.
Leaf development is strongly influenced by the apex
from which it arises, and positional and inductive sig-
A
nals between apex and primordium are paramount in
the early stages of leaf determination. We are using
our gene-trap and enhancer-trap transposon muta-
genesis system to identify genes involved in pattern
formation in the developing leaf and shoot apical
meristem in Arabidopsis.
Approximately 1000 F3 transposant lines were
stained for reporter gene expression in a pilot screen;
9-10-day-old seedlings with 5-6 leaves were stained
by incubating overnight in X-gluc, a chromogenic
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FIGURE 5 Patterns of reporter gene expression in seedlings from enhancer and gene
trap lines. Seedlings from eight independent lines were stained in X-gluc and cleared
in ethanol (A-H). Staining is shown in leaf primordia (A), proximal (C), distal (D), and
marginal (E) domains in the leaf and various domains within the shoot apex (F, G, H).
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substrate for [3-glucuronidase (GUS). About 40% of
enhancer-trap lines and 20% of gene-trap lines dis-
played reporter gene expression in the seedling. Of
these, only 6% of gene traps and 15% of enhancer-
trap lines had GUS activity in the leaf, and only
about 1-4% were specific to leaves and leaf primor-
dia. Only 2-3% of enhancer-trap lines and less than
1% of gene-trap lines were specifically stained in the
shoot apex.
Patterns of reporter gene expression varied widely
in different lines. Some tissues, such as stipules and
lateral root primordia, were stained in a large propor-
tion of the lines and may reflect artifactual or deregu-
lated reporter gene expression. Many patterns stained
one organ predominantly, notably the cotyledon, the
root/hypocotyl system, or the leaves and leaf primor-
dia. Tissue- and cell-type-specific expression was ob-
served in some lines: In one line, expression in
trichomes and root epidermis might reflect common
epidermal patterning mechanisms; in another line,
expression was restricted to guard cells. Of particular
interest, however, were patterns restricted to domains
of the leaf and of the apical meristem that define pat-
tern elements of the primordium. For example,
several enhancer-trap lines stained early leaf primor-
dia in the distal domain, coincident
lular differentiation. In another line, reporter gene ex-
pression in 3-day-old seedlings seemed to be restrict-
ed to a domain of cells within the shoot apical
meristem. Several examples of these patterns are
shown in Figure 5.
Mutant phenotypes have only been characterized
in the F3 generation from some of these lines, but so
far, about 1-2% have seedling pigment phenotypes
(albino, fusca, etc.), whereas only 0.5% have poten-
tial leaf shape or meristem mutants. About 3% of the
F3 lines exhibited seedling defects ranging from root-
less seedlings to those with aberrantly initiated leaf
primordia or distorted trichomes. Of these, about
one- third exhibited reporter gene expression in the
seedling, and two-thirds did not. Segregation ratios
indicated that in some cases, seedling defects might
be caused by physiological germination ab-
normalities. Embryonic lethals and semisterile
gametophyte lethals have not yet been scored for the
whole collection. However, AS in Drosophila, we
anticipate that many of the genes involved in pattern-
ing of secondary fields (such as the leaf) will also be
involved in other stages of development and may
lead to early lethal phenotypes. One such gene has
been identified and characterized from our gene-trap
screen (see below).
Structure and Function of the
prolifera Gene in Arabidopsis
P. Springer, J. Montagu, H. Cross (URP program),
V. Sundaresan, R. Martienssen [in collaboration
with W.R. McCombie, Cold Spring Harbor Laboratory]
Last year, we reported on the cloning and partial se-
quence analysis of an MCM2-3-5-like gene from
Arabidopsis that was identified using a gene-trap
transposon insertion (transposant line GT148). The
gene-trap reporter gene was expressed in proliferat-
ing cells in each plant tissue examined, including pri-
mary and lateral root meristems, heart stage embryos,
leaf primordia, floral buds, developing carpels, and
ovule primordia. In the leaf, the pattern of expression
became restricted to the proximal mitotic domain as
the leaf expanded, and no expression was detected in
the mature organ. For this reason, we have named
this gene PROLIFERA. A partial Prolifera cDNA
clone was obtained via RACE PCR (polymerase
chain reaction). Further clones were recovered from a
flower cDNA library (from D. Weigel, Salk In-
stitute), and last year, we reported that database sear-
ches revealed that these clones had strong homology
with the MCM3 family of proteins (which includes
MCM2, MCM3, and CDC46/MCM5 in Saccharo-
myces cerevisiae, CDC21 of Schizosaccharomyces
pombe, and the mammalian P1 protein). The 5' end
of the cDNA has now been amplified, and the com-
plete cDNA sequence has been deter-mined, along
with a partial genomic map of the insertion allele,
prl-1. The full-length cDNA sequence shows ex-
tensive homology with the CDC47 gene from S.
cerevisiae (S. Dalton, Roche Institute, pers. comm.),
which was first identified from the European yeast
genome sequencing effort (open reading frame
YBR1441). The homology extends beyond the highly
conserved MCM domain, which is 40-70% identical
between members. In yeast, conditional mutants in
these genes arrest in S phase, and localization of the
corresponding proteins changes during the cell cycle:
They are nuclearly localized in G, but disappear
from the nucleus shortly after the Gt -S boundary,
returning only during mitosis. These proteins may be
components of "Licensing Factor" (Tye, Trends Cell
Biol. 4: 160 [1994]), which has been proposed to
regulate initiation of DNA replication via chromatin
access (Blow and Laskey, Nature 332: 546 [1988]).
The DsG insertion in prolifera lies in an 85-bp intron
toward the 3' end of the prl gene and results in a
translational fusion with the GUS reporter gene. Un-
121
der conditions that limit diffusion of the chromogenic
product, staining reveals that the gene fusion appears
to be nuclearly localized in some cells, especially in
the root (not shown).
Disruption of PROLIFERA results in reduced fer-
tility: heterozygous prl /+ plants are semisterile, hav-
ing reduced seed set. This is due to a partial (50%)
reduction in transmission of the mutant allele through
the female gametophyte, resulting from premature ar-
rest of megagametogenesis. Early embryo lethals are
also observed in self-pollinated siliques, suggesting
that the few prl /prl homozygotes that result from fer-
tilization of prl embryo sacs abort early during em-
bryogenesis. When Ac transposase is reintroduced by
crosses, the semisterile phenotype becomes unstable:
whereas most siliques are semisterile, occasional sili-
ques are fully fertile, suggesting that the mutation has
reverted to wild type in these flowers. Amplification
of revertant alleles via PCR has revealed that DsG
has left the locus in these siliques, resulting in
restoration of the wild-type phenotype.
In addition to generating revertants, we are using
Ac transposase to remobilize the Ds element at the prl
locus in order to generate (1) new insertion/deletion
alleles of prl that may be less leaky than prl -1 and (2)
closely linked insertions into nearby genes. We will
identify these insertions by site-selected mutagenesis
using PCR. We have recently developed a method for
this procedure in maize (see below), which should be
applicable to Arabidopsis.
Site-selected Transposon Mutagenesis
at the hcf106 Locus in Maize
L. Das, R. Martienssen
The High chlorophyll fluorescence] 06 (Hcf106) gene
in maize is required for chloroplast development, and
the hcf706-muml allele is caused by the insertion of a
Robertson's Mutator Mul element into the promoter
of the gene. Seedlings homozygous for hcf706-muml
are pale green and die 3 weeks after germination, but
only in the presence of active autonomous Mu regu-
latory transposons (Mutator activity) elsewhere in the
genome. When Mutator activity is lost, the mutant
phenotype is suppressed, and homozygous plants
have an almost wild-type phenotype. We have been
attempting to isolate derivative alleles in which part
of the hcf706 gene has been deleted, so stabilizing the
mutant phenotype in a non-Mutator background.
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Deletions adjacent to Mu elements are known to arise
at a high frequency in Mutator lines.
To isolate new hc f 106 alleles, we have developed
a method for site-selected transposon mutagenesis in
maize. This procedure, first described for Caenorhab-
ditis elegans and Drosophila, involves using the PCR
to screen pools of individuals for insertions and dele-
tions in genes of known sequence. As described last
year, two-dimensional pools of seedlings segregating
for the progenitor allele hcf706-muml were screened
by PCR for deletions associated with Robertson's
Mutator; 1500 seedlings from the cross hcf706I+ x
+/+ were germinated in x-y grids and DNA was
prepared from pools of 32 seedlings from each row
(x) and column (y) of the grids. The DNA was
digested with an enzyme that cuts uniquely in the
hcf106 gene at the initiator ATG codon. DNA from
the hcf706 locus was then amplified using a primer
from the transposon and a primer from the second
exon of the hcf706 gene (Fig. 6a). Digestion ensured
that only alleles that had lost the initiator ATG codon
via deletion would be amplified in subsequent PCR.
As we reported last year, three seedlings were identi-
fied by cross-referencing x and y pools that had PCR
products of the predicted size, and an example is
shown in Figure 6b. The structure and genetic
properties of the three new hcf706 alleles have now
been determined (Fig. 6c).
One of the three new alleles, hcf106-mum3, is a
244-bp deletion of sequences flanking the Mul ele-
ment. This deletion removes the first exon, and the
first two ATG codons. As predicted, progeny tests
have shown that this allele is no longer suppressible:
In the absence of Mutator activity, plants hetero-
zygous for hcf106-mum3 give rise to 1/4 mutant
progeny following outcrossing and self-pollination,
regardless of the presence of Mu activity, as
monitored by Mu element methylation, or phenotypic
suppression at other loci. The other two alleles,
hcf706-mum2 and hcf106-mum4, were not simple
deletions of this type. Instead, they are new insertions
of Mu elements at the hcf706 locus. hcf706-mum2
results from the insertion of a Mul element into the
first intron of the hcf706-muml allele, whereas
hcf706-mum4 results from the insertion of a dMuDR
element at the same location in the + allele. Remark-
ably, all three new alleles have breakpoints at the
same nucleotide in the first intron of the gene. This
probably reflects the fact that the target size for
recovered events was very small (360 by between the
Taql site and the primer). One of these insertions
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FIGURE 6 Site-selected transposon mutagenesis at the hcf106 locus in maize. (a) Map of the hcf106-mum1 allele. The Mul
element is inserted in the promoter. The locations of the initiator ATG and the primers described in the text (arrows) are
shown. The 4.3-kb second intron is shown not to scale (broken line). (b) PCRs with pooled samples. Seeds were germinated
in a 16 x 16 grid, with two seedlings at each position in the grid as shown (x). DNA was extracted from pools of 32 seedlings
from each row and each column and amplified using primers from the Mul element and the second exon of the gene as de-
scribed in the text. Each lane of each gel was loaded with PCR products from individual rows and columns. M is a molecular-
weight marker lane. The same derivative allele was amplified in one row and one column, and thus identified by a unique ad-
dress. (c) Schematic maps of progenitor hcf106-mum1 and derivative hcf106-mum2, hcf106-mum3, and hcf106-mum4 al-
leles. Exon sequences are represented by horizontal lines, and introns are shown as dips. The deletion in hcf106-mum3 is
shown as a triangle.
(hcf106-mum2) also gave a lethal phenotype in the
absence of Mu activity, whereas the other (hcf106-
mum4) gave only a weak, viable pale green
phenotype in this background. The affect of Mu ac-
tivity on this allele has not been determined.
Although the sample size is small, our results sug-
gest that this procedure can be used to rapidly identi-
fy transposon insertions into known genes in a single
generation. Null derivative alleles can then be isola-
ted in a second generation using the insertion as a
starting point. This two-step procedure represents a
powerful and simple way to "knock out" maize genes
identified by sequence alone, by using only a few
thousand progeny from a simple cross.
Role of Hcf106 in Chloroplast
Development
A.M. Settles, A. Yonetani, R. Martienssen [in
collaboration with R. Voelker and A. Barkan, University
of Oregon; and with R. Derby and D. Spector,
Cold Spring Harbor Laboratory]
High chlorophyll fluorescent (hcf) mutants of higher
plants and algae represent a class of nuclear genes re-
quired for the development of photosynthetically ac-
tive chloroplasts. hcf106 is an example of such a
mutation in maize: In mutant seedlings, chloroplast
thylakoid membranes have lost their characteristic
123
lateral heterogeneity and fail to accumulate a subset
of membrane protein complexes. This suggests that
the Hcf106 gene product has a role in membrane or-
ganization and thylakoid protein uptake or assembly.
Three thylakoid protein uptake pathways have been
defined by in vitro studies in higher plant
chloroplasts (Cline et al., EMBO J. 12: 4105 [1993]),
and each is required for uptake of a subset of
thylakoid lumenal proteins. hcf706 thylakoid mem-
branes accumulate reduced levels of some of these
proteins. For example, they accumulate low levels of
the 23-kD subunit of the oxygen-evolving complex
but normal levels of plastocyanin (A.Yonetani and R.
Martienssen, unpubl.). Using antibodies raised
against recombinant lumenal proteins, R. Voelker
and A. Barkan have shown that labeled precursors to
0E23 accumulate in hcf106 mutant seedlings. Fur-
thermore, labeled precursors to 0E16, another
protein taken up by the same pathway, also accumu-
late, whereas other lumenal proteins are found at
normal levels. These results suggest that hcf706
mutants may be blocked in this pathway.
By using our deletion and insertion derivative al-
leles, we have found that substantial amounts of ma-
ture lumenal 0E23 and 0E16 proteins are found in
hcf706 null mutants. This implies either that the path-
way is leaky or that hcf706 activity is partially
redundant. The latter possibility is supported by the
fact that a duplicate gene closely related to hcf706
has been found in maize (unpubl.). However, this
gene is mutant in the genetic backgrounds we are
using. To test the former possibility, we are con-
structing double mutants with other hcf mutations. In
particular, hcf737 (thal) has been found to be defec-
tive in the other lumenal protein import pathway (R.
Voelker and A. Barkan, pers. comm.). hcf706 hcf137
double mutants should be very informative in this
context.
We have cloned the Hcf106 gene by transposon
tagging, and antisera have been raised against the
gene product. Hcf106 is a chloroplast membrane
protein, and immunolocalization by light and electron
microscopy suggests that much of the protein is
found in thylakoid grana, which do not form in
mutant chloroplasts. The mature protein sequence has
a putative membrane spanning domain close to the
amino terminus, and a carboxy-terminal acidic
domain. The Hcf106 protein is protease sensitive in
intact thylakoids and lysed plastids, suggesting that
the carboxy-terminal domain protrudes outward into
the stroma. Hcf106 behaves as an integral membrane
protein after washing with alkali and sodium
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bromide. It may therefore be a component of the
thylakoid uptake apparatus.
Molecular Genetic Characterization
of lojap in Maize
C.-D. Han, R. Martienssen
Plants homozygous for the iojap (if) mutation have
patterned white stripes on their leaves (Jenkins, J.
Hered. 15: 467 [1924]) and give rise to albino see
dlings in their maternal progeny when pollinated by
wild-type plants (Rhoades, Cold Spring Harbor
Symp. Quant. Biol. 11: 202 [1946]). The degree and
extent of striping and the maternal transmission of
the if- affected plastids are largely dependent on ge-
netic background (Jenkins, J. Hered. 15: 467 [1924];
Coe et al., Am. J. Bot. 75: 634 [1988]). These
properties have made iojap a genetic paradigm for
cytoplasmic inheritance and nuclear-organellar inter-
actions in plants, and many models have been pro-
posed for If function.
On the basis of rRNA profiles of mutant and wild-
type plants, Walbot and Coe (Proc. Natl. Acad. Sci.
76: 2760 [1979]) proposed that iojap plants suffered
a programmed loss of plastid ribosomes that could
account for the maternal transmission of ij-affected
plastids. Some ribosomal proteins are encoded by
plastid genes, so that loss of plastid translation due to
homozygous nuclear mutation could lead to the
permanent loss of plastid-encoded ribosomal
proteins. Restoration of the nuclear components of
the plastid translational apparatus in heterozygous
maternal progeny would not be expected to restore
plastid ribosomal function if the plastid-encoded
components were no longer present. Heritable
ribosome-deficient plastids would result. Last year,
we reported that the Ij protein was associated with
50S plastid ribosomal subunits and that this associa-
tion was EDTA-sensitive. Association with SOS
ribosomal subunits suggests a role for the Ij protein in
plastid translation and supports the model proposed
by Walbot and Coe.
This model has now been tested genetically by ex-
amining Ij-ribosome association in ribosome defi-
cient plastids. The cold-sensitive mutant virescent 16
becomes chlorotic and fails to accumulate plastid
ribosomes when grown at 16°C. In preliminary ex-
periments, Ij protein was found at normal levels in
v16 mutants grown in the cold, but it was no longer
associated with 505 complexes on polysome gradi-
ents. In contrast, ribosomes from wild-type plants
grown at 16°C or from mutant plants grown at 24°C
have normal levels of ribosome-associated Ij protein.
This confirms that Ij is associated with plastid
ribosomal proteins.
P Alleles and Expression
of Flavonoid Biosynthetic Genes
E. Grotewold
The P gene encodes a Myb-domain protein required
for normal flavonoid pigmentation in some maize flo-
ral tissues. The pigment specified by P has been
called "phlobaphene," and this pigment accumulation
is most dramatic in pericarp and cob glumes. We
have shown that P achieves the regulation of pigment
accumulation by directly activating a subset of
flavonoid biosynthetic genes (Grotewold et al. 1994).
Our previous studies on the P gene have con-
centrated on the analysis of the P-rr allele, which
specifies red pigmentation in the pericarp and cob
glumes (Fig. 7). Genetic analysis as well as saturation
mutagenesis of the P-rr allele suggested that a single
P component is responsible for both pericarp and cob
pigmentation. Yet, the P-wr and P-rw alleles show
independent pigmentation in the pericarp and the cob
(Fig. 7). Biochemical experiments indicate that the
nonpigmented P-wr pericarps lack flavonoids in gen-
eral, not just the phlobaphene pigment (Styles and
FIGURE 7 Pericarp and cob pigmentation in maize ears
with different P alleles. From left to right: P-rr (red pericarp
and red cob glumes), P-wr (white pericarp and red cob
glumes), P-rw (red pericarp and white cob glumes), and P-
ww (white pericarp and white cob glumes). (Taken by Dr.
Thomas Peterson.)
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FIGURE 8 Northern blots of pericarp (P) or cob glumes (C)
poly(A)+ RNA from ears with different P alleles. Northern
blots were probed with a P-specific probe (P), with probes
corresponding to three P-regulated genes (C2, CHI1, and
Al), and with a ubiquitin (Ubi) probe as loading control.
Ceska, Maydica 34: 227 [1989]). We decided to in-
vestigate this phenomena with the idea that it could
provide important information on the mechanisms
regulating tissue-specific P expression or function.
To carry out these studies, poly(A)+ RNA was isola-
ted from P-rr, P-wr, and P-rw pericarps and cob
glumes. Northern blots were hybridized with probes
specific for the P gene transcripts and for the genes
regulated in the pericarp by P in the P-rr allele
(Grotewold et al. 1994). As had been found previous-
ly (P. Athma and T. Peterson, unpubl.), the nonpig-
mented P-wr pericarps accumulate P transcripts at
levels similar to those of the pigmented cob glumes
(Fig. 8). Yet, instead of the 2-kb and 1-kb transcripts
normally found in P-rr pericarps or cob glumes, P-wr
transcripts are 1.8 kb and 1 kb long. A similar result
was observed in the nonpigmented P-rw cob glumes:
A single 1.8-kb transcript accumulates in the nonpig-
mented cob glumes at levels comparable to those
found in the pigmented pericarps (Fig. 8). Since P ex-
pression could not account for the different pigment
distribution found in the P-wr and P-rw alleles, we
decided to investigate if the P regulatory function
was affected in the nonpigmented tissues of these
other P alleles. We had previously shown that C2,
CHIT, and Al transcript accumulation in pericarps is
completely dependent on the presence of a functional
P gene. When probes corresponding to these P-
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regulated genes were used to probe the same North-
ern blots containing pericarp and cob poly(A)+ RNAs
from the different P alleles, transcripts for these three
P-regulated genes could be detected in both pig-
mented and nonpigmented tissues (Fig. 8).
These results have several important implications.
First, they show that expression of the P-regulated
genes is not sufficient for the accumulation of the P-
specified pigment. Second, they indicate that ac-
cumulation of the P-specified pigment requires other,
yet unidentified (enzymatic?), steps. These steps are
probably regulated differentially in the pericarp and
the cob glumes by the different P alleles.
Analysis of BMS Transgenic
Cell Lines for P and R+C1
E. Grotewold [in collaboration with Ben Bowen,
at Pioneer Hi-Bred International, Johnston, Iowa]
Our studies have shown that in P-rr pericarps (Fig.
7), a functional P gene is required for the accumula-
tion of transcripts from the C2, CH /1, and Al genes.
Using transient expression experiments, we showed
that the Al promoter can be activated by a cloned P
cDNA (corresponding to the 2-kb P mRNA; Grote-
wold et al., Proc. Natl. Acad. Sci. 88: 4587 [19911).
In addition, we demonstrated that the Al gene con-
tains P-binding sites that are sufficient for the regula-
tion by P (Grotewold et al. 1994). However, when
this P cDNA (35S::P, 35S is a plant constitutive
promoter derived from CaMV) was introduced into
P-ww pericarps (Fig. 7) using the particle gun, no
synthesis of the P-specified pigment was observed.
Pericarps derived from the same ears, however, effi-
ciently produced purple anthocyanin sectors when
bombarded with 35S::R+C1, the regulators of
anthocyanin biosynthesis. (Anthocyanins are also
flavonoid-derived pigments, yet they derive from 3-
hydroxy flavonoids, not from 3-deoxy flavonoids as
the P-specified pigments, the phlobaphenes.) These
results could mean that the cloned P cDNA was not
sufficient to activate all the P-regulated genes or that
the bombarded pericarps were not able to form the
red phlobaphene pigment from the colorless precur-
sors.
To distinguish between these two possibilities, we
introduced 35S::P cDNA into BMS (Black Mexican
Sweet) cells and selected for stably transformed lines
using an herbicide resistance gene as a selectable
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marker (in collaboration with Dr. Ben Bowen, at
Pioneer Hi-Bred International, Johnston, Iowa). As a
control, similar lines were generated with
35S::R+35S::C1 (35S::R+C1). BMS cells do not
normally express any of these regulators. The 35S::P
transgenic cell lines did not show any evident pig-
mentation, whereas the cells transgenic for
35S::R+C1 showed the purple color characteristic of
anthocyanin accumulation. Some of the 35S::P trans-
genic cell lines were analyzed for flavonoid ac-
cumulation; in most of the lines, variable amounts of
a compound behaving on TLC as flavan-4-ol could
be detected (Bowen and Butler, pers. comm.). The
accumulation of flavonoids in these cell lines is sug-
gestive that P is activating all the structural genes of
the pathway. Northern blot analysis (Fig. 9) showed
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FIGURE 9 Northern blots of pericarp or BMS cells poly(A)+
RNA. Four BMS cell lines transgenic for 35S::P and one
transgenic for 35S::R+C1 were used for this study. Northern
blots were hybridized with probes specific for the P gene
(P), with probes corresponding to three P-regulated genes
(C2, CHI1, and A1), with two genes specifically regulated by
RI-C1 (Bzl and Bz2), and with a ubiquitin (Ubi) probe as
loading control.
that this is in fact the case: 35S::P is able to activate
the C2 and Al genes. 35S::R+C1 activates C2 and
Al, in addition to all of the C/-specific genes (A2,
Bzl , and Bz2) (Fig. 9).
Expression of CHI1, which encodes chalcone
flavanone isomerase (Grotewold and Peterson 1994),
could not be detected in either the 35S::P or
35S::R+C1 lines (Fig. 9). This was unexpected, since
it is believed that in both types of cell lines, the
isomerization of chalcone must take place in order to
accumulate the flavonoids present in the 35S::P lines
or the anthocyanins present in the 35S::R+C1 lines.
Preliminary studies indicate that BMS cells do have
CHI genes (not shown), suggesting that for some un-
known reason, P and R +C1 are not able to activate
CHI in these cells. These results suggest that CHI is
likely regulated by a mechanism different from that
of C2 and Al, which probably requires specific fac-
tors expressed in the tissues where P and R +C1 are
normally expressed, yet absent in these BMS cells.
This lack of CHI activation, however, has interest-
ing consequences. CHI mutants have never been
found in maize. Although in other systems it has been
proposed that the isomerization of chalcone to
flavonone could be spontaneous, this has never been
proven in maize. Our results indicate that this can be
the case and may explain why CHI mutants have
never been observed in maize.
Myb Homologs in
Arabidopsis Flowers
C. Roberts (URP program), E. Grotewold
Myb homologous proteins are characterized by a con-
served amino-terminal region involved in DNA bind-
ing, called the Myb domain. The Myb domain is
formed by two or three repeats each containing three
a-helixes. Each Myb repeat has a helix-turn-helix
structure formed by the second and third helixes of
each repeat, similar to the structures found in homeo-
domain proteins or the X repressor. The third helix of
each repeat is involved in DNA contact; hence,
among different Myb-domain proteins, conservation
is the highest in this region.
Our previous studies have been focused on the
study of two Myb-domain proteins, P and Cl, that
regulate maize flavonoid biosynthesis (Grotewold et
al. 1994). In plants, Myb-domain proteins have been
shown to be involved in cellular processes other than
the regulation of flavonoid accumulation. Our interest
was to determine if Myb-domain proteins are in-
volved in normal flower development. Given the in-
formation available about the homeotic genes that
regulate flower development and morphogenesis in
the dicot Arabidopsis thaliana, we decided to use
Arabidopsis as the system to study the possibility that
Myb-domain proteins are involved in a regulatory
hierarchy required for normal flower development.
We started these studies by cloning Myb
homologous genes from Arabidopsis flowers. For this
purpose, we designed degenerate primers correspond-
ing to the conserved third helices of the first and sec-
ond Myb repeats. We isolated poly(A)+ RNA from
wild-type Arabidopsis flowers and synthesized a
first-strand cDNA, primed with oligo(dT). Using this
set of primers and polymerase chain reaction (PCR)
amplification, we obtained products approximately
190 by long, very close in size to what was expected
from the position of the primers in the sequence of
the Myb domain. These PCR products were cloned
and grouped according to their patterns of cross-
hybridization; 23 different clones were grouped into
five classes, according to this classification. About
three members of each class were sequenced to con-
firm their homology with Myb-like genes. Once this
was confirmed, some of these clones were used as
probes to screen 500,000 clones from an Arabidopsis
flower-specific cDNA library and to pull out 35
cDNA clones corresponding to four of the five
classes previously identified. Partial sequence in-
formation of 9 cDNA clones suggest that 8 of them
correspond to different genes.
Northern hybridization of flower and cauline leaf
RNAs indicates that two of these clones are not
flower-specific. Future studies will involve the com-
plete sequencing of these clones and the analysis of
their expression in different Arabidopsis tissues. In
addition, we want to determine if mutations in
homeotic genes that affect Arabidopsis flower devel-
opment affect the expression of any of these Myb
genes.
PUBLICATIONS
Grotewold, E. and T. Peterson 1994. Isolation and charac-
terization of a maize gene encoding chalcone flavonone
isomerase. Mol. Gen. Genet. 242: 1-8.
127
Grotewold, E., B. Drummond, B.J. Bowen, and T. Peterson.
1994. The myb homologous P gene controls phloba-
phene pigmentation in maize floral organs by directly
activating a flavonoid biosynthetic gene subset. Cell 76:
543-553.
Martienssen, R.A. and A. Baron. 1994. Co-ordinante sup-
pression of mutations by Robertson's Mutator trans-
posons in maize. Genetics 136: 1157-1170.
Renaudin, J.P., J. Colasanti, H. Rime, Z. Yuan, and V.
Sundaresan. 1994. Cloning of four cyclins from maize
indicates that higher plants have three structurally dis-
tinct groups of mitotic cyclins. Proc. Natl. Acad. Sci. 9:
7375-7379.
In Press
Das L. and R.A. Martienssen. 1995. Site-selected trans-
poson mutagenesis at the hcf106 locus in maize. Plant
Cell (in press).
Martienssen R.A. and E. Richards. 1995. DNA methylation in
eukaryotes. Curr. Opin. Genet. Dev. (in press).
Springer, P., R. McCombie, V. Sundaresan, and R. Martians-
sen. 1995. Gene trap tagging of Prolifera, an MCM2/3/5
homolog in Arabidopsis. Science 268: 877-880.
Sundaresan, V., P. Springer, T. Volpe, S. Haward, J. Jones,
C. Dean, H. Ma, and R. Martienssen. 1995. Patterns of
gene action in plants revealed by gene trap trans-
posable elements. Genes Dev. (in press).
ARABIDOPSIS FLOWER DEVELOPMENT AND
G PROTEIN FUNCTION
H. Ma C. Flanagan
Y. Hu
H. Huang
D. Kostic T. Su
Y. Mizukami H. Tu
P. Rubinelli C. Weiss
L. Stricker Y. Zhang
We are interested in understanding at the molecular
level morphogenesis, cell-cell interaction, and cel-
lular differentiation during development, using the
small plant Arabidopsis thaliana. Recent studies in
Arabidopsis, the snapdragon, and other plants (Coen
and Meyerowitz, Nature 353: 31 [1991]; Ma 1994)
have led to considerable progress in the understand-
ing of the molecular mechanisms controlling flower
development. Genetic analyses have identified a
number of Arabidopsis floral homeotic genes; muta-
tions in one of these genes, AGAMOUS (AG), cause
double-flower phenotypes, where the stamens are
converted to extra petals and the ovary is replaced by
a new flower. AG is a member of the MADS-box
gene family (Schwarz-Sommer et al., Science 250:
931 [1990]) and likely encodes a transcription factor.
We continue to study AG and other MADS-box
genes AGLI , AGL2, and AGL3 .
Given the complexity of flower development, it is
likely that many genes important for flower develop-
ment remain to be discovered. We have recently iso-
lated a new mutant, fonl (floral organ number),
which has an increased number of reproductive
organs. We have performed initial phenotypic char-
acterization and have begun the cloning of the FONI
gene. Furthermore, to identify new genes required for
flower development, we have collaborated with Drs.
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V. Sundaresan and R. Martienssen to establish an en-
hancer trap/gene trap transposon insertional muta-
genesis system (see 1993 Annual Report from Drs.
V. Sundaresan and R. Martienssen). During 1994, we
were joined by the newly arrived Cold Spring Harbor
Fellow Dr. Ueli Grossniklaus in our efforts to gener-
ate a large number of independent insertional lines.
In an alternative approach to isolate new genes that
function during flower development, we have begun
a new project aimed at identifying genes specifically
expressed in carpels or stamens.
Plant development is highly plastic, modulated by
a variety of external signals and signals from other
plant cells. Little is known about cell-cell interaction
during development, and the mechanisms by which
plant development is regulated by environmental sig-
nals is also poorly understood, if at all. In animals
and simple eukaryotes, G proteins are known to have
important roles in signal transduction, including path-
ways that are important for regulating development.
It is possible that G proteins also have a role in
regulating plant development. We continue to study
GPA1, encoding a G protein a subunit (Ma et al.,
Proc. Natl. Acad. Sci. 87: 3821 [1990]). In addition,
we have isolated a new Arabidopsis gene that en-
codes a G protein 13 subunit (Weiss et al. 1994).
In 1994, in addition to the people previously in-
troduced, Yue Zhang and Hua Tu from the Molecular
and Cellular Biology Program SUNY Stony Brook
conducted laboratory rotation research projects with
Hai Huang; Leigh Stricker, who was one of ten
finalists for the Partner for the Future program in
1992 and is now an undergraduate student at Boston
College, spent the summer working with Hai Huang
on the molecular analysis of the FONI gene; Thomas
Su, an undergraduate at UCLA, was 1994's URP in
our lab, and he worked on AGL2 DNA-binding ex-
periments.
Expression of the AGLI Gene in
Wild-type Arabidopsis Flowers
C. Flanagan, Y. Hu, H. Ma
AGL1 is one of the Arabidopsis MADS-box genes
cloned by their homology with AG, and it is preferen-
tially expressed in flowers. To obtain clues about the
function of AGLI, we have extensively characterized,
using RNA in situ hybridization, its spatial and
temporal expression patterns within the flower. Our
results indicate that AGLI expression is restricted to
only one type of floral organ, the gynoecium com-
posed of two fused carpels. This is the first known
example of a MADS-box gene that is expressed in
only one of the four floral organs; others are ex-
pressed in two (e.g., AG) or four (e.g., AGL2) types
of organs. AGLI expression arises late in flower de-
velopment, when the carpels have begun to elongate.
AGLI expression is clearly visible at stage 8 (of 12
floral stages), and it is limited to the tops of carpels.
During stage 10, AGLI expression is also seen in the
developing ovule primordia. In mature stage-12 flow-
ers, AGL1 expression is primarily in the ovules, along
the edges of the septum, and as verticle stripes along
the margins of each carpel. Some expression can also
be seen in the transmitting tissue of the gynoecium
and in the nectaries. Within the ovules of mature
flowers, AGL1 is highly expressed in the endothelium
and inner integument but is reduced in the outer in-
tegument. AGLI expression is also seen along the
edges of the funiculus, in continuum with the edges
of the septum of the gynoecium. At a slightly later
stage, AGLI expression in the endothelium is particu-
larly pronounced. These results suggest that AGLI is
probably involved in late carpel development, partic-
ularly in ovule development. That expression is high
at the top of the developing carpels, in the carpel
margins (near the placenta), and along the edges of
the septum and funiculi suggests that AGLI may be
involved in carpel fusion and/or in providing
nutrients to the developing ovules.
In Vitro DNA-binding Analysis of a
Plant MADS Domain Protein: AGL2
H. Huang, Y. Zhang, T. Su, H. Ma
Our previous results indicated that the MADS-
domain protein AGL2 is a DNA-binding protein and
its binding consensus sequence resembles the target
sequences (CArG box) of SRF and MCM1. Com-
parison of plant MADS-domain proteins, including
AGL2, indicates that AGL2 can be divided into four
regions: the MADS domain (M) at the amino
terminus, the K domain (K) near the center, an inter-
domain region (I), and the carboxy-terminal region;
the M, I, K, and C regions contain 56, 35, 65, and 90
amino acids, respectively. AGL2 is thought to bind
DNA as a dimer. To test this, and to define the
regions required for DNA-binding and/or dimeriza-
tion, we made four AGL2 deletions from the car-
boxyl terminus using restriction sites. These trun-
cated AGL2 proteins, AGL2A70, AGL2A77,
AGL2A98, and AGL2A158, have 70, 77, 98, and 158
amino acids, respectively, starting from the presump-
tive translation initiation codon. The first two contain
M and a portion of I, the third one has both M and I,
and a small portion of K, and the last one contains all
of the AGL2 except C. Our results demonstrated that
all of the truncated AGL2 proteins except AGL2A70
can bind to oligo(A) (containing a sequence CCAT-
TAATGG to which AGL2 binds). This result indi-
cates that the first 77-amino-acid residues are suffi-
cient for DNA binding.
To test whether AGL2 binds DNA as a dimer, we
tested DNA binding with pairs of two different trun-
cated AGL2 proteins. We found for each of two such
pairs (AGL2A77/AGL2A158 and AGL2A98/AGL2A
158) that in addition to the band expected for each
truncated protein, one band, and only one band, of in-
termediate mobility was observed, suggesting the
binding of the heterodimer, but not higher multimers.
Interestingly, the AGL2A70/AGL2A158 heterodimer
could also bind DNA, although the AGL2A70 homo-
dimer failed to bind. This suggests that the portions
of I and K that are absent in AGL2A70 (but present in
AGL2A98) are important for dimerization and/or
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protein-DNA complex formation/stability. This hypo-
thesis is supported by the fact that other MADS
domain proteins (Arabidopsis AP3 and PI and
Antirrhinum DEFA and GLO) require I and at least a
portion of K to bind DNA.
Arabidopsis has numerous MADS-domain pro-
teins, some of which are expressed in overlapping
regions of the plant. Therefore, heterodimers between
different MADS-domain proteins may form and may
have physiological significance. This is known to be
the case for AP3 and PI. Since AG and AGL2 are
both expressed in the center of the floral meristem,
and later in reproductive organs, we tested the
dimerization between a truncated AG protein (lack-
ing its carboxy-terminal region) and each of the
smaller truncated AGL2s. Like AGL24158, this trun-
cated AG formed heterodimers with AGL2470,
AGL2477, and AGL2498, and the heterodimers
bound to oligo(A).
Characterization of the
Floral Organ Number
Mutant fonl
H. Huang, Y. Hu, H. Tu, L. Stricker, H. Ma
We previously reported the isolation of an Ara-
bidopsis floral organ number mutant, fonl, among the
T-DNA insertional lines that we generated (H. Huang
and H. Ma, 1993 Annual Report). The fonl mutation
is recessive to wild type, and mutant plants have
normal vegetative development. However, the mutant
produces flowers with increased numbers of the
reproductive organs: stamens and carpels, of which
there are six and two, respectively, in wild-type flow-
ers. In fonl plants, the early-appearing flowers have
more severe phenotypes, with eight to ten stamens
and four carpels, whereas later flowers tend to have
only six or seven stamens, and three or four carpels.
In addition, carpel development in fonl plants is
often affected, such that the carpels fail to fuse on
one side, resulting in curled pistils that are sterile or
minimally fertile. Because the increase in stamen and
carpel numbers of the fonl mutant is similiar to that
of previously identified floral mutants c/v/ and clv2,
we crossed homozygous fonl with c/v/ or clv2 plants
to test if fonl can complement clv mutants. The Ft
progeny of both fonl x c/v/ and fonl x clv2 produced
normal flowers with normal numbers of floral organs,
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indicating that fonl is in a gene different from that of
CLV1 and CLV2. The fonl clvl double mutant (F2
segregation: 73 wild type, 14 fonl, 19 c/v/, and 6
double mutant) and fonl clv2 double mutant (F2
segregation: 126 wild type, 37 fonl, 33 clv2 and 4
double mutant) showed very similar phenotypes, with
up to 20 stamens and 8 or more fused carpels, more
severe than the single mutants. We have also per-
formed crosses of fonl with several other floral
mutants, and the double mutants are being character-
ized.
Cosegregation studies indicated that the fonl
mutation is tightly linked to the T-DNA insertion:
DNA blot hybridization showed that 153 fonl plants
from segregating F2 and F3 progeny of a cross be-
tween fonl and wild type contained the same T-DNA
bands. Using a T-DNA fragment as a probe, we have
isolated a junction fragment that contains both T-
DNA and plant sequences. RNA analysis with this
junction fragment as a probe identified a 2.7-kb tran-
script that is expressed in both flowers and vegetative
tissues from wild type but not in tissues from the fonl
mutant. We are in the process of isolating the FON1
gene.
Generation and Preliminary
Characterization of Enhancer/Gene
Trap Transposants
H. Ma, C. Flanagan, Y. Hu
To be able to identify new genes important for
Arabidopsis development, we have collaborated with
Drs. Sundaresan and Martienssen to establish an en-
hancer/gene trap system for Arabidopsis using the
maize Ac /Ds transposable elements (Martienssen et
al., 1992 Annual Report; Sundaresan et al., 1993 An-
nual Report; Ma and Hu, 1992 Annual Report;
Sundaresan et al., in prep.). As part of the joint effort
between four laboratories at CSHL (Sundaresan,
Martienssen, Ma, and Grossniklaus) to generate a
large number of the enhancer/gene trap transposon
insertional lines (transposants), we have performed a
number of crosses between homozygous Ac- and Ds-
carrying plants. Thus far, we have obtained a total of
more than 45,000 F, seeds from crosses between Ac
and Ds lines. About 8000 of the Ft seeds have been
planted. The F2 seeds from a single Ft plant form an
F2 family, and more than 2000 F2 families have been
plated on agar medium to select for transposants car-
rying a Ds element at a new locus. Thus far, we have
generated about 1000 transposants.
Our interest in flower development has prompted
us to investigate the expression patterns of the GUS
reporter gene, carried within the Ds elements, in 468
F, transposant lines. We have examined the staining
patterns in the inflorescences, individual mature
flowers, seed pods, and cauline leaves (as a control
for vegetative tissue). Overall, nearly 50% of the
lines have a staining pattern in these tissues. Of the
374 gene trap lines we tested, 159 (or 43%) stained
positively for GUS; of 94 enhancer trap lines, 83
(88%) had staining patterns.
These results are consistent with our expectations,
since more patterns are expected in the enhancer trap
lines. Of those lines with staining patterns, 67 (81%)
of the enhancer trap lines and 86 (54%) of the gene
trap lines had staining exclusively within the flower.
A large majority of these stained anthers and/or pol-
len grains, which is consistent with findings of other
investigators that a large number of genes are ex-
pressed in anthers and/or pollen (e.g., in tobacco,
25,000 transcripts are expressed in the anthers,
11,000 of which are specific; and in maize 20,000
transcripts are found in pollen, 7,000 of which are
specific; Scott et al., Plant Science 80: 167 [1991]).
Because the anther/pollen staining occurs at such a
high frequency, we do need to be cautious in inter-
preting the staining patterns; further analysis is
needed before we are certain that they reflect expres-
sion of endogenous genes.
The other patterns are quite unique and cover a
broad spectrum of floral parts and stages of flower
development. Some interesting examples of patterns
among the gene trap lines are in the carpels and seed
pods only, in the style region of the gynoecium, in
young buds only, and in developing petals (but not
mature ones). Among the enhancer trap lines, inter-
esting patterns include stamens only, the gynoecium
of mature flowers, and in young buds, becoming
restricted to anthers, carpels, and petals in intermedi-
ate flowers and later to filaments and the style, trans-
mitting tissue and stigmatic tissue in the gynoecium
of mature flowers. These many patterns strongly sug-
gest that a wide variety of gene and enhancer trap in-
sertions are being obtained by this mutagenesis sys-
tem, which will be extremely useful in our efforts to
study and understand flower development in
Arabidopsis.
Analysis of Multiple Functions
of the Arabidopsis MADS-box
Gene AG in Sexual Reproduction
Y. Mizukami, H. Ma
AG EXPRESSION IN THE SEED IS NEGATIVELY
REGULATED BY AP2 DURING SEED DEVELOPMENT
We have continued our analyses of the Arabidopsis
floral organ identity gene AG, by characterizing
transgenic plants with a fusion of the CaMV 35S
promoter and AG cDNA (Mizukami and Ma, Cell 71:
119 [1992]).
Since AP2 negatively affects AG function in
specifying organ identity during early flower devel-
opment, it is possible that there is also an antagonism
between AG and AP2 functions during ovule devel-
opment. To test this possibility, we compared the AG
expression pattern in wild-type ovules and seeds to
that in the ap2 mutant. We found that there is a pos-
sible negative regulation of AG expression by AP2 in
a specific group of cells, the chalazal cells, of devel-
oping seeds. During early stages of ovule develop-
ment, AG is expressed in the chalazal region to which
the nucellus is attached. As ovules develop, AG ex-
pression remains high in the endothelium, but it
diminishes in other regions including the chalazal
cells. AG expression is very weak in the wild-type
chalazal cells at full maturity of the ovule, and it is no
longer detected in developing seeds with a heart-
stage embryo. However, in mature ap2 ovules and
developing ap2 seeds, AG expression remains high in
the chalazal cells at least until the embryo reaches the
late torpedo stage. Recently, it was observed that AP2
expression remains relatively high in the chalazal
cells of wild-type seeds at this stage (K.D. Jofuku and
J.K. Okamuro, pers. comm.).
These observations suggest that the AG mRNA
level may be negatively controlled by AP2 after the
maturation or fertilization of ovules. In addition, a
structural difference at the chalazal region was also
seen between wild type and ap2. Furthermore, AG
expression under the control of the CaMV 35S
promoter in transgenic plants resulted in ap2-like
seeds. Together, these results strongly suggest that
heterochronic or ectopic AG expression in the
chalazal cells may cause aberrant development of ap2
mutant and 35S-AG transgenic seeds and that nega-
tive regulation of AG expression by AP2 may be re-
quired for normal seed development.
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AG MAY BE INVOLVED IN THE MAINTENANCE OF
FLORAL MERISTEM IDENTITY
We reported previously that 35S-A G transgenic
plants flower much earlier than wild-type plants and
that the apex terminates with a cluster of sessile flow-
ers (Mizukami and Ma, 1993 Annual Report), similar
to those of the Arabidopsis early flowering mutant
terminal flower (tfll); thus, AG may be involved in
the regulation of the fate of meristems. To examine
this possibility, we generated double mutants be-
tween ag and tfll mutant plants, and 35S -AG trans-
genic lines in a tfll mutant background. We found
that ectopic AG expression in wild-type and tfll
mutant plants accelerates flowering under both short-
day (SD) and continuous light (CL) photoperiods,
whereas flowering in tfll mutant plants under SD
photoperiods is much later than under the CL
photoperiods. Furthermore, ag-1 tfll-1 double-mutant
plants flower later than tfll -1 mutant plants in CL
photoperiods. These results together indicate that ec-
topic AG expression and the ag mutation are epistatic
to tfll, suggesting that the effect of the tfll mutation
on maintaining floral induction is largely through
AG. It is known that the AG mRNA is only detectable
in floral buds. Furthermore, the ag-1 mutation alone
does not affect flowering time. Therefore, although it
is not likely that AG is involved in the primary apical
meristem transition from the vegetative to the
reproductive phase, AG probably does function to en-
hance flowering after the transition. On the other
hand, the apical meristem of ag-1 tfll-1 double-
mutant plants grown under CL photoperiods pro-
duces a terminal ag-1 flower at the apex; however, it
partially reverts to an inflorescence, producing axil-
lary, secondary ag-1 flowers. Since similar reversion
of flowers to inflorescences was seen in axillary ag-1
mutant flowers under SD photoperiods, AG probably
inhibits reversion of established floral meristems to
inflorescence meristems, therefore maintaining floral
meristem identity under SD photoperiods as well as
its determinacy under both photoperiods.
Isolation of Organ-specific cDNAs
by Subtractive Hybridizations
P. Rubinelli, H. Ma
Last year, we described subtractive hybridizations be-
tween cDNAs from wild-type floral mRNAs and
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cDNAs from that of ag mutant flowers, which lack
stamens and carpels, using a method developed by
Wang and Brown (Proc. Natl. Acad. Sci. 88: 11505
[1991]). We have characterized a number of cDNA
clones resulting from the subtractions by Southern
analyses with both wild-type and ag mutant floral
cDNAs as probes. On the basis of the hybridization
patterns, the clones were divided into three classes.
The first class hybridized with both wild-type and ag
probes and are likely to be not specific to reproduc-
tive organs. The second class hybridized weakly to
the wild-type cDNA probe but not detectably to the
ag probe. These clones were therefore potentially
specifically expressed in the reproductive organs. The
third class hybridized to neither probe, suggesting a
lower level of expression relative to the clones of the
first and second classes. To further analyze the organ
specificity of the clones of the second and third
classes, RNA dot-blot or gel-blot hybridizations were
performed with RNAs from leaf, wild-type floral
buds, ag mutant floral buds, and apetala3 (ap3)
mutant floral buds, which lack stamens but have car-
pels, using individual class-2 or class-3 clones as
probes. Of 21 clones tested, 18 hybridized only with
wild-type floral RNA; 13 of these putatively stamen-
specific clones were sequenced. Many of these (8)
showed significant sequence homology with known
enzymes or structural proteins. Two clones showed
no significant homology with known proteins and
have relatively low expressions.
To identify carpel-specific cDNAs, we performed
a second series of subtractive hybridizations, between
ap3 floral cDNA and ag floral cDNA, since ap3 flo-
ral buds have no stamens. A total of 168 clones were
analyzed and 20 showed either no hybridization to ei-
ther ap3 or ag cDNA probes or weak hybridization to
the ap3 probe only. Of these 20, only 4 clones
showed putative carpel specificity on RNA dot blots.
Three of these clones showed strong sequence
homology with the same drought-induced proteinase
inhibitor from Brassica napus. In situ hybridization
has confirmed the carpel-specific expression, which
is confined to late-stage carpels beginning just prior
to anthesis and localized to the transmitting tract.
It is likely that the stamen- and carpel-specific
genes perform functions that are needed during the
growth and differentiation of these organs. In addi-
tion, these stamen- and carpel-specific cDNAs should
be useful as molecular markers of specific cell or tis-
sue types in Arabidopsis floral organ mutants. The
promoter regions of these genes can be used to ana-
lyze organ-specific cis-regulatory elements that con-
fer developmentally regulated cell or tissue specifici-
ty; they can also be used to direct tissue- or cell-
specific expression of other genes to study the func-
tion of the expressed genes.
Characterization of
Plant G Proteins
C. Weiss, H. Ma
SUBCELLULAR LOCALIZATION
We are characterizing the subcellular localization of
GPal using fractionation methods and immuno-
fluorescence. The subcellular fractionation suggests
that GPal is not present in the nucleus or in
chloroplasts. It is associated with the microsomes and
not found with soluble proteins. Isolation of endo-
and plasma membranes indicates a relatively good
correlation between GPal and both the plasma mem-
brane and the endoplasmic reticulum (ER) compart-
ment. Similarly, immunofluorescence experiments
suggest that GPal is associated with the plasma
membrane and the ER, as it colocalizes to some ex-
tent with ConA, which stains the plasma membrane
and the ER in plant cells. These results suggest that
the Arabidopsis G protein a-subunit GPal might be
involved in the transmission of extracellular signals
across the plasma membrane, similar to G proteins in
mammalian cells and also that it might be involved in
regulating lipid and protein synthesis occurring in the
ER.
BIOCHEMICAL CHARACTERIZATION
Although the amino acid sequence of GPal suggests
that it is a GTP-binding protein similar to mammalian
heterotrimeric G protein a subunits, no biochemical
function was ascribed to GPal. Some heterotrimeric
G proteins are ADP-ribosylated by the cholera or
pertussis bacterial toxins. We expressed GPal in in-
sect cells using the bacculovirus expression system.
The cell extracts were tested for ADP-ribosylation by
cholera toxin. In cells expressing GPal, an ADP-
ribosylated product of the size of the overexpressed
GPal protein (45 kD) was observed when the cell
extracts were supplemented with plant cell extracts.
This product could be immunoprecipitated with anti-
bodies directed against GPal . The ADP-ribosylation
result strongly suggests that the biochemical function
of GPal is indeed related to animal G protein a sub-
units.
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STRUCTURE AND COMPUTATION
Scientists in this section are engaged in basic research and methodology development in gene
discovery and in gene and protein functional analysis. The program is comprehensive and has
major programs both in the experimental and computational aspects of gene discovery and in the
analysis and prediction of gene and protein structure and function. The main scientific thrust and
overall goals of this section are to develop and apply methods that
establish chromosomal position of heritable disease genes by linkage and segregation
analysis of affected families
automate high-speed DNA sequencing over long contiguous regions of genomic DNA
automate the detection of segments of genomic DNA sequences that have specific biologic
content
predict gene function by homology/analogy to existing sequences
isolate and characterize minuscule amounts of proteins for cloning genes directly
use X-ray diffraction patterns with crystalline proteins to determine their three-dimensional
structure with the goal of understanding their function
COMPUTATION
T. Marr W. Chang R. Koskela
S. Cozza W. Li
D. Cuddihy S. Lincoln
M. Hiller M. Mallison
C. Reed
J. Salit
A. Tracy
In addition to the basic research in genome in-
formatics done in this program, we have had a major
software development project for several years lead-
ing to a computer program that we call Genome
Topographer (GT). GT has been designed to be a
general-purpose scientific computing system used to
study complex problems in human genetics and dis-
ease, such as cancer, diabetes, psychiatric disorders,
and infectious diseases. A major design goal with GT
was to build a computer system that could support
such studies from start to finish, i.e., from epide-
miologic and genetic analyses to functional analysis
of candidate genes.
We now have established much of the basic infra-
structure of this computer system, and it is now being
used for part of its intended purposes. For example,
GT is being used as an integral part of the Dana
Foundation Consortium on the Genetic Basis of
Manic Depressive Disorder project described else-
where herein. With the basic software infrastructure
in place, we have begun to add some of the sophisti-
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cated analysis programs that have been developed in
the Computation Program for sequence analysis (e.g.,
see W. Chang's report) and for genetic linkage analy-
sis.
GT enables users to do the following: (1) Query,
gather, and systematically organize data from all of
the major publicly available genome databases con-
taining genetic and physical mapping data, including
the nascent data required to construct and interpret
the maps (e.g., pedigree and genotyping data), and
DNA and protein sequences. GT can also be used to
store relevant data as gleaned from the scientific liter-
ature or from patient interviews, for example, using
the powerful editing and viewing tools found in GT.
(2) Customize and integrate GT, using network-based
collaboration tools, into their own local laboratory
operations, including direct interfacing into labora-
tory instruments for automated data gathering. (3)
Manipulate, perform sophisticated analyses, and
visualize all data stored in the database in informative
ways. Taken together, these features allow users to
construct, with relative ease, on-line databases of the
primary data needed to study a genetic disease from
the stage of family collection and diagnostic as-
certainment through cloning and functional analysis
of candidate genes, including mutational analysis and
screening for biochemical interactions with candidate
molecules.
Software Developments Resulting
from the Dana Foundation Manic
Depressive Disorder Consortium
R. Koskela
The major role of CSH in this consortium includes
overall project management, data merging, data anal-
ysis, and error checking. One of the major challenges
associated with this project is that genotyping data
(using three different experimental approaches) are
being generated at each of the three sites involved in
the project (see description below). Another chal-
lenge is keeping the variety of data up to date and
consistent across the three sites. The variety of data
includes (1) family information and associated clini-
cal and diagnostic data, (2) DNA samples from the
families, and (3) genotypes of hundreds of individu-
als using hundreds of polymorphic markers. We also
have had to develop methods and software for auto-
mated error checking, including allele calling and
consistency checking. We have also developed meth-
ods for transforming the different allele measurement
systems into a standard form and for transforming
our standard form into formats needed to perform a
variety of sophisticated genetic analyses.
We have used the experiences gained in working
on this project to design and develop general methods
and computer representations for implementation in
the GT system. Therefore, the software in the GT
system will be generally applicable to the study of
complex diseases, including, for example, cancer,
heart disease, and infectious diseases.
Sequence Analyst
W. Chang, a Cuddihy, T. Marr
Sequence Analyst is a powerful computer program
for sequence analysis that has two completely novel
aspects: the search methodology and the visualization
methodology. Both are the direct results of our expe-
rience and research in biological sequence analysis.
We released version 1 in March, 1995, and are in-
corporating it into the Genome Topographer.
The goal of sequence analysis is to aid the inter-
pretation of biological data and to suggest further ex-
periments. The fundamental problem of protein se-
quence comparison is to judge whether two or more
sequences share structural and/or functional features,
based on similarities observed in their amino acid se-
quences. Current understanding of the underlying
processes of structure and function is not sufficient
for a completely rigorous solution, but two develop-
ments in particular have combined to produce meth-
ods that are reasonably rigorous and successful: as-
signing a score to a single aligned pair of residues,
according to chemical properties or statistical analy-
sis of allowed mutations in known homologous se-
quences (Dayhoff et al., Atlas of Protein Sequence
and Structure, vol. 5 [suppl. 3] 345-352 [1979]) and
the alignment of regions by dynamic programming
(Smith and Waterman, J. Mol. Biol. 147: 195 [1981];
Gotoh, J. Mol. Biol. 162: 705 [1982]). There is an
important distinction between algorithms and
heuristics. Algorithms such as Smith-Waterman and
Gotoh solve rigorously a clearly defined problem,
namely, finding the highest scoring local alignment
between two sequences. Heuristics, on the other
hand, do not typically provide performance guaran-
tees (controls). Precisely because we do not fully un-
derstand the biology, we should try to eliminate vari-
ables and unknowns that are introduced by heuristics.
For example, BLAST (Altschul et al., J. Mol. Biol.
215: 403 [1990]) and FASTA (Pearson, Genomics
11: 635 [1991]) work well when sequences are high-
ly similar, but both will introduce poorly understood
artifacts (false positives and negatives) when search-
ing for distant alignments. Sequence Analyst is an al-
gorithm that solves what we feel is the "right" prob-
lem: find every (sufficiently long) alignment that has
the proper evolutionary distance as defined by the
scoring function. We describe below the PAM model
of protein evolution because it is the basis of protein
similarity search and provides the rationale for our
new search method.
The widely used PAM scoring matrices (Dayhoff
et al. need reference) were calculated on the basis of
1600 accepted point mutations in 71 groups of close-
ly related proteins. Qualitatively, each matrix reflects
the intrinsic chemical classification of the 20 amino
acids. Quantitatively, this model of amino acid sub-
stitution assumes that further nonlethal mutations fol-
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low the same rate and distribution, extrapolated to
distantly related proteins. PAM stands for Point Ac-
cepted Mutation where "point" means percent. Thus,
1 PAM = The evolutionary process of mutating one
percent of residues
90 PAM 50% identity over putative domain (usually
significant)
120 PAM 33% identity (sometimes significant)
250 PAM 20% identity (rarely significant)
Generally, 50% identity over a putative domain
(not the entire sequences) is considered extremely
significant; in the PAM scale, this corresponds to
about 90 PAMs. Occasionally, a particular 33%
identity (120 PAMs) alignment is claimed to be sig-
nificant. The key distinction is that xPAMs is an
evolutionary distance, whereas PAMx is a (related)
scoring matrix used to find xPAM alignments. More
precisely, PAMx scores measure the likelihood that
the aligned portions of two sequences are xPAMs
apart evolutionarily (Altschul, J. Mol. Biol. 219: 555
[1991]). The mathematics is quite simple and intui-
tive:
Amino acid substitution matrices are devices for
distinguishing a target frequency of aligned pairs
from a background frequency of random pairs. Let
p(x) denote the frequency of amino acid x. Then
p(x)p(y) is the frequency of observing the pairing
(x,y) by chance. Let q(x,y) denote the frequency of
observing the pairing (x,y) among alignments that
are the target of matrix S. Then q(x,y)/p(x)p(y)
gives the ODDS that the observed pairing (x,y)
comes from the target as opposed to chance. The
score of pairing (x,y) has the form of a log-odds
score:
S(x,y) = log q(x,y)/p(x)p(y)
The score of an aligned block is the sum of the in-
dividual pair scores. (Taking logarithm simplifies
calculations, by converting multiplication of odds
to addition of log-odds.) Because this is an equa-
tion, the q(x,y) target frequencies can be calculated
from the matrix S, and vice versa.
Indeed, PAMx (scoring matrix) detects xPAM
(evolutionary distance) optimally. But what does it
mean to score a yPAM alignment using PAMx, if y is
very different from x? The score would not be useful,
because it only gives the likelihood that the yPAM
alignment is xPAM, not the likelihood that it is
"good." One has to search databases with multiple
PAMs and reject those alignments that do not fit the
particular matrix used. The selection criterion for
136
PAMx has two components: An alignment has to
score at least 30 "bits" because there are many chance
alignments with that score; furthermore, the UNIT
SCORE of an alignment (average score per position)
should be close to the expected unit score of an
xPAM (target) alignment, which can be calculated:
PAM
distance
Percent
identity
Expected
unit score (bits)
Minimum length
to yield 30 bits
40 70 2.3 14
80 55 1.4 21
120 33 1.0 31
250 20 .36 83
One would like to search separately at each PAM
(40, 80, 120; with various gap penalties) for all suffi-
ciently long alignments with a given unit score; un-
fortunately no previous method will work with a unit
score constraint. There are artifacts such as short,
high unit score alignments and long, low unit score
alignments that will cause dynamic programming
(Smith-Waterman-Gotoh, which finds the highest
scoring alignment without regard to unit score) to
miss real targets; it is too late to comb through the
output after a search is done. Examples of artifacts:
Ssicziinagityma:creix,:el:AM19 404.,GthapP-Opeenn'tPageena= Gap-Extension Penalty: 4
P53 42 DLMLS
VII I
BRC1 749 DLMLS
P53 285
EEENLRKKGEPHHELPPGSTICRALPNNTSSSPQPKICKPLDGEYFTLQIRG
I I : : : : 1 I
BRC1 418
EVDEYSGSSEKIDLLASDPHEALICKSDRVHSKSVESNIEGQIEGKTYRK
P53 335
RERFEMFRELNEALELKDAQAGKEPGGSRAHSSHLKSKKGQSTSRH
1: :: I:: II 1::::1
BRC1 468
KASLPNLSHVTENLILXAFVSEPQIIQERPLINKLKRKRRPTSGLH
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This last alignment has the right unit score for
PAM120 but is too short.
We have succeeded in developing an algorithm that
is rigorous and very fast up to PAM120 (Chang and
Marr 1994). In fact, the time needed to do all three
PAMs (40, 80, 120) is comparable to a single Smith-
Waterman-Gotoh (best uniprocessor implementa-
tion), about 15 minutes for a 400-residue query se-
quence. It is fast because each separate search
focuses on a narrow and well-characterized class of
alignments. Sequence Analyst spends most of its time
at PAM120, because distant alignments are more dif-
ficult to discover. (If a program takes the same
amount of time to find close and distant alignments,
then it must be wasting its effort.) Even on relatively
inexpensive workstations (as opposed to massively
parallel computers with thousands of processors), it is
now quite feasible to search routinely at multiple
PAMs and various gap penalties. Compared to
Smith-Waterman-Gotoh, the only loss seems to be
the artifacts. It also works very well for DNA or
cDNA search at the 15% error level (allowing gaps).
This algorithm incorporates a key subroutine called
"maximal unit score targets" (MUST) and extends
previous work by W. Chang on string matching
(Chang and Lawler, Algorithmica 12: 327 [1994];
Chang and Lampe, Proc. Symp. Combinatorial Pat-
tern Matching, Springer-Verlag Lecture Notes in
Computer Science 644:172-181 [1992]). Here is a
brief outline of the algorithm:
Calculate and tabulate 3.2 million pentamer
scores-best match between each pentamer and
the query sequence (allowing gaps).
This gives upper bounds on real alignment scores
for each pentamer.
Given a database sequence, look up scores of
pentamers and solve rigorously the one-dimen-
sional problem, i.e., find all sufficiently long
regions with a given unit score (upper bound).
Apply dynamic programming only to those
regions (5-25% depending on PAM).
This works if the target unit score is greater than
the pentamer noise.
Query sequence may have to be partitioned into
overlapping blocks of size 40-200 depending on
the PAM.
Finally, we will say a few words about the user in-
terface. A similarity search of a protein sequence
against a large database can produce a massive
amount of data that must be scrutinized for useful in-
formation. Therefore, one needs both a rigorous
analytical engine that produces fewer artifacts and a
graphical user interface that is concise and effective.
It should make it possible for one to scan the data in a
few minutes, with just a small number of keystrokes
or mouse-clicks. Related alignments should appear
together on screen. Version 1 of Sequence Analyst
provides a simple, clean interface called Graph that is
based on character graphics (Unix curses); it works
well through both network and dial-up modem con-
nections. Version 2 will be an integral part of
Genome Topographer and will have more informa-
tive graphics as well as mouse drag-and-drop, etc.
The architecture of Sequence Analyst is modu-
lar-one can feed to Graph a BLAST output file
(through a filter that also removes redundancies, a
serious problem with BLAST). It will become fully
object-oriented inside Genome Topographer. The
same interface and visualization will work for a
protein or DNA database search (many-to-one align-
ment), multiple alignment, degenerate PCR (multiple
protein fragments against DNA or cDNA databases),
DNA sequencing contigs, and physical maps of clone
libraries such as our map of fission yeast (Mizukami
et al., Cell 73: 121 [1993]). Sequence Analyst is cur-
rently the test case for several extensions to GT, in-
terfacing external analytical tools and building
experiment-protocol classes.
Dana Foundation Consortium
on the Genetic Basis of
Manic Depressive Disorder
T.S. Breshel (2), E. Chen (3), C.D. Clark (3),
J.R. De Paulo (2), C.J. Friddle (3), D. Botstein (3),
S. Shen (3), H. Feilotter (1), M. Gschwend (3),
R.J. Koskela (1), T.G. Marr (1), M.G. McInnis (2),
F.J. McMahon (2), D.A. Meyers (2), S.G. Simpson (2),
O.C. Stine (2), J.D. Watson (1), J. Witkowski (1)
(1) Cold Spring Harbor Laboratory, Structure and Computa-
tion Program
(2) Johns Hopkins University, School of Medicine, Depart-
ment of Psychiatry
(3) Stanford University, School of Medicine, Department of
Human Genetics
The Dana Foundation Consortium on the Genetic
Basis of Manic Depressive Disorder (MDD) is an ex-
citing new multi-institutional project dedicated to
finding genes involved in susceptibility to MDD.
This is the first major program at CSHL involving
clinicians, computers scientists, human geneticists,
and quantitative biologists.
MDD is a serious psychiatric disorder, with sig-
nificant evidence of a major hereditary component,
which is characterized by extraordinary differences in
an affected person's mood. The mood swings experi-
ened by a person with one form of the disease can
range from extreme elation and unrealistic self-
confidence in one's abilities, or mania, at one time to
extreme dispair and depression at another time. These
patients suffer from the bipolar affective disorder
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type of MDD. Many people suffer from another form
of this disorder wherein they cycle from periods of
feeling "normal" to periods of depression, without the
"highs." These patients suffer from the recurrent
unipolar depression form of the disorder. Typically,
these feelings cycle during an affected person's
lifetime, sometimes weekly and sometimes at longer
periods of time. Untreated, the affects of the disease
usually become more intense and unpleasant, leading
to an extraordinary statistic that 60-80% of all
suicides of adolescents and adults suffered from these
disorders. Estimates of the overall incidence of these
disorders put at risk about 2-5% of the population.
The costs of the illness to individuals who have it, to
their family members, and to society cannot be over-
stated; it is closely associated not only with suicide,
but also with violence, alcohol, and substance abuse,
greatly elevated medical costs, and lost productivity.
The Dana Foundation Consortium draws upon
unique skills at three institutions: informatics and
quantitative analysis and Cold Spring Harbor,
psychiatric diagnostics and clinical psychiatry at
Johns Hopkins, and human genetics and laboratory
analysis at Stanford. The consortium is using a
genomic approach to the problem of finding genes in-
volved in MDD, made possible by the Human
Genome Program. We are involved in a genome-
wide scan for susceptibility genes in the DNAs from
approximately 50 families with individuals suffering
from MDD.
Full time roles of people at CSHL include overall
project management, data analysis and error check-
ing, and genetic analysis system requirements (R.
Koskela, described in Marr Lab section) and develop-
ment of automated, high-speed genotyping capabil-
ities (H. Feilotter, described below).
Genotyping Laboratory at
Cold Spring Harbor
H. Feilotter
During 1994, Cold Spring Harbor initiated a genotyp-
ing effort to complement the genotyping being done
by both of the collaborating groups. Genotyping is a
method used to follow the transmission of chromo-
somes through generations within families. Specific
chromosomal fragments can by identified by the use
of highly polymorphic markers, which can be used to
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differentiate between maternal and paternal chro-
mosomal segments. Linkage between any marker and
the disease phenotype is detected as the co-segre-
gation of the disease phenotype with a particular
chromosomal fragment within a family more often
than expected by chance alone. The markers used for
these studies are short tandem repeats that are dense-
ly scattered throughout the human genome and that
exhibit a high degree of polymorphism because of the
addition or subtraction of repeat units within the
genome. Maps showing the localization of specific
markers to the chromosomes and information about
the surrounding sequence for use in PCRs are public-
ly available and are widely used as a resource for
genotyping studies.
Making use of these maps and the DNA from the
31 families that have been ascertained by the clinical
team at Johns Hopkins Hospital, genotyping at Cold
Spring Harbor is being designed to complement the
genome-wide scan being carried out by the col-
laborating groups at Johns Hopkins and Stanford
Universities. The genotyping technology being im-
plemented here is fluorescent-based semi-automated
genotyping. It makes use of four single-isomer
fluorescein dyes that can be coupled to primers. The
labeled primers corresponding to specific markers are
used in PCRs to amplify the specific polymorphic
region from DNA from individuals in the study. The
products are separated on acrylamide gels using an
ABI 373 PRISM DNA Sequencer and detected as
fluorescent signals after excitation by a laser. In-
formation is automatically collected and stored, mini-
mizing the error caused by human transfer of data.
The availability of multiple color dyes allows the use
of one as a size standard in each lane, increasing the
accuracy of allele sizing. The other three colors can
be used to visualize different PCR products in the
same size range in the same lane. In addition, prod-
ucts of different sizes can be labeled with the same
color and visualized in the same lane. This combina-
tion allows as many as 12 different markers to be an-
alyzed in a single lane, greatly increasing throughput
compared to more traditional genotyping tech-
nologies. Sizing of the alleles from each individual is
done rapidly and with high accuracy through the use
of the interactive software programs GENESCAN
672 and Genotyper DNA Fragment Analysis Soft-
ware (Applied Biosystems).
The genotyping effort initiated here has two major
goals. The first is to provide a rapid and efficient
method for completing the genome-wide scan to 10-
cM resolution. The second is to apply this technology
to screen more markers in any areas where the
preliminary screen has indicated putative linkage to
increase the resolution.
Maps showing the position of all markers current-
ly used in the study have been constructed using the
Genome Topographer software (in collaboration with
T. Marr's laboratory) to provide a clear representa-
tion of the degree of genome coverage already
achieved. A total of 34 gaps greater than 20 cM
remain. Initial genotyping will be aimed at filling
these gaps. Once the gaps are filled, the next stage of
the genotyping project will focus on achieving more
dense coverage in regions of putative linkage.
Currently, the genotyping operation has been in-
itiated in collaboration with the laboratory of Dr. R.
McCombie, who has provided the 373 Sequencers for
use. Initial genotyping has been carried out with a set
of 15 markers that were developed at Johns Hopkins
Hospital by Dr. R. Levitt. Initial estimates of
through-put and accuracy based on preliminary
results suggest that this system will support the pro-
GENOME SEQUENCE ANALYSIS
W.R. McCombie N. Kaplan A. Johnson
M. Lohdi A. Melnikov
The long-term objective of our lab is to apply power-
ful new technologies to analyze the structure and
function of eukaryotic genomes. This program is
divided into technology development and sequence
analysis components. The technology development
effort functions to minimize the cost and maximize
the speed of genome sequencing. The sequence anal-
ysis effort applies the best available technology at
any given time toward determining the structure of
genomic regions of interest, particularly that of the
model organism Schizosaccharomyces pombe. We
have also this year begun sequencing from the plant
model organism Arabidopsis and from the human
genome.
duction of more than 1300 genotypes per week with
very high reproducibility.
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Technology Development
M. Lohdi, A. Johnson, N. Kaplan, A. Melnikov,
W.R. McCombie
Typical DNA sequencing reactions are primed with
an oligonucleotide of 17-24 bases in length.
Oligonucleotides of this length are usually present
only once in a genome, so when a primer is syn-
thesized for a sequencing reaction, it is only used
once for sequencing that region and has no other use.
The typical oligonucleotide synthesizer makes
enough material to prime hundreds of reactions and
thus much money is wasted when primer walking is
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used for sequencing. Moreover, the problems of coor-
dinating oligonucleotide synthesis and sequencing
reactions make managing a sequencing project using
this strategy very difficult once a scale-up in the
number of reactions is done. One way to avoid many
of these problems is to use three adjacent hexamers
that comprise an 18-mer as a primer, rather than the
16-mer itself. Since a given hexamer is present many
times in the genome, each can be used as part of dif-
ferent strings and can hence be used more than once.
Moreover, since there are only 4096 possible
hexamers, they can be synthesized in advance and the
correct set of three chosen to make any primer.
This was originally developed for manual, radio-
active sequencing by Kieleczawa et al. (Science 258:
1787 [1992]). We have been attempting to develop
the use of these hexamer strings on ABI sequencers.
In the previous year, we showed considerable prog-
ress and were able to achieve modest read-lengths
using hexamer primers on single-stranded templates.
The signal from these reactions, however, was very
weak at the lower limit of what is detectable with the
ABI 373 DNA sequencers that we use. To improve
signal strength and hence the quality of the sequence
data, we began trying to carry out cycle-sequencing
reactions. We have been unable to use thermostable
DNA polymerases with hexamers because of a re-
quirement for an extension reaction at 4°C. None of
the thermostable enzymes have activity at this
temperature. We chose to use a thermolabile enzyme
and replenish the enzyme after each cycle. This may
limit the number of cycles that could be carried out,
so we chose to do only three cycles to determine the
effect.
Reactions were carried out as originally deter-
mined, except that at the end of the 37°C extension,
they were heated to 95°C for 2 minutes and cooled to
4°C for 10 minutes and additional Sequenase was
added. The samples were then incubated at 37°C for
10 minutes, followed by 2 minutes at 95°C. The
samples were once again collected and another cycle
was carried out. After a total of three cycles, the
samples were prepared for gel analysis and loaded on
a sequencing gel. Typical reactions yielded about
twice the original strength found with a single reac-
tion cycle. This greatly improved the sequence quali-
ty. Whereas 400-base read-lengths were considered
good with a single cycle, with multiple cycles, reads
of 450-500 by are common. In some cases, even
longer reads were obtained with cycle sequencing in
this manner.
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We now believe that we have demonstrated that
hexamer strings will at least be a useful adjunct to
current sequencing technology. It will be very useful
for primer walking to sequence small regions of
DNA as well as for at least limited gap filling in se-
quencing larger regions of DNA. We are continuing
to test and improve this methodology, and we foresee
it having a more important role in ongoing sequenc-
ing projects in our lab and others in the upcoming
year.
Genome Sequence Analysis
N. Kaplan, M. Lohdi, A. Johnson, A Melnikov,
W.R. McCombie
One of the challenges to large-scale sequencing is
scaling up the handling of data and samples. We dis-
cussed the establishment of our data handling system
in last year's Annual Report. This provides a firm
foundation for handling the DNA-sequencing data.
This year, we emphasize the scale-up of the sequenc-
ing itself by integrating automation into the sequenc-
ing process. Two primary instruments were in-
tegrated to allow our scale-up of sequencing to begin.
We were able to successfully scale-up to running two
to three gels per day as a result of this effort.
One instrument is an ABI catalyst that carries out
DNA-sequencing reactions on either double- or
single-stranded templates. Personnel were trained to
operate the instrument, and lab sample-handling pro-
cedures were modified to integrate the ABI catalyst
into our sequencing stream. As a result, we typically
use the catalyst for between 48 and 72 sequencing
reactions per day.
The second instrument is a robot that carries out
double-stranded DNA template preparation. This is a
prototype instrument on loan to us from Qiagen. We
were one of the U.S. test sites for this device. Our lab
procedures have once again been modified to make
the most use of this device, and we have worked with
the manufacturer to solve problems with the instru-
ment. This device can now readily provide 96-192
templates per day with minimal human intervention.
Since we sequence each of these templates twice, this
is enough for 192-384 sequencing reactions per day.
The sequencers themselves have also been up-
graded. We changed from 24-cm gels to 34-cm gels
for standard runs and now have the capability of run-
ning 48-cm gels as well. These have substantially im-
TABLE 1 S. pombe Contig Status
Cosmid
Sequence
reads
Contig
size (number) (largest)
PGAA 1012 38,335 (1) (38,335)
PGAB 532 43,789 (1) (43,789)
PGAC 618 43,701 (5) (34,737)
PGAD 486 40,863 (18) (5,664)
PGAE 574 44,724 (6) (14,509)
proved sequence read-lengths. The net result of all of
these changes is that we now can obtain 450-550
bases routinely off double-stranded templates pro-
duced by a robot. This compares to 350-400 that we
were getting per read previously, which is a drastic
improvement in sequence throughput. This capability
has been applied to sequencing a region of the fission
yeast genome.
We began last year to sequence three overlapping
cosmids from the genome of S. pombe. The current
status of all of the S. pombe cosmids currently in
progress is shown in Table 1. This year, we com-
pleted a 31-kb contig from the first of these cosmids,
PGAA, as well as the shotgun phase of sequencing
on the two other cosmids being sequenced. We have
been carrying out gap filling and conflict resolution
on these additional cosmids, PGAB and PGAC. The
contig from cosmid PGAA has a region of about 31
kb, which has been completed. The remaining part of
this cosmid, which is proximal to the telomere, has
some problems in the assembly and is still being ana-
lyzed. Cosmid PGAB has a single large contig, which
is partially a cosmid cloning vector. PGAB is missing
what is probably a small region at one of the cosmid
insert junctions. In addition, a large number of
regions of single-stranded coverage and ambiguities
in PGAB need to be resolved. Cosmid PGAC has
five major contigs; most of this sequence is, however,
present in one 34-kb contig. Some conflict resolution
and joining of the remaining contigs remain with
PGAC.
We have started sequencing two additional cos-
mids, PGAD and PGAE. An initial shotgun phase on
these cosmids has been completed and a preliminary
assembly has been carried out on each. The results
indicate that additional shotgun reactions should be
carried out on PGAD and PGAE and these will be
done in the upcoming year.
We have begun an analysis of the sequence thus
far obtained. The initial phase has been to carry out
database searches using the S. pombe DNA sequence
as a query to search public databases. Blastx search-
es, which translate the S. pombe sequence to protein
sequence and then search protein databases were
carried out. The results showing some possible
matches are shown in Table 2. These are genes, the
TABLE 2 Putative S. pombe Genes Found by Genomic
Sequencing
Amino acid permease
Alanine racemase
Agglutinin attachment subunit
MDR
Aminotriazole resistance
AMP deaminase
fI- glucosidase
Hypothetical 33.7-kD protein
Oligo-1,6-glucosidase
High-affinity glucose transporter
Ferric reductase
Isocitrate lyase
Allantoin permease
Nitrogen assimilation tf
Alcohol dehydrogenase
Guanylate
Adenosine deaminase
Hypothetical protein 4B0218
Ubiquitin-conjugating enzyme
Asparaginyl tRNA synthetase
S. cerevisiae chromosome IX protein
DNA-binding protein REB1
cdc20
DTFIlf30
Fructose-1,6 biphosphatase
Sulfated surface glycoprotein
Replication protein A
Membrane-associated protein
Elongation factor EF-G
Neutral trehelase
Mitosis inhibitor protein kinase
Hypothetical 23.3-kD protein
Poly(A)-binding protein
23-kD cortical cytoskeletal-associated protein
p60-related protein
Sorbitol dehydrogenase
a-tubulin
Hypothetical 40.2-kD protein K12H
YBL0520 gene product (egf-1 receptor)
VSP-3 gene product
Ribosomal protein L37a
Myosin heavy chain (NuMA protein)
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putative homologs of which were found by our se-
quencing of the S. pombe genome. We are continuing
analysis of this region and will intensify our analyses.
Once this is completed, an accurate sequence for this
region will be obtained. This work has already
resulted in more than 30 new genes being found from
S. pombe.
As a further test of the sequencing capability, we
chose to sequence a human cosmid obtained from
Mike Wig ler and Nikolai Lisitsyn (CSHL). A total of
895 sequence reads were carried out. These were as-
sembled with large contigs following assembly. Gap
filling was carried out and the project currently has a
small number of gaps of approximately known size
and a number of ambiguities that need to be resolved.
Initial analysis of this region of the human genome
indicates that it is gene-poor. No clear homologies
with other genes were found. In addition, Grail analy-
sis for potential coding regions has not been helpful
in finding obvious coding regions with similarities to
database entries. We will continue analysis of this
region, particularly in light of the rapidly expanding
public cDNA databases.
PROTEIN CHEMISTRY
R. Kobayashi H. Cai
N. Poppito
B. Schwender
Two new people joined our group this year. Hui-Zhi
Cai is a post-doc who earned her Ph.D in chemistry
at the University of Basel, Switzerland. She will be
working primarily on methods development. Nora
Poppito had been working with Dan Marshak on pep-
tide synthesis and transferred to my group to assist us
with protein sequencing. Brian Schwender continued
work with yeast protein database construction in two-
dimensional gels within the QUEST project but left
at the end of the year when the project come to an
end. Brian is now at Massachusetts General Hospital.
Our task at Cold Spring Harbor Laboratory is to
sequence proteins, and thus a major part of the re-
search is in collaboration with many other scientists
here at the Laboratory. In addition, we have been
trying to develop a new method for micro-charac-
terization of protein, especially a protein-sequencing
method.
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We began an effort in collaboration with R.
Martienssen and V. Sundaresan here at the Labora-
tory to sequence sites of insertion of transposable ele-
ments in Arabidopsis thaliana. Transposed lines were
isolated by the Martienssen and Sundaresan labs and
cDNA clones containing the transposon were ob-
tained by P. Springer. Several clones of different
lengths were sequenced, and the data were used for
searching public databases. This revealed that these
clones have considerable similarity to the highly con-
served MCM2 gene. We sequenced additional over-
lapping partial cDNA clones provided by Dr.
Springer. This provided most of the sequence of the
gene. We chose primers and walked through regions
of inadequate coverage until the sequence of the
entire coding region was obtained.
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Yeast Protein Database
Construction
B.J. Schwender, R. Kobayashi [in collaboration
with J.I. Garrets, B. Futcher, G.I. Latter, Cold
Spring Harbor Laboratory]
Yeast Saccharomyces cerevisiae protein database
construction in two-dimensional (2D) gels as part of
the Quest project has continued this year. We have
been identifying protein spots on the 2D gels by
analyzing their internal amino acid sequences. In this
manner, we can determine from the sequence rela-
tively abundant proteins; however, some of the
proteins turned out to be unknown. By the end of the
year, we identified 38 proteins including 5 unknown
proteins.
Protein Sequencing
N. Poppito, R. Kobayashi
The collaboration with other scientists at Cold Spring
Harbor Laboratory is a major activity in our labor-
atory. In April, Nora Poppito started working in the
protein-sequencing section of the protein chemistry
core facility. This summer, the Association of Bio-
molecular Resource Facilities (ABRF) sponsored a
comparison of the three, different, most widely used
methods for internal sequence analysis by five dif-
ferent facilities at Harvard University, Yale Univer-
sity, Rockefeller University, Wistar Institute, and
Cold Spring Harbor Laboratory. These methods are
in-gel digestion, blotting to PVDF or NC membranes
after gel electrophoresis, and enzymatic digestion.
Our in-gel method proved to be the most sensitive in
terms of peptide recovery. Since internal sequence
analysis of protein has an essential role in the strategy
of cloning a particular gene, this technique has been
extensively used at Cold Spring Harbor since 1992
and has been very successful. Much attention has
been paid to telomerase in cancer research. This year,
protein components of Tetrahymena telomerase have
in collaboration with Dr. Carol
Greider's lab. Cold Spring Harbor Laboratory is the
first to sequence the protein components and clone
the gene of this important enzyme.
Methodological Study of
Protein Sequence Analysis
H. Cai, R. Kobayashi
This project was initiated to develop a more sensitive
method than Edman degradation by utilizing highly
sensitive chemiluminescence detection. Chemilumin-
escence is a luminescence induced by chemical reac-
tion. To use the chemiluminescence detection system,
chemiluminergic (fluorescence) compounds must be
introduced into sequencing products. We finally
synthesized a fluorescent isothiocyanate to replace
phenylisothiocyanate which is used in Edman
degradation. We are currently examining this new
reagent to determine whether it can be used for
protein sequencing.
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MACROMOLECULAR CRYSTALLOGRAPHY
X. Cheng 0. Antar T. Malone
C. Casciato K. Mc Cloy
J. Horton M. O'Gara
Y. Liu R. Xu
The goal of our group is to determine the structures
of a number of biologically important proteins to
atomic resolution to understand better their functions
in cell processes. Our studies are designed to benefit
from and to complement the genetic and biochemical
studies by other groups at Cold Spring Harbor
Laboratory. During the year of 1994, several new
projects have been initiated that resulted from the in-
teractions between the members of our group and
other members of the Laboratory or outside of the
Laboratory. Below are short summaries of accom-
plishments we made during the past year.
Cell Cycle Protein Regulators
J. Horton, R. Xu, 0. Antar, T. Malone [in collaboration with
G. Hannon, H. Zhang, D. Beach, S. Waga, and B. Stillman,
Cold Spring Harbor Laboratory]
We continue our quest to understand the underlying
molecular mechanisms of regulation and activity of
proteins that control the proliferation and differentia-
tion of eukaryotic cells. Unto this end, we have
chosen to concentrate our efforts on determining the
three-dimensional structures of several cyclin-depen-
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dent-kinase inhibitors (CDIs). CDIs appear to be
potent regulators of cell proliferation: When their
mediation is absent or hindered, neogenesis ensues.
Before crystallization and structural determination
can occur, large amounts (tens of milligrams) of pure,
homogeneous protein are needed. This first step is
often a deterrent in structure analysis, and it has been
particularly troublesome in our study of CDIs. Last
year, several recombinant systems for high expres-
sion of p16, a CDI whose activity appears to be ab-
sent in many human tumors, were evaluated. Each
expression system yielded no or little protein. This
year, in collaboration with G. Hannon in David
Beach's laboratory, good expression of a GST-p16
fusion protein was obtained that contains a thrombin
cleavage site. After digesting the fusion protein, and
after a few additional purification steps, more than 5
mg of very pure p16 per liter of Escherichia coli cul-
ture was attained. This expression has finally allowed
us to do an extensive screening for crystallization
conditions of p16. Although thin, needle-like crystals
have been observed under certain conditions, they are
not suitable for X-ray diffraction analysis. We are
following several leads to grow larger p16 crystals
under similar conditions.
Additionally, expression systems that would allow
us to obtain large, soluble amounts of two other
CDIs, p21 and p27, have been explored. A new con-
struct (by S. Waga in Bruce Stillman's laboratory)
has been prepared that appears to have increased p21
expression levels to an appropriate amount for purifi-
cation and crystal screening. A GST-p27 fusion
protein has also been expressed to a high level (by H.
Zhang in David Beach's laboratory). A fast-screen
search for crystals of this protein has also been in-
itiated.
The DNA-binding Domain of MBP1,
a Eukaryotic Transcription Factor
R. Xu, T. Malone [in collaboration with C. Koch
and K. Nasmyth, Institute of Molecular Pathology,
Vienna, Austria]
In eukaryotic organisms,- genes involved in DNA
replication are often subject to some form of cell
cycle control. In the yeast Saccharomyces cerevisiae,
most genes involved in DNA replication are tran-
scribed transiently during late G, as cells become
committed to enter a new cell cycle at Start. Their
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promoters all contain one or more versions of an 8-
base -pair motif (ACGCGTNA) containing an M/uI
restriction enzyme site (bold-face) and called the
M/uI cell cycle box (MCB). A transcription factor,
called MCB-binding factor (MBF), is composed of
two proteins, Swi6 and Mbpl. MBF activates the
transcription of genes encoding S-phase proteins by
binding their MCB via Mbpl.
Mbpl is a 120-kD protein and its amino-terminal
124 amino acids bind MCB elements (Koch et al.,
Science 261: 1551 [1993]). The sequence of this
DNA-binding domain is not related to previously de-
scribed DNA-binding motifs. To facilitate structural
study of the DNA-binding domain of Mbpl, termed
Mbp1A(1-124), an overexpression strain was con-
structed by C. Koch and K. Nasmyth. A 16-residue
peptide (MARRASVGTDHHHHHH) was fused ami-
no-terminal to Mbp1A(1-124), which allows affinity
purification on immobilized nickel columns via the
six histidine residues.
Initial conditions for crystallization were searched
using a sparse matrix screening method by the
hanging-drop vapor diffusion technique. Single crys-
tals were grown at 16°C, and they reached their max-
imum size of approximately 0.2-0.3-mm long after
MONTHS. Luckily, the crystals diffract X-rays to
high resolution beyond 2.0 A. Crystals were of a
tetragonal space group and had unit-cell dimensions
of a = b = 43.8 A, c = 124.9 A. From the molecular
mass of polyhistidine-tagged MBPIA(1 -124) and unit
cell parameters, we calculated the crystal's packing
density (1.85 A3/dalton) and the solvent content
(34%). After a failure in isolating conventional
isomorphous heavy atom derivatives, we attempted to
apply the phasing method of multiwavelength
anomalous diffraction (MAD). The method requires
the use of a synchrotron radiation source to select a
wavelength associated with a particular resonant
electronic transition. The experiment also requires
anomalous scattering centers. The polyhistidine-
tagged Mbp1A(1-124) contains three methionines at
positions -16, 1, and 26. We replaced the methio-
nines in the protein with selenomethionine by over-
expressing the protein in minimal medium that sup-
plies selenomethionine to obtain the Se-containing
proteins (and crystals) for MAD analysis (Hendrick-
son et al., EMBO J. 9: 1665 [1990]). This technique
was pioneered by J. Horton of this group during his
graduate study in Wayne Hendrickson's laboratory
(Columbia University). Peaks in Figure 1 correspond
to Se sites in one unit cell.
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FIGURE 1 The Harker section from an isomorphous Patter-
son map. The map was computed from differences between
Se-met data measured at the edge wavelength (0.979 A) of
Se K-edge and remote wavelength (0.950 A) at beamline
X12C of National Synchrotron Light Source, Brookhaven Na-
tional Laboratory. The map was contoured in increments of
1.0 o, starting at 2.5 o.
Viral Protein VP16
Y. Liu, K. Mc Cloy [in collaboration with C. Huang
and W. Herr, Cold Spring Harbor Laboratory]
The herpes simplex virus (HSV)-encoded protein
VP16 is not only an essential structural component of
the HSV viron, but also the activator of HSV imme-
diate-early (IE) gene expression. VP16 is one of the
most potent transcriptional activators identified in
eukaryotes. It forms a multiprotein complex with cel-
lular proteins Oct-1 and HCF to activate viral IE gene
transcription by binding to TAATGARAT elements
in the IE promoters. This binding enables the activa-
tion domain of VP16 to interact with the basal tran-
scriptional machinery and activate transcription of
the viral IE genes. Therefore, structural studies of
VP16 will lead to an understanding of multiprotein-
DNA interactions involved in transcriptional regula-
tion. Since transcriptional regulation is intimately re-
lated to cell growth, cell cycle control, and onco-
genesis, VP16 has been a subject of intensive studies.
A three-dimensional crystal structure of VP16 will
not only shed light on the mechanism of VP16 func-
tion, but also facilitate further biochemical character-
ization of the protein.
A construct encoding a GST fusion with the cen-
tral region (amino acids 48-412) of VP16 that is suf-
ficient for VP16-induced complex formation but
lacks the activation domain has been made by C.
Huang in Winship Herr's laboratory. We carried out
large-scale production of the protein for crystal-
lography. The fusion protein was purified on a
glutathione-agarose column, and VP16 was released
from the fusion by thrombin digestion at the junction
between the GST and VP16 sequences. Thrombin
and VP16 were then separated by Q-Sepharose
column chromatography. Purified VP16 was crystall-
ized by the hanging-drop method into rod-like crys-
tals with an average dimension of 0.2 x 0.2 x 1.0
mm3 at 16°C (Fig. 2).
Preliminary results indicate that the VP16 protein
crystallizes into an orthorhombic space group with
unit cell dimensions of a = 60 A, b = 77 A, c = 83 A.
The crystals diffract X-rays beyond 3 A. Conven-
tional screening of heavy atom derivatives and X-ray
data collections are under way.
FIGURE 2 Crystals of VP16. Demensions: 0.48 x 0.07 mm
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Casein Kinase I
R. Xu, T. Malone [in collaboration with J. Kuret,
Molecular Geriatrics Corp.]
Casein kinase I (CKI) is a serine/threonine-specific
protein kinase that is ubiquitous in eukaryotic
organisms. Last year, we reported the structure of the
catalytic domain of CKI from Schizosaccharomyces
pombe in complex with MgATP at 2.0 A resolution.
The crystals were formed in a trigonal space group
(P3221). This year, we solved the same binary com-
plex in an orthorhombic space group (P212121) by
molecular replacement.
Casein Kinase II
J. Horton [in collaboration with D. Marshak,
Cold Spring Harbor Laboratory]
Casein kinase II (CKII) is involved in the phosphor-
ylation cascade originating with the cdc2 kinase, one
of the most important macromolecular control sites of
the cell cycle, and participates in mitogenic signaling,
particularly in neural development. Last year, the
growth of three different crystal forms of the
regulatory subunit (CKII(3) of the CKII kinase was
reported: One is of the full-length protein (residues
1-215), one of a truncated form (residues 1-189),
and another contains a mixture of both full-length
and truncated proteins. The truncation appears to oc-
cur as the result of some unknown protease, and most
protein preparations yield a mixture of the two forms
that does not produce good crystals. An investigation
is under way so that we can reproducibly obtain ei-
ther the full-length or truncated form during expres-
sion and/or protein purification.
To achieve good expression of CKIIa, the cata-
lytic subunit, site-specific mutagenesis at the active
site of CKIIa is being done in further collaboration
with Dan Marshak's laboratory. Active CKIIa, when
expressed in E. coli, has a deleterious effect on cell
growth. It is for this reason that good expression of
an inactive mutant of this kinase is being undertaken.
CKIIa has an active site similar to that of other
kinases whose three-dimensional structures have
been solved, and the mutation should not affect the
rest of the structure. We hope to get crystals of
CKIIa and reconstituted whole CKII to understand
how protein-protein interactions of the subunits affect
this kinase's activity and regulation.
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FIGURE 3 Reaction pathway for C5-cytosine methyltrans-
ferases based on the mechanism proposed by Wu and
Santi (J. Biol. Chem. 262: 4778 [1987]), modified by Baker
et al. (Gene 74: 207 [1988]) and Chen et al. (J. Am. Chem.
Soc. 115: 5318 [1993]), and confirmed by the crystal-
lographic work on M-lhal. The residues are inferred from
the MHhal structure. A base (:B) that abstracts a proton
from carbon-5 is needed for the 0-elimination step. A water
molecule bound to the side chains of Asn-304 and Gln-82
may serve as the required general base catalyst.
DNA Modification by
Hhal Methyltransferase
M. O'Gara, K. Mc Cloy [in collaboration with R.J. Roberts,
New England Biolabs, Inc.]
In 1993, we solved and published the structure of the
MHhaI-AdoMet complex (Cheng et al., Cell 74: 299
[1993]). From this binary structure determined at 2.5
A resolution, we learned that the MHhal folds into
two broad domains: a catalytic domain that contains
catalytic and cofactor-binding regions and a DNA-
recognition domain. Later, we solved and published
the ternary structure for a chemically trapped coval-
ent reaction intermediate between the M Hhal, a
duplex 13-mer DNA oligonucleotide containing
methylated 5-fluorocytosine at its target, and reaction
product AdoHcy (Klimasauskas et al. 1994). This
structure determined at 2.8 A resolution reveals the
three-dimensional basis for the functions of amino
acids implicated in DNA-sequence specificity,
catalysis, and cofactor binding. The DNA is bound in
a cleft between the two domains. The structure is the
first to demonstrate "an amazing distortion in DNA
induced by a methyltransferase," i.e., the substrate
nucleotide is completely flipped out of the helix dur-
ing the modification reaction. The structure also pro-
vides a clear example of induced-fit for both protein
and the DNA in the sequence-specific substrate bind-.
ing by MHhal.
The above ternary structure represents one step of
the reaction pathway (Fig. 3, step 3). During the past
year, we crystallized, collected, and solved structures
of MHhal with cognate DNA (Fig. 3, step 1) and
methylated DNA (Fig. 3, step 4). The latter two
structures reveal the role of two conserved residues,
Gln-82 and Asn-304 in MHhal, in the proton
elimination step of C5-cytosine methylation. Thus,
all of the amino acids implicated in catalysis have
been identified from the MHhal structures.
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NEUROSCIENCE
Neuroscience research at CSHL matured this year to yield significant results. Technological ad-
vances and biological discoveries have advanced our understanding of several molecular me-
chanisms underlying development of behavioral plasticity. As a result, we are a few steps closer to
exposing various factors that contribute to cognitive dysfunction. Holly Cline, Roberto Malinow, and
their co-workers, neurobiology newcomers in 1994, have developed a technique for delivering for-
eign proteins to vertebrate neurons. Combining this technique with in vivo imaging, the Cline lab
has shown that expression of an altered calcium/calmodulin kinase (CAMKII) produces shorter
neurons with fewer branches in the developing visual system. Using similar virus-delivered con-
structs in electrophysiological experiments, the Malinow lab has produced clear evidence that
CAMKII functions during long-term potentiation-a form of synaptic plasticity in vertebrate brains
strongly correlated with learning.
At a cellular level of analysis, Hiro Nawa and co-workers have shown that seizure induces per-
sistent expression of a growth factor (BDNF) lasting for several days. This observation implies last-
ing effects from such neural trauma. Grisha Enikolopov and colleagues have revealed for the first
time a clear cellular function for nitric oxide (NO) in the brain. Nerve growth factor (NGF) produces
an increase in NO, which then promotes the terminal differentiation of new neurons by inhibiting
cell proliferation. Interfering with this process can lead to premature neuronal death.
At a physiological level of analysis, Yi Zhong has shown that the Ras/Raf pathway is activated
during synaptic transmission and is required to function along with the cAMP pathway to modulate
potassium channels. This discovery has served to blur our conceptual distinctions between "devel-
opment" and "physiology" in neuronal function. We, in fact, may be studying the same molecular
processes only manifested at different times in the life of the neuron.
Finally, Tim Tully and co-workers have revealed a critical function for the transcription factor
CREB during the formation of long-term memory (LTM). In essence, CREB appears to act as a
"molecular switch." Turning the CREB switch off in transgenic fruit flies suppresses the formation of
LTM, although learning and short-term memory remain normal. Turning the CREB switch on, in con-
trast, enhances the formation of LTM. Consistent with these fruit fly results, Alcino Silva and col-
leagues have shown impaired long-term memory, but normal short-term memory, in mutant mice
carrying a gene knockout of CREB. Taken together, these behavioral analyses of fruit flies and
mice suggest the existence of an evolutionarily conserved molecular mechanism underlying the
formation of long-term memory.
MOLECULAR NEUROBIOLOGY OF LEARNING
AND MEMORY IN DROSOPHILA
T. Tully J. Yin H. Zhou R. Mihalek Z. Asztalos
J. DeZazzo I. Sanchez (URP) M. Del Vecchio S. Pinto
H. Tobin C. Jones J. Wallach (M.I.T.) D. Wood
J. Christensen G. Bolwig M. Regulski N. Arora (Eton College)
Our demonstration last year that a fruit fly homolog tional model, in which the opposing functions of
(dCREB2) of the vertebrate CREB transcription fac- CREB (family member) activators and repressors
for functions specifically in the formation of long- defined two specific behavioral parameters-the
term memory (LTM) led us to conceptualize a func- number of training sessions and the rest interval be
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tween them-required to form maximal LTM. This
"C" model yielded three general predictions: (1) No
number of massed training sessions (no rest interval
between them) will ever induce LTM. (2) Over-
expression of CREB repressor will block the LTM
normally induced by ten spaced training sessions.
(This is the result we reported last year.) (3) Over-
expression of CREB activator will enhance LTM by
reducing the required number of training sessions or
the rest interval between them or both.
This year, we have confirmed predictions 1 and 2.
Since work in other laboratories already has impli-
cated CREB in LTM formation in mollusks and in
mice, our demonstration of enhanced LTM formation
by overexpression of a CREB activator is likely to be
an evolutionarily conserved function. Thus, CREB
becomes the first bona fide mechanistic component
of LTM formation against which drug therapies can
be developed. Such "cognitive enhancers" promise to
ameliorate the memory dysfunction associated with
learning disabilities, Alzheimer's disease, and the
normal aging process (senile dementia).
dCREB2 as a Modulator
of Long-term Memory
T. Tully, J. Yin, M. Del Vecchio, H. Zhou, H. Tobin
[in collaboration with J. Wallach, visiting from
the Massachusetts Institute of Technology]
Genetic dissection of long-lasting, consolidated
memory has yielded a clear characterization of LTM
in fruit flies (Tully et al. 1994). As a result, we have
been able to show a specific disruption of LTM by
induced expression of a repressor isoform of dCREB2
(Yin et al. 1994). The dCREB2 gene is alternatively
spliced into both repressor and activator isoforms (J.
Yin et al., submitted), and we now have generated
transgenic hsp-dCREB2-a flies carrying an inducible
activator CREB isoform (dCREB2-a). Using a proce-
dure identical to that of Yin et al. (1994), we
quantified 7-day memory in wild-type or hsp-
dCREB2-a transgenic flies with or without heat-
shock induction of the dCREB2-a transgene. Seven-
day memory retention is produced only after spaced
training in wild-type flies and is completely blocked
in hsp-dCREB2-b transgenic flies with induced ex-
pression of the dCREB2-b repressor isoform (Tully et
al. 1994; Yin et al. 1994). Thus, 7-day memory is
composed solely of LTM, which shows no decay
from 1 to 7 days after spaced training (Tully et al.
1994).
In the absence of heat shock, one, two, or ten
massed training sessions failed to produce any LTM
in wild-type flies or in hsp-dCREB2-a transgenic flies
from two independently derived lines (Fig. 1). Ten
spaced training sessions, however, produced maximal
levels of LTM in all three lines. These data indicate
that memory formation was normal in transgenic flies
when the hsp-dCREB2-a transgene was not induced.
When flies were trained 3 hours after heat shock,
ten spaced training sessions still produced maximal
LTM in wild -type and transgenic flies. Moreover,
one, two, or ten massed training sessions failed to
produce any LTM in wild-type flies. In contrast, one,
two, or ten massed training sessions produced maxi-
mal LTM in transgenic flies. These data indicate that
(1) heat shock itself did not produce any nonspecific
effects, (2) memory formation after spaced training
still was normal in transgenic flies, and (3) LTM
formation was enhanced in transgenic flies after heat-
shock induction of the hsp-dCREB2-a transgene.
CI Can-S
M C28
II C30
1m 12mi1 orril1 0 s
induced uninduced
7-DAY RETENTION
FIGURE 1 Induced expression of a transgene carrying a
dCREB2 activator isoform enhances long-term memory.
Seven-day retention in wild-type (Can-S) or uninduced
transgenic flies (C28 or 030) is produced normally by
spaced (10 sec) but not massed (1, 2, or 10 min) training.
Maximal LTM is produced after just one training session (1
min), however, in induced transgenic flies. This effect is the
functional equivalent of a 'photographic" memory.
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The observation that maximal LTM was formed
after just one training session is particularly reveal-
ing. The usual requirement for multiple training ses-
sions to form LTM was no longer necessary. Thus,
induced overexpression of a CREB activator has pro-
duced in otherwise normal flies the functional equi-
valent of a photographic memory.
This enhanced memory effect appeared to be
specific to LTM. Untrained transgenic (C28) flies'
abilities to smell odors (olfactory acuity) or sense and
react to electric shock (shock reactivity) were normal
3 hours (equivalent to the time of odor-shock train-
ing) or 7 days (equivalent to the time of conditioned
odor avoidance testing) after heat-shock induction of
hsp-dCREB2-a (Fig. 1). In addition, "learning" -
determined by measuring conditioned odor avoidance
immediately after one training session-was normal
in transgenic (C28) flies 3 hours (PI + SEM = 83 + 1
for Can-S or 83 + 2 for C28; N = 6 PIs per group) or
7 days (PI + SEM = 83 + 2 for Can-S or 84 + 2 for
C28; N = 6 PIs per group) after heat-shock induction
of hsp-dCREB2-a. Thus, enhanced memory forma-
tion in hsp-dCREB2-a transgenic flies was specific to
the induction of LTM.
Mammalian CREB must be phosphorylated at
Ser-133 to function as a PICA-responsive transcrip-
tional activator. In Drosophila, the dCREB2-a ac-
tivator isoform contains a consensus PICA phosphor-
ylation sequence surrounding Ser-231 (J. Yin et al.,
submitted). Transgenic flies, carrying a mutant ac-
tivator with an alanine substituted for Ser-231, were
generated to test the hypothesis that enhanced LTM
formation depended on phosphorylation of the ac-
tivator transgene. Wild-type (Can-S) flies, flies from
two independently derived hsp-dCREB2-pka trans-
genic lines (1-2 and 2-26), and flies from an hsp-
dCREB2-a transgenic line (C28) were subjected to
one training session 3 hours after heat shock. Sub-
sequent 7-day memory was maximal in transgenic
C28 flies carrying the induced CREB activator
isoform but was not detected in wild-type flies (as ex-
pected) or in transgenic 1-2 or 2-26 flies carrying the
induced CREB mutant activator (data not shown).
For flies carrying both the wild-type and mutant
CREB activator isoforms, Western blot analysis
revealed similar induced levels of expression after
heat shock (data not shown). These data indicate that
enhanced formation of LTM depends on phosphory-
lation of the CREB activator transgene.
Taken together, results from these experiments
and our previous work (Yin et al. 1994) support a
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model based on the notion that opposing functions of
CREB activators and repressors act as an LTM
modulator to determine the parameters of extended
training (number of training sessions and rest interval
between them) required to form LTM. In its simplest
form, this model supposes that associative learning
(training) functionally induces both CREB activator
and repressor isoforms. Immediately after training,
enough CREB repressor exists to block the ability of
CREB activator to induce downstream events. Then,
CREB repressor isoforms functionally inactivate
faster than CREB activator isoforms. In this manner,
the net amount of functional activator (C =
activators-repressors) increases during a rest interval
and then accumulates over multiple spaced training
sessions to induce further the downstream targets in-
volved with the formation of LTM.
Conceptually, C defines a quantal amount of
CREB activator available after a single training ses-
sion. For olfactory learning in wild-type flies, this
quantal amount presumably is small-even after rela-
tively long rest intervals. As a result, multiple train-
ing sessions are required to sum quanta and thereby
to produce maximal LTM. This perspective yields an
enlightening interpretation of results from transgenic
flies with induced expression of hsp-dCREB2-a: The
quantal size of C after one training session was large
enough to induce maximal LTM.
Molecular Cloning of a
Cail-dependent Nitric
Oxide Synthase
M. Regulski, T. Tully
In recent years, a novel type of intercellular mes-
senger, nitric oxide (NO) gas, has been shown to be
involved with several aspects of developmental
plasticity, long-term potentiation, and learning. These
reports have been controversial, however, because of
the variable and nonspecific effects of pharmacologi-
cal agonists and antagonists of the enzyme that
synthesizes NO, NOS. In an effort to clarify some of
these issues, we have cloned a Drosophila homolog
(dNOS) of the vertebrate NOSs.
The dNOS message contains one long open read-
ing frame (ORF) of 4350 by encoding a protein of
1350 amino acids. This conceptual Drosophila
protein shows a significant degree of amino acid se-
quence homology with the vertebrate NOS proteins:
It is 38% identical to rat brain NOS, 36% identical to
bovine endothelial NOS, and 28% identical to mouse
macrophage NOS. The Drosophila sequence contains
all the known functional domains of vertebrate NOS:
heme, calmodulin, FMN, FAD, and NADPH binding.
In the NADPH-binding domain, all amino acids that
have been shown to be contact points with the
dinucleotide in crystals of ferrodoxin NADP+ reduc-
tase are perfectly conserved in the putative Drosoph-
ila protein. Moreover, the region between the heme-
and calmodulin-binding sites is 70% identical be-
tween rat and Drosophila proteins and is likely in-
volved with binding of arginine and possibly cofactor
tetrahydrobiopterine.
Extracts made from dNOS-transfected human em-
bryonic kidney 293 cells showed significant NO
synthase activity as measured by the standard L-
arginine to L-citrulline conversion assay (0.1276 ±
0.002 pmole/mg/min). (In a parallel experiment,
specific activity of the rat neuronal NOS expressed
from the same vector in 293 cells was 3.0 ± 0.02
pmole/mg/min, N = 4.) DNOS activity was dependent
on exogenous Ca"/calmodulin and on NADPH, two
cofactors necessary for activity of constitutive mam-
malian NOSs. DNOS activity was reduced 90% by
the Ca++ chelator EGTA (data not shown). In addi-
tion, 500 mm N-(6-aminohexyl)-1-naphthalenesul-
fonamide (W5), a calmodulin antagonist, diminished
DNOS activity to 18% (0.0222 a 0.001 pmole/
mg/min, N = 2). DNOS activity also was blocked by
inhibitors of mammalian nitric oxide synthases. /VG-
nitro-L-arginine methyl ester (L-NAME) reduced
DNOS activity 84%, and 100 mm /VG-monomethyl-L-
arginine acetate produced a complete block (data not
shown). These enzymatic data demonstrate that
DNOS is a Ca++/calmodulin-dependent nitric oxide
synthase.
Molecular Genetics of
latheo, linotte, nalyot,
and amnesiac
T. Tully, R. Mihalek, S. Pinto, J. Christensen, I. Sanchez,
D. Wood, G. Bo !wig, J. DeZazzo
We continue to work on these learning and memory
genes to understand better their cellular functions and
distributions in time and space. In the last year, we
have rescued the lethality associated with latheo null
mutants and have fully rescued the learning and
memory deficits associated with the linotte mutant by
inducing the expression of each gene's corresponding
wild-type transcripts in transgenic flies. These results
provide conclusive evidence that we have cloned the
appropriate transcripts. The nalyot transcript has been
cloned (partially), sequenced, and identified. It is a
helix-turn-helix (HTH) transcription factor called
Adf-1, which originally was identified as a binding
protein in the promoter region of the Alcohol
dehydrogenase (Adh) gene. It also is known to regu-
late the Dopa decarboxylase (Ddc) gene, tempera-
ture-sensitive alleles of which produce deficits in ol-
factory learning. We also have discovered a P-
element insertion into cytological region 19A, which
fails to complement the memory defect of amnesiac
mutants. This has allowed the resurrection of our at-
tempts to clone the gene. Finally, we have begun
neuroanatomical work on brain slices of various
mutants. To date, we have established that linotte and
nalyot mutants have normal (gross) adult brain struc-
tures. In the upcoming year, work on each of these
genes will likely yield significant new molecular in-
formation.
Behavioral Properties of
Learning and Memory in
Normal and Mutant Flies
T. Tully, N. Arora, Z. Asztalos, C. Jones
Our behavioral work continues to yield important
"genetic dissections" of learning and memory. We
nearly have finished behavioral experiments charac-
terizing olfactory habituation of the jump response in
normal and mutant flies. Development of such a non-
associative olfactory learning task will allow us to as-
sess whether similar molecular-genetic processes un-
derlie associative and nonassociative forms of learn-
ing and memory. We also have confirmed an obser-
vation from Dr. M. Heisenberg's lab (University of
Wurzburg, Germany) that first-instar larvae fed
hydroxyurea during a specific 1.5-hour period fail to
develop mushroom body structures in the adult brain
and fail to show any olfactory associative learning.
We extended these results, however, by showing that
habituation of the olfactory jump response was
normal in mushroom body ablated flies. These data
indicate an anatomical dissection of associate and
nonassociative learning in fruit flies.
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SIGNAL TRANSDUCTION UNDERLYING
NEUROTRANSMISSION
Y. Zhong N.J.D. Wright J. Shan ley
H. Zhou C. Kim
We are interested in understanding signal transduc-
tion mechanisms underlying neurotransmission and
how these mechanisms are involved with or contrib-
ute to the cellular basis of learning and memory. The
approach we are taking is to first analyze neurotrans-
mission in Drosophila learning and memory mutants.
Further pharmacological and genetic manipulation
may then allow us to elucidate the signal transduction
mechanism disrupted by mutations and its role in
neurotransmission. On the basis of such an under-
standing, we may be able to manipulate and mutate
other components in the signal transduction pathway.
The effects of these genetic alterations on learning
and memory can then be tested. Thus, these com-
bined genetic, electrophysiological, and pharma-
cological studies may lead to a better understanding
of cellular mechanisms of Drosophila learning and
memory.
Currently, we are focusing on neurotransmission
coupled by heterotrimeric G proteins. There are prob-
ably more than 1000 types of such receptors that
have been analyzed up to now. Upon ligand binding,
the transmitter receptors interact with heterotrimeric
G proteins, allowing Ga and Goy subunits to dis-
engage. The Ga subunit is known to modulate the ac-
tivity of adenylyl cyclase or phospholipase C, result-
ing in synthesis of second messengers, cAMP, or di-
acylglycerol and IP3, respectively. These second
messengers, in turn, lead to modulation of ion chan-
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nel activity. In addition, a recent report (Crespo et al.,
Nature 369: 418 [19941) has indicated that the Goy
subunit complex activated via muscarinic receptors
can stimulate the small guanine-nucleotide-binding
protein Ras, leading to activation of mitogen-
activated protein kinase (MAPK). This result has
raised the possibility that the Ras/MAPK pathway
might provide another second-messenger cascade for
neurotransmission. We have developed both neuro-
muscular and central nervous system preparations for
examining the roles of these signal transduction
mechanisms in Drosophila neurotransmission.
Coactivation of cAMP and
Ras/Raf Pathways in
Peptidergic Transmission
Y. Zhong
We have previously shown that a pituitary adenylyl
cyclase-activating polypeptide (PACAP38)-like neu-
ropeptide functions as a neurotransmitter at the larval
neuromuscular junction by Western blot, immuno-
histochemical, and electrophysiological analyses. Ei-
ther high-frequency stimulation of motor axons or
application of PACAP38 induces a similar biphasic
muscle response: an inward synaptic current fol-
Control
100 nA
Ls
0
PACAP38
25
8'
6' 7'
13'
FIGURE 1 PACAP38-induced responses in larval body-wall
muscles recorded by voltage clamp. The muscle membrane
is held at -80 mV. At 0' (0 minute), a pulse of 4 um
PACAP38 (as indicated by the bar) is focally applied to the
neuromuscular junction, which induces an inward current as
the early response. This early inward current lasts for many
seconds. The muscle K+ currents are also monitored before
the application and each minute after the application. The
command voltages are stepped from -80 to -50 and 0 mV,
respectively. Only the leakage current is elicited by the volt-
age step to -50 mV, but voltage-dependent currents are ac-
tivated by depolarization to 0 mV. The amplitude of voltage-
activated K+ currents remains relatively stable during the
period prior to the application and 6 minutes after applica-
tion. But a dramatic increase, as the late response, is seen
at 7 minutes (7 ' ) after the application, which peaks at 8
minutes and returns to the control level at about 13 minutes.
lowed by more than 100-fold enhancement of
voltage-activated K+ currents (Fig. 1). For the sake of
clarity, we will focus on the mechanisms underlying
the enhancement of K+ currents. Since the vertebrate
PACAP38 receptors are known to activate adenylyl
cyclase, the effects of rutabaga (rut) mutations on
this PACAP38 response were examined.
The rut mutants have been isolated on the basis of
poor performance in an associative learning test. The
gene encodes a Ca++/CaM-sensitive adenylyl cyclase.
The PACAP38-induced enhancement of K+ currents
was eliminated in two rut mutants examined (Fig.
2A), suggesting that the cAMP cascade is necessary
for this neuropeptide response. However, application
of a membrane-permeable cAMP analog was not suf-
ficient to produce the PACAP38-like response. Fur-
ther analysis revealed that the PACAP38-like re-
sponse was also defective in rasl and raf mutants
(Fig. 2B,C). Finally, activation of both the cAMP and
Ras/Raf pathways was sufficient to induce PA-
CAP38-like enhancement of IC+ currents. Therefore,
coactivation of the cAMP and Ras/Raf pathways is
suggested to mediate PACAP38-like neuropeptide
transmission at the Drosophila neuromuscular junc-
Wild Type
rue
rue7.
PACAP38 5 pM
Control 90 s 180s 220s 5000
B PACAP38 10 pM
Wild
R.02.
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I40 s 80 s 120 s
r------
C PACAP38 100M
Wild Type
raf
50s 80 s 120 s
100 nA
10 me
nA
FIGURE 2 Diminished PACAP38 response in rut, Rasi, and
raf mutants. (A) PACAP38-induced enhancement of voltage-
activated K+ currents is abolished in rut mutants. The arrow
indicates focal application of PACAP38 (5 w). (8) Enhance-
ment of K+ currents induced by 10 Ian PACAP38 is
eliminated in Ras1 mutants. N = 14, 8, and 10 for wild-type,
Ras112a/Ras112a, and Ras112a/Ras1e2F larvae. (C) Enhan-
cement of voltage-activated K+ currents induced by
PACAP38 (10 AM) is eliminated in raf mutants. N = 14 and
10 for wild-type and raf HM7 larvae. 'Control' current traces
were recorded before application of PACAP38. The time in
seconds after pressure-ejection of PACAP38 is indicated at
the top of the current traces. Data were recorded with the
bath saline containing 1 mm Ca++.
tion (Fig. 3). These findings establish a role for the
Ras/Raf pathway as another signal transduction me-
chanism, in addition to the cAMP and phosphoinosi-
tide pathways, in neurotransmission and neuro-
modulation.
Cloning the Gene Encoding the
PACAP38-like Neuropeptide
H. Zhou [in collaboration with J. Yin and T. Tully,
Cold Spring Harbor Laboratory]
As discussed above, the PACAP38-like neuropeptide
functions as a transmitter and this peptide-induced
transmission is defective in the learning and memory
mutant rut. Since the PACAP38-like neuropeptide
also appears to act in the Drosophila central nervous
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FIGURE 3 A coincident signal transduction model for
modulation of K+ currents induced by a PACAP38-like
neuropeptide. Question marks indicate molecules whose
function has not yet been tested. Dashed arrows indicate
where the CAMP and Ras/Raf pathways may converge;
whether such convergence is on channels directly or via an
intermediate target remains to be determined.
system, it is possible that this peptide transmitter may
be involved in learning or memory. To test this pos-
sibility, we will clone the gene encoding this peptide
and generate mutants or transgenic flies, which will
then allow us to test learning and memory of those
flies with an altered expression of this peptide.
We have been able to recover a polymerase chain
reaction (PCR) product with primers derived from the
amino- and carboxy-terminal amino acid sequences
of vertebrate PACAP38 from both Drosophila
genomic DNA and mRNA. The deduced amino acid
sequence of the PCR product matches well in all crit-
ical charged residues, which are critical for the func-
tion of the peptide. Twelve clones that hybridize with
the PCR product have been pulled out of the larval
cDNA library. We are now sequencing these clones
to determine whether they encode the PACAP38-like
neuropeptide.
Neurotransmission in
the Drosophila Central
Nervous System
N. Wright
To understand cellular mechanisms of learning and
memory, we will first study the Drosophila central
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nervous system. However, the small-sized Dro-
sophila brain and neurons made this task very dif-
ficult. As a first step, we have developed a prepara-
tion of cultured neurons for studying signal transduc-
tion mechanisms of neurotransmission. Neuro-
transmitters are delivered to patched neurons in cul-
ture by a micropipette via either pressure ejection or
iontophoresis. The neuronal responses to perfused
transmitters are recorded by the patch-clamp method.
We have examined a number of transmitters includ-
ing serotonin, PACAP38, and AmP peptides. AmP is
a neuropeptide that may be encoded by the amnesiac
(amn) gene (cloned by M. Feany and W. Quinn at the
Massachusetts Institute of Technology). The amn
mutants disrupt middle-term memory without appar-
ently affecting learning and short-term memory.
These preliminary analyses have led to the study of a
new type of neurotransmission, as well as underlying
signal transduction pathways.
It appears that serotonin, AmP, and PACAP38 can
induce similar responses: an outward synaptic current
and modulation of voltage-activated K+ currents (Fig.
4), when applied to patched CNS neurons. We are
focusing on the outward synaptic current. Closer ex-
amination has revealed that this outward synaptic
current is a result of closing "leakage" current chan-
nels. This leakage current has a reversal potential of 0
to +10 mV. These channels remain open all the time
but are closed in response to application of serotonin,
AmP, or PACAP38. The leakage current may have
AmP (30 µg /ml)
Serotonin (10 mM) 11°2'
5 sec
FIGURE 4 AmP neuropeptide- and serotonin-induced
responses in cultured Drosophila central nervous system
neurons. Neurons were clamped at -80 mV. Transmitters
were delivered at the periods and concentrations as indi-
cated.
an important modulatory function since it is recorded
from all central nervous system neurons and appears
to mediate actions of a number of neurotransmitters.
We are characterizing the channels gating this
leakage current and chasing the gene that possibly
codes for these channels. The purpose of these
analyses is to lay a foundation for determining how
neurotransmission mediated by this leakage current is
affected in learning and memory mutants and
whether this neurotransmission mechanism can be
further manipulated for testing its role in learning and
memory.
Plasticity of Nerve Terminal
Arborization
C. Kim, J. Shan ley, Y. Zhong
In addition to modulation of ion channel activity, sig-
nal transduction activated by neurotransmitters may
also lead to regulation of gene expression, which may
produce a long-term change in nerve terminal ar-
borization or neural connectivity. Such neural plas-
ticity has been hypothesized as a mechanism under-
lying formation of long-term memory. We have used
motor nerve terminal arborization in Drosophila as a
model to dissect the molecular mechanisms under-
lying activity-dependent neural plasticity.
It was previously shown that increased neural ac-
tivity leads to enhanced motor nerve terminal ar-
borization. This activity-dependent plasticity is prob-
ably mediated, at least in part, by the cAMP cascade.
This is supported by observations that the enhance-
ment of nerve terminal arborization is partially
blocked in rut mutants that lack Ca++/CaM-activated
adenylyl cyclase activity and that the arborization is
enhanced in dunce mutants, resulting probably from
higher cAMP due to disrupted phosphodiesterase ac-
tivity by the mutations. We hypothesize that neural
activity leads to synthesis of cAMP, which then in-
fluences nerve terminal arborization by activating
transcription factors, cAMP-response-element bind-
ing proteins (CREBs), to regulate gene expression.
Jerry Yin and Tim Tully here at the Laboratory have
made transgenic flies carrying an inducible CREB ac-
tivator or CREB blocker. We are using these trans-
genic flies to test whether CREB is required for
neural plasticity. Preliminary results are very en-
couraging, but more extensive analysis is needed for
making any conclusions.
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DEVELOPMENT AND MODIFICATION OF NEURONAL
CIRCUITS
H. Cline J. Edwards G.-Y. Wu
I. Miloslayskaya D.-J. Zou
S. Witte
Neural circuits in the brain can be modified by
changing the inputs and electrical activity in the cir-
cuit; however, the mechanisms underlying these
modifications are only partially understood. One pos-
sibility is that neurons add or retract branches in
response to different patterns of input activity. Addi-
tion or retraction of branches would also mean that
the synaptic connections on the branches are added
or retracted. To test this hypothesis and to determine
how activity-dependent changes in neuronal connec-
tions might occur, we take time-lapse images of
neurons in the visual system of albino Xenopus tad-
poles under conditions that modify synaptic activity.
This system is particularly well suited for these ex-
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periments because the neuronal connections in the
visual system are sensitive to the changes in visual
stimulation or synaptic activity. In addition, the heads
of albino Xenopus are virtually transparent so that the
central nervous system can be observed in the intact
animal.
Single neurons in intact living animals are labeled
with fluorescent dyes. We then use in vivo time-lapse
confocal microscopy to study the dynamic rearrange-
ments of either the presynaptic retinal axons or the
postsynaptic tectal neurons as they elaborate the
axonal or dendritic processes or "arbor" within the
central nervous system. The morphology of the
neurons can then be observed by placing the
anesthetized animal on the stage of the microscope.
High-resolution images of the neuronal morphology
are collected with a laser scanning confocal micro-
scope. This system offers the unique opportunity to
observe neurons growing in their normal complex en-
vironment.
Observations of single axons taken over a 3-day
period show large-scale rearrangements in the shape
of the axon arbors. Time-lapse images of growing
axons taken at 30-minute or 2-hour intervals show
that the net increase in axon branch number that oc-
curs over several days is the result of dynamic addi-
tion and retraction of branches, rather than a
straightforward addition of branches and the per-
sistence of those new branches. In fact, 90% of the
branches that are added to the growing axon are sub-
sequently retracted. During 8 hours of observation, a
0 hours 2 hours
modest increase is seen in the total number of new
branches that reflects the slight imbalance in branch
additions versus retractions that occurs at each obser-
vation. The modest changes in total branch number
seen during 8 hours accumulate to result in the more
obvious changes seen over a period of days. The por-
tion of the axon that persists throughout the 8-hour
observation, or the "core" structure of the axon, is
surprisingly small, whereas the portion that changes
from one observation to the next can be 50% of total
branch length. Prior to these in vivo observations, we
had not recognized the dynamic capacity of neurons
to change their structure over such a short time
course of hours.
Dynamic Rearrangement
of Axon Branches Is
Activity-dependent
S. Witte, H. Cline
We tested whether one of the factors controlling the
dynamic rates of branch rearrangements in retinal
axons is synaptic activity. In support of this
hypothesis, we have found that blocking the NMDA
type of neurotransmitter receptors on the postsynaptic
neurons over 24 hours causes the presynaptic axons
to grow larger than normal. Such a change in
neuronal morphology could result from a relative
4 hours 6 hours 8 hours
FIGURE 1 Reconstruction of an axon imaged at 2-hr intervals over 8 hr. The portion of the axons
that is unchanged over the 8 hr is gray. The portion of the axon that changes from one observation to
the next is black. This includes branches that are added or retracted and the portion of branches
that elongate or shorten.
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decrease in branch retractions or an increase in
branch additions. Further observations taken at
shorter intervals indicated that blocking the NMDA
receptors increased the relative number of branch ad-
ditions, and this accounts for the net increase in the
number of branches in the neuron observed over 24
hours. In addition, blocking the postsynaptic NMDA
receptors increased the absolute rates of branch addi-
tions and retractions in the presynaptic neurons so
that the neuronal structure was more dynamic than
normal.
In a separate set of experiments, we have increased
NMDA receptor activity in the postsynaptic neurons
by synchronizing visual activity with strobe illumina-
tion. We predicted that strobe illumination would sta-
bilize neuronal structure and increase the lifetimes of
axon branches; however, the results indicate that the
influence of synaptic activity on neuronal structure is
more complex than our simple hypothesis predicted.
Strobe illumination did increase in the lifetimes of
axon branches and thereby stabilize neuronal struc-
ture, but the increased stability was transient. Early in
the course of the 8-hour experiment, branches were
stabilized, but later in the experiment they were not.
We also observed a change in the distribution of
branch additions on the axon. The transient stabiliza-
tion of branches is best explained by a model in
which the probability of synaptic modifications
reflects two major variables: (1) the recent history of
electrical activity in the neuron and (2) the relative
strength of the synaptic stimulation. Early in the ex-
periment, the summed electrical activity in the
neuron is low and the relative strength of the input is
high, so many synapses and their branches are stabi-
lized. Later in the experiment, when the neurons have
experienced 6 hours of synchronized inputs, the
summed electrical activity of the neuron is higher.
Even though the strength of the inputs is the same,
their strength relative to the history of activity in the
neuron is now low. Consequently, synapses and bran-
ches are not stabilized. The ability to vary the
threshold for synaptic modifications could provide
the neuron control over the proportion of its contacts
which are stabilized.
Taken together, these studies indicate that synap-
tic activity can clearly modify neuronal structure.
Specifically, decreasing activity of the NMDA-type
receptor destabilizes the neuronal structure and can
cause a net growth, whereas increasing NMDA
receptor activity transiently stabilizes neuronal struc-
ture and decreases local sprouting in the axon.
Regulation of Neuronal
Growth by CaMKII
D.-J. Zou, I. Miloslayskaya, H. Cline
Traditionally, experiments probing the roles of
protein kinases have used pharmacological tools to
manipulate kinase activity. In previous experiments,
we have found that drugs that decreased protein
kinase activity in the entire optic tectum resulted in
modified growth of the retinal ganglion cell axons;
however, these experiments could not resolve be-
tween different calcium-sensitive protein kinases, nor
could we determine whether the result was due to
decreased kinase activity in the retinal axons, tectal
cells, or both.
To address both the problem of pharmacological
specificity and the need to alter kinase activity in ei-
ther the pre- or postsynaptic cell population, we have
used vaccinia virus as a vector to introduce the gene
for the constitutively active truncated calcium-
calmodulin kinase II (tCaMKII) into frog neurons. A
major advantage of vaccinia virus is that synthesis of
foreign proteins does not require insertion of the viral
genome into the host genome. Therefore, vaccinia
virus can be used to express foreign proteins in post-
mitotic neurons. Another essential feature of vaccinia
virus is that all synthesis of the viral proteins is
cytoplasmic and requires the host-cell protein
synthesis machinery. In the case of the visual system,
this means that the central nervous system can be in-
fected by injection of the virus into the brain
ventricle, but the retinal axons will not synthesize
foreign protein because they lack polyribosomes.
Finally, infections of Xenopus larvae with high-titer
virus result in intense expression of ectopic protein in
the majority of cells within the central nervous sys-
tem. Therefore, vaccinia virus can be used to express
ectopic protein specifically in tectal neurons without
expression in the presynaptic retinal ganglion cells.
We have used vaccinia virus to deliver tCaMKII
into tectal neurons. Truncated CaMKII, consisting of
amino acids 1-290, lacks the regulatory domain of
the protein and is constitutively active. Infection of
tectal neurons with tCaMKII alters the elaboration of
the retinal axon arbor, whereas infection with a con-
trol virus, carrying the gene for p-galactosidase (1-
gal) does not. In these experiments, single retinal
axons were imaged and then either the (3 -gal virus or
the virus containing the genes for (3 -gal and tCaMKII
(tCaMKII virus) was injected in the brain ventricle.
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Three days later, the same axon was found in the op-
tic tectum, and confocal optical sections were col-
lected through the axon.
Over a period of 3 days, retinal axons typically
increase their branch number and total branch length.
Axons from animals infected with the (3 -gal virus ((3-
gal axons) are comparable to untreated controls.
Axons whose postsynaptic partners express tCaMKII
(tCaMKII axons) show a significant decrease in
branch number, total branch length, and arbor com-
plexity during the same 3 days. Close examination of
the axon arbors reveals that there are relatively fewer
short branches in the tCaMKII axons, although some
axon branches have persisted and continued to extend
in length.
These data indicate that increasing CaMKII ac-
tivity in the postsynaptic tectal neurons decreases the
complexity of the presynaptic retinal axons. There
are two possible mechanisms by which tCaMKII in
tectal neurons might cause such a change in axonal
morphology. One is that CaMKII phosphorylation of
cytoskeletal proteins prevents the addition of new
branches to tectal neurons. The axons become sim-
pler because the tectal cells have failed to sprout as
many branches. Another possibility is that CaMKII
activity decreases the stability of some synapses and
causes the retraction of preexisting branches in both
tectal neurons and retinal axons. The tCaMKII axons
show a net loss of branch tips. This observation fa-
vors the hypothesis that some synapses are destabi-
lized and branches retract. Taking images at the 2-
hour intervals used in the experiments described
above will demonstrate whether the stability of
branches has changed in tCaMKII axons or whether
the rates of branch additions are decreased.
Regulation of Tectal
Cell Development
G.-Y. Wu, H. Cline
Studies on the factors controlling the morphological
development of tectal neurons have been limited by
the technical difficulty of reproducibly labeling
single tectal cells early in their process of differentia-
tion. We have found that iontophoresis of DiI is an
excellent method to visualize single tectal neurons in
the living animal. To study the development of tectal
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cell morphology, we labeled cells in the ventricular
layer of the optic tectum. Most of these cells have
completed their final round of cell division or divide
one more time before the progeny differentiate into
neurons. Individual DiI-labeled neurons are then
repeatedly imaged in vivo over a period of up to 4
days to observe the time course of the elaboration of
the axonal and dendritic arbors as well as the migra-
tion of the neuron from the ventricular layer into the
more mature layers of the tectum.
Cells that extend an axon out of the optic tectum
into either the spinal cord or thalamus typically ex-
hibit the following sequence of morphological devel-
opment: While still close to the ventricular layer, the
cell extends a large growth cone that grows toward
the pia, where it turns either rostrally or caudally and
heads rapidly toward the target region (thalamus or
spinal cord). Once the axon growth cone has reached
the pia and is heading out of the tectum, the dendrites
exhibit a burst of growth and rapidly become more
elaborate over the next few days.
These data suggest that dendritic outgrowth may
be controlled by contact of the axon with its target.
An accurate description of the normal processes of
neuronal growth in vivo will now serve as a com-
parison for future experimental studies on the cellular
events controlling axonal outgrowth and the elabora-
tion of dendrites. In particular, we have begun to ex-
amine the effect of tCaMKII expression on the devel-
opment of dendritic structure.
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THE BIOLOGY OF LEARNING
A. Silva R. Bourtchuladze K.P. Giese
B. Frenguelli Z. Marowitz
C.-M. Chen Z. Wang
The key difficulty in the study of learning and
memory is the integration of behavioral, anatomical,
and physiological information into a theory un-
restrained by disciplinary boundaries. Gene targeting
techniques provide the opportunity to study the im-
pact of the loss of specific genes in the biochemistry,
electrophysiology, anatomy, and behavior of mice.
Thus, our laboratory is studing the physiology and
behavior of mice that are mutant for genes expressed
in key forebrain structures, such as the hippocampus
and neocortex. The results of these studies suggest
that this approach might uncover the cellular pro-
cesses underlying learning and memory formation in
mammals. Summarized here are the key features of
the phenotypes of mutants studied in our laboratory.
aCAMKII CAN BOTH PROMOTE AND LIMIT
NEUROTRANSMITTER RELEASE
Previously, we found that a-calcium calmodulin
kinase II (aCaMKII) is required for long-term
potentiation in the CAl region of the hippocampus.
Recently, we have confirmed that this kinase also has
a crucial role in presynaptic plasticity. With field and
whole-cell studies, we have shown that paired-pulse
facilitation is blunted in the CAl region of mice
heterozygous for a targeted mutation of aCaMKII,
confirming earlier results with field recordings of
aCaMKII homozygotes and indicating that this
kinase can promote neurotransmitter release. Un-
expectedly, field and whole-cell recordings of post-
tetanic potentiation show that the synaptic responses
of mutants are larger than those of controls,
demonstrating that aCaMKII can also inhibit trans-
mitter release immediately after tetanic stimulation.
Thus, aCaMKII has the capacity to either potentiate
or depress excitatory synaptic transmission, depend-
ing on the pattern of presynaptic activation.
IMPAIRED LEARNING IN MICE WITH ABNORMAL
SHORT-TERM PLASTICITY
The loss of the aCaMKII in mice homozygous for a
targeted disruption of this kinase leads to a deficit in
LTP in the hippocampus (CAl) and to abnormalities
in presynaptic plasticity. Heterozygotes show similar
presynaptic abnormalities, but no LTP deficit in CAl.
To determine the impact of deficits of short-term
plasticity in learning and memory, we tested these
mutants in water maze tasks. In the visible-platform
test (hippocampus-independent), the performance of
the heterozygotes was indistinguishable from that of
controls. However, in the hidden-platform test
(hippocampus-dependent), the heterozygotes were
impaired after 3 days of training. In contrast to
homozygotes, the heterozygotes learn to find the plat-
form with an additional 2 days of training.
To extend these findings, we tested mice on an-
other task known to require hippocampal function:
contextual fear conditioning. After a single trial, the
controls, but not the heterozygotes, were able to show
contextual fear conditioning (40±5% and 6±4%,
respectively). However, the heterozygotes did show
conditioning to a discrete tone (43±5%), a behavior
that is known to be hippocampus-independent.
Similarly to the water maze, the heterozygotes
showed significant contextual conditioning (43±4%)
with extended training (five trials); homozygotes did
not. Our results show that despite impaired short-
term plasticity, heterozygotes have normal LTP
(CAl) and suggest that their deficits in hippocampal
short-term plasticity could underlie the behavioral
impairments detected in hippocampus-dependent
tasks. To further address this possibility, we looked at
another mutant (mice lacking Synapsin II).
MICE WITH A TARGETED MUTATION THAT
COMPLETELY ELIMINATES SYNAPSIN II HAVE
NORMAL LTP BUT DECREASED PTP AND SLOW
LEARNING
The results described above suggest that deficits in
short-term plasticity could affect learning. To further
address this hypothesis, we tested learning in another
mutant known to have normal LTP, but abnormal
short-term plasticity. The complete removal of
Synapsin II in Sy mice is known to have a very
specific effect in synaptic function: LTP, LTD, and
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PPF are normal, even though PTP is decreased.
Nevertheless, this mutant appears to groom, eat,
drink, walk, and mate normally. Our analysis indi-
cates that the Sy mutation does not affect
sensitivity to shock. Confirmation that the Sy II -/-
mutants have normal nociception was obtained with
the hot plate test (p > 0.1). A study of contextual con-
ditioning shows that similar to aCaMKII heterozy-
gotes, Sy IV"- mutants trained with a single 0.75-mA
shock (for 2 sec) show little or no contextual con-
ditioning (n = 14; 7±3%), whereas control littermates
express clear evidence of conditioning (n = 13;
34±7%; p < 0.002). Even though the Sy mutants
do not reveal any contextual conditioning, they can
be conditioned to a tone (CS) (51±8% vs. 30±4% for
controls and mutants, respectively). Just as with
aCaMKII heterozygotes, the Sy mutation seems
to affect mostly hippocampus-dependent learning,
since contextual, but not cued, conditioning is
hippocampus-dependent.
Next, we determined whether additional trials
could compensate for the fear conditioning deficits
shown by the Sy mutants. Another group of
mice was trained with five trials with 1 minute be-
tween trials. Similar to aCaMKII heterozygotes, Sy
mice (n = 10) showed nearly normal contextual
conditioning with additional training.
The evanescent nature of short-term plasticity ex-
cludes its involvement in memory storage. However,
electrophysiological and behavioral studies in in-
vertebrates suggest that short-lived changes in synap-
tic strength could function directly in adaptive
responses such as sensitization. Furthermore, elec-
trophysiological studies in the neuromuscular junc-
tion of Drosophila learning mutants detected altera-
tions in PTP. Recently, modeling work suggested that
short-term plasticity could endow networks with the
ability to make temporal discriminations, a property
essential for complex learning tasks. Our results
show that two mutations that affect presynaptic func-
tion also compromise learning, even though they do
not seem to disrupt LTP, and they suggest that short-
term plasticity could have a direct involvement in
learning.
THE cAMP RESPONSIVE ELEMENT BINDING PROTEIN
(CREB) IS REQUIRED FOR LTP AND FOR LONG-TERM
MEMORY
CREB is a factor that mediates transcriptional re-
sponses to changes in the intracellular concentration
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of cAMP and calcium. Interestingly, phosphorylation
of CREB at Ser-133 increases dramatically its ability
to promote transcription of CREB-containing genes.
CaMKII and PKA both phosphorylate CREB at this
site. Since studies in our laboratory had involved
CaMKII in learning, and in the induction of long-
term potentiation (LTP) in the hippocampus, we
determined whether CREB is involved in the
maintenance of LTP and in memory consolidation.
CREB has also been implicated in the activation of
protein synthesis required for long-term facilitation in
Aplysia and long-term memory in Drosophila. Our
studies with fear conditioning and with the water
maze show that mice with a targeted disruption of the
a and 8 isoforms of CREB are profoundly deficient
in long-term memory. In contrast, short-term
memory, lasting between 30 and 60 minutes, is
normal. Consistent with models claiming a role for
LTP in memory, LTP induced with a single tetanus in
hippocampal slices from CREB mutants decayed to
baseline 90 minutes after tetanic stimulation, even
though similar studies in controls revealed stable
LTP. However, paired-pulse facilitation and post-
tetanic potentiation are normal. These results impli-
cate CREB-dependent transcription in mammalian
long-term memory.
MUTATION OF THE NF1 GTPASE ACTIVATING PROTEIN
(NF1-GAP) GENE IN MICE AFFECTS BEHAVIOR AND
SYNAPTIC FUNCTION
Recent biochemical studies in our laboratory show
that aCaMKII can phosphorylate the NF1 GAP
(neurofibromin), a protein that when mutated causes
the genetic disorder known as neurofibromatosis type
I (NF1). NF1 is an autosomal dominant genetic dis-
order affecting 1/3500 humans. The manifestations of
this disorder are complex, but they have a clear im-
pact on tumorigenesis and on the function of the cen-
tral nervous system: In 30-50% of children affected,
the partial loss of the NF1 protein leads to cognitive
deficits and learning disabilities. The NF1 protein is
the most abundant GAP in the brain, and it is known
to be highly enriched in the cytoskeleton and in
dendritic endoplasmic reticulum of neurons.
We have studied a mouse with a targeted disrup-
tion of the NF1 gene. Similar to humans, the
homozygous mutation is lethal in mice. Strikingly,
heterozygous mutant mice have subtle but significant
"learning" deficits: Performance in the hidden-
platform version of the Morris water maze is im-
paired, whereas performance of the mutant mice in
the visible-platform version is indistinguishable from
that of controls. We also generated mice with
heterozygous mutations on NF1, and on the NMDA
receptor 1 (NMDAR1). The addition of the NF1
heterozygous mutation exacerbated significantly the
"learning" deficits of the NMDAR1 mutant mice. Ad-
ditionally, electrophysiological analysis showed that
the NF1 protein is involved in the modulation of
synaptic function. These data demonstrate that the
NF1 mutation affects brain function in mice, and they
strongly suggest that the mutant mice are an impor-
tant model for investigating the etiology of the
neurological disorders associated with NFl. These
studies suggest that this approach might be useful to
model neurogenetic disorders.
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REGULATION OF NEUROTRANSMITTER AND RECEPTOR
EXPRESSION AND ITS IMPLICATION IN NEURAL PLASTICITY
H. Nawa K. Mizuno
R. Lundsten
M. Waga
Neurons communicate with each other using a large
variety of neurotransmitters and neuropeptides.
Despite this enormous diversity, each functional
neural pathway can be recognized by the particular
set of transmitters, neuropeptides, and their receptors
employed. Clearly, this "chemical coding" of path-
ways is critical for determining neural function. The
long-term objective of our laboratory is to define the
molecular and cellular mechanisms that regulate the
synthesis and release of neurotransmitters and
neuropeptides as well as expression of their receptors
in the nervous system. In particular, we are interested
in effects of intercellular protein factors such as
cytokines and growth factors. The alteration in ex-
pression of neurotransmitters and receptors presum-
ably changes the mode of neurotransmission at each
synapse and consequently modulates neural functions
such as cognition and memory,
Our previous observations suggest the possibility
that many distinct, diffusible factors can influence
the development of neurotransmitter/peptide pheno-
type in the peripheral nervous system. Recently, we
found that such factors can also change expression of
neurotransmitters and receptors in the brain. For ex-
ample, brain-derived neurotrophic factor (BDNF),
which belongs to the nerve growth factor family (i.e.,
neurotrophin), increases expression of putative in-
hibitory neuropeptides and AMPA receptors in
forebrain neurons.
Conversely, activin, which is a member of TGF
family, suppresses the expression of AMPA recep-
tors. Our findings suggest that expression of
neurotransmitters and their receptors is positively and
negatively regulated in the brain by various diffusible
protein factors.
Our current efforts have been focused on three
projects: (1) characterization of neurotransmit-
ter/peptide differentiation activity of neurotrophins in
vivo, (2) physiological consequences of regulated
neurotransmitter production, and (3) identification of
novel factors that influence receptor expression.
These studies will elucidate how such diffusible
protein factors contribute to neural plasticity such as
learning and memory processes.
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Induction of Neuropeptide
Expression in Neonatal
Rat Brain by Neurotrophins
H. Nawa
We have shown that brain-derived neurotrophic fac-
tor (BDNF) specifically enhances and maintains the
expression of neuropeptide Y and somatostatin in
forebrain neurons both in vivo and in vitro. As an ex-
tension of this research, neuropeptide differentiation
activity was then compared among neurotrophins
both in vivo and in vitro. In cultured neocortical
neurons, BDNF and neurotrophin-5 (NT-5) remark-
ably increased levels of neuropeptide Y and somato-
statin, and neurotrophin-3 (NT-3) also increased
these peptides but required higher concentrations. At
elevating substance P, however, NT-3 was as potent
as BDNF. In contrast, NGF had negligible or no ef-
fect.
Neurotrophins administered into neonatal brain
exhibited slightly different potencies for increasing
these neuropeptides: The most marked increase in
neuropeptide Y levels was obtained in the neocortex
by NT-5, whereas that in the striatum and hip-
pocampus was obtained in the neocortex by BDNF,
although all three neurotrophins increased somato-
statin in similar degrees in all the brain regions exam-
ined. Overall spatial patterns of the neuropeptide in-
duction were similar among the neurotrophins:
Neurons in deep cortical layers responded to the
neurotrophins and initiated expression of neuropep-
tide Y and somatostatin, whereas substance P was in-
duced most prominently in superficial layers. These
observations suggest that all of the neurotrophins can
contribute to the complex patterning of neuropeptide
expression in the brain.
Regulation of Brain-derived
Neurotrophic Factor Protein
after Seizures
M. Waga, H. Nawa
Despite numerous previous studies on BDNF mRNA,
regulation of the production of BDNF protein has
been poorly understood because of a lack of its
quantitative measurement. Recently, we have estab-
lished an ultrasensitive enzyme immunoassay
(ELISA) for BDNF protein. The ELISA system
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enables us to measure trace amounts of BDNF
protein in tissues, cells, blood, and cerebrospinal
fluid. Using the ELISA system, we will address the
question of how BDNF protein production and secre-
tion are regulated by neuronal activity. BDNF con-
tent was measured in various brain regions of adult
rats. The highest concentration was found in the hip-
pocampus (200 ng/g tissue), in particular, dentate
gyrus (>800 ng/g). The BDNF level in the hip-
pocampus is more than a hundred times higher than
the NGF levels (2 ng/g tissue) reported. The result
suggests that BDNF is one of the most abundant
neurotrophic molecules in the brain. After hilus
lesion-induced limbic seizures, BDNF protein levels
increased rapidly in forebrain regions and reached the
maximum after 8-16 hours. In limbic structures,
BDNF concentrations remained elevated 4 days after
seizure onset, whereas BDNF mRNA is reported to
return to basal levels within 46 hours (Isackson et al.,
Neuron 6, 937 [1991]). The temporal and spatial dif-
ferences of the dynamics of protein and mRNA levels
suggest the importance of posttranslational and/or
subcellular processes for BDNF production. Per-
sistence of the increases in BDNF content was also
reflected in its biological activity, e.g., peptidergic
differentiation activity. After limbic seizures,
neuropeptide Y content was most markedly and per-
sistently elevated in the entorhinal/amygdaloid region
where the most sustained up-regulation of BDNF
protein was observed. These results suggest that the
sustained increase of BDNF protein in these limbic
structures is involved in prolonged post-seizure
phenomena including peptidergic alterations.
Influence of Neurotrophins
on Transmitter Secretion
from Striatal Neurons
K. Mizuno
Recently, we found that neurotrophins can enhance
development of GABAergic properties of the striatal
neurons both in vivo and in vitro. Among
neurotrophins, BDNF and NT-5 specifically elevated
cellular GABA content in striatal culture without
altering neuronal survival. In the next set of experi-
ments, we addressed the question of whether the in-
crease in GABA content results in elevation of
GABA release. GABA secretion was triggered by ap-
plication of high potassium to striatal cultures. The
amount of GABA released from BDNF-treated
neurons was three times higher than that from control
neurons. In contrast, levels of glutamate released
were not affected by BDNF treatment. The release of
GABA from cultured striatal neurons did not require
extracellular calcium ion, implying that the GABA
release might reflect an activity of GABA transport-
ers. However, blockers for the GABA transporters
failed to inhibit the GABA release triggered by potas-
sium. Moreover, the enhancement of GABA release
by BDNF was also reproduced by the administration
of glutamate instead of potassium. We are currently
investigating the molecular mechanism of the GABA
secretion.
Activin Inhibits Development
of Pyramidal Neurons
R. Lundsten, H. Nawa
Activin is a member of the transforming growth fac-
tor (TGF) family, which is now known to be involved
in germ-layer differentiation. We have examined the
effects of activin on immature neocortical neurons. In
cultured neocortical neurons prepared from rat em-
bryo, activin, but not TGF -)3, reduced protein levels
of a calmodulin-dependent kinase 2, AMPA receptor
(types I and II), and glutaminase, which are all ex-
pressed predominantly by pyramidal neurons in
neocortex. The data were also reproduced at mRNA
levels. These results suggest that activin might be a
negative regulator for development of cortical
pyramidal neurons. Expression of activin itself in the
neocortex is also regulated during development. The
highest expression of activin mRNA was found in
neonatal rats, and its level decreases sharply in a
postnatal period. This observation on activin produc-
tion is quite consistent with phenotypic development
of the neocortical neurons. Some of pyramidal
neurons are known to be born as early as embryonic
day 16, a week before birth of rats, although their
phenotypic development initiates only after birth.
Thus, activin might have a role in suppressing
phenotypic development until the postnatal period,
when all types of neocortical neurons are produced.
Currently, we are trying to identify the neurons that
have activin receptors.
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TRANSMISSION AND PLASTICITY IN MAMMALIAN
CENTRAL SYNAPSES
R. Malinow N. Dawkins D. Liao
B. Frenguelli M. Maletic-Savatic
H. Hinds A. Shirke
T. Koothan A. Weissmann
An understanding of learning and memory will re- to show glimpses of emergent properties and simple
quire analysis at several levels of complexity. Synap- enough to allow hard-nosed biophysical scrutiny. It is
tic transmission in rat brain slices is complex enough our philosophy that there exist key processes in this
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system whose understanding is possible and that such
an understanding will provide insight into phenom-
ena at higher levels of complexity.
We focus our efforts on understanding how fast
signals are propagated from one neuron to another
(synaptic transmission) and how the gain of such sig-
nals can be modulated (activity-dependent synaptic
plasticity). The skeleton of synaptic transmission in-
volves:
1. The invasion of a presynaptic terminal by an ac-
tion potential;
2. opening of presynaptic calcium channels and rise
in presynaptic calcium;
3. interaction of calcium with release machinery
producing release of transmitter; and
4. postsynaptic receptor binding of transmitter and
channel opening.
At each of these steps, there is the possibility for
modulation; thus, we wish to understand each step
completely.
Our first year at CSHL has been exhilarating.
Two students completed their Ph.D.s: Diana Pettit
(now as postdoc with G. Augustine and J. McNa-
mera, Duke University) and Neal Hessler (now post-
doc with A. Doupe, Keck Neuroscience Center,
UCSF). New arrivals were Bruno Frenguelli and
Marjana Maletic-Savatic as postdocs; Heather Hinds
as visiting Ph.D. student (from Harvard-MIT
M.D./Ph.D. program); and Adriana Weissmann as a
predoctoral student. We had two visiting scientists
working for short periods in the lab: John Lisman
from Brandeis the University and Osvaldo Uchitel
from the University of Buenos Aires.
What Is the Basis of the
Trial-to-Trial Variability
in Transmitter Release?
B. Frenguelli, R. Malinow
It has been known for some time that the release of
transmitter is a probabilistic phenomenon; i.e., from
trial to trial, there is great fluctuation in transmitter
release. We have previously provided evidence that
such fluctuation will have an impact on how informa-
tion is processed by a neuronal circuit (Otmakhov et
al., Neuron 10: 1101 [19931). Most investigators are
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expecting that the critical determinants of this fluc-
tuation are in step 3 above; hence, the intense interest
in synaptic vesicle-associated proteins. We have
asked if step 2 can be the basis for such fluctuations;
i.e., is the rise in presynaptic calcium produced by an
action potential always the same or does it vary from
trial to trial? Even small fluctuations in calcium could
be important because the release of transmitter
depends on the fourth power of calcium concentra-
tion.
We have addressed this issue by obtaining simul-
taneous patch-clamp and optical measurements from
cortical slice neurons. With such recordings, we as-
sess the role of the variability in calcium rise on
transmitter release. Presynaptic boutons on axon col-
laterals were visualized and rises in intracellular cal-
cium, assessed by Fura-2, were observed in response
to single-action potentials. Calcium responses
showed trial-to-trial variability and occasional fail-
ures despite the faithful conduction of the action
potential. These results suggest that a factor con-
tributing to the fluctuation in transmitter release is the
variability with which depolarization of a presynaptic
terminal produces an increase in intraterminal cal-
cium. Such a fluctuation may be due to the presence
of a small number of calcium channels in such struc-
tures, and the small probability that any calcium
channel will open with an action potential. It will be
interesting to determine if this fluctuation in calcium
rise can be modulated by activity or pharmacological
agents.
Monitoring the Release of
Transmitter at Individual
Synapses in Cultured
Neurons
M. Maletic-Savatic, R Malinow
We have begun to study the release of transmitter
(step 3 above) in cultured neurons with the dye FM-
143. This dye is applied in the bath and taken into
neurons by endocytosis. Excitation of nerve terminals
produces recycling of membrane (to replace the
released vesicles), and this dye becomes incorporated
into such vesicles. Monitoring (with digital-imaging
microscopy) the uptake of the dye indicates location
of synaptic sites. Monitoring the loss of dye upon
restimulation indicates active release process. With
this technique, we have asked a number of questions:
(1) With repeated stimulation, do the synaptic sites
remain at the same location? (2) Do the kinetics of
release change after repeated stimulation? One inter-
esting aspect of these cultured neurons is that (at the
age we study them) they completely lack expression
of calcium-calmodulin kinase II (CaMKII), an en-
zyme we have studied in the context of long-term
potentiation (LTP) (see below). We have confirmed
this with immunohistochemistry. These neurons are
thus effectively CaMKII knock-out tissue. With the
transfection methods we have developed (see below),
we can ask the question (3) Do these neurons behave
differently, with respect to those processes studied
with FM-143, if they express CaMKII?
"Silent" Synapses and LTP
D. Liao, R. Malinow
The synapses we study (which are similar to and
serve as a model for most excitatory synapses in the
vertebrate brain) use glutamate as the neurotransmit
ter and have two types of postsynaptic glutamate-
sensitive receptors: AMPA-type receptors and
NMDA-type receptors. These receptors differ in their
activation properties as well as their permeation
(what they allow to pass into the cell once activated).
AMPA-type receptors need only glutamate to open,
and NMDA-type receptors require both glutamate
and membrane depolarization. The AMPA-type re-
ceptor allows Na+ and K+ to pass, whereas the
NMDA-type receptor also allows ca++ to enter the
cell. This year, we found direct evidence that a large
fraction of the synapses we study have only NMDA-
type receptors. These synapses will thus be silent
(even if transmitter is released) when the postsynaptic
cell is at resting membrane potential (most of the
time), because the postsynaptic receptors will not
open if only transmitter is released. We have reached
this conclusion by looking at failure rates during
transmission elicited when the postsynaptic cell is
held at hyperpolarized and depolarized potentials. If
there were AMPA-type receptors at all synapses, the
failure rates should be the same; we find twice as
many failures at hyperpolarized potentials. This dif-
ference is not present if NMDA-type receptors are
blocked. This and several other pieces of evidence in-
dicate that there are many (in fact, more) synapses
with only NMDA receptors.
The classical interpretation of a synaptic failure
has been that such an event is due to the failure of
transmitter to be released. A change in failure rates
after long-term potentiation of synaptic transmission
(LTP) has been the strongest evidence indicating that
a presynaptic modification has occurred during LTP.
This evidence has to be re-interpreted in light of what
we have found: Release of transmitter at pure NMDA
synapses will be observed as synaptic failures. Spe-
cifically, we have tested the hypothesis that pure
NMDA synapses add AMPA receptors during LTP.
This process would be seen as a change in synap-
tic failures (at hyperpolarized potentials, which had
been the only conditions studied previously). We
have three independent pieces of electrophysiological
evidence supporting such a model. We would now
like to find biochemical, cell biological, and/or im-
munocytological evidence for such a process.
These results have led to a specific hypothesis of
synapse formation and modulation of gain by LTP:
We predict that initial synapses form with only
NMDA receptors. These synapses will transmit in-
formation only if coactive with other synapses (that
have AMPA receptors). LTP induction involves
repetitive coactivity producing calcium entry through
NMDA receptors and calcium accumulation trigger-
ing CaMKII activation. Such activity will promote
incorporation of AMPA receptors to the synapse,
possibly by a postsynaptic exocytotic process.
Use of Recombinant
Viruses to Elucidate
Mechanisms in LTP
T. Koothan, H. Hinds, R. Malinow
This year, we published the first successful use of a
recombinant virus to modify synaptic transmission.
We generated a recombinant vaccinia virus that pro-
duces a protein of interest driven by a strong
synthetic vaccinia promoter. Micro-application of
this virus into brain slices produces efficient expres-
sion in cells of a restricted region within several
hours. We have used this technique to show that ex-
pression of a constitutively active form of CaMKII in
postsynaptic neurons can mimic and occlude LTP.
We have begun to look with immunocytochem-
istry at the cellular localization of recombinant pro-
ducts and to determine conditions that allow expres-
sion of recombinant products in cultured neurons. We
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are preparing to determine if expression of CaMKII
in slices from mice lacking this enzyme can rescue
LTP.
We are making viruses that produce an AMPA
receptor-GFP fusion protein. This protein shows
normal receptor function but can be monitored by the
fluorescent GFP protein. We want to see if an LTP-
producing protocol will cause such a protein to move
from intracellular to plasma membrane sites. This can
be monitored in cultured neurons.
Does Injection of Active CaMKII
into Postsynaptic Neurons
Mimic LTP?
A. Shirke, R. Malinow
We are developing a method to inject with a record-
ing micropipette active CaMKII enzyme into a
neuron. With such a protocol, it is possible to com-
pare directly transmission before and after inclusion
of this enzyme into the postsynaptic cell. We have
preliminary evidence that injection of this enzyme (1)
increases transmission and (2) decreases synaptic
failures.
It will be interesting to determine if the decrease
in failures is due to the activation of AMPA receptors
at synapses with only NMDA receptors. If so, will
drugs that prevent exocytosis (various well-character-
ized neurotoxins) prevent this decrease in failures if
co-injected with the active CaMKII in the postsynap-
tic cell? Such a result would indicate that a post-
synaptic exocytotic process is necessary for active
CaMKII to mimic LTP.
Chimeric Constructs to
Study Role of CaMKII in
Neuronal Function
A. Weissmann, R. Malinow [in collaboration with
G. Enikolopov, Cold Spring Harbor Laboratory]
Chimeric proteins containing steroid-binding do-
mains and protein kinase catalytic domains are being
designed. We are making a virus that will generate
such a construct. It is expected that the resulting
protein will only show catalytic activity in the
presence of the hormone. In this manner, we should
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be able to express this construct in neurons and ac-
tivate the kinase by exogenous application of the
hormone. The activation should occur quickly (within
minutes). This will allow localized activation (e.g.,
localized dendritic or cell body application of the
hormone with a pipette) to determine the region of
the cell that requires kinase activity to produce ef-
fects on synaptic transmission.
Monitoring Activity of
Single Synapses in
Brain Slices
R. Malinow [in collaboration with J. Lisman,
Brandeis University]
This year, we published results in which we resolve
activity at single synapses in brain slices using digital
fluorescence microscopy. This has allowed us to
show that some synapses only transmit when ac-
tivated in a repetitive manner. Such resolution may
be required to unravel the pre- or postsynaptic modi-
fication underlying LTP.
In conclusion, we are continuing
basic mechanisms involved in central synaptic trans-
mission. Such an understanding is necessary to derive
a mechanistic flowchart of plastic processes. We also
continue to probe the role of CaMKII in synaptic
plasticity.
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SIGNAL TRANSDUCTION IN NEURONS
G. Enikolopov N. Peunova
P. Krasnov
S. John
We study signal transduction in neurons and are in-
terested in how neuronal activity and neuronal devel-
opment are linked. Recently, we have shown that a
gaseous messenger molecule, nitric oxide (NO), may
provide such a link. We have found a crucial role for
NOS genes in the commitment cascade during
neuronal differentiation. We now see a potential for
NO to act as a trigger of growth arrest during termi-
nal differentiation in other systems as well. Experi-
ments are now being carried out to investigate the
role of NO as an important switch during develop-
ment of neuronal cells in culture, brain development
in Xenopus (in collaboration with H. Cline, CSHL),
Drosophila development (with B. Kuzin, Moscow,
Russia), and terminal differentiation in mammals.
NO Triggers a Switch to Growth
Arrest during Differentiation of
Neuronal Cells and Couples
It with Prevention of Apoptosis
N. Peunova, G. Enikolopov
Arrest of cell division is a prerequisite for cells to en-
ter a program of terminal differentiation. Differentia-
tion of neuronal cells induced by nerve growth factor
(NGF) involves a proliferative phase that is followed
by cytostasis and, ultimately, by manifestation of the
fully differentiated phenotype. We have found that
NO executes a critical step in differentiation by in-
itiating cytostasis. We have found that:
NGF treatment induces NOS activity. All three
forms of NOS are induced in fully differentiated
PC12 cells, but at the first stages, a substantial part
of the NO-producing activity comes from an in-
ducible form of the enzyme.
NO can inhibit proliferation of PC12 cells. Both
DNA synthesis and cell proliferation are restored
once NO sources are washed away. At low con-
centration, NO causes the cells to accumulate spe-
cifically in G2 phase while the proportion of cells
in S phase decreases. Remarkably, within a range
of concentrations of NO donors, the proportion of
PC12 cells in G2 and S phases are similar to the
levels reached after prolonged treatment with
NGF.
NOS inhibitor reverses the cytostatic action of
NGF and forces the cells to continue to proliferate
instead of ceasing to divide after 6-8 days of NGF
treatment. Neurite outgrowth, the principal mani-
festation of the differentiated phenotype, is also
prevented by NOS inhibition.
Mutant cells' capacity to differentiate can be
rescued by addition of NO. PC12-U2 cells (de-
scribed by Burstein and Greene) retain the early
steps of the response to NGF but have lost the ca-
pacity to execute the later steps. They do not stop
dividing after NGF treatment and, as a con-
sequence, do not develop the fully differentiated
phenotype; in particular, they do not send out pro-
cesses. We have shown that this phenotype can be
overcome by the addition of NO. Neither NGF nor
NO alone had any effect on the phenotype of U2
cells, but in combination, these treatments restored
the differentiated neuronal phenotype. Inducible
NOS is expressed at much lower levels in U2 cells
than in the wild-type PC12 cells. Thus, NGF-
treated U2 cells are deficient in inducible NOS and
this defect can be rescued by NO.
The crucial phase of NOS action is cell-cycle-
specific, and a critical time window for NOS ac-
tion exists within the first 2-3 days of NGF treat-
ment.
These experiments indicate a causative role for
NO action in NGF-induced growth arrest and differ-
entiation in PC12 cells. We conclude that induction
of NOS is an important step in the commitment of
neuronal precursors during differentiation and that
NOS serves as a growth arrest gene, initiating the
switch to cytostasis during differentiation. We
propose that NO produced by a group of adjacent
neuronal precursors may contribute to the syn-
chronized development of that domain.
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What is the target of NO action during differentia-
tion? Guanylate cyclase is among several potential
effectors for NO. It can be directly activated by NO
and thus NGF/NO-induced growth arrest can be
mediated by cGMP- or cAMP-dependent kinases.
Our data indicate that NO-mediated changes in the
activity of cyclic-nucleotide-dependent protein ki-
nases accompany the NGF action and are critical for
the cessation of growth. Another direct target for NO
is ribonucleotide reductase (RNR), the rate-limiting
enzyme in deoxynucleotide biosynthesis. We have
now shown that addition of deoxynucleosides (which
permits the bypass of the RNR step by employing a
salvage nucleotide biosynthesis pathway) leads to a
partial release of the NO-induced block in DNA
synthesis in PC12 cells. Inhibition of RNR, beyond
preventing DNA synthesis directly by limiting the
supply of nucleotides, possibly also serves as a
sensor, transmitting the signal further and activating
other growth-arrest/checkpoint systems.
An intriguing question is whether antiproliferative
NOS action cooperates with other growth arrest sys-
tems in the differentiating cell. Growth arrest systems
supporting NOS could act in parallel with NOS ac-
tion (although blockade of NOS activity alone can
reverse the constraining action of NGF) or con-
sequent to it, for instance, by inducing other growth
arrest genes, such as TGF-I3, Rb, and cdk inhibitors,
possibly as a direct consequence of NO synthesis. We
are currently testing these possibilities.
Finally, we have found that NO can prevent cells
from apoptosis. It can both suppress the apoptosis of
undifferentiated PC12 cells after withdrawal of serum
and prevent the differentiated cells from death after
withdrawal of NGF. Establishment of the fully differ-
entiated state of PC12 cells after NGF treatment is
accompanied by a switch in NOS gene expression,
with expression of the inducible form going down
and expression of the neuronal isoform going up. We
propose that this switch from the calcium-inde-
pendent to the calcium-dependent form may underlie
the dual role for NOS as a trigger of cytostasis and as
an inhibitor of apoptosis during differentiation.
Targeting Proteins to
the Nerve Terminals
P. Krasnov, J. Chubb, G. Enikolopov
We want to restrict signal transduction cascades in
the nerve cell to the terminals. This way, we may be
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able to manipulate the signaling in the nerve termi-
nals, including synapses, without affecting the pro-
cesses in the nucleus and in the cell soma. One ap-
proach is to target the molecules that participate in or
interfere with signal transduction to the nerve termi-
nals as part of chimeric protein vectors.
We tested several synaptic vesicle proteins for this
purpose by fusing them to the HA epitope tag, trans-
fecting them into differentiated PC12 cells, and
visualizing the distribution of the chimeric molecules
by immunofluorescence. We found one form (rat
synaptotagmin II-HA fusion) that permits efficient
accumulation of the recombinant molecules in the
terminals, with some material being present in the
Golgi network.
We prepared an extensive series of deletions
covering the entire coding region of the synaptotag-
min gene, fused them with the HA epitope, and tested
each mutant after transfection of PC12 cells by West-
ern blot analysis and immunofluorescence. We were
thus able to visualize the distribution of chimeric
molecules in the cell and confirm that different
mutant proteins are of predicted lengths and are
synthesized at comparable levels. We have shown
that the transport to the nerve terminal is dependent
on two structural determinants. One signal, located
near the transmembrane domain and the dimerization
domain, is responsible for the accumulation of the
recombinant molecules in the Golgi network. The
other signal is located near the carboxyl terminus and
is responsible for the actual transport (and/or ac-
cumulation) of the molecule to the nerve terminal.
This second signal overlaps with the region of
neurexin binding, which in turn might determine the
location of the synaptotagmin molecules (and, proba-
bly the whole synaptic vesicle) near the voltage-gated
calcium channels.
We have thus determined which parts of the
synaptotagmin molecules are necessary for transport
to the terminal. Currently, we are trying to determine
if the same short sequences are also sufficient for the
targeted transport of the chimeric molecules to the
terminal. Our next step is to use these novel targeting
vectors to transport protein kinases and recombinant
protein kinase inhibitors to the terminals of neuronal
cells for the of neuronal plasticity.
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NEURONAL GROWTH AND DIFFERENTIATION
D.R. Marshak Y.S. Bae L. Pena
G.Y. Cha P. Recksiek
N. Chester S. Srinivasan
This laboratory conducts research on the biochemical
basis of neuronal growth and differentiation. Overall,
the questions that we approach in our research in-
volve the decisions of neuroblasts to cease prolifera-
tion and to subsequently elaborate neuritic processes
prior to terminal differentiation. These questions thus
involve understanding how signal transduction sys-
tems that control cell proliferation in the neuroblast
are altered upon becoming post-mitotic as well as
learning which growth factor molecules control these
switches within cells. Specifically, we are interested
in the action of a growth-stimulating protein, sloop,
that is produced by astrocytes in the brain. The me-
chanism of action of S10013 is compared to that of
other growth factors, such as those in the family of
neurotrophins or the family of heparin-binding
(fibroblast) growth factors. The involvement of such
neurotrophic factors in degenerative diseases, such as
Alzheimer's disease, has prompted our interest in the
role of such factors in neuropathological processes.
Mechanism of Action
of S10013
L. Pena, S. SrivaSan, D.R. Marshak [in collaboration with
N. Arispe, National Institutes of Health]
We have been studying the S100[1 protein in the con-
text of a typical growth factor that binds to a cell sur-
face receptor, which in turns triggers a Ca-+-
dependent intracellular second messenger cascade
mediated by protein kinases. Although there remains
some support for this model, our accumulated data
have led us to adopt a different model.
S10013 appears to have direct effects on the ion
permeability of cell membranes. In our bioassays, (1)
a 7ED chick neurite assay and (2) a glial cell
proliferation assay, divalent cations such as Ca++ are
required for 510013 action. This is demonstrated by
the ability of 1 mm Ni'' to block the S10013 effect.
By itself, this finding could support either the recep-
tor model or the direct membrane permeability
model. However, we have data from a cell-free,
synthetic lipid bilayer system that supports the latter.
In this system, S10013 is delivered to a planar lipid
bilayer interposed between two chambers fitted with
recording electrodes (Fig. 1). The potential across the
lipid bilayer was held at +40 mV, with symmetrical
baths of 100 mm KCl /1 mm CaC12 on each side of the
lipid bilayer. The tracing shows on/off current flow
typical of an S10013 ion pore. For comparison with a
classical ion channel, the conductance was estimated
to be three times that of a typical Na+ channel, and
the pore could remain open for unusually long peri-
ods of time. Since S10013 shows no sequence
similarity to classical ion channels and exhibits dif-
ferent behavior, we provisionally refer to it as an ion
"pore" rather than an ion "channel."
We have initiated a mutational analysis of the
S10013 protein to better understand the structure that
permits the formation of the S10013 ion pores. In ad-
dition to the two bioassays described above, the
synthetic lipid bilayer system is now the basis of a
new, third assay to study S100f3 function. In these as-
says, we can study the effects of strategically placed
mutations in sloop protein. The mutations are
designed with the aid of a three-dimensional struc-
tural model (developed by Jim Pflugrath, formerly of
CSHL) patterned after the known structure of
ICABP, a member of the superfamily of S100 pro-
teins.
Distribution of S10013 in
Neurological Disease
D.R. Marshak [in collaboration with W.S.T. Griffin,
Arkansas Children's Hospital]
Under the auspices of a major grant from the Nation-
al Institute on Aging, we are continuing our studies
of the brain distribution of S10013, a polypeptide
growth factor produced by glial cells in the brain.
This is a multisite program grant that brings together
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FIGURE 1 Current flow tracing for the S1000 ion pore in an artificial planar lipid
bilayer.
anatomists, pharmacologists, pathologists, molecular
biologists, and biochemists who work on S100(3.
Several years ago, our lab discovered the function of
this molecule and have more recently discovered its
abnormal levels in Alzheimer's disease. This work is
central to understanding the potential role of this fac-
tor in the pathology of neurodegenerative disease.
This year, in collaboration with W.S.T. Griffin and
colleagues in Arkansas, we found reactive glial cells
containing abnormal amounts of the S10013 protein in
the brains of HIV patients who showed symptoms of
dementia in the clinic. This broadens our understand-
ing of the widespread appearance of astrogliosis in
neurodegeneration. The observation strengthens the
argument that abnormal glia containing 5100f3 are as-
sociated with amyloid plaques in the brain.
Regulation of S1000 by
p-Amyloid
L. Pena, S. Srinivasan, D.R. Marshak
In Alzheimer's disease and Down syndrome, severely
afflicted brain regions exhibit up to 20-fold higher
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protein levels of 510013, and astrocytes surrounding
neuritic plaques exhibit higher protein levels of
sloop. A major constituent of the plaques is 13-
amyloid protein, which has been reported to have
both neurotrophic and neurotoxic effects in vitro. We
examined the responses of central nervous system
glia to a 3- amyloid peptide. Primary astrocyte cul-
tures, obtained from neonatal rats, and rat C6 glioma
cells were synchronized by serum deprivation and
treated with (3A(1-40), a synthetic fragment of (3-
amyloid. A weak mitogenic activity was observed, as
measured by [3H]thymidine incorporation. Northern
blot analysis revealed increases in 510013 mRNA
within 24 hours in a dose-dependent manner. Nuclear
run-off transcription assays showed that I3A(1-40)
specificially induced new synthesis of S10013 mRNA
in cells maintained in serum but caused a general
elevation of several mRNA species in cells main-
tained under serum-free conditions. At the protein
level, corresponding increases in S100[3 protein
synthesis were observed in response to the r3A(1-40)
peptide, measured by immunoprecipitation of 35S-
labeled cellular proteins. The data indicate that
S100(3 expression can be influenced directly by (3-
amyloid.
Protein Kinase Modulation
during Neuronal Differentiation
Y.S. Bae, L. Pena, D.R. Marshak
We have continued our studies of protein kinase
responses to growth factors in neuronal cells. Two
model systems are currently in use: chicken embryo
neurons stimulated with S10013 and rat pheochro-
mocytoma (PC12) cells stimulated with nerve growth
factor (NGF) or epidermal growth factor. A complete
study of p34"1°2 kinase and MAP kinases in PC12
cells that respond to NGF has been continued by Y.S.
Bae in conjunction with the work of a former post-
doctoral fellow, A. Rossomando. The rat pheochro-
mocytoma cell line, PC12, undergoes morphological
and biochemical differentiation into sympathetic
neurons in culture under the influence of NGF. The
enzyme p34cdc2 kinase, which is critical to the induc-
tion of mitosis, appears to be down-regulated during
NGF-stimulated differentiation. The previously iden-
tified p46 protein seems to be a form of MAP kinase
in these cells. This protein kinase is known to be
stimulated indirectly by growth factor receptor
tyrosine kinases and associated molecules. These
studies will enable us to work out pathways of signal-
ing from the surface of the neuron to the genome.
Our earlier work has demonstrated that the protein
kinase CKII is modulated during neuronal develop-
ment (Diaz-Nido et al. 1994). This reinforces our
studies of the regulation of CKII in human cells (II.
Yu et al., submitted) and that it varies during the cell
division cycle as cdc2 activity increased. In a related
paper (Suzuki et al. 1994), we demonstrated that the
amyloid precursor protein (APP), which gives rise to
the pathological form of (3- amyloid, is itself
phosphorylated by cdc2 in a cell-cycle-dependent
manner. These observations point out the inter-
relationships of the cell-cycle-dependent protein
kinases and their alterations in neurological diseases.
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CSH LABORATORY JUNIOR FELLOWS
In 1986, Cold Spring Harbor Laboratory began a Junior Fellow program to encourage independent
research by outstanding young scientists who, during their graduate studies, displayed exceptional
promise of becoming leading scientists of the future. The purpose of this program is to provide an
opportunity for each Fellow to work independently at the Laboratory for a period of up to 3 years on
projects of their choice. The Fellow is provided with a salary, research support, and technical as-
sistance so that they can accomplish their goals free from other distractions. The interaction among
research groups at the Laboratory and the program of courses and meetings on diverse topics in
molecular biology contribute to a research environment that is ideal for innovative science by these
Fellows.
Three previous Cold Spring Harbor Fellows, Dr. Adrian Krainer (1987), Dr. Carol Greider (1988),
and Dr. Eric Richards (1989), are currently members of the scientific staff at the Laboratory. Dr.
David Barford, our Junior Fellow since 1991, left this year to go to Oxford University (Laboratory of
Molecular Biophysics) as a university lecturer. Our newest Fellow, Dr. Ueli Grossniklaus, joins us
from the Department of Cell Biology, University of Basel, Switzerland.
U. Grossniklaus
Dissection of Arabidopsis
Ovule Development by
Enhancer Detection
U. Grossniklaus, J. Moore, W. Gagliano
The plant life cycle is divided into two generations:
the diploid sporophyte and the haploid gametophyte.
Whereas in lower plants (e.g., mosses and ferns), the
two generations are distinct from each other, tissues
of both generations contribute to the ovule in flower-
ing plants. The ovule is the site of megasporogenesis
and megagametogenesis, the processes that lead to
the formation of the mature embryo sac containing
the egg cell. Whereas the mechanisms controlling
oocyte development in animals are being studied ex-
tensively at the cellular, genetic, and molecular
levels, very little is known about the genetic and
molecular basis of the corresponding process in flow-
ering plants. Only five mutants affecting ovule devel-
opment have been reported in Arabidopsis thaliana:
Two affect the gametophyte (Redei, Genetics 51: 857
[1965]; Springer et al., Science, in press [1995], see
Plant Genetics Section of this Annual Report), and
the remaining three affect primarily sporophytic parts
of the ovule (for review, see Reiser and Fisher, Plant
Cell 5: 1291 [1993]).
Within the ovule primordium, a single cell un-
dergoes meiosis, three of the haploid megaspores die
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and the fourth produces the mature embryo sac by
three subsequent mitotic divisions. These eight pro-
ducts differentiate along four alternative developmen-
tal pathways to become an oocyte, two synergids,
three antipodals, or the binucleate central cell whose
two nuclei fuse prior to fertilization (Fig. 1). Follow-
ing fertilization of both the oocyte and the central
cell, the ovule differentiates into a seed. The seven
sister cells of the embryo sac are highly specialized.
It is likely that the development of each cell type is
significantly influenced by its position within the em-
bryo sac and by cell-cell communication. Proper de-
velopment of the gametophyte appears to depend on
interactions between gametophytic and sporophytic
tissues of the ovule.
The goal of our research is the identification of
genes that are important for the development of the
gametophyte and the sporophytic parts of the ovule.
We hope to isolate and characterize some of the
genes involved in cell specification of the embryo sac
cells and of genes that are important for cellular com-
munication processes between sporophytic and game-
tophytic tissues.
ENHANCER DETECTION/GENE TRAP SCREEN
In Drosophila, enhancer detection screens have been
very successful in identifying new developmentally
regulated genes. Application of a similar approach in
AFIGURE 1 Ovule development in Arabidopsis thaliana. (A) Schematic representation of a mature ovule. The haploid embryo
sac or gametophyte is embedded within the diploid sporophyte: The outer and inner integuments consisting of two cell layers
each and the innermost endothelial cell layer. The gametophyte is a highly polar structure with three antipodals at the
chalazal end and the egg apparatus consisting of the oocyte and two synergids at the micropylar pole. The two nuclei of the
large central cell are in proximity of the oocyte. (V) Vacuole. (8) Ovule primordia (op) in a carpel of a stage-9 flower. (C) Ovule
of a stage-11 flower. A single cell in the nucellus has differentiated into the megasporocyte (MS) which will give rise to four
megaspores. (D) Two-nucleate embryo sac (ES) derived from the surviving megaspore through mitotic division. (E) Mature
ovule with the gametophyte in the center. The nuclei of the central cell (cc) and oocyte (o) are in the focal plane at the micro-
pylar end of the ovule. (F) Carpel of a transposant with specific staining in the ovules (ov). The carpel wall has been removed
prior to staining. Bars, 20 mm.
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flowering plants should lead to the identification of
many genes that control ovule development and
gametogenesis. The enhancer detection technique
(O'Kane and Gehring, Proc. Natl. Acad. Sci. 84:
9123 [1987]) relies on a transposon carrying a
reporter gene under the control of a weak constitutive
promoter. If this promoter comes under the control of
nearby genomic regulatory elements (e.g., enhan-
cers), the reporter gene is expressed in a specific spa-
tial and temporal pattern that reflects the action of
these elements. Reporter gene expression thereby in-
dicates the activity of a gene that is usually regulated
by these enhancers. A modification of this approach
involves the generation of transcriptional fusions to a
reporter gene (gene trap). Both approaches have been
extremely successful, also allowing the identification
of genes that are not easily amenable to classical ge-
netic analyses. They have been especially useful in
studying developmental processes occurring late in
development, i.e., after the effective lethal phase of a
corresponding mutation, and in processes character-
ized by high complexity and redundancy.
The plant group here at the Laboratory has gener-
ated a series of enhancer detector and gene trap con-
structs. They are based on the Ac /Ds transposable ele-
ment system from maize which also functions in
Arabidopsis. For detailed description of the system,
see Plant Genetics Section of this Annual Report. In
brief, a Ds element acting as an enhancer detector or
gene trap transposon can be mobilized by crossing a
Ds-containing line to a line bearing an immobile Ac
element producing transposase. Self-pollination of
these Ft plants will result in some F2 progeny con-
taining a transposed Ds element (transposants). A
positive/negative selection system allows the identi-
fication of the plants that contain a Ds element at a
new location by selecting for the transposed Ds ele-
ment but against the donor element and the
transposase source. The enhancer detector/gene trap
mutagenesis system is a new means of creating ran-
dom insertions in the Arabidopsis genome. An inser-
tion in or close to a gene of interest (as defined by its
expression pattern and/or mutant phenotype) provides
an entry point to both its molecular and genetic char-
acterization.
A large-scale systematic screen for enhancer
detector/gene trap insertions showing specific expres-
sion patterns in the Arabidopsis ovule and/or mutant
phenotypes (female sterility and semisterility) is like-
ly to lead to the identification of genes involved in
ovule development. Our goal is to generate 4000
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transposants. In collaboration with the other plant
groups here at the Laboratory, we should have a col-
lection of approximately 15,000 independent trans-
posants within 1-2 years. This will provide sufficient
material for a large-scale screen, although it is far
from saturation level. I am interested in insertions
that show reporter gene expression in specific cell
types or spatially restricted domains of the ovule. At
present, virtually nothing is known about the genetic
control of cell fate decisions that govern embryo sac
cell development. Genes expressed in only one cell
type or in a subset of cell types within the embryo sac
should provide a basis for studying the process of cell
specification. Patterns specific to a subset of sporo-
phytic cells may be involved in cell-cell communica-
tion processes, and the corresponding gene products
may provide the developing gametophyte with posi-
tional cues that direct embryo sac cells to a particular
developmental pathway.
During the last year, we have focused our efforts
on the large-scale production of transposants. On
average, one of four F2 families yields a transposant
(750 seeds per family are screened). Thus, to isolate
4000 transposants, 16,000 Ft plants must be grown
and their F2 seeds put through the positive/negative
selection process. Our progress is summarized in
Table 1. I have generated between 20,000 and 25,000
Ft seeds in more than 1,000 crosses. Three different
enhancer detector (DsE) and three gene trap (DsG)
starter lines were crossed to five Ac lines (Ac). In
general, the different combinations yielded similar
frequencies of transposition to unlinked sites that
were distributed around 25%. There are two excep-
tions: First, the DsG1 element gives a higher
transposition frequency than the other elements
(30%). This may be due to a favorable chromosomal
location of this element. Second, the combination of
TABLE 1 Present Status of Enhancer/Gene Trap Screen
F1 seeds generated 20,000
F2 families harvested 10,116
F2 families screened for transposants 6,471
Transposants isolated 1,482
F3 families screened for steriles 0 plants) 574
Male-sterile mutations recovered 9
Female-sterile mutations recovered 1
F2 plants screened for semisteriles 1,481
Semisterile candidates identified 30
Heritable semisteriles 9
Possibly tagged semisterile mutants 3
DsE2 with Ac3 gave a very low transposition fre-
quency (13%), suggesting that these two elements are
located relatively closely linked on the same
chromosome. We have grown 10,000 F, plants to
maturity and harvested their F2 seeds. So far, we have
screened about 6,500 F2 families for transposants.
The screening of F2 families is currently proceeding
at a steady rate of 300 families per week, and we
recover between 70 and 80 transposants every week.
IDENTIFICATION OF MUTANTS AFFECTING OVULE
DEVELOPMENT
Two classes of mutations are of primary interest to
us. Female sterile mutations are likely to have defects
in the diploid sporophytic tissue of the ovule and are
typically recessive. The second class of mutations are
semisteriles that result from female gametophyte
lethality. In such mutants, the defective allele is not
transmitted through the haploid female gametophyte
and their progeny are therefore heterozygous for the
mutation. Half of the gametophytes will receive the
mutant allele and abort, leading to only 50% seed
production. The transposants we isolate during the
selection process (F2 plants) can be either homozy-
gous or heterozygous for the Ds insertion. We can
screen these plants for semisteriles but not for
steriles. A screen for sterile mutations must be per-
formed in the F3 generation where one of four plants
should show the mutant phenotype.
In collaboration with the other plant groups partic-
ipating in the enhancer detection/gene trap effort, we
have planted 1036 F3 families whereof we contrib-
uted 350 lines. We aimed at growing approximately
12-15 plants per family; 574 of the F3 families had
10 or more plants (corresponding to a 95% con-
fidence level that a recessive mutation would be
detected). Among them, we identified 9 sterile muta-
tions producing no seed and showing an extended
flowering period. All of them were reciprocally
crossed to wild-type plants to determine whether they
were male- or female-sterile. All nine mutations were
male-sterile and one line was both male- and female-
sterile. Examination of the carpels of this mutant
showed that it had no ovules at all. In addition, the
mutant had other defects such as missing stamens
( -male sterility), altered organ numbers, in-
florescence, and leaf abnormalities.
We have screened approximately 1500 F2 plants
for reduced seed production and have identified 30
putative semisterile mutants. Since growth conditions
greatly influence seed set, many plants that are not
mutant produce a reduced number of seeds. There-
fore, the putative mutants are checked for segregation
of the kanamycin resistance marker which is linked
to the Ds element that presumably causes the muta-
tion. A female gametophyte lethal mutation with
normal transmission through the male gametophyte
should yield a 1:1 segregation of kanamycin-sensitive
to -resistant seedlings. We have tested the putative
semisterile mutations and three of them behaved as
expected, indicating that the mutation may be caused
by the Ds insertion. They are currently being recipro-
cally outcrossed to wild type to determine to which
degree transmission through the female and male
gametophyte is reduced.
SCREEN FOR EXPRESSION PATTERNS
We invested considerable effort into optimizing the
staining procedures to detect the p-glucuronidase ac-
tivity of the reporter gene. We tested numerous fixa-
tion methods, different staining conditions, postfixa-
tion, and clearing procedures. Unfortunately, 13-
glucuronidase is very sensitive to these treatments,
and we could not find a condition allowing optimal
activity and a high degree of product localization at
the same time. We decided to use conditions yielding
the highest activity in order not to miss any weak ex-
pression patterns. Transposants staining in ovules can
then be restained under conditions giving better cel-
lular localization. We dissected carpels containing
mature ovules of four plants from each of the 1000 F3
families that were planted. The removal of the thick
carpel wall allows the ovules to be directly exposed
to the staining solution. We also stained entire in-
florescences of these plants, allowing the analysis of
the expression pattern at various stages of ovule de-
velopment. This material is currently being analyzed
for ovule-specific expression patterns. The most
severe problem we encountered was that the blue
product of the enzymatic reaction is forming large
crystals in organic clearing solutions. Since the em-
bryo sac is surrounded by five or six cell layers (Fig.
1), it is essential to clear the tissue in order to identify
the cells of the gametophyte and the internal cell
layers. We tested more than 30 different clearing pro-
cedures used in plant and fly labs based on phenol,
lactate, chloralhydrate, methylbenzoate, methylsalici-
late, clove oil, xylene, and sodium hydroxide. All of
them led to the formation of blue crystals, severely
obscuring the microscopic analysis of our samples.
175
The two procedures showing the least crystalization
did not clear sufficiently. However, we were able to
establish conditions (20% lactate, 20% glycerol in
PBS) that lead to the formation of small punctuate
crystals rather than the usual large needles. The mor-
phology of the cleared tissue is excellent and the
crystalization process takes a few days, leaving us
enough time for microscopic inspection.
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ACADEMIC AFFAIRS
The academic program continues to bring thousands of scientists to the Laboratory to participate in a
series of advanced laboratory and lecture courses in molecular biology, neurobiology and structural biol-
ogy, a set of conferences including the annual Symposium, and a summer research program for un-
dergraduates. The meetings continue to emphasize presentations of the latest scientific results by junior
faculty, postdoctoral fellows, and graduate students as well as their more senior colleagues. The courses,
which extend from April through November, succeed in teaching a variety of new techniques and state-of-
the-art methodologies by instructors who come from universities, medical schools, and institutes from
around the United States and abroad. Thus, the academic program brings together scientists as teachers,
students, meetings organizers, and participants to share new scientific knowledge.
In 1994, 15 meetings and 24 courses were held over an 8-month period. The annual Symposium, held
this year on the Molecular Genetics of Cancer, provided much discussion and interest as insights into the
genetic alterations found in different forms of cancer continue to increase. The Symposium was, in fact,
oversubscribed this year, and other meetings that filled the Laboratory to capacity included those on
Genome Mapping and Sequencing, Mouse Molecular Genetics, and Retroviruses. Two new meetings were
held this year-one on Zebrafish Development and Genetics, which explored research being done on this
quite new experimental organism, and one on Epstein-Barr Virus and Associated Diseases. A small special
meeting was held in the fall-A Decade of PCR: Celebrating Ten Years of Amplification. This meeting,
organized by Stan Rose of Perkin-Elmer and David Stewart, the Meetings Program Director, and sponsored
by Perkin-Elmer, brought together scientists from academia and industry. This represents the first in a
potential series of biotechnology meetings that David is exploring, to hold in the ever-shrinking off-season
courses and conferences.
Although the list of course instructors, assistants, and meetings organizers is listed below, it should be
acknowledged here that their great efforts, intelligence, and "grace under pressure" allow the program to
run on an intense, almost 24-hour a day schedule. Maintaining and expanding the Academic Program are
made possible by support from the National Institutes of Health, National Science Foundation, Department
of Energy, and Department of Agriculture which help to support courses and meetings. The Laboratory is
also most fortunate to have an education grant from theHoward Hughes Medical Institute, which funds
neurobiology courses as well as new courses, thus providing crucial flexibility for the program. Funds from
the Esther and Joseph A. Klingenstein Fund and scholarship monies from the Grass Foundation help to
support neurobiology courses. The meetings receive support from the Corporate Sponsors Program and
the courses receive much support from many companies that donate supplies and lend large amounts of
equipment for the courses.
While graduate students, postdoctoral fellows, and faculty participate in the courses and meetings, the
Undergraduate Research Program (URP) provides an opportunity for college undergraduates to spend 10
weeks at the Laboratory during the summer. The program, headed by Winship Herr, allows students to do
research in the laboratories of staff scientists.
The large numbers of courses and meetings proceed with skill and efficiency, thanks to the collabora-
tive efforts of a large number of people at the Laboratory. The staff of the Meetings Office, ably led by
David Stewart and including the Course Registrar Micki McBride, Diane Tighe, Marge Stellabotte, Andrea
Stephenson, Nancy Weeks, Drew Mendelsohn, and Jim Koziol, coordinates with both skill and tact the
visits of the thousands of scientists who come here to participate in the meetings and courses. Herb Par-
sons and Ed Campodonico of the audiovisual staff manage with great efficiency and good humor the thou-
sands of slides and projections provided by the scientists at our meetings. The course instructors have
come to depend on the skills of Cliff Sutkevich and his staff in setting up and maintaining all of the neces-
sary equipment and supplies, as well as those of the Purchasing Office headed by Phil Lembo and the new
Purchasing Agent in charge of the courses, Edie Kappenberg. The many grants that support the academic
program are ably coordinated by Mary Horton of the Grants Office.
Terri Grodzicker
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59th COLD SPRING HARBOR SYMPOSIUM
ON QUANTITATIVE BIOLOGY
Molecular Genetics of Cancer
June 1-June 8 421 participants
ARRANGED BY Bruce Stillman, Cold Spring Harbor Laboratory
Investigation of the mechanistic aspects of cancer has its roots in the studies on tumor viruses and
their effects on cell proliferation, function, and growth. This outstanding progress was well docu-
mented in previous Cold Spring Harbor Symposia on Quantitative Biology. The classic 1974
Symposium on Tumor Viruses, followed by the 1979 Symposium on Viral Oncogenes, chronicled
the valuable insights that the study of viruses provided to the cancer problem. Studies on the
genetics of human cancer arose from cytological observations of the abnormalities that are pres-
ent in the chromosomes of tumor cells. Quite a number of the genes affected by either a transloca-
tion break point, amplification, deletion, or point mutation had been identified by the time that the
Laboratory hosted a comprehensive meeting on the Origins of Human Cancer in our centennial
year of 1990.
In the early to mid 1980s, progress on the development of chromosome mapping strategies
and the accumulation of DNA probes that identified polymorphisms, encouraged by the interna-
tional Human Genome Project, enabled the identification of other genes that contributed to familial
inheritance of high susceptibility to specific cancers. This approach was very successful and led
to a degree of optimism that one aspect of cancer, the multistep genetic process from early
neoplasia to metastatic tumors, was beginning to be understood. It therefore seemed appropriate
that the 59th Symposium on Quantitative Biology focus attention on the Molecular Genetics of
Cancer. The concept was to combine the exciting progress on the identification of new genetic
alterations in human tumor cells with studies on the function of the cancer gene products and how
they go awry in tumor cells.
The meeting was attended by a record 421 participants, with 86 oral presentations in 14 ses-
sions and 185 poster presentations on three separate afternoons. Outstanding first night intro-
ductory lectures by Leland Hartwell, Robert Weinberg, Bert Vogelstein, and Suzanne Cory set a
high standard that was maintained throughout the next seven days. Harold Varmus, whom we are
fortunate to have as the current Director of the National Institutes of Health, presented a masterful
Dorcas Cummings Lecture to members of our local community. Ed Harlow, who generously
agreed to summarize the meeting, provided the audience with sound advice, good humor, and
great insight.
Essential funds to hold such a meeting were provided by the National Cancer Institute (a
branch of the National Institutes of Health) and the U.S. Department of Energy. Additional funding
came from our Corporate Sponsors who provide increasingly essential funding: Alafi Capital Com-
pany, American Cyanamid Company, Amgen Inc., Becton Dickinson and Company, Biogen,
Bristol-Myers Squibb Company, Chugai Pharmaceutical Co., Ltd., Ciba-Geigy Corporation, Pfizer
Inc., Diagnostic Products Corporation, The Du Pont Merck Pharmaceutical Company, Forest
Laboratories, Inc., Genentech, Inc., Glaxo, Hoffmann-La Roche Inc., Johnson & Johnson, Kyowa
Hakko Kogyo Co., Ltd., Life Technologies, Inc., Mitsubishi Kasei Institute of Life Sciences,
Monsanto Company, New England BioLabs, Inc., Oncogene Science, Inc., Pall Corporation, The
Perkin-Elmer Corporation, Research Genetics, Sandoz Research Institute, Schering-Plough Corpo-
ration, SmithKline Beecham Pharmaceuticals, Sterling Winthrop Inc., Sumitomo Pharmaceuticals
Co., Ltd., Takeda Chemical Industries, Ltd., Toyobo Co., Ltd., Wyeth-Ayerst Research, Zeneca
Group PLC.
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PROGRAM
M.-C. King
Welcoming Remarks and Introduction: Bruce Stillman
Control of Cell Cycle and Cell Growth
Chairperson: T. Tlsty, University of North Carolina School of
Medicine
Genetic Methods for Diagnosis and Cancer Therapy
Chairperson: D.M. Livingston, Dana-Farber Cancer Institute
and Harvard University Medical School
p53
Chairperson: E. Fearon, Yale University School of Medicine
Transcription and Cell Growth Controls
Chairperson: C. Prives, Columbia University
Genetic Models
Chairperson: S. Cory, Walter and Eliza Hall Institute of Medi-
cal Research, Royal Melbourne Hospital, Victoria, Austra-
lia
Signaling by Proto-oncogenes
Chairperson: M.-C. King, University of California, Berkeley
Genetic Mechanisms and Neoplasia
Chairperson: M. Skolnick, University of Utah
B. Vogelstein
Cell Surface and Metastasis
Chairperson: J.M. Bishop, University of California, San Fran-
cisco
Dorcas Cummings Lecture: Why is it important to under-
stand the genetic basis of cancer?'
Speaker: Harold Varmus, Director, National Institutes of
Health
Cancer Genes
Chairperson: J. Sambrook, McDermott Center, University of
Texas Southwestern Medical School, Dallas
Cancer Genes and Their Products
Chairperson: D. Hanahan, University of California, San Fran-
cisco
Apoptosis
Chairperson: J. Rowley, University of Chicago
Checkpoints and Genome Stability
Chairperson: E. White, Rutgers University
Finale
Chairperson: D. Lane, University of Dundee, U.K.
Summary: E. Harlow, Massachusetts General Hospital Can-
cer Center, Charlestown
T. Kelly, B. Stillman
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MEETINGS
Zebrafish Development and Genetics
April 27-May 1 328 participants
ARRANGED BY Wolfgang Driever, Massachusetts General Hospital
Judith Eisen, University of Oregon
David Grunwald, University of Utah Medical School
Charles Kimmel, University of Oregon
This meeting was the first open-invitation meeting to deal specifically with the biology of the ze-
brafish, an organism that has recently become a major focus for studies of vertebrate biology. Ses-
sions dealing with determinants of cell fate, early morphogenesis and patterning of the embryo,
genetics and genomics, nervous system development, growth control, and organogenesis were
led by prominent researchers in each field. In addition, one entire session was devoted to develop-
ing informational and technical resources that will be made available to the entire zebrafish re-
search community and that would facilitate communication among workers in this field and aid in
the development of their research programs.
A major breakthrough for genetic analyses of vertebrate development was announced at the
meeting. The laboratories of Nusslein-Volhard (Tubingen, Germany) and Driever (Boston, USA)
reported the recovery of mutations in most of the genes that contribute to embryogenesis in the ze-
brafish. Many presentations described the initial characterizations of these mutants, including
mutants that affected embryonic morphogenesis, how the retina sends topologically relevant sig-
nals to the brain, and how certain organ systems such as the heart and hematopoietic system are
formed. Thus, it appears that studies with the zebrafish will for the first time offer us a way to study
systematically the functions of single genes that are essential for vertebrate development and
physiology.
This meeting was funded in part by the National Institute of Child Health and Human Develop-
ment (a branch of the National Institutes of Health), National Science Foundation, Pet Warehouse,
Applied Scientific Instrumentation, Inc., Marine Biotech, Inc., and Society for Developmental Biol-
ogy.
PROGRAM
Keynote Speaker: Charles Kimmel, University of Oregon
Cell Fate
Chairperson: R. Ho, Princeton University
Genetics
Chairperson: C. NOsslein-Volhard, Max-Planck-Institut fur
Entwicklungsbiologie, TObingen, Germany
Methods
Chairperson: N. Hopkins, Massachusetts Institute of Tech-
nology
Gastrulation, Patterning, and Morphogenesis I
Chairperson: M. Westerfield, University of Oregon, Eugene
Gastrulation, Patterning and Morphogenesis II
Chairperson: N. Holder, Kings College London, U.K.
Growth Control
Chairperson: M. Schartl, Biocenter, University of Wdrzburg,
Germany W. Griever, S. Jesuthasan
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Nervous System I
Chairperson: J. Campos-Ortega, Institut Mr Entwick-
lungsbiologie, Universitat KO In, Germany
Nervous System II
Chairperson: J. Kuwada, University of Michigan, Ann Arbor
Organogenesis I
Chairperson: M.-A. Akimenko, Loeb Institute for Medical Re-
search, University of Ottawa, Ontario, Canada
Community Organizing, Gestalt
Chairpersons: W. Driever, Massachusetts General Hospital;
J. Eisen, University of Oregon; D.J. Grunwald, University of
Utah
Organogenesis II
Chairperson: M. Fishman, Massachusetts General Hospital N. Hopkins
Biology of Heat Shock Proteins and Molecular Chaperones
May 4-May 8 408 participants
ARRANGED BY Costa Georgopoulos, University of Geneva, Switzerland
Susan Lindquist, University of Chicago
Richard Morimoto, Northwestern University
This 4-day meeting attracted more than 400 participants during which 49 platform presentations
and 281 posters were given. The topics covered the areas of (1) regulation of heat shock gene ex-
pression in prokaryotic and eukaryotic systems, (2) the GroEL, GroES, HSP60, and TCP-1
molecular chaperones, (3) the HSP70, DnaJ, and grpE family of chaperones, (4) HSP90 and other
heat shock proteins and chaperones, (5) protein modification and proteolysis, and (6) the role of
heat shock proteins and molecular chaperones in thermotolerance, immunobiology, infectious dis-
eases, and pathophysiology. The 1994 meeting was recognized as a transition to more mechan-
istic studies on the activities of heat shock transcription factors, biochemical properties of heat
shock proteins, and a more exacting understanding of their role in diverse cellular processes. The
relationship between protein damage and proteolysis was highlighted by the addition of a new ses-
sion to stimulate discussion and future research. Finally, the observations on the role of heat shock
proteins in human diseases has achieved recognition for understanding how aberrations in the ex-
pression or function of heat shock proteins can profoundly influence cellular function.
This meeting was funded in part by the National Institute of General Medical Sciences, National
Institute of Diabetes and Digestive and Kidney Diseases (both branches of the National Institutes of
Health), National Science Foundation, Affinity BioReagents, Inc., Otsuka Pharmaceutical Factory,
Inc., StressGen Biotechnologies Corp., Pharmaceutical Basic Research Laboratories, Japan To-
bacco, Inc., and Kureha Chemical Industry Co., Ltd.
C. Georgopoulos, Cori
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PROGRAM
Regulation of Heat Shock Gene Expression
Chairperson: T. Yura, H.S.P. Research Institute, Kyoto,
Japan
Regulation of Heat Shock Gene Expression
Chairperson: C. Gross, University of California, San Francis-
co
groEL, HSP60, TCP1
Chairperson: E.A. Craig, University of Wisconsin, Madison
HSP70 Family, dnaJ, and grpE
Chairperson: F.-U. Hartl, Memorial Sloan-Kettering Cancer
Center
HSP70 Family and dnaJ
Chairperson: I. Yahara, Tokyo Metropolitan Institute of Medi-
Genome Mapping and Sequencing
cal Science, Japan
HSP90
Chairperson: M.-J. Gething, University of Texas South-
western Medical Center
Other HSPs and Chaperones
Chairperson: S. Gottesman, National Cancer Institute,
National Institutes of Health
Protein Modification and Proteolysis
Chairperson: W. Neupert, Institut fur Physiologische
Chemie, MCinchen, Germany
Thermotolerance, Immunobiology, Infectious Diseases, and
Pathophysiology
Chairperson: W.J. Welch, University of California, San Fran-
cisco
May 11-May 15 434 participants
ARRANGED BY Richard Myers, Stanford University
David Porteous, MRC Human Genetics Unit, Edinburgh, U.K.
Robert Waterston, Washington University School of Medicine
The primary impact of the HGP continues to be in the pursuit of human disease genes. The data
and resources of the various mapping efforts have made possible virtually every recent disease
gene hunt, and this was fully apparent in the highly competitive search for the breast cancer
(BRCA I) gene.
The wealth of data in poster sessions was most impressive, indicating a new depth of field.
Reports of the current status of the human mapping projects were done in a new format, with all
large groups first presenting posters, followed by a round-table discussion. The poster session
gave everyone a chance to review progress in detail. The quality of the recently released CEPH
map came under scrutiny, and various problems in the product were raised. Individual
chromosome projects, on the other hand, have benefited enormously from the CEPH megaYAC
resource, but it is clear that they must be used with caution because of their very high rate of
chimerism. The genetic linkage map, spearheaded by J. Weissenbach and the CHLC, continues
to be a real success story with the ever-increasing density of informative markers.
Model organism genomes are also a bright spot. Several labs working on the yeast genome
have coordinated their sequencing efforts and it seems likely that the entire sequence of the S.
D Porteous, R. Meyers, R. Waterston S. Brenner
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cerevisiae genome will be known by early 1996 at the latest. The C. elegans consortium reported
more than 5 Mb of completed genomic sequence, another landmark achievement. Groups on
several organisms including Drosophila and E. coli have passed or are rapidly approaching the 1-
Mb mark. Among new mapping methods, the single molecule restriction digests presented by D.
Schwartz were particularly impressive and point to the possibilities of miniturization in the future.
The EST efforts continue to sample human genes, but the issue of public availability of commer-
cially produced sequences remains a frustration among the wider genome community. Without the
ability to compare and analyze the large amount of data held, it is difficult to know how many dif-
ferent genes are represented and what fraction of these may be of the total human complement.
The best guesses seemed to indicate that perhaps as many as 30,000-40,000 different genes
have been sampled, which might represent about half the full set.
Informatics is increasingly central to progress in genomics, and the communication between in-
formatics and the rest of the community has improved markedly in recent years, as each group be-
gins to appreciate the strengths and weaknesses of the other. The solid progress here was
reflected in several excellent talks.
Although several novel approaches to sequencing were presented, it was clear from B. Roe's
interminable talk that the current methods of shotgun sequencing followed by directed assembly
and using fluorescence-gel-based methods remain powerful and can be satisfactorily applied to
human DNA. Automation and optimization of such approaches may indeed prove sufficient to meet
the challenge of sequencing the entire human genome.
This meeting was funded in part by the National Center for Human Genome Research (a
branch of the National Institutes of Health).
PROGRAM
Human Diseases
Chairpersons: A. Bowcock, Southwestern Medical Center;
E. Green, Washington University
Human Genome Center Poster Symposium
Chairpersons: H. Willard, Case Western Reserve University;
D. Porteous, Western General Hospital, Edinburgh
Model Organisms
Chairpersons: R. Rothstein, Columbia University College of
Physicians & Surgeons; R. Waterston, Washington Univer-
sity School of Medicine
Mapping and Other Methods
The Cell Cycle
May 18-May 22
Chairpersons: D. Bentley, The Sanger Centre, U.K.; J. Weis-
senbach, Genethon and Institut Pasteur, France
cDNA and Gene Cloning
Chairpersons: B. Soares, Columbia University; R.M. Myers,
Stanford University
Informatics
Chairpersons: D. States, Washington University; P. Little,
Imperial College, U.K.
Sequencing and Sequencing Methods
Chairpersons: JA. Mao, Collaborative Research, Inc.; R.
Gibbs, Baylor College of Medicine
373 participants
ARRANGED BY David Beach, Cold Spring Harbor Laboratory
Charles Sherr, St. Jude Children's Research Hospital
After opening remarks by David Beach and Charles Sherr, the sessions were chaired by Fred
Cross, Jim Roberts, Lee Johnston, David Morgan, David Beach, Michael Kastan, Mitsuhiro
Yanagida, and Helen Piwnica-Worms. The program included scientists from research centers in
Europe, the Far East, and the United States. They gathered to discuss their latest research con-
cerning control of the cell cycle and cell proliferation. The program included 75 speakers who dis-
cussed such fundamental problems as control of mitosis; entry into the cell cycle; the role of anti-
oncogenes and tumor suppressor genes in regulating cell growth; DNA replication; cell differentia-
tion and cessation of proliferation; role of oncogenes and growth factors in control of cell prolifera-
tion; and chromosome behavior and division. The participating leading researchers in these areas
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of research use a variety of approaches from genetics to biochemistry to study control of the cell
cycle. A variety of model systems from yeast to humans were discussed, and the meeting provided
the opportunity to demonstrate how these different approaches complement each other. The meet-
ing was one of great intensity and scientific interchange.
Contributions from Corporate Sponsors provided core support for this meeting.
PROGRAM
Yeast G1 Control
Chairperson: F. Cross, Rockefeller University
Cyclins D and E
Chairperson: J. Roberts, Fred Hutchinson Cancer Research
Center
Transcription at Gi/S
Chairperson: L. Johnston, National Institute for Medical Re-
search, London
Cdk Regulators
Chairperson: D. Morgan, University of California, San Fran-
Retroviruses
cisco
S Phase
Chairperson: D. Beach, Cold Spring Harbor Laboratory
Apoptosis/Checkpoints
Chairperson: M. Kastan, Johns Hopkins University Medical
School
Mitosis
Chairperson: M. Yanagida, Kyoto University, Japan
Meiosis and Cdk5
Chairperson: H. Piwnica-Worms, Harvard Medical School
May 24-May 29 432 participants
ARRANGED BY Stephen Goff, Columbia University
Joseph Sodroski, Dana-Farber Cancer Institute
The annual Retrovirus meeting, originally the RNA tumor virus meeting, stands as one of the
longest-running continuously held meetings of Cold Spring Harbor. The 1994 meeting was the
largest one to date, both in number of abstracts (372) and attendees; for the first time, applicants
had to be turned away from a few large laboratories. The increase in applicants, although in part
attributable to the recent expansion in AIDS research, also reflects the strong continued interest in
this field. The retrovirus meeting thus brings many long-standing attendees from the early days of
the field together with newly recruited HIV investigators.
This year, there were advances in several areas to be considered as highlights of the meeting.
Virus receptors were the major focus of one session. Reports described the cloning and character-
ization of the receptors for several classes of leukemia viruses, including the avian leukosis viruses
type A and the amphotropic murine leukemia viruses. The various receptors now known include a
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surprising range of types of molecules; retroviruses seem to be able to evolve to the utilization of
very diverse surface molecules to mediate their entry. Substantial efforts addressed how the
preintegration complex enters the nucleus and suggested that two HIV proteins may facilitate that
process in nondividing cells. There was also considerable interest in the viral integrase function,
with enhanced understanding of the reactions it catalyzes and the mechanism of action. Finally, the
process of virion assembly was advanced by the development of in vitro systems in which Gag
proteins assemble to form fibers and particles closely resembling virus cores. All these findings
bode well for the future development of antiviral therapies for the control of retroviral disease.
Contributions from Corporate Sponsors provided core support for this meeting.
PROGRAM
Receptors, Envelope and Virus Entry
Chairpersons: M. Eiden, National Institute of Mental Health,
A.D. Miller, Fred Hutchinson Cancer Research Center
Reverse Transcription
Chairpersons: S. Hughes, Frederick Cancer Research Fa-
cility, ABL-Basic Research Program, National Institutes of
Health; M. Roth, UMDNJ-Robert Wood Johnson Medical
School
Nuclear Transport and Integration
Chairpersons: R. Craigie, NIDDK, National Institutes of
Health; A. Skalka, Fox Chase Cancer Center
Expression I-Transcription
Chairpersons: B. Felber, Frederick Cancer Research Facil-
ity, ABL-Basic Research Program, National Institutes of
Health; J. Lenz, Albert Einstein College of Medicine
Expression II-Post Transcriptional Gene Expression
Chairpersons: B. Cullen, Howard Hughes Medical Institute,
Duke University Medical Center; D. Rekosh, University of
Virginia, Charlottesville
Accessory Genes
Chairpersons: L. Ratner, Washington University School of
Medicine; K. Strebel, NIAID, National Institutes of Health
Virus Assembly
Chairpersons: E. Hunter, University of Alabama, Birming-
ham; A. Rein, Frederick Cancer Research Facility, ABL-
Basic Research Program, National Institutes of Health
Virus Assembly and Packaging
Chairpersons: E. Barklis, Oregon Health Sciences Univer-
sity; C. Carter, State University of New York, Stony Brook
Potpourri
Chairpersons: J. Elder, Scripps Clinic and Research Foun,
dation; V. Hirsch, LID, NIAID, National Institutes of Health
Pathogenesis
Chairpersons: D. Derse, NCI, National Institutes of Health;
G. Franchini, NCI, National Institutes of Health
Molecular Biology of Papovaviruses and Adenoviruses
August 17-August 21 265 participants
ARRANGED BY Terri Grodzicker, Cold Spring Harbor Laboratory
Peter Howley, Harvard Medical School
David Livingston, Dana-Farber Cancer Institute
Carol Prives, Columbia University
The DNA tumor viruses-SV40, polyoma and adenoviruses-have served as important model sys-
tems to study cell growth and transformation as well as cellular transcription, replication, and RNA
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processing. In recent years, much work using these viruses as well as papillomaviruses have con-
verged, especially with respect to the interaction of viral oncogene proteins with the products of
cellular genes, including tumor suppressor genes. Thus, it was most welcome for the meeting to in-
clude once more, after a gap of many years, work on the molecular biology of papillomaviruses. A
total of 265 scientists gathered at the 1994 meeting to present their latest results.
Much of the emphasis of the meeting concerned the interaction of viral regulatory with cellular
proteins. Thus, many talks addressed interactions of viral nuclear proteins such as E1A, SV40 T
antigen, and papillomavirus E6 and E7 proteins with Rb and its relatives, p107 and p130; p300 and
p53. Studies of interactions of cytoplasmic and membrane-bound proteins such as the PDGF
receptor with the BPV-1 E5 oncoprotein and polyoma middle T antigen with proteins involved in
signal transduction pathways also received attention. Adenovirus E1A and E1B proteins have come
to serve as models for inducers and inhibitors of apoptosis, and several talks and posters ad-
dressed this area of research. Much research continues to focus on the analysis of cellular proteins
involved in viral DNA replication and their interaction with each other and viral replication proteins.
A number of presentations addressed interactions of this type such as PCNA with the cdk inhibitor
p21 and RPA with p53 and their likely role in the regulation of replication. The study of transcrip-
tional regulation and interactions of viral E1A proteins, T antigenes, and E2 proteins with com-
ponents of the transcriptional apparatus using in vitro as well as in vivo systems was extensively
discussed. Since several of the cellular transcription factor targets of viral proteins (e.g., p53, E2F,
p300) are transcription regulators, these studies addressed issues of growth control as well. The
meeting provided a useful and interesting forum for the discussion of new results, and the inclusion
of talks and posters on papillomaviruses was most valuable and will be continued in the future.
Contributions from Corporate Sponsors provided core support for this meeting.
PROGRAM
Replication I
Chairperson: L. Chow, University of Alabama
Transcription I
Chairperson: W. Herr, Cold Spring Harbor Laboratory
Transformation I
Chairperson: T. Roberts, Dana-Farber Cancer Institute
Transformation II
Chairperson: D. Galloway, Fred Hutchinson Cancer Re-
search Center
Transcription II
Chairperson: J. Alwine, University of Pennsylvania
Replication II
Chairperson: J. Hassell, McMaster University
Posttranscriptional Regulation
Chairperson: G. Akusjaryi, Karolinska Institute, Stockholm,
Sweden
Virus-Host Cell Interactions
Chairperson: E. White, Rutgers University
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Translational Control
August 24-August 28 379 participants
ARRANGED BY Allan Jacobson, University of Massachusetts Medical School
Michael Mathews, Cold Spring Harbor Laboratory
Debbie Steege, Duke University Medical Center
The large number of participants at this fourth meeting attests to the vigor of this field and the
popularity of the meeting. As has been the case of past meetings, the 1994 meeting encompassed
animal, plant, viral and prokaryotic systems, although the continued downward trend in representa-
tion from prokaryotic research was disappointing. The meeting continued its focus on controls at
each of the steps of translation, the factors, and on translation mechanisms. An increased focus on
additional areas was well received by the participants, including developmental regulation mRNA
stability, RNA-protein interactions, kinases, and signal transduction.
Over the course of the meeting, many excellent talks and posters were presented. One
highlight of the developmental regulation session was that RNA localization is emerging as a mech-
anism for gradient formation in the egg essential for pattern formation. It is also becoming evident
that addition and removal of poly(A) tails on mRNA contributes to complex patterns of translational
control. A second area of very rapid progress is mRNA turnover in eukaryotic cells, where several
possibly related pathways appear to operate. One is initiated by deadenylation and decapping, a
second responds to the presence of nonsense codons within the body of the mRNA, and a third
responds to cis-acting AU-rich elements in the 3'-untranslated region. In the area of initiation, very
exciting evidence was presented that eukaryotic ribosomes can translate RNA circles many con-
secutive rounds, arguing that the free 5' end of an mRNA is not necessarily the entry point for the
small subunit. Evidence is increasing that the 5' and 3' ends of eukaryotic mRNAs communicate
in some way during translation. Perhaps the newest development in frameshifting is the case in
mammalian ornithine decarboxylase antizyme, which appears to be subject to regulation by
polyamines. A highlight of the session on translation factors was the discovery of p67, a glyco-
protein that functions to protect eIF -2 from inactivation through phosphorylation and is itself subject
to regulation at the mRNA level and via 0-linked gly-cosylation. A final highlight was the very rapid
progress being made in developing second-generation models for the three-dimensional folding of
16S and 23S rRNAs. Much progress is expected during the next 2 years in these and many other
areas, a promise that the 1996 Translational Control Meeting will be a great success.
This meeting was funded by RiboGene, Inc. and ICN Biomedicals, Inc.
A. Yoshida, S. Fridman
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PROGRAM
Developmental Regulation
Chairperson: M. Wickens, University of Wisconsin, Madison
mRNA Stability
Chairperson: R. Parker, University of Arizona, Tucson
Initiation
Chairperson: P. Sarnow, University of Colorado, Denver
Elongation and Termination
Chairperson: H. Engelberg-Kulka, Hebrew University-
Hadassah Medical School, Jerusalem, Israel
Kinases
Chairperson: R. Kaufman, University of Michigan Medical
Center, Ann Arbor
Factors
Chairperson: W. Merrick, Case Western Reserve University,
Cleveland, Ohio
Ribosomes and RNA-protein Interactions
Chairperson: T. Fox, Cornell University, Ithaca, New York
Viral and Cellular Regulatory Mechanisms
Chairperson: E. Ehrenfeld, University of California, Irvine
Mouse Molecular Genetics
M. Mathews, R. Schneider
August 31-September 4 429 participants
ARRANGED BY Anton Berns, Netherlands Cancer Institute, The Netherlands
Robb Krumlauf, MRC National Institute for Medical Research, U.K.
Andy McMahon, Harvard University
Elizabeth Robertson, Harvard University
There were eight sessions chaired by Bill Dove, Gail Martin, Mario Capecchi, Nadia Rosenthal,
Mary Beth Hatton, Luis Parada, Michael Brown, and David Houseman. To complement talks pre-
sented by the chairs, each session also included a lecture from invited outside speakers: Rick
Woychik, Scott Fraser, Alex Joyner, Marc Tessier-Lavigne, Ashley Dunn, and Neal Copeland.
The participants of the meeting included leading international scientists from North America,
Europe, Australia, and the Far East. In addition to the invited chairs/speakers, emphasis was
A. Berns, R. Krumlauf, E. Robertson, A. McMahon
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placed on young scientists to provide them with an opportunity to discuss their latest results in
diverse areas of mouse molecular genetics, and 67 talks from participants were added to the pro-
gram. Active areas of discussion included mouse models for human diseases, genetics, lineage
analysis, oncogenesis, pattern formation, embryogenesis, organogenesis, cell-cell interactions,
receptors and signals, mouse genome projects, mutagenesis, gene regulation, development of
the nervous system, and imprinting. To address the growing need to follow the fate of specific
cells, a lineage tracing workshop was held to provide information and help on the various types of
lineage analysis that might be useful in a number of developmental systems. Although the meeting
stressed the value of mouse molecular genetics, there was also an underlying theme of how the
results emerging from mouse research relates to other vertebrate systems and how other systems
can be used to expand the potential of the mouse as a genetic approach. The meeting provided a
stimulating and intense environment for young scientists to exchange information and gain insight
into the diverse ways the mouse molecular genetic approach can advance their research goals.
This meeting was funded in part by the Genetics Institute, National Science Foundation, and
the following branches of the National Institutes of Health: National Institute of Child Health and
Human Development, National Cancer Institute, National Institute of Neurological Disorders and
Stroke, and National Institute of General Medical Sciences.
PROGRAM
Genetics
Chairperson: B. Dove, McArdle Laboratory for Cancer Re-
search, University of Wisconsin, Madison
Embryogenesis/Lineage
Chairperson: G.R. Martin, University of California, San Fran-
cisco
Patterning
Chairperson: M. Capecchi, Howard Hughes Medical In-
stitute, University of Utah, Salt Lake City
Organogenesis/Muscle
Chairperson: N. Rosenthal, Massachusetts General Hospi-
tal, Charlestown
Neural Development
Chairperson: M.E. Hatten, Rockefeller University, New York
Signals and Receptors
Chairperson: L. Parada, NCI-Frederick Cancer Research
and Development Center, Frederick, Maryland
Models of Human Diseases
Chairperson: M. Brown, University of Texas Southwestern
Medical Center, Dallas
Tumorigenesis
Chairperson: D. Housman, Center for Cancer Research,
Massachusetts Institute of Technology, Cambridge
Epstein-Barr Virus and Associated Diseases
September 7-September 11 307 participants
ARRANGED BY Joseph Pagano, University of North Carolina, Chapel Hill
Alan Rickinson, University of Birmingham Medical School, U.K.
The 1994 Cancer Cells meeting was combined with the biannual international meeting of the
Epstein-Barr Virus Association to focus on the basic virology and disease associations of the
Epstein-Barr virus. The meeting encompassed a broad range of subjects from regulation of viral
gene expression to molecular mechanisms of cell immortalization by the Epstein-Barr virus. The
bimodal pathways for replication of the virus leading to latent infection, on the one hand, or to virus
production, on the other hand, were explored. The pathobiology and immunobiology of EBV infec-
tion are complex topics that provide the setting for diseases caused by or associated with EBV and
host responses in these diseases. The conference was unusual because it spanned both basic
molecular mechanisms and pathobiology of disease. Knowledge about the pathogenesis of EBV
lymphomas and nasopharyngeal carcinomas at the molecular pathogenetic level is rapidly emerg-
ing and now includes information on the role of EBV in Hodgkin's disease. Finally, newly emerging
information was presented on attempts to treat EBV diseases as well as to fashion EBV recom-
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binogenic vaccines. The conference included either as speakers or chairpersons virtually every
major researcher in the field plus a large number of new young investigators. Of the invited
speakers, more than 50% were invited for the first time to speak at the EBV meeting, and about
80% of the speakers giving short oral presentations were first-timers. Most thought that this was the
best International EBV Conference ever held. The meeting was greatly facilitated by the excellent
facilities and staff of the Cold Spring Harbor Meetings Office.
This meeting was funded in part by the National Cancer Institute, a branch of the National In-
stitutes of Health; the Burroughs Wellcome Co., Cutter Biomedicals, Miles, Inc., Granbio, Inc.,
INCSTAR Corp., Viral Antigens, Inc., and The Wellcome Foundation Ltd.
PROGRAM
Welcoming Remarks: Bruce Stillman, Director, Cold Spring
Harbor Laboratory; Joseph S. Pagano, M.D., President,
International Association for Research on Epstein-Barr
Virus and Associated Diseases
Gertrude and Werner Henle Lecture on Viral Oncology
Presented by: Professor Harald zur Hausen, German Can-
cer Research Center, Heidelberg
Special Lecture: A. Levine, Dept. of Molecular Biology, Prin-
ceton University
Transformation and Oncogenesis
Chairperson: G. Bornkamm, Institut kir Klinische Molekular-
biologic, Hamatologikum der GSF, Munich, Germany
Replicative Gene Expression
Chairpersons: L. Joab, CNRS, Institut Gustave Roussy, Vil-
lejuif, France; S. Kenney, Lineberger Comprehensive Can-
cer Center, University of North Carolina
Replication and Glycoproteins
Chairpersons: M. Nonoyama, Tampa Bay Research In-
stitute, St. Petersburg, Florida; W. Hammerschmidt, In-
stitut kir Klinische Molekularbiologie and Tumorgenetik,
Miinchen, Germany
Transformation and Oncogenesis II
Chairpersons: A. Rickinson, Institute of Cancer Studies, Uni-
versity of Birmingham Medical School, U.K.; B. Sugden,
McArdle Laboratory for Cancer Research, University of
Wisconsin, Medical School, Madison
Special Lecture: D. Livingston, Sidney Farber Cancer Re-
search Institute, Dept. of Medical Oncology, Harvard Uni-
versity
Immunobiology and Pathobiology
Chairpersons: D. Moss, Queensland Institute of Medical Re-
search, Brisbane, Australia; G. Pearson, Georgetown Uni-
versity Medical Center, Washington, District of Columbia
Immunobiology and Pathology
Chairpersons: E. Klein, Microbiology and Tumorbiology
Center, Karolinska Institutet, Stockholm, Sweden; T. Tursz,
Institut Gustave Roussy and Institut de Recherche sur le
Cancer, Villejuif, France
Lymphomas
Chairpersons: D. Crawford, London School of Hygiene and
Tropical Medicine, U.K.; I. Magrath, National Cancer In-
stitute, National Institutes of Health, Bethesda, Maryland
Latent Gene Expression
Chairpersons: I. Ernberg, Microbiology and Tumor Biology
Center, Karolinska Institutet, Stockholm, Sweden; P. Far-
rell, Ludwig Institute for Cancer Research, St. Mary's Hos-
pital Medical School, London, U.K.
Nasopharyngeal Carcinoma and Epithelial Infection
Chairpersons: M. Ng, University of Hong Kong, Republic of
China; U. Prasad, University of Malaya, Kuala Lumpur,
Malaysia
Intervention and Diagnosis
Chairpersons: E. Littler, Wellcome Foundation, Kent, U.K.;
H. Wolf, Institute for Medical Microbiology, University of
Regensberg, Germany
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Gene Therapy
September 21-September 25 382 participants
ARRANGED BY Theodore Friedmann, University of California, San Diego
Y.W. Kan, University of California, San Francisco
Richard Mulligan, Massachusetts Institute of Technology and Whitehead Institute
Gene therapy has become an established driving concept in modern medicine and is rapidly
progressing toward practical clinical application. Because of the importance of this new field of
medicine, Cold Spring Harbor Laboratory sponsored its second meeting on Human Gene
Therapy. The meeting, organized by Theodore Friedmann, Y.W. Kan, and Richard Mulligan, in-
cluded discussions of basic molecular genetic and cell biological studies for gene transfer into hu-
man and other mammalian cells and their therapeutic implications. Of special importance were
descriptions of new and improved gene transfer techniques, both viral and nonviral, and very im-
pressive advances toward modification of viral and nonviral gene delivery tools to allow targeted
tissue-specific delivery of therapeutic genes in vivo. Applications toward cancer, AIDS,
hematological disease and neurological disorders demonstrated clearly that the techniques and
principles of human gene therapy will have increasingly important roles in the development of
more effective therapies for a wide variety of genetic and acquired human diseases. Because of
the importance of this area of biomedical research, a third meeting on Human Gene Therapy has
been scheduled in 1996.
The following branches of the National Institutes of Health provided support for this confer-
ence: National Institute of Child Health & Human Development, National Cancer Institute, National
Institute of Neurological Disorders & Stroke, National Institute of Allergy and Infectious Diseases,
and the National Institute of Diabetes and Digestive and Kidney Diseases.
PROGRAM
Welcome and Orientation: Theodore Friedmann, University
of California, San Diego
The Hematopoietic System
Chairperson: R. Mulligan, Whitehead Institute for Biomedical
Research and Massachusetts Institute of Technology
Hematopoietic System: Other Vectors and Models
Chairperson: T. Friedmann, University of California, San
Diego
Adenoviral Vectors
Chairperson: J. Wilson, Institute for Human Gene Therapy,
University of Pennsylvania, Philadelphia
Gene Delivery
Chairperson: Y.W. Kan, University of California, San Francis-
co
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T. Friedman Y.-W. Kan
Cancer
Chairperson: P. Greenberg, University of Washington and
Fred Hutchinson Cancer Research Center, Seattle
Muscle Gene Therapy
Chairperson: N.M. Blau, Stanford University School of Medi-
cine
Cell Grafting Approaches
Chairperson: H.M. Blau, Stanford University School of Medi-
cine
New Developments and Models
Chairperson: R.M. Blaese, National Institutes of Health
Cancer, AIDS
Chairperson: G. Nebel, Howard Hughes Medical Institute,
University of Michigan, Ann Arbor
S. Leff, H. Blau
Ribosome Synthesis and Nucleolar Function
September 28-October 2 167 participants
ARRANGED BY Richard Gourse, University of Wisconsin, Madison
Robert Perry, Fox Chase Cancer Center
Barbara Sollner -Webb, Johns Hopkins University
Michael Wormington, University of Virginia
Ribosome synthesis involves the regulation of numerous processes, encompassing transcription
by all three RNA polymerases, RNA processing, translation, RNA-protein interaction, and nucleo-
cytoplasmic transport. In addition, the synthesis of ribosomal components is coordinated and
balanced with the production of many other cell constituents. The regulation of ribosome synthesis
also impacts on virtually every other cellular component, responding to regulatory networks that
control cell growth, proliferation, and development.
Modern genetic and biochemical methodologies have greatly increased our knowledge about
many aspects of ribosome biogenesis. These include the eukaryotic rRNA gene transcription ma-
chinery, rRNA maturation, and an emerging family of nucleolar snRNAs that likely are involved in
rRNA processing and/or ribosome assembly. Recent studies are also revealing unexpected
alternative roles for ribosomal proteins outside of the ribosome and the unexpected nucleolar
localization of other known proteins. Thus, molecular mechanisms that govern ribosome
biogenesis are being elucidated, but many key elements of how this regulation occurs and how
these processes are integrated remain largely uncharacterized.
The Ribosome Synthesis and Nucleolar Function meeting was successful in bringing together
researchers working on these various aspects of ribosome synthesis and nucleolar function in
both prokaryotes and eukaryotes. Presentations were largely made by graduate students, post-
docs, and young independent investigators.
This meeting was funded in part by the National Institute of General Medical Sciences, a
branch of the National Institutes of Health.
PROGRAM
rRNA Biosynthesis
Chairperson: M. Nomura, University of California, Irvine
Regulation of rRNA Biosynthesis
Chairperson: R. Course, University of Wisconsin, Madison
rRNA Processing
Chairperson: B. Sollner-Webb, Johns Hopkins School of
Medicine
Small Nucleolar RNAs: Synthesis and Function
Chairperson: J. Steitz, Howard Hughes Medical Institute,
Yale University
J. Steitz, L. Lindahl
Synthesis and Regulation of Ribosomal Proteins
Chairperson: B. Perry, Fox Chase Cancer Center
Function and Organization of Ribosomal Components
Chairperson: M. Wormington, University of Virginia, Char-
lottesville
Localization, Assembly, and Activity of Nucleolar Proteins
Chairperson: G. Blobel, Howard Hughes Medical Institute,
Rockefeller University
Nucleolar Organization
Chairperson: J. Warner, Albert Einstein College of Medicine
M. Nomura J. Warner
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Molecular Approaches to the Control of Infectious Diseases
October 5-October 9 201 participants
ARRANGED BY Fred Brown, USDA, Plum Island Animal Disease Center
Robert Chanock, NIAID, National Institutes of Health
Harold S. Ginsberg, Columbia University College of Physicians & Surgeons
Er ling Norrby, Karolinska Institute, Sweden
The 12th Annual Meeting on Modern Approaches to New Vaccines (now renamed Molecular Ap-
proaches to the Control of Infectious Diseases) was held in October. As in the previous year, key-
note speakers introduced a diverse program which included sessions on Antibody Design and
Therapy, DNA Immunization, Vectors for Vaccine Delivery, and Vaccine Design in addition to
those dealing with individual bacteria, parasites, and viruses.
The renewed interest in vaccination worldwide has led to several innovative approaches to the
design of vaccines. None has attracted more attention than the potential of using directly DNA
coding for immunogenic proteins. Some of the experiments that were described have been spec-
tacularly successful, and information on the way this type of approach provides protection is
eagerly awaited. At the practical level, the view of control authorities such as the Food and Drug
Administration on the use of DNA is awaited with some trepidation.
The sophisticated technology that is being applied to the design and production of antibodies
in the test tube was also a hot topic at the meeting. In addition, there were extremely interesting
and innovative presentations on the basic sciences underlying vaccines. It is somewhat invidious
to pinpoint individual presentations in a meeting of such high quality. Nevertheless, it was refresh-
ing to hear about such diverse topics as the expression of a variety of immunogens in plants and
the protection of dogs against lethal parvovirus infection by a synthetic peptide, the first descrip-
tion of a successful peptide vaccine in the natural host. Maybe there is still hope for chemists in
the field of vaccination. Pasteur would have been pleased.
The meeting also included the inaugural Albert B. Sabin Memorial Lecture. This was delivered
by Dr. D.A. Henderson, Deputy Assistant Secretary for Health, who spoke on prospects for the
global eradication of poliomyelitis. Dr. Henderson was an appropriate choice because he was a
leading figure in the World Health Organization's successful campaign to eradicate smallpox-so
far the only infectious disease that has been eradicated. These annual lectures will be sponsored
by the Albert B. Sabin Vaccine Foundation, which is the creation of Mr. H.R. Shepherd.
This meeting was funded in part by American Cyanamid Company, Leder le-Praxis Biologicals
Division; and Pharmacia LKB Biotechnology.
E. Norrby
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H. Ginsberg, R. Chanock Fred Brown
PROGRAM
Antibody Design and Therapy
Chairperson: D. Burton, Scripps Research Institute
DNA Immunization
Chairperson: H. Robinson, University of Massachusetts
Bacteriology and Mycology
Chairperson: J. Collier, Harvard Medical School
HIV -SIV
Chairperson: J. Berzofsky, National Cancer Institute
Vectors for Vaccine Delivery
Chairperson: R. Curtiss III, Washington University
Parasitology
Chairperson: A. Mahmoud, Case Western Reserve Univer-
sity
Vaccine Design
Chairperson: I. Ramshaw, John Curtin School of Medical
Research, Canberra, Australia
Immunology
Chairperson: R. Zinkernagel, Institute of Experimental Imm-
Learning and Memory
unology, Zurich, Switzerland
Virology
Chairperson: B. Murphy, LID, NIAID, National Institutes of
Health
Albert B. Sabin Vaccine Foundation Inaugural Award
Ceremony and Memorial Lecture
Introduction: Mr. David Luke III, Cold Spring Harbor
Laboratory
Award Ceremony
Mr. H.R. Shepherd, Albert B. Sabin Vaccine Foundation; Dr.
P.K. Russell, Albert B. Sabin Vaccine Foundation; Mrs.
Heloisa Sabin
1994 Albert B. Sabin Memorial Lecture
Dr. Donald A. Henderson, Deputy Assistant Secretary for
Health, Department of Health and Human Services
Closing Remarks: Mr. David Luke III, Cold Spring Harbor
Laboratory
October 12-October 16 124 participants
ARRANGED BY Jack Byrne, University of Texas Medical School
Richard Morris, University of Edinburgh Medical School, U.K.
Charles Stevens, The Salk Institute
Richard Thompson, University of Southern.California, Los Angeles
The second biennial meeting on Learning and Memory at Cold Spring Harbor consisted of plat-
form and poster presentations and discussions of current research and concepts in the biological
basis of memory. Discussion focused on mechanisms underlying memory, including molecular
genetic substrates, biophysical and biochemical cellular/synaptic processes, developmental pro-
cesses, neural systems, and behavioral phenomena. One key aspect of the meeting was sessions
seeking common ground between vertebrate and invertebrate systems, from which several princi-
ples that may have general relevance to adult plasticity emerged: short-term forms of learning and
memory require changes in existing neural circuits, which may involve multiple cellular mechan-
isms within single neurons; second messenger systems appear to have a key role in mediating
cellular changes; changes in the properties of membrane channels are commonly correlated with
learning and memory; and long-term, but not short-term, memory requires new protein synthesis.
Another key feature of the meeting was the new and rapidly developing field concerned with
molecular genetic mechanisms of memory.
Yet another aspect of the meeting related neural mechanisms and systems to the behavioral
phenomena of learning and memory. Widespread interest in associative synaptic plasticity (such
as LTP) as a neural substrate of learning also prompted a reassessment of the enormous scope of
associative learning principles with respect to such diverse phenomena as recognition memory,
spatial learning, and the role of context in occasion-setting and retrieval and in instrumental habit-
learning.
This meeting was funded in part by the National Science Foundation.
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PROGRAM
C. Stevens, E. Kandel, C. Chen
Introductory Comments: Jack Byrne, University of Texas
Medical School
Higher Brain Systems and Memory
Chairperson: M. Mishkin, National Institute of Mental Health,
National Institutes of Health, Bethesda, Maryland
Basic Processes of Learning and Memory I
Chairperson: J.L. McGaugh, University of California, Irvine
Basic Processes of Learning and Memory II
Chairperson: R. Morris, University of Edinburgh, U.K.
Basic Processes of Learning and Memory Ill
Chairperson: R. Thompson, University of Southern Califor-
nia, Los Angeles
Brain Plasticity and Development
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J. Byrne
Chairperson: C. Shatz, University of California, Berkeley
Biophysics and Molecular Biology of Synaptic Transmission
and Memory I
Chairperson: J. Byrne, University of Texas, Houston
Biophysics and Molecular Biology of Synaptic Transmission
and Memory II
Chairperson: S. Tonegawa, Massachusetts Institute of Tech-
nology
Biophysics and Molecular Biology of Synaptic Transmission
and Memory Ill
Chairperson: C. Stevens, Salk Institute, La Jolla, California
Biophysics and Molecular Biology of Synaptic Transmission
and Memory IV
Chairperson: E. Kandel, Columbia University, New York
SPECIAL MEETING
A Decade of PCR: Celebrating Ten Years of Amplification
September 12-14
ARRANGED BY Stan Rose, Perkin-Elmer Corporation
David Stewart, Cold Spring Harbor Laboratory
This special meeting was held to commemorate the first decade since the discovery of the polymerase
chain reaction by Nobel laureate Kary Mullis, who gave the opening perspective for the meeting. The
polymerase chain reaction, which permits the faithful amplification of tiny quantities of DNA into manage-
able quantities, has transformed molecular biology, greatly expanding horizons in gene mapping and dis-
covery, HIV research and diagnosis, human identity testing, and genetic analysis. This meeting brought to-
gether 221 practitioners in the field of DNA amplification ranging from basic studies of the thermostable en-
zymes and oligonucleotide primers that fuel the reaction, recent advances in automation, quantitation, and
miniaturization, to applications ranging from criminal forensics to the study of human evolution and migra-
tion. Summarized by Maynard Olson, the meeting provided an exciting and informative review of PLR's first
decade of application, while providing new insights into the future directions of this valuable technique.
Videotapes of the meeting were made available through the Cold Spring Harbor Laboratory Press.
The meeting was wholly sponsored by The Perkin-Elmer Corporation. This represents a departure from
the traditional Cold Spring Harbor meeting in that both the scheduling and choice of program and invited
speakers were a joint decision of the Laboratory and the sponsor organization. The Perkin-Elmer Corpora-
tion has supported the Laboratory's program of meetings through the corporate sponsor program since
1989. This special meeting arose since the Laboratory has decided to offer corporations that have already
demonstrated their support for academic meetings through the corporate sponsor program, the opportunity
to sponsor individual technical meetings in Grace Auditorium.
S. Rose, J. Chamberlain T. Caskey, J. Grace, K. Mullis, G. Kelly
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PROGRAM
Introduction: J.D. Watson, Cold Spring Harbor Laboratory
Perspective: K. Mullis
An In-Depth Look at PCR
Chairperson: J. Chamberlain, University of Michigan
Primers, Oligos, and Hybridization, W. Rychlik, National
Biosciences, Inc.
Biology of DNA Polymerases, T. Kunkel, National Institutes
of Health
PCR Automation, Genotyping, S. Rose, Perkin-Elmer Corpo-
ration
Applications of PCR I
Chairperson: J. Chamberlain, University of Michigan
Human Genome Project, G. Evans, University of Texas
Human Genetics, H. Erlich, Roche Molecular Systems
Molecular Diagnostics, T. Caskey, Baylor College of Medi-
cine
Applications of PCR II
Chairperson: S. Rose, Perkin-Elmer Corporation
Forensic Analysis, B. Budowle, FBI Academy
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Ancient DNA/Gene Evolution, S. Paabo, University of
Munich
Agriculture and the Third World, R. Jefferson, CAMBIA
Gene Expression in Single Cells, J. Eberwine, University of
Pennsylvania
In Situ PCR, A. Haase, University of Minnesota
Combinatorial Libraries and Rapid Evolution, A. Ellington, In-
diana University
PCR and Education, D. Mick los, Cold Spring Harbor
Laboratory
The Future of PCR
Chairperson: R. Gibbs, Baylor College of Medicine
Transposon PCR, E. Rose, Perkin-Elmer Corporation
PCR Quantitation, F. Ferre, The Immune Response Corpora-
tion
Analysis of PCR Products in Microchips, S. Fodor, Affymetrix
RNA Differential Display, P. Liang, Dana Farber Cancer In-
stitute
Representational Difference Analysis, N. Lisitsyn, Cold
Spring Harbor Laboratory
Summary, M. Olson, University of Washington
POSTGRADUATE COURSES
The summer program of Postgraduate Courses at Cold Spring Harbor Laboratory is aimed at meet-
ing the special need for training in interdisciplinary subjects that are either so new or so specialized
that they are not adequately treated by universities. Our aim is to provide intensive study in the
most recent developments and techniques in these subjects and to prepare students to enter
directly into research in a particular area. To ensure up-to-date coverage of current research work,
we bring together a workshop staff from many laboratories around the world and supplement this
staff with a series of seminar speakers.
Early Development ofXenopus laevis
April 6-13
INSTRUCTORS
Grainger, Robert, Ph.D., University of Virginia
Sive, Hazel, Ph.D, Whitehead Institute
ASSISTANTS
Amaya, Enrique, University of California, Berkeley
Papalopulu, Nancy, Salk Institute for Biological Studies
This course provided extensive laboratory exposure to the biology and manipulation of embryos
from the frog, Xenopus laevis. The course was particularly suited for investigators who had current
training in molecular biology and knowledge of developmental biology, but had no experience with
Xenopus. Intensive laboratory sessions were supplemented by daily lectures from experts in both
experimental and molecular embryology. Six main areas were covered: (1) care and handling of
adults and embryos, (2) stages of embryonic development and anatomy, (3) whole mount in situ
hybridization and immunocytochemistry, (4) microinjection of eggs and oocytes, (5) microman-
ipulation of embryos, and (6) induction assays. Lecturers and instructors included E. Amaya, R.
Elinson, J. Gurdon, R. Harland, R. Keller, N. Papalopulu, and C. Wylie.
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PARTICIPANTS
Alonso, D., M.S., Conicet, Argentina
Bellefroid, E., Ph.D., George August Universitat, Germany
Beltman, J., Ph.D., Stanford University School of Medicine
Delvecchio, R., Ph.D., Cold Spring Harbor Laboratory
Guadagno, S., Ph.D., University of California, San Diego
Holland, L., Ph.D, University of Missouri School of Medicine
Huard, V., B.S.c., Hotel-Dieu de Quebec, Canada
Jones, T., Ph.D., National Cancer Institute
SEMINARS
Amaya, E., University of California, Berkeley. Pseudogenetic
analysis of Xenopus development.
Elinson, R., University of Toronto. Cytoplasmic organization
of the egg and dorsoventral polarity of the embryo.
Grainger, R., University of Virginia. Completing the body
plan: Inductive mechanisms leading to formation of partic-
ular tissues and organs.
Gurdon, J., Wellcome/Cancer Research Campaign Institute.
From egg to muscle: Localized determinants or cell inter-
actions?
Harland, R., University of California, Berkeley. Molecular na-
Kabler, B., M.D., M.S.c., University of Pisa, Italy
Lagna, G., Ph.D., Rockefeller University
Moos, M., M.D., Ph.D., Food & Drug Administration
Neilson, K., M.S., American Red Cross
Puccini, D., University of Genova, Italy
Shain, D., M.S., Colorado State University
Strobel, S., Ph.D., University of Colorado
Zhang, J.J., M.S., Mt. Sinai School of Medicine
ture of Spemann's organizer: Role of peptide growth fac-
tors.
Keller, R., University of California, Berkeley. Morphogenesis
of the early Xenopus development.
Papalopulu, N., Salk Institute. Neuroanatomy and neural de-
velopment in Xenopus.
Sive, H., Massachusetts Institute of Technology. Antero-
posterior patterning in Xenopus.
Wylie, C., University of Minnesota. Early development and
maternal control of development in Xenopus.
Protein Purification and Characterization
April 6-19
INSTRUCTORS
Burgess, Richard, Ph.D., University of Wisconsin, Madison
Kadonaga, James, Ph.D., University of California, San Diego
Lin, Sue-Hwa, Ph.D., M.D., Anderson Cancer Center, University of Texas
Marshak, Daniel, Ph.D., Cold Spring Harbor Laboratory
ASSISTANTS
Burke, Thomas, University of California, San Diego
Carpino, Nicholas, Cold Spring Harbor Laboratory
Earley, Karen, University of Texas
George, Catherine, University of California, San Diego
Grabski, Anthony, University of Wisconsin, Madison
This course was intended for scientists who are not familiar with techniques of protein isolation and
characterization. It was a rigorous program that included laboratory work all day and a lecture with
discussion session every evening. Each student became familiar with each of the major techniques
in protein purification by actually performing four separate isolations including: (1) a regulatory
protein from muscle tissue; (2) a sequence-specific, DNA-binding protein; (3) a recombinant
protein overexpressed in Escherichia coli; and (4) a membrane-bound receptor. A variety of bulk
fractionation, electrophoretic, and chromatographic techniques were employed including precipita-
tion by salts, pH, and ionic polymers; ion exchange, gel filtration, hydrophobic interaction, and
reverse-phase chromatography; lectin affinity, oligonucleotide affinity, and immunoaffinity chroma-
tography; polyacrylamide gel electrophoresis, and electroblotting; and high-performance liquid
chromatography. Procedures were presented for solubilizing proteins from inclusion bodies and
refolding them into active monomeric forms. Methods of protein characterization were utilized, in-
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cluding immunological and biochemical assays, peptide mapping, amino acid analysis, protein se-
quencing, and mass spectrometry. Emphasis was placed on strategies of protein purification and
characterization, rather than on automated instrumental analysis. Guest lecturers discussed protein
structure, modifications of proteins, methodologies for protein purification and characterization, and
applications of protein biochemistry to cell and molecular biology. Guest lecturers included K. Col-
lins, N. Pace, Y. Paterson, G. Rose, J. Rothman, B. Stillman, and N. Tonks.
PARTICIPANTS
Chung, B.-C., Ph.D., Duke University
Corda, D., Ph.D., Consorzio Mario Negri Sud., Italy
Futcher, B., Ph.D., Cold Spring Harbor Laboratory
Genetta, T., Ph.D., University of Pennsylvania Medical School
Grether, M., Ph.D. Massachusetts Institute of Technology
Hans, S., University of California, San Francisco
MacDonald, M.E., Ph.D., Massachusetts General Hospital
McCarthy, D., Ph.D., University of Oklahoma
Mohnen, D., Ph.D., University of Georgia
SEMINARS
Burgess, R., University of Wisconsin, Madison. (1) Protein
purification: Basic methods. (2) Protein purification: Ad-
vanced methods.
Collins, K., Cold Spring Harbor Laboratory. Purification of
telomerase.
Kadonaga, J., University of California, San Diego. Purification
of transcription factors.
Lin, S.-H., University of Texas. Cell surface proteins.
Marshak, D., Cold Spring Harbor Laboratory. Applications to
microsequencing.
Pace, N., Texas A&M University. Thermodynamics of protein
Parent, S., Ph.D., Merck Research Laboratories
Paty, P., M.D., Memorial Sloan-Kettering Cancer Center
Rawson, R., Ph.D., University of Texas Southwestern Medical
Center
Rupp, B., Ph.D., Lawrence Livermore National Laboratory
Vasil, M., Ph.D., University of Colorado Medical School
Warrior, R., Ph.D., University of Southern California
Williams, K., B.S., Meharry Medical College
folding.
Paterson, Y., University of Pennsylvania. Designing synthetic
antigens.
Rose, G., Washington University. Fundamentals of protein
structure.
Rothman, J., Memorial Sloan-Kettering Institute. Protein traf-
ficking.
Stillman, B., Cold Spring Harbor Laboratory. Eukaryotic DNA
replication proteins.
Tonks, N., Cold Spring Harbor Laboratory. Protein tyrosine
phosphatases.
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Cloning and Analysis of Large DNA Molecules
April 6-19
INSTRUCTORS
Abderrahim, Hadi, Ph.D., Cell Genesys, Inc.
Birren, Bruce, Ph.D., California Institute of Technology
Vollrath, Doug, Ph.D., Stanford University
ASSISTANTS
Dewer, Ken, University of Laval, Canada
Gschwend, Michele, Stanford University School of Medicine
Mendez, Michael, Cell Genesys, Inc.
This course covered the theory and practice of manipulating and cloning high-molecular-weight
DNA. The course focused on the use of yeast artificial chromosome (YAC), bacterial artificial
chromosome (BAC), and bacteriophage P1 cloning systems for library construction and techniques
of pulsed-field gel electrophoresis (PFGE). Lectures and laboratory work included an introduction
to yeast genetics, the isolation and manipulation of high-molecular-weight DNA from a variety of
sources, and preparative and analytical PFGE. YAC, BAC, and P1 clones were produced and char-
acterized by a number of approaches, including library screening, contig assembly, long-range
restriction mapping, and recovery of YAC ends. A variety of size standards for PFGE were
prepared and their separations on many different types of PFGE gel boxes were compared. Lec-
tures by outside speakers on topics of current interest supplemented the laboratory work.
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PARTICIPANTS
Bentley, E., B.S., University College London, United Kingdom
Berx, G., University of Ghent, Belgium
Carriero, F., B.S., Metapontum Agrobious, Italy
Du, L., Ph.D., Shriner's Hospital, Canada
Fulmek, S., M.D., Mt. Sinai Medical Center
Galli, J., Ph.D., Karolinska Institute, Sweden
Leung, M., B.S., Tulane University Medical Center
Lindpainter, K., M.D., Children's Hospital
SEMINARS
Lai, E., University of North Carolina, Chapel Hill. Physical
mapping using PFGE and BAC cloning.
Lisitsyn, N., Cold Spring Harbor Laboratory. Representa-
tional differential analysis.
Lovett, M., University of Texas Southwestern Medical Col-
lege. Identification of genes from large genomic regions by
cDNA selection.
Myers, R., Stanford University. Integrated mapping ap-
proaches for the Human Genome Project.
Advanced Bacterial Genetics
Liu, Q., Ph.D., Myriad Genetics, Inc.
Millar, A., Ph.D., University of British Columbia, Canada
Peichel, C., M.A., Princeton University
Quackenbush, J., Ph.D., Salk Institute
Schutte, M., Ph.D., Johns Hopkins University
Smith, E., Ph.D., Tuskegee University
Swanson, K., B.S., Research Genetics
Wight, D., Ph.D., Ohio University
Shepherd, N., DuPont Merck Pharmaceutical Company. P1
cloning: Principles and applications.
Shizuya, H., California Institute of Technology. The BAC sys-
tem: Library construction, clone analysis, and mapping.
Strauss, W., Whitehead Institute/MIT Center for Genome Re-
search. Construction of transgenic mice using YACs.
Strobel, S., University of Colorado. Chromosome dissection:
Chemical and enzymatic techniques for cleaving complex
DNA at unique sites.
June 10-30
INSTRUCTORS
Maloy, Stanley, Ph.D., University of Illinois, Urbana
Stewart, Valley, Ph.D., Cornell University
Taylor; Ronald, Ph.D., Dartmouth Medical School
ASSISTANTS
Lin, Janine, Cornell University
Pfau, James, Dartmouth Medical School
Muro-Pastor, Alicia, University of Illinois, Urbana
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This laboratory course demonstrated genetic approaches that could be used to analyze biological
processes and their regulation, as well as detailed structure/function relationships of genes. Tech-
niques covered included isolation, characterization, and mapping of mutations; use of trans-
posable genetic elements as mutagens, linked selectable markers and portable regions of homol-
ogy; construction and analysis of operon and gene fusions; use of bacteriophage in genetic analy-
sis; molecular cloning and restriction endonuclease mapping; allele exchange; Southern blot analy-
sis; polymerase chain reaction; and site-specific mutagenesis. The course consisted of a series of
experiments that employed these techniques in the genetic analysis of diverse bacterial and bac-
teriophage species. Lectures and discussions concentrated on the application of genetic analysis
to contemporary questions in bacterial physiology, diversity, and pathogenesis. Guest lecturers
were J. Beckwith, V. Miller, I. Herskowitz, A. Grossman, and N. Trun.
PARTICIPANTS
Barsom, L., B.S., University of Pittsburgh
Boot, H., M.S., University of Amsterdam, The Netherlands
Calla, K., M.D., Massachusetts General Hospital
Dominguez, A., M.D., Hospital Bellvitge, Spain
Feng, X., M.S., Washington State University
Gold, H., M.D., New England Deaconess Hospital
Gupte, G., M.S., Arizona State University
Hendrick, J., Ph.D., Memorial Sloan-Kettering Cancer Center
Hentschel, U., B.S., University of California, San Diego
SEMINARS
Bass ler, B., The Agouron Institute. Intercellular communica-
tion in luminous bacteria: The glow of social interaction.
Highlander, S., Baylor College of Medicine. Using gene fu-
sion in E. colt to identify and characterize regulators of
Pasteurella haemolytica leukotoxin expression.
Silhavy, T., Princeton University. Genetic analysis of protein
secretion in E. coll.
Shuman, H., Columbia University. Genetic analysis of
Holmes, A., M.D., Boston University
Hoover, T., Ph.D., University of Georgia
Krajewska-Gynkiewicz, K., Ph.D., Polish Academy of
Sciences, Poland
Macfadyen, L., B.S., University of British Columbia, Canada
Madison, L., B.S., Harvard Medical School
Troup, B., M.S., Philipps Universitat Marburg, Germany
Van Dissel, J., Ph.D., University Hospital Leiden, The Nether-
lands
Legionella: Identification of genes required for intracellular
manipulation and host cell killing.
Winkler, M., University of Texas Medical School. Mediation of
spontaneous mutagenesis and global control by genes re-
quired for intracellular multiplication and host killing.
Westpheling, J., University of Georgia. Transcriptional regu-
lation of genes for carbon utilization and morphogenesis
and streptomyces.
Molecular Approaches to Ion Channel Structure, Expression,
and Function
June 10-30
INSTRUCTORS
Margulies, Jody, Ph.D., University of California, Los Angeles
Robertson, Gail, Ph.D., University of Wisconsin
Ruben, Peter, Ph.D., University of Hawaii
ASSISTANT
Henteleff, Mark, University of Hawaii
This intensive laboratory/lecture course was designed to introduce students to the combined use of
molecular biological techniques and electrophysiological analysis for the study of ligand-gated and
voltage-gated ion channels. The course covered expression of cloned channels and receptors in
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Xenopus oocytes and cultured cells, including in vitro preparation of RNA transcripts, microinjec-
tion into oocytes, site-directed mutagenesis, and characterization of channels and receptors using
two-electrode voltage clamp and patch clamp. Lectures covered molecular biology and elec-
trophysiology techniques as well as the theory and analysis of ionic currents. Students were en-
couraged to bring their own samples to study using the techniques taught in the course. Guest lec-
turers included J. Adelman, 0. Andersen, F. Bezanilla, R. MacKinnon, G. Mandel, F. Sigworth, J.
Trimmer, and M. White.
PARTICIPANTS
Berthelier, V., B.S., CNRS, France
Cheffings, C., B.A., University of Oxford, United Kingdom
Fraser, D., B.S., University of Calgary, Canada
Huang, C.-C., M.S., University of Oxford, United Kingdom
Linne, M.-L., M.S., University of Tampere, Finland
Lundbaek, J., M.D., Cornell University
SEMINARS
Bennett, M., Albert Einstein College of Medicine. NMDA
receptors.
Bezanilla, F., University of California, Los Angeles. Voltage-
dependent gating.
Czajkowski, C., Columbia University. Mapping the agonist
binding site and channel of the nicotinic Ach receptor.
Goldin, A., University of California, Irvine. Sodium channel in-
activation.
MacKinnon, R., Harvard Medical School. Structure/function
studies in cation selective channels.
Mandel, G., SUNY, Stony Brook. Molecular studies of neural-
specific sodium channels.
Margulies, J., University of California, Los Angeles. Func-
tional analysis of novel signaling proteins (RC3 and Gam-
Moroni, A., Ph.D., University of Milan, Italy
Piedras-Renteria, E., M.S., University of Illinois, Urbana
Rosenthal, J., B.S., Brown University
Wolff, M., M.S., Rhone Poulec AG Company
Yun, L., M.D., Karolinska Institute, Sweden
ZhuGe, R., D.V.M., Iowa State University
ma 7) in oocytes.
Nerbonne, J., Washington University School of Medicine.
Molecular basis of functional channel diversity.
Papazian, D., University of California, Los Angeles. Com-
plementation of folding defects identifies electrostatic inter-
actions of S4 voltage sensor in Shaker K channel.
Robertson, G., University of Wisconsin, Madison. Gating and
modulation in the eag family of potassium channels.
Ruben, P., University of Hawaii. (1) Introduction to voltage
clamping. (2) Gating modes in rat brain sodium channels.
Sigworth, F., Yale University School of Medicine. How do
voltage-gated channels work?
White, M., Medical College of Pennsylvania. Probing the
pocket and pore of the Ach receptor.
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Molecular Embryology of the Mouse
June 10-30
INSTRUCTORS
Mann, Jeff, Ph.D., Beckman Research Institute of the City of Hope
Soriano, Philippe, Ph.D., Fred Hutchinson Cancer Research Center
CO-INSTRUCTORS
Behringer, Richard, Ph.D., University of Texas
Papaioannou, Virginia, Ph.D., Columbia University
ASSISTANTS
Nichols, Jenny, University of Edinburgh, United Kingdom
Pease, Shirley, California Institute of Technology
This course was designed for biologists interested in applying their expertise to the study of mouse
embryonic development. Laboratory components provided an intensive introduction into the techni-
cal aspects of working with and analyzing mouse embryos, and lecture components provided the
conceptual basis for current research. Procedures that were described included isolation and cul-
ture of pre- and postimplantation embryos, oviduct and uterus transfer, formation of aggregation
chimeras, isolation of germ layers in gastrulation-stage embryos, establishment, culture, and genet-
ic manipulation of embryonic stem cell lines, in situ hybridization to whole mounts and sections of
embryos, immunohistochemistry, microinjection of DNA into pronuclei, and microinjection of em-
bryonic stem cells into blastocysts. Speakers were R. Behringer, A. Bradley, M. Bronner-Fraser, V.
Chapman, P. Donovan, T. Gridley, B. Hogan, R. Jaenisch, N. Jenkins, T. Jessell, R. Lovell-Badge,
G. Papaioannou, L. Parada, G. Rinchik, J. Rossant, R. Schultz, S. Strickland, P. Wassarman and D.
Wilkinson.
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PARTICIPANTS
Bates, G., Ph.D., UMDS, Guy's Hospital, United Kingdom
Battaglino, M.S., Mount Sinai School of Medicine
Bowles, J., Ph.D., University of Queensland, Australia
Brophy, P., Ph.D., University of Stirling, United Kingdom
Brusa, R., B.S., University of Heidelberg Germany
Hamre, K., Ph.D., University of Tennessee
Hanlon, D., Ph.D., University of California, San Diego
SEMINARS
Behringer, R., University of Texas. Research talk.
Bradley, A., Baylor College of Medicine. (1) Introduction to
ES cells. (2) Homologous recombination in ES cells.
Bronner-Fraser, M., University of California, Irvine. Cell
lineage in the neural crest.
Jenkins, N., Frederick Cancer Research & Development
Center. History of mouse genetics and research talk.
Jessell, T., Columbia University. Establishing symmetry and
pattern in the vertebrate nervous system.
Lovell-Badge, R., National Institute for Medical Research,
United Kingdom. (1) Introduction to sex determination. (2)
Sex and Sox genes in development.
Mann, J., Beckman Research City of Hope Medical Center.
Genomic imprinting in ES cells and embryos.
McLaren, A., The Wellcome/CRC Institute, United Kingdom.
Primordial germ cells.
McMahon, A., Harvard University. Research talk.
Papaioannou, G., Columbia University. Chimeras in experi-
mental embryology and research talk.
Parada, L., Frederick Cancer Research & Development
Heyer, B., B.S., Max-Planck Institute, Germany
Levi, G., Ph.D., INSERM U368, France
Lutz, B., Ph.D., Baylor College of Medicine
Mo, F.-E., M.S., University of Illinois
Panicker, M., Ph.D., Tata Institute, India
Peralta, D., Ph.D., University of Texas
Wang, Y., Ph.D., Johns Hopkins University
Center. Research talk.
Rinchik, G., Sarah Lawrence College. Genetic resources.
Robertson, L., Harvard University. Research talk.
Rossant, J., Mount Sinai Hospital, Canada. Preimplantation
development and research talk.
Solter, D., Max-Planck Institute of Immunology, Germany.
Genomic imprinting and cellular and nuclear totipotency in
mammals.
Soriano, P., Fred Hutchinson Cancer Research Center. Re-
search talk.
Strickland, S., SUNY at Stony Brook. Maternal control and the
initiation of development.
Tam, P., Children's Medical Research Institute, Australia.
Postimplantation development and research talk.
Wassarman, P., Roche Institute of Molecular Biology. Mech-
anisms of mammalian fertilization and research talk.
Wilkinson, D., National Institute for Medical Research, United
Kingdom. Segmentation in the vertebrate embryo and re-
search talk.
Genetic-Epidemiologic Studies of Complex Diseases
June 15-21
INSTRUCTORS
Risch, Neil, Ph.D., Yale University
Squires-Wheeler, Elizabeth, Ph.D., Columbia University
This course considered the difficulties in studying the genetic basis of complex disorders, such as
diabetes, cardiovascular disease, cancer, Alzheimer's disease, migraine, affective disorder, al-
coholism, and epilepsy, with a particular emphasis on neuropsychiatric conditions. Discussions
were held on genetic-epidemiologic study designs, including family, twin, and adoption studies, as
well as mode of inheritance analyses, and their role in setting the framework for understanding the
genetic and nongenetic components of a disease.
A major focus was on the identification of specific gene effects using both linkage and associa-
tion analyses. Discussions took place on the efficiency and robustness of different designs for such
analysis, as well as how evidence from genetic epidemiologic studies inform both the design and
interpretation of molecular genetic studies. Recent discoveries of genes for both Mendelian and
non-Mendelian diseases guided the discussion of the various methodologic issues.
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PARTICIPANTS
Borg lum, A., M.D., Aahus University, Denmark
Buu, N., B.S., Montreal General Hospital, Canada
Buxbaum, J., Ph.D., Rockefeller University
Ely, J., Ph.D., Trinity University
Gavras, H., M.D., Boston University School of Medicine
Grice, D., M.D., Yale University
Kaufmann, C., M.D., Columbia University
Kelner, K., Ph.D., Science Magazine
Kockum, I., B.A., Karolinska Institute, Sweden
Kowallis, G., M.D., St. Vincent's Hospital
SEMINARS
Eaves, L., Medical College of Virginia. Twin and adoption de-
signs.
Easton, D., Institute of Cancer Research, United Kingdom.
Breast cancer and related disorders.
Keats, B., Louisiana State University Medical Center. Link-
age analysis: Introduction and standard approaches.
Kidd, K., Yale University. Population genetic principles.
Merikangas, K., Yale University. (1) Trait assessment, pre-
valence, and family studies. (2) Neurologic and psychi-
atric disorders.
Ott, J., Columbia University. Complex disorders: Two locus
models and intervening variables.
Marder, K., M.D., Columbia University College of
Physicians/Surgeons
McNamara, J., M.D., Duke University Medical Center
Murray, J., B.S., University Hospital, Canada
O'Connor, D., M.D., University of California, San Diego
Petronis, A., Ph.D., Clark Institute of Psychiatry, Canada
Santangelo, S., Sc.D., New England Medical Center
Tracey, M., Ph.D., Florida International University
Ulrich, M., Ph.D., Elon College
Wadelius, C., Ph.D., University Hospital, Sweden
Ottman, R., Columbia University. Epidemiologic principles.
Pericak-Vance, M., Duke University Medical Center.
Alzheimer's disease.
Peterson, G., Johns Hopkins University. Colon cancer.
Sing, C., University of Michigan Medical School. Coronary
artery disease: Intervening variables.
Spielman, R., University of Pennsylvania. Association
studies.
Suarez, B., Washington University. Linkage analysis: Non-
parametric approaches.
Todd, J., University of Oxford, United Kingdom. Diabetes.
Neurobiology of Human Neurological Diseases: Mechanisms
of Neurodegeneration
June 23-29
INSTRUCTORS:
Choi, Dennis W., Washington University
Mobley, William C., University of California, San Francisco
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Why do neurons and glia die in specific acute or chronic human neurological disorders? Do dif-
ferent pathological deaths share common mechanisms? What practical treatments can be con-
templated? This lecture course explored possible answers to these important questions. Recent
advances in molecular and cell biology have begun to shed light on the mechanisms that underlie
nervous system injury in disease states such as Alzheimer's disease, Huntington's disease, and
stroke. Taking advantage of small class size and extensive discussion, invited faculty lecturers ex-
amined critical issues in their areas of expertise. Overview was provided and course participants
did not need to be familiar with neurological diseases, but the course did focus principally on the
specific hypotheses and approaches driving current research. Emphasis was placed on the highly
dynamic interface between basic the interdependence of clini-
cal research and disease model development, and the value of disease research for understand-
ing the nature of the normal nervous system. An interview was conducted with a patient with
Huntington's disease. Last year's faculty were: M. Chalfie, R. Ciaranello, I. Diamond, K. Fischbeck,
A. Goate, D. Landis, J. McNamara, J. Mazziotta, H. Monyer, L. Ptacek, S. Prusiner, and D. Selkoe.
PARTICIPANTS
Bernstein, H.-G., Ph.D., University of Magdeburg, Germany
Darius, S., M.D., Ph.D., University of Magdeburg, Germany
Dopazo, A., Ph.D., Institute Cajal, Spain
Doster, S.K., M.D., Ph.D., Washington University Medical
School
Gottron, F., B.S., Washington University
Harrigan, M., B.S., University of Washington School of Medi-
cine
Hoban, C., D.Sc., Cambridge NeuroScience, Inc.
Jung, I., B.S., University of Arizona
Kurada, P.K., M.S., University of Notre Dame
Laake, J., M.D., University of Oslo, Norway
Lee, A., B.A., Cyto Therapeutics, Inc.
Chun, W.-L., Ph.D., Abbott Laboratories
SEMINARS
Chalfie, M., Columbia University. Genetically determined
neurodegeneration.
Choi, D., Washington University School of Medicine. (1)
Patient presentation. (2) Excitotoxicity.
Dawson, V., Johns Hopkins University School of Medicine.
Nitric oxide and neurodegeneration.
Malchiodi-Albedi, F., M.D., Ph.D., Institute Superiors Di
Sanita, Italy
Markopoulou, K., Ph.D., University of Nebraska Medical Cen-
ter
McKee, M.A., M.D., National Institutes of Health
McLaughlin, B.A., B.A., University of Pennsylvania
Montemayor, M., B.A., Ph.D., Columbia University College of
Physicians & Surgeons
Neff, N., Ph.D., Cephalon, Inc.
Oron, L., Ph.D., Tel Aviv University
Sheffield, L., M.A., University of Kansas Medical Center
Talbot, C., B.S., Washington University School of Medicine
Tishler, T., B.A., University of California, Los Angeles
Edwards, R., UCLA School of Medicine. Dopamine uptake
and neurodegeneration.
Pinchbeck, K., University of Pennsylvania School of Medi-
cine. Molecular genetics of neurological diseases.
Goate, A., Washington University School of Medicine.
Genetics of familial Alzheimer's disease.
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Hefti, F., Genetech Inc. Therapeutic approaches to neuro-
degeneration.
Hsiao, K., University Hospital, Minneapolis. Animal models of
neurodegeneration diseases.
Kriegstein, A., Columbia University. Epilepsy and neuro-
degeneration.
Landis, D., Case Western Reserve School of Medicine. Role
of glia in CNS injury.
Mobley, W., University of California School of Medicine. (1)
Neuronal growth factors. (2) Taped patient presentation.
Monyer, H., University of Heidelberg, Germany. Glutamate
receptors in health and disease.
Price, D., Johns Hopkins University. Motor neuron disease
and Alzheimer's disease.
Selkoe, D., Brigham & Women's Hospital. Molecular path-
ogenesis of Alzheimer's disease.
Computational Neuroscience: Vision
July 1-14
INSTRUCTORS
Heeger, David, Ph.D., Stanford University
Movshon, J. Anthony, Ph.D., New York University
Simoncelli, Eero, Ph.D., University of Pennsylvania
ASSISTANTS
Carandini, Matteo, New York University
Darrell, Trevor, Massachusetts Institute of Technology
Computational approaches to neuroscience have produced important advances in our understand-
ing of neural processing. Prominent successes have come in areas where strong inputs from
neurobiological, behavioral, and computational approaches can interact. Through a combination of
lectures and hands -on experience with a computer laboratory, this intensive course examined
several areas, including feature extraction, motion analysis, binocular stereopsis, color vision,
higher-level visual processing, visual neural networks, and oculomotor function. The theme was
that an understanding of the computational problems, the constraints on solutions to these prob-
lems, and the range of possible solutions can help guide research in neuroscience. Students had
experience in neurobiological or computational approaches to visual processing. A strong back-
ground in mathematics was beneficial.
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Past lecturers have included E. Adelson, R. Andersen, H. Bulthoff, R. Desimone, R. von der
Heydt, E. Hildreth, P. Lennie, S. Lisberger, J. Malik, J. Maunsell, S. McKee, M. Morgan, K.
Nakayama, W. Newsome, T. Poggio, T. Sejnowski, D. Sparks, S. Ullman, and B. Wandell.
PARTICIPANTS
Backus, B., M.A., University of California, Berkeley
Beutter, B., Ph.D., NASA Ames Research Center
Buracas, G., M.S., Salk Institute
Chen, C.-C., B.S., University of California, Santa Barbara
Cohen, G., M.S., Stanford University Medical Center
Dykstra, T., M.D., University of Nijmegen, The Netherlands
Duvdevani-Bar, S., B.S., M.S., Weizmann Institute of Science,
Israel
Groh, J., M.S., Ph.D., Stanford University School of Medicine
Lin, L.-M., M.S., University of Chicago
Niyogi, S., B.S., M.S., Massachusetts Institute of Technology
Parnas, B., Ph.D., NASA Ames Research Center
SEMINARS
Adelson, E., Massachusetts Institute of Technology. (1) The
elements of early vision, (2) Lightness, transparency, and
shading.
Glimcher, P., New York University. Neurophysiology of sac-
cadic eye movements.
Graham, N., Columbia University. Visual segregation among
textured regions, with an emphasis on low-level mechan-
isms.
Heeger, D., Stanford University. (1) Psychophysical meth-
ods, signal detection theory, and color matching. (2)
Normalization of neural responses in primary visual cortex.
(3) Methods for recovering three-dimensional motion and
shape from image sequences.
Kersten, D., University of Minnesota. Visual perception of the
shapes and depth relationships of surfaces.
Lennie, P., University of Rochester. Color physiology.
Lisberger, S., University of California, San Francisco. (1)
Visual control of eye movements I. Smooth pursuit. (2)
Visual control of eye movements II. Learning in the
vestibulo-ocular reflex.
Arabidopsis Molecular Genetics
Ringach, D., M.S., New York University
Ruksenas, O., Ph.D., Vilnius University, Lithuania
Skoczenski, A., Ph.D., New York University
Speigle, J., B.S., University of California, Santa Barbara
Spivey-Knowlton, M., B.A., University of Rochester
Sumnall, J., B.S., M.S., St. John's College, United Kingdom
Tang, C., M.S., New York University
Teo, P., M.S., Stanford University
Thomas, J.I., Ph.D., University of Pennsylvania
Verghese, P., Ph.D., NASA Ames Research Center
Weiss, Y., M.S., Massachusetts Institute of Technology
Zhou, Y.-X., Ph.D., New York University
McKee, S., Smith-Kettlewell Institute. The psychophysics of
stereopsis.
Movshon, J.A., New York University. (1) Anatomy and
physiology of the retina, lateral geniculate nucleus, and pri-
mary visual cortex. (2) Analysis of pattern motion by area
MT neurons.
Ohzawa, I., University of California, Berkeley. Physiology of
binocular vision and stereopsis.
Shad len, M., Stanford University. (1) Visual motion percep-
tion I: Psychophysics and physiology. (2) Visual motion
perception III: Decisions.
Simoncelli, E., University of Pennsylvania. (1) Introduction to
signal and image processing. (2) Visual motion perception
II: Algorithms and models.
Tanaka, K., Riken Institute, Japan. Processing of visual im-
ages of objects in the inferotemporal cortex.
Wandell, B., Stanford University. (1) Functional imaging of
the human brain. (2) Color appearance: Theory and
measurements.
July 4-24
INSTRUCTORS
Chory, Joanne, Ph.D., Salk Institute
Ecker, Joseph, Ph.D., University of Pennsylvania
Theologis, Athanasios, Ph.D., University of California, Berkeley
ASSISTANTS
Abel, Steffer, University of California, Berkeley
Dunn, Patrick, University of Pennsylvania
Soowal, Lara, Salk Institute
Telfer, Abby, University of Pennsylvania
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This course provided an intensive overview of current topics and techniques in Arabidopsis biol-
ogy, with an emphasis on molecular genetics. It also introduced approaches used in yeast that
have the potential to be utilized for the advancement of Arabidopsis molecular genetics. It was
designed for scientists with experience in molecular techniques who are working or wish to work
with Arabidopsis. The course consisted of a rigorous lecture series, a hands-on laboratory, and in-
formal discussions. Speakers provided both an in-depth discussion of their work and an overview
of their specialty. Speakers included Frederick Ausubel, Development of Model Pathogenesis Sys-
tems in Arabidopsis; Tony Cashmore, The Blue Light Photoreceptor in Arabidopsis; Joanne Chory,
Molecular and Genetic Analysis of Light-regulated Development; Gloria Coruzzi, Molecular
Genetics of Nitrogen Assimilation into Amino Acids in Arabidopsis; Nigel Crawford, The Nitrate As-
similation Pathway: The First Steps in the Acquisition of N2 from the Environment; Gary Drews, Ap-
plications of In Situ Hybridization; Joe Ecker, Physical Mapping of the Arabidopsis Genome;
Pamela Green, Control of mRNA Stability in Plants; Gerry Fink, Molecular Genetics of Growth
Regulation; David Marks, Trichome Development in Arabidopsis as a Model System to Study Cell
Fate and Differentiation; David Meinke, Genetic Dissection of Embryogenesis in Arabidopsis; June
Nasrallah, Pollination Responses in Crucifers; Neil Olzewski, Molecular Genetic Approaches to Un-
derstanding Gibberellin Signal Transduction; Daphne Preuss, Cell-Cell Communication during
Arabidopsis Fertilization; Ian Sussex, Organization and Function of Apical Meristems; Abby Telfer,
Genetic Regulation of Plant Morphogenesis; Athanasios Theologis, Early Events in Plant Hormone
Action; Richard Vierstra, Organization, Function, and Expression of the Ubiquitin Proteolytic Path-
way in Arabidopsis; Robert Waterston, The Caenorhabditis elegans Genome Sequencing Project;
Detlef Weigel, Genetic Hierarchy Controlling Flower Development in Arabidopsis; and Patricia Zam-
bryski, Biology of Agrobacterium.
The laboratory sessions covered Arabidopsis genetics and development; transient gene ex-
pression assays in protoplasts; complementation of yeast mutants for cloning Arabidopsis genes;
two-hybrid system in yeast; transformation by Agrobacterium; in situ detection of RNA; biochemical
analysis of transcription factors; pulsed-field gel electrophoresis; analysis of yeast artificial
chromosomes containing the Arabidopsis genome, and techniques for PCR-based mapping of
mutations.
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PARTICIPANTS
Della Penna, D., Ph.D., University of Arizona
Bergelson, J., Ph.D., Washington University
Chen, L., B.S., University of Illinois, Urbana
Jeddeloh, J., B.A., Washington University
Jones, A., B.S., Washington University
Kauschmann, A., B.S., GmbH, Germany
McKhann, H., Ph.D., C.N.R.S., France
Mundy, J., Ph.D., Copenhagen University, Denmark
Murali, D., Ph.D., Center for Cellular & Molecular Biology,
SEMINARS
Ausubel, F., Harvard Medical School. Development of model
pathogenesis systems in Arabidopsis.
Bender, J., Whitehead Institute. (1) Yeast complementation.
(2) Gene isolation by complementation in yeast.
Cashmore, T., University of Pennsylvania. The blue light
photoreceptor in Arabidopsis.
Chory, J., Salk Institute. Molecular and genetic analyses of
light-regulated development.
Corruzzi, G., New York University. Molecular genetics of
nitrogen assimilation into amino acids in Arabidopsis.
Crews, G., University of Utah. Applications of in situ
hybridization.
Ecker, J., University of Pennsylvania. Physical mapping of
the Arabidopsis genome.
Fink, G., White Institute. Molecular genetics of growth regula-
tion.
Green, P., Michigan State University. Control of mRNA
stability in plants.
Marks, D., University of Minnesota. Trichome development in
Arabidopsis as a model system to study cell fate and dif-
ferentiation.
Meinke, D., Oklahoma State University. Genetic dissection of
embryogenesis in Arabidopsis.
Nasrallah, J., Cornell University. Pollination responses in
Molecular Cloning of Neural Genes
India
Neuenschwander, U., Ph.D., CIBA, Agricultural Biotechnol-
ogy Research
Osteryoung, K., Ph.D., University of Arizona
Overvoode, P., B.S., Washington State University
Pascal, E., Ph.D., University of Illinois, Urbana
Schrick, K., Ph.D., University of Washington, Seattle
Ward, S., B.S., University of Warwick, United Kingdom
Werner, J., Ph.D., University of California, Santa Barbara
crucifers.
Olszewski, N., University of Minnesota. Molecular genetics
approaches to understanding gibberellin signal transduc-
tion.
Preuss, D., Stanford University. Cell-cell communication dur-
ing Arabidopsis fertilization.
Sussex, I., University of California, Berkeley. Organization
and function of apical meristems.
Telfer, A., University of Pennsylvania. Genetic regulation of
plant morphogenesis.
Theologis, A., University of California, Berkeley. Early events
in plant hormone action.
Vierstra, R., University of Wisconsin, Madison. Organization,
functions, and expression of the ubiquitin proteolytic path-
way in Arabidopsis.
Waterston, R., Washington University, St. Louis. The C.
elegans genome sequencing project.
Wiegel, D., Salk Institute. Genetic hierarchy controlling flower
development in Arabidopsis.
Yang, M., SUNY, Stony Brook. The two-hybrid system in
yeast.
Zambryski, P., University of California, Berkeley. Biology of
Agrobacterium.
July 4-24
INSTRUCTORS
Blakely, Randy, Ph.D., Emory University, Atlanta, Georgia
Boulter, James, Ph.D., Salk Institute, La Jolla, California
Chao, Moses, Ph.D., Cornell University, New York, New York
Julius, David, Ph.D., University of California, San Francisco
Lai, Cary, Ph.D., Scripps Research Institute
ASSISTANTS
Bauman, Andrea, Emory University School of Medicine
Elgohyen, Be len, Salk Institute
Kong, Haeyoung, University of Pennsylvania
Sun, Linda, University of California, San Francisco
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This intensive laboratory/lecture course was intended to provide scientists with a basic knowledge
of the use of the techniques of molecular biology in examining questions of neurobiological sig-
nificance. Particular emphasis was placed on using and discussing methods for circumventing the
special problems posed in the study of the nervous system; for example, examination of low abun-
dance mRNAs in extremely heterogeneous cell populations.
The laboratory work included mRNA quantitation methods (nuclease protection, etc.), prepara-
tion of hybridization probes, library construction (? ZAP and 1ST procedure), plaque-screening
techniques (probe hybridization, antibody interaction), DNA sequencing, PCR amplification, and
RNA amplification. A major emphasis of the laboratory work was devoted to characterization and
analysis of nucleic acids. A portion of the laboratory concentrated on gene transfer techniques, in-
cluding the use of Xenopus oocytes and transfection in cultured cells. Other methodologies that
were emphasized were in situ hybridization and DNA sequence analysis. The lecture series, pre-
sented by invited speakers, focused on emerging techniques and how they may be applied to the
of the nervous system. Guest lecturers were R. Edwards, B. Ganetzky, D. Julius, G. Lemke,
C. Lai, G. Mandel, J. Morgan, R. Neve, M.-M. Poo, R. Reed, and A. Silva.
PARTICIPANTS
Arribas, M., Ph.D., Yale University School of Medicine
Balice-Gordon, R., Ph.D., University of Pennsylvania
Blumenstein, S., M.S., Weizmann Institute of Science, Israel
Buser, C., Ph.D., SUNY, Stony Brook
Carnell, L., B.S., University of California, Berkeley
Giffard, R. M.D., Ph.D., Stanford University School of Medi-
cine
Jenner, A., B.A., Harvard Medical School
Kelley, D., Ph.D., Columbia University
SEMINARS
Barres, B., Stanford University School of Medicine. Cell
death and control of cell survival in the oligodendrocyte
lineage.
Cline, H., Cold Spring Harbor Laboratory. Retinotectal
plasticity: Moving toward a molecular genetic analysis.
Eberwine, J., University of Pennsylvania. RNA-binding
proteins and neurological diseases.
Ingraham, H., University of California, San Francisco. Tran-
scriptional regulators in the hypothalamic-pituitary axis.
Lemke, G., The Salk Institute. Targeted disruption of mam-
malian peripheral nervous system development.
Morgan, J., Roche Institute. Genetic control of neural func-
tion: From yeast to transgenic mice.
Niswander, L., Sloan-Kettering Institute. In situ hybridi-
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Lindenboim, L., M.S., Tel Aviv University, Israel
Lois, C., M.D., Rockefeller University
Mc Bain, C., Ph.D., National Institutes of Health
Nitsch, R., M.D., Ph.D., Massachusetts Institute of Technol-
ogy
Osterhout, D., Ph.D., University of Michigan
Rubin, W., B.A., Duke University Medical Center
Storey, K., Ph.D., University of Oxford, United Kingdom
Wigston, D., Ph.D., Emory University School of Medicine
zation-Methods and applications.
O'Malley, K., Washington University School of Medicine. In
vitro and in vivo analysis and neural-specific gene expres-
sion.
Poo, M.-M., Columbia University. Nerve growth, transmitter
secretion, and synaptogenesis: Random walks in culture
dish.
Quinn, A.M., Yale University School of Medicine. Navigating
the World Wide Web: An introduction to Internet services
for the molecular biologist.
Weinmaster, G., University of California, Los Angeles. Func-
tional analysis of rat notch genes
Zinn, K., California Institute of Technology. Cell-fate deci-
sions and axon guidance in the insect CNS.
Neurobiology of Drosophila
July 4-24
INSTRUCTORS
Bieber, Allan, Ph.D., Purdue University
Hardie, Roger, Ph.D., University of Cambridge, United Kingdom
Taghert, Paul, Ph.D., Washington University School of Medicine
ASSISTANTS
Renn, Susan, Washington University School of Medicine
Rutherford, George, Purdue University
This laboratory/lecture course was intended for researchers at all levels who want to use Dro-
sophila as an experimental system for studying neurobiology. Daily seminars introduced the history
behind special topics and further developed those topics by including recent contributions and
outstanding questions. Guest lecturers brought original preparations for viewing and discussion
and/or direct lab exercises and experiments in their areas of special interest.
The course introduced students to various preparations useful for studying Drosophila
neurobiology: the larval and adult nervous systems for studying physiology and behavior and the
embryonic and metamorphosing nervous systems for studying development. Students learned a
broad range of methods including electrophysiological, anatomical, and behavioral techniques that
are critical for the study of Drosophila neurobiology. Topics and techniques of special value in
Drosophila (e.g., an introduction to genetics, early embryogenesis, spreading of chromosomes,
and embryo injections) were also included.
Physiological emphasis was given to genetics and molecular biology of excitability, develop-
mental emphasis to neurogenesis, axonal pathfinding and synaptogenesis, and behavioral empha-
sis to courtship, learning and memory, and biological rhythms. Guest lecturers included C.F. Wu,
R. ffrench-Constant, E. Isacoff, B. Ganetzky, V. Hartenstein, G. Technau, S. Crews, N. Patel, C.
Doe, A. Tomlinson, H. Keshishian, B. Taylor, K. White, R. Davis, R. Jackson, and T. Tully.
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PARTICIPANTS
Atashi, J., B.S., University of North Carolina
Baldwin, D., B.A., University of Washington, Seattle
Forjanic, J.P., B.S., Max-Planck Institute, Germany
Lenz, B., B.A., Max-Planck Institute, Germany
Pereira, H., B.S., York University , Canada
Petersen, C., B.S., Vanderbilt University
Pimentel, A., M.A., City College, New York
SEMINARS
Bieber, A., Purdue University. Axon guidance.
Campos-Ortega, J., University of Koln, Germany. Early
neurogenesis
Carlson, J., Yale University. Sensory transduction.
Dickinson, M., University of Chicago. Wing structure and
function.
ffrench-Constant, R., University of Wisconsin, Madison.
Neurotransmitter receptors.
Hardie, R., Cambridge University, United Kingdom. Physiol-
ogy of the visual system.
Hartenstein, V., University of California, Los Angeles. Em-
bryonic development and early neurogenesis.
Iverson, L., Beckman Research Institute City of Hope. Ion
channels 2.
Jackson, R., Worcester Foundation. Circadian rhythms.
Keshishian, H., Yale University. Muscle development and
Sawin, E., B.S., M.S., McMaster University, Canada
Sayeed, 0., B.A., M.A., Indiana University
Sun, Y., M.S., Oregon State University
Therianos, S., B.A., University of Basel, Switzerland
Van de Goor, J., Ph.D., University of California, San Francis-
co
synaptogenesis.
Patel, N., Carnegie Institute of Washington. Neuronal deter-
mination.
Restifo, L., University of Arizona. Development of the larval
nervous system.
Sokolowski, M., York University, Canada. Behavioral
genetics.
Strausfeld, N., University of Arizona. Brain structure.
Taghert, P., Washington University. Peptide neurotransmit-
ters.
Taylor, B., Oregon State University. Sex determination and
behavior.
Tully, T., Cold Spring Harbor Laboratory. Learning and
memory.
Wu, C.-F., University of Iowa. Ion channels 1.
Molecular Neurobiology: Brain Development and Function
July 17-30
INSTRUCTORS
McKay, Ronald, Ph.D., National Institutes of Health
Reichardt, Louis, Ph.D., University of California, San Francisco
Schwarz, Thomas, Ph.D., Stanford University
This lecture course presented both basic concepts and currently exciting research problems in
molecular neurobiology. It focused on approaches and methods now used to study the develop-
ment and function of the nervous system. Topics covered included gene expression, receptor
structure and function, ion channel cloning, second messenger systems, learning, sensory trans-
duction, behavioral genetics, neural induction, cell lineage, immortal cell lines, cell adhesion, on-
cogenes, and neurite outgrowth. The course provided the opportunity to discuss this rapidly ex-
panding research area with invited lecturers. Individuals from a wide variety of backgrounds (grad-
uate students to faculty) were encouraged to apply. Lectures were given by T. Albright, C. Barg-
mann, J. Byrne, K. Campbell, H. Cine, S. Crews, K. Harris, M. Hatten, R. Jahn, D. Jay, A. Joyner, D.
Julius, L. Katz, S. McConnell, R. McKay, J. Patrick, R. Reed, U. Rutishauser, E. Schuman, T.
Schwarz, M. Simon, and G. Yancopoulos.
PARTICIPANTS
Condie, B., Ph.D., University of Utah
Francesconi, A., Ph.D., Cornell University Medical College
Gadient, R., Ph.D., University of Basel, Switzerland
Goldner, F., M.D., Baylor College of Medicine
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Holz, A., B.S., University of Zurich, Switzerland
Hong, A.-S.T., B.S., National University of Singapore
Hu, B., B.S., University of California, Los Angeles
Laferriere, N., B.S., University of Ottawa, Canada
Lopez-Rubalcava, C., B.S., CINVESTAV, Mexico
Mackarehtschian, K., M.A., Princeton University
Nakagawa, Y., M.D., Tokyo University, Japan
Okada, A., B.A., Columbia University
Rokhsar, D., Ph.D., University of California, Berkeley
Roth, M., Ph.D., Northwestern University
Scott, K.E., B.S., University of California, San Diego
Serpente, N., Ph.D., National Institute of Medical Research,
United Kingdom
Sommer, W., M.D., Karolinska Institute, Sweden
Sutula, T., M.D., Ph.D., University of Wisconsin
Astride V., M.D., Clark Institute of Psychiatry, Canada
Williams, R., Ph.D., Karolinska Institute, Sweden
Yeo, S.-L., B.S., University of Singapore
SEMINARS
Bialek, W., NEC Research Institute, Princeton, New Jersey.
Modeling vision.
Bredesen, D., University of California, Los Angeles. Genetic
control of neural cell death.
Cleveland, D., Johns Hopkins University. Transgenic models
of motoneuron disease.
Doupe, A., University of California, San Francisco. The neural
basis of vocal learning in songbirds.
Hudspeth, J., University of Texas, Dallas. How hearing hap-
pens: Mechanoelectrical transduction, frequency tuning,
and synaptic transmission by hair cells of the inner ear.
Jahn, R., Yale University. Exocytosis of synaptic vesicles: A
neurobiologist's view.
Kaplan, D., National Cancer Institute. Neurotrophins, trk
receptors, and neuronal signal transduction.
Katz, L., Duke University Medical Center. Linking layers and
connecting columns: The formation of cortical circuits.
Malinow, R., Cold Spring Harbor Laboratory. Mechanisms of
synaptic transmission and plasticity in the central nervous
system.
Matthews, G., SUNY, Stony Brook. Neuronal exocytosis and
endocytosis: Physiological perspective.
Mayford, M., Columbia University. Genetic approaches to
synaptic plasticity, learning, and memory.
McKay, R., National Institutes of Health. Neuronal stem cells
in mammals.
Meister, M., Harvard University. Multineuronal signals in
brain development and function.
Movshon, J.A., New York University. Neural basis of visual
motion perception.
Reichardt, L., University of California, San Francisco. Stud-
ies of neuronal survival, differentiation, and axon out-
growth.
Rothman, J., Memorial Sloan-Kettering Cancer Center. Mem-
brane transport in cells and synapses.
Rubenstein, J., University of California, San Francisco. Pat-
terning of the vertebrate forebrain.
Schuman, E., California Technical Institute. Diffusible signals
and long-term potentiation.
Sejnowski, T., Salk Institute. Predictive Heggian learning.
Schwarz, T., Stanford University. Synaptotagmin mutations
and synaptic function.
Ts'0, D., Baylor College of Medicine. Functional organization
and connectivity in visual cortex.
Wilson, M., Massachusetts Institute of Technology. Sleep,
memory, and behaviorally induced changes in hip-
pocampal ensemble activity.
Zuker, C., University of California, San Diego. Molecular
genetics of sensory transduction in Drosophila.
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Yeast Genetics
July 26-August 15
INSTRUCTORS
Kaiser, Chris, Ph.D., Massachusetts Institute of Technology
Michaelis, Susan, Ph.D., Johns Hopkins University
Mitchell, Aaron, Ph.D., Columbia University
CO-INSTRUCTOR
Adams, Alison, University of Arizona
ASSISTANTS
Frand, Alison, Massachusetts Institute of Technology
Li, Weishi, Columbia University
Romano, Julia, Johns Hopkins University
Nijbroek, Gaby, Johns Hopkins University
The major laboratory techniques used in the genetic analysis of yeast were studied, including the
isolation and characterization of mutants, tetrad analysis, complementation, and mitotic recombina-
tion. Micromanipulation used in tetrad analysis was carried out by all students. Molecular genetic
techniques, including yeast transformation, gene replacement, analysis of gene fusions, and elec-
trophoretic separation of chromosomes, were applied to the analysis of yeast DNA. Indirect immu-
nofluorescence experiments were done to identify the nucleus, microtubules, and other cellular
components. Lectures on fundamental aspects of yeast genetics were presented along with semi-
nars given by outside speakers on topics of current interest.
PARTICIPANTS
Batiza, A., M.A., University of Wisconsin, Madison
Biosca, J., Ph.D., Universitat Autonoma, Spain
Dunstan, H., Ph.D., University of Oregon
Grant, A., B.S., Emory University
La Marco, K., Ph.D., Tularik, Inc.
Loidl, J., Ph.D., University of Vienna, Austria
Mitchell, T., Ph.D., Duke University Medical Center
Moczko, M., B.S., Universitat Freiburg, Germany
Mulhaupt, Y., B.S., Ciba Geigy Ltd., Switzerland
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Shani, N., Ph.D., Johns Hopkins University School of Medi-
cine
Srinivasan, S., B.S., M.S., National Institutes of Health
Stochaj, U., Ph.D., McGill University, Canada
Tesseur, I., M.S., Katholieke Universiteit Leuven, Belgium
The lin, A., Ph.D., Dartmouth College
Toikkanen, J., M.S., VTT Biotechnology & Food Research,
Finland
Young, K., Ph.D., American Cyanamid Company
SEMINARS
Adams, A., University of Arizona. Genetic analysis of yeast
cytoskeleton.
Errede, B., University of North Carolina, Chapel Hill. Organi-
zation and dynamics of map-kinase activation pathways in
yeast.
Carlson, M., Columbia University. Transcriptional control in
response to glucose availability.
Fields, S., SUNY, Stony Brook. The two-hybrid system to
detect protein-protein interaction.
Fink, G., Whitehead Institute. Single transduction in haploids
and diploids.
Fox, T., Cornell University. Mitochondria! genetics: Shoot
first, ask questions later.
Futcher, B., Cold Spring Harbor Laboratory. The yeast cell
cycle engine.
Gottschling, D., University of Chicago. Unstable and near the
end: The dynamics of telomeric position effects.
Herskowitz, I., University of California, San Francisco. Spe-
cialized cell types in yeast.
Hieter, P., Johns Hopkins Medical School. Chromosome
transmission, yeast genetics, and human disease.
Kaiser, C., Massachusetts Institute of Technology. Genes
and protein of the secretory pathway.
Michaelis, S., Johns Hopkins Medical School. Maturation and
export of the mating pheromone a-factor.
Mitchell, A., Columbia University. Control of meiotic gene ex-
pression.
Petes, T., University of North Carolina, Chapel Hill. Macro-
and microrearrangements of yeast genome.
Pringle, J., University of North Carolina, Chapel Hill. Bud-site
selection and polarity establishment in yeast.
Rose, M., Princeton University. Nuclear fusion in yeast: A
window onto the functions of microtubules, the SPB, and
the nucleus.
Wig ler, M., Cold Spring Harbor Laboratory. RAS and signal
transduction.
Winston, F., Harvard Medical School. Analysis of histones,
the TATA-binding protein, and other transcription factors of
yeast.
Advanced Molecular Cloning and Expression of Eukaryotic Genes
July 26-August 15
INSTRUCTORS
Burtis, Ken, Ph.D., University of California, Davis
Freedman, Len, Ph.D., Sloan-Kettering Institute
Learned, Marc, Ph.D., University of California, Davis
ASSISTANTS
Towers, Tern, Sloan-Kettering Institute
Case, Ryan, University of California, Davis
This course focused on both the cloning and the characterization of eukaryotic genes to probe their
structure, function, and expression. As a model, they examined cis- and trans-acting components
involved in the regulation of eukaryotic gene expression. Eukaryotic transcription factors were ex-
pressed in E. coli and purified by affinity chromatography. Mutations were generated in the DNA-
binding domain of these factors by oligonucleotide directed and random mutagenesis procedures
and characterized by DNA sequencing and DNA-binding assays. Using both the wild-type and
mutant proteins, students learned the techniques and theory for detecting and characterizing the
interaction between regulatory DNA sequences and trans-acting protein factors. In addition, trans -
faction was used to introduce cloned DNA molecules that had been manipulated in vitro into mam-
malian tissue culture cells. The regulated expression of these transfected DNAs was analyzed by
nuclease protection and enzymatic assays. Finally, expression libraries from various organisms
were prepared and screened with recognition site probes for specific DNA-binding proteins as a
means of learning the theoretical and practical aspects of constructing cDNA libraries. Guest lec-
turers discussed current problems in eukaryotic transcriptional regulation as well as technical ap-
proaches to their solutions. Experience with basic recombinant DNA techniques was a prerequisite
for admission to the course.
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PARTICIPANTS
Au, K., Ph.D., Glaxo Research Institute
Barasch, J., M.D., Ph.D., Columbia University College of
Physicians & Surgeons
Brown, M., Ph.D., Emory University
Ciani, E., B.S., University of Bologna, Italy
Cosby, N.C., Ph.D., University of Missouri, Columbia
Fiddler, T., B.S., Oregon Health Sciences University
Huang, S., M.S., University of Georgia
Krisinski, S., B.S., University of New Mexico
SEMINARS
Burley, S., Rockefeller University. X-ray crystallographic
studies of eukaryotic transcription factors.
Burtis, K., University of California, Davis. Structure and func-
tion of Doublesex proteins of Drosophila.
Carey, M., University of California Medical School, Los
Angeles. Mechanism of DNA binding and transcriptional
activation by GAL4-VP16.
Curran, T., Roche Institute of Molecular Biology. The com-
plex world of Fos and Jun.
Desplan, C., Rockefeller University. Transcriptional control
during early Drosophila development.
Freedman, L., Sloan-Kettering Institute. Modulation of
nuclear receptor target gene selectivity by receptor
dimerization.
Fields, S., SUNY, Stony Brook. The two-hybrid system to
detect protein-protein interaction.
Kornberg, R., Stanford Medical School. Yeast RNA
polymerase II transcription: Structure, mechanism, and
regulation.
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Melendez, P., B.S., University of Puerto Rico
Nel, A., M.D., Ph.D., University of California, Los Angeles
Robles, J., M.S., Promega Corporation
Roxstrom, K.A., B.S., Stockholm University, Sweden
Sastry, G., Ph.D., University of Leeds, United Kingdom
Slezynger, T., Ph.D., Empresas Polar, Venezuela
Smith, E., B.A., M.S., University of Chicago
Turetsky, D., B.S., Washington University Medical School
Learned, M., University of California, Davis. Molecular
genetics of isoprenoid biosynthesis in Arabidopsis.
Smale, S., University of California, Los Angeles. Transcrip-
tional regulation during lymphocyte development: Analysis
of initiator elements and of a composite regulatory region.
Stillman, B., Cold Spring Harbor Laboratory. Mechanism and
regulation of eukaryotic DNA replication.
Struhl, K., Harvard Medical School. Molecular mechanisms
of transcriptional regulation in yeast.
Winston, F., Harvard Medical School. Analysis of histones,
TATA-binding protein, and other transcription factors of
yeast.
Young, R., Whitehead Institute for Biomedical Research. A
pre-assembled complex of general transcription factors
and RNA polymerase II in yeast.
Zaret, K., Brown University. Mechanism of gene activation in
hepatocyte development.
Imaging Structure and Function in the Nervous System
July 26August 15
INSTRUCTORS
Augustine, George, Ph.D., Duke University
Lichtman, Jeff, Ph.D., Washington University
Smith, Stephen, Ph.D., Stanford University
ASSISTANTS
Ba lice-Gordon, Rita, University of Pennsylvania
Dailey, Michael, Stanford University School of Medicine
Eilers, Jens, University of Saarlandes, Germany
Guild, Jeff, Cornell University
Tang, Nina, Duke University
Zipfel, Warren, Cornell University
Advances in optical microscopy and digital image processing, coupled with the development of a
variety of powerful fluorescent probes, present expanding opportunities for visualizing the structure
and function of neurons, synapses, and networks in the brain. This intensive laboratory/lecture
course provided participants with the theoretical and practical tools to utilize these emerging tech-
nologies. The primary emphasis of the course was on optical microscopy-including fluorescence,
differential interference (Normarski), phase, and confocal microscopy-as well as the application of
video cameras and digital image processors to enhance microscopic images. Students used
calcium-sensitive probes (e.g., fura-2), "caged" compounds, exocytosis tracers, and other methods
to explore neuronal function in a variety of neural systems, including living animals, brain slices,
peripheral synapse preparations, acutely dissociated neurons, and cultured cells. A new feature of
this year's course was to have lectures (A. Konnerth) and laboratory exercises on the use of whole-
cell patch-clamp methods to microinject fluorescent indicators into single cells. Applicants had a
strong background in the neurosciences or in cell biology. Lecturers included W. Betz, J. Connor,
S. Fraser, A. Grinvald, T. Inoue, L. Katz, R. Lewis, J. Nerbonne, W. Ross, R.Y. Tsien, W. Webb, and
R. Wick.
PARTICIPANTS
Albuquerque, C., B.S., Columbia University
Avery, R., B.S., Baylor College of Medicine
Beierlein, M., M.S., Brown University
Carey, M., B.S., M.S., Oregon Health Sciences University
Galuske, R., M.D., Max-Planck Institute, Germany
Jordan, C., Ph.D., University of California, Berkeley
SEMINARS
Augustine, G., Duke University Medical Center. (1) Calcium
indicators. (2) Calibration of fluorescent Ca indicator dyes.
Betz, W., University of Colorado School of Medicine. Fluores-
cence measurements of synaptic vesicle cycling.
Cohen, L., Yale University School of Medicine. Voltage-
sensitive dyes.
Conner, J., Roche Institute of Molecular Biology. Calcium im-
aging in brain slices.
Korschina, S., Ph.D., Max-Planck Institute, Germany
Pettit, D., B.A., Duke University Medical Center
Ross, L., Ph.D., Ohio University
Shear, J., B.S., Stanford University
Stoeckli, E., Ph.D., Case Western Reserve University
Tombaugh, G., Ph.D., Duke University Medical Center
Fay, F., University of Massachusetts Medical School. (1)
Digital deconvolution of blurred images. (2) Volume
rendering.
Fraser, S., Beckman Institute. MRI imaging.
Heuser, J., Washington University School of Medicine. (1)
Reflectance microscopy. (2) Demonstration of reflectance
microscopy.
Inoue T., Universal Imaging Corporation. Image processing.
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Katz, L., Duke University Medical Center. Flash photolysis in
brain slices.
Konnerth, A., University of Saalandes, Germany. Patch-
clamp measurements from CNS neurons in slices.
Lewis, R., Stanford University School of Medicine. Calcium
signaling pathways.
Lichtman, J., Washington University. (1) Structure and func-
tion of the light microscope. (2) Fluorescence microscopy.
to confocal microscopy.
Nerbonne, J., Washington University School of Medicine. (1)
Advanced Drosophila Genetics
Design of caged compounds. (2) Acute dissociation of cen-
tral neurons.
Smith, S., Stanford University School of Medicine. (1) Inter-
ference microscopy. (2) Detectors for imaging, Part I. (3)
Detectors for imaging, Part II. (4) Properties of video sig-
nals. (5) Laser confocal microscopy.
Tsien, R., University of California, La Jolla. Design and func-
tion of indicator dyes.
Webb, W., Cornell University. 2-Photon microscopy.
August 1-14
INSTRUCTORS
Ashburner, Michael, Ph.D., University of Cambridge, United Kingdom
Hawley, Scott, Ph.D., University of California, Davis
This intensive seminar course provided an introduction to the theory and practice of methods used
to manipulate the Drosophila genome. It was suitable for graduate students and researchers with
some experience with Drosophila who are interested in expanding their knowledge of the wide
range of genetic techniques now available for use with this organism. Topics covered included
chromosome mechanics, the design and execution of genetic screens, and the use of trans-
posable elements as genetic tools.
PARTICIPANTS
Afshar, K., B.S., University of California, Davis
Bhattacharya, A., M.S., Indian Institute of Science, India
Birman, S., Ph.D., University of Virginia
Broadie, K., Ph.D., University of Cambridge, United Kingdom
Brummel, T., B.A., University of California, Irvine
Burgess, R., B.S., Stanford University Medical School
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Diamond, M., M.D., Ph.D., University of California, Berkeley
Grammont, M., INSERM, France
Grieder, N., B.S., University of Basel, Switzerland
Haenlin, M., Ph.D., LGME, France
Kelly, D., B.S., University of Glasgow, United Kingdom
Marques, G., Ph.D., University of California, Irvine
Myers, M., Ph.D., Rockefeller University
Mythreyi, D.S., B.S., Iowa State University
Pinter, M., Ph.D., Hungarian Academy of Sciences, Hungary
Swanson, B., M.D., CNRS, France
SEMINARS
Ashburner, M., Cambridge University, United Kingdom.
Evolution of the genus Drosophila.
Bingham, P., SUNY, Stony Brook. Nuclear structure, gene
structure, and gene isolation in Drosophila.
Cherbas, P., University of Wisconsin, Madison. Somatic cell
genetics of Drosophila.
Cline, T., University of California, Berkeley. Genetic dissec-
tion of the sex determination gene hierarchy in D.
Engels, W., University of Wisconsin, Madison. P element biol-
ogy and gene replacement techniques.
Ganetsky, B., University of Wisconsin, Madison. Neuro-
genetics of ion channels in Drosophila: From mutants to
molecules.
Macromolecular Crystallography
Scholz, H., B.S., University of Koln, Germany
Wisotzkey R Ph D Massachusetts General Hospital
Zars, T., M.A., University of Notre Dame
Zhang, N., Ph.D., Roche Institute of Molecular Biology
Hall, J., Brandeis University. What can behavioral analysis
tell us about Drosophila genetics and its genome?
Hawley, S., University of California, Davis. (1) An introduction
of Drosophila genetics. (2) Chromosome rearrangements.
(3) Meiosis in Drosophila males and females.
Lehmann, R., Whitehead Institute. Making and analyzing de-
velopmental mutants.
Perrimon, N., Harvard Medical School. Mosaic analysis.
Spradling, A., Carnegie Institution of Washington. Single P
element insertional mutagenesis.
Theukauf, W., SUNY, Stony Brook. Looking at the cyto-
skeleton during oogenesis and embryogenesis.
October 13-26
INSTRUCTORS
Furey, William, Ph.D., V.A. Medical Center
Gilliland, Gary, Ph.D., Center for Advanced Research in Biotechnology
McPherson, Alexander, Ph.D., University of California, Riverside
Pflugrath, James, Ph.D., Molecular Structure Corporation
ASSISTANT
Ji, Xinhau, Center for Advanced Research in Biotechnology
Crystallography and X-ray diffraction yield a wealth of structural information unobtainable through
other methods. This intensive laboratory/computational course focused on the major techniques
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used to determine the three-dimensional structures of macromolecules. It was designed for
scientists with a working knowledge of protein structure and function, but who are new to macro-
molecular crystallography. Topics covered included protein crystallization, crystal characterization,
data collection, cryo-crystallography, data reduction, anomalous dispersion, phase determination,
molecular replacement and averaging, electron density interpretation, structure refinement,
molecular graphics, molecular dynamics, and multidimensional nuclear magnetic resonance.
Participants learned through extensive hands-on experiments, informal discussions, and lectures
on current applications of these and related procedures given by outside speakers.
PARTICIPANTS
Adams, A., Ph.D., University of Dublin, United Kingdom
Braig, K., Ph.D., Yale University
Darimont, B., Ph.D., University of California, San Francisco
de la Calle, A., M.S., Harvard Medical School
Donlan, M., Ph.D., Molecular Simulations Inc.
Groppe, J., Ph.D., Biozentrum, Switzerland
Ladias, J., M.D., Harvard Medical School
Larsen, T., B.S., University of Copenhagen, Denmark
Mohammadi, M., Ph.D., New York University Medical Center
SEMINARS
Brunger, A., Yale University. Simulated annealing refinement
and the free R-factor.
Cheng, X., Cold Spring Harbor Laboratory. DNA modifica-
tion by methyltransferase.
Clore, G.M., National Institutes of Health. Determination of
high-resolution structures of proteins by 3D and 4D NMR.
Fitzgerald, P., Merck Research Laboratories. (1) Molecular
replacement: An overview. (2) HIV protease: A target for
structure-based drug design.
Furey, W., V.A. Medical Center. (1) Noncrystallographic
symmetry and molecular averaging. (2) Phasing statistics:
What do those numbers mean? Do they lie? (3) Isomor-
phous replacement.
Gilliland, G., Center for Advanced Research in Biotechnol-
ogy. (1) Development of crystallization strategies. (2)
Glutathione S-transferase: Crystallographic analysis of
catalysis and substrate specificity.
Ginell, S., Brookhaven National Laboratory. Cryocrystal-
lography and the immortal crystal.
Harrison, S., Harvard University. Applications of molecular
averaging in virus crystallography and elsewhere.
Heinemann, U., Max-Delbruck Centrum, Germany. (1) Crys-
tallization and structure analysis of DNA and DNA/protein
complexes. (2) The universal nucleic-acid-binding cold-
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Montoya, G., Ph.D., EMBL, Germany
Reichert, P., M.D., Shering-Plough Research Institute
Ribeiro, S., B.S., Max-Planck Institute, Germany
Schad, E., B.S., M.S., University of Lund, Sweden
Smith, C., B.S., University of Michigan
Tran, A., M.A., Brookhaven National Laboratory
West, A., Ph.D., University of Medicine & Dentistry of New
Jersey
shock domain.
Kjeldgaard, M., Aarhus University, Denmark. Electron density
map interpretation for A to 0.
McPherson, A., University of California, Riverside. (1) Crystal-
lization of macromolecules. (2) What is a crystal? Miller in-
dices, Bragg's Law. (3) Fourier transforms and the electron
density equations.
Newcomer, M., Vanderbilt University. Crystallographic
studies on retinoid-binding proteins.
Otwinowski, Z., University of Texas Southwestern Medical
Center. (1) Scaling and merging of data. (2) Sources of er-
rors in measurements.
Pflugrath, J., Molecular Structure Corporation, Texas. Data
Collection: Design and setup.
Smith, J., Purdue University. (1) MAD phasing: From theory
to experiment. (2) Crystallographic problems and solutions
in the structure determination of GMP synthetase.
Sprang, S., University of Texas Southwestern Medical Cen-
ter. Mechanism of G-protein a subunits.
Sweet, R., Brookhaven National Laboratory. X-ray sources
and optics.
Tronrud, D., University of Oregon. Macromolecular refine-
ment.
Analysis and Genetic Manipulation of Yeast Artificial
Chromosomes (YACs)
October 13-26
INSTRUCTORS
Carle, Georges, Ph.D., Universite de Nice, France
Green, Eric, Ph.D., National Institutes of Health
Huxley, Clare, Ph.D., St. Mary's Hospital Medical School, United Kingdom
ASSISTANTS
Courseaux, Anouk, Universite de Nice, France
Borbye, Lisbeth, National Institutes of Health
Manson, Ania, St. Mary's Hospital Medical School, United Kingdom
Cloning in yeast artificial chromosomes (YACs) is rapidly being applied to a wide variety of
molecular genetic problems. This course provided basic scientific expertise in current techniques
for the analysis and manipulation of YACs. In general, a blend of theoretical and practical informa-
tion was provided, with the goal of establishing a strong foundation for applying YAC cloning to a
diversity of scientific problems. Topics included standard yeast genetic techniques (such as the
propagation and storage of cells, tetrad dissection, colony hybridization, and DNA transformation),
YAC library screening, characterizing YAC inserts by pulsed-field gel electrophoresis and PCR,
manipulating YAC clones by recombination-mediated disruption, targeted integration, and YAC-
YAC recombination, identifying genes in YACs, and techniques for introducing YACs into mam-
malian cells. Participants learned through hands-on experience, informal discussions, and lectures
given by prominent experts designed to complement the experimental activities.
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PARTICIPANTS
Alderborn, A., Ph.D., University Hospital, Sweden
Banga, S., Ph.D., New Jersey Medical School
Bilbe, G., M.D., Ciba-Geigy, Switzerland
Byrne, K., B.S., University of Queensland, Australia
Compton, S., M.A., National Institutes of Health
Hiemisch, H., German Cancer Research Center, Germany
Kaname, T., M.D., Ph.D., Kumamoto University School of
Medicine, Japan
Kimbro, K., Ph.D., The Children's Hospital
SEMINARS
Carle, G., Universite de Nice, France. Meiotic and mitotic
recombination between overlapping YACs.
Cook, G., MRC Laboratory of Molecular Biology, United
Kingdom. Analyzing complex gene families.
Gnirke, A., Mercator Genetics, Inc. RARE cleavage analysis
of YACs.
Green, E., National Institutes of Health. Application of YAC
cloning to the mapping of human chromosomes.
Huxley, C., St. Mary's Hospital Medical School, United King-
dom. Transfer of YACs into mammalian cells.
Kulkarni, G., Ph.D., University of North Texas
Matza, Y., B.S., Tel Aviv University, Israel
McCormick, S., Ph.D., Gladstone Institute of Cardiovascular
Disease
Ngan, B., M.D., Ph.D., FRCP. University of Toronto, Canada
Perez-Jimenez, J., B.S., University of Puerto Rico
Szalay, A., B.S., M.S., Ph.D., University of Alberta, Canada
Xu, J., Ph.D., Purdue University
Krizman, D., National Institutes of Health. Identifying genes in
genomic clones by exon trapping.
Lovett, M., University of Texas. Identifying genes in genomic
clones by direct selection.
Rodstein, R., Columbia University. Introduction to yeast.
Schwartz, D., New York University. New physical ap-
proaches to genome analysis.
Spencer, F., Johns Hopkins University School of Medicine.
Methods for YAC analysis: The Johns Hopkins tool kit for
YAC manipulation.
Advanced In Situ Hybridization and Immunocytochemistry
October 18-31
INSTRUCTORS
Hough, Paul, Ph.D., Brookhaven National Laboratory
Jacobson, Ken, Ph.D., University of North Carolina, Chapel Hill
Mastrangelo, Iris, Ph.D., Brookhaven National Laboratory
Spector, David, Ph.D., Cold Spring Harbor Laboratory
Ried, Thomas, Ph.D., National Institutes of Health
ASSISTANTS
Derby, Robert, Cold Spring Harbor Laboratory
Oliver, Tim, University of North Carolina, Chapel Hill
Sheets, Erin University of North Carolina, Chapel Hill
This course focused on specialized techniques in microscopy related to localizing DNA sequences
and proteins in cells and preparing DNA and DNA-protein spreads for microscopic examination.
The course emphasized the use of the latest equipment and techniques in epifluorescence micro-
scopy, confocal laser scanning microscopy, electron microscopy, and digital image processing.
The aims of the course were designed to provide state-of-the-art technology and scientific ex-
pertise in the use of microscopic applications to address basic questions in genome organization
and cellular and molecular biology. The course was designed for the molecular biologist who was
in need of microscopic approaches and for the cell biologist who was not familiar with the practical
application of advanced techniques presented in the course. Among the methods presented were
the preparation of tagged nucleic acids probes, fixation methods, detection of multiple DNA se-
quences in single nuclei or chromosome spreads, use of a variety of reporter molecules and non-
antibody fluorescent tags, indirect antibody labeling, and detection of multiple proteins in a single
cell. In addition, molecular electron microscopy was used to examine DNA-protein interactions. In
228
each method, several experimental protocols were presented allowing the students to assess the
relative merits of each and to relate them to their own research. Students were encouraged to bring
nucleic acid or protein probes to the course, which were used in addition to those provided by the
instructors. The laboratory portion of the course was supplemented by invited lecturers who gave
up-to-the-minute reports on current research using the techniques being presented in the course.
PARTICIPANTS
Bear, D., Ph.D., University of New Mexico Cancer Center
Bonner, W., Ph.D., National Institutes of Health
Heby, 0., Ph.D., University of Umea, Sweden
Hendricks-Munoz, K., M.D., Ph.D., New York University
Medical Center
Huie, P., M.A., Stanford University Medical Center
Lewis, A., D.V.M., Children's Hospital Research Foundation
Lund, L., Ph.D., University of California, San Francisco
Moseley, C., B.S., Meharry Medical College
Richardson, J., D.V.M., Ph.D., University of Texas South-
SEMINARS
Bagasra, 0., Thomas Jefferson University. In situ PCR and its
applications in research and diagnosis.
Brinkley, W., Baylor College of Medicine. Ultrastructural or-
ganization of the kinetochore.
Hough, P., Brookhaven National Laboratory. Image produc-
tion in the electron microscope and brief overview of dif-
ferent applications.
Jacobson, K., University of North Carolina, Chapel Hill. Basic
introduction to light microscopy and fluorescence.
Lanni, F., Carnegie-Mellon University. Near field and stand-
ing wave microscopy.
Murray, J., University of Pennsylvania. Use of confocal mi-
western Medical Center
Rothenpieler, U., M.D., University of Munich, Germany
Sandbrink, R., Ph.D., University of Heidelberg, Germany
Soderberg, C., M.S., B.S., University of Uppsala, Sweden
Stein, E., B.S., Vanderbilt University
Thou less, M., Ph.D., University of Washington, Seattle
Tsou, H., M.D., Beth Israel Hospital
Yamanaka, S., M.D., Ph.D., Gladstone Institute of Cardiovas-
cular Disease, California
croscopy and deconvolution techniques.
Oshira, M., Hamamatsu Photonic Systems, Inc. Video mi-
croscopy.
Ried, T., National Institutes of Health. Comparative genomic
hybridization.
Singer, R., University of Massachusetts Medical School.
Cytoplasmic organization of mRNA.
Spector, D., Cold Laboratory. (1) Immune-
cytochemistry. (2) An integrated microscopic approach to
examining nuclear organization.
Waggoner, A., Carnegie-Mellon University. Development of
fluorochromes and filters for fluorescence microscopy.
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Molecular Genetics, Cell Biology, and Cell Cycle of Fission Yeast
November 1-14
INSTRUCTORS
Chappell, Tom, Ph.D., University College London, United Kingdom
Young, Paul, Ph.D., Queens University, Canada
ASSISTANTS
Balasubramanian, Mohan, Vanderbilt University School of Medicine
Den Haese, Greg, Vanderbilt University School of Medicine
Panaretou, Barry, University College London, United Kingdom
Studies with the fission yeast Schizosaccharomyces pombe have contributed greatly to the field of
cell cycle research and have prompted a broad interest in the biology of this organism. S. pombe
is increasingly being chosen as a model organism for investigations into other aspects of cell biol-
ogy and genetics using the powerful molecular and genetical techniques available. The content of
the course reflected all these areas of interest and provided participants with the skills necessary to
pursue their own investigations. Topics covered included mutagenesis and analysis of mutants,
transformation and gene transplacement techniques, extraction of proteins, preparation of nuclear
DNA, plasmid recovery from yeast into bacteria, cell cycle methods, cytology, and immunological
techniques. In addition to hands-on experience, participants had the opportunity to learn through
informal group discussions and formal lectures given by prominent S. pombe researchers drawn
from the expanding international community.
PARTICIPANTS
Brisken, C., M.D., Whitehead Institute
Champlin, E., M.S., Colby College
Cooper, J., Ph.D., University of Colorado, Boulder
Ghazvini, M., B.S., Institut Pasteur, France
Higgins, R., Ph.D., Memorial Sloan-Kettering Cancer Center
Kelman, B.S., M.S., Cornell University Medical College
Martin, B.S., Ph.D., Memorial Sloan-Kettering Cancer Center
May, K., B.S., University College London, United Kingdom
Ritchie, S., M.S., Simon Fraser University, Canada
Rupes, I., Ph.D., St. John's University
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SEMINARS
Balasubramanian, M., Vanderbilt University School of Medi-
cine. Cytoskeletal elements associated with septum for-
mation in fission yeast.
Chappell, T., University College London, United Kingdom.
Regulation of Golgi development in fission yeast.
Connelly, T., Cold Spring Harbor Laboratory. Cell cycle con-
trol.
Den Haese, G., Vanderbilt University School of Medicine.
Threonine-14 phosphorylation of cdc2 is mediated by
weel in fission yeast.
Enoch, T., Harvard Medical School. Checkpoint control in fis-
sion yeast.
Computational Genomics
Hoffman, C., Boston College. G proteins and tyrosine phos-
phatase activators of S. pombe adenylate cyclase.
Klar, A., ABL-Basic Research Program. Developmental deci-
sions in yeast and mice.
McLeod, M., SUNY, Brooklyn. Initiation of meiosis.
Russell, P., Scripps Research Institute. Cell cycle control in
fission yeast.
Wig ler, M., Cold Spring Harbor Laboratory. RAS signal
transduction.
Young, P., Queens University, Canada. Ion transport and pH
regulation in yeast.
November 2-7
INSTRUCTORS
Marr, Thomas, Ph.D., Cold Spring Harbor Laboratory
Pearson, William, Ph.D., University of Virginia
Smith, Randall, Ph.D., Baylor College of Medicine
This course was intended to be a comprehensive overview of the theory and practice of some of
the major computational methods and tools for genomic analysis. Topics included tools for access-
ing computational resources over the Internet, the analysis of complex genetic traits, theory, and
practice of DNA sequence assembly, protein evolution and analysis (including tools for viewing
and analyzing 2-D and 3-D structures of proteins from the perspective of primary sequence analy-
sis), theory and practice of DNA and protein sequence analysis and statistical scoring systems,
and interpretation of matches, multiple sequence alignment, and sequence clustering techniques.
State-of-the-art UNIX workstations and computer programs were used and made available to stu-
dents. The course was intended for people with a solid fundamental knowledge of using UNIX
workstations who wanted to acquire significant skills in the area of computational genome analysis.
This course was ideal for computer core directors and staff for molecular biology and genetics
resources, for biologists wishing to acquire advanced skills in genome analysis, and for scientists
from other disciplines, such as computer science and physics, who wished to gain an overview of
the state-of-the-art work in this area. Funding for this course was provided by the National Center
for Human Genome Research at the National Institutes of Health. Instructors included S. Altschul,
W. Chang, D. Davison, J. Kececioglu, G. Myers, and G. Schuler.
PARTICIPANTS
Bouffard, G., B.S., National Institutes of Health
Bryer, J., B.S., Simon Fraser University, Canada
Cowles, S., Ph.D., Stanford University
Feldmann, K., M.S., Max-Planck Institute, Germany
Grimaila, R., B.S., M.S., Burroughs Wellcome Company
Hastwell, C., M.S., SmithKline Beecham, United Kingdom
Learn, G., Ph.D., Stanford University
Lewitter, F., Ph.D., Whitehead Institute
Maidak, B., Ph.D., University of Illinois, Urbana
Miller, M., Ph.D., National Institutes of Health
Nakai, K., Ph.D., National Institute for Basic Biology, Japan
Omani, K., B.S., DuPont Central Research & Development
Price, C., B.A., M.S., University of Nebraska Medical Center
Reid, R., B.S., SmithKline Beecham Pharmaceuticals
Roter, A., Ph.D., Sequana Therapeutics
Rousley, S., B.S., University of California, San Diego
Sartiel, A., M.S., Tel Aviv University, Israel
Servenius, B., Ph.D., Lund University, Sweden
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SEMINARS
Altschul, S., National Institutes of Health. Sequence
matching-Theory and statistical evaluation.
Chang, W., Cold Spring Harbor Laboratory. Sequence
matching-More theory and practice.
Davison, D., University of Houston. Molecular biology
resources on Internet.
Kececioglu, J., University of California, Davis. Multiple se-
quence alignment-Theory and a new algorithm.
Marr, T., Cold Spring Harbor Laboratory. (1) Introduction
and overview. (2) Wrap-up, summary, course evaluation.
Myers, G., University of Arizona. DNA sequence assembly.
Pearson, W., University of Virginia. (1) Protein evolution. (2)
Sequence matching-Practice.
Schuler, G., National Institutes of Health. MACAW and NCB!
applications.
Smith, R., Baylor College of Medicine. (1) Pattern-induced
multiple sequence alignment. (2) Multiple sequence align-
ment laboratory.
Molecular Markers for Plant Breeding and Plant Genetics
November 8-21
INSTRUCTORS
Burr, Ben, Ph.D., Brookhaven National Laboratory
Doerge, Rebecca, Ph.D., Cornell University, Ithaca
Tingey, Scott, Ph.D., DuPont Experimental Station
ASSISTANT
del Tufo, Joseph, DuPont Experimental Station
The course was designed to explore both theoretical and practical concepts for the use of
molecular markers in plant genetics and plant breeding. This was accomplished through invited
lecturers, lab work, interactive instruction, and computational analysis. Participants learned ap-
proaches to problems such as single gene introgression, analysis of genetic diversity, gene map-
ping, and quantitative trait analysis. The techniques employed were DNA-amplification-based and
included simple-sequence repeat polymorphisms, RAPDs, RFLPs, and bulk segregant analysis.
Computational work included utilization of databases, gene mapping, quantitative trait mapping,
and germplasm analysis. A variety of mapping techniques from both plant and animal systems
were examined with respect to their strengths for specific purposes. Experimental design and
potential future strategies were emphasized. The 15 students were outstanding and represented a
broad variety of backgrounds. The lecturers were W. Beavis, M. Clegg, D. Duvick, M. Gale, M.
Mazur, R. Michelmore, A. Rafalski, J. Romero-Severson, R. Sederoff, S. Tanks ley, and J. Wendel.
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PARTICIPANTS
Cervera, M., Ph.D., University of Gent, Belgium
Chaparro, J., Ph.D., Forbia Pty, Australia
Devaux, P., M.S., Ph.D., Florimond Desprez Seed Company,
France
DeVerno, L., M.S., Petawawa National Forestry Institute, Can-
ada
Dookun, A., B.S., M.S., Ph.D., Mauritius Sugar Industry Re-
search Institute, Mauritius
Garcia, G., M.S., North Carolina State University
SEMINARS
Beavis, W., Pioneer Hi-Bred International. Lessons from com-
parative linkage mapping and QTL analysis.
Clegg, M., University of California, Riverside. Molecular
diversity in plant species.
Duvick, D., Iowa State University. Molecular markers in plant
breeding-A view from the field.
Gale, M., John Innes Centre, United Kingdom. Wheat
genome research, maps, markers, and comparative
genetics.
Mazur, B., DuPont Company. Development of improved
quality grains through biotechnology.
Michelmore, R., University of California, Davis. The future of
Ghislain, M., Ph.D., International Potato Center, Peru
Lio, P., M.S., University of Florence, Italy
Prosen, D., Ph.D., Harris Moran Seed Company
Satagopan, J., M.S., University of Wisconsin, Madison
Sebastian, L., Ph.D., PhilRice Research Institute, Philippines
Shoemaker, J., M.S., North Carolina State University
Sterling, F., B.S., Chiquita Brands International, Costa Rico
Taramino, G., B.S., Ph.D., E.I. DuPont de Nemours
Vogel, J., B.S., Ph.D., E.I. DuPont de Nemours
molecular markers and the manipulation of disease
resistance.
Rafalski, A., DuPont Company. Choosing technologies for
marker-assisted breeding and genetic mapping.
Romero-Severson, J., Mycogen Company. Statistical treat-
ment of molecular markers and quantitative trait loci.
Sederoff, R., North Carolina State University. Application of
molecular markers to novel genetic systems.
Tanks ley, S., Cornell University. Map-based cloning of a dis-
ease resistance gene in tomato.
Wendel, J., Iowa State University. The evolution of cotton and
its genome.
Monoclonal Antibodies from Combinatorial Libraries
November 8-21
INSTRUCTORS
Barbas, Carlos, Ph.D., Scripps Research Institute
Burton, Dennis, Ph.D., Scripps Research Institute
CO-INSTRUCTOR
Silverman, Gregg, Ph.D., University of California, San Diego
ASSISTANTS
Bastidas, Raiza, Scripps Research Institute
Briones, Amelia, Scripps Research Institute
Pilkington, Glenn, American Bio-Technologies
Recent advances in the generation and selection of antibodies from combinatorial libraries allow for
the rapid production of antibodies from immune and nonimmune sources. This laboratory/lecture
course focused on the construction of combinatorial antibody libraries expressed on the surface of
phage and selection of desired antibodies from libraries by panning. Students learned the theoreti-
cal and practical aspects of constructing combinatorial libraries from immune and nonimmune
sources as well as the construction of synthetic antibody libraries. Production, purification, and
characterization of Fab fragments expressed in E. co/i were also covered. The lecture series, pre-
sented by a number of invited speakers focused on the biology of filamentous phage and the utility
of surface expression libraries, expression of antibodies in E. coil and mammalian cells, antibody
structure and function, antibody diversity, catalytic antibodies, and recent results on the use of
antibodies in therapy.
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PARTICIPANTS
Almeida, F., B.S., University of Lisbon, Portugal
Berry, J., B.S., University of Manitoba, Canada
Chen, L., Ph.D., National Institutes of Health
Haahr-Hansen, M., M.S., DAKO A/S, Denmark
Klasse, P.J., M.D., Ph.D., Institute of Cancer Research,
United Kingdom
Lee, M.-C., Ph.D., Beckman Instruments, Inc.
Lesseur, M.C., B.S., Empresas Polar, Venezuela
Machado, D., M.S., University of Sheffield, United Kingdom
Masataka, T., Ph.D., Tokai University, Japan
SEMINARS
Barbas, C., The Scripps Research Institute. Synthetic human
antibodies.
Burton, D., The Scripps Research Institute. Human anti-
bodies from phage display libraries.
Carter, P., Genetech, Inc. Expression of antibodies and
antibody fragments.
Janda, K., The Scripps Research Institute. Catalytic anti-
bodies.
Larrick, J., Palo Alto Institute for Molecular Medicine. An
Minenkova, 0., Ph.D., University of Rome, Italy
Ojala, P., M.S., Medix Biochemica, Finland
Penneck, 0., M.S., USAMRIID
Rimarachin, J., M.D., Ph.D., Cornell University Medical Col-
lege
Shearing, L., B.S., La Trobe University, Australia
Sinclair, C., B.S., Ph.D., University of Glasgow, United King-
dom
van den Bos, C., M.S., Ph.D., Cold Spring Harbor Laboratory
overview of antibodies in biotechnology.
Model, P., Rockefeller University. Phage biology.
Sanz, I., University of Texas Health Science Center. Genera-
tion and features of antibody diversity.
Scott, J., Simon Fraser University, Canada. Phage display.
Silverman, G., University of California, San Diego. Evaluation
of diversity in combinatorial antibody libraries.
Wilson, I., The Scripps Research Institute. Structural basis of
antigen recognition by antibody.
The Laboratory would like to acknowledge the generosity of the following companies who loaned
equipment and reagents to the various courses:
Adams & List Assoc. Ltd.
Alpha Innotech Corporation
Ambion, Inc.
AMRESCO, Inc.
Axon Instruments Inc.
Baxter Scientific
Becton-Dickinson
BIO 101, Inc.
Bio Control
Bio -Rod Laboratories
Biometra Inc.
Boehringer Mannheim Corp.
Brinkmann Instruments, Inc.
C.B.S. Scientific Co. Inc.
Cellex Biosciences Inc.
Chroma Technology Corp.
Dage-MTI, Inc.
Denton Vacuum
Digital Instruments
Drummond Scientific Co.
DYNAL, Inc.
Edge Scientific Instrument
Corporation
Electron Microscopy Sciences
Epicentre Technologies
Eppendorf
FMC Corporation
Fostec, Inc.
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Gatan Inc.
General Valve Corporation
Grass Instrument Company
Hamamatsu Photonic Systems
Hewlett-Packard Co.
Hitachi
Hoefer Scientific Instruments
Instrutech
Intermountain Scientific
IntelliGenetics, Inc.
Invitrogen Corporation
Kodak/Scientific Imaging Systems
Kramer Scientific
Leica
Life Technologies, Inc.
Medical Systems Corp.
Micro Video Instruments
Millipore Corp.
MJ Research Inc.
Molecular Probes Inc.
Nalgene
Narishige USA Inc.
New England Bio labs, Inc
Newport Corp.
Nikon, Inc.
NORAN Instruments Inc.
Novagen, Inc.
Olympus Corporation
Omega Optical Inc.
Oncor Inc.
Operon Technologies Inc.
Optronics
Organon Teknika Corp.
Paultek Imaging
Perkin-Elmer Cetus
Perkin-Elmer, Applied Biosystems
Division
Pharmacia LKB
Photometrics
Promega Corporation
Qiagen, Inc.
Sarstedt Inc.
Savant Instruments, Inc.
Scanalytics
Sigma Chemical Co.
Spectra Physics
Stoelting Autogenics
Stratagene Cloning Systems
SUN BlOscience, Inc.
Sutter Instrument Co.
Technical Products International Inc.
USB/Amersham
Vector Laboratories, Inc.
Wal lac, Inc.
Warner Instrument Corp.
Carl Zeiss, Inc.
SEMINARS
Cold Spring Harbor Seminars were initiated to provide a semiformal avenue for communication be-
tween the various research groups at the Laboratory. They are particularly useful for research per-
sonnel who have joined the Laboratory during the summer. The seminars also afford a necessary
opportunity for the graduate students and postgraduate staff to develop their skills in defending,
organizing, and presenting their research.
1994
January
Angus Wilson, Cold Spring Harbor Laboratory. The VP16-
induced complex: A protein jigsaw.
Jorge Galan, State University of New York, Stony Brook.
Molecular mechanisms of Salmonella entry into mam-
malian cells. (Host: Winship Herr)
Adrian Krainer, Cold Spring Harbor Laboratory. Mechan-
isms of splice site selection.
George Reeke, Rockefeller University. Neural Darwinism:
Connecting brain and behavior. (Host: John Anderson)
Sridar Natesan, Cold Spring Harbor Laboratory. Structural
organization of the c-fos promoter by transcription factor
YY1.
February
Ward Odenwald, National Institutes of Health, NINDS. Func-
tional analysis of the Drosophila castor/pollux gene cluster
in CNS development and the role of ectopical mini-white
gene expression in sexual behavior. (Host: Yi Zhong)
George Tokiwa, Cold Spring Harbor Laboratory. Inhibition of
G1 cyclin activity by the RAS/cAMP pathway in yeast.
Don Rio, University of California, Berkeley. Mechanism of
Drosophila P element transposition and control by tissue-
specific RNA splicing. (Host: Adrian Krainer)
Mary Lou Pardue, Massachusetts Institute of Technology.
Drosophila telomeres: Transposable elements earning an
honest living? (Host: David Spector)
Ray O'Keefe, Cold Spring Harbor Laboratory. The nuclear
organizaton of pre-mRNA splicing.
Peter Gergen, State University of New York, Stony Brook.
Functions of the Drosophila Runt protein, a member of a
new family of heteromeric DNA-binding transcriptional
regulators. (Host: Michael Gilman)
Stefan Stamm, Cold Spring Harbor Laboratory. Is the neur-
on-specific splicing mechanism of clathrin light chain B
exon EN used by other neuron-specific exons?
Thomas Meier, Albert Einstein College of Medicine. Nucleo-
lar-cytoplasmic transport on tracks. (Host: David Spector)
Ann Sutton, Cold Spring Harbor Laboratory. The role of the
Sit4 phosphatase in the yeast dell cycle.
March
Michel Charbonneau, Scripps Research Institute. Phosphor-
ylation of Cdc25 in the fission yeast. (Host: Kim Arndt)
Jerry Yin, Cold Spring Harbor Laboratory. CREB and long-
term memory in Drosophila.
Toshiya Yamada, Columbia University. Factors controlling
cell patterning in the vertebrate nervous system. (Host:
Hiroyuki Nawa)
Johannes Hofmann, Cold Spring Harbor Laboratory. Gi/S
transition in fission yeast: Target genes of the cell-cycle-
regulated transcription factor cdc10+.
David Allis, Syracuse University. Linker histone (H1)
phosphorylation: Opening or closing functional domains
in chromatin? (Host: Carol Greider)
David Barford, Cold Spring Harbor Laboratory. The struc-
ture of protein tyrosine phosphatase 1B.
Joe Gray, University of California, San Francisco. Genetic
progression in breast and ovarian cancer. (Host: David
Spector)
Jacek Skowronski, Cold Spring Harbor Laboratory. HIV-1
Nef interaction with CD4 and p56Ick protein tyrosine kin-
ase.
Lester Lau, University of Illinois, Chicago. Endocrine and
neurogenic regulation of the orphan nuclear receptor
Nur-77. (Host: Nicholas Tonks)
April
Rob Martienssen, Cold Spring Harbor Laboratory. Enhan-
cer-trap and gene-trap transposons in Arabidopsis.
Gary Ruvkun, Harvard Medical School. Pattern formation in
C. elegans by an antisense RNA and by POU proteins.
(Host: Winship Herr)
Arne Stenlund, Cold Spring Harbor Laboratory. DNA rep-
lication of papillomaviruses.
Raymond White, University of Utah, Salt Lake City. Mole-
cular genetics of the APC gene. (Host: Alcino Silva)
Catherine Weiss, Cold Spring Harbor Laboratory. Molecular
analysis of heterotrimeric G protein(s) in plants.
Paul Kaufman, Cold Spring Harbor Laboratory. Chromatin
assembly during DNA replication.
October
Stephen Sprang, HHMI/University of Texas Southwestern
Medical Center. Mechanism of G-protein alpha subunits.
(Host: James Pflugrath)
Linda Van Aelst, Cold Spring Harbor Laboratory. Ras func-
tion and map kinase cascade.
Jim Bliska, State University of New York, Stony Brook. Signal
transduction during yersinia-mammalian cell interactions.
(Host: Nicholas Tonks)
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Xiaodong Cheng, Cold Spring Harbor Laboratory. How does
DNA become methylated? The crystal structure of Hhal
methylase in complex with DNA,
Brad Olwin, Purdue University. FGF receptor complexes
and signaling pathways in skeletal muscle cells. (Host:
Nicholas Tonks)
Cindy Sadowski, Cold Spring Harbor Laboratory. Targeting
TBP to the PSE, a non-TATA box cis-regulatory element
present in snRNA promoters.
November
William Theurkauf, , State University of New York, Stony
Brook. Cytoskeletal functions during early Drosophila de-
velopment. (Host: Dave Helfman)
Carol Greider, Cold Spring Harbor Laboratory. Telomerase
mechanism, reconstitution, and potential role in cellular
immortalization.
Tom Maniatis, Harvard University. Mechanisms of regulated
alternative splicing and pre-mRNA editing. (Host: Adrian
Krainer)
Anthony Rossomando, Cold Spring Harbor Laboratory. Neg-
ative regulation of map kinase kinase (MKK).
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Joanne Chory, Salk Institute. Signal transduction pathways
controlling light-regulated development in plants. (Host:
Venkatesan Sundaresan)
December
Roger Traub, IBM. Network oscillations in the hippocampal
slice. (Host: Ancino Silva)
Hong Sun, Cold Spring Harbor Laboratory. MKP-1, a phos-
phatase that dephosphorylates and inactivates MAP
kinases in vivo.
Claude Desplan, Rockefeller University. Functional speci-
ficity of homeoproteins during early Drosophila develop-
ment. (Host: Ueli Grossniklaus)
Yi Zhong, Cold Spring Harbor Laboratory. Genetic analysis
of a neuropeptide action in Drosophila.
Mike Rosbash, Brandeis University. Analysis of pre-mRNA
structure and HIV REV function in yeast. (Host: Adrian
Krainer)
Dafna Bar-Sagi, Cold Spring Harbor Laboratory. The Ras
signaling complex.
UNDERGRADUATE RESEARCH
An important aspect of the summer program at the Laboratory is the participation of college un-
dergraduate students in active research projects under the supervision of full-time laboratory staff
members. The program was initiated in 1959. Since that year, 418 students have participated in
the course, and many have gone on to productive careers in biological science.
The objectives of the program are to provide (1) a greater understanding of the fundamental
principles of biology; (2) an increased awareness of major problem areas under investigation; (3)
a better understanding of the physical and intellectual tools for modern research and the
pertinence of this information to future training; and (4) a personal acquaintance with research, re-
search workers, and centers for study.
The following students, selected from more than 180 applicants, took part in the program,
which was supported by Bio-Rad Laboratories, Burroughs-Wellcome Fund, C. Bliss Memorial
Fund, Gardner, The Garfield Internship, Hanson Industries, Libby Internship, National Science
Foundation, Olney Fund, Phillips Petroleum Foundation, Inc., Powers Foundation, William
Shakespeare Internship, and Frederica von Stade Internship.
Omar Antar, Harvard University
Advisor Xiaodong Cheng
Sponsor: Burroughs-Wellcome Fund
Toward solving the three-dimensional structure of p16:
Crystallization trials.
Nadine Bewry, Tennessee State University
Advisor: Holly Cline
Sponsor: National Science Foundation
BDNF in the development of retinal axon arbors in Xenopus.
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Timothy Chan, Harvard University
Advisor: David Beach
Sponsor: Phillips/Bio-Rad
The p21 cyclin-dependent kinase inhibitor modulates
DNA repair by association with a cyclin-like uracil-DNA
glycosylase.
Jonathan Chubb, Cambridge University
Advisor: G. Enikolopov
Sponsor: Hanson Industries
Synaptotagmin II targeting to synapses.
Hannah Cross, Cambridge University
Advisor: Robert Martienssen
Sponsor: Wm. Shakespeare
Isolating a derivative allele in Arabidopsis.
Michelle Da Costa, Yale University
Advisor: Arne Stenlund
Sponsor: National Science Foundation
Characterizing the bovine papillomavirus protein E2.
Daniel Debowy, Yale University
Advisor: Michael Hengartner
Sponsor: Burroughs-Wellcome Fund
Construction and modification of episomes for a two-hybrid
system assay on the C. elegans programmed cell death
suppressor protein CED-9.
Romy Hogue, Columbia University
Advisor: Thomas Marr
Sponsor: Burroughs-Wellcome Fund
Hydrophobic character of transcriptional activation
domains.
Jerry Hsu, Harvard University
Advisor: Hiroyuki Nawa
Sponsor: National Science Foundation
Identification of a possible agrin isoform in the rat brain.
Frank Lee, Duke University
Advisor: Alcino J. Silva
Sponsor: Olney Fund
Mutation of the NF1 GTPase activating protein (NF1-GAP)
and aCaMKII genes in transgenic mice affects synaptic
plasticity and performance on learning tests.
Ulo Maivali, Tartu University
Advisor: Michael Mathews
Sponsor: Gardner
Studies on unusual translation in mammalian cells.
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Steve Miller, Pomona College
Advisor: Ann Sutton
Sponsor: National Science Foundation
Molecular and genetic analyses of the yeast PDL3 gene.
Jill Nemacheck, Purdue University
Advisor: V. Sundaresan
Sponsor: Burroughs-Wellcome Fund
Cloning and analysis of indeterminate.
Elizabeth O'Connor, C.W. Post College /L.I.U.
Advisor: Michael Wig ler
Sponsor: Burroughs-Wellcome Fund
Cloning homologs of Schizosaccharomyces pombe mor-
phogenic and mating genes from Drosophila melanogaster
and humans.
Loren del Mar Pena, Duke University
Advisor: Winship Herr
Sponsor: National Science Foundation
Exploring the cellular function of host cell factor (HCF).
Samanthi Perera, Mount Holyoke College
Advisor. Adrian Krainer
Sponsor: Libby
Selection for high-affinity binding sequences in RNA for
hnRNP A2 and B1.
Caroline Roberts, Cedar Crest College
Advisor: Erich Grotewold
Sponsor: National Science Foundation
Myb homologs in Arabidopsis flowers.
Elaine Round, Washington University
Advisor: Kim Arndt
Sponsor: National Science Foundation
Characterization of CTR9.
Ibis Sanchez-Serrano, Iowa State University
Advisor: Tim Tully
Sponsor: Frederica von Stade Fund
Comparisons between cs, linotte, and nalyot brains.
Thomas Su, University of California, Los Angeles
Advisor: Hong Ma
Sponsor: National Science Foundation
Investigation of AGL2 DNA binding.
Yong Yu, University of Utah
Advisor: Bruce Stillman
Sponsor: Bliss/Powers
Characterization of the CAF-I large subunit p150.
NATURE STUDY PROGRAM
The Nature Study Program gives elementary and secondary school students the opportunity to ac-
quire a greater knowledge and understanding of their environment. Through a series of special-
ized field courses, younger students can engage in introductory programs such as Nature Bugs,
Nature Detectives, and Nature Discovery, and older students can enroll in more advanced pro-
grams such as Marine Biology and Nature Photography.
During the summer of 1994, a total of 406 students participated in 28 courses within the pro-
gram. The classes were held outdoors, weather permitting, at the West Side School. The
Laboratory has equipped and maintains classroom and laboratory facilities as well as a darkroom
at West Side School. This facility is used as a base for the students' exploration of the local en-
vironment. Field classes are held on Laboratory grounds, St. John's Preserve, Fire Island National
Seashore, Caumsett State Park, the Cold Spring Harbor Fish Hatchery and Aquarium, as well as
other local preserves and sanctuaries.
In addition to the three 2-week sessions, the Adventure Education course meets on two Fri-
days for trips. The students go on a 10-mile bicycle hike to Sagamore Hill and a 12-mile canoe trip
on the Nissequogue River.
PROGRAM DIRECTOR
William M. Payoski, M.A., Adjunct Professor, Nassau Community College
REGISTRAR
Amy Anderson, Cold Spring Harbor Laboratory
INSTRUCTORS
Jennifer Gensel, Elementary Teacher, Hicksville School District
Linda Payoski, M.S., Science Teacher, Uniondale High School
Marjorie Pizza, B.A., Science Teacher, Locust Valley School District
Donna Stokes, Teaching Candidate
Camille Walker, B.S., Biological Oceanography
Brian Withers, Fine Arts Teacher, New York City School System
COURSES
Nature Bugs
Nature Detectives
Nature Discovery
Ecology Explorers
Frogs, Flippers, and Fins
Pebble Pups
Bird Study
Freshwater Life
Seashore Life
Marine Biology
Nature Photography
Adventure Education
239


BANBURY CENTER
DIRECTOR'S REPORT
Banbury Center maintained the numbers and quality of its meetings during 1994. There were again
16 meetings at the Center, attended by 510 participants. In addition, five neurobiology courses
were held over the summer months and the Center was made available to ten other groups. All
told, the Center was used on 31 different occasions in 1994!
Participants
For the second year, we can give some demographic information about our participants, although
these figures are approximate because some individuals come to more than one meeting each
year. Of the 510 participants, 418 came from the United States. This year, New York (85) sup-
planted California (64) as the leading source of participants. Massachusetts (42) and Maryland (41)
were third and fourth. These four states accounted for 45% of visitors to Banbury Center in 1994,
the remaining U.S. participants coming from 26 other states. Ninety-two participants (18%) came
from 17 foreign countries, figures very similar to those in 1993. Again most came from the United
Kingdom, with equal numbers (10) from Germany and Japan. It was especially pleasing that we
were able to maintain attendance by foreign participants despite increased travel costs.
Scientific Meetings
It becomes ever more difficult to categorize the diverse topics of our meetings, so this year I shall
describe them in chronological order.
The year opened with an outstanding meeting, Secretory Pathways: The Molecular Basis for
Their Specificity. This is a very exciting area of research, one that endeavors to understand the
mechanisms by which proteins move from the sites of their synthesis in the cytoplasm to the places
where they are needed-elsewhere in the cytoplasm or to the outside of the cell. This presents
many problems to the cell, not the least of which is that it involves complex interactions between
different sorts of molecules. We were honored to have Nobel laureate, George Pa lade, one of the
founders of the field, attend and deliver the closing remarks.
Banbury Center has established a tradition for meetings dealing with both scientific and policy
aspects of genome projects. In this case, a group of scientists working on the Arabidopsis genome
came to Banbury for The Arabidopsis Genome meeting to review the scientific progress being
made and to make plans for future efforts. The cross-disciplinary nature of genomic research was
evident in the first session that included contributions from scientists working on yeast, nematode,
fruit fly, and mouse genomes.
The third meeting of the year, Melatonin: Mechanisms and Actions, was unusual in that it cov-
ered a physiological subject, the role of the chemical melatonin in regulating circadian rhythms.
Quite apart from the fascinating biology involved in the ways in which organisms set and maintain
internal clocks, understanding this for human beings could have significant implications for the mil-
lions of people who work hours that do not coincide with the light-dark cycle of the day and for
those of us who find it difficult to adapt as we cross time zones.
The final scientific meeting of the spring, Genetics of Learning and Memory, could not have
been held even a few years ago. Here, the tools of recombinant DNA are being used to dissect the
processes underlying the ways in which organisms learn from their experiences and retain those
memories while discarding memories of no functional significance. Once again, it was impressive
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how studies on very different organisms-fruit fly, nematode, and mouse-are being brought togeth-
er through the use of genetics, and in so doing, findings on each organism are reinforced by re-
search on the others.
Scientific meetings began again in September with a meeting, Targets for Specific Therapies
in Leukemia. These cancers have been studied intensively for many years, and there have been
significant advances in understanding their genetics and molecular pathology, and basing
therapies on that knowledge. This meeting brought together the leaders in these topics to review
the current standing and future directions. It was a special pleasure to have Baynard Clarkson as
one of the organizers. Barney has been a devoted supporter of the Laboratory as a trustee and as
chairman of the trustees; it was good to put his scientific skills to use as well!
Some topics justify having follow-up meetings because of their intrinsic interest and because of
the benefits that would accrue if the topics could be advanced. Protein Design/Folding is an ex-
cellent example. The problem of predicting how a peptide chain will fold is a great intellectual chal-
lenge and one, if solved, would help with designing proteins with new or modified activities.
A paradox of chromosome replication is that chromosomes will become progressively shorter
because of the way that DNA is made. To prevent loss of DNA from their ends, chromosomes
terminate in structures called telomeres, and an enzyme complex called telomerase made of RNA
and protein maintains the telomeres. It appears that telomerase may have an important role in can-
cer and in aging. The October meeting entitled, appropriately, Telomeres, was the first intensive
meeting devoted to telomeres and telomerase, a meeting in which the advances of the previous
years were reviewed in detail.
Genomes played a large part in the Center's activities this year. Following the example set by
the Arabidopsis meeting in the Spring, Grass Genomes was also intended to assess the current
status and potential benefits of having the complete DNA sequence of grasses available for genet-
ic manipulation.
Banbury Center has a long tradition of promoting studies of genetic disorders. There have been
several very notable examples, and the meeting Candidate Gene Approaches to ALS was an ex-
cellent example of what such meetings can achieve. Advances in this field have been rapid and
now the Amyotrophic Lateral Sclerosis Association wanted to look forward to the next step in their
research program. We brought scientists working on ALS together with scientists from other areas
who have expertise and approaches that are likely to be important in the next phase of ALS re-
search.
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The next meeting also dealt with genomes but with genes and genomes in general. The
genome sequencing projects are beginning to produce very large amounts of sequence data,
data that should make it possible to evaluate the various ideas proposed to account for the present
arrangement of genes within species and for the differences between species. Evolution of
Genes and Genomes was designed to carry out such an evaluation. It was clear that we can ex-
pect major evolutionary insights to come from comparisons of the genome sequences of the
"model" organisms being sequenced.
The major challenge facing human genetics is the analysis of so-called complex disorders
where mutations in more than one gene are necessary for development of the disorder or where
mutations in different genes may lead to the same disorder. The Molecular Genetics of Diabetes
meeting provided a snapshot of the tools being developed to tackle the genetic analyses of these
types of disorders.
The most successful practical applications of biomedical research have come in the area of
public health, where the health of many millions of people has been improved. Vaccines exemplify
this, but for reasons both technical and social, the development of new vaccines is fraught with the
difficulties. Planning for the Next Generation of Vaccines was sweeping in its coverage of these
issues, ranging from new technical advances through analyses of those factors that influence the
decisions of scientists, companies, and governments to undertake and support the development of
new vaccines.
Robert Wood Johnson Foundation Meeting
The Robert Wood Johnson Foundation is funding two meetings at Banbury Center to examine the
role that human genetics should play in primary health care and how genetic services can be pro-
vided. The first meeting, held in August, was a Workshop on Human Genetics and Health Care.
It was notable for including individuals involved in different areas of health care provision who are
concerned,that genetics is properly introduced in primary health care. As well as clinical
geneticists and genetic counsellors, there were nurses, primary care physicians, social workers,
nurse practitioners, and representatives of professional organizations.
JP Morgan-Cold Spring Harbor Laboratory Meeting for Executives
This meeting, sponsored by J.P. Morgan, for the senior executives of pharmaceutical, biotechnol-
ogy, and venture capital companies tackled The Biology of Human Behavior for the ninth meet-
ing in this series. The origins of recent interest in this subject can be traced to the work of E.O. Wil-
son, who established the field called sociobiology in the mid 1970s. More recently, human
molecular genetics has found some evidence for the genetic basis of traits such as male
homosexuality and anti-social behavior. The controversy over the claims made in the book The Bell
Curve demonstrates how interesting and contentious such findings are, especially when it is urged
that public policy be based on these findings. This was an extraordinarily interesting and exciting
meeting, made especially memorable by the participation of E.O. Wilson.
Charles A. Dana Foundation Project on Manic-Depressive Illness
As part of the Cold Spring Harbor Laboratory contribution to the Charles A. Dana Foundation Con-
sortium on the genetic basis of manic-depressive illness, we held a Workshop on Manic-
depressive Illness in June to introduce the findings of recent research to nonscientists. The meet-
ing was modeled on the extremely successful meetings for journalists and congressional staff that
had been sponsored by the Alfred P. Sloan Foundation here at Banbury Center. This workshop
brought together journalists, congressional staff, and staff of the Dana Foundation and covered the
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field of manic-depressive illness from clinical studies through genetics to the economic impact of
the disorder.
Human Genome and Genetic Analysis Workshops
We have held a number of Genetics Workshops for Nonscientists for the Health Effects & Life
Sciences Division of the Department of Energy. These workshops have proved popular, and the
DOE made a grant to the DNA Learning Center and the Banbury Center for a further two work-
shops. Previous workshops targeted teachers, Congressional staff, theologians, bioethicists, jour-
nalists, lawyers, and patient advocates. The new series is targeting a different group who also need
to understand modern human genetics, namely primary care physicians. To maximize the impact
of the workshop, with the help of Bernard Rosof and Andrew Packard at Huntington Hospital, we in-
vited directors of continuing medical education in New York State hospitals to participate. The
workshop went very well and we are confident that they returned to their colleagues and en-
couraged them to take the same course. As a consequence of this workshop, I gave a total of five
lectures at Long Island Jewish and Long Island College Hospitals.
Other Meetings
The Center is a valuable resource for our community and I was pleased that several groups came
here during 1994. Banbury Center hosted seminars given by the nonprofit groups in the village of
Lloyd Harbor in February and March. In August, West Side School held a faculty meeting and, in
September, Huntington Hospital brought its Board of Trustees here. Holiday House, which provides
summer vacations for disadvantaged girls, spent a day at the Center reviewing Holiday House's
activities. The New York Biotechnology Association held a 1-day discussion meeting here and the
Esther A. and Joseph Klingenstein Fund held a 2-day meeting for its Neuroscience Research Fel-
lows. The Carnegie Council for Ethical Affairs and the Uehiro Foundation on Ethics and Education
held a joint discussion meeting reviewing the impact of modern human genetics. The Albert B.
Sabin Vaccine Foundation held a board meeting here. In addition, two groups of scientists from
Cold Spring Harbor Laboratory came from the main campus to hold group meetings here.
Funding
Once again, the generosity of the members of the Cold Spring Harbor Laboratory Corporate
Sponsor Program and other companies and foundations supported our program. It is difficult to
overemphasize how important this funding is in enabling us to hold timely and exciting meetings.
The Corporate Sponsors provided support for six meetings in 1993: Secretory Pathways: The
Molecular Basis for Their Specificity; Arabidopsis Genome; Targets for Specific Therapies in
Leukemia; Protein Design/Folding; Telomeres; Evolution of Genes and Genomes. Support for
the latter meeting was also provided by the Alfred P. Sloan Foundation, which has played a critical
role in promoting research in molecular evolution and in supporting Banbury Center.
Foundations provided funds for a significant proportion of Banbury Center meetings in 1994.
Four foundations supported meetings on human genetic disorders: The Amyotrophic Lateral
Sclerosis Association funded the meeting on Candidate Gene Approaches to ALS; The William
Stamps Farish Fund provided support for the third of the series of meetings on complex human
genetics (Molecular Genetics of Diabetes); the Charles A. Dana Foundation funded two meetings
related to manic-depressive illness; and the Robert Wood Johnson Foundation supported the first
of two meetings on genetics and health care. The Albert B. Sabin Foundation funded the meeting
on Planning for the Next Generation of Vaccines, the first in the series of meetings on con-
temporary issues in vaccine development.
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The outstanding 1994 Executives' meeting, the Biology of Human Behavior, was generously
funded by J.P. Morgan. The Office of Health and Environmental Research of the Department of En-
ergy funded the Genetics Workshop for Nonscientists.
Looking Forward to 1995
The 1995 Banbury Center program promises to be even more eclectic and interesting than usual.
Genetics will continue to be the dominating theme of the program, but there will also be meetings
on imaging, plant molecular biology, genomics, and cell biology. It is clear that the Center's ac-
tivities are going to continue to expand and that this will require close coordination with other ac-
tivities at the Laboratory. I want to thank David Stewart (Meetings Office), Susan Cooper (Public Af-
fairs), Jim Hope (Catering), and Jack Richards (Buildings and Grounds) and their staffs for their
help and forbearance.
Here at the Banbury Center, Bea To liver and Ellie Sidorenko in the Banbury Center office and
Katya Davey in Robertson House continue to make running a complex operation seem easy. Danny
Miller and Andy Sauer worked their magic in keeping the Banbury Center grounds beautiful, but,
after 10 years here, Danny moved to the main laboratory site. We were sorry to see him go but we
were pleased to welcome Chris McEvoy, whose home is here on the estate, in his place. No doubt
there will be changes, but the Center will remain dedicated to providing an environment in which
scientists can reflect on their research with few interruptions from outside.
Jan Witkowski
Sammis Hall
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MEETINGS
Secretory Pathways: The Molecular Basis for Their Specificity
February 27-March 2
FUNDED BY
Cold Spring Harbor Laboratory Corporate Sponsor Program
ARRANGED BY
J.E. Rothman, Memorial Sloan-Kettering Cancer Center, New York, New York
G. Warren, Imperial Cancer Research Fund, London, United Kingdom
SESSION 1: The Synapse
Chairperson: R.H. Scheller, Howard Hughes Medical Institute,
Center, California
J.E. Rothman, Memorial Sloan-Kettering Cancer Center, New
York, New York: Opening remarks.
R.H. Scheller, Howard Hughes Medical Institute, Stanford
University Medical Center, California: Synaptic transmis-
sion.
T.C. Sudhof, Howard Hughes Medical Institute, University of
Texas Southwestern Medical Center, Dallas: Composition
and regulation of the synaptic fusion complex.
Stanford University Medical
P. DeCamilli, Howard Hughes Medical Institute, Yale Univer-
sity School of Medicine, New Haven, Connecticut: Mem-
brane traffic at the synapse.
T. So liner, Memorial Sloan-Kettering Cancer Center, New
York, New York: Intracellular vesicle docking and fusion.
T.F.J. Martin, University of Wisconsin, Madison: Character-
ization of ATP-dependent and Ca * *-activated steps of the
regulated secretory pathway.
SESSION 2: Toxins
Chairperson: G. Warren, Imperial Cancer Research Fund, London, United Kingdom
G. Schiavo, University of Padua, Padova, Italy: Tetanus and
botulism neurotoxins are zinc endopeptidases specific for
the neuroexocytosis apparatus.
R. Jahn, Howard Hughes Medical Institute, Yale University
School of Medicine, New Haven, Connecticut: Clostridial
neurotoxins as tools to study exocytosis in neurons.
SESSION 3: Mutants
Chairperson: H.F. Lodish, Whitehead Institute for Biomedical Research, Cambridge, Mas-
sachusetts
B.J. Meyer, University of California, Berkeley: C. elegans T.L. Schwarz, Stanford University Medical Center, California:
mutants defective in neurotransmission. Synaptotagmin mutations in the fly.
SESSION 4: Yeast
Chairperson: H.R.B. Pelham, MRC Laboratory of Molecular
Kingdom
S. Ferro-Novick, Yale University School of Medicine, New
Haven, Connecticut: Factors mediating the late stages of
ER to Golgi transport in yeast.
R.W. Schekman, Howard Hughes Medical Institute, Univer-
sity of California, Berkeley: Mechanism and regulation of
vesicle budding from the ER.
J.E. Gerst, Mount Sinai School of Medicine, New York, New
Biology, Cambridge, United
York: Synaptobrevin-like proteins and their role in vesicle
transport.
P. Novick, Yale University School of Medicine, New Haven,
Connecticut: Components of the yeast secretory machin-
ery that confer specificity to the final stage of the exocytic
pathway.
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J. Fernandez, J. White
SESSION 5: Rabs
Chairperson: W.E. Balch, The Scripps Clinic and Research Institute, La Jolla, California
S.R. Pfeffer, Stanford University School of Medicine, Califor-
nia: Functional analysis of rab 9 protein.
M. Zerial, European Molecular Biology Laboratory, Heidel-
SESSION 6: Calcium
Chairperson: J.M. Fernandez, Mayo Clinic, Rochester, Minnesota
W. Almers, Max-Planck Institut fur medical Forschung,
Heidelberg, Germany: Fast steps in Ca-triggered exo-
and endocytosis in neuroendocrine cells,
E. Neher, Max-Planck Institute for Biophysical Chemistry,
Gottingen, Germany: Sources of secretory delays in
berg, Germany: The GTPase molecular switch of lab
proteins in the regulation of intracellular transport.
neuroendocrine cells.
K.L. Wilson, Johns Hopkins University School of Medicine,
Baltimore, Maryland: Calcium mobilization via IP3 recep-
tors during nuclear vesicle fusion.
SESSION 7: Endosomes
Chairperson: J. Gruenberg, University of Geneva, Sciences II, Switzerland
P.D. Stahl, Washington University School of Medicine, St. I. Mellman, Yale University School of Medicine, New Haven,
Louis, Missouri: In vitro reconstitution of the endocytic Connecticut: Molecular sorting during intracellular trans-
pathway. port.
SESSION 8: Hydrophobic Peptides
Chairperson: J.M. White, University of Virginia Medical Center, Charlottesville
D.M. Engelman, Yale University, New Haven, Connecticut:
Peptide interactions with and within lipid environments
Specificity of helix-helix interactions and the spontaneous
insertion of a transmembrane helix.
F. Hughson, Harvard University, Cambridge, Massachu-
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setts: Three-dimensional structure of the fusion-active con-
formation of influenza hemagglutinin.
G.E. Pa lade, University of California, San Diego, La Jolla:
Closing remarks.
The Arabidopsis Genome
March 20-March 23
FUNDED BY
Cold Spring Harbor Laboratory Corporate Sponsor Program
ARRANGED BY
M. Bevan, John Innes Centre, Norwich, United Kingdom
J.R. Ecker, University of Pennsylvania, Philadelphia
R. Martienssen, Cold Spring Harbor Laboratory, New York
SESSION 1: Large-scale Genome Projects
Chairperson: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory, New York
J.R. Ecker, University of Pennsylvania, Philadelphia: Intro-
ductory remarks.
S.G. Oliver, UMIST, Manchester, United Kingdom: Yeast as a
subject and a tool for genome analysis.
R. Wilson, Washington University School of Medicine, St.
Louis, Missouri: Sequencing C. elegans.
M. Palazzolo, Human Genome Center, Berkeley, California:
SESSION 2: Physical Mapping and Markers
Chairperson: M. Beven, John Innes Center, Norwich, United
E. Meyerowitz, California Institute of Technology, Pasadena:
The Arabidopsis genome (structure, size, contents).
E. Richards, Washington University, St. Louis, Missouri:
Molecular chromosome studies in Arabidopsis.
P.A. Scolnik, E.I. du Pont de Nemours & Co., Wilmington,
Delaware: Mapping and sequencing the Arabidopsis
genome: New high-throughput markers for genome and
mutation analysis.
M. Zabeau, Keygene n.v., Wageningen, The Netherlands:
Progress in physical mapping of the Arabidopsis genome
using AFLP markers.
F.M. Ausubel, Massachusetts General Hospital, Boston: Use
Drosophila human genome project.
W. Dietrich, Whitehead Institute Genome Center, Cambridge,
Massachusetts: Construction of a dense genetic linkage
map of the mouse.
L. Rowen, University of Washington, Seattle: Redundancy is
our friend: Large-scale sequencing of the human and
mouse T-cell receptor ft loci.
Kingdom
of RFLP/genomic subtraction to identify large numbers of
CAPS (cleaved amplified polymorphic sequences), co-
dominant ecotype-specific PCR-based markers, for
Arabidopsis.
J.R. Ecker, University of Pennsylvania, Philadelphia: Prog-
ress toward a complete map of the Arabidopsis genome.
R. Schmidt, John Innes Centre, Norwich, United Kingdom:
Strategies for completion of the physical maps for
chromosomes 4 and 5.
H.M. Goodman, Massachusetts General Hospital, Boston:
Progress on the physical map and sequence of
chromosome II.
E. Richards, R. Schmidt, U. Grossniklaus, V. Sundaresan, P. Scolnik, K. Feldmann
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SESSION 3: Gene Identification
Chairperson: R. Martienssen, Cold Spring Harbor Laboratory,
C.R. Somerville, Carnegie Institution of Washington, Stanford,
California: MSU Arabidopsis EST project.
M. Caboche, INRA Versailles Cedex, France: Present and fu-
ture of Arabidopsis genome projects in France.
C. Gigot, IBMP-CNRS, Strasbourg Cedex, France: Ex-
pressed sequence tags obtained by partial sequencing of
cDNA5 from A. thaliana.
R.W. Davis, Stanford University School of Medicine, Califor-
nia: A simple genetic map and a proposal of complete
SESSION 4: Sequencing and Informatics
Chairperson: H.M. Goodman, Massachusetts General Hospital
M. Bevan, John Innes Centre, Norwich, United Kingdom:
Arabidopsis genome sequencing-The ESSA project.
W.R. McCombie, Cold Spring Harbor Laboratory, New York:
Strategies for automated sequence analysis of the
genomes of model organisms.
D. Searls, University of Pennsylvania School of Medicine,
Philadelphia: Computational gene prediction: Compara-
New York
cDNA sequencing for the total genome for A. thaliana.
J. Ryals, Ciba Biotechnology, Research Triangle Park, North
Carolina: Acquired resistance in Arabidopsis: A genetic
approach-The limitations.
K.A. Feldmann, University of Arizona, Tucson: Utility of T-
DNA-generated populations of Arabidopsis for gene clon-
ing and reverse genetics.
V. Sundaresan, Cold Spring Harbor Laboratory, New York:
Exon trapping with transposons.
, Boston
tive studies in vertebrates, invertebrates, and plants.
C. Fields, The Institute for Genome Research, Gaithersburg,
Maryland: Managing and integrating information from high-
throughput genome projects.
T.G. Marr, Cold Spring Harbor Laboratory, New York: Dis-
cussion about Arabidopsis database.
SESSION 5: Policy
Chairperson: J.R. Ecker, University of Pennsylvania, Philadelphia
Remarks by:
J.R. Ecker, University of Pennsylvania, Philadelphia
R.J. Cook, USDA-RNI-CGP, Washington, D.C.
M.W. Dilworth, National Science Foundation, Arlington, Virginia
Melatonin: Mechanisms and Actions
April 10April 13
ARRANGED BY
A.J. Lewy, Oregon Health Sciences University, Portland
SESSION 1: Basic Physiology And Pharmacology
Chairperson: J. Redman, Monash University, Victoria, Australia
S.M. Reppert, Massachusetts General Hospital, Boston:
Molecular biology of melatonin receptors.
M.L. Dubocovich, Northwestern University Medical School,
Chicago, Illinois: Melatonin receptor: Pharmacology and
circadian activity; melatonin analogs.
M.H. Stetson, University of Delaware, Newark: Melatonin
phase hypothesis for seasonal reproductive rhythms.
B.D. Goldman, University of Connecticut: Storrs: Melatonin
duration hypothesis for seasonal reproductive rhythms.
SESSION 2: Melatonin PRCs and Effects of Melatonin in Animals
Chairperson: H. Illnerova, Czech Academy of Sciences, Prague, Czech Republic
J. Redman, Monash University, Victoria, Australia: Melatonin
entrainment and PRC in rodents.
V.M. Cassone, Texas A&M University, College Station: Ef-
fects of melatonin on the avian and mammalian circadian
systems.
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L.P. Morin, State University of New York, Stony Brook: Effects
of pinealectomy on circadian rhythmicity in rodents.
M.U. Gillette, University of Illinois, Urbana: Mechanisms of
melatonin on the suprachiasmatic nucleus.
A. Lewy, T. Wehr, H. Illnerova, M. Dubocovich
SESSION 3: Light Phase Response Curves (PRCs) and Effects of Light in Humans
Chairperson: M.U. Gillette, University of Illinois, Urbana
R.E. Kronauer, Harvard University, Cambridge, Massachu-
setts: Type-0 (amplitude suppression) phase resetting in
humans.
D.G. Beersma, University of Groningen, The Netherlands:
Type-1 phase resetting in humans.
K.-I. Honma, Hokkaido University School of Medicine, Sap-
poro, Japan: A light PRC in humans: Aftereffect of entrain-
ment?
D.S. Minors, University of Manchester, United Kingdom: The
classical light PRC in humans.
S.S. Campbell, New York Hospital-Cornell Medical Center,
White Plains: Alerting/energizing effects of light.
C.I. Eastman, Rush-Presbyterian-St. Luke's Medical Center,
Chicago, Illinois: Treatment of shift workers with light and
dark.
M. Terman, New York State Psychiatric Institute, New York:
Treatment of winter depressives with light.
H. Illnerova, Czech Academy of Science, Prague, Czech Re-
public: Phase resetting with one pulse of light: Entrainment
of the human melatonin rhythm.
SESSION 4: Melatonin PRCs and Effects of Melatonin in Humans
Chairperson: C.I. Eastman, Rush-Presbyterian-St. Luke's Medical Center, Chicago, Il-
linois
A.J. Lewy, Oregon Health Sciences University, Portland: The
human melatonin PRC.
R.L. Sack, Oregon Health Sciences University, Portland:
Phase resetting in blind people and shift workers.
J. Arendt, University of Surrey, Guildford, United Kingdom:
Phase resetting in delayed sleep phase syndrome and air
travelers.
B. Claustrat, Hopital Neuro-Cardiologique, Lyon, France:
Phase resetting in air travelers. Human melatonin PRC
pharmacokinetcs.
SESSION 5: Side Effects and Other Consequences of Melatonin: Melatonin Analogs
Chairperson: M. Terman, New York State Psychiatric Institute, New York
0. Tzischinsky, Brown University School of Medicine, Pro-
vidence, Rhode Island: Melatonin possesses a delayed
hypnotic effect that is time-dependent.
I.V. Zhdanova, Massachusetts Institute of Technology, Cam-
bridge: Soporific effects of melatonin in humans.
C. Singer, Oregon Health Sciences University, Portland:
Melatonin administration and sleep in the elderly.
D. Dawson, University of Adelaide, Woodville, Australia:
Melatonin and 'uncoupling" the clock: A neuroendocrine
cause of age-related sleep disturbances.
B. Myers, Bowling Green State University, Ohio: Hypo-
thermic effects of melatonin in humans.
T.A. Wehr, National Institute of Mental Health, National In-
stitutes of Health, Bethesda, Maryland: Melatonin,
temperature, sleep, and seasonal changes in humans.
R.J. Reiter, University of Texas Health Science Center, San
Antonio: Melatonin, EMF, and scavenging for negative
ions. Intracellular melatonin: Antioxidant actions and non-
enzymatic degradation.
D.E. Blask, The Mary Imogene Bassett Hospital, Coopers-
town, New York: Melatonin and cancer: Mechanisms of ac-
tion and potential impact of EMF.
A.J. Lewy, Oregon Health Sciences University, Portland:
General discussion.
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Genetics of Learning and Memory
April 17-April 20
FUNDED BY
H. Robertson Memorial Fund
ARRANGED BY
A. Silva, Cold Spring Harbor Laboratory, New York
T. Tully, Cold Spring Harbor Laboratory, New York
SESSION 1
Chairperson: J.C. Hall, Brandeis University, Waltham, Massachusetts
Part I: Genes, Physiological Mechanisms, and Behavior: Part II: Genetic Strategies for the Dissection of Learning and
What Are the Interconnections? Memory: Are There Common Patterns Amongst
Evolutionary Divergent Organisms?
A. Silva, Cold Spring Harbor Laboratory, New York: Gene-
tics of learning and memory.
R. Hen, Columbia University, New York, New York: 5HT,B
receptor knockout: Behavioral consequences.
Y. Zhong, Cold Spring Harbor Laboratory, New York: The
function of neuropeptides in mushroom body neurons of
Drosophila learning mutants.
J.M. Wehner, University of Colorado, Boulder: Multiple be-
havioral and genetic strategies to study hippocampal-
dependent learning and memory.
C. Rankin, University of British Columbia, Vancouver, Cana-
da: Issues in the genetic dissection of learning in C.
elegans.
SESSION 2
Chairperson: L.C. Griffith, Brandeis University, Waltham, Massachusetts
Part I: The Interplay between Genes, Development, and
Learning: Can We Alter Learning without Causing Physio-
logical and Structural Changes?
W. Quinn, Massachusetts Institute of Technology, Cam-
bridge: Forward and reverse genetic studies of learning in
Drosophila.
S.G.N. Grant, Columbia University, New York, New York:
Fyn mutant mice: Biochemical, physiological, and behav-
ioral deficits.
K.-F. Fischbach, Institut fir Biologie III, Freiburg, Germany:
Targeted misexpression of cell adhesion molecules in
Drosophila.
K. Kaiser, University of Glasgow, United Kingdom: Dro-
SESSION 3
Chairperson: R. Greenspan, New York University, New York
S. Tonegawa, Howard Hughes Medical Institute, Massachu-
setts Institute of Technology, Cambridge: Elec-
trophysiological and behavioral analyses of mouse
mutants generated by gene targeting.
Discussion: Specificity of Gene Disruptions: How Specific
Do They Have To Be?
Moderator: R. Greenspan, New York University, New York
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sophila mushroom bodies: Covert cellular organization and
in vivo manipulation.
Part II: Strategies to Circumvent the 'Developmental Prob-
lem': Is It Possible to Actually Study Learning without Inter-
fering with It?
R.F. Lathe, University of Edinburgh, United Kingdom: Redi-
recting gene expression in the mouse hippocampus.
R. McKay, National Institute of Neurological Disorders and
Stroke, Bethesda, Maryland: Transplantation of cultured
stem cells: A new method to analyze the molecular me-
chanisms of neuronal function in mammals.
R. Bourtchouladze
SESSION 4
Chairperson: S.F. Heinemann, The Salk Institute, San Diego, California
Part I: Neurotransmitter: Release and Receptor Function:
Mechanisms of Learning?
T.C. Sudhof, Howard Hughes Medical Institute, University of
Texas Southwestern Medical Center, Dallas: Genetic ap-
proaches to neurotransmitter release.
S. Nakanishi, Kyoto University Faculty of Medicine, Japan:
Physiological functions of glutamate receptors in neuron
plasticity and development.
P.H. Seeburg, University of Heidelberg, Germany: Genetic
regulation of excitatory postsynaptic cation channels.
SESSION 5
Chairperson: J. Roder, University of Toronto, Ontario, Canada
Part I: The Study of Plasticity in Cells, Circuits, and Behav-
ior: Is There a Link?
T.J. O'Dell, University of California, Los Angeles, School of
Medicine: Snaptic plasticity in transgenic mice express-
ing an a-CaMKII variant.
R. Malinow, Cold Spring Harbor Laboratory, New York:
Acute expression of genes to dissect mechanisms of
learning and memory.
J.O. McNamara, Duke University, Durham, North Carolina:
Effect of null mutations of a-CaCMKII on epileptogenesis
in transgenic mice.
SESSION 6
Chairperson: M. Stryker, University of California, San Francisco
E.R. Kandel, Howard Hughes Medical Institute, Columbia
University, New York, New York: A molecular switch for
long-term memory in Aplysia and mice.
Part II: Functional Plasticity: What Are the Implications to
Learning and Memory?
C.-F. Wu, University of Iowa, Iowa City: Physiological and
developmental plasticity of neurons in Drosophila learn-
ing mutants.
J. Gordon, University of California, San Francisco: Using
transgenic mice to dissect the mechanisms underlying
ocular dominance plasticity.
C.I. Bargmann, University of California, San Francisco: Be-
havioral plasticity in olfactory responses of C. elegans.
Part II: Creating Biological Explanations of Cognitive Pro-
cesses: Will Genetics Do It?
Y. Dudai, The Weizmann Institute of Science, Rehovot, Is-
rael: Neurogenetic dissection of learning: How specific
can it be?
A.M. Smith, American University in Cairo, Egypt: Genetics
of learning and memory: Creating a new interdisciplinary
paradigm.
Discussion: Developmental vs. Behavioral Plasticity: Are
There Common Mechanisms and Common 'Switches?'
Moderator: M. Stryker, University of California, San Francis-
co
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SESSION 7: Issues in the Behavioral Analysis of Mutants: How Can We Integrate Data from
Different Laboratories and from Different Model Systems?
Chairperson: M. Davis, Connecticut Mental Health Center, Yale University, New Haven
D. Wahlsten, University of Alberta, Edmonton, Canada:
Standardizing and validating tests of mouse behavior: Ge-
netic aspects.
M. Heisenberg, Theodor -Boveri- Institut (Biozentrum),
Wurzburg, Germany: Learning in tethered flies.
B.H. Smith, The Ohio State University, Columbus: Higher-
order conditioning in invertebrates; behavioral and ge-
netic analyses.
D. Van Der Kooy, University of Toronto, Ontario, Canada:
Mutations that block associative and/or nonassociative
learning in C. elegans.
T. Tully and J. Yin, Cold Spring Harbor Laboratory, New York:
Genetic dissection of memory.
Workshop on Human Molecular Genetics
April 21-April 24
FUNDED BY
Office of Health and Environmental Research, U.S. Department of Energy
ARRANGED BY
M. Bloom, DNA Learning Center, Cold Spring Harbor Laboratory, New York
D. Mick los, DNA Learning Center, Cold Spring Harbor Laboratory, New York
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory, New York
SESSION 1
D. Mick los, DNA Learning Center, Cold Spring Harbor Lab-
oratory, New York: Mendelian view of the gene: From
peas to eugenics.
J. Witkowski, Banbury Center, Cold Spring Harbor Labo-
ratory, New York: Modern view of the gene.
J. Witkowski, Banbury Center, Cold Spring Harbor Labo-
ratory, New York: PCR, RFLPs, and (CA)n: What they are;
what they do.
SESSION 2
S. Airhart, Oncor Science, Gaithersburg, Maryland:
Cytogenetics in the age of DNA.
SESSION 3
D. Mick los, DNA Learning Center, Cold Spring Harbor Labo-
ratory, New York: Laboratory: Using restriction enzymes to
construct chromosome maps.
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SESSION 4
D. Mick los, DNA Learning Center, Cold Spring Harbor Labo-
ratory, New York: Laboratory: Construction of
chromosome maps.
SESSION 5
M. Bloom, DNA Learning Center, Cold Spring Harbor Labo-
ratory, New York: Cloning human disease genes.
P. Ward, Institute of Molecular Genetics, Baylor College of
Medicine, Houston, Texas: DNA-based diagnosis for hu-
man genetic diseases.
C. Harris, Laboratory of Human Carcinogenesis, National
Cancer Institute, Bethesda, Maryland: Cancer genetics:
New advances, new surprises.
R. Tanzi, Neurogenetics Laboratory, Massachusetts General
Hospital, Boston: Molecular genetics and biology of
Alzheimer's disease.
SESSION 6
M. Bloom and D. Micklos, DNA Learning Center, Cold
Spring Harbor Laboratory, New York: Laboratory: Finger-
printing your own DNA by polymerase chain reaction.
SESSION 7
M. Bloom and D. Micklos, DNA Learning Center, Cold
Spring Harbor Laboratory, New York: Laboratory: Analyz-
ing fingerprinting results.
C. Link, Human Gene Therapy Institute, Des Moines, Iowa:
Human gene therapy trials.
T. Tully, Cold Spring Harbor Laboratory, New York: Genetics
and behavior.
M. Saxton, Massachusetts Office on Disability, Boston:
Genetics and cultural attitudes to disability.
P. Reilly, Shriver Center for Mental Retardation, Waltham,
Massachusetts: Future of genetic testing and screening.
Workshop on Manic-depressive Illness
June 9-June 11
FUNDED BY
The Charles A. Dana Foundation
ARRANGED BY
K. Jamison, Johns Hopkins University Medical School, Baltimore, Maryland
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory, New York
SESSION 1
K. Jamison, Johns Hopkins University Medical School, Balti-
more, Maryland: Clinical description of manic-depressive
illness (MDI).
N. Rosenthal, National Institute of Mental Health, Bethesda,
SESSION 2
W. Drevets, Washington University, St. Louis, Missouri:
Using new brain imaging techniques for studying mental
disorders.
SESSION 3
M. Bloom, DNA Learning Center, Cold Spring Harbor Labo-
ratory, New York: Laboratory: Fingerprint your own DNA
using the polymerase chain reaction.
SESSION 4
T. Wehr, National Institute of Mental Health, Bethesda,
Maryland: Biological rhythms and their significance in
MDI.
P. Reilly, Shriver Center for Mental Retardation, Waltham,
Maryland: Current status of treatments for MDI.
C. Gilliam, Columbia University, New York, New York: Devel-
opments in the molecular genetics of MDI.
Massachusetts: Ethical and societal issues of discovering
genes for human behavior.
R.D. Wyatt, National Institute of Mental Health Neuroscience
Center, Washington, D.C.: Economic impact of MDI.
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Workshop on Human Genetics and Health Care
August 28-August 31
FUNDED BY
The Robert Wood Johnson Foundation
ARRANGED BY
J.G. Davis, New York Hospital, Cornell University College of Medicine, New York
D.H. Lea, Foundation for Blood Research, Scarborough, Maine
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory, New York
SESSION 1: Overview of Current State of Providing Genetic Information
Chairperson: E. Thomson, National Institutes of Health, Bethesda, Maryland
P. Reilly, Shriver Center for Mental Retardation, Waltham,
Massachusetts: Medical geneticists.
A.P. Walker, University of California, Irvine, Medical Center:
Genetic counselors.
J.K. Williams, Iowa City, Iowa: Nurses.
SESSION 2: Current Models for Genetic Services
Chairpersons: A.P. Walker, University of California, Irvine, Medical Center
D.H. Lea, Foundation for Blood Research, Scarborough, Maine
B.R. Haas, New York Hospital-Cornell Medical Center, New
York: Community outreach.
J.D. Schulman, Genetics & IVF Institute, Fairfax, Virginia: Pri-
vate genetic services.
L. Djurdjinovic, Genetic Counseling Program, Binghamton,
New York: Rural outreach genetic services.
N.L. Fisher, Medical Genetic Services, Seattle, Washington:
Community hospital-based genetic services.
D.L. Wethers, St. Luke's-Roosevelt Hospital Center, New
York, New York: Genetic services targeted to single gene
disorders.
K.A. Schneider, Dana-Farber Cancer Institute, Boston, Mas-
sachusetts: Cancer genetics.
G. Cunningham, Department of Health Services-Genetic
Disease Branch, Berkeley, California: State health de-
partment-initiated genetic services.
M. S. Lubinsky, Children's Hospital of Wisconsin, Mil-
waukee: Genetic services in an academic center.
Summary and discussion:
What can we learn from these different approaches?
Is it simplistic to think of a general model for delivering ge-
netic services?
SESSION 3: Cultural and Consumer Issues in Providing Genetic Information
Chairperson: N.L. Fisher, Medical Genetic Services, Seattle, Washington
J. Mackta, Alliance of Genetic Support Groups, Chevy
Chase, Maryland: Partnerships between consumers and
healthcare professionals.
D. Punales-Morejon, Beth Israel Medical Center, New York,
New York: Genetic counselling and ethno-cultural issues.
G. Wang, Chinatown Health Clinic, New York, New York: In-
corporation of genetic information into primary healthcare
for Asian populations.
Summary and discussion:
How to take account of different cultural backgrounds in
viding genetic information?
How to ensure continuing and active interactions between
consumers and genetic healthcare professionals?
SESSION 4: Genetic Services: Providers of Genetic Information
Chairpersons: N.L. Fisher, Medical Genetic Services, Seattle, Washington
J. Hanson, Office of the Assistant Secretary of Health, Washington, D.C.
R.B. Black, Columbia University School of Social Work, New
York, New York: Social workers.
C. Scanlon, American Nurses Association, Washington,
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D.C.: Nurses and nurse practitioners.
J.G. Davis, New York Hospital, Cornell University College of
Medicine, New York: Physicians.
Comments:
J.R. Allen, American Medical Association, Chicago, Illinois
W. Freeman, American Academy of Family Physicians, Al-
buquerque, New Mexico
A.L. Mathews, University of Colorado, Denver
M. Shannon, Health Resources and Services Administration,
Rockville, Maryland
G. Anderson, New England Medical Center, Boston, Massa-
chusetts
Summary and conclusions:
What are the current roles of different healthcare providers?
What resources and people are available to develop new
routes for providing genetic information?
SESSION 5: Education of Primary Care Providers in Genetics
Chairpersons: J. Hanson, Office of the Assistant Secretary of Health, Washington, D.C.
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory, New York
N.A. Holtzman, Johns Hopkins Medical Institutes, Baltimore,
Maryland: State of genetic knowledge of primary
healthcare providers.
M.E. Carlin, 4 Tarrant County Hospital District, Fort Worth,
Texas: Primary care physicians: A regional approach to
continuing education.
A.L. Matthews, University of Colorado, Denver: Continuing
education of nurses.
K. Greendale, New York State Department of Health, Al-
bany: Genetic counselors' initiatives in providing educa-
tion to other health professionals.
J.S. Lin-Fu, Maternal and Child Health Bureau, Rockville,
Maryland: Maternal and Child Health initiatives in genetic
education for primary care providers.
S. Feetham, National Institute of Nursing, National Institutes
of Health, Bethesda, Maryland: National Institute of Nursing
Research initiatives on genetic education.
D. Runkle, American Association for the Advancement of
Science, Washington, D.C.: AAAS professional education
outreach.
SESSION 6: Review of Recommendations: Where to Go from Here?
Chairperson: J.G. Davis, New York Hospital, Cornell University College of Medicine, New York
E.H. Thomson, National Institutes of Health, Bethesda,
Maryland
D.H. Lea, Foundation for Blood Research, Scarborough,
Maine
A.P. Walker, University of California, Irvine, Medical Center
N.L. Fisher, Medical Genetic Services, Seattle, Washington
J. Hanson, Office of the Assistant Secretary of Health, Wash-
ington, D.C.
Targets for Specific Therapies in Leukemia
September 11-September 14
FUNDED BY
Cold Spring Harbor Laboratory Corporate Sponsor Program
ARRANGED BY
B.A. Chabner, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
B. Clarkson, Memorial Sloan-Kettering Cancer Center, New York, New York
Introduction: B. Clarkson, Memorial Sloan-Kettering Cancer Center, New York, New York
SESSION 1: Growth Regulation of Normal and Leukemic Cells
Chairperson: R.A. Weinberg, Whitehead Institute for Biomedical Research, Cambridge,
Massachusetts
D.H. Beach, Cold Spring Harbor Laboratory, New York: The
cell cycle and cancer.
C. Greider, Cold Spring Harbor Laboratory, New York:
Telomeres and telomerase in cancer.
J.N. lhle, St. Jude Children's Research Hospital, Memphis,
Tennessee: Role of JAKs and STATs in cytokine receptor
signal transduction.
K. Kelly, National Cancer Institute, National Institutes of
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B. Clarkson C. Greider, R. Weinberg
Health, Bethesda, Maryland: Role of two immediate early
genes (PAC1 and GEM) in regulating signal transduction
and cell cycle advancement in hematopoietic cells.
W. Kaelin, Dana-Farber Cancer Institute, Boston, Massachu-
SESSION 2: Cell Adhesion/Homing/Angiogenesis
Chairperson: T.D. Tlsty, University of North Carolina, Chapel
P.W. Kincade, Oklahoma Medical Research Foundation, Ok-
lahoma City: Sex steroids as regulators of normal
lymphopoiesis.
A. Freedman, Dana-Farber Cancer Institute, Boston, Massa-
chusetts: Adhesion of follicular lymphoma cells: Regula-
tion of homing and activation.
setts: The cell cycle regulatory transcription factor E2F as
a target for antineoplastic drug discovery.
T.D. Tlsty, University of North Carolina, Chapel Hill: Origin of
drug-resistant tumor cells.
Hill
M.W. Long, University of Michigan, Ann Arbor: Role of cyto-
adhesion in hematopoietic cell development.
C.M. Verfaillie, University of Minnesota, Minneapolis: Inter-
feron-x may reverse abnormal circulation and proliferation
in CML.
SESSION 3: Follicular Lymphomas and Hairy Cell Leukemia
Chairperson: C.M. Croce, Thomas Jefferson University, Philadelphia, Pennsylvania
E. Beutler, The Scripps Research Institute, La Jolla, Califor- J.C. Reed, La Jolla Cancer Research Foundation,
nia: 2-chlorodeoxyadenosine: A lympho-lytic nucleoside California: BCL.2 and chemoresistance in can-
designed to take advantage of a cell-specific metabolic car.
pattern.
SESSION 4: CMI
Chairperson: B. Clarkson, Memorial Sloan-Kettering Cancer
D. Afar, Howard Hughes Medical Institute, University of Cali-
fornia, Los Angles: Activation of multiple signals by the
BCR-ABL oncogene.
A.M. Pendergast, Duke University Medical Center, Durham,
North Carolina: Signaling by the BCR/ABL oncogene.
E.A. Sausville, National Cancer Institute, National Institutes
of Health, Bethesda, Maryland: Drugs directed at
pathogenetically relevant protein kinases: Novel
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Center, New York, New York
strategies for the treatment of leukemia and lymphoma.
R. Van Etten, Center for Blood Research, Harvard Medical
School, Boston, Massachusetts: New targets for therapy
of Philadelphia-positive leukemia derived from studies of
c-ABL and BCR/ABL.
J.Y.J. Wang, University of California, San Diego, La Jolla:
BCR-ABL, mechanism of action and target of interven-
tion.
SESSION 5: APL
Chairperson: R.A. Weinberg, Whitehead Institute for Biomedical Research, Cambridge,
Massachusetts
H. De The, CNRS, Paris, France: Acute promyelocytic leu-
kemia and RA.
R.P. Warrell, Jr., Memorial Sloan-Kettering Cancer Center,
New York, New York: Retinoids as targeted cancer thera-
pies: Clinical, pharmacologic, and molecular studies.
SESSION 6: New Therapies/Conclusions
Chairperson: B.A. Chabner, National Cancer Institute, National Institutes of Health,
Bethesda, Maryland
D. Cheresh, The Scripps Research Institute, La Jolla, Cali-
fornia: Cell adhesion, angiogenesis, and apoptosis.
J.R. Bertino, Memorial Sloan-Kettering Cancer Center, New
York, New York: p53 and drug resistance in leukemia.
A.B. Deisseroth, University of Texas M.D. Anderson Cancer
Center, Houston: Interferon inducible transcriptional
regulatory factors using MDR-1 vectors and autologous
bone marrow transplantation.
L. Fairbairn, Paterson Institute for Cancer Research, Man-
chester, United Kingdom: Gene therapy to reduce hema-
totoxicity and secondary hematopoietic neoplasms fol-
Protein Design/Folding
lowing antitumor treatment.
A.I. Oliff, Merck Research Laboratories, West Point, Pennsyl-
vania: Pharmaceutically realistic targets in molecular oncol-
ogy.
I.H. Pastan, DCBD, National Cancer Institute, National In-
stitutes of Health, Bethesda, Maryland: Recombinant im-
munotoxins for the therapy of leukemia and lymphoma.
M. Feldman, Weizmann Institute of Science, Rehovot, Israel:
Cancer metastasis: Immunotherapy via peptide and gene
therapy.
October 16-October 19
FUNDED BY
Cold Spring Harbor Laboratory Corporate Sponsor Program
ARRANGED BY
B. Honig, Columbia University, New York, New York
R.L. Jernigan, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
H.A. Scheraga, Cornell University, Ithaca, New York
J. Skolnick, H. Scheraga
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SESSION 1
F.M. Richards, Yale University, New Haven, Connecticut:
Nonpolar, solvent-accessible, surface area: Can we
measure it experimentally?
C.R. Matthews, Pennsylvania State University, University
Park: Size and structure in early folding intermediates of
dihydrofolate reductase.
D.M. Rothwarf, Cornell University, Ithaca, New York: Fold-
ing/unfolding pathways of ribonuclease A.
J.S. Weissman, Yale University, New Haven, Connecticut:
SESSION 2
G.D. Rose, Washington University, St. Louis, Missouri: Pre-
diction of protein helices from a stereochemical code.
A.-S. Yang, Columbia University, New York, New York:
Energetics of the coil-helix transition for poly-L-alanine in
water.
L. Holm, EMBL, Heidelberg, Federal Republic of Germany:
The slow death of the protein folding problem. (When will
we know all natural protein structures?)
SESSION 3
W.L. Jorgensen, Yale University, New Haven, Connecticut:
Thermal and urea-induced unfolding of proteins with
molecular dynamics simulations.
R.M. Levy, Rutgers University, Piscataway, New Jersey:
Thermodynamics of solvation and pKas in proteins.
D.G. Covell, PRI/NCI-FCRDC, Frederick, Maryland: Role of
surface hydrophobicity in protein-protein recognition.
B. Honig, Columbia University, New York, New York: The
free energy balance in protein folding.
SESSION 4
E. Shaknovich, Harvard University, Cambridge, Massachu-
setts: Design of stable and fast-folding sequences and
their mechanism.
J. Skolnick, The Scripps Clinic Research Institute, La Jolla,
California: De novo simulations of globular protein fold-
ing.
A. Sali, Harvard University, Cambridge, Massachusetts:
Thermodynamics and kinetics of protein folding.
SESSION 5
Z. Huang, University of California, San Francisco: Prion in-
fectivity: A case of protein folding and refolding.
R. Friesner, Columbia University, New York, New York: Com-
putational studies of protein folding.
A.T. Hagler, Biosym Technologies, Inc., San Diego, Califor-
nia: On the effect of long-range interactions on protein
structure, specificity, and ligand-binding free energies.
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GroEl-mediated folding proceeds by multiple rounds of
binding and release of nonnative polypeptides.
P.E. Wright, The Scripps Research Institute, La Jolla, Califor-
nia: NMR structural characterization of protein folding path-
ways and folding intermediates.
K.A. Sharp, University of Pennsylvania, Philadelphia: Cyclic
dipeptides as models for protein folding and association
energetics.
D. Eisenberg, University of California, Los Angeles: 3D pro-
files for protein folding and design.
R.L. Jernigan, DCBDC, National Cancer Institute, National In-
stitutes of Health, Bethesda, Maryland: Coarse-grained in-
teraction energies.
S. Rackovsky, Mount Sinai School of Medicine, New York,
New York: Studies of the protein-folding code.
M.R. Pincus, State University of New York Health Science
Center, Brooklyn: Use of the electrostatically driven Monte
Carlo. Method for exploring the conformational space
around folded proteins and identification of effector
domains of the ras p21 protein using this method.
J. Hermans, University of North Carolina at Chapel Hill: Do
molecular dynamics forcefields correspond to stable
proteins?
C.L. Brooks, Carnegie Mellon University, Pittsburgh, Pennsyl-
vania: Protein folding pathways and thermodynamics
studied by molecular dynamics,
H.J.R. Weintraub, R.W. Johnson Pharmaceutical Research
Institute, Raritan, New Jersey: The need for reasonably ac-
curate structure predictions in drug discovery.
H. A. Scheraga, Cornell University, Ithaca, New York: The
multiple-minima problem in protein folding.
S.C. Harvey, University of Alabama at Birmingham: New
modeling methods for ribonucleoprotein complexes.
J.A. McCammon, University of Houston, Texas: Kinetic issues
in the design of proteins.
W.G. Guida, Ciba-Geigy Company, Summit, New Jersey:
How protein conformation has influenced the design of in-
hibitors of purine nucleoside phosphorylase.
Telomeres
October 23-October 26
FUNDED BY
Cold Spring Harbor Laboratory Corporate Sponsor Program
ARRANGED BY
E. Blackburn, University of California, San Francisco
T. de Lange, The Rockefeller University, New York, New York
C. Greider, Cold Spring Harbor Laboratory, New York
SESSION 1: Telomerase
Chairperson: H. Cooke, Western General Hospital, Edinburgh,
C. Greider, Cold Spring Harbor Laboratory, New York:
Telomerase, biochemistry reconstitution.
J. Lingner, University of Colorado, Boulder: Hypotrichous
telomerase RNA structure and function.
D. Shippen, Texas A&M University, College Station: Differ-
ential use of the RNA template by the Euplotes and
United Kingdom
Oxytricha telomerases.
E. Blackburn, University of California, San Francisco:
Telomerase, telomerase RNA, and mutant telomeres in
yeast.
D. Gottschling, University of Chicago, Illinois: TLC1: The
template RNA component of S. cerevisiae telomerase.
SESSION 2: Telomere Dynamics and Replication: Small Eukaryotes
Chairperson: E. Blackburn, University of California, San Francisco
V. Lundblad, Baylor College of Medicine, Houston, Texas:
Characterization of EST-mediated pathway for telomere
replication.
T.D. Petes, University of North Carolina, Chapel Hill: Muta-
tions that affect telomeres in yeast.
V.A. Zakian, Fred Hutchinson Cancer Research Center,
Seattle, Washington: Telomere replication in Sac-
charomyces.
B.J. Brewer, University of Washington, Seattle: Telomeres
and other elements that delay replication origin
activation.
E. Henderson, Iowa State University, Ames: Telomere length
regulation in Tetrahymena.
B. Brewer, S. Gasser, E. Blackburn
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SESSION 3: Telomere Dynamics in Human Aging and Cancer
Chairperson: T. de Lange, The Rockefeller University, New York, New York
C.B. Harley, Geron Corporation, Menlo Park, California:
Telomeres and telomerase in cell aging and cancer.
J.W. Shay, University of Texas Southwestern Medical Cen-
ter, Dallas: Telomerase activity in human tissues and
tumors; manipulation of telomere length in immortal cells.
S. Bacchetti, McMaster University Medical Center, Ontario,
Canada: Telomerase in cell immortalization and tumor
progression.
SESSION 4: Telomeric Chromatin, Silencing, and Telomere Binding Proteins
Chairpersons: T.D. Petes, University of North Carolina, Chapel Hill
J. Haber, Brandeis University, Waltham, Massachusetts
D. Gottschling, University of Chicago, Illinois: Transcriptional
silencing in S. cerevisiae.
D.M. Shore, Columbia University College of Physicians &
Surgeons, New York, New York: Regulation of transcrip-
tional silencing at HM loci and telomeres in yeast.
A.J. Lustig, Memorial Sloan-Kettering Cancer Center, New
York, New York: Mechanisms of action of the Rapip in
telomere silencing and size control.
R. Al !shire, Western General Hospital, Edinburgh, United
Kingdom: Fission yeast telomeres and position effect
variegation.
H. Cooke, Western General Hospital, Edinburgh, United
Kingdom: Position effects at mammalian telomeres.
SESSION 5: Dipteran Telomeres
Chairperson: V.A. Zakian, Fred Hutchinson Cancer Research
R.W. Levis, Fred Hutchinson Cancer Research Center,
Seattle, Washington: Drosophila telomeric DNA: Structure
and maintenance.
M. Pardue, Massachusetts Institute of Technology, Cam-
bridge: Drosophila telomeres: Transposable elements
earning an honest living.
S.M. Gasser, Swiss Institute for Experimental Cancer Re-
search, Lausanne, Switzerland: Subnuclear organization
of telomeres and repressed chromatin in yeast.
J. Berman, University of Minnesota, St. Paul, Minneapolis:
Gene products involved in telomere organization in the
nucleus.
T. de Lange, The Rockefeller University, New York, New
York: Mammalian telomeric chromatin.
C. Price, University of Nebraska, Lincoln: The telomere
protein homolog: A novel telomere replication factor?
Y. Hiraoka, Communications Research Laboratory, Kobe,
Japan: Dynamics of telomeres in meiotic prophase.
Center, Seattle, Washington
H. Biessman, University of California, Irvine: Drosophila
telomeres: DNA organization and elongation by Het-A
retrotransposition.
J.-E. Edstrom, University of Lund, Sweden: Complex repeats
at chromosome ends of C. pallidivittatus.
SESSION 6: Chromosome Healing and Subtelomeric Recombination
Chairperson: C. Greider, Cold Spring Harbor Laboratory, New York
J. Haber, Brandeis University, Waltham, Massachusetts:
Mechanism of new telomere formation to repair broken
yeast chromosomes.
F. Muller, University of Fribourg, Switzerland: Nematodes as
a model system for the analysis of telomere function.
W.R.A. Brown, Oxford University, United Kingdom: Dissect-
ing mammalian chromosomes with telomeric DNA.
Coffee Break
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A. Sherf, Institut Pasteur, Paris, France: Chromosome
breakage and healing in the human malaria parasite P. fal-
ciparum.
P. Borst, The Netherlands Cancer Institute, Amsterdam: Con-
trol of telomeric expression sites for VSG genes of
trypanosomes.
J.P. Morgan/Cold Spring Harbor Laboratory Executive Conference
on the Biology of Human Behavior
October 28-October 30
ARRANGED BY
J.D. Watson, Cold Spring Harbor Laboratory, New York
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory, New York
SESSION 1
E. Wilson, Museum of Comparative Zoology, Harvard Uni-
versity, Cambridge, Massachusetts: Animal to human be-
havior: The evolution of complexity.
SESSION 2
S. Snyder, Johns Hopkins University School of Medicine,
Baltimore, Maryland: Neural messengers and brain ac-
tivity.
M. Raichle, Washington University School of Medicine, St.
SESSION 3
T. Tully, Cold Spring Harbor Laboratory, New York: Learning
and memory in fruit flies,
SESSION 4
G. Uhl, National Institute on Drug Abuse, Baltimore,
Maryland: Recent advances in molecular neurobiology
and genetics.
P. McGuffin, University of Wales College of Medicine, Car-
diff: Genetic approaches to psychiatric disorders.
Louis, Missouri: Images of the mind.
L. Squire, University of California, San Diego, School
of Medicine, La Jolla: Learning and memory sys-
tems of the brain.
A. Silva, Cold Spring Harbor Laboratory, New York:
Learning and memory in mice.
D. Hamer, National Cancer Institute, Bethesda,
Maryland: Genetics of human behaviors.
H.E. Fisher, Rutgers University, New Brunswick, New
Jersey: Marriage, adultery, and divorce.
H. Fisher, H. Solomon, J.D. Watson
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Grass Genomes
October 31-November 2
FUNDED BY
USDA Plant Genome Program
The Rockefeller Foundation
United Kingdom Biotechnology and Biological Sciences Research Council
ARRANGED BY
J. Bennetzen, Purdue University, West Lafayette, Indiana
SESSION 1: Presentations on Current Research Status
J. Bennetzen, Purdue University, West Lafayette, Indiana,
and M. Gale, John Innes Centre, Norwich, United King-
dom: Introduction.
J. Gale, John Innes Centre, Norwich, United Kingdom: Com-
parative genetic maps.
S. Mc Couch, Cornell University, Ithaca, New York: Com-
parative genetic maps.
J. Bennetzen, Purdue University, West Lafayette, Indiana:
Physical maps.
T. Sasaki, STAFF Institute, Tsukuba Ibaraki, Japan: Monocot
cDNAs; saturation/specificity.
S. Cartinhour, USDA - NAL, Beltsville, Maryland: Database
integration.
SESSION 2: Discussion Group
Expected/potential benefits of an IGGI program.
What is available (technology, resources, organization)?
What is needed (technology, resources, organization)?
SESSION 3' Discussion Group
Discussion/revision of IGGI document outline prepared from
discussions and presentations on previous day.
Conclusions and designation of next steps and parties
responsible.
Candidate Gene Approaches to ALS
November 2-November 5
FUNDED BY
The Amyotrophic Lateral Sclerosis Association
ARRANGED BY
R.H. Brown, Massachusetts General Hospital East, Charlestown
R.L. Nussbaum, National Center for Human Genome Research, National Institutes of
Health, Bethesda, Maryland
Introduction
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory, New York
R.V. Abendroth, The Amyotrophic Lateral Sclerosis Association, Milwaukee, Wisconsin
SESSION 1: Genetics of ALS
Chairperson: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory, New York
R.H. Brown, Massachusetts General Hospital East, Charles- M.A. Pericak-Vance, Duke University Medical Center, Durham,
town: Overview of inherited motor nerve diseases. North Carolina, and J.L. Haines, Massachusetts
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General Hospital East, Boston: Approaches to linkage
analysis in familial ALS: Present resources and strategies.
J. de Belleroche, Charing Cross & Westminster Medical
School, London, United Kingdom: A survey of super-
oxide dismutase mutations in 100 U.K. families and ex
SESSION 2: Pathophysiology of ALS
Chairperson: T. Siddique, Northwestern University Medical
M. Chalfie, Columbia University, New York, New York: Cell
death genes in nematodes.
D.W. Choi, Washington University School of Medicine, St.
Louis, Missouri: Excitotoxicity and neuronal death.
D.E. Merry, University of Pennsylvania School of Medicine,
Philadelphia: Bcl -2, CAG repeats, and motor neurons.
B. Demple, Harvard School of Public Health, Boston, Mass-
achusetts: Anti-oxidant gene families.
T. Siddique, Northwestern University Medical School, Chica-
go, Illinois: SOD1 transgenic mice.
SESSION 3: Open Discussion: Candidate ALS Genes
Chairperson: A. Tobin, University of California, Los Angeles
clusion studies in extensive pedigrees lacking SOD-1
mutations.
M. Devoto, Columbia University, New York, New York:
Theoretical considerations in analysis of mono- and
multi-genic disease loci.
School, Chicago, Illinois
D.W. Cleveland, Johns Hopkins University School of Medi-
cine, Baltimore, Maryland: SOD1 and neurofilament L
transgenic mice.
D.A. Figlewicz, University of Rochester Medical Center, New
York: Mutations in neurofilament H in ALS.
P.N. Leigh, Institute of Psychiatry, London, United Kingdom:
Cytoskeletal pathology in ALS.
G.D. Yancopoulos, Regeneron Pharmaceuticals, Inc. Tar-
rytown, New York: Neurotrophic growth factors and their
receptors.
SESSION 4: Approaches to Gene Mapping, Genomic Analysis, and Mutational Screening
Chairperson: R.L. Nussbaum, National Center for Human Genome Research, National
Institutes of Health, Bethesda, Maryland
D. Patterson, Eleanor Roosevelt Institute, Denver, Colorado:
Development of YAC contig maps.
R.A. Gibbs, Baylor College of Medicine, Houston, Texas:
Genomic sequencing for gene searching.
M. Borodovsky, Georgia Institute of Technology, Atlanta:
Computational sequence analysis.
W.M. Barnes, Washington University School of Medicine, St.
Louis, Missouri: Long PCR.
E.A. Rose, Perkin-Elmer Cetus Instruments, Emery-ville, Cal-
ifornia: Applications of long PCR.
P. Nisson, Life Technologies, Gaithersburg, Mary-land: Exon
trapping.
V.C. Sheffield, University of Iowa Hospitals & Clinics, Iowa
City: Efficient identification of disease loci and mutation
detection.
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Evolution of Genes and Genomes
November 9-November 12
FUNDED BY
Alfred P. Sloan Foundation
Cold Spring Harbor Laboratory Corporate Sponsor Program
ARRANGED BY
S. Brenner, University of Cambridge School of Medicine, United Kingdom
W. Gilbert, Harvard University, Cambridge, Massachusetts
J. Lake, University of California, Los Angeles
E.S. Lander, Massachusetts Institute of Technology Center for Genome Research, Cambridge
SESSION 1: Contemporary Sequences and the Past
Chairperson: J. Lake, University of California, Los Angeles
R.F. Doolittle, University of California, San Diego, La Jolla:
Evolution of the earliest proteins.
P. Green, University of Washington, Seattle: Ancient con-
served gene families.
M.W. Gray, Duke University, Durham, North Carolina: The
organelle genome megasequencing project: Exploring
mitochondria! DNA evolution.
SESSION 2: Analysis of Populations
Chairperson: D. Botstein, Stanford University School of Medicine, California
M.E. Kreitman, University of Chicago, Illinois: Role of weak ferences.
selective forces on rates of molecular evolution. D.A. Powers, Stanford University, Pacific Grove, California:
J.H. Gillespie, University of California, Davis: What can be A multidisciplinary approach toward resolving the selec-
inferred about the causes of molecular evolution from tionist/neutralist controversy.
species comparisons of DNA sequences? M.-C. King, University of California, Berkeley: Human
C.H. Langley, University of California, Davis: Recombination genome diversity.
and DNA sequence polymorphism: Distributions of S. Paabo, University of Munich, Germany: Human popula-
transposable elements and of single nucleotide dif- tion history and the mitochondria' genome.
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R. Doolittle, F. Ruddle
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M.-C. King
SESSION 3: Origin and Evolution of Eukaryotic Genes
Chairperson: W. Gilbert, Harvard University, Cambridge, Massachusetts
L. Hood, University of Washington, Seattle: DNA sequence
of the T-cell receptor loci of humans and mice; 80 million
years of molecular evolution.
J. Lake, University of California, Los Angeles: Searching for
the prokaryotic origins of eukaryotes.
L. Simpson, Howard Hughes Medical Institute, University of
California, Los Angeles: Evolution of RNA editing in
kinetoplastid protozoa.
D. Helfman, Cold Spring Harbor Laboratory, New York:
Alternative RNA splicing.
SESSION 4: Analysis of Populations
Chairperson: W. Gilbert, Harvard University, Cambridge, Massachusetts
M. Akam, University of Cambridge, United Kingdom: Evolu- F.H. Rudd le, Yale University, New Haven, Connecticut: Hox
tion of HOX genes in arthropods. cluster evolution.
SESSION 5: Evolution of Genomes
Chairpersons: W. Gilbert, Harvard University, Cambridge, Massachusetts
J. Lake, University of California, Los Angeles
D. Sankoff, University of Montreal, Quebec, Canada: The aerofilum.
mathematical inference of evolution via genome rear- S.J. O'Brien, National Cancer Institute, National Institutes of
rangement. Health, Frederick, Maryland: Evolving genes and
P. Green, University of Washington, Seattle: Progress on se- genomes: Lessons from the Felidae.
quencing the C. elegans genome and its analysis. T. Helentjaris, University of Arizona, Tucson: Internal
W.F. Doolittle, Dalhousie University, Halifax, Nova Scotia, duplication of the maize genome and what it reveals
Canada: Archaebacterial genomes: Why we are sequenc- about the evolution of genome structure.
ing Sulfolobus solfataricus? J.E. Womack, Texas A&M University, College Station: Corn-
J.H. Miller, University of California, Los Angeles: Preliminary parative gene mapping in cattle, mice, and humans: Con-
sequence analysis of the archaebacteria Pyrobacu/um tributions to understanding genome evolution.
Molecular Genetics of Diabetes
December 4-December 7
FUNDED BY
The William Stamps Farish Fund
ARRANGED BY
G.I. Bell, Howard Hughes Medical Institute, University of Chicago, Illinois
J. Todd, John Radcliffe Hospital, Oxford, United Kingdom
SESSION 1: Genetics of Diabetes and Obesity in Animal Models
Chairperson: A. Lernmark, Karolinska Hospital, Stockholm, Sweden
L.S. Wicker, Merck Research Laboratories, Rahway, New J.M. Friedman, The Rockefeller University, New York, New
Jersey: Molecular genetics of IDDM in the NOD mouse. York: Genetic analysis of rodent obesity.
E.H. Leiter, The Jackson Laboratory, Bar Harbor, Maine: P. Nishina, The Jackson Laboratory, Bar Harbor, Maine:
Linking genotype to phenotype in mouse models of Genetics of modifying factors in NIDDM and obesity in
diabetes. mouse models.
SESSION 2: Genetics of Insulin-dependent (Type 1) Diabetes Mellitus (IDDM)
Chairperson: G.J. Thomson, University of California, Berkeley
J. Todd, University of Oxford, United Kingdom: Genetics of
type-1 diabetes: Exclusion mapping.
L.L. Field, Health Sciences Center, Calgary, Canada:
Genetics of IDDM.
E.A.M. Gale, St. Bartholomew's Hospital, London, United
Kingdom: Integrated strategies for prediction of IDDM.
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SESSION 3: Clinical Studies: The Diabetic Phenotype
Chairperson: C.R. Kahn, Jos lin Diabetes Center, Boston, Massachusetts
L. Groop, Malmo General Hospital, Sweden: Metabolic
heterogeneity of NIDDM.
P.Z. Zimmet, International Diabetes Institute, Melbourne,
Australia: Latent autoimmune diabetes in adults: Genetics
and autoimmunity.
SESSION 4: Genetics of Noninsulin-dependent (Type 2) Diabetes Mellitus (NIDDM)
Chairperson: G.I. Bell, Howard Hughes Medical Institute, University of Chicago, Illinois
A.D. Roses, Duke University Medical Center, Durham, North
Carolina: Molecular genetics of the Alzheimer diseases: A
model for studies of complex genetic disorders.
P. Froguel, Human Polymorphism Study Center, Paris,
France: MODY: A paradigm for genetics of NIDDM.
K.S. Polonsky, The University of Chicago, Illinois: Distinctive
alterations in B-cell function associated with different ge-
netic forms of diabetes.
F.S. Collins, National Center for Human Genome Research,
National Institutes of Health, Bethesda, Maryland:
Genetics of NIDDM in Finland.
SESSION 5: Genetic Studies of NIDDM In High-Risk Populations
Chairpersons: A.T. Hatters ley, Queen Elizabeth Hospital, Birmingham, United Kingdom
N. Iwasaki, Tokyo Women's Medical College, Japan
C. Bogardus, National Institute of Diabetes and Digestive
and Kidney Diseases, National Institutes of Health, Phoe-
nix, Arizona: NIDDM genes in Pima Indians.
M.P. Stern, University of Texas Health Science Center, San
Antonio: Search for type II diabetes susceptibility genes in
Mexican Americans.
SESSION 6: Candidate Genes: Genetics of Insulin Secretion and Insulin Action
Chairperson: P. Froguel, Human Polymorphism Study Center, Paris, France
M.A. Permutt, Washington University, St. Louis, Missouri: land: Molecular genetics of insulin resistance.
Genetics of rare inherited disorders of pancreatic B-cell G.I. Bell, Howard Hughes Medical Institute, University of
function. Chicago, Illinois: Candidate genes and genetic studies of
S.I. Taylor, National Institutes of Health, Bethesda, Mary- diabetes mellitus.
P. Concannon, G. Thomson, J. Todd
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SESSION 7: Approaches for Mapping Genes for Complex Traits
Chairperson: R.S. Spielman, University of Pennsylvania, Philadelphia
N. Risch, Yale University, New Haven, Connecticut: Assess-
ing the genetic contribution to type 1 diabetes.
J. Ott, Columbia University, New York, New York: Detecting
linkage and association in the haplotype relative risk de-
sign.
M.L. Boehnke, University of Michigan, Ann Arbor: Mapping
and exclusion of genes for complex traits: Application to
NIDDM.
B.K. Suarez, Washington University School of Medicine, St.
Louis, Missouri: Nonparametric linkage analysis and
linkage disequilibrium analysis.
E.S. Lander, Whitehead Institute, Cambridge, Massachu-
setts: Genetic dissection of complex traits.
Planning for the Next Generation of Vaccines
December 11-December 14
FUNDED BY
The Albert B. Sabin Vaccine Foundation
ARRANGED BY
P.K. Russell, The Johns Hopkins University, Baltimore, Maryland
SESSION 1: Future Directions in Vaccine Science
Chairperson: R. Rabinovich, NIAID, NIH, Bethesda, Maryland
F.J. Malinoski, Lederle-Praxis Biologicals, Wayne, New Jer-
sey: Glycoconjugate technology and future combination
vaccines.
M.A. Liu, Merck Research Laboratories, West Point, Penn-
sylvania: DNA vaccines: A new approach to vaccination.
E. Paoletti, Virogenetics Corporation, Troy, New York: At-
tenuated poxvirus recombinants.
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S. Plotkin, Pasteur Merieux Connaught, Mamas la Coquette,
France: How vaccine development of the future may af-
fect vaccination schedules and cost.
R.W. Chesnut, Cytel Corporation, San Diego, California: Im-
mune stimulation.
G.A. Siber, Public Health Biological Laboratories, Boston,
Massachusetts: Overview and discussion.
P. Freeman, P. Russell
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SESSION 2: Perspectives of the Biotechnology Industry
Chairperson: F. Cano, Aviron Corporation, Burlingame, California
T.P. Stagnaro, Univax Biologics, Inc., Rockville, Maryland: T. Elliott, Prime Capital Management Company, Inc., Stem-
Bacterial vaccines and their role as immunizing agents. ford, Connecticut: Venture capital: A partial overview.
L.C. Gordon, Ora Vax Inc., Cambridge, Massachusetts: Dis- J.L. Read, Aviron, Burlingame, California: Overview and dis-
ease and product profile for financability of vaccine devel- cussion.
opment.
SESSION 3: Perspectives of the Large Vaccine Companies
Chairperson: S. Lemon, University of North Carolina, Chapel Hill
L.E. Long, Leder le-Praxis Biologicals, Wayne, New Jersey:
Leder le-Praxis Biologicals perspective.
R. Rappuoli, Biocine S.p.A., Siena, Italy: Perceived vaccine
value and implications on discovery and development.
M. De Wilde, SmithKline Beecham Biologicals, Rixensart,
Belgium: Changes in the vaccine industry and areas for
SESSION 4: Policy Discussions from the Public Sector
Chairperson: M.T. Osterholm, Minnesota Department of Health,
R. Rabinovich, NIAID/NIH, Bethesda, Maryland: Planning for
the next generation of vaccines: Vaccine research and
development supported by NIAID/NIH.
R. Bernier, Centers for Disease Control, Atlanta, Georgia: A
status report on the childhood immunization initiative.
C. Broome, Centers for Disease Control and Prevention, At-
lanta, Georgia: Surveillance opportunities for improved
SESSION 5: Policy Development
Chairperson: P. Freeman, University of Massachusetts, Boston
E.K. Marcuse, Children's Hospital and Medical Center,
Seattle, Washington: Integrating public and private sec-
tors to accomplish universal childhood immunization.
R. Widdus, National Vaccine Program Office, Washington,
D.C.: Behavior of the vaccine development "system."
F Curio
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partnership with the public sector.
C.M. Grant, Connaught Laboratories, Inc., Swiftwater,
Pennsylvania: Vaccine economics and the impact of
globalization.
R. Ellis, Merck & Company, Inc., Rahway, New Jersey:
Overview and discussion.
Minneapolis
vaccine development.
M.C. Hardegree, Center for Biologics Evaluation and Re-
search, FDA, Rockville, Maryland: Role of FDA in the
regulation of vaccines.
A. Robbins, U.S. Public Health Service, Boston, Massachu-
setts: Overview and discussion.
R. Goldberg, Springfield, New Jersey: Reinventing vaccine
policy.
P.K. Russell, The Johns Hopkins University, Baltimore,
Maryland: Overview and discussion.
DNA LEARNING CENTER

DNA LEARNING CENTER
David A. Mick los, Director
Mark V. Bloom, Assistant Director
Susan M. Lauter, Designer
Robert Muratore, Computational Scientist
Judy L. Cumella, Program Coordinator
Jane P. Conigliaro, Education Manager
Melissa A.G. Hewitt, Laboratory Instructor
Diane S. Jedlicka, Laboratory Instructor
Diane Esposito, Laboratory Instructor
Flavio Della Seta, Laboratory Instructor
Time flies. It hardly seems possible, but it was ten years ago that Cold Spring
Harbor Laboratory offered its first summer training course in recombinant DNA
technology for high school faculty. The DNA Learning Center did not exist then,
so the workshop was held in a classroom at the Wheatley School in Nassau
County.
The course was not called DNA Science, as it is today. The title then, Recom-
binant DNA for Beginners, was borrowed from the 1971 record album, Songs for
Beginners, by Graham Nash. This was Nash's first solo album after the split-up of
Crosby, Stills, Nash, and Young-a band propelled into the public consciousness
by Woodstock and in many ways emblematic of that awkward time in American
life. Nash's album was composed largely of simple songs with which nearly any
beginning guitar player or vocalist could easily tag along and so, in some sense,
feel like a pop musician. Our course was likewise intended-a collection of rela-
tively simple experiments that could make high school students feel like
molecular biologists. In 1990, when our manuscript was formally printed, we
opted for the more enduring title, DNA Science. This simple but catchy synopsis
of molecular genetics-looking at biology through the lens of DNA-had been
mentioned casually in conversation by Jim Watson. The name has stuck, be-
cause I now hear biology educators using the term DNA science in a generic
sense.
The project to develop molecular genetic experiments for student use had its
origin in an unlikely collaboration between Dave Mick los, then public affairs and
development director at the Laboratory, and Greg Freyer, then a postdoctoral fel-
low in Richard Roberts' lab group. Beginning in 1984, Greg volunteered to
prepare gels of Lambda restriction digests for Dave to show to school students
who came for tours of the Laboratory. The stained gels were illuminated on a
long-wavelength UV "black light" Dave found in a lab storeroom. This was a relict
from the mid-1970s, when ethidium bromide staining was developed at Cold
Spring Harbor by Phil Sharp, Bill Sugden, and Joe Sambrook. Specialized mid-
wavelength transilluminators were not initially available; however, "black lights"
were available for illuminating the posters that were a popular form of interior
decoration for young people.
Students proved fascinated with those simple "DNA fingerprints" of the
Lambda virus, and we began thinking about hands-on experiments that might be
done in high school biology classes. At about the same time, Fran Roberts be-
came superintendent of Cold Spring Harbor Schools and sent a letter to Jim Wat-
son asking how the school district and the Laboratory could work together in ed-
ucation. Fran, who had just returned from a tour of duty at the National Endow-
ment for the Humanities in Washington, D.C., suggested that we submit a joint
Greg Freyer (left), Dave Mick los, and
student during first DNA Science summer
workshop in 1985.
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grant proposal to the newly resynthesized education directorate of the National
Science Foundation (NSF). Our proposal to develop a workshop to introduce
high school teachers to recombinant DNA was turned down by NSF in 1984.
After this setback, local educators Mike Glennon and Ed Tronolone sug-
gested what seemed a preposterous idea-to get several well-heeled school dis-
tricts of Long Island to each contribute $10,000 toward teacher training and
equipment purchase. By January 1985, $60,000 had been raised from six charter
districts of the Cold Spring Harbor Curriculum Study, and we committed to have
the first training workshop ready for summer.
The workshop would be based upon a laboratory sequence conceived by
Greg and contained in a slim "manuscript" consisting of 10-12 pages of lab
notes comprehensible only to a bench scientist. Happily, Rich Roberts gave
Dave a half-counter of bench space at which the labs could be fleshed out be-
fore being loosed on high school teachers. In the spring, the labs were first
tested with teachers during afternoon sessions at Cold Spring Harbor High
School. Unfortunately, the pivotal lab involving the recombination of ampicillin-
and kanamycin-resistant genes did not work. Anjun Bagwat, another postdoc in
Rich Roberts' lab, solved that problem simply by including a recovery at 37°C
prior to plating on kanamycin. By summer, every experiment worked well, and we
conducted the first full-scale workshop at the Wheatley School in Williston Park.
Our horizons expanded in 1986, when we obtained our first real grant from
Citibank to purchase and equip the first Vector Mobile DNA Laboratory. That
summer, we perfected our capability for long-range instruction, conducting work-
shops in Massachusetts, New Hampshire, Wisconsin, Illinois, Chicago, and Cali-
fornia. Our first NSF grant in 1987 allowed us to expand our national program and
set this pattern of summer training that has extended over the ensuing years.
Also in 1987, we further increased our reach when we joined with Carolina
Biological Supply Company to formally publish the labs and to develop teaching
kits to support wider dissemination of the DNA Science labs. This fruitful col-
laboration was brokered by Neil Patterson, the dean of modern biochemistry and
molecular biology publishing, who, among many accomplishments, had pub-
lished Jim Watson's epic Molecular Biology of the Gene.
The development of DNA Science is one of the first examples of bench
molecular biologists making a substantive commitment to help bring biology edu-
cation into the gene age. Although this educational role is now accepted and
legitimized at high levels of the biological research establishment, this was not
the case in 1984, especially at a "pure" science place like Cold Spring Harbor
Laboratory. At that time, research biologists were generally thought to have only
one responsibility-to the bench. Rich Robert's blessing for Greg to participate in
the project, donating enzymes and lab supplies, and providing lab space for
Dave were almost without precedent at the time.
But Rich's help also made good sense. During the 1970s, prior to the advent
of biotechnology supply houses, the Roberts lab had been a major source of
restriction enzymes. During that period, his group isolated approximately half of
known restriction enzymes, which were made available free of charge. Research-
ers visiting Cold Spring Harbor for symposia and courses would literally line up
outside his lab for samples of enzymes with new cutting specificities. So, just as
the Roberts lab had helped popularize the use of restriction enzymes in research,
it also encouraged their new use as educational tools. Our historical connection
to Rich became even more precious, when in 1993 he was awarded the Nobel
Prize for the codiscovery of RNA splicing.
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Receipt of Key Grants
In July, we were awarded a 5-year grant of $400,000 from the Howard Hughes
Medical Institute through the new Precollege Science Education Initiative for
Biomedical Research Institutions. The DNALC grant was the second largest of
awards to 42 institutions. The Hughes program will support our ongoing work with
local school districts to vertically integrate genetics instruction at the elementary,
middle, and high school levels. Significant resources will also be used to provide
intensive enrichment for minority students at several New York City schools and
to link these resource-poor schools to Long Island schools with well-developed
genetics education programs. The grant provides large-scale support for our
BioMedia Computer Laboratory to model uses of high-level computing in biology
education, including the Student Allele Database, which allows students to elec-
tronically submit personal DNA fingerprints and compare them with those of other
students from around the world. Related collaborations with Helen Donis-Keller at
Washington University, St. Louis, and John Kruper at the University of Chicago
are also supported.
In October, we were notified that the NSF had approved 3-year funding of
$218,503 for "A Novel Mechanism for Introducing Human Genome Research in
Freshman Biology Classes.' Under the new project, to begin in 1995, college
faculty will be trained to implement our polymerase chain reaction (PCR) experi-
ment on human Alu insertion polymorphisms and to use the Student Allele Data
base. Twenty-four participants will attend each of four workshops per year held
at sites around the country. Faculty from 2-year and minority institutions will be
targeted in promotional mailings, and one workshop per year will be sited at a
historically minority institution. This grant follows on 4 years of continuous funding
from the Undergraduate Faculty Enhancement Program and complements our
NSF training program for high school faculty.
Building Our Computational Capability
In the spring, we released the Genetic Computer Arcade through the Carolina
Biological Supply Company. Developed by designer Sue Lauter, this animated
and interactive computer "primer" helps students build mastery of genetics con-
cepts and gives examples of real-life applications of modern genetic technology.
The program can be played on virtually any Macintosh computer with a color
monitor; CD-ROM, laser disk player, other devices, or specialized software are
not needed. Each of five 'chapters" incorporates photographs, animation, and
scientific data. Modules include Gregor Mendel explaining his classic experi-
ments with peas; "Gene' the DNA person demonstrating types and causes of
mutations; and case studies illustrating forensic DNA fingerprinting, DNA diag-
nosis, and gene therapy. The programs build knowledge sequentially, with the in-
troductory topics appropriate for bright elementary students and the more ad-
vanced topics appropriate for high school students.
With 3-year capital support from the Stone Foundation, we have been build-
ing a sophisticated computer network for staff and student use. Our local area
network of 12 Macintosh Quadras in the BioMedia Laboratory and 4 Sun
Sparcstations in the staff office are all linked through a Sun10-30 server. How
ever, it was becoming increasingly difficult for the Laboratory computer center to
provide support for our substantial network, and we were unable to provide stu-
dents regular access to the BioMedia Laboratory.
A scene from 'Human Genetic Disease,'
one of five programs in the Genetic
Computer Arcade.
/44.tikarxastVER6emew
Robert Muratore (right) assists students
in the BioMedia Computer Laboratory.
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I/ V Carolina Exclusive
Polymeruse Chain Reaction Kits
A revolution in molecular genetic analysis
brings the power of PC13 into your classroom!
This situation was remedied in July, with the arrival of full-time computational
biologist, Robert Muratore. With a bachelor's degree in bioengineering from
Johns Hopkins, a master's degree in mechanical and aerospace engineering
from Princeton, and a doctorate in biophysics from Syracuse, Robert is exactly
the sort of hands-on person we were seeking. Prior to joining our staff, Robert
was on the faculty at SUNY Geneseo, where he developed a new biophysics pro-
gram and taught computer science. His thesis research at Syracuse and post-
doctoral work at the National Institutes of Health involved developing computer
programs to image brain activity using antiprotons. Earlier work at the Space
Studies Institute at Princeton and Hughes Aircraft Company included designing a
fault-tolerant electronic interface for the Galileo planetary probe now en route to
Jupiter.
Two events at year's end dramatically increased our computational capability.
First, we took delivery of a Silicon Graphics Indigo2 workstation, a fast graphics
terminal of the type used to create digital effects in movies such as Jurassic Park.
The Silicon Graphics machine will allow us to begin work on Journey to the Cen-
ter of the Cell, a recreation of a three-dimensional microspace of a cell based on
electron micrographical data. Second, the DNALC was connected to the main
Laboratory via a fiber optic cable. This linkage allows our Sun server to communi-
cate at ethernet speeds with the Laboratory's Phage server. This provides us with
extremely fast access to Internet and other international networks. To encourage
student and faculty use of our computational facilities, we now schedule free In-
ternet access on Thursday afternoon each week.
Also at year's end, plans were finalized for renovation of a computer/design
office in the east basement, which will mark the completion of an 8-year effort to
redevelop our 1925 school building as a modern science center. The office will
house computational biologist Robert Muratore and designer Sue Lauter, as well
as several interns. The space will facilitate a synthesis of these two functions,
which will be increasingly important as we begin development of three-
dimensional computer and video programs. The facility will become the com-
mand center for our local computer network, as well as our node on international
networks. Under the new configuration, the Multitorium, Bio2000 Teaching
Laboratory, and research/prep laboratory will be added to the network.
Progress in Making PCR Widely Available to Biology Students
Although the revolutionary importance of polymerase chain reaction (PCR) was
recognized by the 1993 Nobel Prize in Chemistry, the cost, biochemical com-
plexity, and patent protection of the process have kept it beyond the reach of
biology instruction. Believing that PCR offers the only practical means for stu-
dents to examine their own DNA and the best means to introduce human
molecular genetics, we have made it our business to remove the obstacles to its
use in precollege and freshman college classes. Tangible evidence of success
came in September with the release of the first educational PCR kits by Carolina
Biological Supply Company, under license from Perkin-Elmer. One kit amplifies
viral DNA using hand thermal cycling, and the other kit amplifies the D1S80 hu-
man polymorphism using automated cycling.
During the summer, we began to shift emphasis to the class of Alu insertion
polymorphisms, which work brilliantly with the mouthwash/chelex extraction we
Ad for PCR kits in Carolina advocate, show very little nonspecific amplification, and can be analyzed con-
Biological's Biotechnology catalog. clusively on agarose gels. Alu is a family of repeated DNA sequences, approxi-
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mately 300 nucleotides in length, that have the ability to copy themselves and in-
sert randomly throughout the genome. Some Alu elements have inserted so
recently in evolutionary time that they have not been inherited with the same fre-
quency by different groups of people. Such Alu insertions are termed dimorphic
("two forms") because chromosomes can be scored for the presence or absence
of the insertion. Because Alu insertions at a particular chromosome locus have
only two alleles (+ or -), they make simple case studies for studying population
genetics.
Robert Muratore worked quickly to develop a prototype Student Allele Data-
base that allows students to tabulate Alu insertion data and test Hardy-Weinberg
Equilibrium. The database also contains Alu insertion data from several
Mendelian populations in Africa, Greenland, Sardinia, and the Caribbean. Users
can compare any two populations using contingency Chi-square and calculate
simple genetic distances. Initially, the database template and test data are avail-
able on diskette or can be downloaded from Genentech's Access Excellence
gateway on America Online. Soon, Internet users will be able to access the data-
base through our World Wide Web home page and manipulate data in real time.
Robert also led design development of a inexpensive thermal cycler, which
we hope will make PCR accessible to high school and college instructors. The
device consists of computer software and an analog-digital interface that cycles
temperature in a Plexiglas reaction vessel by alternately activating an immersion
heater and a solenoid valve controlling cold water flow. Water-flow regulation was
simplified and a custom analog-digital controller was designed to receive com-
mands from both Macintosh and PC computers. In collaboration with John
Kruper, head of academic computing of the Biological Science Division of the
University of Chicago, development of a much-improved Macintosh controller is
nearing completion.
Training Workshops Reach Faculty and Opinion
Leaders Nationwide
With funding from the National Science Foundation, we continued our tradition of
offering high-level lab training to high school and college faculty. Dave Mick los
took the standard-bearing DNA Science far afield, reaching 100 high school
teachers at workshops in Oklahoma City, Colorado Springs, Moscow (Idaho),
and San Juan. Mark Bloom instructed 47 college faculty at Advanced DNA
Science workshops in San Antonio and Boston. The Leadership Institute in Hu-
man and Molecular Genetics, also known as DNA Boot Camp, drew together top
high school faculty representing 22 states, Sweden, and Australia. In addition to
practical laboratory and computer work, the institute included seminars on an ar-
ray of topics by Laboratory scientists and visiting faculty:
Jack Ballantyne, Suffolk County Examiner's Office: Forensic DNA typing.
Susan Brady, Lawrence Hall of Science: Partnerships.
Xiaodong Cheng, Cold Spring Harbor Laboratory: Structure of DNA/Hhal
methylase cocrystal.
Seth Grant, Columbia University: Molecular basis of memory.
Fred Gil lam, Sachem High School: Laboratory program in molecular genetics.
John Horton, Cold Spring Harbor Laboratory: X-ray crystallography.
Paul Hough, Brookhaven National Laboratory: DNA-binding proteins.
John Kruper, University of Chicago: Computational biology.
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Ruji Kobayashi, Cold Spring Harbor Laboratory: High-performance liquid
chromatography and peptide synthesis.
Gerry Latter, Cold Spring Harbor Laboratory: Two-dimensional protein elec-
trophoresis.
Elaine Lawson, Institute of Medicine: Assessing genetic risks.
Sue Levi-Pearl, Tourette Syndrome Association: Genetic disease support
groups.
Dan Marshak, Cold Spring Harbor Laboratory: Protein kinases and mass
spectrometry.
Dick McCombie, Cold Spring Harbor Laboratory: DNA sequencing.
Rick Michitsch, Oncogene Science: Expression screening for therapeutic
agents.
Bruce Stillman, Cold Spring Harbor Laboratory: Research highlights.
Spencer Teplin, Cold Spring Harbor Laboratory: DNA synthesis.
Tim Tully, Cold Spring Harbor Laboratory: Genes and behavior.
James Watson, Cold Spring Harbor Laboratory: Open question and answer.
Jan Witkowski, Banbury Center: DNA screening and diagnosis.
With funding from the Department of Energy, we continued our collaboration with
Banbury Center to introduce nonresearchers to the science behind the Human
Genome Project. In the past, the project targeted "opinion leaders' in federal
agencies, the media, education, law, and ethics who influence policy and educa-
tion. The 1994 workshop drew education directors from 15 hospitals in New York
State, with the expectation that they will begin the process of educating doctors
about the growing impact of molecular genetics in medicine. In addition to an ex-
periment to illustrate the basis of DNA diagnosis and background briefings,
participants heard high-level seminars about topics on the interface of molecular
genetics, medicine, and society:
Susan Airhart, Oncor Science: Cytogenetics in the age of DNA.
Charles Link, Iowa Methodist Hospital: Human gene therapy trials.
Philip Reilly, Shriver Center for Mental Retardation: Future of genetic testing
and screening.
Marsha Saxton, Massachusetts Office on Disability: Genetics and cultural atti-
tudes to disability.
Rudolph Tanzi, Massachusetts General Hospital: Molecular genetics and biol-
ogy of Alzheimer's disease.
Tim Tully, Cold Spring Harbor Laboratory: Genetics and behavior.
Patricia Ward, Baylor College of Medicine: DNA-based diagnosis for human
genetic diseases.
Expanding Hands-on Opportunities for Local Students
When we first developed the DNA Science curriculum, we were one of only a
handful of institutions offering laboratory training in molecular genetics for precol-
lege faculty. During the last decade, we have maintained the only continuously
funded program operating on a nationwide scale. Our expertise at administering
off-site workshops has provided a "jump-start" for local initiatives in many states.
However, as more and more local universities have accepted the challenge to
provide lab training for teachers, the need for off-site workshops has decreased.
Fortunately, at the same time, demand for local programs and use of our ex-
cellent facilities is increasing. So we find that, after securing our reputation
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through national programs, we are now devoting more effort to fostering innova-
tive biology instruction in the school systems in our own backyard.
Realizing that systematic genetics education needs to begin when children
are still forming fundamental attitudes and behaviors, we are focusing our effort
at the middle-school level (grades 5-8). The flagship of our commitment to
younger learners is Genetics as a Model for Whole Learning, which uses
genetics as a paradigm for integrated learning and which incorporates concepts
across disciplines and relates science to the student's life and culture. Working
almost single-handedly, Education Manager Jane Conigliaro has aided faculty at
15 schools to introduce genetics modules in their elementary and middle school
classes, reaching 1590 students in 1994. We anticipate that these students will
provide an eager audience for the advanced genetics activities currently avail-
able at the high schools in their districts. Thus, in the small school districts of
Long Island, we are beginning to see working models of science education for
the gene age, incorporating hands-on learning about genetics at several stages
in child and adolescent development.
The Bio2000 Laboratory was kept very busy during the academic year. Labs
on bacterial transformation, DNA restriction analysis, and human DNA fingerprint-
ing were performed by 3180 high school students, and experiments on
Mendelian genetics, cell study, and DNA extraction were performed by 780
5th-7th graders. This was a 24% increase in total lab visits over 1993, made pos-
sible through the excellent instruction offered by part-time instructors Flavio Della
Seta, Diane Esposito, Diane Jedlicka, and Malissa Hewitt. The Great Moments in
DNA Science Honors Student Seminar Series, now in its 10th year, continued to
be a popular element of our annual calendar of events, drawing the attendance
of 575 local students and teachers. Speakers and topics were:
Greg Freyer, Columbia University: Fixing DNA.
Tim Tully, Cold Spring Harbor Laboratory: Genes and memory.
Xiaodong Cheng, Cold Spring Harbor Laboratory: A surprising structure of
DNA.
We continued to expand summer learning opportunities for local students, thanks
in part to additional venues at Port ledge School (Locust Valley), Central Islip
School, Roslyn Middle School, and the American Museum of Natural History.
High school students including 233 minority students received laboratory training
during three sessions of DNA Science. Eight sessions of Fun With DNA served a
total of 159 elementary students, including 74 minority students. Three sessions
of the workshop World of Enzymes attracted 62 students.
Multimedia and Exhibit Programs
Although we devote our major effort to curriculum development and lab instruc-
tion, we are also committed to providing stimulating multimedia presentations
and exhibits for our visitors. We were happy to find that Cablevision's multimedia
show, Long Island Discovery, drew 15,000 viewers during its first year of opera-
tion, more than twice the number of DNALC visitors prior to the show's opening in
October 1993.
By year's end, the staff was focused on the development of three new ex-
hibits to fill renovated galleries on the main level: Story of a Gene, The World of
Barbara McClintock, and the Cold Spring Harbor Nobels. Story of a Gene is a
comprehensive presentation on the biochemistry, physiology, medical uses, and
Xiaodong Cheng presents his
research to advanced biology high
school students.
Karin Glaizer and Elizabeth Woerner
present 'Linda,' a study of brain
tumor gene therapy for the World
of Enzymes summer workshop.
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(Left) The Walk of Life construction in progress. (Right) Malissa Hewitt, lab instructor turned
painter, works on a dungeon wall. (Below left) Denise Sauer puts finishing touches on ex-
hibit entry sign.
social aspects of human growth hormone (HGH). The exhibit will encourage
visitors to integrate microscopic through macroscopic perspectives, including (1)
expression of the HGH gene, as illustrated in the Cellarium mural; (2) physiology
of human growth; (3) the danger of isolating HGH from human cadavers and the
link with kuru and Creutzfeldt-Jakob disease; and (4) ethical issues arising from
ready availability of the hormone produced by recombinant DNA technology.
The exhibit employs two- and three-dimensional displays, computer multimedia,
video, and audio-many elements that will encourage visitor interaction.
The World of Barbara McClintock, being developed in cooperation with the
Public Affairs Department, will recreate McClintock's laboratory using equipment
and personal effects saved after her death. The object is to provide visitors with a
glimpse of the day-to-day intellectual life of an extraordinary individual. Cold
Spring Harbor Nobels shows the prizes and highlights the common thread of
Nobel-winning experiments by Al Hershey, James Watson, Barbara McClintock,
and Richard Roberts. All three exhibits will be geared to a level appropriate for
bright elementary students and will also be appropriate for the general public.
Curriculum guides, including vocabulary, questions, and readings, will help stu-
dents get the most out of their exhibit visit and follow up on their interests.
Corporate Advisory Board
In the fall, we bid farewell to Corporate Advisory Board Chairman Doug Fox,
when he left his position at Times Mirror to become Chief Operating Officer of
Landmark Communications of Norfolk, Virginia, which owns the Weather Chan-
nel. Under Doug's leadership, the Corporate Advisory Board has become an ef-
fective advocate for the DNALC, raising substantial unrestricted annual funds
and increasing our visibility in the Long Island business community. Our dis-
appointment at Doug's departure was muted by our good luck that the
chairmanship was taken over by Rick Clark. A partner at Price Waterhouse, Rick
showed his commitment to our cause when he worked closely with Doug to
organize the first annual Cold Spring Harbor Laboratory Golf Tournament. Held at
Piping Rock Club on June 7, the tournament netted $47,750, which was added to
Dave Mick los with Corporate Advisory Board
members (from left to right) Arthur Herman, Rick Clark,
Pat Peterson, Michael Aboff, and Michael Vittorio.
the DNALC Annual Fund. Rick's service to the Laboratory began in 1993 when he
hosted the CSHL Association outreach event at the Manhattan office of Price
Waterhouse. His connection to us is strengthened through his wife Jill, who is as-
sociate development director for the Laboratory.
The Corporate Advisory Board draws strength from Vice-Chairman Gary
Frashier, President and CEO of Oncogene Science, who is our link to the growing
biotechnology industry on Long Island. Other members of the executive com-
mittee represent the gamut of Long Island businesses: Rocco Barrese, founding
partner at the patent law firm Dilworth and Barrese; Howard Blankman, founder
of the public relations firm Howard Blankman Inc.; Tom Calabrese, managing
director at NYNEX; Bob Diller, Vice President of the scientific equipment firm
Brinkmann Instruments; Art Herman, chairman of A.D. Herman Construction; Pat
Peterson, President of the realty company Daniel Gale Agency; and Peter Schiff,
general partner of Northwood Ventures.
Staff and Interns
Administering our rigorous schedule of student field trips, student summer work-
shops, teacher-training institutes, and various follow-up activities has become an
increasingly complicated task. Each program typically requires an informational
mailing of 400 or more pieces, answering queries, taking reservations, process-
ing applications, sending confirmations, and tracking payments. Many programs
take place off-site and require coordination with a local organizer; several pro-
grams require yearly mail surveys. Five part-time staff and five interns provide
cost-effective support and instruction but further complicate scheduling. Since
her arrival at the beginning of the year, Judy Cumella has made herself in-
dispensable in choreographing this complex dance of people and activities. She
functioned single-handedly during parts of the summer when Mark and Dave
were teaching off-site and Sue was out on maternity leave. In recognition of her
key organizational role and the increasingly complicated nature of our activities,
Judy was promoted to Program Coordinator in the fall.
The recruitment of part-time lab instructor Melissa Hewitt enabled us to offer
daily afternoon labs for elementary and middle-school students. Melissa has an
undergraduate degree in early childhood/elementary education and has taught
elementary science at the School of the Holy Child in Old Westbury and kinder-
garten at the Gardens Schools. She is currently working on her master's degree
in secondary biology education.
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Malissa Hewitt and Stacey Trotter organize supplies in the
Bio2000 Teaching Laboratory.
We continued to get excellent laboratory, computational, and design support
from interns drawn from neighboring high schools and colleges. Designer Sue
Lauter was assisted by Donna Conversano and Denise Sauer. An art student at
the New York Institute of Technology, Donna had participated in the painting of
the Cellarium Mural in summer 1993. During the academic year, she added
finishing touches to the 1993 building renovation, including hand-lettering the
names of 35 Nobel Laureates in genetics whose names appear on the Multi-
torium frieze. Donna and Denise overpainted areas of the Cellarium mural to
more accurately portray the cellular expression of human growth hormone
(HGH), including the addition of transcriptional activators, signal recognition ap-
paratus, and barrel depiction of HGH protein. Denise is an art student at SUNY
Farmingdale.
Computational biologist Robert Muratore was assisted by Chris Como (Cold
Spring Harbor High School) and Mark Teoh (Rice University). In addition to help-
ing to maintain our growing computer network, each worked on multimedia
projects for the Story of a Gene exhibit. Chris has developed an animated intro-
duction by "Gene" the gene person, and Mark has assembled a software pack-
age to create a "morph" illustrating human growth.
The laboratory instructional staff was ably assisted by high school interns
Andy Diller (Sachem), Ken Bassett (Massapequa), Jessica Hinton (Huntington),
and Jermel Watkins (Central Islip). In the fall, we bid farewell to Andy, who began
his freshman year at Rutgers, and welcomed Jermel, whose father Jerry is a biol-
ogy instructor at Central Islip High School. Jerry was a participant in the NSF-
sponsored Leadership Institute and coordinates our effort to develop Central Islip
as the hub of an Instructional Resource Cluster serving the underprivileged stu-
dents in Brentwood and Wyandanch. Assisting at Fun With DNA summer camps
were lab aides Tara Marathe (Colby College), Daryn Berger (Walt Whitman High
School), Andrea Conigliaro (St. Anthony's High School), and Michael Conigliaro
(Cold Spring Harbor High School).
Publications
Bloom, M. 1994. Polymerase chain reaction. Carolina Tips 57:
Bloom, M., G. Freyer, and D. Micklos. 1994. Laboratory DNA science: An introduction to
recombinant DNA technology and methods of genome analysis. Benjamin/Cummings,
Redwood, California (in press).
Micklos, D. 1994. Go with the odds: Believe DNA. Newsday. September 27, 1994.
Micklos, D. 1994. Genetic testing: An educational imperative to our schools. In Assessing
genetic risks: Implications for health and social policy, vol. 2. National Academy Press,
Washington, D.C.
Micklos, D. and J. Kruper. 1994. Genetics education in American schools. Biotechnology
Education 4: 2.
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1994 Workshops, Meetings, and Collaborations
January 19
January 22
January 26-28
March 5-6
March 8-10
March 12-13
March 17
March 22-24
March 30
March 31-April 1
April 5
April 14
April 20
April 21-23
April 27-28
April 30-May 1
May 3
May 12-14
May 17
May 20
May 24
June 6-10
June 13-17
June 13-24
June 20-24
June 27-July 1
July 1
July 4-8
July 4-29
July 11-15
July 25-28
August 1-5
August 1-12
August 8-12
Long Island Partnership Meeting, DNALC
Corporate Advisory Board Meeting; DNALC
Site visit by David Hicks, St. Paul's School, Concord, New Hamphsire
National Science Foundation Grant Review, Washington, D.C.
National Science Foundation Follow-up Workshop, Advanced DNA Science, University
of Puerto Rico, Rio Piedras
National Institutes of Health Grant Review, Washington, D.C.
National Science Foundation Follow-up Workshop, Advanced DNA Science,
University of Washington, Seattle
Laboratory for SEED Program, SUNY, Old Westbury, DNALC
Carolina Biological Supply Company, Burlington, North Carolina
Corporate Advisory Board Meeting, DNALC
National Science Teachers Association Meeting, Los Angeles, California
Access Excellence Advisory Committee, Genentech, Inc., South San Francisco,
California
National Institute of Social Sciences Lecture, Harvard Club, New York, New York
Great Moments In DNA Science Honors Student Seminar, DNALC
Great Moments In DNA Science Honors Student Seminar, DNALC
Department of Energy Workshop, Human Genetics and Genome Analysis, DNALC
and Banbury Center
National Science Foundation Grant Review, Ann Arbor, Michigan
Department of Education Follow-up Workshop, Advanced DNA Science, Golden
West College, Los Angeles, California
Great Moments In DNA Science Honors Student Seminar, DNALC
National Science Foundation Grant Review, Washington, D.C.
Hutton House Lecture, Long Island University, Old Westbury, New York
New York Biotechnology Association Meeting, DNALC
Hutton House Lecture, DNALC
National Science Foundation Workshop, DNA Science, Colorado College,
Colorado Springs
National Science Foundation Workshop, DNA Science, Oklahoma School of Science
and Mathematics, Oklahoma City
National Science Foundation Workshop, Advanced DNA Science, Boston University,
Boston, Massachusetts
National Science Foundation Workshop, DNA Science, University of Idaho, Moscow
DNA Science Workshop, DNALC
Site visit by Laurence Smaje, Wellcome Trust, London, England
World of Enzymes Workshop, Port ledge School, Locust Valley, New York
National Science Foundation Leadership Institute, DNALC
Fun With DNA Workshop, Port ledge School, Locust Valley, New York
Fun With DNA Workshop, Port ledge School, Locust Valley, New York
Fun With DNA Minority Workshop, American Museum of Natural History,
New York, New York
National Science Foundation Workshop, DNA Science, University of
Puerto Rico, Rio Piedras
Fun With DNA Workshop, DNALC
National Science Foundation Workshop, Advanced DNA Science, Trinity University,
San Antonio, Texas
Fun With DNA Workshop, DNALC
Fun With DNA Minority Workshop, Roslyn Elementary School, New York
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August 15-19
August 18-19
August 22-26
August 29-Sept. 2
September 12-14
September 22
September 20
September 26-30
October 13
October 17
November 2
November 12-13
November 12-17
November 16-19
December 8
December 9-10
December 12
Fun With DNA Minority Workshop, American Museum of Natural History, New York
Fun With DNA Minority Workshop, DNALC
Advanced Placement Workshop, Stanford University, Palo Alto, California
World of Enzymes Workshop, DNALC
DNA Science Workshop, DNALC
Decade of PCR Meeting, CSHL
Seminar, CSHL Association, DNALC
Site visit by Helen Donis-Keller Laboratory, Washington University Medical School,
St. Louis, Missouri
World Health Organization Workshop, DNA Science, University of Panama,
Panama City
Site visit by Treopia Washingon, Columbus Center, Baltimore, Maryland
Corporate Advisory Board Meeting, DNALC
Seminar, Ade 1phi University, Garden City, New York
National Science Foundation Follow-up Workshop, DNA Science, Oklahoma School of
Science and Mathematics, Oklahoma City
Department of Energy Contractor's Meeting, Santa Fe, New Mexico
National Association of Biology Teachers Meeting, St. Louis, Missouri
Laboratory Seminar, Theodore Roosevelt American Inn of Court, DNALC
National Science Foundation Follow-up Workshop, DNA Science,
University of Puerto Rico, Rio Piedras
Women In Science and Engineering Laboratory, DNALC
Sites of Major 3-10-day Faculty Workshops 1985-94
KEY: High School
College
Middle School
ALABAMA University of Alabama, Tuscaloosa 1987,1988,1989,1990
ARIZONA Tuba City High School 1988
ARKANSAS Henderson State University, Arkadelphia 1992
CALIFORNIA University of California, Davis 1986
San Francisco State University 1991
University of California, Northridge 1993
COLORADO Colorado College, Colorado Springs 1994
CONNECTICUT Choate Rosemary Hall, Wallingford 1987
FLORIDA North Miami Beach Senior High School 1991
University of Western Florida, Pensacola 1991
Armwood Senior High School, Tampa 1991
GEORGIA Fernbank, Inc., Atlanta 1989
Morehouse College, Atlanta 1991
HAWAII Kamehameha Secondary School, Honolulu 1990
ILLINOIS Argonne National Laboratory 1986,1987
University of Chicago 1992
INDIANA Butler University, Indianapolis 1987
IDAHO Univeristy of Idaho, Moscow 1994
IOWA Drake University, Des Moines 1987
KENTUCKY Murray State University 1988
University of Kentucky, Lexington 1992
Western Kentucky University 1992
LOUISIANA Jefferson Parish Public Schools, Harvey 1990
John McDonogh High School, New Orleans 1993
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MANITOBA Red River Community College, Winnipeg 1989
MARYLAND Annapolis Senior High School 1989
McDonogh School, Baltimore 1988
Montgomery County Public Schools 1990-92
St. John's College, Annapolis 1991
MASSACHUSETTS Beverly High School 1986
Dover-Sherborn High School, Dover 1989
Randolph High School 1988
Winsor School, Boston 1987
Boston University 1994
MICHIGAN Athens High School, Troy 1989
MISSISSIPPI Mississippi School for Math & Science, Columbus 1990-91
MISSOURI Washington University, St. Louis 1989
NEW HAMPSHIRE St. Paul's School, Concord 1986, 1987
NEVADA University of Nevada, Reno 1992
NEW YORK Albany High School 1987
Bronx High School of Science 1987
Columbia University, New York 1993
Cold Spring Harbor High School 1985, 1987
DeWitt Middle School, Ithaca 1991, 1993
DNA Learning Center 1988-94
DNA Learning Center 1990, 1992
DNA Learning Center 1990-92
Fostertown School, Newburgh 1991
Huntington High School 1986
Irvington High School 1986
Junior High School 263, Brooklyn 1991
Lindenhurst Junior High School 1991
Orchard Park Junior High School 1991
Plainview-Old Bethpage Middle School 1991
State University of New York, Purchase 1989
State University of New York, Stony Brook 1987, 1988, 1989, 1990
Titusville Middle School, Poughkeepsie 1991, 1993
Wheatley School, Old Westbury 1985
NORTH CAROLINA North Carolina School of Science, Durham 1987
OHIO Case Western Reserve University, Cleveland 1990
Cleveland Clinic 1987
North Westerville High School 1990
OKLAHOMA School of Science and Mathematics, Oklahoma City 1994
PENNSYLVANIA Duquesne University, Pittsburgh 1988
Germantown Academy 1988
PUERTO RICO University of Puerto Rico, Mayaguez 1992
University of Puerto Rico, Mayaguez 1992
University of Puerto Rico, Rio Piedras 1993
University of Puerto Rico, Rio Piedras 1994
SOUTH CAROLINA Medical University of South Carolina, Charleston 1988
University of South Carolina, Columbia 1988
TEXAS J.J. Pearce High School, Richardson 1990
Langham Creek High School, Houston 1991
Taft High School, San Antonio 1991
Trinity University, San Antonio 1994
UTAH University of Utah, Salt Lake City 1993
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VERMONT University of Vermont, Burlington 1989
VIRGINIA Jefferson School of Science, Alexandria 1987
Mathematics and Science Center, Richmond 1990
WASHINGTON University of Washington, Seattle 1993
WASHINGTON, DC Howard University 1992
WEST VIRGINIA Bethany College 1989
WISCONSIN Marquette University, Milwaukee 1986, 1987
University of Wisconsin, Madison 1988, 1989
WYOMING University of Wyoming, Laramie 1991
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1994 PUBLICATIONS
General Books
DNA and Chromosomes
Symposia on Quantitative Biology 58
Vaccines 94: Modern Approches to New Vaccines Including
Prevention of AIDS
E. Norrby, F. Brown, R.M. Chanock, and
H.S. Ginsberg (eds.)
Manipulating the Mouse Embryo: A Laboratory Manual, Sec-
ond Edition
B. Hogan, R. Beddington, F. Costantini, and E. Lacy
Biology of Drosophila
M. Demerec (ed.)
Gene Therapy: Fact and Fiction in Biology's New
Approaches to Disease
T. Friedmann
CSHL Monograph Series
The Biology of Heat Shock Proteins and Molecular
Chaperones
R.I. Morimoto, A. Tissieres, and C. Georgopoulos (eds.)
Arabidopsis
E.M. Meyerowitz and C.R. Somerville (eds.)
Cellular Receptors for Animal Viruses
E. Wimmer (ed.)
Current Communications in Cell & Molecular
Biology Series
Apoptosis II: The Molecular Basis of Apoptosis in Disease
L.D. Tomei and F.O. Cope (eds.)
Video Tapes
SDS-Polyacrylamide Gel Electrophoresis: A Video Guide
M. Basta
Stories from the Scientists
University of California, San Francisco
Hybridomas and Monoclonal Antibodies: A Video Guide
University of Pittsburgh
Cancer Surveys Series
Vol. 19/20: Trends in Cancer Incidence and Mortality
R. Doll, J.F. Fraumeni, Jr., and C.S. Muir (eds.)
Vol. 21: Palliative Medicine: Problem Areas in Pain and
Symptom Management
G.W. Hanks (ed.)
Journals
Genes & Development (Volume 8, 24 issues)
T. Grodzicker and N. Hastie (eds.)
PCR Methods and Applications (Volume 3, 3 issues; Volume
4, 3 issues)
D. Bentley, R. Gibbs, and R. Myers (eds.)
Learning & Memory (Volume 1, 4 issues)
R. Davis, E. Kandel, R. Morris, C. Shatz, L. Squire, and C.
Stevens (eds.)
Other
CSHL Annual Report 1993
Banbury Center Annual Report 1993
Administration and Financial Annual Report 1993
Abstract/program books for 14 CSHL meetings
The CSHL Press sales exhibit at all of the academic society meetings attended each year.
COLD SPRING HARBOR LABORATORY PRESS
Our publishing program continued to expand and diversify in 1994. Twelve new books and three
new videotapes were published, bringing our titles in print to over 200. One journal doubled in fre-
quency and another was launched. An entirely new venture began-the creation of a directory of
products and services for laboratory work-and we embarked successfully on the global informa-
tion highway. Program income rose by 4% to $4.49 million, and the operating margin was reduced
by one-time adjustments in book inventory value.
Book Publishing
New titles were added in all categories of the book catalog. The most notable was the second edi-
tion of Manipulating the Mouse Embryo by Brigid Hogan, Rosa Beddington, Frank Costantini, and
Elizabeth Lacy. First published in 1986, this manual was highly successful in its intention of catalyz-
ing the interaction between molecular biology and mammalian development. The new edition is
completely revised and updated, with additional striking illustrations, and has quickly become an-
other laboratory essential to stand alongside the classics Molecular Cloning and Antibodies, which
continue to sell strongly.
Techniques manuals, the monograph series, and the Symposium continue to be the mainstays
of our book program. A change was evident in this year's Symposium volume, DNA and
Chromosomes-not in its cover color, a time-honored pigment John Cairns called "oxidized blood,"
but in its paper. With so much color artwork to be included, the cream stock selected by Reginald
Harris in 1933 and used ever since, had to be replaced by a bright white sheet that framed the art to
advantage. Reversion is unlikely.
The CSHL monograph series lengthened with the addition of three new titles. The Biology of
Heat Shock Proteins and Molecular Chaperones was edited by Richard Moromoto, Alfred Tissieres,
and Costas Georgopoulos. A review of cellular viral receptors was edited by Lab Trustee Eckard
Wimmer, and Elliot Myerowitz and Christopher Sommerville assembled Arabidopsis, an essential
work of reference on this important experimental organism that is the first of several planned titles in
the resurgent field of plant genetics.
Not every new title can be mentioned here (see opposite for a complete list) but the year was
particularly notable for the growing success of several newer and novel classes of publication.
Science books for children continued to be extraordinarily popular, including our own new publica-
tion, the imaginative book/tape combination Double Talking Helix Blues by Joel and Ira Herskowitz
and Judy Cuddihy, which attracted mass media attention nationwide. Our videotape series con-
tinued to prosper, with strong sales for the cassette library Winding Your Way Through DNA. Three
new tapes were published, two instructional programs, on SDS-PAGE electrophoresis and
hybridomas, and Stories from the Scientists, an educational program on the Watson/Crick and
Boyer/Cohen partnerships produced in collaboration with the University of California at San Francis-
co.
We also experimented with the republication of out-of-print books that had either historic interest
or continued utility for today's investigators. Demerec's 1950 classic Biology of Drosophila falls into
both categories and was so eagerly seized by the fly community that it quickly required a second
printing. We also republished the 1972 Banbury Center volume Gene Therapy, the first and for a
long time the only book on this now widely discussed topic, using new print-on-demand technology.
In producing this year's crop of new titles, the book publishing group led by Nancy Ford rose to
the challenge of producing more books, in more formats, with more color, and in addition took on
new responsibilities, managing the duplication of audiotapes and videotapes and the production of
packaging and other ancillary materials.
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Ira Herskowitz and Joel Herskowitz,
creators of the Double-talking
Helix Blues.
Journal Publishing
Each of the past several years has seen significant change in our journals operation and 1994 was
no exception. In January, Genes & Development shifted smoothly from monthly to twice monthly
publication. This was a decision taken in 1993 to speed up paper publication time and reduce the
average issue size, in correct anticipation of increased demand to publish in the journal. After cita-
tion analysis for 1993 by the Institute for Scientific Information, Genes & Development was once
again the leading journal in the categories of genetics and developmental biology. However, its con-
tent pages were notable for excellent papers on topics such as signal transduction and cell cycle
control, aspects of cell biology in which genetic dissection has made a substantial impact. The
editors, Terri Grodzicker and Nick Hastie, with invaluable advice from the editorial board and other
reviewers, took care to ensure that the journal remained first class. The efforts of the entire journal
team were rewarded by a 4% increase in circulation during the year, with increased penetration of
academic libraries, and a satisfying 100% increase in operating margin. The progress of Genes &
Development in 1994 confirmed its place among the handful of outstanding journals in biology, a
source of pride and satisfaction for both CSHL Press and its co-publishers, the Genetical Society of
Great Britain.
PCR Methods and Applications, having doubled in frequency to bimonthly publication in August
1993, continued to receive a steady flow of papers. Those accepted appeared alongside a series of
specially commissioned articles which will be reassembled to form an introductory lab manual on
PCR technology in 1995. The journal was scored for the first time by citation analysis, placing fifth
among all the journals in biotechnology, with the highest impact factor of any journal devoted to a
single technique. This recognition acknowledges the work of the editors, Eric Green, Richard Gibbs,
Rick Myers, and David Bentley, and their advisors. The journal also benefited from the worldwide
distribution of sponsored subscriptions by the Perkin-Elmer Corporation.
Since its launch in 1990, the journal has been a success editorially and financially and its cir-
culation in 1994 remained stable while its operating margin doubled. However, the powerful and
flexible technology of PCR has become more established and we began to consider what op-
portunities for evolution might be available to the journal. The technique has become a mainstay of
the ever-expanding field of genome studies and we received strong encouragement to reposition
the journal as a new forum for studies using PCR and other techniques to map and sequence the
genomes of many species. The decision was made to relaunch PCR Methods and Applications as
Genome Research in mid 1995.
In 1993, a commitment was made to launch a third journal, Learning & Memory, in 1994. The first
issue of this bimonthly publication appeared in May. Its academic editors, Ron Davis, Eric Kandel,
Richard Morris, Larry Squire, Carla Shatz, and Chuck Stevens, decided that they would best serve
this new journal by accepting from the start only high-quality papers. Research on the biological
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basis of learning and memory is new and fascinating, so our fledgling journal must compete for
papers with the best known serials in science. As a result, issues have been produced less regu-
larly than we would wish. Nevertheless, their standard is excellent, the editors and their advisors are
critical and authoritative, and we have in place the beginnings of a core journal for this exciting,
emergent field.
These changes in the journals program increased the demands on the editorial and production
staff, headed by Judy Cuddihy, who responded efficiently to ensure that the issues appeared error-
free, on time, and on budget throughout the year.
The Laboratory Manual Source Book
Our laboratory manuals have always included a list of the products required to carry out the techni-
ques described in the book, and where possible a suggested supplier of each product. Readers
value this information and as the number of manuals has grown, the lists have expanded and have
begun to overlap.
We reasoned that users of the manuals would benefit even more from a complete, fully indexed
compendium of laboratory products cross-referenced to all their potential suppliers, particularly if it
offered readers ready access to technical advice and further information. It also seemed likely that
suppliers would welcome the chance to place their advertisements in front of a large, targeted
audience of interested users. Market research confirmed that both users and suppliers found the
idea attractive, and we were encouraged to embark on a major new publication, The Lab Manual
Source Book, that would be distributed free to all manual users and supported financially by the
sale of advertising space within it. To manage this publication, we were fortunate to attract back to
Cold Spring Harbor, Joan Boyce, a former lab manager who had moved on to a successful career
in sales at Boehringer Mannheim. With her strong technical and commercial background, she was
able to assemble within just a few months a database of over 16,000 products from more than 570
companies, divided into 1700 product categories. In December, this information was carefully
formatted into a 192-page book and 35,000 copies were distributed internationally to users of our
lab manuals. The book was warmly received and is being widely used, encouraging us to proceed
with an updated and expanded 1996 edition.
Marketing, Fulfillment, and Finance
Our marketing activities, managed by Ingrid Benirschke, remain centered on direct mail, aug-
mented by advertisements in journals and exhibits at the larger society meetings. Three issues of
the Notebook announced the new titles and two subject-specific catalogs designed by Jim Sud-
daby were dispatched to targeted recipients worldwide. A complete catalog of publications was
also produced for the first time in 2 years, at 116 pages the largest ever from the Press. In addition
to the customary meetings in genetics, cell biology, neuroscience, and microbiology, the marketing
department attended the annual meeting of the National Biology Teachers Association for the first
time and learned some valuable lessons about the potential of our children's book program and
videotape series in that marketplace. The conviction that the Double Talking Helix Blues had
widespread popular appeal prompted attempts at more widespread promotion, which were
rewarded with invitations to bookstore signings and features on the book and its creators in major
newspapers, cable and network television, and national public radio.
At a more local level, our bookstore in Grace Auditorium, run by Connie Hallaran, brought our
publications to the attention of the 5000 attendees at the Laboratory's meetings and courses. Al-
though the bookstore is cramped, patrons also appreciated gift items, travel necessities, and an in-
teresting mix of science-related books from other publishers. These were particularly valued by
visitors from other countries where books published in the United States are hard to get and ex-
pensive.
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Our own marketing activities in other countries were much discussed during the year, with the
aim of improving our books' availability in a cost-effective fashion. Several radical strategies were
discussed and discarded. In the interim, direct mail to recipients in Europe was increased and ex-
clusive distribution arrangements with agents in Japan, India, and the Pacific Rim were maintained.
The proportion of books sold abroad went up.
As a result, close attention was paid to the methods and costs of distributing our publications
overseas. The complex and ever-changing world of international and national delivery was
managed by Guy Keyes, whose staff at our Plainview facility dispatched more than 40,000 books
and processed over 85,000 journal issues during the year. Our computer system now contains
records for 50,000 customers worldwide. For many of these individuals and institutions, the Plain-
view staff is their only direct contact with Cold Spring Harbor, and the scientific community's evident
goodwill toward the Press owes much to the care and competence with which the staff conducts the
required order processing, customer service, and dispatch.
The Plainview computer is also the source of all our publication sales information. From these
data, Nancy Hodson, promoted this year to Business Manager, derives an increasingly sophisti-
cated array of reports, analyses, and projections that help us to understand the underlying
dynamics of our business and make better financial decisions.
The World Wide Web
1994 was the year in which the much heralded era of electronic publishing became reality. The
Press was alerted early, thanks to our colleagues in the Laboratory's Computational Biology group.
The group drew our attention to the new software program Mosaic which made it possible to view
hyperlinked multimedia over the international computer network known as the World Wide Web. To a
scientific information company, Mosaic's power and mass appeal were obvious, and we quickly in-
itiated the construction of a site on the Web that would deliver on-demand information about our
books, journals, meetings, courses, and public events. The site's architect was Corprew Reed from
the Computational Biology group, working with staff from the Press and Meetings and Public Affairs
Departments. Cold Spring Harbor Laboratory Online (CLIO) opened in May, the first Web site to be
associated with a science publisher. As the year progressed, the Web and its business potential be-
came front page news everywhere, as thousands of companies joined the network and consumers
clamored for access to this new commercial frontier. By year's end, after including our Web address
in all print catalogs and advertisements, we found we had a new and effective means of communi-
cating directly with our readers, particularly those abroad, who visited our site in the thousands
each month. We learned a great deal from this project and experiments began that will make it pos-
sible in future years to deliver editorial content as well as marketing information through CLIO.
New Projects
From being a highly respected book publisher less than a decade ago, the Press has become a
provider of information in many formats. More than 25 new projects of different types were initiated
in 1994. We continue to aspire to excellence in both the assembly of information, by engaging first-
class authors, and its presentation, by employing talented and committed staff. Our reputation in
traditional publishing is strong. Now we must rise to the challenge of new media, in which experi-
enced authors are rare, development costs are large, the market is uncertain, and the business
risks are high. In five years, the professional use of scientific information will be profoundly different.
The nature of this change is being intensely discussed. To be ill-prepared for it would be to
squander our special place in the communication of science, and our hard-won reputation for in-
novation and quality.
John R. Inglis
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FINANCIAL STATEMENTS
BALANCE SHEET
Year ended December 31, 1994
with comparative am'iunts for 1993
ASSETS
Operating Funds
Endowment &
Similar Funds
Land,
Building, &
Equipment Funds
Total All FundsUnrestricted
RestrictedUndesignated Designated 1994 1993
Cash and cash equivalents $2,676,444 1,150,000 1,333,406 5,295,944 3,497,983 13,953,777 16,921,939
Marketable securities 2,291,694 29,681,513 157,153 32,130,360 29,690,918
Accounts receivable:
Publications (less allowance for doubtful accounts
of $20,500 in 1994 and 1993) 470,706 470,706 436,288
Other 163,780 163,780 138,252
Grants receivable - 2,454,025 2,454,025 1,883,040
Accrued interest receivable - 465,017 465,017 259,517
Publications inventory 1,512,132 - - 1,512,132 1,439,940
Other assets, principally prepaid expenses 484,570 852,754 1,337,324 1,230,600
Investment in employee residences 2,047,999 2,047,999 2,009,967
Land, buildings, and equipment:
Land and improvements - - - 7,372,872 7,372,872 5,825,328
Buildings - - - 58,793,446 58,793,446 56,621,938
Furniture, fixtures, and equipment - - 3,301,440 3,301,440 2,961,229
Laboratory equipment - - - 9,834,902 9,834,902 8,839,803
Library books and periodicals - - - 365,630 365,630 365,630
- - - 79,668,290 79,668,290 74,613,928
Less accumulated depreciation and amortization - - - 21,829,861 21,829,861 19,182,465
Land, buildings, and equipment, net - - - - 57,838,429 57,838,429 55,431,463
Construction in progress 936,028 936,028 1,326,536
Total assets $7,599,326 1,150,000 3,787,431 35,442,474 65,330,346 113,309,577 110,768,460
LIABILITIES AND FUND BALANCES
Operating Funds
Endowment &
Similar Funds
Land,
Building, &
Equipment Funds
Total All FundsUnrestricted
RestrictedUndesignated Designated 1994 1993
Liabilities:
Accounts payable and accrued expenses $ 963,259 123,567 - 156,687 1,243,513 1,268,874
Notes payable - - - 963,877 963,877 1,008,364
Bonds payable - 30,000,000 30,000,000 30,000,000
Deferred revenue 1,534,789 3,663,864 - 221,809 5,420,462 5,673,094
Total liabilities 2,498,048 3,787,431 - 31,342,373 37,627,852 37,950,332
Fund balances:
Unrestricted-undesignated 5,101,278 - - 5,101,278 3,474,376
Unrestricted-designated 1,150,000 - - - 1,150,000 1,350,000
Endowment and similar funds 35,442,474 - 35,442,474 33,770,391
Land, buildings, and equipment:
Expended - - 31,882,880 31,882,880 31,970,878
Unexpended-Donor restricted - 57,094 57,094 242,786
Unexpended-Board authorized - 2,047,999 2,047,999 2,009,697
Total fund balances 5,101,278 1,150,000 - 35,442,474 33,987,973 75,681,725 72,818,128
Total liabilities and fund balances $7,599,326 1,150,000 3,787,431 35,442,474 65,330,346 113,309,577 110,768,460
STATEMENT OF SUPPORT, REVENUE AND EXPENSES,
AND CHANGES IN FUND BALANCES
Year ended December 31, 1994
with comparative amounts for 1993
Operating Funds
Endowment &
Similar Funds
Land,
Building, &
Equipment Funds
Total All FundsUnrestricted
Undesignated Designated Restricted 1994 1993
Support and revenue:
Public support $1,964,892 7,260,160 1,914,818 84,562 11,224,432 10,377,960
Government grant awards 11,905,278 11,905,278 11,550,559
Indirect cost allowances 8,554,344 8,554,344 8,510,065
10,519,236 19,165,438 1,914,818 84,562 31,684,054 30,438,584
Other revenue:
Program fees 1,701,306 - _ - - 1,701,306 1,535,762
Rental income 403,216 - - - - 403,216 289,891
Publications 4,390,023 - - 4,390,023 4,319,267
Dining services 1,854,745 - - - 1,854,745 1,661,674
Rooms and apartments 1,498,087 - - - 1,498,087 1,451,719
Distribution from Robertson Funds 665,000 - 1,120,000 - 41,450 1,826,450 1,575,000
Investment income 225,827 - - 2,154,024 61,488 2,441,339 3,098,475
Royalty & licensing fees 337,398 - - - 337,398 283,870
Miscellaneous 160,808 - - - - 160,808 146,282
Total other revenue 11,236,410 1,120,000 2,154,024 102,938 14,613,372 14,361,940
Total support and revenue 21,755,646 20,285,438 4,068,842 187,500 46,297,426 44,800,524
Expenses:
Program services:
Research - - 14,878,837 - - 14,878,837 14,630,971
Summer programs 1,263,629 - 4,414,434 - - 5,678,063 4,660,085
Publications 4,309,043 - - - - 4,309,043 4,134,244
Banbury Center conferences 244,766 - 604,278 - - 849,044 579,458
DNA Education Center programs 18,008 - 342,845 - - 360,853 449,428
Total program services 5,835,446 20,240,394 26,075,840 24,454,186
Supporting services:
Direct research support 1,308,939 - - - - 1,308,939 1,196,259
Library 548,470 - - - 548,470 505,105
Operation and maintenance of plant 5,371,772 - - - 5,371,772 5,008,217
General and administrative 3,604,612 - - 247,997 - 3,852,609 3,522,136
Dining services 1,885,701 - - - - 1,885,701 1,659,112
Interest - - - - 1,199,557 1,199,557 926,162
Total supporting services 12,719,494 247,997 1,199,557 14,167,048 12,816,991
Depreciation and amortization - - - 2,668,167 2,668,167 2,521,642
Unrealized loss on marketable securities - - - 498,305 24,469 522,774 48,937
Total expenses 18,554,940 - 20,240,394 746,302 3,892,193 43,433,829 39,841,756
Excess (deficiency) of support and
revenue over (under) expenses
before designation $3,200,706 45,044 3,322,540 (3,704,693) 2,863,597 4,958,768
Designation:
Release of funds designated for
research program 200,000 (200,000)
Excess (deficiency) of support and
revenue over (under) expenses
and designation 3,400,706 (200,000) 45,044 3,322,540 (3,704,693) 2,863,597 4,958,768
Other changes in fund balances:
Capital expenditures (2,362,648) (1,106,657) - 3,469,305 - -
Transfer to restricted funds (467,251) 1,061,613 (594,362) - -
Transfer to endowment funds (567,899) - - 567,899 - - -
Transfer to unrestricted funds 1,623,994 - (1,623,994) - - -
Net increase (decrease) in fund balances 1,626,902 (200,000) - 1,672,083 (235,388) 2,863,597 4,958,768
Fund balances at beginning of year 3,474,376 1,350,000 33,770,391 34,223,361 72,818,128 67,859,360
Fund balances at end of year $5,101,278 1,150,000
Copies of our complete, audited financial statements, certified by the independent auditing firm
of KPMG, Peat, Marwick & Co., are available upon request from the Comptroller, Cold Spring
Harbor Laboratory.
COLD SPRING HARBOR LABORATORY
SOURCES OF REVENUE
YEAR ENDED DECEMBER 31, 1994 Federal Grants 43.7
Endowments and Similar Funds 8.6 %
Foundation and Private
Contributions and Grants 17.4 %
Interest and Miscellaneous 4.1 %
Corporate Contributions and Grants 5.6 %
Auxiliary Activities 20.6 %
COMPARATIVE OPERATING HISTORY
1990-1994
(Dollars in Thousands)
1990 1991 1992 1993 1994
Income:
Main Lab:
Grants & contracts $13,535 15,172 16,800 18,136 19,293
Indirect cost reimbursement 6,558 7,170 8,388 8,383 8,460
Other 3,976 5,056 5,520 6,049 6,808
CSH Press 4,223 3,079 3,709 4,319 4,390
Banbury Center 1,120 1,090 1,104 1,281 1,569
DNA Learning Center 585 744 822 796 824
Total income 29,997 32,311 36,343 38,964 41,344
Expenses:
Main Lab:
Grants & contracts 13,535 15,172 16,800 18,136 19,293
Operation & maintenance of plant 3,759 3,904 4,241 4,777 5,141
General & administrative 2,414 2,468 2,634 2,785 2,909
Other 2,973 3,375 4,141 4,385 4,847
CSH Press 3,708 3,488 3,548 4,134 4,309
Banbury Center 1,125 1,063 1,070 1,226 1,498
DNA Learning Center 615 752 843 768 798
Total expenses 28,129 30,222 33,277 36,211 38,795
Excess before depreciation and (designation) release of funds 1,868 2,089 3,066 2,753 2,549
Depreciation (1,485) (1,898) (2,358) (2,522) (2,668)
(Designation) release of funds (1) (250) (100) (600) 0 200
Net operating excess $ 133 91 108 231 81
The above amounts are presented on a combined basis for all funds for which Cold Spring Harbor Laboratory prepares operating budgets.
(1) Funds designated to underwrite future direct and indirect expenses of the neuroscience and other research programs.
FINANCIAL SUPPORT OF THE LABORATORY
Cold Spring Harbor Laboratory, Banbury Center, and the DNA Learning Center receive a substan-
tial portion of their funding through grants from the Federal Government and through grants, capital
gifts, and annual contributions from private foundations, corporations, and individuals. The follow-
ing section summarizes funding that occurred during 1994.
GRANTS January 1, 1994-December 31, 1994
COLD SPRING HARBOR LABORATORY
Grantor Program/Principal Investigator Duration of Grant 1994 Funding+
FEDERAL GRANTS
NATIONAL INSTITUTES OF HEALTH
Program Projects Cancer Research Center, Dr. Herr 1/92 -12/96 $3,365,364
Cancer Center Support, Dr. Stillman 8/90 -7/95 2,754,715
Research Support Dr. Arndt 1/91 -12/94 71,931
Dr. Bar-Sagi 7/91 -6/95 255,788
Dr. Beach 5/94 -4/95 282,250*
Dr. Beach 4/93 -3/97 182,519
Dr. Cheng 4/93 -3/97 190,492
Dr. Enikolopov 9/94 -8/98 196,786*
Dr. Franza 9/85 -11/94 291,638
Dr. Franza 10/91 -6/94 110,940
Dr. Futcher 1/91 -12/94 154,233
Dr. Futcher 4/93 -3/97 251,933
Dr. Garrels 1/90 -3/95 902,386
Dr. Gilman 9/92 -6/97 353,469
Dr. Greider 12/94 -11/98 264,749*
Dr. Greider 8/91-7/96 260,870
Dr. Helfman 4/94 -3/98 276,994*
Dr. Helfman 8/93 -5/98 215,825
Dr. Hernandez 7/92 -6/96 252,935
Dr. Hernandez 9/91 -8/96 231,012
Dr. Herr 3/92 -2/96 219,150
Dr. Krainer 7/94 -6/98 312,002'
Dr. Kuret 7/89 -6/94 425,413
Dr. Lisitsyn 7/94 -6/99 268,129*
Dr. Malinow 5/94 -4/97 118,883
Dr. Marr 8/94 -5/97 366,303*
Dr. Martienssen 8/92 -7/94 178,562
Dr. Mathews 2/92 -1/97 281,111
Dr. Mathews 9/93 -8/98 306,372
Dr. Mathews 9/94 -9/97 26,000*
Dr. McCombie 4/94 -3/95 678,702'
Dr. Roberts 4/91 -3/95 230,492
Dr. Skowronski 12/93 -11/97 309,446
Dr. Spector 4/90 -3/95 271,633
Dr. Stillman 7/83 -5/96 302,719
Dr. Stillman 7/91 -6/95 197,428
Dr. Tonks 8/91 -5/96 326,444
Dr. Tully 4/94 -3/97 307,329*
Dr. Wigler 7/92 -4/99 1,728,220
Fellowships Dr. Buchkovich 7/94 -5/95 26,144*
Dr. Jones 10/91 -9/94 53,731
Dr. Zhang 9/92 -8/97 88,679
Training Support Training in Cancer Cell Biology
and Tumor Virology, Dr. Helfman
7/94 -2/99 179,001'
New Grants Awarded in 1994
+ Includes direct and indirect cost
Grantor Program/Principal Investigator Duration of Grant 1994 Funding+
Course Support Advanced Bacterial Genetics,
Dr. Grodzicker 5/93 -4/98 54,096
Cancer Research Center Workshops,
Dr. Grodzicker 4/92 -3/97 236,697
Neurobiology Short-term Training,
Dr. Hockfield 5/82 -4/96 142,341
CSHL Analysis Large DNA Molecules,
Dr. Grodzicker 1991 -1996 108,906
Essential Computational Genomics for
Molecular Biologists, Dr. Marr 1991 -1996 26,284
Advanced In Situ Hybridization
and Immunocytochemistry, Dr. Spector 1992 -1997 48,805
Molecular Biology & Development
of Xenopus Laevis, Dr. Grodzicker 4/93 -3/96 11,841
Meeting Support Genome Mapping & Sequencing Conference 4/91 -3/96 31,148
Zebrafish Development and Genetics 4/94 -3/95 14,500"
Heat Shock Proteins and Molecular Chaperones 15/94 -4/95 4,000
CSHL 59th Symposium: Molecular
Genetics of Cancer 6/94 -5/95 15,000*
Mouse Molecular Genetics 7/94 -6/95 11,018*
Epstein-Barr Conference 8/94 -7/95 11,000 *
Gene Therapy Conference 9/94 -8/95 22,000 *
Ribosome Synthesis Conference 9/94 -8/95 2,000*
NATIONAL SCIENCE FOUNDATION
Research Support Dr. Cline 9/94 -8/95 72,915
Dr. Grotewold 11/94 -10/98 114,248*
Dr. Ma 5/94 -4/97 127,000*
Dr. Ma 8/94 -7/98 109,901 *
Dr. Martienssen 2/93 -7/94 50,000
Dr. Martienssen 8/94 -7/97 150,000*
Dr. Peterson/Stillman 11/91 -10/94 106,487
Dr. Sundaresan 7/92 -7/95 130,000
Fellowship Support Dr. Pena 6/92 -6/96 35,000
Dr. Springer 12/93 -11/95 32,755
Equipment Support Dr. X. Cheng 6/94 -5/96 155,300*
Training Support Undergraduate Research Program,
Dr. Herr
6/91 -5/97 50,000
Course Support Arabidopsis Molecular Genetics 6/94 -5/95 60,000*
Macromolecular Crystallography 8/94 -7/97 45,000*
Computational Neuroscience: Vision 8/94 -7/95 30,000*
Molecular Genetics of Fission Yeast 9/94 -8/99 80,000"
Construction Support Greenhouse 12/92 -5/95 140,000
Meeting Support The Biology of Heat Shock 4/94 -3/95 5,000 *
Zebrafish Development and Genetics 5/94 -4/95 11,400*
Mouse Molecular Genetics 7/94 -6/95 10,000'
Molecular Biology and Development
of Xenopus Laevis 5/94 -4/95 4,166 *
Ribosome Synthesis 7/94 -6/95 5,000*
Learning & Memory 9/94 -8/95 5,500*
DEPARTMENT OF ENERGY
Research Support Dr. Marr 7/94 -2/97 425,313 *
Meeting Support CSHL 59th Symposium: Molecular 1994 9,700 *
Genetics of Cancer
Course Support Macromolecular Crystallography 1994 14,550 *
* New Grants Awarded in 1994
+ Includes direct and indirect cost
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Grantor Program/Principal Investigator Duration of Grant 1994 Funding*
U.S. DEPARTMENT OF AGRICULTURE
Research Support Dr. Ma 9/94 -9/96 65,678"
Dr. Martienssen 9/94 -9/97 61,443*
Dr. Sundaresan 8/94 -9/97 72,000"
U.S. DEPARTMENT OF ARMY
Research Support Dr. Futcher/Dr. Marshak 6/94 -6/98 195,414*
Dr. Wig ler/Dr. Lisitsyn 7/94 -8/98 200,000*
NONFEDERAL GRANTS
Research Support
Alzheimer's Association Dr. Nawa 12/93 -11/94 30,000
American Cancer Society Dr. Gilman 7/91-5/95 100,000
Dr. Ma 7/94 -6/97 32,000*
Dr. Marshak 7/93 -6/95 103,000
Dr. Sutton 1/92 -12/94 95,000
Dr. Wig ler, Professorship 1986 -2012 50,000
Dr. Wigler, Supply Allowance 1994 10,000*
American Heart Association Dr. Helfman 7/91 -6/96 35,000
Amplicon Corporation Dr. Wigler 6/94 -5/97 660,000*
Baxter Foundation Dr. Skowronski 6/92 -5/95 33,694
Arnold & Mabel Beckman
Foundation Dr. Silva 7/94 - 6/96 100,000*
Sara Chait Foundation Dr. Marshak 12/91 -11/96 25,000
J.W. Cleary Muscular Dystrophy Research 11/93 -10/94 26,899
Council for Tobacco Research Dr. Greider 7/92 -6/95 52,000
Dr. Helfman 7/91 -6/95 80,000
Dr. Spector 7/92 -6/95 80,000
Charles E. Culpeper
Foundation Dr. Spector 5/93 -4/95 60,000
The Daphne Seybolt Culpeper
Foundation Cancer Research 1994 5,000 *
Gertrude Elion Cancer
Research Award Dr. Grieder 7/94 -6/95 30,000'
Ford Foundation Dr. Pena 3/93 -2/94 2,500
Geron Corporation Dr. Greider 2/94 -1/97 192,550*
Greenwall Foundation Dr. Marshak 7/92 -6/94 81,179
Irving A. Hansen Memorial
Foundation Dr. Tonks 7/92 -6/94 17,569
Hitachi Foundation Dr. Nawa 3/92 -2/95 10,000
Human Frontier Dr. Futcher 6/92 -5/96 80,000
Science Program Dr. Tully 5/92 -8/95 53,462
ICI Seeds Dr. Martienssen 1/92 -12/94 7,324
ISIS Pharmaceuticals, Inc. Dr. Spector 9/93 -3/95 27,067
Johnson & Johnson Dr. Skowronski 5/92 -4/95 90,000
Esther A. & Joseph Klingenstein Dr. Cline 7/94 -6/95 33,333*
Fund, Inc. Dr. Malinow 7/94 -6/95 33,333*
Dr. Nawa 7/92 -6/95 33333
Dr. Silva 7/93 -6/96 33,333
Long Island Breast Coalition Dr. Wigler 11/94 -1/95 20,000*
Robert Leet & Clara Guthrie
Patterson Trust Dr. Cline 7/94 -6/95 50,000'
March of Dimes Dr. Barker 7/93 -6/94 40,436
' New Grants Awarded in 1994
a Includes direct and indirect cost
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Grantor Program/Principal Investigator Duration of Grant 1994 Funding'
Lucille P Markey Charitable
Trust Neurobiology Support 7/90 -6/96 314,581
MSCl/US Agency for International
Development Dr. Marshak 11/91 -10/94 106,488
Mathers Charitable Foundation Neurobiology Research Support 8/91 -7/94 286,235
The McKnight Endowment Fund for
Neuroscience Dr. Cline 7/91 -6/94 17,452
Mellam Family Foundation Dr. Tonks 12/93 -11/95 50,000
Memorial-Sloan Kettering (NIH) Dr. Marshak 9/94 -7/97 162,920 *
Dr. Tonks 9/94 -7/97 173,103 *
John Merck Fund Dr. Tully 9/91 -5/94 60,000
NYU Consortium (NIH) Dr. Marshak 5/92 -4/97 70,800
Nanoprobes, Inc. Dr. Spector 6/94 -5/95 24,000*
Oncogene Science, Inc. Monoclonal Agreement 6/92 -5/95 190,365
OSIRIS Dr. Marshak 10/94 -6/95 101,790*
Oxnard Foundation Dr. Gilman 2/91 -1/94 50,000
Samuel Freeman Charitable Freeman Laboratory
Trust of Cancer Cell Biology 7/89 -6/94 100,000
Sloan Foundation, Inc. Dr. Malinow 4/94 -9/94 8,022*
Lauri Strauss Leukemia Foundation,
Felix Schnyder Memorial Fund Dr. Gilman 5/94 -4/95 10,000*
St. Giles Foundation Dr. Beach/Dr. Wig ler 3/93 -2/96 50,000
Whitehall Foundation Dr. Silva 9/93 -8/96 45,000
Dr. Zhong 1/94 -12/96 40,000*
Equipment Support
Arrow Electronics Equipment 7/94 -12/94 10,000 *
Louis Berkowitz Foundation Equipment 7/94 -6/95 25,000*
The Daphne Seybolt Culpeper
Foundation Equipment 1994 10,000*
Ira De Camp Foundation Equipment 7/94 -6/95 300,000*
Edward S. Moore Foundation Equipment 7/94 -12/94 10,000 *
The Perkin Fund Equipment 1/93 -12/95 50,000
Harold A. Peterson Trust Equipment 11/93 -12/94 300,000
Pritchard, Inc. Equipment 12/94 -11/95 75,000*
Fannie E. Rippe! Foundation Equipment 12/93 -12/94 250,000
Fellowships
Rita Allen Foundation Dr. Hengartner 9/94 -8/99 30,000 *
Dr. Hernandez 10/89 -9/94 30,000
American Cancer Society Dr. Flanagan 7/92 -6/95 28,000
Dr. Hinkley 9/92 -8/95 28,000
Dr. Marcus 7/93 -11/94 10,718
American Heart Association Dr. Yung-Chih Wang 7/93 -6/95 30,000
Austrian Science Foundation Dr. Gimona 4/94 - 4/96 27,800*
Swedish Cancer Society Cancer
Fonden-Sweden Dr. Berg 9/93 -9/95 25,000
Cancer Research Institute Dr. Flint 1/92 -12/94 31,500
Cancer Research Fund of the
Damon Runyon - Walter Winchell
Foundation Dr. Conklin 11/93 -10/96 30,000
Dr. Hannon 1/92 -12/94 31,000
Dr. Horton 9/92 -8/95 31,000
Dr. Jung 5/92 -4/95 31,000
Dr. Liang 9/94 -8/97 26,000*
Dr. Sun 5/92 -4/95 31,000
Dr. Weinreich 1/94 -12/96 26,000 *
* New Grants Awarded in 1994
+ Includes direct and indirect cost
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Grantor Program/Principal Investigator Duration of Grant 1994 Funding'
Jane Coffin Childs Dr. Mirzayan 7/93 -6/96 27,000
Dr. Verreault 10/94 -9/97 26,500 *
Cowan Fellowship Support Neurobiology Fellowship
Support 12/93 -12/94 25,000*
DFG Deutsche Forschung
Gemeinschaft Dr. Giese 1/93 -6/95 19,026
Eppley Foundation Dr. Silva 11/93 -10/94 10,000
European Molecular Biological
Organization Dr. Giese 1/93 -5/94 9,930
Fonds Dela Resherchen En Sante
Du Quebc Dr. Autexier 11/91-11/96 16,819
Glaxo Research Institute Fellowship Support 1/94 -12/94 100,000*
Goldring International Group, Inc. Fellowship Support 7/94 -6/97 30,000 *
Human Frontier Dr. Della Seta 4/93 -3/95 39,526
Science Program Dr. Grossniklaus 11/94 -10/96 41,200*
Dr. Hamaguchi 8/94 -7/95 48,700*
Dr. Hanamura 7/93 -6/95 39,500
Dr. Steiner 4/94 -3/96 31,400*
Dr. Vignais 8/93 -7/95 40,500 *
Dr. Watakabe 12/93 -11/95 42,700
Japan Funds Dr. Hidaka 9/94 -12/95 20,109*
Kaplan & Kilsheimer Dr. Tobin 12/94 -12/95 3,000*
Leukemia Society Dr. Rong Li 7/94 -6/95 31,320*
Life Science Research Foundation Dr. Collins 6/92 -5/95 35,000
Dr. Kaufman 7/92 -6/95 35,000
Ministerio De Education Y Ciencia,
Madrid Dr. Blasco 6/94 -6/95 16,000*
Medical Research Council of Canada Dr. Demetrick 11/91 -11/95 43,260
Pew Scholars Program Dr. Greider 7/90 -6/94 50,000
Dr. Krainer 7/92 -6/96 50,000
Dr. Tonks 7/91 -6/95 50,000
Dr. Zhong 7/94 -6/98 50,000 *
Andrew Seligson Memorial Fellowships Fellowship Support 9/90 -5/94 78,200'
Wellcome Trust Dr. Frenguelli 11/93 -10/95 33,000
Wendt Fellowships Neurobiology Fellowship Support 1/94 -12/96 50,000*
Training Support
Bio-Rad Laboratories Summer Undergraduate Program 1994 1,000 *-1-
Burroughs Wellcome Foundation Summer Undergraduate Program 1994 6,600*
Hanson White Industries Summer Undergraduate Program 1994 6,600*
Howard Hughes Medical Institute Graduate Student Support 1994 25,000*
Dr. Ira Herskowitz Summer Undergraduate Program 1994 100*
Phillips Petroleum Co. Summer Undergraduate Program 1994 1,000 *
St. Paraskevi Green lawn AIDS Research 1994 1,000*
Elaine E. & Frank T. Powers Summer Undergraduate Program 1994 2,500*
Course Support
Grass Foundation Neurobiology Scholarships 5/94 -4/95 22,000 *
Howard Hughes Medical Institute Advanced Neurobiology 1991-1995 266,170
Esther A. & Joseph Klingenstein Fund, Inc Advanced Neurobiology 5/94 -4/97 60,000 *
Meeting Support
Affinity Bioreagents, Inc. Heat Shock 1994 1,500*
American Cyanamid Molecular Approaches to Immune
Intervention in Infectious
Diseases 1994 15,000*
* New Grants Awarded in 1994
+ Includes direct and indirect cost
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Grantor Program/Principal Investigator Duration of Grant 1994 Funding'
Amgen, Inc. Zebrafish 1994 3,000*
Applied Science, Inc. Zebrafish 1994 500*
Council for Tobacco
Research, U.S.A., Inc. Cytoskeleton & Cell Function 1994 1,500*
Genetics Institute Mouse Molecular Genetics 1994 500*
Institute for Biological Recognition
& Catalysis, Inc. Advanced Molecular Genetics 1994 1,000*
Kureba Corp. Zebrafish 1994 5,000*
March of Dimes Cytoskeleton & Cell Function 1994 3,000*
Marine Bio Zebrafish 1994 500*
Merck Foundation Zebrafish 1994 500*
Otsuka Pharmaceutical Factory, Inc. Zebrafish 1994 5,000*
Pet Warehouse Zebrafish 1994 500*
Pharmaceutical Basic Research
Laboratories Heat Shock Meeting 1994 800*
Pharmaceutical Biotech Molecular Approaches to Immune
Intervention in Infectious
Diseases 1994 15,000*
Ribo Gene, Inc. Translational Control 1994 25,000*
Social Development Bio Zebrafish 1994 2,500*
Stress Gen Biotechnologies Corp. Zebrafish 1994 2,500*
BANBURY CENTER
Grantor Program/Principal Investigator Duration of Grant 1994 Funding+
FEDERAL GRANTS
DEPARTMENT OF ENERGY
NONFEDERAL GRANTS
The Charles A. Dana Foundation
The Esther A. & Joseph Klingenstein
Fund, Inc.
The Rockefeller Foundation
Alfred P. Sloan Foundation
Ms. Von Stade
The William Stamps Farish Fund
The Robert Wood Johnson
Foundation
The Amyotrophic Lateral Sclerosis
Association
Carnegie Council on Ethics
& International Affairs
Geron Corporation
Albert B. Sabin, Foundation
Inc.
" New Grants Awarded in 1994
+ Includes direct and indirect cost
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Human Genetics for Nonscientists:
Practical Workshops for Policy Makers
and Opinion Leaders
Research on the Genetic Basis
of Manic-Depressive Illness
Neuroscience Conference
Grass Genome Conference
Evolution of Genes/Genome
Conference
Manic Depressive Program
Molecular Genetics of Diabetes
Human Genome Meeting
Candidate Gene Approaches to ALS
Science & Ethics: Genetic Research
Telomeres Meeting
1994
1994
1994
1994
1994
1994
1993 -1996
66,579*
527,878
11,000*
3,000 *
18,000 *
5,000 *
39,827
1994 145,616*
1994
1994
33,876 *
7,151 *
1994 9,391*
Next Generation of Vaccines 1994 29,851 *
DNA LEARNING CENTER
Grantor Program/Principal Investigator Duration of Grant 1994 Funding.
FEDERAL GRANTS
NATIONAL SCIENCE FOUNDATION
A Two-part program to Develop and Support
Nationwide Corps of Human & Molecular
Genetics Resource Teachers at the
Secondary Level, Mr. Mick los 4/93 -3/96 283,918
Laboratory-based Instruction in
Molecular & Human Genetics for
Teaching Faculty, Dr. Bloom 5/93 -4/95 291,275
U.S. DEPARTMENT OF EDUCATION
College Faculty Enhancement
Dr. Bloom 1991 -1994 87,336
NONFEDERAL GRANTS
Harweb Foundation Core Support 1994 1,000
Howard Hughes Medical Institute High School Faculty Enhancement 1994 42,393
Howard Hughes Medical Institute Precollege Science Education
Initiative for Biomedical Research
Institutions 7/94 -6/99 80,000*
New York State Legislature Middle School Program 1994 75,000
Stone Foundation Equipment 1994 64,412
E.S. Webster Foundation Core Support 1991 -1994 20,000
Weezie Foundation Exhibit 1991 -1994 9,886
The following schools each awarded a grant of $5,000 in 1994 for the Genetics as a Model for Whole Learning Program:
Great Neck Public Schools Jericho Union Free School District
Half Hollow Hills Central School District Locust Valley Central School District
The following schools awarded a grant for Curriculum Study in 1994
of $850:
Commack Union Free School District Massapequa Union Free School District
East Williston Union Free School District Northport-East Northport Union Free
Garden City Union Free School District School District
Great Neck Public Schools North Shore Central School District
Half Hollow Hills Central School District Oyster Bay-East Norwich Central School District
Harborfields Central School District Plainedge Union Free School District
Herricks Union Free School District Port ledge School
Island Trees Union Free School District Port Washington Union Free School District
Jericho Union Free School District Roslynm Public Schools
Lawrence Union Free School District Sachem Central School District
Locust Valley Central School District South Huntington Union Free School District
Manhasset Union Free School District Syosset Central School District
of $1,500:
East Meadow Union Free School District
of $2,000:
Ramaz School
New Grants Awarded in 1994
+ Includes direct and indirect cost
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Cold Spring Harbor Laboratory is a nonprofit research and educational institution
chartered by the University of the State of New York. Less than half (44.1%) of
our annual support is derived from Federal grants and contracts, and thus we
rely heavily on support from the private sector: foundations, corporations, and in-
dividuals. Contributions from the private sector are tax exempt under the provi-
sions of Section 501(c)(3) of the Internal Revenue Code. In addition, the
Laboratory has been designated a "public charity" and therefore may receive
funds resulting from the termination of "private foundations."
METHODS OF CONTRIBUTING TO COLD SPRING HARBOR LABORATORY
Gifts of money can be made directly to Cold Spring Harbor Laboratory.
Securities: You can generally deduct the full amount of the gift on your income
tax return, and, of course, you need pay no capital gains tax on the stock's ap-
preciation.
We recommend any of the following methods:
(1) Have your broker sell the stock and remit the proceeds to Cold Spring Har-
bor Laboratory.
(2) Deliver the stock certificates to your broker with instructions to open an ac-
count for Cold Spring Harbor Laboratory and hold the securities in that ac-
count pending instructions from Cold Spring Harbor Laboratory.
(3) Send the unendorsed stock certificates directly to the Laboratory: Com-
ptroller, Cold Spring Harbor Laboratory, One Bungtown Road, Post Office
Box 100, Cold Spring Harbor, New York 11724. In a separate envelope,
send an executed stock power.
Pooled Income Funds: Combine gifts from a number of donors in a pool for at-
tractive investment and tax purposes.
Appreciated real estate or personal property: Sizable tax benefits can result
from such donations; the Laboratory can use some in its program and can sell
others.
Life insurance and charitable remainder trusts can be structured to suit the
donor's specific desires as to extent, timing, and tax needs.
Bequests: Most wills probably need to be updated. Designating Cold Spring
Harbor Laboratory as beneficiary ensures that a bequest will be utilized as
specified for continuing good.
Conversion of private foundation to "public" status on termination: This may
be done by creating a separate fund within Cold Spring Harbor Laboratory
whereby the assets of the private foundation are accounted for as a separate
fund and used for the purposes specified by the donor. Alternatively, the pri-
vate foundation can be established as a supporting organization of Cold Spring
Harbor Laboratory.
For additional information, please contact the Director of Development, Cold Spring Harbor
Laboratory, One Bungtown Road, Post Office Box 100, Cold Spring Harbor, NY 11724, or
call 516-367-8840.
CAPITAL AND PROGRAM CONTRIBUTIONS
January 1, 1994-December 31, 1994
Contributions of $5,000 and above
In 1994, the Laboratory received significant support in the form of capital and program contribu-
tions from individuals, foundations, and corporations.
Arrow Electronics, Inc.
Louis Berkowitz Family Foundation
Gladys Brooks Foundation
Daphne Seybolt Culpeper
Foundation
Ira De Camp Foundation
Goldring Family Foundation
David H. Koch Foundation
Marks Family Foundation
Dextra Baldwin McGonagle Foundation
Total $731,750
Edward S. Moore Foundation
1 in 9: Long Island Breast Cancer
Coalition
Dr. David Pall
Robert Leet and Clara Gunthrie
Patterson Trust
William and Maude Pritchard Charitable
Trust
Alan and Edith Seligson
H. Turner Slocum
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ANNUAL CONTRIBUTIONS
Corporate Sponsor Program
The Corporate Sponsor Program, now in its 11th year, provides support for meetings held both in
Grace Auditorium on the main Laboratory campus and at Banbury Center. The support provided
by this Program is critical to the Laboratory's meetings program by enabling us to plan ahead for
the following year's meetings. We are very grateful to the Corporate Sponsors for their willingness
to contribute to the Program in a period where there are increasing financial constraints on the
pharmaceutical and biotechnology industries. These difficulties were reflected in a small decline in
membership to 35 in 1994. Furthermore, mergers in these industries are continuing to reduce the
numbers of companies to whom we can apply. Thus, the funding provided by the 1994 Corporate
Sponsors (listed below) was especially appreciated.
The members of the Program receive special privileges in acknowledgment of their contribu-
tions. We waive all on-site fees for eight representatives of each company at our meetings. Three of
these scientists may attend meetings at Banbury Center, where attendance is otherwise only by in-
vitation of the organizers. Corporate Sponsors receive gratis copies of Cold Spring Harbor
Laboratory Press publications including the journals Genes & Development, Learning & Memory,
and PCR. Grace Auditorium is made available to Corporate Sponsor Program members for
sponsorship of scientific meetings on topics of their own choice. These meetings are of the same
excellent standard as the regular meetings and will garner kudos from being held here at the
Laboratory. They are strictly limited in number. In 1994, Perkin-Elmer held the very popular and
successful meeting A Decade of PCR to celebrate both the technique and the award to Kary Mullis
of a Nobel Prize for Chemistry in 1993.
In addition, we acknowledge our Sponsors in all relevant publications, including the book of ab-
stracts given to every participant. The names of the sponsoring companies are listed on the poster
describing the meetings and mailed to approximately 7000 scientists throughout the world.
Alafi Capital Company
American Cyanamid Company
Amgen Inc.
Becton Dickinson and Company
Biogen
Boehringer Mannheim Corporation
Bristol-Myers Squibb Company
Chugai Pharmaceutical Co., Ltd.
Ciba-Geigy Corporation
Diagnostic Products Corporation
The Du Pont Merck
Pharmaceutical Company
Forest Laboratories, Inc.
Total
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$720,500
Genentech, Inc.
Glaxo
Hoffmann-La Roche Inc.
Johnson & Johnson
Kyowa Hakko Kogyo Co., Ltd.
Life Technologies, Inc.
Mitsubishi Kasei Institute of Life
Sciences
Monsanto Company
New England BioLabs, Inc.
Oncogene Science, Inc.
Pall Corporation
The Perkin-Elmer Corporation
Pfizer Inc.
Research Genetics
Sandoz Research Institute
Schering-Plough Corporation
SmithKline Beecham
Pharmaceuticals
Sterling Winthrop Inc.
Sumitomo Pharmaceuticals Co.,
Ltd.
Takeda Chemical Industries, Ltd.
Toyobo Co., Ltd.
Wyeth-Ayerst Research
Zeneca Group PLC
Cold Spring Harbor Laboratory Association (CSHLA)
Officers
Mrs. George N. Lindsay, President
Mrs. James M. Large, Vice President
Gordon E. Lamb, Secretary/Treasurer
Directors
Mrs. Joseph S. Augusciak
Mrs. Harry A. Brooks
Mrs. Harry G. Charlston
David C. Clark
John P. Cleary
John S. Grace
Mrs. Edward Greenberg
Mrs. Henry U. Harris, Jr.
President's Report
Donald S. Kent, M.D.
E. Coe Kerr
Alan M. Kisner, M.D.
Edward F. McCann II
Mrs. Walter C. Meier
Mrs. Robert G. Merrill
Mrs. Vincent Nesi
Douglas E. Rogers
Phillip M. Satow
Mrs. Thomas A. Saunders III
Mrs. Peter G. Schiff
James L. Spingarn
Bruce Stillman, Ph.D.
Mrs. Philip R. von Stade
James D. Watson, Ph.D.
George W. Cutting, Honorary Director
The year 1994 was a banner year for science here at Cold Spring Harbor Laboratory. The excite-
ment of this success has infected the members of the Cold Spring Harbor Laboratory Association
and the community. It is rewarding to find photos of Tim Tully and Alcino Silva in the New York
Times and to read in Newsday of Mike Wigler's and Nicholai Lisitsyn's RDA work on genetic
changes that occur in breast cancer and in colon and prostate cancer.
Despite the advances in science, however, our neighbors are concerned about the growth of
the Laboratory. The Association has made a concerted effort this year to reach out to the com-
munity to dispel misunderstandings, to supply historical and current facts, and to familiarize out-
siders with the impact that this basic research can have on our health and on the health of our chil-
dren and grandchildren. Personal contact, letters, and frequent tours have, I think, helped to in-
crease awareness of the Laboratory's work. Two hundred new members have joined the Associa-
tion, bringing the total to 741 members (of course, some members fail to renew or forget to return
the following year). We are growing, and we aim to continue growing as we expand the member-
ship geographically.
The events sponsored by the Association have taken on a cyclical rhythm. The year began with
our Annual Meeting, and we were fortunate to have a well-known alumnus and friend of the Lab, Dr.
Robert Pollack, a Professor at Columbia, as our speaker. He explained DNA and RNA and proteins
as the building blocks of our genome. Based on his recent book, Signs of Life, his interpretation
helped us to understand our need to know our own relationship to what the genome will reveal.
The rhythm of scientific lay talks continued at Grace Auditorium in the spring, with a presenta-
tion on epilepsy by Dr. James McNamara, Duke University Medical Center. In the fall, a lecture on
human behavior was given by Dr. Helen Fisher, a research associate with the American Museum of
Natural History. In December, Drs. Jeffrey Friedman and Kenneth Polonsky spoke on diabetes. Dr.
Fisher's talk, "The Evolution of Marriage, Adultery, and Divorce: The Future of the Family," attracted
a large audience. Each of the above lecturers was attending a meeting at the Banbury Conference
Center and kindly took time out of their busy schedules to present these talks at Grace.
On a beautiful day in May, a special tour of the Laboratory was arranged for the Cosmopolitan
Club of New York City. Also in May, members of the Association joined the North Shore and The
Three Harbors Garden Clubs to hear Dr. Gene Elder Likens' talk on "Human Accelerated Environ-
mental Change-An Ecologist's View."
The Dorcas Cummings lecture held at the height of the Cold Spring Harbor Symposium was
given this year by Dr. Harold Varmus, recently appointed director of the National Institutes of
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Hot Jazz on Cold Spring Harbor-Jerry Jerome and his skilled musicians.
Health. His talk, "Why is it Important to Understand the Genetic Basis of Cancer?" interested all who
attended. After the lecture, guests and visiting scientists were transported to nearby homes of As-
sociation members for dinner. This is one of the very nicest customs, in which worldwide
celebrated scientists, here for the Symposium, join our scientists to be guests of Association mem-
bers. Special thanks go to the following who hosted dinners in 1994:
Mr. & Mrs. Morgan Browne
Mr. & Mrs. John P. Cleary
Mr. & Mrs. Norris Darrell
Mr. & Mrs. John Grace
Mr. & Mrs. Gordon S. Hargraves
Mr. & Mrs. Henry U. Harris, Jr.
Mrs. Wendy Vander Poel Hatch
Mr. & Mrs. George N. Lindsay
Mr. & Mrs. David L. Luke Ill
Mr. & Mrs. Robert Merrill
Dr. & Mrs. Larry Nathanson
Mr. & Mrs. Robert O'Connor
Mr. & Mrs. James F. Stebbins
Mr. & Mrs. Byam K. Stevens
Prof. & Mrs. John Stevenson
Mr. & Mrs. Philip R. von Stade
Our benefit event this year was a summer outdoor jazz concert. Jane Spingarn was able to ob-
tain Jerry Jerome and his skilled musicians, and she and Hope Reese chaired the event. Everyone
who attended "Hot Jazz on Cold Spring Harbor" gave rave reviews. Many thanks to Jane and Hope
for their hard work and for bringing a new audience to Cold Spring Harbor Laboratory. Special
thanks goes to the Spingarns for contributing $2,000 to underwrite the musicians. The Jazz Concert
Committee consisted of:
Mrs. John R. Reese
Mr. & Mrs. James L. Spingarn
Mrs. Lionel E. Chaikin
Mrs. G.W. Chapman, Jr.
Mrs. Neil Fidel
Mr. & Mrs. Henry L. Fox
Mrs. Robert A. Gay
Mrs. John J. Genovese
Mr. & Mrs. Allen Goldring
Mrs. Gerard P. Griffin
Mrs. Margaret Hamilton Howe
Dr. & Mrs. Donald S. Kent
Mrs. E. Coe Kerr Ill
Mrs. Carol Kingston
Mrs. Alan M. Kisner
Mr. & Mrs. Robert Lindsay
Mrs. Peter Maris
Mrs. Gerald D. Olin
Mr. & Mrs. Philip M. Satow
Mrs. Hugh C. Wallace, Jr.
Solicitation mailings for membership in the Association are done in the spring and fall. All major
donors and many Friends and Family letters are personalized by our Directors. This year we
solicited every resident of Laurel Hollow and selected School District #2 residents, and we pros-
pected numerous Long Island lists. This is a worthwhile exercise that I suspect will bring even bet-
ter returns in future years.
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The final report shows 174 major donors of more than $1,000 and includes one gift increased
by $85,000! Our 200 new members helped to bring us an all time high of $600,967. These funds
will go to support young postdoctoral fellows and their laboratories. Today with federal funds hard
to come by, these unrestricted moneys are essential to the excellence of Cold Spring Harbor re-
search.
On Sunday evening, October 23, Lorraine Grace gave a lovely cocktail/buffet reception at her
home, a "thank you" party honoring the Association's Benefactors, Patrons, and Associates. Four of
the postdoctoral fellows who have been recipients of Annual Fund grants as well as several of the
Laboratory's senior scientists were guests at the event. Many thanks to Mrs. Grace for a very good
time and for giving many of us a chance to get to know one another better.
As I turn over the presidency to John Cleary, I feel elation that the Association is performing its
support of the Laboratory well. It will miss the energy of the four wonderful Directors who rotate off
this year: Mary Jeanne Harris, Gordon Lamb, Anne R. Meier, and Marjorie von Stade. I thank them
and all the other Directors who have worked with me, especially the tireless Carol Large and the
enthusiastic Jim Spingarn.
I offer my best wishes to John Cleary; to the new Directors Nick Bartilucci, David Deming,
Laurie Genovese, Joyce Green, Bob Marcus, and Gerry Olin; and to Susan Cooper, Jean Schwind,
and the new staff. I would also like to extend goodbyes and best wishes to Joan Pesek and Debi
Rizzieri in all their future endeavors. It has been a great experience for me.
March 3, 1995 Mary D. Lindsay
Members of the Cold Spring Harbor Laboratory Association
BENEFACTORS*
Mr. and Mrs. John P. Cleary
Joseph H. Cohen & Sons
Foundation, Inc.
Mrs. John L. Davenport
Mr. Robert B. Gardner, Jr.
Mrs. Oliver R. Grace
Mr. and Mrs. George N. Lindsay
Mr. and Mrs. David L. Luke III
Dr. and Mrs. Walter C. Meier
Mr. Arthur C. Merrill
Mr. and Mrs. Robert G. Merrill
Mr. and Mrs. William R. Miller
Mr. and Mrs. Douglas P. Morris
The Dorothy Schiff Foundation
Ms. Margo G. Walker
PATRONS
Mr. and Mrs. Cornelius N. Bliss Ill
Mr. and Mrs. Jeffrey Braverman
Mr. and Mrs. Rod Brayman
Mr. and Mrs. Harry A. Brooks
Mr. and Mrs. G. Morgan Browne
Mr. and Mrs. Peter B. Cannell
Centerbrook Architects
Mr. and Mrs. Ronald M. Craigmyle, Jr.
Mr. and Mrs. Arthur M. Crocker
Mr. and Mrs. Robert L. Cummings
Mr. and Mrs. Norris Darrell, Jr.
Mrs. Edward H. Gerry
Mr. and Mrs. Thomas S. Gimbel
Mr. and Mrs. John W. Hadley
The Joyce Green Family Foundation
Mr. and Mrs. Townsend J. Knight
Dr. Laurie J. Landeau
Mr. and Mrs. James M. Large, Jr.
Mr. and Mrs. John H. Livingston
Mr. and Mrs. Robert R. Maxfield
Mr. George Montgomery
Mr. and Mrs. Charles E. Macon
Mr. and Mrs. John J. Phelan
Mrs. H. Irving Pratt
Mrs. Curtis S. Read
Mr. and Mrs. John R. Reese
Mr. Eric Ridder
Mr. and Mrs. Phillip M. Satow
Seth Sprague Educational 8 Charitable
Foundation
Mr. and Mrs. James L. Spingarn
Mr. and Mrs. Peter Titles
Mr. and Mrs. Douglas A. Warner III
Dr. and Mrs. James D. Watson
Mr. James D. Wolfensohn
ASSOCIATES +
Mr. Warren S. Adams II
Mr. and Mrs. Robert F. Albertson
Mr. and Mrs. Roger Bahnik
Mr. and Mrs. Thomas M. Bancroft, Jr.
Mr. and Mrs. William Bancroft
Mr. and Mrs. David L. Banker
Nicholas Bartilucci, Esq.
Mr. and Mrs. Edmund Bartlett
Mr. and Mrs. Rodney B. Berens
Mr. and Mrs. Allen L. Boorstein
Dr. Renee Fitts 8 Dr. David Botstein
Mr. Lester E. Brion, Jr.
Mrs. Jackson Burke
Mr. and Mrs. John P. Campbell
Mr. and Mrs. Harry G. Charlston
Mr. and Mrs. David C. Clark
Dr. and Mrs. Bayard D. Clarkson
Mrs. Robert L. Clarkson, Jr.
Mr. James W. Cleary
Mr. and Mrs. John H. Coleman
Mrs. John K. Colgate, Sr.
Mr. and Mrs. Peter 0. Crisp
Mr. and Mrs. George W. Cutting
Michael Davidson Memorial Fund
Mr. Charles B. Delafield
Mr. and Mrs. David H. Deming
Mr. and Mrs. Donald L. Deming
On Lester Dubnick
Mr. and Mrs. William T. Dunn, Jr.
Mr. and Mrs. James A. Eisenman
Mr. and Mrs. Duncan Elder
Mr. and Mrs. William Everdell
Mr. and Mrs. Stephen C. Eyre
Mr. and Mrs. Harold L. Fates
Mr. and Mrs. Edward E. Fessenden
Mr. and Mrs. Clarence E. Galston
Mr. and Mrs. Charles S. Gay
Mr. and Mrs. E. Maxwell Geddes, Jr.
Mr. and Mrs. Lionel M. Goldberg
Dr. and Mrs. William E. Gordon III
Mr. and Mrs. Edward Greenberg
Reverend Linda P. Hancock
Mrs. John W. Hanson
Mr. and Mrs. Gordon S. Hargraves
Mr. and Mrs. Henry U. Harris, Jr.
Mrs. Wendy Vander Poel Hatch
Mrs. Horace Havemeyer, Jr.
Mrs. Dorothy H. Hirshon
Mr. and Mrs. Waldo Hutchins III
Mr. Frederic B. Ingraham
Mrs. Gilbert W. Kahn
Mrs. Francis S. Kinney
Dr. and Mrs. Alan M. Kisner
Mr. Winthrop Knowlton
Mr. and Mrs. Gordon E. Lamb
Mr. and Mrs. Edward M. Lamont
Mrs. Henry Lewis III
Dr. Robert V. Lewis
Mr. and Mrs. Robert V. Lindsay
Mrs. Vladimir S. Littauer
Dr. Thomas Maniatis
Mr. and Mrs. Robert L. Marcus
Mr. and Mrs. Gerald M. Mayer, Jr.
Ms. Diana McIlvaine
Mr. and Mrs. George S. Meyer
Mr. and Mrs. Clarence F. Michalis
Dr. Peter Model
Mr. and Mrs. Keith M. Moffat
Mr. and Mrs. F. Warren Moore
Mr. and Mrs. Stephen V. Murphy
Mr. and Mrs. William J. Nammack
Dr. and Mrs. Larry Nathanson
Mr. and Mrs. Vincent R. Nesi
Mr. and Mrs. Adams H. Nickerson
Nordemann Foundation, Inc.
Mr. and Mrs. Charles P. Noyes
Mr. and Mrs. Bernard Nussdorf
Mr. and Mrs. George D. O'Neill
Mrs. William H. Osborn
Mr. and Mrs. Walter H Page
Dr. and Mrs. Philip F. Palmedo
Mr. Edward L. Palmer
Mr. William Parsons, Jr.
Mr. and Mrs. Nicholas B. Paumgarten
Mrs. Francis T.P. Plimpton
Mr. and Mrs. Martin M. Pollak
Mrs. Barbara S. Powers
Mr. and Mrs. F. Thomas Powers, Jr.
Mr. and Mrs. Richardson Pratt, Jr.
Mrs. Sherman Pratt
Ms. Augusta Reese
Ms. Victoria Reese
Mrs. Willis L. Reese
Mr. and Mrs. William S. Robertson
Mr. and Mrs. Arthur M. Rogers, Jr.
Mr. and Mrs. J. Wright Rumbough, Jr.
Drs. Adrienne O'Brien & David G.
Salten
Mr. and Mrs. Thomas A. Saunders
Mr. and Mrs. Peter G. Schiff
Mr. and Mrs. Thomas Seifert
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Mr. and Mrs. Enrique F. Senior Mr. and Mrs. Robert P. Sibert Dr. and Mrs. Salvatore Caravella Mr. Robert L. Garland
Mr. and Mrs. Paul C. Shea line Mr. Herbert A. Slater Mrs. Sybil B. Carton Mr. and Mrs. John W. Gates
M. Alexandra White Smith Mr. Herbert L. Smith III Mr. and Mrs. Vincent Caruso Mr. and Mrs. William C. Gay, Jr.
Mr. and Mrs. Owen T. Smith Ms. Georgette A. Spingarn Ms. Madeline S. Carver Dr. and Mrs. Martin Gellert
Mr. and Mrs. Peter Solbert Mr. and Mrs. Erwin P. Staller Mrs. Jean Cattier Mr. Roger Gerber
Mrs. Helen Grace Spencer Mr. and Mrs. B. Albert Stem, Jr. Mr. and Mrs. Lionel Chaikin Dr. and Mrs. Stephen k Gettinger
Mr. and Mrs. James F. Stebbins Mm. Richard Storrs Mr. and Mrs. Gilbert Chapman, Jr. Mr. Robert Gilmor
Mr. and Mrs. Robert L. Strong Dr. Frances Taylor Mrs. Mary J. Chase Dr. H. Bentley Glass
Mr. and Mrs. Richard M. Sykes Mr. and Mrs. George I. Tournanoff Dr. Eleanor Chernick Mr. and Mrs. Harold Glick
Mr. and Mrs. Daniel G. Tenney, Jr. Mrs. Edward Townsend Dr. and Mrs. Donald E. Chiarello Mr. and Mrs. Bernard J. Gloisten
Mrs. Robert W. Tilney Mrs. Alexander Orr Vietor Mr. and Mrs. Donald C. Christ On and Mrs. Charles Goodwin
Mrs. Martin Victor Dr. Karma Visvanathan Mr. and Mrs. Robert Coe Mr. and Mrs. Elliot H. Goodwin
Mr. and Mrs. Philip R. von Stade Mr. and Mrs. Harold L. Warner, Jr. Dr. Peter F. Cohn Mr. and Mrs. Howard Grace
The Alex J. Weinstein Foundation, Inc. Mr. and Mrs. Charles S. Weiss Mr. and Mrs. Bradley Collins Mr. and Mrs. Austen T. Gray
Mrs. Taggart Whipple Mr. and Mrs. Malcolm D. Widenor Mr. and Mrs. Patrick Collins Mr. and Mrs. Austen T. Gray, Jr.
Mr. and Mrs. S. H. Wolcott III Mr. Alan Wilensky Mr. and Mrs. Jonathan M. Connors Mr. and Mrs. Edward R. Greeff
Mr. Mayer Wolf Dr. and Mrs. Joseph B. Conolly, Jr. Dr. and Mrs. Raymond B. Griffiths
FRIENDS ++ Mr. and Mm. William A. Woodcock Albert W. Cook, M.D. Mr. and Mrs. Frank Gundersen
Mrs. Jules W. Aubry Mr. and Mrs. Robert E. Cooper Dr. Susan Gunduz
Mr. and Mrs. Joseph S. Augusciak FAMILY MEMBERS ++. Mrs. Anne B. Copeland Mr. and Mrs. Hamilton Hadden, Jr.
Mr. and Mrs. W. Dillaway Ayres, Jr. Mr. and Mrs. Michael Aboff Mr. and Mrs. Robert Cuddeback Mr. and Mrs. Frank L. Hain
Mr. John C. Bierwirth Mr. and Mrs. Thomas H. Ackerman Mr. and Mrs. Curtis Cushman Mr. and Mrs. John D. Halajian
Mr. and Mrs. Samuel R. Callaway Mm. Stirling S. Adams Mr. and Mrs. Roderick H. Cushman Ms. Sandra Hamberger C.S.W.
Mrs. Thomas Choate Mr. and Mrs. Alan M. Ades Ms. Lucy Cutting Ms. Beverly Hanson
Mr. and Mrs. C. Payson Coleman, Jr. Mr. Amyas Ames Mr. and Mrs. Joseph D'Ella Mr. and Mrs. John F. Harper
CSHL Arts and Crafts Fair Mr. and Mrs. Charles O. Ames Mrs. Howard H. Dana Mr. Randolph Harrison
Mr. and Mrs. Robert L. Cummings III Mr. and Mrs. Prescott Arnmarell Mr. and Mrs. Theodore N. Danforth Dr. and Mrs. Chester Hartenstein
Mr. and Mrs. Richard T. Cunnift Ms. Jean E. Anderson Mr. and Mrs. Stephen Dannhauser Mr. and Mrs. Thomas Hayden III
Dr. and Mrs. Paul Cushman, Jr. Dr. and Mrs. Carl W. Anderson Ms. Katya Davey Mr. John Heals and Ms. Paula J. Olsiewski
Mr. and Mrs. Claus Dannasch Mr. Ronald C. Anderson Mr. and Mrs. Lawrence L. Davis Mr. Huyler C. Held
Mr. and Mrs. W. Tucker Dean Mr. and Mrs. S. Reed Anthony Mr. and Mrs. Daniel P. Davison Mr. and Mrs. Robert V. Henning
Mr. and Mrs. Don Durgin Mr. and Mrs. Edward H. Auchincloss Mr. and Mrs. Daniel C. de Roulet Dr. Ira Herskowitz
Mr. Maths Elias Mr. and Mrs. Henry D. Babcock, Jr. Dr. Stephen L Dellaporta Mr. and Mrs. Arno Herzog
Mr. and Mrs. Jerry Ellstein Mr. Sepal H. Badlani Mr. and Mrs. William R. Denslow, Jr. Mrs. Fred L. Hayes
Mr. and Mrs. Johnston L. Evans Mr. George Baker Mrs. Douglas C. Despard, Jr. Mr. Lawrence P. Hilbert
Mr. and Mrs. Robert J. Feeney Mr. and Mrs. Jens Bakke Ms. Sylvia Diamond Mr. and Mrs. Landon Hilliard III
Mr. and Mrs. Robert A. Gay Mrs. George C. Barclay Mrs. Suzanne V. Dillenbeck Mrs. Albert L. Hoffman
Col. Alexander W. Gentleman Dr. and Mrs. Henry H. Bard Mrs. Carolyn C. Dilworth Mr. and Mrs. Charles R. Holcomb
Mr. Elbridge T. Gerry, Jr. Dr. and Mrs. Douglas Barkin Mr. and Mrs. Peter DHkes Mr. Irving Holtzman
Mr. and Mrs. Morris W. Geller Mrs. Dudley R. Barr Mr. and Mrs. Joseph T. Donohue Mr. and Mrs. Bruce D. Hooton
Dr. and Mrs. Maurice Green Mr. and Mrs. Joseph M. Barry Mr. E. Richard Droesch Mr. and Mrs. George J. Hossfeld, Jr.
Dr. and Mrs. Gary Gussin Dr. Neil Barton Mr. and Mrs. Leonard K. DuBrul Mr. and Mrs. George H. Howard HI
Mr. and Mrs. John Havens Mr. and Mrs. Frederick Baum Mr. Edgar P. Dunlaevy Mr. and Mrs. George H. Howard
Mr. and Mrs. Harold W. Hawkey Mrs. Patricia Bell-Thomson Mrs. William S. Eakins Mr. and Mrs. Charles J. Hubbard
Mr. and Mrs. Thomas M. Hearn Dr. Bry Benjamin Dr. and Mrs. James D. Ebert Mr. and Mrs. John H. Humpstone, Jr.
Dr. and Mrs. Alfred D. Hershey Mr. and Mrs. Robert E. Benson Mrs. Fred J. Eisster Mrs. Eugene E. Husting
Mr. and Mrs. Hans D. Holterbosch Mr. and Mrs. Anthony J. Berelka Dr. Andrew M. Elmore Mrs. Joan M. Hutchins
Mr. and Mrs. James Hoover Mr. John Berelka Mr. and Mrs. Stephen Ely Mr. and Mrs. Judson A. Hyatt
Dr. and Mrs. Donald S. Kent Dr. and Mrs. Paul Berg Mr. and Mrs. Richard H. Emmert, Sr. Mr. and Mrs. Herbert S. Ingham
Mr. and Mrs. Albert Key Mr. and Mrs. Kenneth Berkman Dr. and Mrs. N. Dennis Eryou Mrs. David Ingraham
Mr. John Klingenstein Mrs. Rynn Berry Mrs. James M. Estabrook Mr. Richard D. Irwin
Mr. and Mrs. David M. Knott Mr. and Mrs. Robert P. Beuerlein Mrs. Raymond Z. Fahs Mrs. Richard M. Jackson
Mr. and Mrs. Mort Kunstler Ms. Marjorie M. Bhavnani Mr. and Mrs. Joel M. Fairman Mr. and Mrs. Valdemar F. Jacobsen
Dr. and Mrs. Ralph Landau Mr. and Mrs. Nicholas Biddle, Jr. Mr. and Mrs. George Farber Mr. and Mrs. Robert D. Jay
Ms. Lois A. Lenahan Mrs. William Binnian Mr. Robert 0. Fehr Mrs. Laurence S. Johnson
Mr. and Mrs. Anthony V. Leness Mrs. George F. Bird Mr. J. Barry Ferguson Dr. Gail and Mr. C. William Jones
Mr. and Mrs. Henry Luce 111 Mr. Frederick Blair Mr. and Mrs. James C. Ferrer Mrs. Ruth B. Jordan
Mr. and Mrs. William H. Mathers Ms. Mary Lenore Blair Robert L. Ferris, Esq. Dr. Paul Joseph
Mr. William B. Matteson Ms. Jane S. Block Mr. and Mrs. Peter L. Fetterolf Dr. and Mrs. Richard S. Joseph
Mr. and Mrs. Richard McDaniel Mr. and Mrs. Peter H. Blohm Dr. and Mrs. Noah Finkel Mr. and Mrs. John Juda, Jr.
Mr. and Mrs. Robert M. McLane Mr. Martin Blumenthal Mr. and Mrs. Dugald A. Fletcher Mr. and Mrs. Howard L. Kane
Mrs. Cynthia R. Mead Dr. Jerome Bogin Ms. Mary Lee Fletcher Mr. and Mrs. Morris I. Karpen
Mr. and Mrs. Francis W. Murray III Dr. Jonathan M. Borkum Mr. and Mrs. Douglas B. Fox Mr. and Mrs. John Kean
Mrs. Richard Neuendorffer Mrs. Shirley Boosting Mr. and Mrs. Henry L. Fox Dr. and Mrs. Francis C. Keil
Mrs. William S. Niven Mr. and Mrs. William Braden Mr. and Mrs. Seth B. French, Jr. Mr. and Mrs. Thomas Kelly
Mrs. Ann L. Nolte Mr. William H. Brinckerhoff Mr. Irwin Frish Mr. and Mrs. A. Claude Kemper
Mr. and Mrs. Arthur W. Page, Jr. Mr. and Mrs. Arthur Brings Mr. Guy Fritts Mrs. Louise M. King
Mrs. Jessie E. Phillips Mr. Daniel Broek Mr. and Mrs. David C. Fuchs Mrs. James Knott
Mr. and Mrs. Howard Phipps, Jr. Mr. and Mrs. Barnett W. Bronfman Dr. and Mrs. Candid° Fuentes Mrs. Anne R. Knowlton
Mr. and Mrs. Sterling Pile, Jr. Mrs. Miranda Brooks Mr. and Mrs. Stephen D. Fuller Mrs. Robert Koenig
Dr. and Mrs. Robert Pollack Mr. F. Sedgewick Browne Mr. and Mrs. Victor Futter Dr. and Mrs. Fred Kornblueh
Mr. and Mrs. Joseph D. Posillico, Jr. Mr. and Mrs. James T. Bryan, Jr. Mr. Charles Gabalis Dr. and Mrs. Mitchell Kramer
Mrs. William Post Dr. and Mrs. Julian G. Buckley Mr. and Mrs. D. Kent Gale Mr. and Mrs. Paul Kramer
Mr. and Mrs. Thomas Pulling Mr. and Mrs. John W. Busby Mr. and Mrs. Stanley C. Gale Mrs. Mitsuko Kurahara
Mr. and Mrs. Douglas E. Rogers Ms. Josephine Callahan Dr. E. John Gall and Dr. Kathleen E. Ward Mrs. Leslie S. Learned
Ms. Gulia Saia Mr. and Mrs. Michael C. Cammarota Mr. and Mrs. John W. Galston Mr. and Mrs. Richard E. Leckerling
Dr. and Mrs. Walter Shropshire, Jr. Mr. and Mrs. Ward C. Campbell Mr. and Mrs. Murray B. Gardner Mr. and Mrs. William LeSuer
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Dr. Arnold J. Levine Mr. and Mrs. F. Barry Nelson Ms. Charlene A. Russert Mr. and Mrs. John W. Taylor
Mr. Eugene J. Levitt Dr. and Mrs. Peter R. Neumann William Ryan, M.D. Mr. and Mrs. Dudley B. Tenney
Dr. Kenneth Levy Dr. and Mrs. Nathan A. Newman Mrs. Robert M. Salant Mrs. Anne M. Thomas
Dr. James B. Lewis Mrs. John S. Nichols Ms. Anita Salembier Mr. and Mrs. Edward M. Thomas
Dr. and Mrs. Jim Jung-Ching Lin Dr. Juniche Nikawa Mr. and Mrs. Henry E. Salzhauer Mr. George M. Thomas
Mr. George N. Lindsay, Jr. Mr. and Mrs. Gary H. Nordmann Mrs. Patricia P. Sands Mr. and Mrs. George H. Tilghman
& Ms. Nancy Metz North Country Garden Club Ms. Phyllis Satz Shirley M.C. Tilghman, Ph.D.
Mr. and Mrs. Robert D. Lindsay Mr. and Mrs. Innis O'Rourke, Jr. Mr. and Mrs. Louis A. Scarcella Dr. Stanford W. Ting
Ms. Freda Hall Lipmann Mr. and Mrs. William K. Oelsner Mr. and Mrs. Adam F. Schaefer Dr. and Mrs. Takashi Toda
Dr. and Mrs. Lawrence J. Lippert Mr. and Mrs. Richard B. Opsahl Mr. and Mrs. Tancred V. Schiavoni Mr. and Mrs. Martin B. Travis
Mrs. Angus C. Littlejohn Mr. and Mrs. Robert J. Osterhus Mr. and Mrs. Randall Schiefer Mrs. Bronson Trevor
Mr. Candido Llovera and Mr. and Mrs. Michael Paloian Ms. Violet Schirone Mr. and Mrs. Robert C. Troxler
Dr. Irene Llovera Mr. and Mrs. Samuel D. Parkinson Mr. and Mrs. Harvey Schlackman Mr. Godfrey G. Truslow
Mr. and Mrs. Alan J. Long Mr. and Mrs. Joseph M. Parriott Mr. and Mrs. Steven M. Schlussel Mr. Mish Tworkowski
Mr. Bevis Longstreth Mr. and Mrs. William H. Peck Dr. and Mrs. Irving M. Schneider Mr. and Mrs. Cornelius M. Ulman
Mrs. Wladimir Z. Lotowycz Mr. and Mrs. Peter J. Pell Dr. and Mrs. Seymour H. Schpoont Mr. and Mrs. Stephen Van R. Ulman
Mr. and Mrs. James R. Lowell III Mr. and Mrs. Paul G. Pennoyer, Jr. Mr. and Mrs. Raymond G. Schuville Mr. Michael D. Unger
Mrs. Gwendolyn MacKay Mr. and Mrs. Thomas Pepitone Mr. and Mrs. Hermann C. Schwab Mr. and Mrs. F.S. Van Davelaar
Dr. Cynthia J. and Mr. Malcolm Mr. and Mrs. Robert A. Pilkington Ms. Ellen Schwabe Mr. and Mrs. Lawrence B. Van Ingen
MacKay Mr. and Mrs. Graham L. Platt Ms. Mary Schwartz Dr. and Mrs. Thornton A. Vandersall
Mrs. Lynette MacLeod Honorable and Mrs. Thomas C. Mr. and Mrs. Steven Schwartzreich Mr. and Mrs. Niklaus Vetsch
Dr. and Mrs. James N. Macri Platt Mr. David R. Schwarz Mr. and Mrs. Joseph C. Viviani
Mrs. Henry R. Macy Dr. and Mrs. Marc Pollner Mr. and Mrs. Michael Schwerin Mr. and Mrs. Alfred H. Von Klemperer
Mr. and Mrs. Herbert Malamed Mr. and Mrs. Everett Post Seminary of the Immaculate Mr. and Mrs. Eugene D. Wadsworth
Mr. and Mrs. Scott Marcus Dr. and Mrs. R. Scott Powers Conception Mr. Charles H. Wagner
Mrs. Lawrence M. Marks Dr. and Mrs. Richard M. Powers Mr. and Mrs. Frederick E. Seymour Mr. and Mrs. Colton P. Wagner
Mr. and Mrs. John Maroney Dr. and Mrs. Alan E. Prestia Mr. and Mrs. Daniel S. Shapiro Mrs. Mildred G. Wagner
Mr. and Mrs. Leonard L. Marshall, Jr. Mr. Millard B. Prisant Mr. and Mrs. Marvin J. Sharfin Mrs. Sherwood Waldron
Mr. and Mrs. Ronald C. Martello Mr. and Mrs. James T. Pyle Dr. and Mrs. Edward M. Shepard Dr. and Mrs. Peter Walker
Ms. Pamela J. Mathews Mr. and Mrs. William J. Quinlan Col. and Mrs. Robert E. Sheridan Mr. and Mrs. Robert P. Walton
Mr. and Mrs. Konrad H. Matthaei Mr. and Mrs. Walter S. Radgowski Paul W. Siegert, Esq. Mr. and Mrs. Charles W. Wardell, Jr.
Dr. and Mrs. Joseph E. May Mr. and Mrs. Robert W. Ralph Mr. William C. Simpson Dr. and Mrs. David E. Warden
Prof. and Mrs. Ernst Mayr Mr. William Rand Dr. Maxine F. Singer Mr. and Mrs. Bradford A. Warner
Mr. and Mrs. Edward McCann II Mr. and Mrs. Willard Rappleye, Jr. Mr. and Mrs. Rowland G. Skinner Mr. and Mrs. Jonathon D. Warner
Mr. and Mrs. Victor C. McCuaig, Jr. Mr. and Mrs. Roy L. Regozin Mr. Richard Slade Mr. Pierre R. Warny, Jr.
Mrs. Martha McDuffie Mr. Arthur G. Reid Mr. Alexander B. Slater Mr. and Mrs. Richard K. Webel
Mr. and Mrs. Victor K. McElheny Mr. Cornelius J. Reid, Jr. Mr. Herbert L. Smith IV Mrs. Bradford G. Weekes, Jr.
Ms. Leila McKnight Mr. and Mrs. Charles J. Reins Mrs. Peter B. Smith Mr. and Mrs. Townsend U. Weekes, Jr.
Mrs. Patricia McNulty Dr. and Mrs. Robert M. Reiss Mr. and Mrs. William S. Smoot Mr. and Mrs. Richard J. Weghorn
Mrs. Bayard H. Megear Dr. and Mrs. Michael Repice Mr. and Mrs. Sedgwick Snedeker Mrs. Anne Wehle
Mr. James Metcalfe & Ms. Dianne Mr. and Mrs. Bernard J. Reverdin Mr. and Mrs. James Sommermeyer Mr. and Mrs. Hugh J. Weidinger III
L. Parker Mr. and Mrs. Harold Van B. Richard Mr. and Mrs. John Specce Mr. and Mrs. Richard Weir III
Ms. Elizabeth Meyer Mr. and Mrs. Bernard Richards Mr. David Stacy Mr. and Mrs. W. Perry Welch
Mr. and Mrs. Richard Meyer Mr. and Mrs. John T. Ricks Mrs. Robert Staniford, Jr. Dr. and Mrs. Charles A. Werner
Mr. and Mrs. William A. Milanese, Jr. Mr. Robert J. Riedy Mr. Lawrence Starr Mr. and Mrs. Edward C. Whitcraft
Ms. Ellen L. Miller Mr. and Mrs. Donald B. Riefler Mr. and Mrs. Thomas Staudt Mr. and Mrs. William F. Whitman
Mr. and Mrs. John R. Miller III Mr. and Mrs. Luis Rinaldini Ms. Judith Steers Mrs. John C. Wilmerding
Ms. Mary Misiorek Mr. and Mrs. Joseph Rizza, Jr. Drs. Joan A. and Thomas A. Dr. and Mrs. Philip D. Wilson, Jr.
Mr. and Mrs. Jesse Mittleman Dr. and Mrs. Francis J. Roberts Steitz, Ph.D. Mrs. Scudder Winslow
Ms. Anne M. Moffit Mr. and Mrs. William D. Roche Mr. and Mrs. Nelson W. Sterner Mr. and Mrs. Neil W. Winter
Ms. Carolyn R. Moomaw Mr. and Mrs. Joseph M. Rogers Mr. and Mrs. John C. Stevenson Mr. and Mrs. Frederick C. Witsell, Jr.
Mr. and Mrs. James D. Mooney, Jr. Mr. and Mrs. Samuel B. Rogers Mr. and Mrs. William M. Stiger Mr. and Mrs. Simeon Wittenberg
Mr. and Mrs. Charles Morton Dr. and Mrs. James N. Romanelli Mr. Dudley W. Stoddard Mr. and Mrs. Steven Woghin
Mr. and Mrs. Brent M. Mowery, Jr. Mr. and Mrs. Garet M. Romeo Mr. and Mrs. Page Storment Mrs. Helen C. Woodbridge
Mr. and Mrs. Thomas F. Mullarkey Miss Elizabeth E. Roosevelt Mr. and Mrs. Joseph S. Stout Mr. and Mrs. James A Woods
Mr. and Mrs. Gardner M. Mundy Mrs. Quentin Roosevelt Mr. and Mrs. Stuart Tane Mr. and Mrs. Warren D. Wylie
Mrs. Alfred E. Munier Dr. and Mrs. Kenneth Ross Dr. Tokio Tani Dr. Keith R. Yamamoto
Dr. and Mrs. Stephen H. Munroe Mr. and Mrs. Francis J. Rue, Jr. Mr. and Mrs. Irwin Tantleff Mr. and Mrs. Mark Zambratto
Mr. and Mrs. Rem V. Myers Mr. and Mrs. Jay Russ Mr. and Mrs. David S. Taylor Ms. Joan C. Zulch
Benefactors, $10,000
* Patrons, $3,000 or more
+ Associates, $1,000 or more
++ Friends, $300 or more
+++ Family, $50 or more
OTHER CONTRIBUTORS TO THE CSHL ASSOICIATION
American Association of Dr. and Mrs. Lewis A. Goldfinger Rev. and Mrs. T. Carleton Lee Mr. and Mrs. David C. Noyes
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CSHLA CORPORATE MATCHING AND FOUNDATION CONTRIBUTIONS AND OTHER DIRECT GIFTS
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Undergraduate Research Program/Partners for the Future
The goal of the Laboratory's two student intern programs, the Undergraduate Research Program
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to produce future research scientists and to encourage awareness among young people in general.
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sustainable level of annual funding for Learning Center programs. As a means of reaching this ob-
jective, the Board conducts an Annual Fund and in June 1994 held the first annual Cold Spring
Harbor Laboratory Golf Tournament with the proceeds benefitting the DNA Learning Center.
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Mr. and Mrs. Robert E. Cooper
Mr. and Mrs. Victor D'Alessandro
Ms. Mary Feight
Mr. and Mrs. Irwin Frish
Mr. and Mrs. Allen Goldring
Ms. Kim Gronachan
IN MEMORY OF
Mr. and Mrs. George J.
Hossfeld, Jr.
Mr. and Mrs. Leonard Insalaco
Ms. Rosemary Kozsdiy
Laird Family
Ms. Thelma Landers
Dr. Monroe L. Levin
Mr. and Mrs. William E. Mahoney
Ms. Helen M. Meehan
Sherburn Becker Dave Kutzel
Armando Conti Daniel Mahoney
Joan Fryberg Norman Morett
Albert Goodlett Joseph Nussbaum
John Hadley Laura Powers
Alan Hahn Diamond Scarduzio
C. Arnold Hannor Muriel Siegler
David G. Hubby Catherine Stark
Andrew Hulko Kitty Turner
Esther Jacobs Lawrence Washer
Ronald E. Johnson
IN HONOR OF
Lester Maslow
The Elders'
Memorials and In Honor Totals $ 1,900
Miscellaneous 5,700
Total All Annual Funds $1,543,476
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Rui-Ming Xu
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James Dezazzo
James Edwards
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Dong-Jing Zou
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*Funding provided by Howard Hughes Medical Institute
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Bae Cong Ma
Judi Smith
On sabbatical at CSHL
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Uplands Postdoctoral Fellows Sridaran Natesan Graduate Students
Timothy Mulligan David Barford Manfred Neumann Celeste Casciato
Stanley Schwarz Stephen Bell Anthony Polverino Kurt Degenhardt
Michael Boyer Judith Scheppler Benhao Dong
Scientific Staff
Departures
During 1994
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Zhong Wang
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